Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,muscle contraction (GO:0006936),0.9026570608536717,2.6113006534627585,0.0,0.0,0.0,55/126,3.36%,MYH11;MYOM1;ACTA2;LMOD1;MYL1;TPM2;MYBPC1;MYLK2;DMD;MYLK;TRDN;RYR1;TPM1;MYOT;NEB;TTN;MYL9;MYH2;TCAP;TNNI2;SMTN;CACNA1S;SCN4A;TNNC2;ACTG2;EDNRA;MYOM2;CALD1;LMOD2;ACTA1;TNNT3;MYL2;VCL;MYOM3;ROCK1;HRC;LMOD3;SGCA;MYL6;CKMT2;GJC1;CACNA1H;SNTB1;KCNJ12;ITGA1;DTNA;DYSF;DES;MYL3;MYBPC2;VIM;SLC8A1;ASPH;SNTA1;SSPN
prerank,muscle filament sliding (GO:0030049),0.9468563155588576,2.3548514765592867,0.0,0.0,0.0,19/38,2.63%,MYL1;TPM2;MYBPC1;DMD;TPM1;NEB;TTN;MYH2;TCAP;TNNI2;TNNC2;ACTA1;TNNT3;MYL2;MYL6;DES;MYL3;MYBPC2;VIM
prerank,actin-myosin filament sliding (GO:0033275),0.9468563155588576,2.3548514765592867,0.0,0.0,0.0,19/38,2.63%,MYL1;TPM2;MYBPC1;DMD;TPM1;NEB;TTN;MYH2;TCAP;TNNI2;TNNC2;ACTA1;TNNT3;MYL2;MYL6;DES;MYL3;MYBPC2;VIM
prerank,myofibril assembly (GO:0030239),0.9077160454744552,2.2998705126864905,0.0,0.0,0.0,17/42,2.57%,LMOD1;TPM1;OBSCN;TTN;MYOZ2;TCAP;MYPN;MYOM2;LMOD2;TNNT3;MYL2;CSRP1;CASQ1;SYNPO2L;LMOD3;CSRP3;WDR1
prerank,sarcomere organization (GO:0045214),0.9437522975074131,2.2498097091394267,0.0,0.0,0.0,14/27,2.57%,TPM1;OBSCN;TTN;MYOZ2;TCAP;MYPN;MYOM2;LMOD2;TNNT3;CSRP1;CASQ1;SYNPO2L;CSRP3;WDR1
prerank,striated muscle contraction (GO:0006941),0.819711390731728,2.157947702165592,0.0,0.0,0.0,15/53,2.70%,MYLK2;DMD;TPM1;TTN;TCAP;RYR2;TNNI2;TNNC2;TNNT3;STAC;LMOD3;CSRP3;DTNA;MYL3;SLC8A1
prerank,actomyosin structure organization (GO:0031032),0.7728819488546919,2.1540206832194277,0.0,0.0001314529973202614,0.001,24/75,6.68%,LMOD1;TPM1;OBSCN;TTN;MYOZ2;TCAP;PDLIM1;MYPN;MYOM2;LMOD2;TNNT3;ROCK1;CSRP1;CASQ1;SYNPO2L;LMOD3;CSRP3;MYH9;WDR1;ITGB1;TNFAIP1;MYO18A;ITGB5;SORBS1
prerank,heart contraction (GO:0060047),0.8278840613875452,2.113010214968228,0.0,0.0004600854906209149,0.004,13/41,2.70%,MYLK2;DMD;TRDN;TPM1;TTN;TCAP;RYR2;TNNI2;SGCG;MYL2;CSRP3;MYL3;SLC8A1
prerank,smooth muscle contraction (GO:0006939),0.9478302446990942,2.0614183940420108,0.0,0.005929990768002903,0.05,7/14,2.70%,MYH11;ACTA2;MYLK;SMTN;EDNRA;ROCK1;SLC8A1
prerank,cardiac muscle cell differentiation (GO:0055007),0.9029235631718171,2.059970138773635,0.0,0.005429008789326796,0.051,8/21,2.70%,MYH11;MYOCD;TTN;TCAP;MEF2C;ALPK3;ALPK2;SLC8A1
prerank,skeletal muscle tissue development (GO:0007519),0.8551153789086674,2.052209143997769,0.0,0.006441196868692808,0.066,9/32,1.74%,MYLK2;RYR1;MYOZ2;MEF2C;KLHL40;ACTA1;LMOD3;CSRP3;MYL6
prerank,cardiac muscle contraction (GO:0060048),0.8319195908543715,2.046402812612679,0.0,0.006671239614003265,0.071,11/34,3.13%,MYLK2;DMD;TPM1;TTN;TCAP;RYR2;TNNI2;CSRP3;MYL3;SLC8A1;CAMK2D
prerank,mesonephric tubule development (GO:0072164),-0.7619496233351635,-2.022529020803801,0.0,0.09374693524470683,0.07,8/15,10.83%,BMP7;BMP4;SLIT2;PKD2;OSR1;SALL1;FGFR2;SIX1
prerank,cardiac muscle cell development (GO:0055013),0.9156231333519661,2.0204206845423522,0.0,0.01366099995228255,0.137,11/20,2.70%,MYH11;SORBS2;TTN;TCAP;PDLIM5;HEY2;MYL2;ALPK3;CSRP3;ALPK2;SLC8A1
prerank,regulation of heart contraction (GO:0008016),0.7202016130094968,2.0165022717285326,0.0,0.01406547071326797,0.152,23/90,3.47%,PLN;TRDN;RYR1;TPM1;ATP2A1;RYR2;ATP2B4;HSPB7;TNNI3K;TBX2;TMIGD3;CASQ1;HRC;ATP2A2;ITPR1;CACNA1H;KCNJ12;DES;SLC8A1;SLC8A2;ASPH;CAMK2D;STIM1
prerank,calcium ion transport into cytosol (GO:0060402),0.8792483546753627,2.01397457274341,0.0,0.014354667307372544,0.164,7/21,2.89%,JPH2;RYR2;CACNA1C;ATP2B4;CACNA2D1;SLC8A1;GRIN2C
prerank,muscle cell differentiation (GO:0042692),0.8228061046362656,2.0045705413290045,0.0,0.016275524230714863,0.189,12/32,5.05%,MYOCD;DMD;NEB;MEF2C;NRAP;HEY2;SPEG;SYNE1;FBXO40;RORA;MRTFA;TBX18
prerank,muscle organ development (GO:0007517),0.7590231068887291,1.9897357511717995,0.0,0.023166657645382536,0.258,19/54,6.13%,SOX6;TAGLN;DMD;NEB;SMTN;MEF2C;SGCG;SGCA;ITGA7;CACNA1H;SPEG;LARGE1;FHL3;FHL1;ITGB1BP2;ANKRD2;UTRN;MEF2A;CHD2
prerank,regulation of muscle contraction (GO:0006937),0.8331764988902058,1.9799916539575615,0.001447178002894356,0.027860732487599845,0.305,10/26,2.60%,MYLK2;TPM1;CNN1;MYL9;TNNC2;PPP1R12B;TNNT3;MYL2;PLCE1;MYL3
prerank,regulation of cation channel activity (GO:2001257),0.7047157171279514,1.9724767050610894,0.0,0.031624823723732355,0.341,15/89,5.77%,JPH2;KCNAB1;CACNB2;DMD;FGF13;MEF2C;STAC;HRC;FGF14;CAMK2D;ITGB1;SHISA9;CACNB4;JPH1;CNIH2
prerank,cellular response to alkaloid (GO:0071312),0.8879052552599506,1.9658914896590969,0.0,0.03427636905125816,0.376,5/17,2.70%,RYR1;RYR2;CACNA1S;HTR1B;SLC8A1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.826687578730149,1.9642085026598546,0.0030816640986132513,0.03365196731398692,0.382,7/24,5.26%,JPH2;DMD;TRDN;AKAP6;HRC;CAMK2D;JPH1
prerank,regulation of calcium ion transport (GO:0051924),0.7349472691802946,1.963763921140969,0.0,0.03266606983408495,0.386,12/54,4.40%,PLN;CACNB2;MYLK;TRPC6;CAMK2G;CACNA2D1;CASQ1;HRC;PACSIN3;CCL5;STIM1;BCL2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.8197328604110143,1.962584414458726,0.0030721966205837174,0.031885924871727755,0.391,8/27,5.26%,JPH2;PLN;CACNB2;DMD;HRC;CAMK2D;CACNB4;JPH1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.7815149759307404,1.9615145281368642,0.0,0.031592537022636154,0.401,4/32,1.46%,JPH2;TRDN;AKAP6;CASQ1
prerank,muscle cell development (GO:0055001),0.8129088144444473,1.9589095219866086,0.0015015015015015015,0.03220598434346404,0.424,12/30,2.70%,MYH11;DMD;NEB;TTN;TCAP;NRAP;HEY2;ALPK3;FER1L5;ALPK2;DYSF;SLC8A1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.8020118047124609,1.952188305995728,0.004347826086956522,0.035391191586224224,0.464,6/29,2.60%,MYLK2;TPM1;TTN;TCAP;MYL2;MYL3
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.7295551548300742,1.9448044726343594,0.0,0.0398059150403873,0.516,11/54,7.01%,KCNAB1;FLNA;KCNMA1;AKAP6;KCNJ12;KCNMB1;FHL1;KCNN2;KCNIP3;CAV1;NEDD4
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.7016735114788254,1.94473474575251,0.0,0.038450001716176456,0.516,10/76,4.06%,LMOD1;SYNPO2;NTF3;NTRK3;LMOD2;SYNPO2L;CDC42EP3;SEMA5A;WDR1;NUP62
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.6587286560305394,1.9435348774673193,0.0,0.03804431056927427,0.523,14/140,2.92%,JPH2;AGTR1;RYR2;CACNA1C;EDNRA;GPR20;CACNA2D1;PTGER3;ADCY5;CD36;S1PR3;PLCE1;SLC8A1;ADRA1D
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.8481082560524047,1.9360429874594458,0.0016501650165016502,0.04340139794857297,0.573,7/22,1.46%,JPH2;TRDN;ATP2A1;RYR2;AKAP6;STAC;CASQ1
prerank,skeletal muscle contraction (GO:0003009),0.8610454557455778,1.932842238565289,0.0015748031496062992,0.04440567057863798,0.586,5/19,1.38%,TCAP;TNNI2;TNNC2;TNNT3;STAC
prerank,muscle tissue morphogenesis (GO:0060415),0.873808911870343,1.9324264112661844,0.0016129032258064516,0.043305546804693604,0.588,5/16,1.08%,MYLK2;MYLK;TTN;TCAP;HEY2
prerank,actin filament organization (GO:0007015),0.6614610764081624,1.9322333544539128,0.0,0.04221632926061,0.59,24/151,4.28%,LMOD1;TPM2;FLNA;TPM1;NEB;TTN;TCAP;ACTN1;ENAH;PLS3;NRAP;XIRP1;DSTN;LMOD2;ACTA1;MYO1E;MYO1D;LMOD3;HIP1;FAT1;LCP1;RHOBTB3;MYO1B;ERMN
prerank,cardiac cell development (GO:0055006),0.9324812426573564,1.9309347819209537,0.0,0.04194897120367165,0.6,7/11,3.07%,MYH11;TTN;TCAP;ALPK3;ALPK2;SLC8A1;JAG1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.7209077886513221,1.926703986078361,0.002699055330634278,0.0444048224947843,0.631,7/48,3.13%,JPH2;DMD;TRDN;AKAP6;CASQ1;HRC;CAMK2D
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.8230342428702346,-1.9180639627580638,0.0,0.3017479478189001,0.365,3/10,0.85%,PRKCB;PID1;APPL2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.8119354698817653,1.9172443973925368,0.001524390243902439,0.05155513525457696,0.68,8/27,3.13%,PLN;CTNNA3;ATP2A1;FGF13;RYR2;CACNA1C;ATP2A2;CAMK2D
prerank,calcium ion import (GO:0070509),0.7980675007635839,1.9142943857463297,0.004424778761061947,0.053121222052231035,0.693,7/28,2.70%,CACNB2;ATP2A1;CACNA1S;CACNA1C;ATP2A2;CACNA1H;SLC8A1
prerank,regulation of blood circulation (GO:1903522),0.7857841929682458,1.909580639580967,0.0013869625520110957,0.05596092467499654,0.717,10/34,3.13%,PLN;TPM1;AGTR1;HSPB7;TBX2;TMIGD3;CACNA1H;KCNJ12;DES;CAMK2D
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.8605548246823045,1.9094391427309856,0.004885993485342019,0.054809158703199246,0.719,3/17,4.18%,KCNAB1;AKAP6;KCNE4
prerank,cytosolic calcium ion transport (GO:0060401),0.8024557396377622,1.902703907411082,0.0015105740181268882,0.06040922491852613,0.762,10/28,7.69%,JPH2;RYR2;CACNA1C;CACNA2D1;ATP2A2;SLC8A1;SLC8A2;JPH1;AFG3L2;ATP2B1
prerank,vasoconstriction (GO:0042310),0.9290474341271799,1.9000849033495297,0.0018656716417910447,0.0617861149111892,0.777,4/11,2.70%,ACTA2;EDNRA;EDNRB;SLC8A1
prerank,divalent inorganic cation homeostasis (GO:0072507),0.8012974663904404,1.8820094090799397,0.004694835680751174,0.08211430565938996,0.851,4/25,3.00%,JPH2;CNNM2;SLC8A1;FAM20A
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.6380791683475389,1.8803569741397121,0.0010893246187363835,0.08260139506031308,0.855,26/142,8.91%,PLN;RYR1;AGTR1;RYR2;CACNA1C;EDNRA;HCRTR1;TRPC6;ATP2B4;PTGER3;HRC;ADCY5;CD36;S1PR3;PLCE1;SLC8A1;SLC8A2;ADRA1D;CXCR6;CAV1;CALB1;C1QTNF1;ATP2B1;FZD9;TRPM4;TRPC5
prerank,positive regulation of heart rate (GO:0010460),0.8303851137512449,1.8724465370210142,0.003305785123966942,0.09228896682318623,0.887,5/17,2.92%,TPM1;RYR2;HRC;ATP2A2;ADRA1D
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.8015551023981877,1.8717211863367178,0.0078125,0.0913627543152999,0.89,9/21,3.13%,DMD;TRDN;RYR2;CACNA1C;AKAP6;CASQ1;HRC;SLC8A1;CAMK2D
prerank,cellular response to copper ion (GO:0071280),-0.7000249856341534,-1.8631872412291606,0.0,0.44686039133310257,0.634,11/16,18.55%,SNCA;MT2A;MT1E;MT1F;MT1M;MT1B;MT1G;MT1A;MT1X;MT1H;HSF1
prerank,striated muscle cell development (GO:0055002),0.8896023815526514,1.8622307440530617,0.0016806722689075631,0.1038993060123927,0.913,3/14,1.62%,LMOD1;LMOD2;LMOD3
prerank,cardiac muscle tissue development (GO:0048738),0.7037638990328843,1.8621831210472528,0.0076824583866837385,0.10174741679816572,0.913,8/50,1.67%,MYOCD;MYLK2;TTN;TCAP;HEY2;SGCG;TBX2;CSRP3
prerank,response to muscle stretch (GO:0035994),0.8562014583203831,1.8589621159601577,0.0,0.10432438499829243,0.926,6/15,2.70%,DMD;TTN;TCAP;RYR2;CSRP3;SLC8A1
prerank,extracellular matrix assembly (GO:0085029),0.8088328344448397,1.8540184937418043,0.001567398119122257,0.1100261587570588,0.94,6/23,6.94%,MYH11;NTN4;EMILIN1;HAS2;PXDN;LAMB2
prerank,positive regulation of cation channel activity (GO:2001259),0.7349294322863106,1.853243341490496,0.005434782608695652,0.10918748863415552,0.943,5/40,1.46%,JPH2;TRDN;AKAP6;STAC;CASQ1
prerank,protein kinase A signaling (GO:0010737),0.8929313431680019,1.8530243780872129,0.0018281535648994515,0.10738936628139942,0.943,3/12,3.09%,MYOM1;TTN;LCP1
prerank,negative regulation of cell development (GO:0010721),-0.5990135391220595,-1.8483618397058321,0.0,0.40486957658807765,0.709,5/25,4.29%,IGF1;FBN1;APPL2;B2M;PCM1
prerank,regulation of smooth muscle contraction (GO:0006940),0.801860307383377,1.8381357416168311,0.006259780907668232,0.13261079487358216,0.974,7/20,8.25%,MYOCD;CNN1;PLCE1;CAV1;ATP2B1;SETD3;DAPK3
prerank,cellular response to purine-containing compound (GO:0071415),0.8930783807205349,1.8377268959305804,0.005128205128205128,0.13076844963610307,0.974,4/10,2.70%,RYR1;RYR2;CACNA1S;SLC8A1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.8454163947694013,1.835335384873079,0.004830917874396135,0.13264094292567413,0.979,5/17,3.56%,TPM1;CNN1;MEF2C;PRKG1;TGFB3
prerank,ureteric bud development (GO:0001657),-0.6673762142275058,-1.8344845895614479,0.0025974025974025974,0.39373712802776867,0.772,8/17,10.83%,BMP7;BMP4;SLIT2;PKD2;OSR1;SALL1;FGFR2;SIX1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.8018339846431372,1.8330169221425943,0.004615384615384616,0.13461264936494113,0.982,6/23,1.62%,MYOCD;MEF2C;RBM24;AKAP6;SMYD1;LMOD3
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.9116883352864047,1.827385362257504,0.001718213058419244,0.14318517733109473,0.988,3/11,0.72%,MYOCD;SOX6;MEF2C
prerank,activation of adenylate cyclase activity (GO:0007190),0.7326322409076007,1.8266896409151283,0.005479452054794521,0.14204534147275194,0.988,8/35,4.30%,CAP2;LHCGR;EDNRA;TMIGD3;ADCY5;ADCY2;ADCY9;TSHR
prerank,regulation of cardiac conduction (GO:1903779),0.690203542619079,1.825625897371291,0.0025974025974025974,0.14162700602665196,0.989,13/54,3.47%,TRDN;RYR1;ATP2A1;RYR2;ATP2B4;TNNI3K;CASQ1;ATP2A2;ITPR1;SLC8A1;SLC8A2;ASPH;STIM1
prerank,skeletal muscle organ development (GO:0060538),0.7751164989781244,1.8254727862470903,0.004518072289156626,0.13953847066390934,0.989,6/26,6.29%,MYOZ2;MEF2C;CSRP3;MYL6;LARGE1;CAV1
prerank,embryonic skeletal system development (GO:0048706),-0.558547610726706,-1.823688274232045,0.0,0.3785032510505038,0.819,15/35,10.83%,PDGFRA;HOXB3;COL1A1;SULF1;PCSK5;HOXA3;KIAA1217;DSCAML1;WNT5A;RBP4;HOXB4;MEGF8;WNT9A;OSR1;SIX1
prerank,negative regulation of reproductive process (GO:2000242),-0.6554580554765994,-1.8152875505585164,0.002551020408163265,0.3604234849675961,0.841,6/17,15.33%,IGF1;SULF1;GJA1;ARHGDIB;CALR;DUSP1
prerank,modified amino acid transport (GO:0072337),-0.6827588506215837,-1.814004699467644,0.0,0.31917901859096276,0.843,5/15,7.62%,SLC6A13;SLC16A12;PDPN;SLC25A32;CTNS
prerank,heart development (GO:0007507),0.6222858732511494,1.8102344912798827,0.0,0.16912742635224828,0.997,21/150,2.26%,MYOCD;PDLIM3;LDB3;TCAP;CACNA1C;PDLIM1;MEF2C;NTRK3;PDLIM5;CRIP1;DLC1;SGCG;TBX2;MYL2;MICAL2;ALPK3;SYNPO2L;CSRP3;PLCE1;PDGFB;ALPK2
prerank,sensory perception of taste (GO:0050909),0.8703637553034906,1.8075319634535407,0.003795066413662239,0.17184570193945778,0.998,3/10,5.24%,ASIC3;CD36;PKD1L3
prerank,epithelial cell development (GO:0002064),0.8067491603088475,1.803074804376314,0.009615384615384616,0.17851317036091496,0.998,2/20,3.59%,ACTA2;TMEM79
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.8911437661960113,1.8020983050515051,0.003745318352059925,0.17766602882262883,0.998,3/10,6.29%,KCNAB1;KCNE4;CAV1
prerank,calcium ion homeostasis (GO:0055074),0.6377770351983353,1.8020723359662099,0.001160092807424594,0.17491875246543906,0.998,12/95,3.47%,JPH2;TRDN;ATP2A1;RYR2;ATP2B4;ATP2A2;CSRP3;SLC8A1;SLC8A2;FAM20A;CCL5;STIM1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.8481166467807089,1.7982330835868756,0.015463917525773196,0.18070742423926087,0.998,8/12,11.32%,TRDN;HRC;GJD3;CAMK2D;CAV1;CALM1;SRI;PDE4D
prerank,anion transport (GO:0006820),-0.5538454105990858,-1.794367217921321,0.0,0.3622277414594089,0.904,8/33,8.15%,SLC13A4;SLC13A3;ABCG2;SLCO2B1;LRRC8B;SLC26A7;SLC22A6;SLC4A2
prerank,blood circulation (GO:0008015),0.6896474777556751,1.793144963125275,0.005235602094240838,0.18945762824386703,0.998,8/49,1.44%,PLN;GUCY1A1;TRDN;AGTR1;ELN;SGCG;MYL2;ROCK1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.7109059034913733,1.7902057519944308,0.0041841004184100415,0.19316723658457216,0.999,7/41,4.13%,FLNA;KCNMA1;AKAP6;STAC;KCNJ12;KCNMB1;KCNN2
prerank,heart morphogenesis (GO:0003007),0.6822579432279658,1.7898438908775065,0.010362694300518135,0.1910843297958217,0.999,14/50,7.85%,MYLK2;TTN;TCAP;RYR2;DLC1;HEY2;TBX2;SYNPO2L;ALPK2;HEYL;BMPR1A;VEGFA;TGFB2;SOX9
prerank,actin nucleation (GO:0045010),0.7998136775929069,1.7864111425842744,0.006289308176100629,0.19684991092913987,0.999,7/21,8.84%,LMOD1;LMOD2;LMOD3;ACTR3;WHAMM;SPIRE1;WASHC1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.5954617907720461,-1.7830139337833597,0.006006006006006006,0.3785032510505038,0.936,13/24,23.38%,ITCH;NOD1;IRAK1;CASP8;IKBKG;TAB2;UBC;RNF34;IRAK2;TAB1;AAMP;UBB;CYLD
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.8360176993615102,1.7828192871573214,0.015202702702702704,0.20289770136382346,0.999,8/13,11.32%,TRDN;HRC;SLC8A1;CAMK2D;CAV1;CALM1;SRI;PDE4D
prerank,dendrite self-avoidance (GO:0070593),0.81038632979318,1.7787590699248095,0.013050570962479609,0.20957866109382575,0.999,4/16,1.62%,NEXN;PALLD;MYPN;ROBO3
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.7132410350487908,1.778399901609921,0.004201680672268907,0.20751133642254985,0.999,8/38,6.29%,CACNB2;CTNNA3;CACNA1C;CACNA2D1;CAMK2D;KCNA5;KCNE4;CAV1
prerank,calcium ion transport (GO:0006816),0.6216910233731953,1.7722995514888595,0.0,0.21958052730455718,1.0,17/113,3.47%,CACNB2;RYR1;ATP2A1;RYR2;CACNA1S;CACNA1C;TRPC6;ATP2B4;CACNA2D1;ATP2A2;ITPR1;CACNA1H;ANO6;SLC8A1;SLC8A2;CCL5;STIM1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.8437655692269841,1.7695724749820114,0.013986013986013986,0.22310415872217446,1.0,2/13,1.08%,RYR2;HEY2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.8334693644826874,1.768505034966196,0.010752688172043012,0.21981189690059758,1.0,3/12,1.61%,MYOZ2;ATP2B4;DYRK2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.8334693644826874,1.768505034966196,0.010752688172043012,0.21981189690059758,1.0,3/12,1.61%,MYOZ2;ATP2B4;DYRK2
prerank,platelet aggregation (GO:0070527),0.7282986674167998,1.767931815432726,0.005633802816901409,0.2185226826362091,1.0,11/33,7.53%,FLNA;MYL9;ACTN1;VCL;CSRP1;MYH9;ACTG1;ACTB;TLN1;ITGB3;PLEK
prerank,metal ion homeostasis (GO:0055065),0.6967088721110218,1.763507950060924,0.009446693657219974,0.22635026432162805,1.0,4/40,3.00%,JPH2;CNNM2;SLC8A1;FAM20A
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.7105667616831642,1.7541254437504032,0.012605042016806723,0.24735127794495562,1.0,11/35,7.85%,PDE3A;CAP2;AKAP6;CD36;IRAG1;ADCY2;GUCY1B1;NUDT4;KSR1;CAP1;SOX9
prerank,negative regulation of cation channel activity (GO:2001258),0.7325277113302069,1.751577188300183,0.01451378809869376,0.25116066932995745,1.0,2/26,0.29%,KCNAB1;TRDN
prerank,negative regulation of neurogenesis (GO:0050768),-0.5397636284566852,-1.7472173704472085,0.003424657534246575,0.5260481434526845,0.986,6/34,5.71%,PTN;NF1;APPL2;B2M;PCM1;RUFY3
prerank,chordate embryonic development (GO:0043009),-0.48466524517185955,-1.744808384166492,0.009615384615384616,0.4974446751422256,0.989,18/55,12.27%,ALDH1A2;CHD7;COL1A1;SULF1;BMP7;PCSK5;KIAA1217;PTCH1;WNT5A;RBP4;ARNT2;PKD2;ADAM10;FUT8;IGF2;TGFB1;FGFR2;TGFBR1
prerank,regulation of glucose import (GO:0046324),-0.5485588250378084,-1.7437853779605363,0.006557377049180328,0.4633261991901857,0.989,14/30,16.60%,IGF1;OSBPL8;PID1;PRKAG2;APPL2;PTPN11;OCLN;CREBL2;APPL1;RHOQ;INSR;ENPP1;AKT1;CAPN10
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.624421585860209,-1.743164770156197,0.005420054200542005,0.43207292833319344,0.989,9/19,12.18%,ROBO1;JCAD;DCN;SEMA6A;CCBE1;XDH;PIK3CB;CD63;SPRY2
prerank,regulation of amyloid-beta clearance (GO:1900221),0.7841172840361844,1.7428760823909073,0.016260162601626018,0.27234789017643984,1.0,2/16,1.44%,MYOCD;ROCK1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.7865957783473625,1.738890370410624,0.01507537688442211,0.27979930788150953,1.0,6/16,7.85%,SOX6;SOX5;RBM24;SP7;TGFB2;SOX9
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.696467940687037,1.7365156397413766,0.01084010840108401,0.28316876148046766,1.0,9/37,5.12%,TPM1;CNN1;MEF2C;PRKG1;HTR1B;PDGFB;IGFBP5;TGFB3;BMPR1A
prerank,smooth muscle cell differentiation (GO:0051145),0.8670147796802056,1.7335032466472848,0.00530035335689046,0.2887584174468409,1.0,6/12,5.05%,MYOCD;MEF2C;HEY2;EDNRB;MRTFA;TBX18
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.7554335804005577,1.7312408572458962,0.007451564828614009,0.2917375032174832,1.0,5/22,6.25%,CACNB2;DMD;STAC;CACNB4;STAC3
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.7211363088508322,1.7307403613440515,0.005563282336578581,0.2899715553794747,1.0,7/33,6.10%,TPM1;CNN1;MEF2C;PRKG1;IGFBP5;TGFB3;OGN
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.8503125861683356,1.7293266342457734,0.011363636363636364,0.29073172336063696,1.0,2/11,0.72%,MYOCD;MEF2C
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.7540464726852146,1.7272811132168664,0.014331210191082803,0.29312673996763877,1.0,9/20,7.15%,DMD;RYR2;CACNA1C;HRC;ATP2A2;SLC8A1;CAMK2D;ATP1B1;CALM1
prerank,zinc ion homeostasis (GO:0055069),-0.5617621274505284,-1.7249428247252496,0.003048780487804878,0.49631189967468536,0.994,15/28,17.69%,SLC39A10;SLC30A10;SLC39A8;PRKN;SLC30A1;SLC39A6;MT2A;MT1E;MT1F;MT1M;MT1B;MT1G;MT1A;MT1X;MT1H
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.6828180091823637,1.724620086650491,0.016,0.29765980393204805,1.0,8/41,2.89%,RYR1;RYR2;ATP2B4;CACNA2D1;ITPR1;SLC8A1;SLC8A2;GRIN2C
prerank,amino acid import (GO:0043090),-0.6023941143838372,-1.7239290103724247,0.0056022408963585435,0.47151778836361136,0.994,8/21,9.87%,SLC6A13;SLC1A3;SLC47A1;SLC6A1;SLC6A6;SLC7A5;SLC22A4;SFXN2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.7392696936414221,1.722891899757529,0.009077155824508321,0.29939296493005,1.0,10/25,8.71%,CTNNA3;FGF13;RYR2;CACNA1C;ATP2A2;CAMK2D;TBX18;CAV1;CALM1;TRPM4
prerank,cardiac myofibril assembly (GO:0055003),0.8176097811751051,1.7223140312144416,0.006666666666666667,0.29796349784893406,1.0,6/15,1.67%,NEB;TTN;TCAP;NRAP;MYL2;CSRP3
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.8533737708319221,1.7180784597218868,0.009057971014492754,0.3075371449046063,1.0,1/10,0.03%,MYOCD
prerank,positive regulation of potassium ion transport (GO:0043268),0.682377284662068,1.7157219766255822,0.01969057665260197,0.31153229586430375,1.0,7/38,4.13%,FLNA;KCNMA1;AKAP6;KCNJ12;KCNMB1;FHL1;KCNN2
prerank,cellular calcium ion homeostasis (GO:0006874),0.5925582555567127,1.7152454751669977,0.0011123470522803114,0.30968648045283537,1.0,24/133,7.78%,PLN;TRDN;RYR1;ATP2A1;RYR2;HCRTR1;TRPC6;ATP2B4;HRC;ATP2A2;CSRP3;SLC8A1;SLC8A2;CAMK2D;CCL5;STIM1;BCL2;ATP1B1;CAV1;AFG3L2;CALB1;RMDN3;ATP2B1;FZD9
prerank,cellular response to cadmium ion (GO:0071276),-0.5659999228579762,-1.714546568895768,0.006060606060606061,0.490999573344152,0.995,14/24,18.55%,EGFR;CHUK;MT2A;AKT1;MAPK9;MT1E;MT1F;MT1M;MT1B;MT1G;MT1A;MT1X;MT1H;HSF1
prerank,response to purine-containing compound (GO:0014074),0.7889383338346427,1.7142320467636412,0.01507537688442211,0.30930336783153,1.0,2/17,0.51%,RYR1;RYR2
prerank,cellular polysaccharide catabolic process (GO:0044247),0.7973267453787989,1.7135271848884321,0.012280701754385965,0.3081326722289698,1.0,9/16,12.44%,PYGM;PHKG1;AGL;PYGB;PHKA2;CALM1;STBD1;AOAH;PHKA1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.7166636174224388,1.713362250604671,0.022900763358778626,0.3052785809004466,1.0,5/26,1.61%,MYOZ2;ATP2B4;AKAP6;LMCD1;DYRK2
prerank,cGMP-mediated signaling (GO:0019934),0.8124985194894913,1.7110232029970738,0.01929824561403509,0.3092995131947665,1.0,4/13,3.91%,PDE3A;CD36;IRAG1;GUCY1B1
prerank,response to cadmium ion (GO:0046686),-0.5534417725494809,-1.7106753671719965,0.006289308176100629,0.48377324708570585,0.996,14/26,18.55%,EGFR;CHUK;MT2A;AKT1;MAPK9;MT1E;MT1F;MT1M;MT1B;MT1G;MT1A;MT1X;MT1H;HSF1
prerank,positive regulation of calcium ion transport (GO:0051928),0.691421332987716,1.7085500820734865,0.018439716312056736,0.31265365118194616,1.0,7/36,7.69%,CACNB2;MYLK;TRPC6;PDGFB;CCL5;CAV1;ATP2B1
prerank,calcium ion import into cytosol (GO:1902656),0.8027278447798813,1.7085154366652617,0.011705685618729096,0.3096927454467502,1.0,5/15,6.64%,ATP2B4;CACNA2D1;SLC8A1;SLC8A2;TRPV2
prerank,striated muscle cell differentiation (GO:0051146),0.7850331185248182,1.706700514943374,0.011164274322169059,0.3120199580749523,1.0,3/16,3.64%,MYOCD;MEF2C;SORT1
prerank,glucan catabolic process (GO:0009251),0.7952767209991887,1.7047909737986529,0.017391304347826087,0.3145000073338497,1.0,7/15,8.41%,PYGM;PHKG1;AGL;PYGB;PHKA2;CALM1;STBD1
prerank,peptidyl-arginine modification (GO:0018195),0.7881114416388834,1.7046788223382334,0.026490066225165563,0.3118218245559692,1.0,6/15,10.69%,ART1;PADI3;PADI2;ART4;PRMT7;KRTCAP2
prerank,homotypic cell-cell adhesion (GO:0034109),0.6840175678489068,1.7034279448718563,0.006858710562414266,0.3123449613442219,1.0,11/39,7.53%,FLNA;MYL9;ACTN1;VCL;CSRP1;MYH9;ACTG1;ACTB;TLN1;ITGB3;PLEK
prerank,striated muscle tissue development (GO:0014706),0.7070920410389812,1.7024603024432128,0.016224188790560472,0.3123498486992504,1.0,6/29,1.74%,MYOZ2;MEF2C;SGCG;TBX2;CSRP3;MYL6
prerank,negative regulation of cell junction assembly (GO:1901889),0.7118163701830025,1.7023278173565646,0.01906158357771261,0.30968093947944375,1.0,7/25,6.91%,SLIT1;DLC1;ROCK1;PHLDB2;CLASP2;ARHGAP6;CORO1C
prerank,hepaticobiliary system development (GO:0061008),-0.6045087107239091,-1.7005220524551565,0.010554089709762533,0.5106124190071893,0.996,6/20,6.44%,TGFBR3;COBL;NF1;WNT4;PKD2;LSR
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.5999700971680061,1.6945243546280615,0.008177570093457943,0.3295158083013382,1.0,7/86,2.57%,LMOD1;SYNPO2;LMOD2;SYNPO2L;CDC42EP3;SEMA5A;WDR1
prerank,renal system development (GO:0072001),0.6347679706206624,1.6913969256159236,0.010296010296010296,0.33564088550963556,1.0,8/52,7.78%,MYOCD;ITGA8;AGTR1;TBX18;CEP290;HAS2;VEGFA;TGFB2
prerank,cardiac ventricle morphogenesis (GO:0003208),0.6600791350390431,1.688225876792584,0.01859229747675963,0.3429367501925399,1.0,8/41,5.12%,TPM1;MEF2C;HEY2;MYL2;MYL3;HEYL;JAG1;BMPR1A
prerank,cellular response to organonitrogen compound (GO:0071417),0.5861801312862027,1.6873126260137368,0.012687427912341407,0.3424374480737777,1.0,26/99,12.92%,PDE3A;MEF2C;RAP1A;AKAP6;NR1H4;HTR1B;IGFBP5;P2RY2;TSHR;ACTB;LARS1;CPEB1;TAF1;SOX9;RELA;CAPN2;IMPACT;GABRB2;RRAGB;SH3BP4;GABRB3;ZFP36L1;TRPM2;HCN2;CPEB3;DMTN
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.8366992461107199,1.6864798103119871,0.023297491039426525,0.3417398966730918,1.0,3/10,2.97%,SOX6;SOX5;LOXL2
prerank,calcium ion import across plasma membrane (GO:0098703),0.8104710704632183,1.6862755532466926,0.015570934256055362,0.3392966177082597,1.0,5/14,6.64%,ATP2B4;CACNA2D1;SLC8A1;SLC8A2;TRPV2
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.5122563584941191,-1.6859351926045556,0.0032679738562091504,0.5608996319359865,0.999,9/36,13.44%,AFDN;SPTBN1;VAMP5;GOLGA4;OPTN;GCC2;GOLPH3;BLZF1;RILPL2
prerank,sulfur compound transport (GO:0072348),-0.5550503475322213,-1.6854010210533903,0.002857142857142857,0.5372592217476413,0.999,16/27,30.44%,SLC6A13;SLC13A4;ABCG2;SLC6A6;SLC26A7;SLC25A14;SLC35F3;SLC25A30;SLC25A11;LRRC8D;SLC36A1;SLC26A6;SLC5A6;SLC25A19;RACGAP1;SLC35B2
prerank,cellular zinc ion homeostasis (GO:0006882),-0.5554794085876441,-1.6850363794462315,0.002967359050445104,0.5148091642841428,0.999,14/26,17.69%,SLC39A10;SLC30A10;SLC39A8;SLC30A1;SLC39A6;MT2A;MT1E;MT1F;MT1M;MT1B;MT1G;MT1A;MT1X;MT1H
prerank,positive regulation of ATPase activity (GO:0032781),0.6743199499957753,1.6832242854635306,0.013966480446927373,0.34546313016109187,1.0,6/41,2.60%,TPM1;ATP2A1;RYR2;DYNLL1;TNNT3;MYL3
prerank,metal ion transport (GO:0030001),0.607544069763853,1.6820361684710854,0.008168028004667444,0.3461860808287793,1.0,20/86,12.46%,RYR1;ATP2A1;RYR2;CACNA1S;CACNA1C;CACNA2D1;ITPR1;SLC8A1;SLC8A2;CCL5;CAV1;RAMP1;TRPC5;SLC30A5;MRS2;ATP2A3;PANX1;CACNA1B;CHRNA7;TRPM2
prerank,positive regulation of reproductive process (GO:2000243),0.686571343891496,1.6819279741102404,0.014903129657228018,0.34353583398814536,1.0,7/31,11.53%,PDE3A;CACNA1H;TACR3;VEGFA;PLCB1;SIRT2;ACVR1B
prerank,regulation of histone modification (GO:0031056),0.7864166699913028,1.6817097265420233,0.026737967914438502,0.34134377149842393,1.0,1/13,0.03%,MYOCD
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.8341560185609962,1.6813261022655097,0.017921146953405017,0.33958241562444214,1.0,3/11,3.13%,CACNB2;CACNA2D1;CAMK2D
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.7482863886026371,1.6810388972342607,0.01564945226917058,0.33750779863667485,1.0,3/20,6.50%,MYOCD;NR2F2;HEXIM1
prerank,focal adhesion assembly (GO:0048041),0.745088036198305,1.6806453032795006,0.020602218700475437,0.3358933382702844,1.0,8/21,10.27%,ARHGEF7;ACTN1;DLC1;FERMT2;PEAK1;SORBS1;WHAMM;ACTN2
prerank,response to calcium ion (GO:0051592),0.5949336826179047,1.6800728542789236,0.005656108597285068,0.3346585177861431,1.0,20/102,9.70%,KCNMA1;RYR1;TTN;RYR2;MEF2C;PPP3CA;RASGRP2;KCNMB1;CAMK2D;STIM1;D2HGDH;SYT10;MEF2A;KCNH1;CAV1;NEDD4;CALM1;CARF;AHCYL1;CPNE2
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.7286255388122056,1.6790569454130966,0.021244309559939303,0.3350715173925311,1.0,3/22,6.50%,MYOCD;NR2F2;HEXIM1
prerank,regulation of cation transmembrane transport (GO:1904062),0.7110898433355335,1.6789400282981433,0.014265335235378032,0.332619182563645,1.0,6/29,5.21%,KCNAB1;ATP2B4;HRC;SNTA1;KCNN2;KCNIP3
prerank,nerve growth factor signaling pathway (GO:0038180),0.8379294804297152,1.67761469333433,0.02952029520295203,0.33382007743880426,1.0,2/10,0.72%,NTF3;RAP1A
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7702967709074299,1.6767467285521418,0.03327495621716287,0.3335768221676027,1.0,4/15,6.54%,NTF3;NTRK3;CDH13;VEGFA
prerank,regulation of striated muscle contraction (GO:0006942),0.6895467243145702,1.6753649001955608,0.020989505247376312,0.3349275144363261,1.0,6/27,2.60%,DMD;RYR2;TNNI3K;TNNT3;MYL2;MYL3
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5006885865435631,-1.6727032969900277,0.0036900369003690036,0.5602398369297805,1.0,10/37,11.09%,ALCAM;HMCN1;CADM1;CXADR;NLGN1;VCAM1;NECTIN1;TENM3;PTPRD;CADM3
prerank,response to metal ion (GO:0010038),0.6143153209156735,1.6716482849639118,0.01756587202007528,0.3430996259501778,1.0,17/67,9.62%,KCNMA1;TTN;CRIP1;PPP3CA;LOXL2;D2HGDH;FXN;BCL2;MAPT;CAV1;NDRG1;NEDD4;CALM1;PPP1CA;AHCYL1;HIF1A;SLC30A5
prerank,positive regulation of calcium ion import (GO:0090280),0.8172004807966053,1.66780222264151,0.01929824561403509,0.3519690230453985,1.0,2/12,2.11%,ATP2A1;PDGFB
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.8180509688163373,1.6675442231785294,0.017094017094017096,0.3498878267814148,1.0,3/12,0.63%,CTNNA3;RYR2;CACNA1C
prerank,circulatory system development (GO:0072359),0.5816860088992419,1.6673168545083683,0.002224694104560623,0.3477532998255944,1.0,21/118,7.85%,PDLIM3;LDB3;CACNA1C;PDLIM1;MEF2C;NTRK3;PDLIM5;CRIP1;HEY2;MYL2;MICAL2;ALPK3;PLCE1;PDGFB;HDAC9;PDLIM7;MEF2A;FBXW7;SMYD4;TGFB2;SOX9
prerank,ether lipid metabolic process (GO:0046485),-0.6352000455777133,-1.6660151891421935,0.024271844660194174,0.5728816620969506,1.0,7/14,15.93%,AGMO;GNPAT;PAFAH1B1;PLA2G6;PLAAT3;PLA2G7;LIPE
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7559796314364902,1.665355523241895,0.021885521885521887,0.3508045692409717,1.0,6/16,3.13%,DMD;RYR2;CACNA1C;HRC;SLC8A1;CAMK2D
prerank,cell-matrix adhesion (GO:0007160),0.5878389613743634,1.6630969716686483,0.012585812356979404,0.3545678686345426,1.0,20/95,8.48%,ITGA8;ARHGEF7;ACTN1;ITGB6;DLC1;VCL;BCAM;ITGA7;ITGA1;FERMT2;ITGA3;ITGB1;PEAK1;EMILIN1;ITGB5;SORBS1;ITGB3;SGCE;WHAMM;ITGA4
prerank,cellular response to zinc ion (GO:0071294),-0.6352041429923178,-1.6614832389789218,0.002457002457002457,0.5758874232082339,1.0,11/15,20.56%,GLRA2;MT2A;MT1E;MT1F;MT1M;MT1B;MT1G;MT1A;MT1X;MT1H;GLRA1
prerank,cAMP-mediated signaling (GO:0019933),0.7174220241089632,1.6604691800173712,0.031484257871064465,0.359612578858502,1.0,7/24,7.85%,PDE3A;CAP2;AKAP6;ADCY2;KSR1;CAP1;SOX9
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.7600615197264504,1.6602592393177538,0.03424657534246575,0.35751064123827303,1.0,4/15,3.09%,AGTR1;CD36;PLA2G3;LPL
prerank,positive regulation of ion transport (GO:0043270),0.6525081448457085,1.6579419709496641,0.01662049861495845,0.3615928608899331,1.0,15/48,11.06%,CACNB2;MYLK;TRPC6;PLA2G3;ANO6;CCL5;FHL1;GDNF;PRSS8;KIF5B;ATP2B1;CNKSR3;AHCYL1;ACTN2;GPD1L
prerank,action potential (GO:0001508),0.6402594500745002,1.6552447360857738,0.022788203753351208,0.3669096586685014,1.0,15/44,16.76%,DMD;SCN4A;AKAP6;CACNA1H;KCNE4;KCNB1;SLC4A3;SRI;GPER1;KCNA2;GNAQ;YWHAH;CHRNA4;CACNA1I;KCNH2
prerank,neurotransmitter uptake (GO:0001504),-0.661295357370761,-1.6550719980504645,0.01366742596810934,0.5901099149802628,1.0,3/12,1.13%,ATP1A2;SLC1A3;GLUL
prerank,lipid phosphorylation (GO:0046834),0.8127400074899391,1.654393554519609,0.025225225225225224,0.36670843391416125,1.0,2/10,0.44%,DGKB;DGKG
prerank,mesenchyme development (GO:0060485),-0.6313485492044713,-1.6534676291810575,0.01015228426395939,0.5772380734975003,1.0,8/15,21.83%,BMP7;BMP4;PKD2;BMPR2;FGFR2;TGFBR1;HMGA2;CRELD1
prerank,regulation of cell communication (GO:0010646),0.6629062458801271,1.6532052531853472,0.02029769959404601,0.36771913051845034,1.0,12/35,10.98%,TRDN;RYR2;IGFBP7;SLC8A1;ANXA1;CAMK2D;NUP62;TBX18;PTPN1;MGLL;SRI;CDC42SE2
prerank,positive regulation of cartilage development (GO:0061036),0.7514564948512361,1.6530650517668448,0.0256,0.36540123023226284,1.0,5/17,7.85%,SOX6;SOX5;LOXL2;TAPT1;SOX9
prerank,regulation of cardiac muscle contraction (GO:0055117),0.6535316506210176,1.6530108438900042,0.02676056338028169,0.36292470291094125,1.0,7/34,7.15%,PLN;RYR2;TNNI3K;ATP2A2;SLC8A1;ATP1B1;CALM1
prerank,glycerolipid metabolic process (GO:0046486),0.8284046279446645,1.652038193410357,0.014311270125223614,0.3633492298929345,1.0,2/11,0.44%,DGKB;DGKG
prerank,negative regulation of catalytic activity (GO:0043086),0.7147487301198673,1.6518201687027407,0.02034428794992175,0.3612943678263133,1.0,2/24,0.41%,PLN;PPP1R12A
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.7495504826827584,1.6503820199694013,0.03064516129032258,0.3627936095479231,1.0,3/18,1.94%,FLNA;POLR2L;RASL11A
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.8410134245713496,1.6503247857232624,0.01694915254237288,0.3604110255898943,1.0,5/10,9.40%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1
prerank,microtubule polymerization (GO:0046785),0.6811762423678808,1.6499649173719233,0.02674591381872214,0.3589305834468998,1.0,9/28,6.98%,FGF13;CLASP2;MAP7D3;TUBGCP6;TPPP;MAPT;PIN1;TPX2;HDGFL3
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.6043782995750856,-1.647581285899295,0.0076726342710997444,0.5910660564558011,1.0,9/18,17.13%,TSHZ3;NLGN1;PTK2B;SHANK3;CACNG4;NRXN1;NLGN2;NLGN3;CACNG8
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.6199998637254669,-1.6463812604112011,0.008241758241758242,0.5772305905045849,1.0,6/18,11.60%,PTN;SLIT2;CAMK1D;PTK2B;IL6R;LYN
prerank,supramolecular fiber organization (GO:0097435),0.5444126019806612,1.6460133212806527,0.0,0.36775109215837265,1.0,53/333,8.51%,MYH11;LMOD1;TPM2;TRDN;TPM1;TTR;FGF13;ACTN1;COL18A1;MFGE8;COL4A1;COL4A2;XIRP1;LMOD2;MYO1E;MYO1D;LMOD3;CD36;ADAMTS14;HIP1;FAT1;P3H2;DES;VIM;LOXL2;KIF2A;HOOK2;CRTAP;COL4A6;RHOBTB3;MYO1B;ERMN;DST;MAP7D3;ARHGEF2;EMILIN1;MYO5C;PXDN;TUBGCP6;TPPP;MAPT;CALB1;PIN1;CORO1C;HDGFL3;COL27A1;NAT8;TGFB2;ARHGAP17;WHAMM;COL4A5;TPM4;RHOF
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.7239257732337568,1.6454156704560292,0.0249609984399376,0.36700956561420706,1.0,8/21,9.68%,GUCY1A1;ADCY5;ADCY2;ADCY9;GUCY1B1;AMPD2;ADCY6;NPR2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5966739311236344,1.6443208002325096,0.012091898428053204,0.3679181604997944,1.0,7/76,2.92%,AGTR1;LHCGR;GPR20;PTGER3;ANO1;PLCE1;ADRA1D
prerank,carbohydrate biosynthetic process (GO:0016051),-0.5737619877672014,-1.6413126655279724,0.01744186046511628,0.5850199371499892,1.0,8/21,22.02%,ST3GAL4;B4GALT1;ST3GAL6;FUT8;ST3GAL3;MPDU1;ST6GALNAC5;B3GALT2
prerank,bicellular tight junction assembly (GO:0070830),-0.462059382437512,-1.6411747490367883,0.004081632653061225,0.5672067594140426,1.0,8/46,6.81%,AFDN;DLG1;CDH5;PECAM1;PARD6G;OCLN;CLDN5;CLDN11
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7223474944344593,1.639909975109207,0.023140495867768594,0.378140534318433,1.0,6/17,5.96%,RYR2;CACNA1C;GJD3;GJC1;SLC8A1;ATP1B1
prerank,B cell proliferation (GO:0042100),0.7548464920891322,1.6357920431608943,0.01584786053882726,0.3880589526731064,1.0,5/17,11.18%,MEF2C;CD79A;BCL2;RASGRP1;CD180
prerank,relaxation of muscle (GO:0090075),0.7556174530577983,1.6352251996192253,0.0392156862745098,0.38718954548693707,1.0,5/13,5.96%,PLN;ATP2A1;SLC8A1;CAMK2D;ATP1B1
prerank,filopodium assembly (GO:0046847),-0.6053074620393355,-1.6326771297577862,0.024875621890547265,0.5941944419064895,1.0,5/16,4.55%,DNM3;FGD6;FGD5;FGD4;SRGAP2
prerank,second-messenger-mediated signaling (GO:0019932),0.5944016899255649,1.6315221941746878,0.017899761336515514,0.39560648961085,1.0,12/82,5.63%,GUCY1A1;AGTR1;RYR2;RCAN2;CD36;PLCE1;EDNRB;GUCY1B1;INPP5A;NUDT4;CAMKK2;CXCR6
prerank,osteoclast differentiation (GO:0030316),-0.5581589053012481,-1.6302321564073863,0.014534883720930232,0.5890432431209078,1.0,5/22,2.94%,GAB2;FOXP1;MAPK14;ANXA2;SBNO2
prerank,negative regulation of viral life cycle (GO:1903901),-0.6229356806530505,-1.6301883643828041,0.020151133501259445,0.5720286339177939,1.0,10/15,30.00%,LY6E;TRIM5;BST2;MID2;IFITM1;SNX3;IFITM3;IFITM2;GSN;PPIA
prerank,vesicle transport along actin filament (GO:0030050),0.7173231472513889,1.6300488595744338,0.02702702702702703,0.39745332633191505,1.0,5/19,5.61%,ACTN4;MYO1E;MYO1D;MYO1B;MYO5C
prerank,metanephros development (GO:0001656),-0.5328698738669235,-1.6292673045747508,0.02064896755162242,0.5604727485701401,1.0,10/26,14.03%,NF1;FOXD1;BMP7;BMP4;PTCH1;PKD2;CTSH;OSR1;SIX1;SOX17
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6114442152419199,-1.6275765734701089,0.01488833746898263,0.5536602852698675,1.0,6/15,13.94%,ADGRV1;KIT;COL11A1;WHRN;PIEZO2;TMEM120A
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.8066894567680388,1.6274565096980413,0.029197080291970802,0.40310706005696,1.0,2/11,2.35%,AGTR1;PLA2G3
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.7357685941231598,1.6274022634782717,0.0297029702970297,0.4007523877395424,1.0,4/17,1.72%,PPP1R12A;VCL;ROCK1;S1PR3
prerank,regulation of receptor recycling (GO:0001919),-0.6100425512986623,-1.6267771912313618,0.024630541871921183,0.5431938129668806,1.0,9/16,24.60%,ANXA2;TBC1D16;LAMTOR1;ECE1;OPTN;SNCA;RAB29;INPP5F;SCRIB
prerank,mesoderm formation (GO:0001707),0.73241731089135,1.6238929275237068,0.03125,0.40903677921640846,1.0,4/17,7.40%,ITGA8;ITGA3;ITGB1;ITGB3
prerank,heterotypic cell-cell adhesion (GO:0034113),0.6874658799862134,1.621417534000328,0.03529411764705882,0.4141477239419959,1.0,9/25,9.52%,CTNNA3;ITGA7;ITGB1;JAM3;CD200R1;CD200;ITGB3;ITGA4;PARVA
prerank,neurotrophin signaling pathway (GO:0038179),0.7047519221461336,1.6200033780025767,0.03338391502276176,0.4160872514095619,1.0,3/21,3.64%,NTF3;RAP1A;SORT1
prerank,actin filament depolymerization (GO:0030042),0.7930999063168779,1.6188915829613202,0.028419182948490232,0.4169481079749767,1.0,5/11,12.52%,DSTN;MICAL2;WDR1;CFL2;MICAL3
prerank,regulation of actin filament bundle assembly (GO:0032231),0.6847173380142874,1.6181224044646156,0.035493827160493825,0.41662332666414664,1.0,6/26,8.64%,SYNPO2;ROCK1;SYNPO2L;ACTG1;PLEK;SYNPO
prerank,actin filament-based transport (GO:0099515),0.71441947495774,1.6170897604691157,0.03035143769968051,0.41717676755188177,1.0,7/21,8.13%,ACTN4;MYO1E;MYO1D;MYO1B;MYO5C;SYNE2;SUN2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.7112927100665977,1.6161493087327852,0.02247191011235955,0.41734612044870123,1.0,3/22,0.75%,NTF3;RAP1A;NTRK3
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.761874853303151,1.6159204865982193,0.042735042735042736,0.4154969585051842,1.0,1/14,0.09%,CCDC3
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.7686736427328095,1.6155588731581338,0.03793103448275862,0.41395274670245946,1.0,5/13,4.13%,CACNB2;CACNA1C;GJC1;KCNA5;KCNN2
prerank,endothelial tube morphogenesis (GO:0061154),-0.6891548222524798,-1.6153982660287036,0.006993006993006993,0.5850548866653218,1.0,4/10,7.18%,STARD13;BMP4;ACVRL1;CTNNB1
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.595777005555249,-1.6137332500007755,0.02710027100271003,0.5782863832434704,1.0,9/18,15.83%,PUM1;UFD1;BIRC2;SEC14L1;DDX60;RNF125;ANKRD17;BIRC3;NOP53
prerank,regulation of multicellular organism growth (GO:0040014),-0.6041872122912053,-1.6126499029325303,0.025252525252525252,0.5691903765216902,1.0,4/15,3.65%,IGF1;APP;GHR;PTCH1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.5417092180521306,-1.6104424316205936,0.031073446327683617,0.5667402374900279,1.0,11/23,17.44%,TGFBR3;SMAD3;DKK3;ENG;LTBP4;LATS2;SMURF2;TGFB1;TRIM33;SMAD2;SMAD4
prerank,sympathetic nervous system development (GO:0048485),-0.6166690568042443,-1.6095877546511863,0.014251781472684086,0.5579058682003446,1.0,6/15,11.99%,NF1;NRP2;NRP1;CTNNB1;SEMA3A;SOX4
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6824755672119569,1.6091980790889984,0.03924418604651163,0.4307746783891629,1.0,2/24,0.72%,MYOCD;MEF2C
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.5592835222623265,-1.6089615469547862,0.01466275659824047,0.5480652949727612,1.0,9/20,32.14%,WNT4;CRY1;SIK1;EP300;C1QTNF3;PGP;CLK2;NCOR1;CDA
prerank,myotube cell development (GO:0014904),0.8052038419981429,1.6086902094995603,0.045112781954887216,0.4298759984670543,1.0,4/10,1.62%,RYR1;KLHL40;ACTA1;LMOD3
prerank,cell-substrate junction assembly (GO:0007044),0.6551018193701513,1.6080945331499967,0.03526093088857546,0.42912672598094126,1.0,9/33,8.08%,ARHGEF7;ACTN1;DLC1;FERMT2;PEAK1;DST;SORBS1;LAMC1;WHAMM
prerank,regulation of epithelial cell migration (GO:0010632),-0.4460704327206698,-1.6074840889680386,0.02145922746781116,0.5428267142493224,1.0,18/51,13.52%,PTN;MCC;SASH1;DOCK5;GLUL;PTPRG;PTK2;RAB11A;BMPR2;CTSH;PLCG2;ENPP2;PRKCE;BMPER;RTN4;PPM1F;PFN1;PFN2
prerank,regulation of cartilage development (GO:0061035),0.7343271434786404,1.6064136068561652,0.047244094488188976,0.4318522205138302,1.0,4/18,7.85%,SOX6;SOX5;TAPT1;SOX9
prerank,regulation of microtubule depolymerization (GO:0031114),0.6888581915477775,1.6062899536701798,0.041604754829123326,0.4297034166152695,1.0,7/25,6.98%,FGF13;TRIM54;CLASP2;MAP1B;ARHGEF2;TPX2;HDGFL3
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.5743460741867529,-1.6058132337048872,0.014285714285714285,0.5379511634125427,1.0,8/20,22.02%,ST3GAL4;B4GALT1;ST3GAL6;FUT8;ST3GAL3;MPDU1;ST6GALNAC5;B3GALT2
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6889827598684827,1.6057065531787533,0.03308270676691729,0.4290338036030323,1.0,6/24,7.85%,SOX6;SOX5;CHADL;LOXL2;SNAI2;SOX9
prerank,connective tissue development (GO:0061448),0.6421803918368695,1.6043698270417246,0.037138927097661624,0.43062919368022057,1.0,6/35,7.85%,SOX6;SOX5;SNORC;ARID5B;DYRK1B;SOX9
prerank,lipid modification (GO:0030258),0.6382558746716198,1.603734026128496,0.03333333333333333,0.4301126697699383,1.0,6/37,9.62%,DGKB;DGKG;ALOX5;PLPPR1;LPCAT3;DGKD
prerank,regulation of sequestering of calcium ion (GO:0051282),0.7598665020154632,1.6033084717735584,0.042279411764705885,0.4290564691604346,1.0,3/12,1.46%,TRDN;RYR2;CASQ1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.6001609645863358,1.602426956884036,0.03553299492385787,0.42921455203636233,1.0,12/59,6.12%,NEXN;PALLD;MYOT;MYPN;IGFN1;ROBO3;CDH13;ITGB1;CDH4;KIRREL3;IGSF21;DSCAM
prerank,diacylglycerol metabolic process (GO:0046339),0.7065881876705015,1.601988752433462,0.04420731707317073,0.42800113807382184,1.0,3/23,1.86%,DGKB;DGKG;PLCE1
prerank,endodermal cell fate commitment (GO:0001711),-0.6936899659165565,-1.601818165589588,0.01702127659574468,0.5454645047444735,1.0,4/10,14.03%,CTR9;RTF1;LEO1;SOX17
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.7606187481929914,1.601336597283327,0.04672897196261682,0.42749040540538286,1.0,4/14,6.57%,FLNA;LIMS1;SLC2A10;LIMS2
prerank,detection of mechanical stimulus (GO:0050982),0.6984060600091706,1.6008609843022443,0.04065040650406504,0.42659335820139693,1.0,4/19,5.24%,TTN;TCAP;CSRP3;PKD1L3
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.6148254373600353,-1.5996609926313494,0.02689486552567237,0.5436823590282119,1.0,4/14,8.32%,IL18;LGALS9;CD55;PTPN22
prerank,spinal cord development (GO:0021510),-0.6464433620583414,-1.5990319923867946,0.02336448598130841,0.5351875818839748,1.0,9/12,28.80%,NF1;VIT;GLI2;PKD2;SOX4;LOXL3;SOX11;RELN;SOX12
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.65968905136435,-1.5983215376410327,0.021739130434782608,0.5277091513034952,1.0,6/11,22.96%,CRY1;SIK1;EP300;C1QTNF3;PGP;CLK2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.6117748215646253,1.598117451780874,0.02454780361757106,0.4322984064698552,1.0,6/51,3.83%,SYNPO2;TPM1;SYNPO2L;FERMT2;TGFB3;PPM1E
prerank,atrioventricular valve development (GO:0003171),0.7432789582323803,1.5966219863301805,0.035211267605633804,0.43458434764076903,1.0,4/14,7.78%,SLIT3;HEYL;BMPR1A;TGFB2
prerank,negative regulation of ATPase activity (GO:0032780),0.7317205635522762,1.5950259757424228,0.03789126853377265,0.43723029407007036,1.0,2/16,6.56%,PLN;TP53
prerank,regulation of metal ion transport (GO:0010959),0.734336877901302,1.5938191004502504,0.031413612565445025,0.43864550675798025,1.0,5/16,4.40%,PLN;CAMK2G;CACNA2D1;STIM1;BCL2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.6684807054018458,1.5936559132454409,0.024464831804281346,0.43666942686621946,1.0,7/30,4.18%,RYR2;CACNA1C;CACNA2D1;GJC1;SNTA1;KCNA5;KCNE4
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.6964708560302488,1.5936113171554707,0.04118616144975288,0.43444710025895156,1.0,5/21,4.18%,FLNA;CACNA2D1;SNTA1;KCNA5;KCNE4
prerank,mitochondrion localization (GO:0051646),0.7119735482210844,1.5933576612721903,0.0380794701986755,0.4328876499786358,1.0,9/19,13.77%,ATP2A1;MARK1;MEF2A;TRAK1;ATCAY;MFN2;NECTIN2;MUL1;LRRK2
prerank,morphogenesis of an epithelium (GO:0002009),0.6765157010845854,1.5923149720688838,0.02857142857142857,0.4337555981413592,1.0,8/25,10.02%,VCL;LAMA5;ACTG1;ACTB;TBX18;SOX9;LIN7C;ARHGAP12
prerank,aorta morphogenesis (GO:0035909),0.7167414014916926,1.591448029748844,0.048,0.434201329613442,1.0,5/17,5.12%,MYLK;HEY2;TBX2;JAG1;BMPR1A
prerank,regulation of muscle cell differentiation (GO:0051147),0.6501215422167705,1.5886916740139376,0.03151862464183381,0.440667904054387,1.0,4/31,5.34%,MYOCD;MEF2C;HDAC9;MEF2A
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.6318153231940181,-1.5884980165732299,0.02040816326530612,0.5638409420292891,1.0,4/14,6.41%,KIT;WNT5A;SEMA7A;PLCG2
prerank,cardiocyte differentiation (GO:0035051),0.7827297905071862,1.5884610897464435,0.04332129963898917,0.4390248927614762,1.0,1/10,0.03%,MYOCD
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.6743535509023594,1.5883205830287108,0.04294478527607362,0.43719379019927634,1.0,5/23,3.13%,TRDN;CACNA2D1;CASQ1;HRC;CAMK2D
prerank,negative regulation of macroautophagy (GO:0016242),-0.5272142154838229,-1.588244637598354,0.027190332326283987,0.5540260055442086,1.0,13/26,24.98%,PIK3CA;NUPR1;SMG1;NRBP2;AKT1;SCFD1;QSOX1;FEZ1;LZTS1;SMCR8;PHF23;CHMP4B;CHMP4A
prerank,histone lysine demethylation (GO:0070076),-0.5271705773724645,-1.5880065020901153,0.014492753623188406,0.544318142764579,1.0,9/25,21.00%,KDM7A;KDM5C;KDM5B;KDM2A;KDM3B;RIOX2;KDM1A;KDM4D;KDM6A
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5537537406726446,-1.5876315114167827,0.030612244897959183,0.5360157903626008,1.0,12/20,31.38%,SULF1;SPRY2;DSTYK;CREB3L1;FGF2;GPC1;SULF2;PRKD2;SPRY1;SPRY4;FGFBP3;SMOC2
prerank,heart process (GO:0003015),0.7475585279686989,1.5870783414206797,0.03333333333333333,0.43884365997986674,1.0,3/14,1.37%,TRDN;SGCG;MYL2
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.5603960926514774,-1.5867431308508724,0.02710027100271003,0.5301258984011442,1.0,8/20,15.61%,NUPR1;CASP8;BIRC2;PELI1;SDCBP;OGT;STUB1;BIRC3
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.6995010513484089,1.5858189181698792,0.04361370716510903,0.4404616336946417,1.0,6/21,6.98%,FGF13;TRIM54;CLASP2;ARHGEF2;TPX2;HDGFL3
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.7125185629561559,1.5849495432174525,0.052969502407704656,0.4409738765759602,1.0,1/18,0.10%,SOX6
prerank,response to cholesterol (GO:0070723),-0.5854183371646474,-1.584375855163367,0.012755102040816327,0.5316942656890133,1.0,10/17,26.67%,PTCH1;GRAMD1C;TGFB1;TGFBR1;GRAMD1A;SMAD2;PMVK;ABCA2;SMO;OSBPL7
prerank,positive regulation of actin filament polymerization (GO:0030838),0.6318835681563535,1.583255057183281,0.03825136612021858,0.44376204081826026,1.0,4/44,1.71%,LMOD1;LMOD2;LMOD3;CDC42EP3
prerank,cell differentiation in spinal cord (GO:0021515),0.7714650397428623,1.5829840143380296,0.04838709677419355,0.44234955253687547,1.0,1/10,0.10%,SOX6
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.6159805625294719,1.581695880237771,0.0326530612244898,0.4439967278973464,1.0,8/44,5.96%,FLNA;KCNMA1;AKAP6;KCNJ12;KCNMB1;ANO6;KCNN2;ATP1B1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.7789917450619047,1.581409876766332,0.0525328330206379,0.4425880855006856,1.0,1/10,0.08%,PDE3A
prerank,embryonic hemopoiesis (GO:0035162),-0.6378606706838832,-1.5813812057049719,0.02968036529680365,0.5352782597231251,1.0,8/12,28.02%,KIT;FLT3LG;THOC5;KDR;ATF4;TAL1;ZFPM1;KMT2A
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.7898634126887722,1.5812362774182274,0.03949730700179533,0.44089804776206104,1.0,5/10,10.27%,SEMA5A;WDR1;PLEK;CFL2;ACTN2
prerank,protein autoubiquitination (GO:0051865),-0.42760392934288893,-1.580400968586206,0.009009009009009009,0.5300813549012107,1.0,20/61,14.99%,RNF220;SH3RF1;RNF146;ITCH;CUL3;RNF185;UBE2D3;RNF13;RNF213;MDM2;PRKN;UBE3A;RNF181;SH3RF3;STUB1;DTX3L;SH3RF2;RNF115;RNF10;OBI1
prerank,platelet degranulation (GO:0002576),0.5484294440443346,1.5793303556400513,0.01580135440180587,0.44456869874433946,1.0,22/118,7.78%,FLNA;TTN;STXBP2;ACTN1;ACTN4;VCL;ITIH4;CD36;PDGFB;ENDOD1;WDR1;LGALS3BP;TGFB3;TAGLN2;RARRES2;VEGFA;PCDH7;TLN1;CALM1;ITGB3;PLEK;TGFB2
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.5040241103717217,-1.577714449660121,0.01592356687898089,0.5332463064468851,1.0,13/28,23.38%,ITCH;NOD1;IRAK1;CASP8;IKBKG;TAB2;UBC;IRAK2;IRGM;TAB1;AAMP;UBB;CYLD
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.639548488095682,1.577100687403235,0.05923836389280677,0.44907597014332956,1.0,4/34,2.37%,FLNA;ARHGEF7;LIMS1;FERMT2
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.5757764468201586,1.5763357928610848,0.0392156862745098,0.44908505461903386,1.0,11/67,6.57%,FLNA;ARHGEF7;CD36;LIMS1;PDGFB;CDK6;FERMT2;CDH13;RSU1;UTRN;LIMS2
prerank,positive regulation of glucose import (GO:0046326),-0.5367351267333748,-1.5759522864119841,0.02023121387283237,0.5317556562090119,1.0,10/21,16.60%,IGF1;OSBPL8;PTPN11;OCLN;CREBL2;APPL1;RHOQ;INSR;AKT1;CAPN10
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.6373750091962742,-1.575549933650419,0.020737327188940093,0.5246898781977185,1.0,4/12,17.54%,NUPR1;IL18;IL33;TTBK1
prerank,superoxide anion generation (GO:0042554),0.7512288010506936,1.5735762670904376,0.05245346869712352,0.455622661361892,1.0,1/13,0.36%,NCF2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.775964240822971,1.5734549808944813,0.05172413793103448,0.45369007340303014,1.0,5/12,3.41%,TPM1;MEF2C;PRKG1;PDGFB;IGFBP5
prerank,epiboly involved in wound healing (GO:0090505),0.7210100332714743,1.5730823561090879,0.05785123966942149,0.45250546828038807,1.0,4/16,3.34%,FLNA;CCN1;LCP1;MRTFA
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5843744609867372,1.571653460525586,0.03409090909090909,0.45468231914485446,1.0,6/57,3.84%,FLNA;ADCY5;HTR1B;NPY1R;ADCY2;ADCY9
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.6313166932776922,-1.5716338826353682,0.02027027027027027,0.5329359585161183,1.0,8/12,27.72%,LY6E;TRIM5;MID2;IFITM1;SNX3;IFITM3;IFITM2;GSN
prerank,ganglioside biosynthetic process (GO:0001574),-0.6072689660422911,-1.56929103351064,0.03694581280788178,0.534641039771577,1.0,6/15,10.81%,ST8SIA4;ST3GAL1;ST3GAL5;ST6GALNAC3;B4GALT6;ST8SIA2
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.729703077176128,1.5663260204152498,0.051194539249146756,0.46941800905321557,1.0,5/14,8.12%,DMD;ACTN4;TESC;ATP1B1;WNK2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.7005366389887727,1.5647598771282967,0.0449438202247191,0.472272145323703,1.0,5/19,7.78%,SLIT3;HEY2;HEYL;BMPR1A;TGFB2
prerank,embryonic heart tube morphogenesis (GO:0003143),0.6110429179890793,1.5640322673242573,0.04353741496598639,0.4723737933849744,1.0,4/43,1.54%,RYR2;MEF2C;TBX2;MICAL2
prerank,heart trabecula morphogenesis (GO:0061384),-0.5753243152714403,-1.5612740726080825,0.04120879120879121,0.5607331567235976,1.0,8/18,12.27%,TGFBR3;BMP7;TEK;ADGRG6;ENG;RBP4;FKBP1A;TGFBR1
prerank,actin filament network formation (GO:0051639),0.7504637658367983,1.5601238500432026,0.07664233576642336,0.48237852188143554,1.0,3/11,3.09%,ACTN1;PLS3;LCP1
prerank,ceramide biosynthetic process (GO:0046513),-0.4614005169776262,-1.5590997752547806,0.030303030303030304,0.5620238627609914,1.0,12/40,10.81%,SGMS1;SGMS2;ST8SIA4;CERS5;ST3GAL5;SPTLC2;ST6GALNAC3;B4GALT6;SPTSSA;CERS6;ASAH2;ST8SIA2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.747331406144561,1.5576778864794691,0.04882154882154882,0.48796047789401475,1.0,5/14,5.12%,TPM1;MEF2C;PRKG1;IGFBP5;BMPR1A
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5961942445181369,-1.5542588665783852,0.03170731707317073,0.5742540631441628,1.0,6/15,13.69%,GRM3;GRM7;HOMER3;DAGLA;GRIK3;GRM5
prerank,cGMP biosynthetic process (GO:0006182),0.7824276121090872,1.5542109726527475,0.06140350877192982,0.49658413863285156,1.0,3/10,9.68%,GUCY1A1;GUCY1B1;NPR2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.5515433197709793,-1.5541378175721137,0.03672316384180791,0.5660858970467779,1.0,9/20,18.33%,DAB2;PID1;BCL2L1;TGFB1;RHOQ;TMEM59;PKDCC;NUMB;TMBIM1
prerank,epithelial cell-cell adhesion (GO:0090136),0.7455677153109215,1.5539451930774941,0.06533575317604355,0.4951220961733419,1.0,3/11,5.97%,SERPINB8;VCL;ITGB5
prerank,regulation of DNA binding (GO:0051101),-0.4432384688478727,-1.5529904601389957,0.015503875968992248,0.5626040421672546,1.0,22/44,27.54%,IGF1;LEF1;HMGB1;HJURP;NFKBIA;ILRUN;PRKN;TGFB1;HES1;SP100;PPARG;KDM1A;SUMO3;HMGA2;MDFI;BCL3;NME1;SMO;TFAP4;MAPK8;HMGB2;EGF
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.5631386110738525,-1.5522946904548913,0.03081232492997199,0.5575702371033988,1.0,3/19,0.49%,AFDN;BMP6;TJP1
prerank,positive regulation of phospholipase activity (GO:0010518),0.6558138421964649,1.55188429339054,0.05421686746987952,0.4994784028178696,1.0,4/22,3.45%,NTF3;AGTR1;NTRK3;CCL5
prerank,Notch signaling pathway (GO:0007219),0.5777883671605918,1.5513988052432421,0.039540816326530615,0.4987456931205421,1.0,12/59,8.74%,SUSD5;SORBS2;NOTCH3;HEY2;PLXND1;HEYL;JAG1;MAML2;SNAI2;NLE1;MAML3;ADAM17
prerank,positive regulation of protein transport (GO:0051222),0.5697453639286775,1.550553180494317,0.04130162703379224,0.4992726782774624,1.0,9/67,8.17%,MYOM1;TTN;OAZ2;TGFB3;CEP290;MYO18A;CNST;TGFB2;FRMD4A
prerank,cartilage development (GO:0051216),0.5931577319757529,1.5492280658555255,0.05167958656330749,0.501187894404516,1.0,8/49,8.82%,SOX6;SOX5;MEF2C;SNORC;OSR2;SOX9;RUNX1;SLC39A14
prerank,branched-chain amino acid metabolic process (GO:0009081),0.6723170248849233,1.5492119023738697,0.06475903614457831,0.4965941263118523,1.0,5/20,6.02%,BCAT2;MCCC2;HSD17B10;HIBADH;DLD
prerank,branched-chain amino acid catabolic process (GO:0009083),0.6723170248849233,1.5492119023738697,0.06475903614457831,0.4965941263118523,1.0,5/20,6.02%,BCAT2;MCCC2;HSD17B10;HIBADH;DLD
prerank,detection of calcium ion (GO:0005513),0.7391243249441366,1.5486349928468468,0.04208754208754209,0.4961884202720344,1.0,4/13,7.15%,RYR2;KCNMB1;STIM1;CALM1
prerank,regulation of actin filament-based movement (GO:1903115),0.7656582608665028,1.5477593169027584,0.07224334600760456,0.4968501201925494,1.0,2/10,0.23%,PLN;MYLK2
prerank,N-glycan processing (GO:0006491),-0.5625381850038369,-1.5474608099408882,0.0446927374301676,0.5708712828470245,1.0,9/18,12.38%,MAN1C1;ST8SIA4;ST8SIA1;FUT8;MGAT4B;GANAB;MAN2A1;ST8SIA2;GNPTAB
prerank,neuron remodeling (GO:0016322),-0.6653194919595136,-1.5469833736697132,0.042826552462526764,0.564892246945962,1.0,6/10,13.37%,APP;ADGRB3;ANKS1A;SCARF1;EPHA8;CX3CL1
prerank,UV protection (GO:0009650),-0.6725255527328424,-1.5467842476868354,0.03361344537815126,0.5579097979008495,1.0,7/10,22.71%,SCARA3;ERCC5;CAT;GPX1;XPA;MFAP4;ERCC2
prerank,artery development (GO:0060840),-0.5357298028987109,-1.5452245689415192,0.0443213296398892,0.5568828361689043,1.0,9/23,12.27%,ROBO1;NF1;ENG;NRP1;ACVRL1;PKD2;BMPR2;HES1;TGFBR1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.494284928806989,-1.5450247050025037,0.029900332225913623,0.5501532473812658,1.0,12/29,14.06%,TJP1;PIK3CA;PLEKHH2;SLIT2;KANK3;SHANK3;CYRIB;PRKN;SSH2;PFN1;PFN2;SSH1
prerank,calcium-mediated signaling (GO:0019722),0.5456468862590356,1.5448614090069128,0.030732860520094562,0.5041066384312831,1.0,24/93,15.00%,AGTR1;RYR2;CACNA1C;RCAN2;ATP2A2;PLCE1;PPP3CA;EDNRB;SLC8A1;NUDT4;CAMKK2;CXCR6;ATP1B1;RCAN3;TRPM4;SAMD14;HTR2B;DMPK;TRPM2;DMTN;PPP3CB;LRRK2;PPP1R9A;PRKACA
prerank,glycogen catabolic process (GO:0005980),0.7270496237978383,1.544046553147814,0.05344827586206897,0.5043833581769704,1.0,7/15,8.41%,PYGM;PHKG1;AGL;PYGB;PHKA2;CALM1;STBD1
prerank,negative regulation of vascular permeability (GO:0043116),0.7592043992455169,1.542886132652253,0.06525573192239859,0.5059441475774648,1.0,3/12,2.37%,PDE3A;ANGPT1;FERMT2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.651592778592216,1.5427488139305838,0.04983922829581994,0.5041625096052645,1.0,3/25,1.46%,CACNB2;AKAP6;CASQ1
prerank,regulation of protein secretion (GO:0050708),0.53781065767816,1.5420812024698902,0.03192702394526796,0.5040226233933947,1.0,15/119,8.20%,MYOM1;TTN;CACNA1C;RAP1A;ITPR1;KCNA5;CCL5;TGFB3;ALOX5;KCNB1;MYO18A;ENSA;TGFB2;FRMD4A;DPH3
prerank,protein localization to cilium (GO:0061512),-0.4793731664722087,-1.5410181250777748,0.02258064516129032,0.5597895542061463,1.0,18/32,36.36%,BBS9;ZNF423;RABEP1;IFT122;TULP3;RAB29;EHD1;TCTN2;BBS1;TCTN1;BBS4;ARL6;TULP1;CSNK1D;ATP6V1D;TMEM107;IFT20;INVS
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5936701007017999,1.5403198825799342,0.049136786188579015,0.507535914747363,1.0,8/47,6.91%,FLNA;ARHGEF7;ACTN4;LIMS1;FERMT2;KANK1;LIMS2;CORO1C
prerank,tight junction assembly (GO:0120192),-0.4357585208684872,-1.5369957587331096,0.008928571428571428,0.570590721366908,1.0,9/49,6.81%,AFDN;DLG1;CDH5;PECAM1;PARD6G;OCLN;CLDN5;LSR;CLDN11
prerank,negative regulation of complement activation (GO:0045916),-0.6535032381296713,-1.5348088803967106,0.04398148148148148,0.5727660203182771,1.0,6/10,32.25%,CD55;CD46;SERPING1;CR1L;A2M;CR2
prerank,negative regulation of biomineral tissue development (GO:0070168),0.670927123081827,1.534014732690972,0.05198776758409786,0.5259124777945525,1.0,6/21,10.78%,ASPN;HEY2;ROCK1;SOX9;TRPM4;ROCK2
prerank,cation transport (GO:0006812),0.5182502308930311,1.533801750844655,0.013963480128893663,0.5243468118463122,1.0,27/167,11.36%,KCNAB1;KCNMA1;FGF13;SCN4A;TRPC6;ANO1;KCNJ12;SLC6A17;KCNMB1;ANO6;SLC8A1;SLC8A2;KCNA5;KCNQ4;KCNN2;PKD1L3;KCNH1;ATP1B1;SLC25A29;SLC23A1;ANO10;TRPM4;ABCC8;SLC7A8;PANX1;KCNK3;KCNA2
prerank,chondrocyte differentiation (GO:0002062),0.6245402916671337,1.5337224127419375,0.05106382978723404,0.5223044526961609,1.0,7/32,8.82%,SOX6;SOX5;MEF2C;OSR2;SOX9;RUNX1;SLC39A14
prerank,regulation of adenylate cyclase activity (GO:0045761),0.6672906184574652,1.529791182631943,0.05692307692307692,0.5331745102274479,1.0,4/22,3.47%,CAP2;CACNA1C;EDNRB;STIM1
prerank,primary alcohol metabolic process (GO:0034308),-0.5007974774923378,-1.5297774435224005,0.023952095808383235,0.5876837096444154,1.0,11/25,23.18%,IGF1;GPD2;RBP4;ALDH3A2;NAAA;NAPEPLD;CYP1B1;GDPD1;GDE1;PECR;ADH1A
prerank,negative regulation of lipid metabolic process (GO:0045833),0.6497230879450555,1.5296868693652543,0.07142857142857142,0.5311556397266977,1.0,1/22,0.09%,CCDC3
prerank,protein autoprocessing (GO:0016540),0.6877597933818865,1.528084966982361,0.08090614886731391,0.5343112828599569,1.0,3/17,6.30%,HJV;FXN;AFG3L2
prerank,positive regulation of secretion by cell (GO:1903532),0.5557684090486003,1.5252250752283836,0.03841387856257745,0.5419249400131807,1.0,10/70,8.17%,MYOM1;TTN;CLASP2;UNC13D;TGFB3;KCNB1;MYO18A;RAB3A;TGFB2;FRMD4A
prerank,myotube differentiation (GO:0014902),0.6851038980847282,1.524061754993684,0.04897314375987362,0.5434006269655953,1.0,6/17,5.55%,MEF2C;KLHL40;CACNA1H;ADAMTS5;SORT1;KCNH1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6914480010629209,1.52386534100511,0.052901023890784986,0.5417003125022181,1.0,2/17,0.75%,NTF3;NTRK3
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.7515633379202128,1.5230782371584828,0.06463195691202872,0.5421419344908861,1.0,4/10,10.33%,CACNB2;CACNA2D1;CALM1;SRI
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.6487807489146675,1.5216621996635051,0.06507936507936508,0.5445924272896858,1.0,4/24,8.60%,PDE3A;CGAS;PEX5L;PRKAR1B
prerank,aortic valve morphogenesis (GO:0003180),0.6343868961145609,1.5214506259464604,0.05217391304347826,0.5429593643764026,1.0,9/30,7.85%,SLIT3;HEY2;ELN;ROCK1;HEYL;JAG1;EMILIN1;SNAI2;SOX9
prerank,regulation of calcium-mediated signaling (GO:0050848),0.6574954177486491,1.5206253437692538,0.057926829268292686,0.5437317506203831,1.0,5/25,7.53%,ITPR1;CDH13;SLC8A2;MAPT;PLEK
prerank,cardiac muscle cell action potential (GO:0086001),0.6197638548331893,1.5197114379658974,0.047407407407407405,0.5446059016332159,1.0,6/30,5.96%,DMD;CACNA1C;CACNA2D1;SLC8A1;SLC4A3;ATP1B1
prerank,cellular response to organic cyclic compound (GO:0071407),0.5189441868967617,1.519046760195531,0.022123893805309734,0.5445294660668439,1.0,28/141,12.92%,PDE3A;MEF2C;RAP1A;AKAP6;NR1H4;ADCY5;PDGFB;ADCY2;RORA;ABCB4;IGFBP5;CCL5;P2RY2;ACTB;TAF1;ARL6IP5;AR;MED1;IMPACT;GABRB2;ADCY6;ROCK2;GPER1;GABRB3;ZFP36L1;TRPM2;HCN2;DMTN
prerank,microtubule polymerization or depolymerization (GO:0031109),0.6536595754403441,1.5184703984990962,0.05581395348837209,0.5442504630385009,1.0,7/24,6.98%,FGF13;KIF2A;MAP7D3;TPPP;MAPT;PIN1;HDGFL3
prerank,dicarboxylic acid transport (GO:0006835),-0.4853540376683614,-1.517837845868506,0.02476780185758514,0.6351505098302035,1.0,7/28,7.63%,SLC13A3;SLC1A3;PDPN;GJA1;SLC26A7;SLC25A32;SLC22A6
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.6845485986018296,1.5159763425341557,0.07532051282051282,0.5507204232048093,1.0,5/17,9.69%,PPP1R12A;ITGA1;CALM1;CD300A;PDGFRB
prerank,regulation of potassium ion transport (GO:0043266),0.621029062727149,1.5146161533242068,0.06488011283497884,0.5531900635411109,1.0,6/31,7.56%,KCNAB1;KCNA5;FHL1;KCNN2;KCNIP3;KIF5B
prerank,cellular response to catecholamine stimulus (GO:0071870),0.6566378778028304,1.51437720468999,0.061514195583596214,0.5516671168815472,1.0,8/23,15.00%,RYR2;ATP2B4;GABPA;ADCY6;SIRT2;LRRK2;MAPK1;PRKACA
prerank,regulation of histone acetylation (GO:0035065),0.6112451343798132,1.5141298529808962,0.0821529745042493,0.5501717381615084,1.0,5/33,9.33%,MYOCD;SET;PPARGC1A;CHEK1;PAXIP1
prerank,T-helper cell differentiation (GO:0042093),-0.5776034084718259,-1.512834727174401,0.04018912529550828,0.6504880302667925,1.0,3/14,1.69%,LEF1;FOXP1;HMGB1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.6201670572061594,1.511223868115154,0.057931034482758624,0.5579991946248924,1.0,6/31,7.78%,TPM1;RYR2;MYL2;MYL3;BMPR1A;TGFB2
prerank,positive regulation of vasoconstriction (GO:0045907),0.7037915449173193,1.5099125811717231,0.06506849315068493,0.5601260308376333,1.0,5/13,19.58%,ADRA1D;CAV1;TRPM4;TBXA2R;ADRA1A
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6497045341746224,-1.5097294985680971,0.035955056179775284,0.6578398221624662,1.0,6/10,20.71%,LRP1;APOD;SNCA;HGS;NDRG4;PTPN2
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.3802099079153982,-1.5093381737637785,0.017241379310344827,0.6516424697881682,1.0,24/74,19.56%,EYA2;IGF1;EYA1;EYA4;SH3RF1;TCF7L2;BMP4;ITGA6;DDX3X;BIRC6;TNFSF10;ITGAV;CASP8;BCL2L1;NOS3;RNF34;TGFBR1;FAIM;AKT1;GPX1;SERPINE1;TMBIM1;SIAH2;PARK7
prerank,response to fatty acid (GO:0070542),0.6852168917221538,1.508717761079364,0.06710310965630115,0.561907811508776,1.0,6/17,7.85%,NR1H4;CD36;PDK4;LPL;IRS1;SOX9
prerank,inhibitory synapse assembly (GO:1904862),0.7320466745412453,1.5080690893180717,0.09233449477351917,0.5618831157876522,1.0,5/11,11.95%,FGF13;PLXNB1;GABRB2;CBLN4;GABRB3
prerank,cellular response to drug (GO:0035690),0.6298241620767372,1.5074278765244824,0.07611940298507462,0.5618512274941578,1.0,6/25,9.65%,MEF2C;HTR1B;PPM1E;TP53;RAP2A;CERS1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.6853370805689847,1.5070738861883965,0.06050420168067227,0.5607742800723209,1.0,5/17,8.37%,NOTCH3;PLXND1;HEYL;MAML2;MAML3
prerank,regulation of focal adhesion assembly (GO:0051893),0.5682327984613866,1.5067141319342485,0.05874840357598978,0.559874550817738,1.0,14/54,8.25%,DLC1;VCL;ROCK1;LIMS1;FERMT2;PHLDB2;CLASP2;ACTG1;PEAK1;ARHGAP6;DUSP3;VEGFA;CORO1C;DAPK3
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.5857395272474387,-1.5067066509462437,0.04460093896713615,0.655828407355196,1.0,8/14,29.41%,SULF1;SPRY2;CREB3L1;FGF2;GPC1;SULF2;SPRY1;SPRY4
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.6740685732718912,1.5065777063168049,0.07188498402555911,0.5580289280409529,1.0,4/20,4.40%,ATP2A1;ATP2A2;CAMK2D;BCL2
prerank,macrophage chemotaxis (GO:0048246),0.73688611951739,1.5056053020209872,0.07871198568872988,0.5590675192948137,1.0,2/10,3.45%,EDNRB;CCL5
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.39314428886314146,-1.5037125849771507,0.011494252873563218,0.6620171375940216,1.0,20/67,14.94%,FLT1;PDGFRA;EFEMP1;IL15;KIT;GHR;EPHA4;TEK;EGFR;PTK2;ABI1;EPHA3;PTK2B;ABL2;FGFR2;LYN;PRLR;KDR;INSR;PKDCC
prerank,positive regulation of phosphatase activity (GO:0010922),0.6613010447905203,1.5036155047378796,0.05873261205564142,0.5635648760862362,1.0,6/21,9.69%,MEF2C;ITGA1;CALM1;PLEK;CD300A;PDGFRB
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.6607181024201108,1.5031679969058003,0.05855161787365177,0.5629930829466188,1.0,9/21,13.20%,VCL;ROCK1;ACTG1;PEAK1;DUSP3;CORO1C;DAPK3;ROCK2;CLASP1
prerank,protein-DNA complex disassembly (GO:0032986),0.68945846561871,1.5028239532437164,0.07166123778501629,0.5620123988829249,1.0,4/16,6.15%,SMARCD3;SET;ARID1A;SMARCB1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.6873808559588428,1.5027314510188257,0.06506849315068493,0.5601227560524197,1.0,4/17,2.70%,CACNB2;CACNA1C;CACNA2D1;SLC8A1
prerank,cytoskeleton organization (GO:0007010),0.5278251163737199,1.502558137632882,0.02547065337763012,0.5586186832517986,1.0,15/114,4.85%,PALLD;TPM1;WTIP;MAST4;MICAL2;PLCE1;LIMD1;CNN2;DES;PACSIN3;PACSIN2;RHOBTB3;ARHGAP10;DST;MARK1
prerank,membrane lipid metabolic process (GO:0006643),-0.5188163698033093,-1.5020272987413552,0.05361930294906166,0.6626038963270596,1.0,7/22,13.98%,AGMO;ST3GAL6;CERK;SERINC1;CYP1B1;ARV1;B4GALT4
prerank,dopamine metabolic process (GO:0042417),-0.5629356547270989,-1.5000179792747226,0.04521276595744681,0.6638799509865967,1.0,6/18,14.58%,SNCAIP;MOXD1;MAOA;PRKN;SNCA;GCH1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.6322074002502823,1.4996774760049651,0.06466165413533835,0.5664735988575427,1.0,8/26,13.27%,NR1H4;ANO1;ADCY5;KLF7;TRPM4;NR1D1;LRP5;PPP3CB
prerank,glycogen metabolic process (GO:0005977),0.6312163877312371,1.4988908702050592,0.0696594427244582,0.566892567708981,1.0,11/27,12.44%,PYGM;PHKG1;AGL;PYGB;PHKA2;CALM1;STBD1;NR1D1;NHLRC1;GYS1;PHKA1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.6757358104575282,1.4988590957965728,0.07804878048780488,0.5648192811946736,1.0,6/17,7.14%,CACNA1H;UNC13D;SLC4A8;SYT10;KCNB1;RAB3A
prerank,aortic valve development (GO:0003176),0.6042338766349775,1.4984537985631123,0.057692307692307696,0.5639594484117865,1.0,9/34,7.85%,SLIT3;HEY2;ELN;ROCK1;HEYL;JAG1;EMILIN1;SNAI2;SOX9
prerank,chromatin disassembly (GO:0031498),0.7054460679540667,1.4979701075319258,0.0728476821192053,0.5614576603877232,1.0,4/14,6.15%,SMARCD3;SET;ARID1A;SMARCB1
prerank,nucleosome disassembly (GO:0006337),0.7054460679540667,1.4979701075319258,0.0728476821192053,0.5614576603877232,1.0,4/14,6.15%,SMARCD3;SET;ARID1A;SMARCB1
prerank,sulfate transport (GO:0008272),-0.5724622331593784,-1.4969409920305934,0.05925925925925926,0.6707129932485761,1.0,6/14,17.12%,SLC13A4;SLC26A7;SLC25A14;SLC26A2;SLC25A30;SLC25A11
prerank,negative regulation of defense response to virus (GO:0050687),-0.6458730494747134,-1.4966708104196733,0.05203619909502263,0.6642428321253904,1.0,4/10,7.40%,ITCH;PPM1B;ILRUN;PCBP2
prerank,blood vessel diameter maintenance (GO:0097746),0.6033885218195603,1.4953917799970986,0.06102635228848821,0.5680545339821732,1.0,4/34,2.28%,AGTR1;EDNRA;ROCK1;EDNRB
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.4787203924392885,-1.4942584844334648,0.03773584905660377,0.6692785462214439,1.0,7/30,10.93%,SPTBN1;VAMP5;GOLGA4;OPTN;GCC2;GOLPH3;BLZF1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6588088316852142,1.4940701087506987,0.06912442396313365,0.5706132463414325,1.0,10/21,15.32%,DMD;CAV1;CNKSR3;GPD1L;PDE4D;DMTN;NCK2;MLXIPL;INPP5J;PTEN
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3944122832997266,-1.4928852140206914,0.01015228426395939,0.6683682481589618,1.0,13/65,7.25%,LEF1;GAB2;FOXP1;IL31RA;PIR;IL15;KIT;BMP4;MAPK14;SBNO2;LGALS9;PML;CASP8
prerank,regulation of calcium ion import (GO:0090279),0.6584739099577385,1.492871905657226,0.07547169811320754,0.5725255596620982,1.0,2/21,2.11%,PLN;PDGFB
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5754213654678129,1.4927798673296204,0.0684931506849315,0.5707326176414342,1.0,10/42,8.24%,ROCK1;CD36;LIMS1;CDK6;FERMT2;CDH13;UTRN;VEGFA;RRAS;RIN2
prerank,lymphocyte proliferation (GO:0046651),0.6735142428170672,1.4927054953676806,0.07424242424242425,0.5688401226157903,1.0,6/22,13.27%,MEF2C;CD79A;BCL2;RASGRP1;LMBR1L;PPP3CB
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.4728788823054292,-1.4897025246608335,0.04823151125401929,0.6767226683900546,1.0,15/30,18.87%,TGFBR3;SMAD3;FSTL1;DKK3;ENG;LTBP4;LATS2;FKBP1A;SMURF2;TGFB1;SFRP4;TRIM33;SMAD2;SMAD4;TWSG1
prerank,cellular metal ion homeostasis (GO:0006875),0.5255175902874574,1.4892530969465039,0.03788748564867968,0.57835472603586,1.0,15/102,7.69%,KCNMA1;TRDN;ATP2A1;RYR2;ATP2B4;ATP2A2;CSRP3;SLC8A1;SLC8A2;CCL5;STIM1;ATP1B1;CAV1;RMDN3;ATP2B1
prerank,cGMP metabolic process (GO:0046068),0.728152904917027,1.4888561680933694,0.08547008547008547,0.5775040614781979,1.0,2/12,3.91%,GUCY1A1;GUCY1B1
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.7471376069831834,1.4870835610932263,0.09107468123861566,0.5814093579013404,1.0,4/10,11.40%,PFKP;HK2;GFPT1;PFKM
prerank,RNA stabilization (GO:0043489),0.6110562622634734,1.4869903925612784,0.07365439093484419,0.5796470475682048,1.0,9/33,10.43%,RBM24;TENT5B;TRDMT1;PARN;CIRBP;GDNF;NAF1;FUS;HNRNPU
prerank,cardiac muscle cell contraction (GO:0086003),0.6693193912390469,1.4869294698756632,0.07550335570469799,0.5777733441487933,1.0,3/19,3.13%,CACNA1C;CACNA2D1;CAMK2D
prerank,positive regulation of heart contraction (GO:0045823),0.6641301137467884,1.4868323059230237,0.0707070707070707,0.5760169960284991,1.0,5/19,8.71%,RYR2;HRC;ATP2A2;TGFB2;TRPM4
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.6327431375167956,1.4866838141792589,0.07625899280575539,0.5744634103798404,1.0,5/28,6.31%,ATP2A1;MAP3K5;ITPR1;BCL2;DAB2IP
prerank,neural tube development (GO:0021915),-0.5603426722801605,-1.4865130381660547,0.05693069306930693,0.6845715418329477,1.0,5/15,11.99%,ALDH1A2;PTCH1;PKD2;TGFB1;SOX4
prerank,regulated exocytosis (GO:0045055),0.5033083265574304,1.4859832957939172,0.020105820105820106,0.5748477537579599,1.0,28/173,8.01%,FLNA;TTN;STXBP2;ACTN1;ACTN4;VCL;ITIH4;CD36;PDGFB;ENDOD1;MYH9;WDR1;LGALS3BP;TGFB3;TMEM79;TAGLN2;RIMS3;SYT10;RARRES2;VEGFA;PCDH7;TLN1;RAB3A;CALM1;ITGB3;PLEK;TGFB2;ARHGAP17
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.5099717995950854,-1.485475880005459,0.05084745762711865,0.6822637010118853,1.0,15/23,29.49%,PTCH1;IFT122;MEGF8;TULP3;MGRN1;HERC4;GLIS2;ENPP1;GPR161;BTRC;GPC3;RFX4;RACK1;ULK3;PTCH2
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5475344150282857,1.4798083411557394,0.040892193308550186,0.5941921362180155,1.0,14/70,9.52%,ITGA8;NTN4;ACTN1;MEF2C;LAMA5;FERMT2;PEAK1;YTHDF2;LAMB2;LAMC1;ITGB3;ITGA4;EPHA2;PARVA
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.7170427884646754,1.4788799887846542,0.0990990990990991,0.5951824215658175,1.0,4/11,13.84%,TRDN;LPCAT3;STX18;BNIP1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.6357205737822497,1.478589279762059,0.07317073170731707,0.5940130906157303,1.0,3/23,2.60%,TPM1;MYL2;MYL3
prerank,positive regulation of cell development (GO:0010720),0.6111781052361718,1.4778727281088,0.07025411061285501,0.5943616866558659,1.0,2/31,1.62%,PDE3A;LMOD3
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.529850175540133,-1.4777752453850566,0.047752808988764044,0.7115568790596558,1.0,8/20,18.33%,DAB2;PID1;BCL2L1;TGFB1;RHOQ;TMEM59;NUMB;TMBIM1
prerank,acylglycerol metabolic process (GO:0006639),0.5830625968040163,1.4765728577277286,0.07280219780219781,0.5967569854766384,1.0,9/37,13.91%,DGKB;DGKG;LPL;CAV1;MGLL;DGKD;DGAT1;PNPLA3;DGKZ
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.6345596432016514,1.4761563787441006,0.06656346749226007,0.5961504908047552,1.0,11/23,12.16%,TUBA1C;HOOK2;KIF1A;F8A1;KIF5B;HOOK1;KIF1C;KIF5C;DYNC1I2;MYO10;KIF5A
prerank,glucose transmembrane transport (GO:1904659),0.6619394719666076,1.475353695342607,0.07859531772575251,0.5966660805619997,1.0,4/18,6.49%,SLC2A4;SLC5A3;SORT1;SLC2A10
prerank,regulation of execution phase of apoptosis (GO:1900117),0.7109662992775873,1.474086818231829,0.10018552875695733,0.5990183941079926,1.0,5/11,11.70%,DLC1;PTGIS;TP53;SIRT2;BOK
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.6253141636909018,1.473865370898973,0.06782106782106782,0.5977475737481671,1.0,2/27,0.66%,AGTR1;GPR20
prerank,vasodilation (GO:0042311),0.6959402115500183,1.4729108214141393,0.10695187165775401,0.5988581755724484,1.0,1/13,0.27%,KCNMA1
prerank,sensory perception of sound (GO:0007605),-0.3780484481564455,-1.4725981348576693,0.024242424242424242,0.7300168591748387,1.0,17/88,9.86%,EYA1;COL1A1;CEMIP;ADGRV1;KIT;COL11A1;USP53;GRM7;GSDME;COL4A3;DCDC2;ATP6V0A4;ALDH7A1;EML2;WHRN;RIPOR2;CLIC5
prerank,positive regulation of ruffle assembly (GO:1900029),-0.6018076576410302,-1.471272753740628,0.04455445544554455,0.728746735173952,1.0,11/13,37.22%,EPS8;NLGN1;PLEKHM1;PFN1;EPS8L2;EPS8L1;NDEL1;DEF8;HRAS;FAM98A;P2RY12
prerank,skeletal system morphogenesis (GO:0048705),-0.4355856394294194,-1.470710539710111,0.03829787234042553,0.7241462482365869,1.0,13/42,12.27%,PDGFRA;HOXB3;FBN2;HOXA3;CYP26B1;DSCAML1;WWOX;HOXB4;MEGF8;FGFR2;SIX1;SFRP4;TGFBR1
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.4036063667665161,-1.4700660467229592,0.02510460251046025,0.7198097477687329,1.0,21/47,18.82%,BMP7;CARM1;MEDAG;ASXL2;SOX13;NOCT;TMEM64;NAPEPLD;CREBL2;SIX1;CREB1;AAMDC;PTGS2;CEBPB;AKT1;TFE3;LMO3;PPARG;CDS1;ZC3H12A;METRNL
prerank,membrane depolarization during action potential (GO:0086010),0.6249205416574025,1.4696972513455935,0.08472012102874432,0.608495011727453,1.0,4/26,2.70%,SCN4A;CACNA1C;CACNA1H;SLC8A1
prerank,ganglion development (GO:0061548),-0.6219934168332915,-1.4696968943626343,0.046460176991150445,0.7141866328266078,1.0,4/11,7.43%,NRP2;NRP1;CTNNB1;SEMA3A
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5073093485797919,-1.4693266214575837,0.059154929577464786,0.7087362998373821,1.0,8/21,13.08%,PRKCB;ELF1;FOXP1;PRKCH;SLC39A10;PTPN22;LYN;ELF2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.4894719502588624,-1.4692434019920897,0.05555555555555555,0.7020473613137982,1.0,13/26,25.86%,ITCH;NOD1;IRAK1;CASP8;IKBKG;TAB2;UBC;IRAK2;TAB1;AAMP;UBB;CYLD;ALPK1
prerank,positive regulation of cytokinesis (GO:0032467),-0.4532540655543612,-1.4691425452700901,0.05373134328358209,0.6957693332617053,1.0,12/32,22.81%,PKP4;CDC14B;SPAST;CUL3;PRKCE;CDC25B;CIT;GIPC1;CDC42;DRD2;CSPP1;SVIL
prerank,granulocyte differentiation (GO:0030851),-0.5349106465964777,-1.4691418148104727,0.062162162162162166,0.6889480652885513,1.0,11/18,31.23%,LEF1;LBR;PML;EP300;RARA;CBFA2T3;TAL1;CDK2;CDKN1A;RXRA;E2F1
prerank,triglyceride homeostasis (GO:0070328),0.617273716888904,1.4679723335093258,0.09104477611940298,0.6123530921293163,1.0,4/26,3.09%,NR1H4;ANGPTL8;RORA;LPL
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.6220870575508577,1.4663573727579728,0.07976366322008863,0.6159243788026777,1.0,2/26,0.29%,PLN;TRDN
prerank,mitochondrion distribution (GO:0048311),0.7059568860033316,1.4659825674897116,0.10124333925399645,0.6151010989144482,1.0,6/12,13.77%,MEF2A;MAPT;TRAK1;ATCAY;DNM1L;LRRK2
prerank,phasic smooth muscle contraction (GO:0014821),0.7383710062262399,1.4659408360339976,0.1169811320754717,0.6130796726047876,1.0,4/10,11.69%,PTGER3;EDNRB;GDNF;HTR2B
prerank,regulation of cellular respiration (GO:0043457),0.6805635418927195,1.4657530342008085,0.08661417322834646,0.6116341966646205,1.0,1/17,0.28%,PRDM16
prerank,peptidyl-tyrosine modification (GO:0018212),-0.401952561032531,-1.4649220275344859,0.02197802197802198,0.7023169975231793,1.0,18/56,14.94%,FLT1;PDGFRA;EFEMP1;KIT;EPHA4;TEK;EGFR;PTK2;ABI1;EPHA3;PTK2B;TPST1;ABL2;FGFR2;LYN;KDR;INSR;PKDCC
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.3868627371711916,-1.4646310181851865,0.005235602094240838,0.6971526895986179,1.0,14/63,8.03%,IGF1;SH3RF1;TCF7L2;DEPTOR;BMP4;ITGA6;WWOX;BIRC6;TNFSF10;ITGAV;PML;CASP8;MADD;STX4
prerank,V(D)J recombination (GO:0033151),-0.626729459514481,-1.462613236964474,0.06881720430107527,0.6993856179738145,1.0,8/11,35.23%,HMGB1;PRKDC;LIG3;DCAF1;LIG1;HMGB2;TCF3;LIG4
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.6268123056048784,-1.4625327497559248,0.057569296375266525,0.6932298429704989,1.0,3/10,16.10%,IL18;LGALS9;RARA
prerank,cellular response to growth factor stimulus (GO:0071363),0.49751257190118536,1.4621512162907828,0.02159827213822894,0.6219479479879301,1.0,26/151,7.91%,PDE3A;SOX6;SOX5;HJV;MEF2C;RAP1A;NTRK3;LIMS1;PDGFB;ANXA1;NR4A1;CCL5;ACVR2A;MTSS2;BMPR1A;HAS2;MAPT;DAB2IP;MAPKAPK2;DUSP3;VEGFA;SNAI2;GAREM1;MED1;SOX9;RELA
prerank,amide transport (GO:0042886),-0.479339639803633,-1.4618281382966405,0.027472527472527472,0.6900694380571235,1.0,9/26,21.95%,ABCG2;PDPN;PLTP;SLC25A32;CERT1;PLEKHA3;SLC38A5;ABCB9;TAP1
prerank,regulation of acrosome reaction (GO:0060046),0.7241600755882481,1.460606129463298,0.10037878787878787,0.6254386563382391,1.0,2/10,8.15%,CACNA1H;PLCB1
prerank,peripheral nervous system development (GO:0007422),0.640792165976829,1.4605773064430125,0.09936908517350158,0.6234593613918038,1.0,2/23,1.02%,NTF3;SERPINI1
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.4377795946428619,-1.4577446370414162,0.040293040293040296,0.7026245993872957,1.0,21/35,38.35%,ACSS3;FAR2;PAM;HMGCL;HMGCLL1;PPT1;HMGCS2;ACLY;BDH2;AACS;GGT7;HPGD;ALOX12;HSD17B8;BDH1;GCDH;SCD;SLC25A1;ACACA;GGT1;AWAT2
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.3733671473663037,-1.4576173865187105,0.017241379310344827,0.6967482942975005,1.0,17/85,10.21%,EYA1;COL1A1;CEMIP;ADGRV1;COL11A1;USP53;GRM7;GSDME;COL4A3;DCDC2;ATP6V0A4;ALDH7A1;EML2;WHRN;RIPOR2;CLIC5;PIEZO2
prerank,embryonic heart tube development (GO:0035050),0.6734586476427085,1.4567896208784434,0.08922558922558922,0.6342084849534808,1.0,2/14,1.30%,RYR2;TBX2
prerank,ceramide metabolic process (GO:0006672),-0.4134874183348255,-1.4562776713136845,0.042735042735042736,0.6965716880506415,1.0,11/49,9.83%,SGMS1;SGMS2;CERK;CERS5;SPTLC2;ST6GALNAC3;PPP2CA;SPTSSA;ACER2;CERS6;ASAH2
prerank,negative regulation of developmental process (GO:0051093),0.5323088021566154,1.4545139244083107,0.06650544135429262,0.6400499373616408,1.0,17/69,14.26%,HEY2;TBX2;ROCK1;CDK6;ALPK2;LOXL2;KANK1;PTPRS;KLF7;MAPT;SOX9;ROCK2;ADCK1;MUL1;FOXJ1;GAS6;HOPX
prerank,regulation of microtubule nucleation (GO:0010968),0.7240910421745868,1.4541694913936847,0.120817843866171,0.6392849423491104,1.0,1/10,0.35%,ARHGEF7
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4926197161640413,-1.4526056435740082,0.07317073170731707,0.7071031504228851,1.0,5/21,9.15%,PRKCB;FOXP1;PRKCH;SLC39A10;IKBKG
prerank,neuromuscular junction development (GO:0007528),0.6150819145888269,1.4524759388816848,0.08517350157728706,0.6432087175978514,1.0,7/24,7.01%,CACNB2;PDZRN3;MUSK;CACNB4;DOK7;PPFIBP2;NEDD4
prerank,peptidyl-threonine modification (GO:0018210),0.5331379593558182,1.452035972550013,0.061968408262454436,0.6425789354588294,1.0,28/66,19.14%,MYLK2;ROCK1;DYRK2;CAMK2D;GALNT16;DYRK1A;TAF1;DYRK1B;CHEK1;MAP3K10;MAP2K1;GALNT3;ROCK2;PRKCD;ACVR1B;GALNT2;CDC42BPB;LRRK2;MAPK1;GALNT1;PRKCA;HIPK2;MARK2;GALNT11;GALNTL6;ULK1;PRKD1;ACVR1
prerank,response to glucocorticoid (GO:0051384),0.6157697444938705,1.451965409316402,0.10179640718562874,0.640697991465524,1.0,6/26,14.53%,SLIT3;ANXA1;GOT1;HNRNPU;ZFP36L1;PDCD7
prerank,negative regulation of organelle assembly (GO:1902116),-0.44480388182038577,-1.4511643932342966,0.04590163934426229,0.7077265841319709,1.0,19/35,29.07%,NUPR1;LIMK2;CEP97;TBC1D30;MDM1;SMAD4;ODF2L;SCFD1;NBDY;TBC1D7;FEZ1;SMCR8;PHF23;CCP110;CHMP4B;CHMP4A;KAT2A;TESK1;STYXL1
prerank,negative regulation of nervous system development (GO:0051961),0.6520870975311701,1.4504534524851078,0.0799347471451876,0.6440589495107831,1.0,1/17,0.16%,SLIT1
prerank,negative regulation of ion transport (GO:0043271),0.6280790677956977,1.4501811764490589,0.09408194233687406,0.6428786667958954,1.0,7/24,10.27%,PLN;HTR1B;PACSIN3;NEDD4;WNK2;HRH3;ACTN2
prerank,mitotic spindle assembly (GO:0090307),0.5654132768279561,1.4497707281991234,0.07258064516129033,0.6421888362856913,1.0,11/42,10.77%,FLNA;CLASP2;KIF2A;TOGARAM2;KIF3B;TPX2;PIBF1;TOGARAM1;CEP192;WRAP73;AAAS
prerank,thyroid hormone generation (GO:0006590),0.7404594115100424,1.4492356358627168,0.10185185185185185,0.6419786354358031,1.0,2/10,7.63%,TG;DIO2
prerank,xenobiotic transport (GO:0042908),-0.5334008403893593,-1.4488016090363884,0.06435643564356436,0.7122693031357791,1.0,6/17,13.57%,ABCG2;SLC47A1;GJA1;SLC7A5;SLC22A4;SLC22A18
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.49254769257798237,-1.448277750439001,0.06865671641791045,0.7084780721349703,1.0,9/24,18.92%,DAB2;PID1;BCL2L1;TGFB1;RHOQ;TMEM59;NUMB;TMBIM1;ITGB1BP1
prerank,protein monoubiquitination (GO:0006513),-0.4472884198867382,-1.44649532255763,0.04918032786885246,0.7105304399650176,1.0,13/36,14.99%,CUL3;RNF20;KLHL12;UBE2D3;CTR9;TOPORS;TRIM25;PRKN;MGRN1;KLHL22;DTX3L;LEO1;OBI1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.5497354253603878,1.4462620035879796,0.07802340702210664,0.6506717838236608,1.0,5/53,4.30%,LHCGR;HTR1B;NPY1R;ANXA1;TSHR
prerank,purine ribonucleotide transport (GO:0015868),-0.5332536561027794,-1.4448671475651662,0.07637231503579953,0.7119311976762358,1.0,10/16,36.77%,SLC25A17;ABCC4;LRRC8D;ABCC5;LRRC8A;SLC25A24;SLC35B2;SLC17A9;SLC25A4;SLC19A1
prerank,amino acid import across plasma membrane (GO:0089718),-0.4829417110460011,-1.4446635684717735,0.061946902654867256,0.7066676028980272,1.0,8/24,9.68%,SLC6A13;SLC1A3;SLC47A1;SLC6A6;SLC3A2;SLC7A5;SLC6A9;SLC22A4
prerank,oligodendrocyte differentiation (GO:0048709),0.638022393869102,1.4440103566628668,0.09822866344605476,0.6568766027455881,1.0,3/19,7.85%,SOX6;TPPP;SOX9
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.626233420704674,1.4438334079500563,0.07057057057057058,0.655376147416511,1.0,5/26,7.01%,KCNAB1;ITGB1;FHL1;ATP1B1;NEDD4
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.5641068948933696,-1.4435672011629483,0.07936507936507936,0.7054953418134764,1.0,7/13,24.98%,NUPR1;SCFD1;FEZ1;SMCR8;PHF23;CHMP4B;CHMP4A
prerank,acidic amino acid transport (GO:0015800),-0.5350954021063911,-1.4424933945094418,0.06766917293233082,0.7046480509774671,1.0,5/17,3.62%,SLC6A13;SLC1A3;GJA1;SLC6A1;SLC6A6
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4630434168735272,-1.4423957068933106,0.07936507936507936,0.699293545090985,1.0,10/26,16.60%,IGF1;OSBPL8;PTPN11;OCLN;CREBL2;APPL1;RHOQ;INSR;AKT1;CAPN10
prerank,regulation of cell junction assembly (GO:1901888),0.6052646387938893,1.4421794395003718,0.09449929478138223,0.6590442665263258,1.0,8/27,10.78%,MEF2C;RAP1A;PDLIM5;ROCK1;CBFB;SNAI2;RUNX1;ROCK2
prerank,ketone body metabolic process (GO:1902224),-0.6206841606183198,-1.4416739028798382,0.06502242152466367,0.6968360776510734,1.0,6/10,17.37%,ACSS3;HMGCL;HMGCLL1;HMGCS2;BDH2;AACS
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.606058158217575,-1.4411169419743266,0.08775981524249422,0.6939002147487818,1.0,3/11,9.61%,DAB2;RDX;PRKN
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.35448147327159596,-1.4399295462996433,0.013422818791946308,0.6935558325146511,1.0,39/91,24.85%,SEC62;RPL27A;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;SEC63;RPLP0;RPS29;RPL28;RPS10;RPLP1;RPS20;RPL34;RPL23A;RPS8;RPL36A;RPS21;RPL9;SSR1;RPL27;RPS7;SEC61A1;RPL18A;RPL11;SRPRA;SRP9;RPL37A;RPL38;SSR2;RPL29;RPL32;RPL10A;RPS4X;RPS27
prerank,negative regulation of calcium ion transport (GO:0051926),0.6728650060338209,1.439780278111846,0.11054421768707483,0.6652451556990773,1.0,2/15,2.85%,PLN;PACSIN3
prerank,relaxation of cardiac muscle (GO:0055119),0.6728361828666934,1.4392369654125847,0.11012433392539965,0.6650358810967394,1.0,4/13,5.96%,PLN;SLC8A1;CAMK2D;ATP1B1
prerank,positive regulation of dendrite development (GO:1900006),-0.6368316536620872,-1.4381580543001204,0.0576036866359447,0.6960898947837314,1.0,6/10,13.67%,PTN;COBL;BMP7;ZDHHC15;ALK;LRP8
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.6312272098837667,1.4381322914877295,0.09538950715421304,0.6665800903730751,1.0,6/22,6.47%,LMCD1;ROCK1;MLIP;CAMK2D;MEF2A;PARP1
prerank,SNARE complex assembly (GO:0035493),-0.6116914363956321,-1.4379976932228589,0.08863636363636364,0.6912524017203703,1.0,5/10,20.17%,STXBP1;SNCA;VAMP8;VAMP1;UVRAG
prerank,androgen metabolic process (GO:0008209),0.645985971196062,1.4379636172952028,0.10947712418300654,0.6650609028946123,1.0,5/18,10.88%,HSD17B10;HSD17B7;HSD17B4;MED1;SRD5A3
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7161923045856335,1.4377493015632883,0.1310592459605027,0.6637441587803368,1.0,2/10,1.91%,CD36;MYD88
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6115457769612116,-1.437740495076573,0.07777777777777778,0.6869009070737656,1.0,5/10,12.18%,DCN;SEMA6A;XDH;PIK3CB;SPRY2
prerank,cellular response to fatty acid (GO:0071398),0.6961005526504682,1.4359778968774022,0.10327022375215146,0.6683207660626379,1.0,4/12,5.71%,NR1H4;PDK4;LPL;IRS1
prerank,regulation of interleukin-13 production (GO:0032656),-0.5751246047469867,-1.4356203028643861,0.0744920993227991,0.6912913768241571,1.0,3/13,5.41%,LEF1;IL18;LGALS9
prerank,regulation of cellular localization (GO:0060341),0.5594203783904333,1.4348352620148643,0.0964332892998679,0.6704272881405575,1.0,12/46,14.32%,STXBP2;NR1H4;ADCY5;CAMK2D;UNC13D;PARP1;BRSK1;NR1D1;LRP5;LRRK2;CSNK1E;DVL1
prerank,positive regulation of wound healing (GO:0090303),0.5873698075721683,1.4345330064055013,0.08380681818181818,0.669427282472869,1.0,6/36,3.64%,MYLK;FERMT2;ANXA1;KANK1;ITGB1;ACTG1
prerank,ruffle organization (GO:0031529),0.6584336247711315,1.4335815021333436,0.1127946127946128,0.670634456961992,1.0,3/16,7.53%,TPM1;CYFIP1;PLEK
prerank,protein localization to cell surface (GO:0034394),0.6021687222556169,1.4332281161719893,0.0973724884080371,0.6698672211381538,1.0,4/26,4.86%,FLNA;ANGPT1;VCL;JAM3
prerank,BMP signaling pathway (GO:0030509),-0.3926077782558434,-1.4311136266788698,0.046875,0.7058301966305085,1.0,17/62,10.41%,BMP6;TGFBR3;SMAD3;DDX5;BMP7;BMP4;SMAD6;ENG;RUNX2;ACVRL1;BMPR2;MEGF8;RGMB;SMAD9;TMEM100;TGFB1;PDCD4
prerank,adenine nucleotide transport (GO:0051503),-0.51726055110674,-1.431100933582931,0.0794044665012407,0.7004040647454098,1.0,10/17,36.77%,SLC25A17;ABCC4;LRRC8D;ABCC5;LRRC8A;SLC25A24;SLC35B2;SLC17A9;SLC25A4;SLC19A1
prerank,oligosaccharide metabolic process (GO:0009311),-0.4044313238781292,-1.4304085689308297,0.03111111111111111,0.6980000176671758,1.0,12/46,10.81%,ST3GAL4;B4GALT1;ST3GAL6;ST8SIA4;ST6GALNAC3;ST8SIA1;AMY1A;AMY1B;AMY1C;FUT8;ST3GAL3;ST8SIA2
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.45056524311362667,-1.4293154538758104,0.06711409395973154,0.6975022451117147,1.0,11/33,16.18%,MCC;DCN;PTPRG;SLIT2;APOE;ACVRL1;PTPRM;ADAMTS9;SP100;PFN2;EVL
prerank,positive regulation of protein secretion (GO:0050714),0.5229947423680765,1.429031546468315,0.08508014796547472,0.6829130634709808,1.0,2/69,0.37%,MYOM1;TTN
prerank,basement membrane organization (GO:0071711),0.6661585218270589,1.4287645701723293,0.13368055555555555,0.6816780943427634,1.0,4/14,6.94%,NTN4;COL4A1;PXDN;LAMB2
prerank,lamellipodium organization (GO:0097581),0.5727719513522878,1.4287272182013897,0.11208151382823872,0.6797186236544136,1.0,7/29,9.01%,ARHGEF7;VCL;CDH13;ITGB1;CYFIP1;WHAMM;ARHGEF4
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.6046967310654929,1.4286991585327375,0.09658246656760773,0.6777201278540711,1.0,5/25,5.38%,NDST3;CSGALNACT1;EXT2;HS2ST1;HAS2
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.6740812803387599,1.427990376843178,0.11490125673249552,0.6781971574238245,1.0,5/12,17.38%,IRS1;PPARGC1A;PPARA;IRS2;MTLN
prerank,telomere capping (GO:0016233),-0.5367010592853385,-1.4271364792749521,0.07769423558897243,0.7025249735407079,1.0,14/16,36.65%,PRKDC;STN1;MRE11;RAD50;NBN;CTC1;TERF2IP;DCLRE1A;DCLRE1B;TINF2;TEN1;ACD;TFIP11;DCLRE1C
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.4989772851425539,1.4271228813149792,0.06436781609195402,0.6790805389357265,1.0,22/107,12.41%,TRDN;ATP2A1;RYR2;ATP2B4;ATP2A2;CSRP3;SLC8A1;SLC8A2;CCL5;STIM1;ATP1B1;CAV1;RMDN3;ATP2B1;SLC39A14;PTH1R;SLC30A5;CCL14;ATP2A3;HTR2B;DMPK;CHRNA7
prerank,acetyl-CoA metabolic process (GO:0006084),0.6573030265100285,1.4269834623456612,0.12374581939799331,0.6775103561763621,1.0,4/15,8.71%,ACSS1;NUDT7;ACACB;MVD
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.615076080358624,1.426967953246672,0.11229135053110774,0.6754980784094938,1.0,3/24,1.66%,RYR1;RYR2;ITPR1
prerank,activation of protein kinase B activity (GO:0032148),0.5913906441239454,1.4268152515228207,0.1043872919818457,0.6739707047501138,1.0,4/29,2.11%,NTF3;NTRK3;FGF1;PDGFB
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6745110103827936,1.4265822183959964,0.10902896081771721,0.6727788303395945,1.0,6/13,18.34%,HEY2;TAF1;TMSB4X;SIN3A;MAD2L2;DDIT3
prerank,outflow tract septum morphogenesis (GO:0003148),-0.47295716169126123,-1.4265049796056923,0.06371191135734072,0.7002032604165505,1.0,9/24,5.68%,ROBO1;SEMA3C;NRP2;BMP4;SMAD6;ENG;NRP1;ZFPM2;BMPR2
prerank,epithelial structure maintenance (GO:0010669),-0.5919733230663216,-1.424645821380378,0.0847457627118644,0.7034518163324829,1.0,2/11,4.04%,CXADR;RBP4
prerank,regulation of protein acetylation (GO:1901983),-0.5809242626532449,-1.42428511812652,0.07746478873239436,0.6999250348631195,1.0,6/12,26.79%,DDX3X;CAMK1;TAOK1;TERF2IP;PARK7;RAPGEF3
prerank,nitric oxide mediated signal transduction (GO:0007263),0.6681042280648847,1.4240082359802761,0.11557788944723618,0.6798812563638273,1.0,3/16,3.91%,GUCY1A1;CD36;GUCY1B1
prerank,positive regulation of transporter activity (GO:0032411),0.6785407391672582,1.4230162380848232,0.12142857142857143,0.6814115560036447,1.0,2/13,1.99%,TRPC6;KCTD7
prerank,negative regulation of protein depolymerization (GO:1901880),0.6071922817132169,1.422075250612281,0.11585365853658537,0.6826535737564199,1.0,6/24,6.98%,FGF13;TRIM54;CLASP2;ARHGEF2;TPX2;HDGFL3
prerank,glucose import (GO:0046323),0.661074188253285,1.4215285804039277,0.13080895008605853,0.6825464678464097,1.0,3/13,6.49%,SLC2A4;SORT1;SLC2A10
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.7049354950051725,1.4203049779600343,0.11245674740484429,0.6848406862630424,1.0,2/11,2.73%,MEF2C;ANXA1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6648027391795985,1.4198940807567186,0.14046822742474915,0.6842511915095123,1.0,4/14,8.60%,ATP2B4;PKIB;PKIA;PRKAR1B
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6079638652775191,1.419277210689684,0.1111111111111111,0.6844297289941268,1.0,3/26,1.66%,RYR1;RYR2;ITPR1
prerank,positive regulation of protein polymerization (GO:0032273),0.525519826814851,1.4191349290142294,0.08754623921085081,0.6828703192568436,1.0,6/65,7.54%,LMOD1;LMOD2;CDC42EP3;TPPP;MAPT;TOGARAM1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6948373116486146,1.4189712786433886,0.1261595547309833,0.6814368274300853,1.0,2/11,2.32%,ATP2B4;MLIP
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.45769278909485556,-1.4184727263723675,0.07213114754098361,0.7208174278337496,1.0,8/29,11.60%,IGF1;NOTCH2;GRB2;RASGRF1;RAPGEF1;ITGAV;RASGEF1A;LYN
prerank,regulation of wound healing (GO:0061041),0.5618052092171663,1.4181274393994208,0.10540540540540541,0.6825097614837378,1.0,8/42,6.70%,MYLK;ANXA1;KANK1;ITGB1;ACTG1;ALOX5;CAV1;AJAP1
prerank,protein targeting to ER (GO:0045047),-0.34107382056458985,-1.417159285188545,0.013888888888888888,0.7213296346826068,1.0,44/99,24.98%,SEC62;RPL27A;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;SRPRB;RPL18;RPS13;SEC63;RPLP0;SGTA;RPS29;RPL28;RPS10;RPLP1;SGTB;RPS20;RPL34;RPL23A;RPS8;RPL36A;RPS21;RPL9;RPL27;RPS7;SEC61A1;RPL18A;RPL11;SRPRA;SRP9;RPL37A;RPL38;ZFAND2A;RPL29;RPL32;RPL10A;SPCS1;RPS4X;RPS27;CHMP4B;CHMP4A
prerank,response to ketone (GO:1901654),0.6092360581016418,1.4162791116126736,0.11976047904191617,0.6870520044984818,1.0,6/24,7.78%,SLIT3;ABCB4;TGFB3;CAV1;YAP1;TGFB2
prerank,inorganic cation transmembrane transport (GO:0098662),0.4652054430535839,1.4156535259236347,0.024539877300613498,0.6872601006506595,1.0,28/268,5.96%,KCNAB1;ATP2A1;SCN4A;CACNA1C;ASIC3;TRPC6;ATP2B4;ATP2A2;CACNA1H;KCNJ12;SLC6A17;ANO6;SLC8A1;SLC8A2;KCNA5;KCNQ5;ATP5MF;SLC4A8;KCNQ4;SLC6A5;SLC6A2;KCNN2;UCP3;KCNB1;CCDC51;ATP6V1H;KCNH1;ATP1B1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5795577782017126,1.4147845517202107,0.0953058321479374,0.6882691149692715,1.0,11/33,11.01%,HIP1;BCAR3;NUP62;FBXW7;NEU3;DOK1;AREG;ADAM17;DGKD;HBEGF;GPER1
prerank,lamellipodium assembly (GO:0030032),0.5744721830498697,1.4135550876368552,0.12537764350453173,0.6907728906013703,1.0,7/26,9.01%,ARHGEF7;VCL;CDH13;ITGB1;CYFIP1;WHAMM;ARHGEF4
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.6492671268854016,1.412045961410409,0.10586319218241043,0.6942970105507374,1.0,2/15,2.65%,RYR2;ZFAND2B
prerank,calcium ion transmembrane transport (GO:0070588),0.5121472945309433,1.4117232691122785,0.0729665071770335,0.6933754289027487,1.0,15/86,8.91%,ATP2A1;CACNA1C;TRPC6;ATP2B4;CACNA2D1;ATP2A2;ANO6;SLC8A1;SLC8A2;GRIN2C;AFG3L2;TRPV2;ATP2B1;TRPM4;TRPC5
prerank,cellular response to nitrogen compound (GO:1901699),0.6029911707615474,1.410347892748993,0.1248,0.6961557536269419,1.0,2/20,1.24%,ATP2B4;NR1H4
prerank,regulation of membrane repolarization (GO:0060306),0.6647782771542703,1.4084007448183005,0.13211009174311927,0.701289275333159,1.0,3/13,6.29%,AKAP6;CACNA2D1;CAV1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6194673214410021,1.407886053520739,0.11574074074074074,0.7010990996933989,1.0,5/20,11.32%,PLN;CAMK2D;NEDD4;ACTN2;GOPC
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.46985293485270746,-1.4078858141013275,0.07668711656441718,0.7591718525074751,1.0,6/25,6.41%,KIT;B2M;WNT5A;CD55;SLC7A5;PLCG2
prerank,spindle assembly (GO:0051225),0.5143425817204527,1.407775481921415,0.08827085852478839,0.6994403662615396,1.0,21/67,16.69%,FLNA;CLASP2;KIF2A;TOGARAM2;HAUS8;KIF3B;MAPRE2;TUBGCP6;TPX2;PIBF1;TOGARAM1;CEP192;WRAP73;AAAS;CLASP1;HAUS7;HAUS2;MAPRE3;ABRAXAS2;INO80;MAP9
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5475084434793718,1.4068606445136913,0.1068090787716956,0.7005935423619061,1.0,5/48,2.59%,FLNA;ARHGEF7;LIMS1;FERMT2;SS18L2
prerank,response to interferon-beta (GO:0035456),-0.48210043528202495,-1.4064833368228757,0.07871720116618076,0.7599993224258161,1.0,17/22,39.83%,IFNAR2;IRGM;BST2;IFITM1;IFITM3;SHFL;PNPT1;IFITM2;HTRA2;IKBKE;CDC34;XAF1;NDUFA13;TRIM6;PLSCR1;IRF1;AIM2
prerank,renal filtration (GO:0097205),0.702509706822627,1.4055085895616182,0.13966480446927373,0.7036746166836313,1.0,3/10,2.68%,MCAM;MYO1E;ITGA3
prerank,liver development (GO:0001889),-0.4370715770964445,-1.405268462458302,0.07987220447284345,0.7603043853587231,1.0,9/32,13.14%,TGFBR3;COBL;NF1;WNT4;PKD2;LSR;PCK2;CEBPB;CCDC39
prerank,Notch signaling involved in heart development (GO:0061314),0.6919325931675953,1.404785712602625,0.14156079854809436,0.7043869760656295,1.0,4/11,6.93%,HEY2;HEYL;JAG1;SNAI2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.5604092844255846,-1.4043097796891892,0.09655172413793103,0.7592088902073771,1.0,6/12,10.39%,PTPN14;BMP4;KHDRBS1;UHMK1;SIRT7;TGFB1
prerank,entry into host (GO:0044409),-0.5553012548228216,-1.4040269520084698,0.07785888077858881,0.7550589425307831,1.0,5/13,7.18%,GRB2;CDH1;CTNND1;ITGAV;CTNNB1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.5767606109703188,1.4035661600982268,0.11522048364153627,0.7067173071242688,1.0,11/32,14.60%,FGF13;TRIM54;CLASP2;ARHGEF2;DYRK1A;TPX2;HDGFL3;TBCD;CLIP3;CLASP1;STMN2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.49030176394580055,1.402942792664805,0.05660377358490566,0.7069323724705012,1.0,14/112,7.85%,PDE3A;SOX6;SOX5;MEF2C;LIMS1;FERMT2;LRRC32;TGFB3;ITGB1;GCNT2;BMPR1A;ITGB5;TGFB2;SOX9
prerank,regulation of cell-cell adhesion (GO:0022407),-0.41135879872435466,-1.4027887738326092,0.03832752613240418,0.7553347910179726,1.0,9/39,10.39%,AFDN;EPHA7;PTPRG;NF2;PODXL;PTK2;CDH1;TENM3;TGFB1
prerank,protein localization to synapse (GO:0035418),-0.5773303881314626,-1.4016840566814714,0.07109004739336493,0.7551266807432362,1.0,5/12,14.59%,NLGN1;ZDHHC15;NRXN1;NLGN2;PCLO
prerank,regulation of synapse assembly (GO:0051963),0.5394206331837555,1.4016467525786769,0.10185185185185185,0.7098188610299685,1.0,5/46,5.61%,SLIT1;MEF2C;PDLIM5;MUSK;GPC4
prerank,axon extension (GO:0048675),0.595886331551371,1.4013131845210618,0.11800302571860817,0.7089646771944403,1.0,4/23,3.81%,SLIT1;SLIT3;SEMA5A;MAP1B
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5649346069438201,-1.4012964382640924,0.09195402298850575,0.7516807063832265,1.0,6/12,19.92%,SLIT2;NBL1;CCN3;DUSP1;AKT1;MIA3
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4743196581312538,1.4012633362508704,0.045647558386411886,0.7071950943544052,1.0,19/159,6.22%,NEXN;PALLD;MYOT;CDH6;MYPN;IGFN1;ROBO3;CDH13;MILR1;ITGB1;CDH4;KIRREL3;PTPRS;IGSF21;GPC4;CDHR3;PTPRF;DSCAM;PCDHB14
prerank,diol metabolic process (GO:0034311),-0.5031501476336082,-1.4005510975234159,0.08011049723756906,0.7500396921872743,1.0,10/19,22.76%,NAAA;NOS3;SGPP1;ASAH2;GCH1;PRKG2;AKT1;PTS;SPR;SPHK1
prerank,positive regulation of protein depolymerization (GO:1901881),0.697848900719347,1.4004353464255772,0.11754068716094032,0.7082753405196514,1.0,4/11,8.09%,SEMA5A;WDR1;PLEK;CFL2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5530847504518758,1.4003747214059037,0.09478021978021978,0.7065072793974769,1.0,7/39,8.12%,DMD;FGF13;FGF14;CAMK2D;UTRN;NEDD4;WNK2
prerank,apoptotic mitochondrial changes (GO:0008637),0.5758261811346397,1.40035555337141,0.1013215859030837,0.7046164682232796,1.0,10/32,12.46%,ATP2A1;HK2;BCL2;NDUFS1;FZD9;THEM4;DNM1L;GGCT;BOK;CLU
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.4272914758556517,-1.4001657015546642,0.04395604395604396,0.7468585557943314,1.0,15/36,23.38%,MECOM;DLG1;ITCH;FOXO1;PTPN22;PRKN;SIRPA;SH3RF2;PER1;IGBP1;DUSP1;AIDA;QARS1;DACT1;CYLD
prerank,positive regulation of phospholipase C activity (GO:0010863),0.5591446061471972,1.3998160635475585,0.10290237467018469,0.7045713616645658,1.0,3/40,0.75%,NTF3;EDNRA;NTRK3
prerank,heart looping (GO:0001947),0.5511108145191237,1.399738955458109,0.12345679012345678,0.7029219079488035,1.0,3/39,1.54%,MEF2C;TBX2;MICAL2
prerank,positive regulation of DNA repair (GO:0045739),-0.39779024593750734,-1.3996751541538457,0.07782101167315175,0.7438866818560347,1.0,10/46,10.40%,EYA2;EYA1;EYA4;HMGB1;EGFR;SLF2;SMCHD1;XRCC1;BRCC3;SLF1
prerank,embryonic digit morphogenesis (GO:0042733),0.6396446780521887,1.3993420856322325,0.1282051282051282,0.7023963397005113,1.0,3/18,4.96%,MAP3K20;TBX2;OSR2
prerank,positive regulation of behavior (GO:0048520),0.7024635822651835,1.3982063505884366,0.14519056261343014,0.7044123147799098,1.0,1/10,0.72%,MEF2C
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.4592651909518039,1.3977864198333552,0.025278058645096056,0.7039861114740088,1.0,39/348,7.85%,MYOM1;ACTA2;NTF3;MYLK2;TTN;ACTG2;MEF2C;NTRK3;HEY2;ACTA1;ANGPT1;ROCK1;FGF1;CD36;LIMS1;MYD88;PDGFB;GABPA;HINFP;ACTG1;RBMS3;MUSK;UBR5;OSR2;EMILIN1;SLC38A2;TESC;SLC2A10;VEGFA;TP53;PTPN1;YAP1;AR;MED1;CELF1;PPARGC1A;C1QTNF1;NAT8;SOX9
prerank,regulation of monooxygenase activity (GO:0032768),-0.48500379529292514,-1.396636245613231,0.062146892655367235,0.7530741642132264,1.0,13/23,21.50%,POR;EGFR;LYPLA1;NOS1AP;NOSTRIN;NOS3;DDAH1;SNCA;NOSIP;AKT1;DDAH2;CYGB;SPR
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.6325747985975458,1.396576501269032,0.12419354838709677,0.7062851345774822,1.0,4/17,4.25%,ANGPTL8;LPL;SORT1;HDAC9
prerank,import into cell (GO:0098657),-0.4072351513874963,-1.3948023579337818,0.045081967213114756,0.7559284123456934,1.0,8/41,5.87%,ATP1A2;SLC6A13;SLC1A3;GLUL;SLC47A1;SLC12A7;SLC6A6;SLC7A5
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.4815460140368499,1.3945868367855472,0.0664451827242525,0.7113896866202291,1.0,17/116,9.57%,LHCGR;GPR20;ADCY5;CRHR2;FCGR3A;ADCY2;VIPR2;MYH9;ADCY9;TSHR;CYSLTR2;RAMP1;PRKACB;PRKAR1B;ADAM17;PTH1R;ADCY6
prerank,negative regulation of transmembrane transport (GO:0034763),-0.6036851542568162,-1.393996511227491,0.0944700460829493,0.7545231395779691,1.0,3/10,15.93%,PRKCB;CTTNBP2NL;AKT1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.46279739309055923,-1.3915025785748099,0.09480122324159021,0.7605836877879767,1.0,9/25,19.82%,SDF2;DNAJB12;HSPA5;BAG1;HSPA13;HSPA9;HSPE1;DNAJB4;ST13
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.6715182274817928,1.3903793948836876,0.140893470790378,0.7243416393531553,1.0,3/12,4.76%,LAMA5;ACTG1;ACTB
prerank,regulation of cell motility (GO:2000145),0.47854643181138795,1.3902350709347189,0.06622516556291391,0.722906218452365,1.0,12/121,4.00%,NEXN;FLNA;ROCK1;FGF1;CAVIN1;CDK6;PLXND1;PLXNB1;KIF2A;SERPINE2;DOCK10;NTN1
prerank,eye photoreceptor cell differentiation (GO:0001754),0.6576396513971632,1.3901116658052393,0.15726495726495726,0.7213768456151076,1.0,4/12,6.54%,NKD1;CEP290;DSCAM;VEGFA
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5091512680010971,-1.3899789762524308,0.08443271767810026,0.762766117730421,1.0,7/18,20.76%,UNC13C;UNC13B;GRIK3;SLC17A6;GRID2;GRIK1;SLC1A4
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.539094074443371,1.3899042225991314,0.11067193675889328,0.7201723131844994,1.0,10/46,9.52%,ITGA8;NTN4;LAMA5;FERMT2;PEAK1;LAMB2;LAMC1;ITGB3;ITGA4;PARVA
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.6549471053780911,1.3893591936047687,0.11442786069651742,0.7202003116990343,1.0,5/16,6.47%,AKAP6;ROCK1;CAMK2D;MEF2A;PARP1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.5132687798151158,1.3893232123470325,0.08462455303933254,0.7184025806277122,1.0,11/78,9.42%,MYOCD;PDGFB;CCNA2;CCND2;NR2F2;ACTB;HEXIM1;CCND1;ADAM17;CCNT1;CDK7
prerank,mesenchymal cell development (GO:0014031),0.6347240371099717,1.3891603344677979,0.11320754716981132,0.7170683884728497,1.0,5/18,8.81%,HEY2;HEYL;TAPT1;SNAI2;CDH2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5691281683334332,1.3889835364734262,0.13596491228070176,0.7158098164557121,1.0,7/27,11.25%,AGTR1;CD36;PLA2G3;LPL;ITGB3;PPARA;ABCG1
prerank,RNA destabilization (GO:0050779),0.6290449412890937,1.3884580532677473,0.125,0.7157880702173016,1.0,8/18,13.81%,RBM24;ROCK1;YTHDF2;CELF1;FTO;ROCK2;DXO;GIGYF2
prerank,cellular response to BMP stimulus (GO:0071773),-0.37348564626547814,-1.3877476911719315,0.0374331550802139,0.7677660935325025,1.0,17/66,10.41%,BMP6;TGFBR3;SMAD3;DDX5;BMP7;BMP4;SMAD6;ENG;RUNX2;ACVRL1;BMPR2;MEGF8;RGMB;SMAD9;TMEM100;TGFB1;PDCD4
prerank,transepithelial transport (GO:0070633),-0.5271098671647798,-1.387364008610074,0.09976798143851508,0.7644986966838709,1.0,4/15,4.01%,SLC1A3;ABCG2;SLC12A2;CXADR
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.5259556089983046,-1.3870097724521462,0.09476309226932668,0.7610929069706486,1.0,9/15,29.51%,USP46;NLGN1;STXBP1;SYN3;NLGN2;CLN3;DRD2;BAIAP3;CNTNAP4
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5058674666010112,-1.386468083505986,0.11704834605597965,0.7586411023254177,1.0,4/16,23.77%,CLDN5;CLDN11;CLDN1;CLDN14
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5418664054238536,-1.384933233889855,0.10561797752808989,0.7607890129376216,1.0,3/13,9.79%,ATP1A2;ATP1B3;ATP1B2
prerank,regulation of cellular component organization (GO:0051128),0.4751309504854809,1.384640188173029,0.058305830583058306,0.7277432676830886,1.0,22/135,7.01%,AGTR1;RAP1A;PAPPA2;STK38L;ROCK1;CD36;PLCE1;HIP1;RASGRP2;CDH13;PACSIN3;PACSIN2;CAMK2D;NET1;ERMN;ATAD3A;PRKCQ;SLITRK4;DAB2IP;SLC2A10;PTPN1;NEDD4
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.5701514716402037,-1.3842368117180528,0.11697247706422019,0.7590774839252029,1.0,4/12,5.51%,EPHA4;GLI2;MYCBP2;PAFAH1B1
prerank,ERAD pathway (GO:0036503),-0.3550507137067577,-1.3829441748357734,0.06962025316455696,0.7600532774964606,1.0,28/83,18.35%,ECPAS;ATXN3;RNF185;SEL1L;UBXN4;UBQLN1;DNAJB12;UFD1;DERL1;HSPA5;DNAJC10;USP19;TRIM25;UGGT2;PRKN;SGTA;UBE4B;STUB1;DNAJB2;RCN3;HSP90B1;SGTB;OS9;UBQLN2;DNAJB9;SYVN1;UBXN8;HERPUD1
prerank,protein import into mitochondrial matrix (GO:0030150),-0.4907125719515315,-1.3826907208138672,0.08785529715762273,0.756402387533825,1.0,12/18,39.39%,TIMM44;DNAJC19;TIMM17B;TOMM70;TIMM21;TIMM23;GRPEL1;DNLZ;TOMM40L;TOMM40;TIMM50;GRPEL2
prerank,microvillus organization (GO:0032528),0.6559784132902023,1.3824377362257445,0.1361344537815126,0.7336239170103891,1.0,6/13,12.33%,RAP1A;RAP2C;STK26;RAPGEF6;RAP2A;TNIK
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.4114347030454132,-1.3819963597640825,0.0684931506849315,0.7546845293993447,1.0,15/39,27.84%,TCF7L2;MYRIP;RBP4;MCU;PSMD9;NNAT;SOX4;NLGN2;CAPN10;AACS;ACSL4;DRD2;HFE;ADCYAP1;LRRC8A
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5130356290424908,1.381597751413599,0.1060419235511714,0.7345870233408459,1.0,17/59,15.00%,MYLK2;ROCK1;DYRK2;CAMK2D;DYRK1A;TAF1;DYRK1B;CHEK1;MAP3K10;MAP2K1;ROCK2;PRKCD;ACVR1B;CDC42BPB;LRRK2;MAPK1;PRKCA
prerank,protein depolymerization (GO:0051261),0.580572920646604,1.381251103308957,0.12893553223388307,0.7339365861380535,1.0,8/27,14.60%,DSTN;MICAL2;WDR1;KIF2A;CFL2;MICAL3;KIF18A;STMN2
prerank,"wound healing, spreading of cells (GO:0044319)",0.5981643403965787,1.3811002507191708,0.13808801213960548,0.7325837687700824,1.0,8/24,13.76%,FLNA;CCN1;LCP1;MRTFA;ADAM17;ARHGAP35;PDCD10;ARHGAP24
prerank,retinoic acid metabolic process (GO:0042573),-0.550315297886711,-1.3803838222261327,0.1025,0.7572653126584317,1.0,2/14,2.93%,ALDH1A2;CYP26B1
prerank,cellular response to misfolded protein (GO:0071218),-0.47969943509833807,-1.3795455416168558,0.08461538461538462,0.7565063279038179,1.0,8/20,11.46%,ATXN3;CUL3;RNF185;DNAJB12;UFD1;DERL1;UGGT2;STUB1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4895975662486691,1.3792651224574435,0.08018327605956473,0.7371218244250803,1.0,22/93,16.25%,NTF3;DMD;NTRK3;ATP2B4;HRC;BCAR3;CAV1;VEGFA;CNKSR3;GPD1L;PDE4D;PDCD10;DMTN;FNIP2;NCK2;GAS6;MLXIPL;INPP5J;PTEN;RAF1;NOS1;MAD2L2
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.47837371147995594,1.378620917203929,0.07597765363128492,0.7375362116941023,1.0,17/117,9.57%,LHCGR;GPR20;ADCY5;CRHR2;FCGR3A;ADCY2;VIPR2;MYH9;ADCY9;TSHR;CYSLTR2;RAMP1;PRKACB;PRKAR1B;ADAM17;PTH1R;ADCY6
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.36142135604727904,-1.3783699764584307,0.03125,0.7568857674116773,1.0,11/66,3.46%,TGFBR3;ROBO1;MCC;NF1;SULF1;SPARC;NUPR1;APOE;B2M;XDH;MTSS1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.3937676018986191,-1.377014423322429,0.028925619834710745,0.7581501017628783,1.0,11/45,5.61%,PIK3CA;EFEMP1;TGFA;GRB2;PDPK1;PTPN11;EGFR;PTK2;SLC30A10;GAB1;PTK2B
prerank,positive regulation of GTPase activity (GO:0043547),0.4638675639729152,1.3763510776425836,0.03948772678762007,0.7439140223258298,1.0,36/188,10.49%,NTF3;ARHGEF7;RAP1A;NTRK3;RALGAPA2;TBC1D1;RGS6;ABR;LIMS1;RASGRP2;FERMT2;DOCK8;PLXNB1;CCL5;BCAR3;DOCK10;ITGB1;NET1;TBC1D20;RSU1;ARHGEF16;MTSS2;LARS1;MAPRE2;RABGAP1;PIN1;CORO1C;RAPGEF6;RASGRP1;RALGAPA1;EVI5;RALGAPB;EPHA2;AGRN;SNX18;CCL14
prerank,polyol biosynthetic process (GO:0046173),-0.5148990830971081,-1.3758552214297877,0.09693877551020408,0.7586554938511952,1.0,10/16,29.40%,CYP27A1;IP6K1;ISYNA1;IP6K2;PPIP5K2;FGF2;ITPKB;IPPK;CYP2R1;PPIP5K1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5390608121630062,1.3755011359015499,0.10554089709762533,0.745121563305123,1.0,3/48,3.29%,CCDC3;SLIT3;PADI2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.5943465355552583,-1.3751393213957368,0.1252847380410023,0.7574738417335519,1.0,3/10,18.47%,RC3H2;NFKBIZ;ZC3H12A
prerank,protein K48-linked ubiquitination (GO:0070936),-0.3898003871134368,-1.3749582757129677,0.06637168141592921,0.7537198122115112,1.0,19/54,15.03%,TTC3;NEDD4L;RNF146;ITCH;CUL3;UBE2D3;RNF6;PELI1;UBE2E3;TOPORS;UBE2E2;PRKN;UBE3A;RNF34;SKP2;DTX3L;RNF115;UBE2H;KLHL3
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5045615569932609,1.3746012229099065,0.1166464155528554,0.7463918171435827,1.0,13/65,9.27%,ASPN;PRDM16;LTBP1;VASN;TGFB1I1;EMILIN1;CAV1;SLC2A10;PPM1A;PIN1;PPARA;ADAM17;SKI
prerank,modification-dependent protein catabolic process (GO:0019941),-0.31055356660754624,-1.3732526994730323,0.0,0.7569306773739715,1.0,71/193,22.61%,TTC3;NEDD4L;ARRB1;FBXL7;TRIP12;RNF146;ATXN3;AREL1;ITCH;FBXO10;CUL3;RNF185;ANAPC1;RNF20;UBQLN1;BIRC6;RNF144B;RC3H2;RNF217;UBL7;RNF6;UFD1;RNF13;WDR91;PSMD9;PSMD13;RNF213;MDM2;TOPORS;CDC23;TRIM25;FBXO7;PRKN;SMURF2;RNF144A;UBE4B;UBC;DDB1;RNF34;STUB1;RNF125;RNF166;DTX3L;SIAH1;BUB3;OS9;PSMC2;UBE2H;CDC26;KLHL3;TOLLIP;RNF43;UBQLN2;RNF130;ANAPC4;UBE2S;SYVN1;HERPUD1;SIAH2;ARRDC1;SPSB4;BTRC;CHFR;ARIH1;NUB1;PPP1R11;WDR81;UBB;UBE2B;ZNRF3;KEAP1
prerank,regulation of activated T cell proliferation (GO:0046006),-0.43957016006975513,-1.3732518591468306,0.0707070707070707,0.7525178878769372,1.0,6/30,8.39%,IGF1;IGFBP2;HMGB1;IL18;LGALS9;IGF2
prerank,positive regulation of receptor internalization (GO:0002092),0.5960567607487777,1.3732068799481196,0.1308411214953271,0.7495361820141245,1.0,5/22,10.50%,NTF3;ANGPT1;VEGFA;ATAD1;SCYL2
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.6947658267360408,1.3731464114802,0.1657559198542805,0.7478222468118048,1.0,1/10,0.55%,AOC3
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5906737748236139,-1.3728101320316957,0.09785202863961814,0.7502071240941605,1.0,5/10,21.17%,APP;RAB5A;SHANK3;SYP;DRD2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.44717179347468833,-1.3726237977819862,0.09146341463414634,0.7466631805606415,1.0,11/29,18.98%,IL31RA;IFNAR2;IL15;GHR;PKD2;SOCS2;CTR9;STAT2;IFNAR1;STAT5A;STAT6
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.4416752910917474,-1.372006020671531,0.09316770186335403,0.7450658903058305,1.0,15/26,34.42%,ITCH;PPM1B;MAPKBP1;ILRUN;PCBP2;IRAK3;TRIB1;TRIM21;NLRC3;NFKBIL1;NMI;TNFAIP3;SIGIRR;TYRO3;LYAR
prerank,negative regulation of heart contraction (GO:0045822),0.6543500291548237,1.3716159857667594,0.16370106761565836,0.7514800462524782,1.0,1/11,0.13%,PLN
prerank,protein localization to Golgi apparatus (GO:0034067),-0.4430191559462098,-1.371375746754898,0.07371794871794872,0.7436341714093163,1.0,13/27,25.10%,VPS13A;GBF1;ZDHHC15;OPTN;ARL5B;GCC2;GOLPH3;TMED10;COG7;OBSL1;GBP5;SYS1;ARL1
prerank,positive regulation of B cell proliferation (GO:0030890),0.5813034153419305,1.37100182651115,0.12372634643377002,0.7518338193793538,1.0,4/29,4.40%,MEF2C;IL2;TNFSF13B;BCL2
prerank,sodium ion homeostasis (GO:0055078),-0.48623153870698005,-1.3707505801313522,0.11396011396011396,0.7419990026662371,1.0,4/21,2.85%,ATP1A2;ATP1B3;NEDD4L;SLC12A2
prerank,cellular response to oxygen-containing compound (GO:1901701),0.4532539445463071,1.3704869339394938,0.019348268839103868,0.7517773442996227,1.0,49/291,11.28%,PDE3A;TPM1;MEF2C;RAP1A;ATP2B4;AKAP6;NR1H4;MYD88;PDGFB;RORA;ABCB4;PDK4;VIM;LPL;IGFBP5;FZD4;P2RY2;GUCY1B1;TSHR;CAMKK2;ACTB;CD14;UPF1;LARS1;TESC;IRS1;CPEB1;TAF1;MAPT;DAB2IP;CHMP5;SOX9;RELA;NFKBIB;ADNP2;CAPN2;IMPACT;GSTP1;NR1D1;ADCY6;CERS1;RRAGB;AXL;BRINP1;ROCK2;SH3BP4;GPER1;CD180;PRKCD
prerank,receptor-mediated endocytosis (GO:0006898),-0.32498426739910213,-1.3702589011729776,0.0,0.7397599790563423,1.0,39/132,18.75%,DAB2;DNM3;LRP1;SPARC;GRB2;FCHO2;DNAJC6;CALCRL;APOE;LDLR;FNBP1L;CTSL;SCARB2;CXCL16;CANX;DNM1;TMEM108;PPT1;SCARF1;EPS15;ARHGAP27;RAMP2;DNAJC13;RABEPK;HSP90B1;AP2S1;GRK2;INSR;SNCA;CALR;NLGN3;CLN3;LMBRD1;STAB1;CLTB;M6PR;CUBN;AP2A2;CLTA
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6293353024164832,1.3701853618749447,0.14638157894736842,0.7491336162386687,1.0,5/16,6.91%,DLC1;PHLDB2;CLASP2;ARHGAP6;CORO1C
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6293353024164832,1.3701853618749447,0.14638157894736842,0.7491336162386687,1.0,5/16,6.91%,DLC1;PHLDB2;CLASP2;ARHGAP6;CORO1C
prerank,positive regulation of vascular permeability (GO:0043117),0.6652708117477348,1.3695457295374365,0.1456140350877193,0.7494548039801968,1.0,2/12,1.27%,PDE3A;ANGPT1
prerank,microvillus assembly (GO:0030033),0.6430434567539587,1.3694557619970213,0.1505016722408027,0.7478991726375196,1.0,6/14,12.33%,RAP1A;RAP2C;STK26;RAPGEF6;RAP2A;TNIK
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.507812075593884,-1.3692638993552655,0.10344827586206896,0.7397252025913618,1.0,5/17,8.75%,ATP1A2;BMP7;BMP4;TFPI;NR3C1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.5759300044153358,-1.3692111765015507,0.0871559633027523,0.7358086964919043,1.0,3/11,1.59%,AFDN;TJP1;TJP2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.4940466088662442,1.3686550392640981,0.11417816813048934,0.7488847456907688,1.0,10/69,7.78%,NTF3;MEF2C;PLA2G3;CRLF1;TGFB3;SET;BCL2;GDNF;PPARGC1A;FZD9
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.6770478100278563,1.3676787099888246,0.16234887737478412,0.7505566503452358,1.0,2/11,1.90%,WTIP;LIMD1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.36087157261961955,-1.3673938520943374,0.05291005291005291,0.7395526456155175,1.0,24/69,18.35%,ECPAS;RNF185;SEL1L;UBXN4;UBQLN1;DNAJB12;UFD1;DERL1;HSPA5;DNAJC10;USP19;TRIM25;SGTA;UBE4B;STUB1;DNAJB2;HSP90B1;SGTB;OS9;UBQLN2;DNAJB9;SYVN1;UBXN8;HERPUD1
prerank,regulation of chemotaxis (GO:0050920),-0.4281328281932581,-1.3672418678291458,0.09342560553633218,0.7359781840295431,1.0,12/30,12.66%,PDGFRA;EFNB2;ADGRA2;MYCBP2;STX3;ZSWIM6;CYRIB;STX4;TGFB1;ZSWIM5;ZSWIM4;PPM1F
prerank,actin crosslink formation (GO:0051764),0.6569897230878062,1.3668134652079873,0.17094017094017094,0.7519549623376686,1.0,2/12,3.09%,FLNA;LCP1
prerank,regulation of ossification (GO:0030278),-0.4121366461723597,-1.3659417924552713,0.06521739130434782,0.7374715981496038,1.0,9/36,5.68%,PTN;SGMS2;BMP4;CHSY1;SMAD6;PTPN11;BMP2K;WNT5A;BMPR2
prerank,macrophage migration (GO:1905517),0.6384445930758517,1.3644905554327,0.14659685863874344,0.7584302274415002,1.0,2/13,3.45%,EDNRB;CCL5
prerank,keratan sulfate metabolic process (GO:0042339),-0.4194936875567671,-1.3644859098460689,0.08695652173913043,0.7392432508463069,1.0,15/31,23.36%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL1;B4GALT6;ST3GAL3;HEXA;FMOD;B4GALT4;GALNS;CHST2;SLC35D2;OMD;B3GNT2;B4GALT3
prerank,mitotic chromosome condensation (GO:0007076),0.5791140519162451,1.3641464808375574,0.15441176470588236,0.757794076068178,1.0,6/26,11.49%,TTN;SET;NCAPD3;TENT4A;RB1;NCAPD2
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.5613589353931876,1.3636926338199062,0.13105413105413105,0.7575662395367126,1.0,9/34,15.53%,MEF2C;GABRE;GRIN2C;GABRA4;GABRA5;GABRG1;INSYN2A;LRRK2;CHRNA4
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6615156234375487,1.363641337212634,0.17487266553480477,0.7558942031093088,1.0,3/11,6.91%,ARHGEF7;KANK1;CORO1C
prerank,regulation of DNA repair (GO:0006282),-0.38688403697760954,-1.3636058045254857,0.08196721311475409,0.7386456043896971,1.0,9/44,9.43%,EYA2;EYA1;EYA4;TRIP12;EGFR;PML;SMCHD1;SIRT7;BRCC3
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5182238851223891,1.3630646772483108,0.12928759894459102,0.7560662307505578,1.0,11/47,11.28%,AGTR1;CD36;PDGFB;SLC5A3;DHRS4;MAPT;TP53;CBR1;GSTP1;PDGFRB;PRKCD
prerank,regulation of endothelial cell migration (GO:0010594),-0.34882366770723716,-1.362963316113774,0.024539877300613498,0.7373133114472379,1.0,23/85,8.78%,PTN;SASH1;NF1;FOXP1;DCN;GLUL;NRP2;SPARC;BMP4;SLIT2;APOE;TEK;NRP1;PTK2;WNT5A;ACVRL1;PTPRM;PTK2B;BMPR2;FOXC2;PIK3CB;ANXA3;BMPER
prerank,negative regulation of cell cycle (GO:0045786),0.49763854535420465,1.362886832363187,0.11561382598331346,0.7548264800346868,1.0,14/73,11.46%,MYOCD;CDK6;NR4A1;GMNN;BTG2;NR2F2;RPS6KA2;HEXIM1;HECA;BTG1;BRINP1;GPER1;TRIM35;RB1
prerank,regulation of telomere maintenance (GO:0032204),-0.4374310609467278,-1.3624423630875422,0.08868501529051988,0.7354283264818463,1.0,15/26,25.48%,XRCC5;SMG1;MRE11;PML;RAD50;USP7;GNL3;NBN;HNRNPD;TERF2IP;SMG6;YLPM1;ERCC1;ERCC4;TINF2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5256564102271442,-1.3610779123450683,0.10471204188481675,0.7370602123360409,1.0,6/14,16.91%,SPRED2;XDH;ZEB1;OSR1;SPRY2;NOTCH4
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.6592577645604906,1.3606164230510671,0.14462081128747795,0.7609247407122862,1.0,4/11,7.78%,HEY2;JAG1;BMPR1A;TGFB2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.5721103547097344,1.3595822253579457,0.138328530259366,0.7626770482583234,1.0,2/27,1.24%,MAP3K20;MAP3K5
prerank,negative regulation of inflammatory response (GO:0050728),0.4572789667987856,1.3593455785789332,0.06900212314225053,0.76176850852732,1.0,34/182,11.46%,LHCGR;GPR20;NR1H4;ADCY5;CRHR2;FCGR3A;ADCY2;VIPR2;RORA;MYH9;FEM1A;ADCY9;PTGIS;TSHR;ALOX5;MFHAS1;CYSLTR2;CD200R1;TNFAIP6;CD200;RAMP1;LPCAT3;PRKACB;PRKAR1B;PPARA;ADAM17;GSTP1;NR1D1;PTH1R;ADCY6;AOAH;GPER1;PRKCD;RB1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.5229174483845079,1.359167746271261,0.13246753246753246,0.7605494385813735,1.0,9/49,8.79%,MYL9;MEF2C;THPO;CBFB;CNOT4;PRKCQ;TESC;KMT2D;RUNX1
prerank,protein N-linked glycosylation (GO:0006487),-0.36884178546198776,-1.3586373737406572,0.034653465346534656,0.7434244162035198,1.0,30/66,27.83%,MAN1C1;MGAT4C;TUSC3;B4GALT1;ST3GAL1;MGAT1;PGM3;SLC39A8;FUT8;MGAT4B;ENTPD5;UGGT2;OSTC;MCFD2;PMM2;MGAT5;MPDU1;LMAN1;ALG14;ALG1;B4GALT7;ALG12;RPN2;GFPT2;MGAT2;DPM3;STT3B;MGAT4A;PMM1;ASGR1
prerank,modulation by symbiont of host process (GO:0044003),-0.5781814935942373,-1.358590787573656,0.10810810810810811,0.7397017602843425,1.0,7/10,30.35%,B2M;UBC;PGK1;HGS;UBB;ENO1;MRC1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5857707868417309,-1.3581977266128293,0.12727272727272726,0.7372271322766804,1.0,8/10,34.78%,FN1;HSP90AB1;FURIN;GATA6;CD24;TSKU;TYROBP;CDH3
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.32154087216215965,-1.3580610009100185,0.025,0.7339133434451781,1.0,35/128,13.47%,BMP6;TGFBR3;SMAD3;APPL2;DDX5;BMP7;BMP4;CDH5;PXN;COL1A2;SMAD6;ENG;RUNX2;PTK2;ACVRL1;ID1;BMPR2;MEGF8;RGMB;SMAD9;CLDN5;ZMIZ1;FURIN;FKBP1A;ZMIZ2;TMEM100;SMURF2;TGFB1;PDCD4;UBC;STUB1;TGFBR1;ZYX;ARHGEF18;APPL1
prerank,mRNA splice site selection (GO:0006376),-0.43565556905390557,-1.3557091783432176,0.0778816199376947,0.7397768407601347,1.0,8/30,10.98%,CELF2;KHDC4;SRSF6;SRSF5;CELF4;SETX;SFSWAP;ISY1
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.38680692298772695,-1.3551573884452395,0.05303030303030303,0.7383785489060102,1.0,21/44,30.40%,NF1;BMP7;BMP4;APOE;STK38;PIK3CB;PTPN22;IRAK3;PDCD4;LYN;SPRY2;DUSP1;AIDA;HIPK3;DUSP7;MAPK8IP1;UCHL1;PTPRJ;SPRY1;SPRY4;DUSP19
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.6565821301471607,1.3551255691304387,0.16817359855334538,0.7713786619173755,1.0,3/11,10.33%,TRDN;CALM1;SRI
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.6565821301471607,1.3551255691304387,0.16817359855334538,0.7713786619173755,1.0,3/11,10.33%,TRDN;CALM1;SRI
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.613970282662599,1.354889826830142,0.1505016722408027,0.7703863529481808,1.0,4/16,5.12%,MEF2C;AKAP6;TBX2;BMPR1A
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.5040278669036252,-1.3547350057971714,0.11510791366906475,0.7363966732959212,1.0,7/16,17.98%,AUTS2;CTR9;CTNNB1;SNW1;BCOR;SMAD4;KDM1A
prerank,regulation of phospholipase C activity (GO:1900274),0.6225804124809989,1.3546829683965158,0.15692821368948248,0.7692807644533995,1.0,2/15,0.75%,NTF3;NTRK3
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.535934717306322,-1.354627439816036,0.12162162162162163,0.7331310807082372,1.0,7/13,18.82%,BMP7;SOX13;NAPEPLD;SIX1;PTGS2;TFE3;METRNL
prerank,DNA damage checkpoint signaling (GO:0000077),0.5592515024354482,1.3545001145070397,0.1492109038737446,0.768064939934379,1.0,11/28,14.35%,MAP3K20;HINFP;BRIP1;RAD9A;CHEK1;ERCC6;STK33;FBXO6;RHNO1;CLOCK;INTS7
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6871730988540654,1.3541570325113204,0.17481203007518797,0.7675135068140738,1.0,4/10,11.28%,PRKG1;SERPINE2;C1QTNF1;PRKCD
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.5267555266615745,-1.3536800042135737,0.11031175059952038,0.7331871277378117,1.0,7/14,22.78%,KMT2E;AUTS2;CTR9;CTNNB1;SNW1;SMAD4;PRDM9
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5169201132037863,-1.353365243506356,0.13316582914572864,0.7306907380450062,1.0,4/15,2.85%,ATP1A2;ATP1B3;NEDD4L;SLC12A2
prerank,metanephric mesenchyme development (GO:0072075),-0.5943056469041957,-1.352356202264745,0.11187214611872145,0.7310899724648604,1.0,4/10,10.83%,WNT4;PKD2;OSR1;SIX1
prerank,sensory organ development (GO:0007423),-0.3759575107934921,-1.3523182692010725,0.034334763948497854,0.7275515919192223,1.0,8/51,9.99%,SHROOM2;SMOC1;CHD7;PBX3;RBP4;ECE1;SMCHD1;MEIS2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.575926333134641,1.35223534296996,0.1480916030534351,0.7724149683188177,1.0,6/24,6.54%,ROCK1;LIMS1;FERMT2;MAPRE2;DUSP3;VEGFA
prerank,neural crest cell migration (GO:0001755),-0.4229092518840062,-1.3518055462824898,0.09019607843137255,0.7260758726537071,1.0,11/36,10.54%,SEMA3D;SEMA3C;SEMA6A;FN1;NRP1;RADIL;ANXA6;SEMA7A;SEMA3A;SEMA4D;SEMA6D
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5682881811532436,-1.3512356069693712,0.1310344827586207,0.724801398227142,1.0,3/11,12.27%,TGFBR3;TGFB1;TGFBR1
prerank,positive regulation of interferon-beta production (GO:0032728),-0.41839513911758464,-1.351199654133903,0.07518796992481203,0.7213583017867302,1.0,13/33,25.69%,DDX3X;PTPN11;RNF135;POLR3F;RIOK3;POLR3B;POLR3A;TRIM56;TLR3;OAS2;POLR3C;TOMM70;POLR3D
prerank,negative regulation of protein catabolic process (GO:0042177),0.5344731900999902,1.3503665847864803,0.13025780189959293,0.7773194013553733,1.0,12/40,16.47%,FLNA;ROCK1;DAB2IP;PIN1;TIMP4;SF3B3;SIRT2;ADGRB1;CTSA;AZIN2;MAD2L2;AGAP2
prerank,positive regulation of intracellular transport (GO:0032388),0.5375794751090237,1.3502555441829391,0.14597544338335608,0.7758340177799085,1.0,10/38,12.64%,ATP2A1;OAZ2;EHD2;TBC1D20;CEP290;NEDD4;ACTN2;STX18;PDCD10;KIF20B
prerank,cellular response to glucagon stimulus (GO:0071377),0.6059085781683655,1.3497020418901005,0.15358931552587646,0.7760291617816687,1.0,7/17,9.57%,ADCY5;ADCY2;ADCY9;CYSLTR2;PRKACB;PRKAR1B;ADCY6
prerank,cytoplasmic sequestering of protein (GO:0051220),0.651468147168661,1.3483876030374955,0.16934046345811052,0.7787932826238887,1.0,4/13,11.32%,FLNA;NFKBIE;GET4;GOPC
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.33605153831477635,-1.3481346848584381,0.037037037037037035,0.7306661532388403,1.0,24/87,13.47%,TGFBR3;SMAD3;APPL2;CDH5;PXN;COL1A2;SMAD6;ENG;PTK2;ACVRL1;ID1;SMAD9;CLDN5;ZMIZ1;FURIN;FKBP1A;ZMIZ2;TGFB1;UBC;TGFBR1;ZYX;FMOD;ARHGEF18;APPL1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.3336159270016388,-1.3481126052244452,0.056179775280898875,0.7271821094667847,1.0,32/88,22.49%,VPS13A;ARRB1;DNAJC6;APP;RABEP1;MON2;SCAMP2;GBF1;PUM1;SORCS1;STX4;COMMD1;FTL;DTNBP1;AP1M1;FTH1;EPS15;EXOC2;HGS;STEAP2;VAMP8;SH3GL2;EXOC1;SCFD1;CLTA;SCAMP3;CLINT1;AP1B1;ACBD3;VAMP7;SYS1;SCAMP1
prerank,regulation of cytoskeleton organization (GO:0051493),0.467754535414537,1.3480279359458178,0.10089686098654709,0.778149912312776,1.0,33/108,18.78%,NEXN;DLC1;ROCK1;PHLDB2;PLXNB1;RHOBTB3;BICD2;TPPP;MAPT;ARHGAP17;RHOF;CAPN2;PAK2;PDGFRB;ROCK2;PDGFA;PRKCD;RHOH;ARHGAP35;RICTOR;DMTN;CLASP1;MAPK1;PRKAA2;RHOG;CDK2AP2;CLIC4;MARK2;S100A8;S100A9;BICD1;MAP6;ABL1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.5358738598786272,1.3478739686182486,0.12584573748308525,0.776829275163926,1.0,9/39,8.47%,ACTN4;MYO1E;MYO1D;MYO1B;MYO5C;KIF1A;F8A1;KIF5B;TRAK1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5496525302623095,1.3478003124986955,0.14407988587731813,0.7752625421296707,1.0,3/33,3.42%,NTF3;ABR;SLC4A8
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.45528819206513066,-1.346766314156453,0.09850746268656717,0.7290196121645389,1.0,10/25,11.46%,ATXN3;CUL3;RNF185;NGLY1;UFD1;DERL1;ZER1;UGGT2;ZYG11B;STUB1
prerank,embryonic limb morphogenesis (GO:0030326),0.5427401971210651,1.3465564589542893,0.1393103448275862,0.7779698412067125,1.0,7/34,10.39%,MAP3K20;CACNA1C;TBX2;OSR2;TGFB2;SKI;MBNL1
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4501074935115044,-1.3465265461653395,0.1,0.7264079120111243,1.0,14/24,28.30%,PALM;DOCK11;NRP1;NLGN1;FNBP1L;RIPOR2;DPYSL3;RHOQ;CDC42;FMR1;GPM6A;FSCN1;ARAP1;TENM1
prerank,chromosome condensation (GO:0030261),0.5383116856443422,1.346199215548561,0.15694444444444444,0.7774946816609496,1.0,8/36,11.49%,TTN;H1-0;SET;NCAPD3;TENT4A;GPER1;RB1;NCAPD2
prerank,regulation of vasoconstriction (GO:0019229),0.5602523620554904,1.346124865798139,0.14540059347181009,0.7759222997903963,1.0,5/27,8.71%,AGTR1;ADRA1D;CAV1;ATP2B1;TRPM4
prerank,sphingoid metabolic process (GO:0046519),-0.546444485480494,-1.34609301907684,0.13975903614457832,0.7246536195573181,1.0,9/12,43.68%,NAAA;SGPP1;ASAH2;SPHK1;DEGS2;PLPP2;SPHK2;PLPP1;SPTLC3
prerank,eye morphogenesis (GO:0048592),-0.4889579926578943,-1.3459354502248595,0.11977715877437325,0.7217894292515687,1.0,9/19,10.01%,SHROOM2;FBN1;NF1;EFEMP1;FBN2;MFAP5;IFT122;COL5A1;TENM3
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.48958976878084554,-1.3453375307715665,0.14325842696629212,0.7206571371972137,1.0,4/18,5.28%,PRKCB;PRKAG2;SLC2A1;OCLN
prerank,Rho protein signal transduction (GO:0007266),0.5104676555705742,1.345182251732081,0.13266583229036297,0.7774173360863642,1.0,13/53,11.44%,AGTR1;ROCK1;CDC42EP3;CDH13;MYO9B;NTN1;ARHGAP6;ARHGDIG;RHOJ;GNA12;ARHGAP1;ROCK2;ARHGAP5
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6451213926860141,1.3451599049262235,0.15370705244122965,0.7756933875258667,1.0,4/13,3.61%,CD36;CDH13;LPL;ITGB1
prerank,potassium ion transport (GO:0006813),0.4712006609128435,1.3451016738607375,0.08183856502242152,0.7740718525324919,1.0,11/120,5.55%,KCNAB1;KCNMA1;KCNJ12;KCNMB1;KCNA5;KCNQ5;KCNQ4;KCNN2;KCNB1;CCDC51;KCNH1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6450762013462228,1.3450281678013576,0.16755793226381463,0.7707510126474633,1.0,2/12,1.17%,AKAP6;LMCD1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.6450762013462228,1.3450281678013576,0.16755793226381463,0.7707510126474633,1.0,2/12,1.17%,AKAP6;LMCD1
prerank,protein localization to cell junction (GO:1902414),-0.45863700244486094,-1.3443546144729532,0.09248554913294797,0.7210869174480208,1.0,9/22,14.59%,TJP1;CGNL1;TJP2;HEG1;NLGN1;NECTIN1;ARHGEF18;NLGN2;PCLO
prerank,sphingosine metabolic process (GO:0006670),-0.4874397170170157,-1.3436985498949217,0.1211340206185567,0.7202463738791645,1.0,5/17,9.83%,SPTLC2;ACER2;NAAA;SGPP1;ASAH2
prerank,cAMP metabolic process (GO:0046058),0.6306478697773513,1.3433588722443044,0.17247386759581881,0.7748499969936264,1.0,6/13,11.32%,ADCY5;ADCY2;ADCY9;EPHA2;ADCY6;PDE4D
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.5743012700290844,1.3413221602829368,0.15239477503628446,0.7802454891196888,1.0,7/29,10.43%,RBM24;TENT5B;CIRBP;GDNF;NBAS;FUS;HNRNPU
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.4369537628699207,-1.3412535294474022,0.09668508287292818,0.7270417535183687,1.0,8/25,5.68%,FOXD1;SULF1;ZNF423;BMP4;CDH5;ENG;ACVRL1;BMPR2
prerank,regulation of actin filament polymerization (GO:0030833),0.49681129493943965,1.34114917892637,0.12469437652811736,0.779096472601579,1.0,4/69,3.34%,LMOD1;LMOD2;CDC42EP3;KANK1
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.530538354026203,-1.3403549456142267,0.1575178997613365,0.7272044394120066,1.0,9/13,39.49%,GAB2;STX4;LAMP1;SYK;AP1G1;ITGB2;ITGAM;FGR;SPHK2
prerank,positive regulation of response to wounding (GO:1903036),0.5687510939928466,1.339347389266018,0.15994020926756353,0.7836577990017345,1.0,5/24,3.64%,MYLK;ANXA1;KANK1;ITGB1;ACTG1
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.4103787131691486,-1.3390923140607076,0.1103202846975089,0.7290083665924687,1.0,22/33,37.84%,STN1;MRE11;HSP90AB1;RAD50;ANKRD28;CTC1;PPP6R3;TERF2IP;WRAP53;TELO2;CDK2;DCLRE1B;GAR1;TINF2;PPP6C;NOP10;ACD;ZBTB48;RAD51;RPA1;RFC1;NHP2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5634103185092341,-1.3390743121305222,0.1201923076923077,0.7256830348422093,1.0,5/11,11.35%,DDX5;BMP4;EGFR;TGFB1;MAP2K2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.49896509334685574,1.338946587897972,0.11883691529709228,0.7833293155245383,1.0,13/64,8.25%,VCL;ROCK1;CD36;CDK6;CDH13;JAG1;ACTG1;PEAK1;UTRN;DUSP3;AJAP1;CORO1C;DAPK3
prerank,positive regulation of viral life cycle (GO:1903902),0.6002372762247861,1.3384917902059563,0.15014577259475217,0.7831307803237959,1.0,6/22,13.62%,TMPRSS4;AXL;CHMP2B;KPNA2;TSG101;CHMP2A
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5388258221251983,1.3380779905147944,0.150354609929078,0.7828533194908942,1.0,5/33,5.46%,MEF2C;ATP2B4;ANGPT2;ANGPT4;MMRN2
prerank,phosphatidic acid metabolic process (GO:0046473),0.5144918596527587,1.3378715250522948,0.1316818774445893,0.7818204445291487,1.0,3/48,2.35%,DGKB;DGKG;PLA2G3
prerank,negative regulation of hemostasis (GO:1900047),-0.5364289010256545,-1.3373692346459523,0.14545454545454545,0.728963799075551,1.0,5/12,8.19%,APOE;VTN;TFPI;CD34;THBD
prerank,proteoglycan metabolic process (GO:0006029),-0.43491545151593564,-1.337342258334564,0.10793650793650794,0.7256909216007741,1.0,10/26,20.19%,IGF1;CHST11;SULF1;BMPR2;CHST9;CANT1;XYLT1;FOXL1;CHST12;B4GALT7
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.5260156576757571,1.3373157689909716,0.13852242744063326,0.7818818305472907,1.0,10/48,9.68%,GUCY1A1;AMPD1;ADCY5;ADCY2;ADCY9;GUCY1B1;AMPD2;NUDT2;ADCY6;NPR2
prerank,regulation of vasculogenesis (GO:2001212),0.6232253313023912,1.3371850502368967,0.17667238421955403,0.7805699846432251,1.0,4/14,8.24%,RAP1A;HEY2;RRAS;RIN2
prerank,vasculature development (GO:0001944),-0.5086339571779094,-1.3367095514472862,0.10972568578553615,0.7247809931106397,1.0,6/16,9.33%,PIK3CA;PDGFRA;CDH5;ACVRL1;BMPR2;STK11
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.46772949348279275,1.3361083731287031,0.11235955056179775,0.7827115931209349,1.0,19/104,10.70%,ASPN;PRDM16;RBPMS2;VASN;CRIM1;FST;ACVR2A;TGFB1I1;BMPR1A;EMILIN1;CAV1;SLC2A10;PPM1A;PIN1;PPARA;ADAM17;SKI;VWC2L;UBE2D1
prerank,pharyngeal system development (GO:0060037),-0.5104488542234396,-1.3351975378062257,0.11055276381909548,0.7272611132296991,1.0,6/15,12.27%,BMP7;BMP4;PTCH1;BMPR2;HES1;TGFBR1
prerank,epithelial tube morphogenesis (GO:0060562),0.5443175967960214,1.3351898597976048,0.15683453237410072,0.7840978413295221,1.0,3/32,0.73%,RYR2;MEF2C;COL4A1
prerank,positive regulation of glucose metabolic process (GO:0010907),0.6311757914268415,1.334918921440415,0.18134715025906736,0.7833059100679324,1.0,6/14,14.87%,PMAIP1;IRS1;PPARGC1A;ARPP19;NNMT;IRS2
prerank,heterochromatin organization (GO:0070828),0.6267468789427757,1.3344672485816162,0.16234887737478412,0.78318750523431,1.0,2/14,2.97%,PRDM16;LOXL2
prerank,motor neuron axon guidance (GO:0008045),0.6350174891191321,1.3333001426131732,0.18074324324324326,0.785405132598968,1.0,3/15,4.66%,SLIT1;NTN1;CHN1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.4997541766237696,-1.3332649481329208,0.13730569948186527,0.7314604622468249,1.0,6/16,18.47%,APPL2;APOD;ADCY7;PDCD4;SIRPA;ZC3H12A
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.4390329415027867,-1.3318360769377424,0.10031347962382445,0.7339674504246358,1.0,11/26,22.76%,SPTLC2;ACER2;NOS3;CYP1B1;ASAH2;GCH1;AKT1;DDAH2;SPR;ABCA2;SPHK1
prerank,amino sugar metabolic process (GO:0006040),0.6469844574049504,1.331591075180231,0.1973929236499069,0.7896322733369346,1.0,4/10,9.84%,CSGALNACT1;GNE;GFPT1;ST6GAL1
prerank,positive regulation of protein binding (GO:0032092),-0.3691496136187292,-1.3308159942257374,0.0776255707762557,0.7349052398335759,1.0,15/56,9.61%,LRP1;TCF7L2;BMP4;APP;APOE;VTN;B2M;PPP2CA;NVL;CLDN5;PPP2CB;DERL1;NMD3;FKBP1A;PRKN
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.5111767561690985,-1.3306119996132582,0.11302211302211303,0.7323401279957019,1.0,10/13,44.49%,B3GALNT1;B3GNT2;B3GALT2;B3GALT1;B3GNT9;B3GNT3;B3GNT8;GAL3ST3;B3GNT6;B4GAT1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.6153821091728401,1.3303678453773875,0.18845500848896435,0.79238839808112,1.0,2/15,2.53%,FGF1;SEMA5A
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.48617687729558573,1.3300726615752119,0.12094763092269327,0.7916585494117347,1.0,16/65,12.13%,ARHGEF7;HIP1;ITGA1;CDH13;BCAR3;NUP62;DAB2IP;DUSP3;NEU3;DOK1;AREG;DGKD;HBEGF;STAM2;GPER1;TSG101
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.5722597162007258,1.3289017033734032,0.16539050535987748,0.7939971362939501,1.0,7/25,11.01%,HIP1;BCAR3;NUP62;NEU3;DOK1;DGKD;GPER1
prerank,protein glycosylation (GO:0006486),-0.3172040308422366,-1.3288177613337446,0.030612244897959183,0.7360494584296742,1.0,47/125,27.22%,MAN1C1;ST3GAL4;MGAT4C;TUSC3;B4GALT1;ST3GAL6;ST8SIA4;ST3GAL1;GALNT10;ST3GAL5;ST8SIA1;TET3;MGAT1;PGM3;SLC39A8;SERP2;FUT8;MGAT4B;TET2;ENTPD5;FUT10;ST3GAL3;ST8SIA2;OGT;B3GALNT1;PLOD2;PMM2;MGAT5;COG7;PLOD3;ALG1;B4GALT7;ALG12;B3GNT2;POMT1;RPN2;B3GALT2;EOGT;GFPT2;NPC1;MGAT2;DPM3;STT3B;MGAT4A;SERP1;PMM1;ST6GALNAC2
prerank,negative regulation of endopeptidase activity (GO:0010951),0.5102050462527443,1.3287731487095855,0.14416775884665792,0.7926671117723272,1.0,4/47,6.91%,SERPINB8;SERPINI1;SERPINE2;TIMP4
prerank,cellular defense response (GO:0006968),0.5209659377148673,1.328687595777419,0.1455026455026455,0.7912391477130936,1.0,5/40,7.91%,NCF2;LGALS3BP;ITGB1;VEZF1;RELA
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.6271934443179715,1.3282411792362636,0.1872852233676976,0.7911621971587175,1.0,3/13,4.77%,CACNA1H;SYT10;KCNB1
prerank,cell junction organization (GO:0034330),0.4860722272877559,1.328218114048279,0.11124694376528117,0.7895107555221474,1.0,14/71,7.78%,FLNA;MYOT;LIMS1;FERMT2;SLC8A2;TGFB3;ACTG1;FLNC;ACTB;PPFIBP2;MAPT;LIMS2;PIN1;TGFB2
prerank,DNA integrity checkpoint signaling (GO:0031570),0.5309440318737646,1.3266541678186086,0.15049226441631505,0.7932521011522148,1.0,12/36,14.35%,MAP3K20;HINFP;BRIP1;TIPIN;RAD9A;CHEK1;ERCC6;HUS1B;FBXO6;RHNO1;CLOCK;INTS7
prerank,positive regulation of axonogenesis (GO:0050772),-0.38695200665022267,-1.3256714982743414,0.06557377049180328,0.7454808372289777,1.0,9/43,7.77%,PLXNA2;ROBO1;SLIT2;SEMA7A;RUFY3;TIAM2;GOLGA4;SEMA4D;PLXNA4
prerank,determination of heart left/right asymmetry (GO:0061371),0.5204548174123833,1.3254540217465802,0.14972527472527472,0.7957905011063386,1.0,3/42,1.54%,MEF2C;TBX2;MICAL2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.5064931057934827,-1.3253434167983376,0.15165876777251186,0.7435200099233813,1.0,2/14,0.73%,ANK2;ATP1B3
prerank,positive regulation of lyase activity (GO:0051349),0.6348660241347421,1.3250847405825705,0.18150087260034903,0.7954485499703579,1.0,3/14,4.30%,CACNA1C;STIM1;FXN
prerank,regulation of stress fiber assembly (GO:0051492),0.4833425654384327,1.32470185926468,0.14285714285714285,0.7951201467124543,1.0,11/74,4.80%,TPM1;DLC1;ROCK1;SYNPO2L;FERMT2;PHLDB2;CLASP2;TGFB3;ACTG1;PPM1E;ARHGAP6
prerank,synaptic vesicle recycling (GO:0036465),-0.4236498135021482,-1.3243298610620524,0.11842105263157894,0.74413694760954,1.0,13/31,15.92%,FCHO2;RAB5A;NLGN1;SYT1;CANX;STON2;OPHN1;TBC1D24;SNCA;NLGN2;NLGN3;PLD2;STX1A
prerank,positive regulation of acute inflammatory response (GO:0002675),0.6083118311988202,1.3233371877532818,0.19930675909878684,0.7982373002133508,1.0,1/14,1.48%,PTGER3
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.37712296327306455,-1.3232799898118641,0.092,0.7448564058883713,1.0,13/46,10.77%,LGR4;ALDH1A1;ZNF423;IL15;NPR3;NRDC;IP6K1;ID1;FOXC2;NOVA1;STK11;LAMA4;RHEB
prerank,peptidyl-amino acid modification (GO:0018193),-0.5586394742098125,-1.323038388969169,0.16414686825053995,0.7425350865512242,1.0,3/10,11.17%,METAP1D;TTLL4;FKBP10
prerank,B cell homeostasis (GO:0001782),0.6590595689566204,1.3224259306872188,0.21715328467153286,0.7996845931067039,1.0,2/10,3.57%,MEF2C;DOCK10
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.5171760178627495,-1.3221959526663893,0.14987714987714987,0.742740664128987,1.0,7/14,21.60%,PIK3CA;NRP1;GAB1;KDR;VEGFC;VEGFB;FLT4
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.64942933610101,1.3219648035702596,0.18974358974358974,0.799554729496751,1.0,2/11,3.05%,ANXA1;SOCS5
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.5100154979248417,1.3210083242812871,0.15013054830287206,0.8011163916233657,1.0,2/46,0.44%,DGKB;DGKG
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.4259762971190979,-1.3209739752519054,0.11764705882352941,0.7440554238715846,1.0,13/26,23.36%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL1;B4GALT6;ST3GAL3;FMOD;B4GALT4;CHST2;SLC35D2;OMD;B3GNT2;B4GALT3
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5391455764747918,1.3205514186503389,0.1553672316384181,0.8009700846696429,1.0,13/33,19.01%,MAP3K5;ANXA1;NET1;FXN;RELA;IMPACT;PRKCD;TRPM2;PLEKHA1;ANKZF1;ABL1;SIGMAR1;HDAC6
prerank,positive regulation of gene expression (GO:0010628),0.43488077224557165,1.320218330751138,0.033099297893681046,0.8004139010365892,1.0,52/442,8.43%,MYOM1;ACTA2;MYLK2;TTN;ACTG2;MEF2C;NTRK3;RBM24;HEY2;ACTA1;ANGPT1;ROCK1;FGF1;CD36;POLR2L;LIMS1;MYD88;PDGFB;VIM;GABPA;HINFP;SAMD4A;ACTG1;RBMS3;NAT10;MUSK;UBR5;ACTB;OSR2;EMILIN1;SLC38A2;DYRK1A;TESC;U2AF2;MYBBP1A;SLC2A10;VEGFA;TP53;RPS27L;CIRBP;YAP1;AR;MED1;CELF1;PPARGC1A;C1QTNF1;NAT8;SOX9;ERCC6;TENT4A;PYM1;CUX2
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.6395082989186007,1.3198994526609737,0.17437722419928825,0.7999135388739862,1.0,2/12,2.87%,CD36;SLC5A3
prerank,cellular protein catabolic process (GO:0044257),-0.3633291031908756,-1.3197888003054086,0.06511627906976744,0.7453588494784701,1.0,21/59,23.22%,DENND3;RAB12;CTSL;CTSH;CASP8;AFG1L;MDM2;PRKN;AP2S1;CTSB;TCIRG1;YME1L1;CLPX;CHEK2;SIAH2;AP2A2;CLTA;BNIP3L;CLPP;CTSS;MAGEC2
prerank,regulation of tube diameter (GO:0035296),0.644411639494146,1.319123434203391,0.18228279386712096,0.7992148013157222,1.0,2/13,1.44%,AGTR1;ROCK1
prerank,vascular process in circulatory system (GO:0003018),0.644411639494146,1.319123434203391,0.18228279386712096,0.7992148013157222,1.0,2/13,1.44%,AGTR1;ROCK1
prerank,reticulophagy (GO:0061709),-0.5406618647950678,-1.3190431930303754,0.14634146341463414,0.7449109345439519,1.0,5/12,13.19%,RB1CC1;RETREG1;TEX264;ATG2B;ATG2A
prerank,neural crest cell differentiation (GO:0014033),0.6060660027194026,1.3185537495613642,0.18973561430793157,0.7995224091243914,1.0,5/18,11.69%,MEF2C;TAPT1;SNAI2;CDH2;HTR2B
prerank,excitatory postsynaptic potential (GO:0060079),0.5914254049185552,1.318435142627767,0.18808777429467086,0.7982924708905665,1.0,2/19,2.89%,MEF2C;GRIN2C
prerank,synapse organization (GO:0050808),0.4541855698922796,1.3182619826841815,0.11098901098901098,0.7972008975571503,1.0,24/125,8.81%,CACNB2;MYOT;IGFN1;FZD5;PLXND1;SLC8A2;PDZRN3;MUSK;CACNB4;KIRREL3;PTPRS;DOK7;GPC4;PPFIBP2;PTPRF;DSCAM;MAPT;PCDHB14;PIN1;NEDD4;CYFIP1;PCDHB11;ARHGAP39;CDH2
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.5114002020772157,-1.3165600695433313,0.15270935960591134,0.7516581192569185,1.0,8/14,18.98%,PXN;GHR;PTK2;SOCS2;LYN;PRLR;STAT5A;STAT6
prerank,positive regulation of hydrolase activity (GO:0051345),0.45173851243517793,1.316382983700213,0.10363836824696802,0.8019260796714227,1.0,26/137,10.49%,ARHGEF7;RAP1A;RGS6;LIMS1;RASGRP2;FERMT2;DOCK8;PLXNB1;CCL5;BCAR3;DOCK10;ITGB1;NET1;TBC1D20;RSU1;LARS1;MAPRE2;PIN1;CD200;CALM1;RAPGEF6;RASGRP1;EVI5;AGRN;SNX18;CCL14
prerank,neuronal action potential (GO:0019228),0.5671720773753446,1.3150377864782283,0.1872146118721461,0.8050209406104104,1.0,2/22,1.96%,SCN4A;CACNA1H
prerank,mesenchyme morphogenesis (GO:0072132),0.5878920717851579,1.3149124877066807,0.1819672131147541,0.8037508708793857,1.0,5/17,7.85%,TBX2;HEYL;BMPR1A;TGFB2;SOX9
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.48504938607642206,-1.3146503276418895,0.12589073634204276,0.7559044769579715,1.0,10/17,19.92%,ROBO1;EFNB2;SLIT2;PIK3R3;NRP1;KDR;AKT1;FGF2;EPHB4;MIA3
prerank,protein localization to cell periphery (GO:1990778),0.45160991956325003,1.3135264841291805,0.1040268456375839,0.8070578956637333,1.0,39/133,16.37%,CACNB2;FLNA;TSPAN32;FGF13;RAP1A;ROCK1;CLASP2;EHD2;KCNB1;FYB2;KCNIP3;TESC;ZDHHC2;ATP1B1;CAV1;TTC7A;RAB3A;RAMP1;RAPGEF6;LIN7C;EPHA2;RAP2A;ACTN2;ROCK2;DPP10;TMEM88;TNIK;PACSIN1;RAB40C;SLMAP;GAS6;RAB34;RAB8B;TSPAN17;FLOT1;PRAM1;ANK1;SMURF1;RAB8A
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.4798780311160675,1.3133509463349826,0.12826603325415678,0.8059864798790146,1.0,24/75,18.59%,MEF2C;SDC2;MAP1B;CDHR1;SLITRK5;ACTB;KLF7;MEF2A;SLITRK4;AFG3L2;RAB3A;BRSK1;S100A6;TBCD;ZDHHC17;RB1;DVL1;ADGRB1;RAB8A;RYK;MAP1A;MAP1S;MAP6;BRSK2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.4959433628879,-1.313321972811542,0.15113350125944586,0.7576718670015792,1.0,7/15,18.35%,SEL1L;UFD1;DERL1;HSP90B1;OS9;SYVN1;HERPUD1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.4859428076895018,-1.3132428177017388,0.12894736842105264,0.7547814957265289,1.0,5/18,8.39%,IGF1;IGFBP2;HMGB1;IL18;IGF2
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.46651859498574116,-1.3131206769969725,0.13774104683195593,0.7520778948436573,1.0,5/21,4.97%,LRP1;PLTP;APOE;PTCH1;NFKBIA
prerank,actin polymerization or depolymerization (GO:0008154),0.4967059188228457,1.3127202157724485,0.1622340425531915,0.8064950686768202,1.0,7/50,8.36%,ENAH;DSTN;MICAL2;WDR1;ARHGAP6;CFL2;SPIRE1
prerank,estrogen metabolic process (GO:0008210),0.6197208430054523,1.3124316904257187,0.21986970684039087,0.8058363609331883,1.0,3/15,5.68%,HSD17B10;HSD17B7;HSD17B4
prerank,regulation of cell adhesion (GO:0030155),0.45373911094092734,1.3124037336897263,0.09492273730684327,0.8042698635271291,1.0,21/129,7.62%,TPM1;PPP1R12A;ZFHX3;ANGPT1;ROCK1;PPP3CA;PLXND1;SEMA5A;PLXNB1;CDH13;CCL5;CYTIP;RSU1;ARHGDIG;TESC;CBLL1;ZDHHC2;DSCAM;VEGFA;YTHDF2;NUAK1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.421132369219331,-1.3123074269728918,0.12025316455696203,0.7521622567023795,1.0,17/29,28.95%,DCPS;LSM1;DIS3;EXOSC1;DCP2;EXOSC9;EDC4;LSM7;EXOSC2;EDC3;LSM5;LSM2;EXOSC3;EXOSC7;LSM3;EXOSC5;LSM6
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.45747289033574934,1.3122913473506161,0.12862108922363846,0.8030345600472539,1.0,28/102,15.00%,LHCGR;SLC2A4;ADCY5;ADCY2;NR4A1;ADCY9;HDAC9;TSHR;CYSLTR2;IRS1;CPEB1;CAV1;PARP1;SORBS1;GOT1;RELA;PRKACB;PRKAR1B;SLC39A14;NR4A2;ADCY6;GPER1;PRKCD;ZFP36L1;EPRS1;RAB8B;IRS2;PRKACA
prerank,positive regulation of interleukin-17 production (GO:0032740),0.5664942781335363,1.312241550970799,0.1927710843373494,0.8015628587826354,1.0,4/22,5.56%,NR1H4;MYD88;IL2;PRKCQ
prerank,acylglycerol homeostasis (GO:0055090),0.5678348609368429,1.3122079241729299,0.17295597484276728,0.8000131032131409,1.0,3/20,3.09%,ANGPTL8;RORA;LPL
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.5108564857946565,-1.312033723343197,0.15035799522673032,0.7500047778749186,1.0,8/14,27.46%,ERN1;NCBP2;CPSF2;CPSF6;CSTF2T;CPSF4;CSTF2;CPSF1
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.3916869772292635,-1.3115958406954498,0.08712121212121213,0.7485556632288447,1.0,13/39,16.91%,BMP6;WNK1;NF2;PODXL;PTK2;CDH1;FXYD5;RDX;TGFB1;RGCC;PPM1F;AKT1;NOTCH4
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.5349284158692994,1.3113802436582596,0.16713483146067415,0.8011672918503553,1.0,6/33,6.40%,ATP2B4;TCIM;FAM83D;MN1;TAF1;FBXW7
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5975130324174858,1.310732987099231,0.16721311475409836,0.8017813636697573,1.0,4/18,6.96%,AGTR1;SIRT3;FXN;GDNF
prerank,actin filament capping (GO:0051693),-0.4827255367927036,-1.3098289195223298,0.14698162729658792,0.7494401985311031,1.0,3/18,3.58%,ADD3;EPS8;CAPZA1
prerank,barbed-end actin filament capping (GO:0051016),-0.4827255367927036,-1.3098289195223298,0.14698162729658792,0.7494401985311031,1.0,3/18,3.58%,ADD3;EPS8;CAPZA1
prerank,histone monoubiquitination (GO:0010390),-0.43516923086816783,-1.3094299801672054,0.1151685393258427,0.7480304251557024,1.0,7/24,16.16%,RNF20;RYBP;CTR9;DDB1;DTX3L;LEO1;BCOR
prerank,negative regulation of peptidase activity (GO:0010466),0.5000744729260422,1.3086581044939702,0.1599479843953186,0.8073682853120333,1.0,3/47,3.30%,SERPINB8;SERPINI1;SERPINE2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.44745103530532604,1.3081456038028296,0.0980603448275862,0.807557231215871,1.0,35/140,12.38%,OBSCN;ARHGEF7;DLC1;KALRN;ABR;PLCE1;ARHGEF17;MYO9B;DEPDC1B;ITSN1;NET1;NUP62;ARHGAP21;ARHGAP10;ARHGEF16;CHN1;ARHGAP6;ARHGDIG;ARHGEF2;RHOJ;ARHGAP17;RHOF;ARHGAP39;ARHGAP30;ARHGEF4;ARHGAP1;ARHGAP12;ARHGAP15;VAV1;INPP5B;ARHGAP5;RHOH;ARHGAP35;ARHGAP32;BCR
prerank,negative regulation of developmental growth (GO:0048640),0.5421498335745406,1.3077724565212578,0.1685878962536023,0.8071584592267195,1.0,3/30,4.95%,FGF13;NKD1;PTPRS
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.532381643294405,-1.3076349388711574,0.14874141876430205,0.7519843448557555,1.0,5/12,16.52%,F3;APOD;SNCA;HGS;NDRG4
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.47113225605099146,1.3071565838273613,0.13373493975903614,0.8076323697146335,1.0,14/75,11.46%,MYOCD;SLC8A1;NR2F2;DAB2IP;HEXIM1;PKIB;PTPN1;PKIA;CD300A;PRKAR1B;GSTP1;LRP5;PRKCD;RB1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.6169285687241756,1.307019512131143,0.20774647887323944,0.806445013226177,1.0,9/13,19.72%,UBA2;ATG7;SAE1;UBA3;SENP6;UBA1;DESI2;DESI1;ATG10
prerank,presynapse organization (GO:0099172),-0.5528430889594655,-1.3066608224191223,0.17660550458715596,0.7525239885814309,1.0,4/10,14.53%,WNT5A;NLGN1;NLGN2;NLGN3
prerank,axon guidance (GO:0007411),0.4400970366771367,1.3065745676759306,0.07966457023060797,0.8063953206307362,1.0,27/201,7.56%,SLIT1;SLIT3;NTN4;NEXN;PALLD;NOTCH3;ENAH;MYPN;ROBO3;LAMA5;PLXND1;SEMA5A;PLXNB1;NTN1;PDLIM7;CHN1;SEMA6C;KLF7;PRKCQ;DOK4;DSCAM;DOK2;VEGFA;DOK1;GDNF;CYFIP1;KIF5B
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.599074986553567,1.3059036825165928,0.1592775041050903,0.8071570836456775,1.0,5/17,6.93%,HEY2;HEYL;JAG1;BMPR1A;SNAI2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.3568137528641511,-1.304986285987833,0.11057692307692307,0.7557872226294545,1.0,24/58,24.65%,HMGB1;PRKDC;KDM2A;XRCC5;MRE11;RAD50;HERC2;BRCC3;MDC1;LIG3;POLM;XRCC6;NBN;SMC5;DCLRE1A;ATM;IFFO1;UVRAG;SMARCAL1;PRPF19;NSMCE2;ERCC1;ERCC4;DCLRE1B
prerank,vascular transport (GO:0010232),-0.3398140552867199,-1.3049612211511405,0.035211267605633804,0.7528389216128104,1.0,25/81,10.29%,ATP1A2;SLC24A3;SLC6A13;LEPR;SLC16A12;SLC13A3;SLC1A3;SLC22A8;ABCG2;LRP1;SLC2A13;ATP8A1;SLC2A1;SLC12A2;SLCO2B1;SLC6A1;SLC6A6;SLC16A1;SLCO1C1;SLC7A5;SLC6A9;SLCO3A1;ABCC4;ATP1B2;SLC5A5
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.6418603662009796,1.304797727272879,0.19428571428571428,0.8093812706551226,1.0,1/10,0.13%,PLN
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.6216766411473508,1.3047814148158912,0.20173913043478262,0.8078128676867805,1.0,6/13,7.01%,EMILIN1;MMRN2;EPN2;DAB2IP;PTPN1;NEDD4
prerank,triglyceride biosynthetic process (GO:0019432),-0.4742784100527199,-1.3046712628359498,0.14360313315926893,0.7509025977329161,1.0,6/18,18.60%,AGMO;LPGAT1;LPIN2;PCK2;GPAM;LPIN3
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5533177123369856,-1.3042650575276982,0.14350797266514806,0.7495770574828646,1.0,7/11,30.02%,PARP10;PARP11;PARP3;PARP14;PARP12;PARP4;PARP16
prerank,cAMP biosynthetic process (GO:0006171),0.6426806712162447,1.3041934640263266,0.2037037037037037,0.8081882259445354,1.0,4/10,9.57%,ADCY5;ADCY2;ADCY9;ADCY6
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.5218882777601199,1.3040033550586438,0.16151685393258428,0.8072246500301301,1.0,15/37,18.44%,ROCK1;PHLDB2;CLASP2;BICD2;MAPRE2;TPPP;MAPT;CLASP1;STMN2;MAPRE3;PRKAA2;CDK2AP2;MARK2;BICD1;MAP6
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.2967484059593452,-1.3029731550943087,0.0,0.7517589146898994,1.0,52/173,20.97%,SPTBN1;ANK2;SPTAN1;TGFA;DCTN4;SPAST;CUL3;DYNC1I1;CAPZA1;PROS1;KLHL12;DYNC1LI2;USO1;CD55;GBF1;VTI1A;TMED5;KDELR1;NRBP2;STX5;ERGIC3;TMED7;TMED10;COPB2;COG6;ARFGAP2;SEC24B;ACTR10;RAB2A;MCFD2;COPE;ARFGAP1;TRAPPC11;ARFGAP3;RAB1A;RAB29;F8;YKT6;COG2;COG7;LMAN1;TMED3;RAB1B;SCFD1;TRAPPC3;TRIP11;TMED4;TFG;MIA3;IER3IP1;VAMP7;DYNLL2
prerank,regulation of endocytic recycling (GO:2001135),0.6432118944763229,1.302625029517613,0.19525547445255476,0.8102839767688029,1.0,4/11,10.27%,PLA2G3;EHD2;ARHGAP1;ACTN2
prerank,polyol metabolic process (GO:0019751),0.5022309248272427,1.3019764121706712,0.16644474034620507,0.8109544775388303,1.0,13/46,11.77%,ITPK1;PLCE1;INPP4B;PLCB4;SLC5A3;INPP5A;NUDT4;CALM1;PLCB1;INPPL1;PLCD1;INPP5B;ITPKC
prerank,regulation of receptor binding (GO:1900120),0.645615114572981,1.3010018490677269,0.21228070175438596,0.8127035273058498,1.0,4/10,10.53%,ATP2A2;GREM2;PTPRF;ATP2A3
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.4391707031062198,-1.3009361097850454,0.1511627906976744,0.7563554817173638,1.0,7/23,11.47%,PRKAG2;BMP7;CEMIP;APP;WNK3;TGFB1;IRGM
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6110883567700687,1.3009067075416139,0.1762652705061082,0.8114041844329938,1.0,3/13,5.12%,MEF2C;TBX2;BMPR1A
prerank,cell junction assembly (GO:0034329),0.4647569850774787,1.3006039706046364,0.12217194570135746,0.8107739001553136,1.0,19/100,8.81%,FLNA;CDH6;IGFN1;LIMS1;GJC1;FERMT2;FZD5;PLXND1;ACTG1;FLNC;KIRREL3;ACTB;CDHR3;DSCAM;PCDHB14;LIMS2;TLN1;PCDHB11;CDH2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6008273549482042,1.300194322094548,0.20525451559934318,0.8105326088268657,1.0,2/16,6.54%,AGTR1;VEGFA
prerank,respiratory chain complex IV assembly (GO:0008535),-0.4558848531859764,-1.300042796360068,0.1266490765171504,0.7568351267747203,1.0,14/21,35.27%,COA8;COX10;COX20;SMIM20;COX14;TIMM21;BCS1L;COX16;COX17;COA3;SURF1;COA6;COX18;FASTKD3
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5209551078559591,1.299926639010866,0.1781609195402299,0.8097578101673111,1.0,6/36,6.31%,MEF2C;ATP2B4;ANGPT2;ANGPT4;NR2F2;DAB2IP
prerank,regulation of neuron differentiation (GO:0045664),0.4718196724083756,1.2983787924422494,0.15560916767189384,0.8133486619712519,1.0,7/76,5.08%,NTF3;MEF2C;ZFHX3;ROCK1;HEYL;MMD;ARHGEF2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.41961847199148594,-1.2969989676108522,0.12923076923076923,0.7655692142965872,1.0,11/29,21.08%,SMAD3;AGO3;SRRT;PUM1;METTL3;ADAR;ZC3H7A;TUT4;SMAD2;TUT7;ZC3H7B
prerank,regulation of glycogen metabolic process (GO:0070873),0.6028411317617652,1.2969026186602188,0.22743682310469315,0.8169417003263323,1.0,1/12,1.10%,PPP1R3A
prerank,regulation of gluconeogenesis (GO:0006111),-0.4090147337118496,-1.2960985645418486,0.13719512195121952,0.7658159567512088,1.0,12/27,22.96%,CRY1;USP7;SIRT7;SIK1;DDB1;OGT;EP300;DGKQ;C1QTNF3;PTPN2;PGP;CLK2
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.45670966119232415,1.2952563204358671,0.12808460634547592,0.8211321021774561,1.0,13/90,7.65%,PRDM16;PRKAB2;CD36;PDGFC;EBF2;TSHR;CAV1;VEGFA;TRPV2;FABP4;PPARGC1A;DIO2;PPARGC1B
prerank,regulation of neuroinflammatory response (GO:0150077),-0.4544264062495709,-1.2948499608513813,0.1564102564102564,0.7676262721091971,1.0,6/19,12.45%,IGF1;NUPR1;IL18;DAGLA;PTGS2;IL33
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.47047624483666417,-1.2939326711629655,0.15051020408163265,0.767958843465686,1.0,5/19,18.47%,IGF1;PYDC1;CX3CL1;GIT1;ZC3H12A
prerank,negative regulation of hippo signaling (GO:0035331),0.625220179481275,1.2931874819243758,0.21143847487001732,0.8266779653061499,1.0,2/12,1.90%,WTIP;LIMD1
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.345992289371083,-1.292452813172818,0.10204081632653061,0.770877778275297,1.0,18/61,17.56%,EYA2;EYA1;EYA4;HMGB1;EGFR;MRE11;PML;RAD50;USP7;PARP3;SMCHD1;BRCC3;RGCC;GNL3;NBN;FGF2;NPAS2;WRAP53
prerank,Golgi to plasma membrane transport (GO:0006893),-0.36760517342717963,-1.2922043076605243,0.0859375,0.7688379806562639,1.0,10/47,12.26%,SPTBN1;VAMP5;RABEP1;GOLGA4;COMMD1;OPTN;GCC2;GOLPH3;BLZF1;EXOC2
prerank,positive regulation of mitochondrial translation (GO:0070131),0.6091567510025097,1.2911424579577573,0.20860927152317882,0.8320546079294329,1.0,9/14,20.54%,RPUSD3;TRMT10C;RCC1L;RPUSD4;FASTKD2;TRUB2;RMND1;UQCC2;C1QBP
prerank,cellular response to virus (GO:0098586),-0.40960916193533137,-1.2909099481121138,0.11290322580645161,0.7709964293606023,1.0,14/30,23.74%,MAPK14;DDX3X;GSDME;LGALS9;GBF1;RIOK3;CHUK;IRGM;LGALS8;BAX;ZC3H12A;FMR1;POU2F2;TOMM70
prerank,regulation of mast cell degranulation (GO:0043304),0.6011625566631569,1.2908689739525703,0.2017857142857143,0.8314552460661259,1.0,3/14,8.34%,STXBP2;UNC13D;CD300A
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.537264583769744,-1.290323339691145,0.15164835164835164,0.7702962975188397,1.0,8/12,24.98%,SEC62;HSPA5;SEC63;SGTA;SGTB;SEC61A1;CHMP4B;CHMP4A
prerank,positive regulation of peptidase activity (GO:0010952),-0.4628911495151432,-1.2901240865425518,0.15405405405405406,0.7681121147065709,1.0,11/20,34.54%,CTSH;APH1A;RCN3;NCSTN;APH1B;GRN;PSME3;PSENEN;PSME1;PSME2;NDUFA13
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.4040469173203488,-1.2899252219833595,0.13186813186813187,0.7659623642607918,1.0,10/31,12.27%,PDGFRA;HOXB3;HOXA3;DSCAML1;HOXB4;MEGF8;OSR1;FGFR2;SIX1;TGFBR1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5883421552098992,1.2893629615036215,0.21875,0.8351729038899146,1.0,5/16,8.15%,MEF2C;RBM24;SMYD1;BTG1;PLCB1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.3813935854567485,-1.2890797333251538,0.09057971014492754,0.766150379307641,1.0,13/39,8.56%,PIK3CA;PI4KA;PIK3R3;IP6K1;EFR3A;SOCS7;SMG1;PI4K2A;PIP4K2B;SOCS2;EFR3B;PIK3CB;TTC7B
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.49308760952990494,1.2882976041335115,0.16579634464751958,0.8372055454026721,1.0,6/54,2.11%,MEF2C;ATP2B4;ANGPT2;ANGPT1;ANGPT4;PDGFB
prerank,negative regulation of neuron death (GO:1901215),0.4533233957995269,1.2874471715901448,0.13647342995169082,0.8386113556809364,1.0,13/93,7.78%,NTF3;MEF2C;PLA2G3;CRLF1;TGFB3;INPP5A;SET;BCL2;CD200R1;GDNF;CD200;PPARGC1A;FZD9
prerank,intestinal lipid absorption (GO:0098856),0.6513294205135167,1.2874376096424442,0.2014519056261343,0.836997248457918,1.0,1/11,1.65%,CD36
prerank,necroptotic process (GO:0070266),0.5891552082861558,1.2866062382325134,0.20735785953177258,0.8382919387918365,1.0,3/16,10.76%,ITPK1;CD14;DNM1L
prerank,phospholipid transport (GO:0015914),-0.3622772272747685,-1.2857319715490954,0.11255411255411256,0.7754596134583737,1.0,13/52,8.20%,OSBPL8;PITPNA;ATP8A1;PLTP;APOE;ABCA1;ABCA4;LDLR;ATP11C;ATP8A2;PITPNC1;SCARB2;TMEM30A
prerank,sodium ion transport (GO:0006814),0.46062307635347,1.284856361497164,0.16646848989298454,0.8428945558736806,1.0,10/85,4.01%,FGF13;SCN4A;ASIC3;SLC6A17;ANO6;SLC8A1;SLC8A2;SLC4A8;SLC6A5;SLC6A2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.40028244506459676,-1.2848432809997257,0.13707165109034267,0.7760818888307811,1.0,16/32,26.21%,CDC14B;MRE11;RINT1;BRCC3;BLM;NBN;FOXN3;TAOK1;NOP53;ATM;HMGA2;TAOK2;TRIM39;CLSPN;CDKN1A;DONSON
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.6499925079817023,1.2842116504163148,0.21532846715328466,0.8434835020133156,1.0,1/11,0.93%,AKAP6
prerank,macrophage differentiation (GO:0030225),-0.5067125434059779,-1.284056636826572,0.1619047619047619,0.776133334675747,1.0,4/13,7.25%,IL31RA;IL15;BMP4;CASP8
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.4098096502918131,-1.2835666737823341,0.11864406779661017,0.7751874609045286,1.0,11/30,19.56%,DDX3X;TNFSF10;CASP8;BCL2L1;NOS3;RNF34;FAIM;GPX1;SERPINE1;TMBIM1;PARK7
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.46439308946642754,1.2828771502170098,0.15266272189349112,0.8465019138096319,1.0,6/73,6.54%,NTF3;NTRK3;ATP2B4;BCAR3;CAV1;VEGFA
prerank,gastrulation (GO:0007369),-0.49169287936269535,-1.2825214835800482,0.17929292929292928,0.7761305283893098,1.0,6/15,24.68%,MEGF8;UGDH;LMBRD1;SMAD2;GPC3;MKKS
prerank,synaptic vesicle endocytosis (GO:0048488),-0.4001636995413296,-1.2821794165816118,0.1347517730496454,0.7745927327311721,1.0,13/33,15.92%,DNM3;FCHO2;DNAJC6;NLGN1;SYT1;CANX;DNM1;STON2;OPHN1;SNCA;NLGN2;NLGN3;STX1A
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5558980365511932,-1.2820285954961845,0.16049382716049382,0.7723009167670836,1.0,4/10,12.60%,UFD1;SEC14L1;RIOK3;RNF125
prerank,regulation of amyloid fibril formation (GO:1905906),-0.48655941763953636,-1.2820255328092731,0.16990291262135923,0.7694744998307035,1.0,4/15,7.45%,APP;APOE;LDLR;IAPP
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.5694722328538248,1.2809709171635204,0.21428571428571427,0.8515326458387328,1.0,5/18,13.69%,PMAIP1;BCL2;HEBP2;THEM4;MUL1
prerank,sterol metabolic process (GO:0016125),-0.3425146708887637,-1.2806068426859312,0.07042253521126761,0.771866936616446,1.0,33/60,37.08%,PRKAG2;CYP27A1;APOE;ABCA1;LBR;CYP26B1;CYP1B1;CYP51A1;HMGCR;ARV1;SOAT1;INSIG1;PIP4P1;SQLE;GBA2;PMVK;LIPA;FDXR;CLN8;RXRA;INSIG2;EBP;TSKU;PPARD;ABCA5;ANGPTL3;SC5D;TM7SF2;CLN6;SCAP;DHCR7;LCAT;CH25H
prerank,Golgi inheritance (GO:0048313),-0.531741144826763,-1.2803088257349085,0.17906976744186046,0.7702345710203451,1.0,6/11,23.81%,GBF1;STX5;VCPIP1;STK25;YWHAZ;PLK5
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.43915536829324575,-1.279886297926057,0.15709969788519637,0.7691382077665386,1.0,12/24,32.01%,APOE;EPHA4;PTK2B;UBE3A;GPX1;NUB1;PSME3;UBB;PSME1;CTSC;PSME2;USP14
prerank,positive regulation of protein acetylation (GO:1901985),-0.5218393219627228,-1.27983354657261,0.17045454545454544,0.7665043233936892,1.0,6/12,26.79%,DDX3X;CAMK1;TAOK1;TERF2IP;PRKAA1;RAPGEF3
prerank,C4-dicarboxylate transport (GO:0015740),-0.5129653051820845,-1.2795889054694796,0.16216216216216217,0.7645663294151905,1.0,10/14,31.80%,SLC25A14;SLC25A30;SLC25A11;LRRC8D;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6;SLC13A5
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.5474105382117892,-1.2795489750672657,0.16441441441441443,0.7619762699361475,1.0,2/10,7.18%,WNT5A;CTNNB1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.4267827925064507,-1.278731481906717,0.1531791907514451,0.7622650667482465,1.0,9/24,10.54%,SEMA3D;SEMA3C;SEMA6A;NRP1;SEMA7A;MEGF8;SEMA3A;SEMA4D;SEMA6D
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.43037780755284416,1.2783285452430306,0.12608695652173912,0.8589288858964715,1.0,26/138,10.49%,NOTCH3;NR1H4;POLR2L;POLR2I;RORA;NR4A1;TEAD3;HDAC9;GTF2H4;NR2C1;RXRG;POLR2G;TAF1;TAF8;MAML2;YAP1;AR;MED1;PPARGC1A;MAML3;PPARA;NR1D1;NR4A2;CDK7;TEAD1;NR2C2
prerank,regulation of gastrulation (GO:0010470),0.607758500930996,1.2781953271325421,0.23339011925042588,0.8577574533925407,1.0,2/14,2.62%,PHLDB2;CLASP2
prerank,dorsal/ventral pattern formation (GO:0009953),-0.4608621580770482,-1.2779592755132452,0.1569767441860465,0.7624471724500308,1.0,5/20,4.18%,NBL1;GLI2;PTCH1;DSCAML1;ACVRL1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.4267680470665222,1.2779018453544526,0.11752136752136752,0.8571827067705803,1.0,35/166,13.17%,NOTCH3;NR1H4;CAVIN1;POLR2L;POLR2I;RORA;NR4A1;TEAD3;HDAC9;GTF2H4;NR2C1;RXRG;POLR2G;TAF1;TAF8;MAML2;YAP1;AR;MED1;PPARGC1A;MAML3;PPARA;POLR1E;NR1D1;NR4A2;CDK7;TEAD1;NR2C2;NAT14;TFB2M;ESRRA;POLR1H;NR6A1;SMARCA5;POLR2J
prerank,activation of protein kinase activity (GO:0032147),0.44036179742800163,1.2770754998541116,0.14617169373549885,0.858376191172703,1.0,23/106,12.59%,NTF3;NTRK3;ANGPT1;FGF1;ADCY5;PDGFB;ADCY2;ADCY9;VEGFA;TPX2;PIBF1;ITGB3;TGFB2;PRKACB;PRKAR1B;PAK2;ADCY6;PRR5;PRKCD;COPS8;RICTOR;TNIK;TAOK3
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.46259743852610336,-1.276250471641365,0.16483516483516483,0.7661685135214978,1.0,6/17,4.13%,DOCK4;IGF1;DOCK5;VTN;NRP1;ADAMTS1
prerank,cellular response to hormone stimulus (GO:0032870),0.47108998100366456,1.276130164642749,0.16522811344019728,0.8601355647459136,1.0,9/69,7.29%,SLIT3;LHCGR;MEF2C;CACNA1H;ARID5A;CAV1;AR;MED1;RAMP1
prerank,regulation of lipid metabolic process (GO:0019216),0.4576956762130561,1.2747712702318366,0.15985997666277713,0.8632772677943584,1.0,12/88,9.11%,CCDC3;SMARCD3;ANGPTL8;RORA;RARRES2;CAV1;ACACB;MED1;IDI1;PPARA;MVD;NR1D1
prerank,sodium-independent organic anion transport (GO:0043252),-0.5364013249421035,-1.2745481110106278,0.18018018018018017,0.7700005919285874,1.0,4/10,8.37%,SLCO2B1;SLCO1C1;SLCO2A1;SLCO3A1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.6019835035777812,1.274546960081035,0.21885521885521886,0.862446526703468,1.0,2/14,7.23%,AGTR1;ENPEP
prerank,negative regulation of leukocyte migration (GO:0002686),0.6536231834599255,1.2731516171520876,0.24094202898550723,0.8657983589284886,1.0,4/10,8.34%,EMILIN1;CD200R1;CD200;CD300A
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.5084945612619013,-1.2728979310075794,0.14903846153846154,0.7734908903169607,1.0,9/12,44.49%,B3GALNT1;B3GNT2;B3GALT2;B3GALT1;B3GNT9;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,hexose transmembrane transport (GO:0008645),0.5606083712465123,1.2728384466471825,0.20607028753993611,0.8653691030123282,1.0,3/21,6.49%,SLC2A4;SLC5A3;SLC2A10
prerank,protein polymerization (GO:0051258),0.47165979689701565,1.2723977820196157,0.1773981603153745,0.8652073841702764,1.0,9/55,8.36%,FGF13;CASQ1;ARHGAP6;MAP7D3;TPPP;MAPT;PIN1;HDGFL3;SPIRE1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.40109007804014174,-1.2715855765412576,0.13793103448275862,0.775636229769575,1.0,10/30,19.82%,SDF2;DNAJB12;HSPA5;ENTPD5;BAG1;HSPA13;HSPA9;HSPE1;DNAJB4;ST13
prerank,regulation of hemopoiesis (GO:1903706),-0.5460308333784466,-1.2709217886162212,0.17972350230414746,0.7755338569348957,1.0,2/10,0.39%,PTN;PRKCB
prerank,gliogenesis (GO:0042063),0.5905181790170017,1.2709216438618707,0.23809523809523808,0.8687828367467096,1.0,5/15,11.82%,CDK6;ANXA1;TGFB2;CDH2;NDUFS2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.49634245778749875,-1.2705498311991648,0.18269230769230768,0.7741948060062326,1.0,2/13,5.73%,NFAT5;IRAK1
prerank,neuron migration (GO:0001764),0.48211266606950937,1.270537121320142,0.19140625,0.8684845589659392,1.0,10/48,9.29%,FGF13;MEF2C;ASTN2;MAP1B;MARK1;VEGFA;TUBB2B;CEP85L;ASTN1;NR4A2
prerank,positive regulation of metabolic process (GO:0009893),0.44060609608045453,1.2704171325995257,0.14726027397260275,0.8672968086202647,1.0,15/103,7.65%,PRDM16;PRKAB2;CD36;PDGFC;EBF2;TSHR;PIGA;CAV1;VEGFA;ACACB;TRPV2;FABP4;PPARGC1A;DIO2;PPARGC1B
prerank,negative regulation of JNK cascade (GO:0046329),-0.40316113320407787,-1.2696497221721255,0.14625850340136054,0.774726959372873,1.0,13/31,24.23%,MECOM;ITCH;PTPN22;PRKN;PDCD4;SIRPA;SH3RF2;PER1;AIDA;HIPK3;DACT1;CYLD;MAPK8IP1
prerank,axonogenesis (GO:0007409),0.4244905351413875,1.2691917856813208,0.09165808444902163,0.8698445732545524,1.0,28/237,7.56%,SLIT1;SLIT3;NTN4;NEXN;PALLD;NOTCH3;ENAH;MYPN;ROBO3;LAMA5;SEMA5A;MAP1B;PDLIM7;SLITRK5;ACTB;SEMA6C;KLF7;PRKCQ;SLITRK4;DOK4;DSCAM;AFG3L2;DOK2;DOK1;GDNF;CYFIP1;RAB3A;KIF5B
prerank,negative regulation of hormone secretion (GO:0046888),-0.5382632083240889,-1.2690525312102188,0.20250521920668058,0.7741202004360439,1.0,3/10,13.11%,GJA1;RAB11FIP5;RAB11FIP1
prerank,negative regulation of protein transport (GO:0051224),-0.4246333874817677,-1.2687950350914836,0.12037037037037036,0.7724350093936594,1.0,10/25,28.97%,APOE;ERP29;CYP51A1;HMGCR;PPM1F;PKDCC;SNX3;DRD2;SNX12;RHBDF2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.6082382661258815,1.268704578636456,0.24775583482944344,0.8699064247787403,1.0,4/12,9.42%,GMNN;TIPIN;WRNIP1;KAT7
prerank,regulation of synapse organization (GO:0050807),0.5322650111416088,1.2684091345932802,0.19124087591240876,0.8692606190954538,1.0,6/26,11.41%,MEF2C;PDLIM5;SLITRK4;NEDD4;ABHD17B;IL1RAPL1
prerank,blood vessel morphogenesis (GO:0048514),-0.35021618595905346,-1.2677757689386713,0.0975609756097561,0.7735738484158049,1.0,20/54,14.03%,TGFBR3;FLT1;NF1;EFNB2;LAMA1;CCBE1;RASA1;ENG;NRP1;ID1;RASIP1;CYP1B1;CUL7;TGFB1;HES1;TGFBR1;RAMP2;ITGB8;KDR;SOX17
prerank,membrane assembly (GO:0071709),-0.39514724277481206,-1.2671079130188059,0.14511041009463724,0.7732994617230043,1.0,10/34,15.01%,SPTBN1;ANXA2;SPAST;NLGN1;STX4;PTPRD;NRXN1;NLGN2;NLGN3;S100A10
prerank,oogenesis (GO:0048477),-0.48880386426696987,-1.2659619043450867,0.16962025316455695,0.7747245123366833,1.0,3/15,8.76%,PTN;MARF1;METTL3
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.4483193369827762,1.265809070113883,0.16878612716763006,0.8765224204186831,1.0,21/88,15.49%,SYNPO2;SYNPO2L;EMILIN1;MPP7;TPPP;DAB2IP;VEGFA;TRABD2B;PLEK;SLX4;SYNPO;HRK;STX18;TSG101;CLU;FNIP2;CHMP2A;HYAL1;PRKCA;STAM;FLOT1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.6345063446606609,1.2652609233804482,0.2300556586270872,0.8767678601266252,1.0,4/10,14.45%,GALNT16;GALNT3;GALNT2;GALNT1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.42651131002256626,1.2650988958074574,0.15010799136069114,0.8756605049361151,1.0,20/152,9.75%,LHCGR;PTGER3;ADCY5;CRHR2;S1PR3;HTR1B;NPY1R;ADCY2;VIPR2;ADRA1D;ADCY9;TSHR;GNAO1;GNAZ;RAMP1;PRKACB;GNA12;PTH1R;ADCY6;ADGRL2
prerank,regulation of innate immune response (GO:0045088),-0.3446752423760759,-1.2645202250843732,0.11467889908256881,0.7774316556118744,1.0,24/57,25.69%,APPL2;IFNAR2;PTPN11;RNF135;POLR3F;HSP90AB1;CASP8;BIRC2;PTPN22;SAMHD1;IRAK3;RIOK3;POLR3B;APPL1;LRP8;BIRC3;SLC15A4;TIRAP;GBP5;RNASEL;POLR3C;TRIM21;NLRC3;POLR3D
prerank,C-terminal protein amino acid modification (GO:0018410),0.613017360493142,1.2638970381964332,0.23885918003565063,0.8783821714929704,1.0,2/11,5.42%,AGBL1;ATG7
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.4278361714643047,-1.2634297106891292,0.1642651296829971,0.7788170135661027,1.0,11/24,24.26%,NIBAN2;DACH1;XRCC5;ACVRL1;BMPR2;BLM;TERF2IP;MSH6;CDKN1A;ERCC1;ERCC4
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5221156806911611,1.263124343310711,0.20341614906832298,0.8796046352270828,1.0,6/25,14.28%,CNRIP1;SOCS5;SOCS4;PPARA;TSG101;CBLB
prerank,cell-cell junction assembly (GO:0007043),0.4715649217790281,1.263017923859488,0.16813048933500627,0.8783630640197567,1.0,15/63,11.58%,CDH6;VCL;GJD3;GJC1;WDR1;ACTG1;ACTB;JAM3;CDHR3;TLN1;CDH2;PKN2;PAK2;TBCD;GJA4
prerank,presynaptic endocytosis (GO:0140238),-0.4306932316264641,-1.2627225480248419,0.1609907120743034,0.778862249461871,1.0,10/24,15.92%,FCHO2;NLGN1;SYT1;CANX;STON2;OPHN1;SNCA;NLGN2;NLGN3;STX1A
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.4745840429931273,-1.2621746794122568,0.18912529550827423,0.778103521438805,1.0,4/15,16.15%,EDA;GLI2;HDAC2;WNT6
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.4282599596546405,-1.2620981577685744,0.16265060240963855,0.7757203789472048,1.0,6/23,9.09%,UACA;BMP7;DDX3X;PPM1B;HDAC7;CCN3
prerank,negative regulation of secretion (GO:0051048),0.6202749413009218,1.261839469943436,0.2530541012216405,0.880788004681036,1.0,1/10,1.48%,PTGER3
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.4505731679043265,-1.2616648611796868,0.1510989010989011,0.7747570753264525,1.0,7/20,10.54%,SEMA3D;SEMA3C;SEMA6A;SEMA7A;SEMA3A;SEMA4D;SEMA6D
prerank,regulation of protein kinase C signaling (GO:0090036),0.589163082194586,1.2616521437103212,0.2482758620689655,0.8798760123651157,1.0,4/14,11.06%,DGKG;VEGFA;DGKD;GPD1L
prerank,ear morphogenesis (GO:0042471),-0.4425202134799901,-1.260252363887628,0.1871508379888268,0.7773235636523688,1.0,9/20,26.53%,ZIC1;CHD7;OSR1;FGFR2;SIX1;MYO6;EPHB2;PAX8;TWIST1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5163819473663611,1.2588899083319187,0.20202020202020202,0.8879854073452694,1.0,4/30,3.99%,ABRA;GPR20;SYNPO2L;NET1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.611918637111,1.2577887105546348,0.2417391304347826,0.8902993790002246,1.0,5/12,14.60%,ARHGEF7;DYRK1A;TBCD;CLIP3;STMN2
prerank,defense response to tumor cell (GO:0002357),0.6212540705508434,1.2566985106638386,0.2411214953271028,0.8924862053292187,1.0,2/10,3.80%,DLEC1;RBMS3
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5208706300850443,1.2562397501095375,0.20658682634730538,0.8924186921072071,1.0,11/27,18.59%,CAMK2G;MARK1;NCS1;BRSK1;IL1RAPL1;FRMD7;HOMER1;PTEN;VPS35;ULK4;BRSK2
prerank,regulation of peptide hormone secretion (GO:0090276),0.45806324376914026,1.2561281415775858,0.19249394673123488,0.8911779975906652,1.0,7/67,4.77%,CACNA1C;RAP1A;ITPR1;KCNA5;CCL5;ALOX5;KCNB1
prerank,protein localization to plasma membrane (GO:0072659),0.4331884228669242,1.2560651866696848,0.1449438202247191,0.8897379270673518,1.0,37/129,16.37%,CACNB2;FLNA;TSPAN32;FGF13;RAP1A;ROCK1;CLASP2;EHD2;KCNB1;FYB2;KCNIP3;TESC;ZDHHC2;ATP1B1;TTC7A;RAB3A;RAMP1;RAPGEF6;EPHA2;RAP2A;ACTN2;ROCK2;DPP10;TMEM88;TNIK;PACSIN1;RAB40C;SLMAP;GAS6;RAB34;RAB8B;TSPAN17;FLOT1;PRAM1;ANK1;SMURF1;RAB8A
prerank,catecholamine biosynthetic process (GO:0042423),-0.5346625054713051,-1.2558437533285431,0.195852534562212,0.7910405457171381,1.0,4/11,18.03%,MOXD1;SNCA;GCH1;DDC
prerank,neuromuscular process controlling balance (GO:0050885),-0.5094344294703169,-1.2557808995724067,0.18501170960187355,0.7886460927460961,1.0,8/12,39.72%,PAFAH1B1;NRXN1;CLN3;TPP1;PCDH15;CDH23;SHANK1;MYO7A
prerank,triglyceride catabolic process (GO:0019433),0.5679157592599664,1.2550839888265186,0.2487644151565074,0.8914892349343833,1.0,3/19,13.49%,LPL;FABP4;PNPLA3
prerank,L-serine metabolic process (GO:0006563),-0.5286894776260113,-1.2541436671829491,0.19413092550790068,0.7922818906899824,1.0,5/10,26.46%,SERINC5;SRR;PSPH;PSAT1;CBS
prerank,regulation of hydrolase activity (GO:0051336),-0.32316063970253067,-1.2534458373939779,0.11290322580645161,0.7922389517742452,1.0,20/71,11.92%,PLXNA2;NF1;FGD6;FGD5;EPHA4;PTK2;CHN2;FGD4;TBC1D15;SIPA1L1;EPHA3;PAFAH1B1;SCARB2;VAV2;PLXNA4;RDX;RASIP1;RAB3GAP2;ARHGAP27;RALBP1
prerank,regulation of lymphocyte migration (GO:2000401),-0.5217181449312646,-1.2529698787794665,0.1894273127753304,0.791294289477721,1.0,4/10,19.92%,JAM2;AKT1;SLC8B1;MIA3
prerank,regulation of myoblast differentiation (GO:0045661),0.5121212348329033,1.252816877563266,0.2157968970380818,0.8979004926940005,1.0,7/32,8.15%,MEF2C;RBM24;SMYD1;ANKRD2;BTG1;SOX9;PLCB1
prerank,negative regulation of axon extension (GO:0030517),-0.400000890859494,-1.251305296875498,0.13861386138613863,0.7952160623882457,1.0,10/30,12.29%,SEMA3D;SEMA3C;SEMA6A;SEMA7A;RNF6;SEMA3A;SEMA4D;CDKL3;SEMA6D;RTN4
prerank,regulation of platelet aggregation (GO:0090330),0.571227903453349,1.2509292244727717,0.24794745484400657,0.9029894280019208,1.0,7/17,15.00%,PRKG1;SERPINE2;PRKCQ;C1QTNF1;PRKCD;DMTN;PRKCA
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5323597040739699,1.2508689224343426,0.22290076335877862,0.9015199519711318,1.0,3/25,1.38%,DMD;TRPC6;STAC
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5370650971904489,-1.2506931307934468,0.2247191011235955,0.7949188656190876,1.0,3/10,9.53%,ADGRV1;WHRN;IFT88
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5491376428293886,1.250297276148851,0.2696629213483146,0.9018493917042543,1.0,4/19,6.54%,ROCK1;LIMS1;FERMT2;VEGFA
prerank,regulation of protein export from nucleus (GO:0046825),-0.42922279367847743,-1.2497337520158187,0.18529411764705883,0.7958183440215362,1.0,8/23,14.73%,PTPN14;TCF7L2;CAMK1;UHMK1;SIRT7;RANGAP1;SP100;EMD
prerank,T cell migration (GO:0072678),-0.4938186715888145,-1.2494515076553945,0.21212121212121213,0.7943378709573821,1.0,2/13,6.70%,SLC12A2;CXCL16
prerank,negative regulation of multicellular organismal process (GO:0051241),0.42020667105165965,1.2487971140304788,0.12916666666666668,0.9054199069429005,1.0,22/199,7.85%,MYOCD;MEF2C;ATP2B4;HEY2;VASN;NR1H4;ROCK1;ALPK2;ADAMTS5;LOXL2;PLCL1;HDAC9;ASB1;TBX18;KLF7;LNPEP;PROCR;SDHAF2;DAB2IP;CORO1C;ATP2B1;SOX9
prerank,monosaccharide transmembrane transport (GO:0015749),0.5837999615150599,1.2487174586530638,0.2206896551724138,0.9040505174691881,1.0,4/16,8.14%,SLC5A3;SLC2A10;SLC23A2;SLC23A1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.5179892929951936,1.2486703836436657,0.19405099150141644,0.9025997018003905,1.0,8/32,11.42%,NR1H4;ROCK1;ATXN2;CYFIP1;SAMD8;RBM3;PRKCD;DDX25
prerank,early endosome to Golgi transport (GO:0034498),-0.5119992893263068,-1.2483959794449888,0.20094562647754138,0.7954230253222406,1.0,5/11,18.95%,STX5;SURF4;RBSN;LMAN1;EHD3
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.5257419574144714,-1.2482546853477239,0.18993135011441648,0.7908917990726977,1.0,5/11,27.53%,AGO3;TNRC6A;NOTCH4;AGO4;ZFP36
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.5257419574144714,-1.2482546853477239,0.18993135011441648,0.7908917990726977,1.0,5/11,27.53%,AGO3;TNRC6A;NOTCH4;AGO4;ZFP36
prerank,plasma membrane tubulation (GO:0097320),0.6051085093593286,1.2482301261144786,0.256140350877193,0.9024854607789349,1.0,6/13,12.51%,PACSIN3;PACSIN2;EHD2;WHAMM;SNX9;PACSIN1
prerank,protein homotetramerization (GO:0051289),0.481800900806103,1.2481696372774909,0.20079260237780713,0.9010906732512954,1.0,10/49,12.46%,RYR1;KCNJ12;HSD17B10;CRYZ;ACACB;TRPM4;ALDOA;GLS;OSBPL2;TRPM2
prerank,fatty acid transmembrane transport (GO:1902001),0.5475306471070583,1.2480113664181085,0.24462809917355371,0.9000312964441294,1.0,7/19,14.85%,PRKAB2;CD36;ACACB;CPT1B;ABCD4;CPT1A;PRKAA2
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.3442266458231433,-1.2479130554496956,0.12735849056603774,0.789528726150844,1.0,14/57,12.40%,IGF1;IL31RA;IL15;KIT;GHR;NF2;IL18;PPP2CA;ARL2BP;TNFRSF1A;IL6R;HES1;LYN;PARP14
prerank,replication fork processing (GO:0031297),-0.3649732080682704,-1.2477244435108712,0.16333333333333333,0.7877213526100961,1.0,18/38,37.68%,ATR;MRE11;FBH1;SAMHD1;BLM;MMS22L;PRIMPOL;SMARCAL1;NUCKS1;ALYREF;DNA2;ATRX;BOD1L1;RFWD3;TRAIP;RAD51;CENPX;GEN1
prerank,positive regulation of glycolytic process (GO:0045821),-0.44727005211104387,-1.247596622138739,0.20865139949109415,0.783110559426885,1.0,10/20,21.49%,IGF1;ZBTB20;APP;ENTPD5;PFKFB2;INSR;ARNT;PRXL2C;PFKFB3;PRKAA1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.44727005211104387,-1.247596622138739,0.20865139949109415,0.783110559426885,1.0,10/20,21.49%,IGF1;ZBTB20;APP;ENTPD5;PFKFB2;INSR;ARNT;PRXL2C;PFKFB3;PRKAA1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.6146406414614712,1.2474726565172445,0.24778761061946902,0.900321343067622,1.0,6/11,12.68%,MAP3K5;ARL6IP5;STK24;PRKCD;PDCD10;DIABLO
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.4613491370255434,-1.2470295929633874,0.2032520325203252,0.7827683675735146,1.0,3/16,5.73%,NFAT5;ST3GAL4;IRAK1
prerank,inorganic ion transmembrane transport (GO:0098660),0.5963522353151294,1.2468812690762023,0.24723247232472326,0.9007864848641843,1.0,3/12,9.48%,CACNA1H;TRPM4;ABCC8
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.3683281827741236,-1.2465320637380413,0.14634146341463414,0.7820180069853012,1.0,17/46,15.19%,ATP1A2;TSHZ3;GRM3;GRM7;NLGN1;PTK2B;SHANK3;SYT1;DGKI;CACNG4;NRXN1;GRIK3;OPHN1;GRM5;NLGN2;NLGN3;CLN3
prerank,cellular response to cAMP (GO:0071320),0.519300271725901,1.2463567482448317,0.2066365007541478,0.9010692175687293,1.0,3/30,3.41%,RAP1A;AKAP6;IGFBP5
prerank,positive regulation of stress fiber assembly (GO:0051496),0.48879534818542925,1.2460833601631467,0.2013157894736842,0.9003782838610005,1.0,5/44,3.83%,TPM1;SYNPO2L;FERMT2;TGFB3;PPM1E
prerank,membrane depolarization (GO:0051899),0.508834758671962,1.245680203456451,0.21637426900584794,0.9001564437423634,1.0,11/32,18.78%,SCN4A;CACNA1H;CACNB4;CAV1;CACNA1B;YWHAH;CHRNA4;CACNA1I;KCNH2;P2RX4;ABL1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.5297015261665984,1.245602754680701,0.23672230652503792,0.8988354359680627,1.0,8/25,15.74%,CHMP4C;SORT1;LYST;CHMP5;DENND10;CHMP2B;CHMP2A;LEPROT
prerank,regulation of interleukin-17 production (GO:0032660),0.5134064016706494,1.245424908759658,0.22127659574468084,0.8978927281410192,1.0,4/31,5.56%,NR1H4;MYD88;IL2;PRKCQ
prerank,protein deacetylation (GO:0006476),0.49275752016241064,1.2453593714768343,0.20491803278688525,0.8965331730617521,1.0,16/41,19.01%,FLNA;SIRT3;HDAC9;MSL3;MTA3;SIRT2;MIDEAS;BAZ2A;MORF4L1;SIRT4;MTA1;SIN3A;SIRT6;HDAC1;RBM14;HDAC6
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.5402424219260374,1.2443772742368575,0.21889055472263869,0.8983648798789381,1.0,4/22,7.53%,DYNLL1;ROCK1;TP53;PLEK
prerank,negative regulation of immune response (GO:0050777),0.42236265231453723,1.244367764072161,0.15442764578833693,0.8968259026436574,1.0,21/154,9.79%,LHCGR;GPR20;ADCY5;CRHR2;FCGR3A;ADCY2;VIPR2;MYH9;ADCY9;TSHR;HAVCR2;CYSLTR2;RAMP1;PRKACB;CD300A;PRKAR1B;ADAM17;PTH1R;ADCY6;SIRT2;SAMSN1
prerank,positive regulation of cellular component movement (GO:0051272),0.5305088895043139,1.244361953080363,0.2311178247734139,0.8952729041103056,1.0,6/24,8.74%,ACTN4;CAVIN1;NTN1;VEGFA;TUBB2B;ADAM17
prerank,negative regulation of histone methylation (GO:0031061),-0.5393920616855852,-1.2438547064941,0.2080536912751678,0.7894973326062191,1.0,6/10,38.00%,BCOR;KDM1A;JARID2;BRCA1;DNMT3B;AASS
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5380928589137441,1.2436971156628787,0.22403560830860533,0.8961171619536207,1.0,15/28,20.98%,CLASP2;MAP1B;PRUNE1;MAPRE2;MAPT;CLASP1;STMN2;MAPRE3;FKBP4;MAP1A;MAP1S;ABL1;CAMSAP1;STMN3;MAPRE1
prerank,response to glucagon (GO:0033762),0.5504001539555762,1.243158166112563,0.233387358184765,0.8964515562815031,1.0,7/19,9.57%,ADCY5;ADCY2;ADCY9;CYSLTR2;PRKACB;PRKAR1B;ADCY6
prerank,activin receptor signaling pathway (GO:0032924),0.5730712878401727,1.2430294433017177,0.2422680412371134,0.8952844655442508,1.0,2/15,4.03%,HJV;ACVR2A
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3267751033995262,-1.2426883769460972,0.12568306010928962,0.7914269089678926,1.0,19/67,8.11%,ELMO1;FLT1;PIK3CA;NRP2;SULF1;MAPK14;CYFIP2;PXN;NRP1;PTK2;ABI1;BAIAP2;PTK2B;VAV2;WASF2;ITGAV;NCK1;PIK3CB;CLEC14A
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.45189577168221406,1.2421336613052076,0.17865707434052758,0.8968047513422884,1.0,15/72,11.01%,NTF3;NTRK3;PDGFB;PDGFC;ROR1;PLXNB1;CCL5;PDGFD;PIK3AP1;NEDD4;TGFB2;SOX9;PDGFRB;PDGFA;GPER1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.46532407486703103,1.2415091066523924,0.18796068796068796,0.897271089108307,1.0,7/63,4.40%,MEF2C;ANXA1;IL2;TNFSF13B;CCL5;CD276;BCL2
prerank,neuromuscular process (GO:0050905),-0.47623184526818113,-1.241372564152744,0.20316622691292877,0.7937362583707112,1.0,7/16,26.18%,MYCBP2;PAFAH1B1;NRXN1;GCH1;CLN3;TPP1;UBA5
prerank,programmed necrotic cell death (GO:0097300),0.553436723670612,1.241019029438941,0.2605177993527508,0.8973638862067643,1.0,3/18,10.76%,ITPK1;CD14;DNM1L
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5940533963489713,1.2404137670065012,0.24744027303754265,0.8962289630198309,1.0,3/12,6.91%,ACTN4;KANK1;CORO1C
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5940533963489713,1.2404137670065012,0.24744027303754265,0.8962289630198309,1.0,3/12,6.91%,ACTN4;KANK1;CORO1C
prerank,endothelial cell development (GO:0001885),0.5204348129060122,1.2400880205378917,0.24041297935103245,0.8957330261004955,1.0,2/25,0.72%,COL18A1;RAP1A
prerank,regulation of cholesterol esterification (GO:0010872),0.6170403119471422,1.2400202091909096,0.25874125874125875,0.894438033593399,1.0,1/10,0.48%,AGTR1
prerank,regulation of insulin secretion (GO:0050796),0.4331607150166374,1.239987315132659,0.18213058419243985,0.8929870008719827,1.0,23/101,16.02%,CACNA1C;RAP1A;NR1H4;ADCY5;ITPR1;KCNA5;CCL5;ALOX5;KCNB1;IRS1;ENSA;NR1D1;ABCC8;GPER1;LRP5;PPP3CB;CLOCK;SIRT4;IRS2;PRKCA;GIPR;RFX3;HADH
prerank,neuron projection extension (GO:1990138),-0.38411794833395846,-1.2392027924906286,0.18213058419243985,0.7993715014590614,1.0,9/32,8.97%,ALCAM;NRP2;AUTS2;NRP1;HSP90AB1;CTNNB1;SEMA3A;TMEM108;CDKL3
prerank,female gonad development (GO:0008585),0.5583224558539303,1.2390946279696498,0.24587458745874588,0.8945331139024022,1.0,4/19,10.58%,LHCGR;NR2F2;VEGFA;NUP107
prerank,positive regulation of lamellipodium organization (GO:1902745),0.5089208639941517,1.238588684055854,0.23925501432664756,0.8946865212432716,1.0,5/32,7.08%,ARHGEF7;PLCE1;ACTR3;CORO1C;CYFIP1
prerank,protein localization to chromosome (GO:0034502),-0.3794365523247056,-1.237468300380552,0.14788732394366197,0.8032030702685662,1.0,18/34,33.77%,ATR;TNKS2;XRCC5;SLF2;PARP3;ESR1;SLF1;LEMD2;TERF2IP;IFFO1;TPP1;TINF2;CHMP7;BOD1;ATRX;ACD;MCM8;RPA2
prerank,bile acid and bile salt transport (GO:0015721),0.5290125685380498,1.2364269411178077,0.24237560192616373,0.9005122080790102,1.0,3/24,2.87%,NR1H4;ATP8B1;SLC10A1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5018776441278094,1.2351120841205436,0.21888412017167383,0.9035921202007248,1.0,7/32,6.91%,DLC1;PHLDB2;CLASP2;JAG1;ARHGAP6;AJAP1;CORO1C
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.501550921371644,1.2347350037394773,0.2297872340425532,0.9032943521663482,1.0,5/35,8.17%,CDH6;CDH13;CDHR3;PCDHB14;PCDHB11
prerank,mitochondrion disassembly (GO:0061726),-0.37529633194987555,-1.2346992015547171,0.13694267515923567,0.8109726654820066,1.0,20/34,29.62%,RB1CC1;CISD2;ATG3;ATG5;FBXO7;PRKN;ATG2B;WIPI2;AMBRA1;ATG2A;FIS1;GABARAPL2;WDR45B;ULK2;MAP1LC3A;GABARAPL1;ATG12;MAP1LC3B;SQSTM1;WIPI1
prerank,regulation of myotube differentiation (GO:0010830),0.5316507460096879,1.2342812393709441,0.24169184290030213,0.9032948881516698,1.0,3/24,4.25%,RBM24;SMYD1;HDAC9
prerank,cellular response to reactive oxygen species (GO:0034614),0.4691167122313731,1.2333182425735814,0.2057356608478803,0.9050038626278113,1.0,14/59,14.48%,TPM1;MAP3K5;ANXA1;NET1;FXN;CAMKK2;MAPT;RELA;IMPACT;PRKCD;TRPM2;PDK2;MAPK1;PLEKHA1
prerank,endocardial cushion morphogenesis (GO:0003203),0.5499529011222873,1.2330222814745961,0.24719101123595505,0.9045453179692257,1.0,5/18,7.85%,TBX2;HEYL;BMPR1A;TGFB2;SOX9
prerank,positive chemotaxis (GO:0050918),0.5527431095111348,1.2329126425649197,0.24715447154471545,0.9033622116678187,1.0,3/17,6.54%,ANGPT1;SEMA5A;VEGFA
prerank,regulation of protein localization to cell surface (GO:2000008),-0.3843310409691267,-1.2327794655856723,0.17253521126760563,0.8151173049010348,1.0,16/33,29.27%,NEDD4L;STX3;GBF1;HSP90AB1;CTNNB1;STX4;COMMD1;RAB11FIP5;ABCA2;RIC3;LEPROTL1;TOR1A;KCNAB2;HFE;EGF;TAX1BP3
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.38082811692921475,-1.2326418608306902,0.17582417582417584,0.8131500993585203,1.0,10/37,14.35%,PRKAG2;BMP7;CEMIP;APP;SPRED2;WNK3;TGFB1;IRGM;SPRY2;DGKQ
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5183115551798734,-1.2323286663999622,0.2261904761904762,0.8118096376355476,1.0,3/10,23.60%,BMP4;SALL1;PAX8
prerank,response to hydrogen peroxide (GO:0042542),0.48107524515346833,1.231562026221847,0.22913907284768212,0.9065465141324749,1.0,12/45,14.48%,MAP3K5;ANXA1;NET1;FXN;STK26;RELA;IMPACT;STK24;PRKCD;TRPM2;PDCD10;PLEKHA1
prerank,aminoglycan metabolic process (GO:0006022),-0.5287413575271865,-1.2314879036690722,0.22429906542056074,0.8123014260622395,1.0,9/10,44.45%,CHST9;XYLT1;B4GALT7;B3GAT1;CLN6;B3GALT6;B3GAT3;B3GAT2;GAL3ST3
prerank,positive regulation of nervous system development (GO:0051962),-0.3576666925515935,-1.2311896523355235,0.15867158671586715,0.8108895538296916,1.0,20/42,28.17%,NLGN1;SPEN;PTPRD;NRXN1;SNW1;FAIM;NLGN2;NLGN3;NUMB;LRRC4B;GRID2;NAP1L1;IL1RAP;EPHB2;SRPX2;TRIM32;MME;SOX11;SYNDIG1;EPHB3
prerank,histone H2B ubiquitination (GO:0033523),-0.5311060672889852,-1.2311817960720308,0.21100917431192662,0.8084711475170704,1.0,4/10,13.63%,RNF20;CTR9;DTX3L;LEO1
prerank,organic hydroxy compound transport (GO:0015850),0.4848450267287332,1.2308758572481355,0.21830985915492956,0.9073166605174311,1.0,4/36,2.87%,NR1H4;ATP8B1;SLC5A3;SLC10A1
prerank,protein ADP-ribosylation (GO:0006471),0.5079659750586849,1.2303186332910914,0.2474964234620887,0.9075906402461715,1.0,7/28,13.93%,ART1;SIRT3;PARP1;ART4;SIRT2;HPF1;SIRT4
prerank,camera-type eye development (GO:0043010),-0.39774906050036385,-1.2301813597576083,0.17941176470588235,0.80986343888576,1.0,10/25,12.13%,SHROOM2;FBN1;NF1;EFEMP1;LAMA1;FBN2;IFT122;CYP1B1;TENM3;NES
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5764378075309401,1.2294575377313295,0.26936026936026936,0.9089905929511667,1.0,9/15,20.61%,ROCK1;CAMK2D;MEF2A;PARP1;ROCK2;PRKCA;PDE9A;AGT;SLC9A1
prerank,glycoprotein biosynthetic process (GO:0009101),-0.3172665246908227,-1.2293304651251853,0.10638297872340426,0.8105711218235309,1.0,26/79,22.02%,IGF1;CHST11;ST3GAL4;ST3GAL6;ST8SIA4;ST3GAL5;ST8SIA1;BMPR2;MGAT1;CHST9;SERP2;GOLPH3;FUT10;ST3GAL3;ST8SIA2;B3GALNT1;PMM2;CANT1;XYLT1;FOXL1;COG7;CHST12;ALG1;B4GALT7;B3GNT2;B3GALT2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.5566825419380614,1.2280571863232674,0.24525316455696203,0.9121594419903093,1.0,6/18,9.58%,LTBP1;ITGB6;LRRC32;CD200;TGFB2;HIF1A
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.4145982516354843,1.2278339433688306,0.1641949152542373,0.9114386515764086,1.0,48/190,15.68%,PDE3A;DGKG;WTIP;ATP2B4;NR1H4;ITPR1;LIMD1;RORA;BCL2;CARD19;CAV1;DAB2IP;DUSP3;PPM1A;PHLDA3;BCL2L2;PLEK;RELA;TNIP1;OTUD7A;PPARA;GSTP1;NR1D1;THEM4;EPHA2;NDUFS3;DGKD;NPRL2;ARHGAP12;EPM2A;RTKN2;SH3BP4;GPER1;GPD1L;PDE4D;RHOH;SHANK2;MUL1;MAP2K3;TMSB4X;MCL1;PLEKHA1;STAT1;VGLL4;PRKAA2;PTEN;URI1;PPP2R5C
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.40610916089333104,-1.227687567968802,0.19808306709265175,0.8144335591955625,1.0,11/27,16.51%,FLT1;PDGFRA;KIT;TEK;PTK2;PTK2B;TGFB1;AMBRA1;EPHA8;TNFAIP8L3;FGF2
prerank,ovarian follicle development (GO:0001541),0.5821497331794102,1.2276748523922332,0.2676056338028169,0.9104496454635337,1.0,2/13,6.54%,LHCGR;VEGFA
prerank,blood vessel endothelial cell migration (GO:0043534),-0.4159940743303683,-1.2274085021429681,0.1989795918367347,0.8129485077160641,1.0,7/22,5.58%,ROBO1;EFNB2;CDH5;SLIT2;PIK3R3;NRP1;ID1
prerank,positive regulation of endocytosis (GO:0045807),-0.3523025120067761,-1.2271099737931372,0.1593625498007968,0.8115705865667892,1.0,9/45,4.31%,DAB2;APPL2;LRP1;NEDD4L;APOE;VTN;B2M;HNRNPK;NLGN1
prerank,negative chemotaxis (GO:0050919),0.4903636830775477,1.2268961027153962,0.23056300268096513,0.9116748387757664,1.0,4/33,4.78%,SLIT1;SLIT3;NTN1;SEMA6C
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5569529768909031,1.2268161486191687,0.2608695652173913,0.9104051465062382,1.0,3/17,4.18%,RYR2;SNTA1;KCNE4
prerank,regulation of cellular biosynthetic process (GO:0031326),0.5193183598140905,1.2266790878752265,0.23076923076923078,0.9093243503943821,1.0,5/28,7.26%,NR1H4;PRKAB2;PDK4;CCL5;MED1
prerank,cellular macromolecule catabolic process (GO:0044265),-0.35116715648016217,-1.226507202373663,0.14893617021276595,0.8112118195842905,1.0,19/49,27.61%,DENND3;NGLY1;RAB12;RNASEH2B;PRKN;ADAMTS9;HNRNPD;CHEK2;PNPT1;SIAH2;FBXO17;PPP1R8;MAGEC2;PABPC4;STT3B;EXOSC7;SND1;HTRA2;FBXO44
prerank,regulation of interferon-beta production (GO:0032648),-0.3487236704821465,-1.2259950071982317,0.15151515151515152,0.8107261465792152,1.0,18/46,25.69%,DDX3X;PTPN11;PPM1B;RNF135;POLR3F;RIOK3;POLR3B;POLR3A;SIRPA;RELB;TRIM56;TLR3;OAS2;TIRAP;POLR3C;TOMM70;NLRC3;POLR3D
prerank,transport across blood-brain barrier (GO:0150104),-0.3194122181649871,-1.2256227249701168,0.11194029850746269,0.809607017288199,1.0,25/83,10.29%,ATP1A2;SLC24A3;SLC6A13;LEPR;SLC16A12;SLC13A3;SLC1A3;SLC22A8;ABCG2;LRP1;SLC2A13;ATP8A1;SLC2A1;SLC12A2;SLCO2B1;SLC6A1;SLC6A6;SLC16A1;SLCO1C1;SLC7A5;SLC6A9;SLCO3A1;ABCC4;ATP1B2;SLC5A5
prerank,regulation of microtubule-based process (GO:0032886),0.48638160529042296,1.2251350280943967,0.2257617728531856,0.9130554019678527,1.0,6/36,6.20%,ROCK1;PHLDB2;CLASP2;BICD2;TPPP;MAPT
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5654091922213977,1.2247649312744304,0.2618657937806874,0.9127191299120729,1.0,6/16,10.90%,PDGFB;PDGFC;PDGFD;PTPN1;PDGFRB;PDGFA
prerank,lipoprotein catabolic process (GO:0042159),-0.5120062825696693,-1.2245513446101823,0.2309322033898305,0.8109387256463723,1.0,8/11,31.92%,APOE;LYPLA1;PPT1;NOTUM;ABHD17C;LYPLA2;CTSD;ABHD10
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.4354331660940778,1.224465620923296,0.21022727272727273,0.9121971867820835,1.0,22/94,14.44%,ATP2A1;CRIP1;MAP3K5;PMAIP1;ITPR1;BCL2;CUL2;MYBBP1A;DAB2IP;ARL6IP5;TP53;BCL2L2;EPHA2;STK24;ATP2A3;PRKCD;BOK;DIABLO;FNIP2;TNFRSF10B;PDK2;MCL1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5732739011064549,1.2238541330125325,0.271356783919598,0.9128340697634896,1.0,1/16,0.92%,ACSS1
prerank,organic acid transport (GO:0015849),-0.3085700686247913,-1.223692104380966,0.08759124087591241,0.8117233250356856,1.0,19/94,8.93%,SLC7A11;SLC6A13;SLC13A3;ABCG2;PDPN;SLCO2B1;SLC6A12;SLC6A6;SLC26A7;SLC16A1;SLCO1C1;NCOA1;SLC25A17;SLC7A14;SLC3A2;SLC25A32;SLC22A6;ABCC4;SLC25A14
prerank,mitotic nuclear division (GO:0140014),0.4432468517352625,1.222870164753708,0.21445783132530122,0.9146804751215841,1.0,22/71,17.49%,FLNA;CLASP2;KIF2A;TOGARAM2;NUP62;KIF3B;TPX2;PIBF1;TOGARAM1;ZWINT;CEP192;WRAP73;AAAS;CLASP1;CHMP2A;KIF18A;KNSTRN;ABRAXAS2;INO80;MAP9;DSN1;CENPK
prerank,generation of neurons (GO:0048699),0.41230651879658436,1.2215459192737592,0.1517386722866175,0.917680121052541,1.0,29/190,9.29%,FGF13;MEF2C;HEY2;CDK6;FZD5;ASTN2;HEYL;IRX5;FZD4;MAP1B;PRUNE1;MARK1;FZD8;ITM2C;MAPT;EML1;TUBB2B;PIN1;YTHDF2;YAP1;CEP85L;TGFB2;ERCC6;ADNP2;ASTN1;MAP2K1;RUNX1;BRSK1;NR4A2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5319845685341513,1.2212863725661005,0.2595419847328244,0.9170469627369195,1.0,5/19,9.53%,NDST3;CSGALNACT1;EXT2;HS2ST1;HS6ST1
prerank,wound healing (GO:0042060),0.4564973908654185,1.221213526018221,0.21189591078066913,0.9157902992601752,1.0,10/62,7.78%,TPM1;FGF1;FER1L5;PPP3CA;MYH9;DYSF;DST;RAB3A;ITGB3;TGFB2
prerank,substrate-dependent cell migration (GO:0006929),-0.4757244475919593,-1.2211817439877382,0.20642201834862386,0.8185003557273334,1.0,8/14,18.92%,NRP1;ANKS1A;CD2AP;SDCBP;EPHA8;OPHN1;VEGFC;ITGB1BP1
prerank,positive regulation of developmental process (GO:0051094),0.4169298642711871,1.2210242118010801,0.17091295116772823,0.914881893015219,1.0,38/164,15.38%,SOX6;ARHGEF7;SOX5;PDGFB;PHLDB2;CLASP2;FST;FZD4;TMEM79;BMPR1A;TAPT1;DAB2IP;VEGFA;CORO1C;GDNF;PA2G4;AR;SOX9;MIEF2;MIEF1;PLCB1;SPIRE1;TRPM4;PAXIP1;RBM19;RIF1;NR2C2;DNM1L;ACVR1B;BMPR1B;PACSIN1;CPEB3;CLASP1;MUL1;DVL1;KMT5B;VLDLR;FBXO5
prerank,telomere maintenance (GO:0000723),-0.3382784716689277,-1.2209263449310228,0.14473684210526316,0.8169626157085736,1.0,25/50,28.30%,ATR;PRKDC;XRCC5;STN1;MRE11;RAD50;PARP3;SP100;BLM;XRCC6;NBN;CTC1;SMC5;TPRKB;HUS1;TERF2IP;LTO1;ATM;NSMCE2;ERCC4;DCLRE1B;TINF2;RPA3;DNA2;TEN1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5753984462231484,1.2208447151936854,0.2898089171974522,0.9140400393914832,1.0,4/16,12.85%,RBM24;UPF1;ZFP36L1;CPEB3
prerank,presynapse assembly (GO:0099054),-0.45984437039842874,-1.2203181916591892,0.21119592875318066,0.8168044375502264,1.0,6/16,14.59%,WNT5A;NLGN1;PTPRD;NLGN2;NLGN3;PCLO
prerank,regulation of receptor internalization (GO:0002090),0.4893846713840988,1.2202528160902928,0.22833562585969738,0.9145033928171366,1.0,6/35,10.50%,NTF3;ANGPT1;ATXN2;VEGFA;ATAD1;SCYL2
prerank,somite development (GO:0061053),-0.5288709588421514,-1.220236685851735,0.22939866369710468,0.8147271460864056,1.0,5/11,26.58%,PTCH1;MEOX2;SMO;LOXL3;SOX11
prerank,regulation of neuron apoptotic process (GO:0043523),0.4249916331634285,1.2200667402399255,0.20023696682464456,0.9136649198613443,1.0,13/96,7.78%,NTF3;MEF2C;TRIM2;PLA2G3;CRLF1;TGFB3;SET;BCL2;KCNB1;GDNF;PPARGC1A;FZD9;TGFB2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.48782252109813296,-1.2197699074067783,0.22787610619469026,0.81390871163326,1.0,3/12,6.85%,UNC13C;UNC13B;SYT1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.4750390777727625,1.219571983417054,0.22005208333333334,0.9138577950661083,1.0,13/44,13.81%,RBM24;ROCK1;BTG2;UPF1;POLR2G;YTHDF2;CELF1;FTO;ROCK2;CNOT7;ZFP36L1;CPEB3;GIGYF2
prerank,fatty acid elongation (GO:0030497),-0.4702988657622894,-1.2195686514014152,0.23,0.8122526579617018,1.0,7/13,22.46%,ELOVL7;HACD4;ELOVL4;ELOVL6;HACD2;ELOVL1;HACD3
prerank,regulation of store-operated calcium entry (GO:2001256),0.6078995862649029,1.2195006112041662,0.27956989247311825,0.9126457267302033,1.0,4/10,12.68%,CASQ1;STIM1;GRAMD2A;HOMER1
prerank,regulation of ion transmembrane transport (GO:0034765),0.4961293947158071,1.2194689438014257,0.21965317919075145,0.9112875034816517,1.0,5/33,9.43%,AKAP6;KCNJ12;ANO6;NEDD4;AHCYL1
prerank,odontogenesis (GO:0042476),-0.37215337907671486,-1.2194030907818278,0.14950166112956811,0.8105248933848537,1.0,10/35,16.16%,EDA;BMP4;COL1A2;GLI2;OSR1;LAMB1;FGFR2;HDAC2;WNT6;BCOR
prerank,digestive tract development (GO:0048565),-0.38119189055826574,-1.218893726447503,0.16774193548387098,0.8099890549487816,1.0,10/32,14.94%,COBL;CLMP;KIT;PCSK5;GLI2;MEGF8;SALL1;FGFR2;CCDC39;PKDCC
prerank,membrane lipid catabolic process (GO:0046466),-0.520607553386384,-1.2183614596556684,0.2317596566523605,0.8095674184887457,1.0,4/10,20.47%,ENPP2;CYP1B1;PPT1;NAGA
prerank,inositol phosphate metabolic process (GO:0043647),0.4697648001996862,1.218093759326713,0.22563417890520696,0.9145015890235271,1.0,12/46,11.77%,ITPK1;PLCE1;INPP4B;PLCB4;INPP5A;NUDT4;CALM1;PLCB1;INPPL1;PLCD1;INPP5B;ITPKC
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4411390439354906,1.2176354992597211,0.20718562874251498,0.9145990841131394,1.0,14/75,11.01%,RGS6;ROCK1;PLCE1;RGS4;CCL5;SAG;RPGRIP1L;CALM1;PLEK;PLCB1;SLC39A14;MGLL;ROCK2;GPER1
prerank,acute inflammatory response (GO:0002526),0.5203460706300996,1.217378563349199,0.25306748466257667,0.9140240598330471,1.0,4/23,7.80%,ITIH4;ANO6;IL22;MBL2
prerank,regulation of blood coagulation (GO:0030193),-0.3950889311222864,-1.2173055349957211,0.19571865443425077,0.8109546399440127,1.0,6/27,8.19%,ST3GAL4;APOE;VTN;TFPI;CD34;THBD
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.5026866904579157,-1.2169461919800033,0.25333333333333335,0.8098094633775887,1.0,6/11,30.97%,LGALS9;PARK7;HTRA2;PIH1D1;GSN;PLAUR
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.29956085072858185,-1.2166858410617134,0.10909090909090909,0.8084771752017071,1.0,35/87,24.85%,RPL27A;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;SEC63;RPLP0;RPS29;RPL28;RPS10;RPLP1;RPS20;RPL34;RPL23A;RPS8;RPL36A;RPS21;RPL9;RPL27;RPS7;SEC61A1;RPL18A;RPL11;SRP9;RPL37A;RPL38;RPL29;RPL32;RPL10A;RPS4X;RPS27
prerank,myoblast fusion (GO:0007520),0.5779334608251461,1.2158422915440883,0.26842105263157895,0.9177624299700216,1.0,3/12,5.55%,CACNA1H;ADAMTS5;KCNH1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.5184451086081862,1.2156637934260262,0.2434017595307918,0.9169295375101736,1.0,6/25,11.40%,PFKP;ENO3;HK2;ADPGK;ALDOA;PFKM
prerank,nitrogen compound transport (GO:0071705),-0.2771232244176326,-1.2155965171394207,0.06422018348623854,0.810082048571404,1.0,42/141,22.68%,SLC7A11;SLC6A13;ABCG2;PDPN;CALCRL;SLC12A2;SLC6A12;SLC6A6;SLC7A14;SCAMP2;SLC3A2;SLC52A1;SLC7A5;SCARB2;TMEM30A;SEC14L1;CERT1;SLC35F3;SLC22A4;PPT1;RALBP1;SLC43A2;RAMP2;RCN3;HSP90B1;TOM1;SLC38A5;NDC1;PICK1;LRRC8D;CUBN;ARRDC1;SCAMP3;SLC15A4;SLC7A7;MIA3;SLC1A4;SLC36A1;SLC43A1;SCAMP1;TXNIP;SLC5A7
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.34767643791533936,-1.2155074005138522,0.16956521739130434,0.8081556798010943,1.0,17/49,21.18%,LDLRAD4;HMGB1;DDX3X;SMAD6;HSPA5;IAPP;PYDC1;PEX5;RIOK3;EP300;AIDA;NOP53;CDC42;HSF1;PMEPA1;PARK7;DACT1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.4410121452477207,-1.2154349324752558,0.22311827956989247,0.8061309554566378,1.0,7/17,18.35%,SEL1L;UFD1;DERL1;HSP90B1;OS9;SYVN1;HERPUD1
prerank,cytoplasmic translation (GO:0002181),-0.30364657663590505,-1.2151885856883164,0.07692307692307693,0.804721711571509,1.0,35/91,24.85%,RPL27A;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;RPLP0;ZC3H15;RPS29;RPL28;RPS10;RWDD1;EIF2B3;RPLP1;RPS20;RPL34;RPL23A;RPS8;RPL36A;RPS21;RPL9;RPL27;RPS7;RPL18A;RPL11;RPL37A;RPL38;RPL29;RPL32;RPL10A;RPS4X;RPS27
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3555940148336647,-1.215010807928212,0.15444015444015444,0.8031163008688395,1.0,6/41,9.15%,AFDN;TJP1;BMP7;PODXL;CD44;PIEZO1
prerank,regulation of actin filament-based process (GO:0032970),0.4460505887061552,1.214867692666837,0.22611850060459493,0.9181359019634451,1.0,15/70,12.92%,DLC1;ROCK1;CNN2;ABRACL;RHOBTB3;ARHGAP17;RHOF;PDGFRB;ROCK2;PDGFA;PRKCD;RHOH;ARHGAP35;RICTOR;DMTN
prerank,endothelial cell differentiation (GO:0045446),-0.49072559690016626,-1.214552640328598,0.2556053811659193,0.802514468145567,1.0,6/12,13.45%,FSTL1;ACVRL1;BMPR2;TIE1;SCUBE1;KDR
prerank,substantia nigra development (GO:0021762),0.485779640682525,1.2142375880123304,0.24043715846994534,0.91881447111787,1.0,8/37,9.73%,DYNLL1;SYPL2;PADI2;ACTB;CALM1;MBP;NDUFS3;SIRT2
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.545795700432227,1.2129649836984706,0.2544570502431118,0.9217105265711538,1.0,3/20,7.31%,WTIP;LIMD1;CELF1
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.3793584473935224,-1.2123240983279162,0.20689655172413793,0.808122149474658,1.0,10/32,16.54%,IGF1;ZBTB20;PID1;NUPR1;APP;ENTPD5;PFKFB2;INSR;ARNT;PRXL2C
prerank,histone H3-K36 demethylation (GO:0070544),-0.5199813582466892,-1.2120426294686464,0.2605042016806723,0.806964609479846,1.0,3/10,12.50%,KDM7A;KDM2A;RIOX2
prerank,regulation of intracellular transport (GO:0032386),0.48304691739239825,1.2117835064744926,0.23593964334705075,0.9242348231798865,1.0,4/38,6.67%,MYLK2;PLA2G3;LCP1;PTPN1
prerank,water transport (GO:0006833),-0.49536828106271447,-1.2116290872294264,0.23595505617977527,0.8062008573910512,1.0,1/12,1.67%,PDPN
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4856133930893091,-1.2115352252981988,0.22170900692840648,0.8042824842652704,1.0,3/12,7.45%,APOE;LDLR;IAPP
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.5918458905608097,1.2114517342197089,0.2787769784172662,0.9237925851680014,1.0,4/11,18.76%,MERTK;AXL;GAS6;CCL19
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.48674733436459666,1.2111984280992398,0.25578034682080925,0.9232175729842106,1.0,3/32,6.29%,AKAP6;CASQ1;CAV1
prerank,regulation of establishment of protein localization (GO:0070201),0.5643821997325582,1.2110360540357823,0.26362038664323373,0.9222763324469111,1.0,5/13,19.14%,PTP4A3;CEP290;CEP120;CEP295;CEP135
prerank,mRNA stabilization (GO:0048255),0.4830730307147491,1.2108626436269856,0.23490813648293962,0.9213939560922982,1.0,10/40,13.18%,RBM24;TENT5B;MYD88;MAPKAPK2;CIRBP;GDNF;FUS;HNRNPU;HNRNPC;SYNCRIP
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.39838212133783624,-1.2106892780393772,0.19753086419753085,0.8048802391636447,1.0,6/28,8.28%,PTN;APP;APOE;EPHA4;SHANK3;ADCY1
prerank,regulation of autophagosome assembly (GO:2000785),-0.3744996318559941,-1.2101195777914548,0.16896551724137931,0.8047418991899705,1.0,17/33,24.98%,NUPR1;RAB5A;NPRL3;PIP4K2B;IFT88;RAB3GAP2;UBQLN2;RAB1B;SCFD1;RALB;TBC1D14;FEZ1;SMCR8;LRSAM1;PHF23;CHMP4B;CHMP4A
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.44399426959534655,-1.2091913851510865,0.22518159806295399,0.8057439627009257,1.0,7/16,18.82%,BMP7;SOX13;NAPEPLD;SIX1;PTGS2;TFE3;METRNL
prerank,postsynaptic membrane organization (GO:0001941),-0.4413639832078323,-1.2091390674766958,0.21750663129973474,0.8036969705689451,1.0,10/17,28.22%,APOE;NLGN1;SHANK3;NRXN1;NLGN2;NLGN3;DNAJA3;CHRNB1;SHISA7;LHFPL4
prerank,activation of GTPase activity (GO:0090630),0.4333188726340636,1.2091128664681532,0.22637106184364061,0.9258167512016978,1.0,14/89,9.49%,NTF3;NTRK3;RALGAPA2;TBC1D1;ABR;ARHGEF16;MTSS2;RABGAP1;CORO1C;RASGRP1;RALGAPA1;EVI5;RALGAPB;EPHA2
prerank,positive regulation of cell differentiation (GO:0045597),0.3989307552044901,1.208584287456721,0.15,0.926086156801182,1.0,38/237,8.90%,SOX6;AGTR1;SOX5;MEF2C;RAP1A;RBM24;SMYD1;CD36;CCN1;PLA2G3;FERMT2;LOXL2;HEYL;LPL;TGFB3;GCNT2;MMD;ACVR2A;TGFB1I1;SP7;ARHGEF2;BMPR1A;MEF2A;RARRES2;RRAS;GDNF;YAP1;PA2G4;AR;BTG1;TGFB2;SOX9;PLCB1;RIN2;TRPM4;SUCO;CDH2;IMPACT
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.4156147045938184,-1.2082552169794347,0.208,0.8046900098400588,1.0,6/23,20.25%,IGF1;PYDC1;CX3CL1;GIT1;ZC3H12A;CEACAM1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.44030684678522064,-1.2081332940173974,0.20202020202020202,0.8029284511026893,1.0,12/18,35.27%,COA8;COX20;SMIM20;COX14;TIMM21;BCS1L;COX16;COX17;COA3;SURF1;COX18;FASTKD3
prerank,positive regulation of cell adhesion (GO:0045785),0.4387221639833821,1.2080966214235331,0.23429951690821257,0.9262230438004903,1.0,9/74,7.78%,TPM1;ZFHX3;LIMS1;PDGFB;PPP3CA;CCL5;RSU1;VEGFA;TGFB2
prerank,regulation of response to biotic stimulus (GO:0002831),-0.3900259775646932,-1.2077053361986252,0.17096774193548386,0.8022591412573434,1.0,13/28,15.61%,APPL2;FOXP1;RNF135;CD55;CASP8;BIRC2;PTPN22;SAMHD1;TRIM5;CX3CL1;APPL1;LRP8;BIRC3
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.46342170583095166,-1.2075770052199928,0.23404255319148937,0.8004978394376018,1.0,4/15,7.32%,DAB2;AAK1;BMP2K;PIK3CB
prerank,smooth muscle tissue development (GO:0048745),0.6063453210631383,1.206965259771838,0.2857142857142857,0.92857813071489,1.0,1/10,0.25%,MYLK
prerank,intermediate filament organization (GO:0045109),0.5446804366955832,1.205748866902966,0.2731707317073171,0.9311955337270726,1.0,2/17,2.63%,DES;VIM
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5960762868894673,1.2053648903308503,0.290448343079922,0.931000461872331,1.0,2/10,5.60%,ACTN4;RXRG
prerank,regulation of B cell proliferation (GO:0030888),0.4704207938578009,1.2051073134123087,0.2529182879377432,0.930428053032734,1.0,6/44,9.92%,MEF2C;IL2;TNFSF13B;BCL2;CD300A;TNFRSF21
prerank,secretion (GO:0046903),-0.4579361508046735,-1.2049920158779703,0.23218997361477572,0.8076805211522006,1.0,4/14,15.34%,SLC22A6;NPR1;SLC22A4;FBLN5
prerank,2-oxoglutarate metabolic process (GO:0006103),0.5618935151006267,1.2049236889594785,0.2760416666666667,0.9295642723941913,1.0,4/13,7.92%,D2HGDH;DLST;GOT1;GOT2
prerank,activation of protein kinase A activity (GO:0034199),0.5504470537401758,1.2047573971141363,0.26791808873720135,0.9286481469745301,1.0,6/16,9.57%,ADCY5;ADCY2;ADCY9;PRKACB;PRKAR1B;ADCY6
prerank,positive regulation of vasculogenesis (GO:2001214),0.6018723465879774,1.204667754747506,0.27624309392265195,0.9274773703224448,1.0,3/10,8.24%,RAP1A;RRAS;RIN2
prerank,hyaluronan catabolic process (GO:0030214),-0.4264331822123397,-1.203705286631013,0.21513002364066194,0.809976047385837,1.0,6/18,16.51%,CEMIP;CD44;TGFB1;HEXA;CEMIP2;FGF2
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5246914867682311,1.2036442527670577,0.27827380952380953,0.9295677037425802,1.0,6/21,15.05%,FZD5;CAV1;AMER1;PPP1CA;DVL1;CSNK1A1
prerank,skin development (GO:0043588),0.4481872580012681,1.2034253474498835,0.2399497487437186,0.928853472318751,1.0,12/65,12.38%,RYR1;ITGA3;ANXA1;JAG1;TMEM79;FA2H;SLC2A10;MED1;EPHA2;PDGFA;COL3A1;BCR
prerank,negative regulation of blood coagulation (GO:0030195),-0.36608581898841996,-1.202932204200725,0.1821705426356589,0.8104479253680256,1.0,9/38,8.92%,PDGFRA;APOE;VTN;TFPI;PLAT;F3;CD34;THBD;NOS3
prerank,regulation of macrophage migration (GO:1905521),0.5929758621630893,1.2017072528303303,0.2857142857142857,0.9333687387427395,1.0,3/10,7.13%,EMILIN1;CD200R1;CD200
prerank,T cell mediated immunity (GO:0002456),-0.4820186148467342,-1.2015333452245787,0.2449438202247191,0.8130975805815369,1.0,5/13,12.11%,CADM1;CD55;CTSH;CD46;GNL1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.4951458532986661,-1.20080575621387,0.2379862700228833,0.8135241230215966,1.0,8/11,30.64%,TET3;CTR9;TET2;OGT;SETD1A;PRDM9;KMT2A;BEND3
prerank,negative regulation of platelet activation (GO:0010544),0.5665923500167036,1.200795956210354,0.2733224222585925,0.9349526653951848,1.0,6/16,11.28%,PRKG1;PDGFB;SERPINE2;C1QTNF1;PDGFA;PRKCD
prerank,RNA catabolic process (GO:0006401),-0.342759103703473,-1.200482844010558,0.18532818532818532,0.812420315524154,1.0,20/46,28.95%,AGO3;RNASEH2B;METTL3;ERN1;DCP2;HNRNPD;PNPT1;METTL16;LSM5;LSM2;PPP1R8;PABPC4;EXOSC7;CNOT10;SND1;NUDT12;AGO4;ZFP36;DNA2;LSM6
prerank,epithelial cell migration (GO:0010631),0.4776027445058606,1.2003358255812633,0.25757575757575757,0.9350286562119592,1.0,7/37,3.34%,PTP4A3;ROCK1;ZEB2;PLXND1;CDH13;LOXL2;KANK1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.3884590719200749,-1.1997198162551923,0.21283783783783783,0.8129336547927052,1.0,11/29,16.51%,FLT1;PDGFRA;KIT;TEK;PTK2;PTK2B;TGFB1;AMBRA1;EPHA8;TNFAIP8L3;FGF2
prerank,response to laminar fluid shear stress (GO:0034616),-0.5127594225123641,-1.1997081414121076,0.2537634408602151,0.8108084153022885,1.0,5/10,24.34%,SMAD6;ABCA1;KLF2;ASS1;MAPK7
prerank,histone ubiquitination (GO:0016574),-0.4201249001257501,-1.1994435075984877,0.21485411140583555,0.8094849452168276,1.0,6/21,13.63%,RNF20;UBR2;CTR9;PHC1;DTX3L;LEO1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3721003323452673,-1.1990737145164314,0.18983050847457628,0.8086446144203299,1.0,13/34,16.51%,FLT1;PDGFRA;KIT;TEK;PIK3R3;PTK2;PTK2B;WDR91;TGFB1;AMBRA1;EPHA8;TNFAIP8L3;FGF2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.45507034458724627,-1.1986083255408826,0.21867321867321868,0.8081756763284886,1.0,4/14,5.61%,WNK1;WNT5A;ADAM10;PTK2B
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.3210640634673325,-1.1983424121374557,0.1377551020408163,0.8069618079489251,1.0,23/59,21.77%,LEF1;AGO3;MED13;TCF7L2;CDK8;RUNX2;MED15;MED17;CTNNB1;MED25;MED27;SETX;TNRC6A;MED6;CEBPB;MED7;PPM1D;BAX;MED24;TNRC6B;MECP2;MED16;MED30
prerank,leukocyte tethering or rolling (GO:0050901),0.551477954798172,1.1983072272076147,0.2731788079470199,0.9404677744900628,1.0,4/17,8.48%,ROCK1;ITGB1;ADD2;ITGA4
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.3946962309998481,-1.1982197359974025,0.2005420054200542,0.805211323450331,1.0,5/24,16.64%,RBBP4;PPHLN1;AEBP2;PPM1D;MPHOSPH8
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.4279097866573325,-1.1976046243795582,0.22972972972972974,0.8053914248803743,1.0,14/19,33.41%,PGM3;RENBP;UGDH;PMM2;SLC35D1;UAP1;AMDHD2;GFPT2;PMM1;GNPDA1;UAP1L1;NANS;GNPNAT1;MPI
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.47736112670342723,-1.1974953989044284,0.2459396751740139,0.8036633020019296,1.0,7/13,27.46%,NCBP2;CPSF2;CPSF6;CSTF2T;CPSF4;CSTF2;CPSF1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4432637012211883,1.197198065379819,0.24428399518652227,0.942730196402477,1.0,18/66,14.47%,MAP3K5;FGF1;MST1R;PDGFB;PDGFC;PDGFD;TNFRSF11A;DAB2IP;VEGFA;RASGRP1;MAP3K10;PDGFRB;PDGFA;HTR2B;PDCD10;TAOK3;LRRK2;DIRAS2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.5839054717987164,1.1971842282052894,0.2913907284768212,0.9413077659087713,1.0,3/12,5.80%,MYO1E;JAG1;KLF15
prerank,positive regulation of bone mineralization (GO:0030501),0.4801386658840373,1.1968264897039558,0.25314685314685315,0.9411038010988241,1.0,11/35,7.78%,MEF2C;CCN1;ANO6;SLC8A1;TGFB3;ACVR2A;ALOX5;OSR2;BMPR1A;ATP2B1;FZD9
prerank,positive regulation of protein sumoylation (GO:0033235),0.5956905378155251,1.1966571416263165,0.28970331588132636,0.9402139005561545,1.0,3/10,5.99%,UBA2;PIAS4;SAE1
prerank,gonad development (GO:0008406),0.4801214319406433,1.1960557301184194,0.26141078838174275,0.9407574958530746,1.0,8/41,10.58%,LHCGR;IRX5;NR2F2;CSDE1;AR;TGFB2;SOX9;NUP107
prerank,negative regulation of cell differentiation (GO:0045596),0.4070286754591179,1.1959082766846623,0.17486910994764399,0.9398098156100003,1.0,32/181,11.46%,MYOCD;VASN;CHADL;CRIM1;LIMD1;CDK6;RORA;FERMT2;RUNX1T1;JAG1;ANKRD2;ASXL1;SDHAF2;CAV1;DAB2IP;BBS12;SNAI2;YTHDF2;YAP1;MED1;ITGB3;SOX9;PPARA;TRPM4;IQCB1;SKI;SIRT2;HNRNPU;GPER1;LRP5;ABCG1;RB1
prerank,organic substance transport (GO:0071702),-0.28772100580176474,-1.1958446924885324,0.06862745098039216,0.8071428500669432,1.0,37/121,22.53%,ABCG2;SLC47A1;ATP8A1;ABCA9;PLTP;CALCRL;ABCA1;SLCO2B1;CHKA;ABCA4;SLCO2A1;SCAMP2;SLC22A6;SLC35F3;SLC22A4;PPT1;SPNS2;RAMP2;RCN3;HSP90B1;ABCD3;TOM1;ABCA6;SLC22A18;NDC1;PICK1;ABCB9;CUBN;ARRDC1;SLC50A1;SCAMP3;MIA3;TAP1;MFSD2A;ABCA2;SCAMP1;TXNIP
prerank,heme catabolic process (GO:0042167),-0.47255554472354844,-1.1956610938611143,0.22985781990521326,0.8035953375556284,1.0,3/14,11.18%,ABCG2;SLCO2B1;BLVRB
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.47255554472354844,-1.1956610938611143,0.22985781990521326,0.8035953375556284,1.0,3/14,11.18%,ABCG2;SLCO2B1;BLVRB
prerank,response to interleukin-6 (GO:0070741),-0.509579029428624,-1.1956333221740412,0.23799126637554585,0.8016208618766135,1.0,3/10,2.94%,PID1;ST3GAL6;SBNO2
prerank,negative regulation of immune system process (GO:0002683),0.5408413319841351,1.1955538960342484,0.28865979381443296,0.9395484493475803,1.0,4/16,11.31%,CD200;SOX9;GPER1;COL3A1
prerank,protein mannosylation (GO:0035268),-0.41583031361645,-1.1952978635378317,0.23684210526315788,0.8006777527514741,1.0,6/22,7.62%,TMTC1;TMTC2;DPY19L4;RXYLT1;TMTC4;DPY19L1
prerank,positive regulation of cell motility (GO:2000147),0.40000902188112447,1.1949601220467505,0.15828092243186584,0.9401117942291718,1.0,26/205,6.93%,NTF3;MYLK;NTRK3;ACTN4;FGF1;CAVIN1;PDGFB;PPP3CA;CCN1;PDGFC;FERMT2;SEMA5A;CDH13;CCL5;ITGB1;ACTG1;GCNT2;NTN1;PDGFD;SEMA6C;HAS2;SYNE2;CBLL1;CAV1;VEGFA;SNAI2
prerank,cellular response to heat (GO:0034605),0.4850841249513469,1.1948386898496908,0.27045769764216365,0.9390889050712318,1.0,5/35,9.50%,FGF1;ANO1;TCIM;MAPT;BAG3
prerank,regulation of axonogenesis (GO:0050770),-0.3269507593939655,-1.1944625706484153,0.17040358744394618,0.8014701927340581,1.0,9/51,7.77%,PLXNA2;ROBO1;SLIT2;KIF13B;EPHA4;SIPA1L1;RUFY3;TIAM2;PLXNA4
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.41221502711365365,-1.1938520947335827,0.24345549738219896,0.8015722606396518,1.0,3/21,5.43%,OSBPL8;OSBPL10;PLA1A
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.3963086402518178,-1.1933514729088586,0.22608695652173913,0.8011536557902242,1.0,9/23,18.35%,SEL1L;UFD1;DERL1;SURF4;HSP90B1;OS9;LMAN1;SYVN1;HERPUD1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5415502153584444,1.1933423296362766,0.28885400313971743,0.9427433963859738,1.0,5/17,10.43%,FERMT2;THPO;TERT;KAT7;HNRNPU
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.4958753401272186,1.1930095372253817,0.24893314366998578,0.94247632038743,1.0,7/30,12.92%,NTF3;CAV1;PIBF1;CD300A;SAMSN1;PRKCD;DMTN
prerank,mRNA destabilization (GO:0061157),0.4763264796103461,1.1928365831768974,0.2608108108108108,0.9415966138142313,1.0,11/38,13.81%,RBM24;ROCK1;UPF1;YTHDF2;CELF1;FTO;DIS3L2;ROCK2;ZFP36L1;CPEB3;GIGYF2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.49404325410851596,-1.1928218204329515,0.24213075060532688,0.8009160876103445,1.0,6/12,15.31%,KDELR1;HSPA5;ANKRD13C;OS9;RER1;INSIG1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.3809466319758766,-1.1927995852817475,0.20058997050147492,0.7989606349868527,1.0,11/27,26.43%,ENPP2;PLA2G6;GDPD1;ABHD12;PLA2G7;GPCPD1;GDE1;PNPLA6;INPP5F;ENPP6;PNPLA8
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.2532121442753591,-1.1924021086049947,0.0,0.7983085537616662,1.0,56/248,14.09%,RNF220;MCC;BICC1;DAB2;MLLT3;LRRK1;LGR4;TLE1;IGFBP2;COL1A1;TCF7L2;ADGRA2;DKK3;FZD6;WNK1;RNF146;APOE;DDX3X;PTK7;CUL3;EGFR;LYPD6;TNKS2;WNT5A;SOX13;KLHL12;PPM1B;CTNND1;TMEM64;CTNNB1;PSMD7;LATS2;PSMD9;PSMD13;STK11;WLS;ATP6AP2;PRKN;SMURF2;TGFB1;IGFBP6;FGFR2;KREMEN1;PSMB3;CCNY;SFRP4;WWTR1;SOX4;ZBED3;PSMC5;NOTUM;PSMA5;PSMA1;SOX17;PSMC2;HECW1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.46473562505341437,-1.1923546497343933,0.22613065326633167,0.7964849700018799,1.0,9/13,30.82%,ELOVL7;HACD4;ELOVL4;ELOVL6;HACD2;ELOVL1;HACD3;ELOVL5;TECRL
prerank,response to cAMP (GO:0051591),0.4759490587398376,1.1910779947633856,0.24714285714285714,0.9460776576770672,1.0,3/37,3.41%,RAP1A;AKAP6;IGFBP5
prerank,kidney development (GO:0001822),0.4382539366887248,1.1910570283440969,0.25375,0.94470419840939,1.0,8/65,7.78%,ITGA8;AGTR1;OSR2;CEP290;HAS2;VEGFA;GDNF;TGFB2
prerank,regulation of fatty acid metabolic process (GO:0019217),0.5419727002190833,1.190838047856995,0.28434504792332266,0.9440898244954795,1.0,4/17,8.66%,PRKAB2;PDK4;CAV1;PPARA
prerank,sulfur amino acid catabolic process (GO:0000098),0.5872369630786693,1.1906257868384515,0.3126142595978062,0.9434451539482246,1.0,2/10,5.95%,TXN2;BLMH
prerank,protein insertion into membrane (GO:0051205),-0.37437233394439284,-1.1898641274354795,0.2,0.8028822850850516,1.0,10/32,17.29%,APP;EGFR;ALDH3A2;CYB5A;STX5;SGTA;MAIP1;EMD;STX1A;TRAM2
prerank,organelle organization (GO:0006996),0.3885623842966095,1.1896191072983895,0.14271255060728744,0.9453032384366273,1.0,71/388,13.93%,PALLD;TPM1;ARHGEF7;WTIP;MAST4;MICAL2;CHMP4C;PLCE1;LIMD1;SYNE1;ATP8B1;CNN2;DES;CLASP2;HSD17B10;PACSIN3;GABPA;PACSIN2;ARMC2;SORT1;GEM;TBC1D20;ARHGAP21;ARHGAP10;SIRT3;ATAD3A;DST;MARK1;LNPK;MYO18A;PEX2;PITPNB;TERT;CAV1;SEC31B;CHMP5;PARP1;ABCA3;YTHDF2;PPARGC1A;MTX1;OPA1;AUP1;MREG;MIEF2;ABCD4;LONP1;NSFL1C;DNM1L;PEX19;TFB2M;KIF5C;LONP2;KIFAP3;ESRRA;CHMP2B;NECTIN2;TNIK;CDC42BPB;PACSIN1;MICAL3;DMTN;CLASP1;MAST1;CAPZB;PNPLA3;CHMP2A;ADCK1;LRRK2;BNIP1;SIRT4
prerank,negative regulation of protein metabolic process (GO:0051248),0.45477493282802867,1.189317664074827,0.24226110363391656,0.9448482939205879,1.0,7/48,9.73%,FLNA;ROCK1;EDNRB;PIN1;ITGB3;SF3B3;SIRT2
prerank,mesenchymal cell differentiation (GO:0048762),0.45315619080091757,1.1888317026565212,0.24805194805194805,0.9450949468214874,1.0,14/51,11.69%,MEF2C;HEY2;ROCK1;LIMS1;LOXL2;FAM83D;HEYL;SNAI2;TGFB2;SOX9;HIF1A;AKNA;ROCK2;HTR2B
prerank,response to muramyl dipeptide (GO:0032495),0.5686751951344653,1.1886490190175083,0.3027823240589198,0.9442997547514626,1.0,3/12,6.42%,VIM;ARHGEF2;CHMP5
prerank,external encapsulating structure organization (GO:0045229),0.3977981552852789,1.1883453153393497,0.19773429454170957,0.9439288799701823,1.0,39/205,12.48%,ITGA8;TTR;MMP17;COL18A1;COL4A1;COL4A2;ITGB6;ELN;ADAMTS14;ITGA7;LAMA5;PDGFB;ITGA1;ITGA3;ADAMTS5;ADAMTS19;COL4A6;BGN;ITGB1;JAM3;PXDN;ITGB5;LAMB2;LAMC1;COL27A1;ITGB3;COL4A5;ITGA4;ITGA9;AGRN;COL6A3;COL19A1;PDGFA;THSD4;COL3A1;ADAMTS20;ADAMTS16;COL8A1;COL14A1
prerank,glycoprotein metabolic process (GO:0009100),-0.33509309306689106,-1.188140486081481,0.1813953488372093,0.8067241763642651,1.0,13/53,10.81%,MAN1C1;ST3GAL4;ST8SIA4;ST6GALNAC3;NGLY1;ST8SIA1;FUT8;MGAT4B;GANAB;GOLPH3;MAN2A1;ADAMTS9;ST8SIA2
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.4973134750652666,-1.1878728853372236,0.2540045766590389,0.8056274454899839,1.0,5/11,22.44%,RASA1;NOVA1;PCBP2;NOVA2;PCBP4
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.36990594520026526,-1.187844559209212,0.22333333333333333,0.8037100534032299,1.0,18/29,37.84%,MRE11;HSP90AB1;RAD50;ANKRD28;PPP6R3;TERF2IP;WRAP53;TELO2;CDK2;GAR1;TINF2;PPP6C;PPIA;NOP10;ACD;RPA1;RFC1;NHP2
prerank,pentose-phosphate shunt (GO:0006098),-0.5103602083540387,-1.187485275927394,0.25653206650831356,0.8028308690452797,1.0,5/11,26.48%,PGD;TKT;SHPK;DERA;PGLS
prerank,regulation of cell migration (GO:0030334),0.39082634230263397,1.1873234873463725,0.12084592145015106,0.9459163675212132,1.0,45/382,7.18%,NTF3;NEXN;FLNA;MYLK;TPM1;NTRK3;DLC1;ACTN4;VCL;TMIGD3;ROCK1;FGF1;NKD1;PDGFB;PPP3CA;CCN1;PDGFC;FERMT2;PLXND1;SEMA5A;PLXNB1;CDH13;ANXA1;JAG1;KIF2A;SERPINE2;KANK1;IGFBP5;CCL5;DOCK10;ITGB1;ACTG1;GCNT2;PDGFD;SEMA6C;HAS2;SYNE2;CBLL1;RAP2C;CAV1;DUSP3;VEGFA;CORO1C;SNAI2;STK26
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.5263723576789879,1.1871026265432418,0.27980132450331124,0.9452093179419363,1.0,6/19,11.37%,FZD5;CAMKK2;FBXW7;VDAC1;DNM1L;SREBF2
prerank,regulation of kinase activity (GO:0043549),0.4252994976788706,1.1870695053456093,0.23344947735191637,0.9438895626757313,1.0,16/89,10.43%,TTN;NTRK3;MERTK;PLCE1;MST1R;ROR1;SMG8;MUSK;CAMKK2;MAPT;ANKRD54;EPHA2;NPRL2;PDGFRB;AXL;HNRNPU
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.4959470929407317,-1.1868778222762277,0.24561403508771928,0.8029996346971203,1.0,5/11,8.61%,YBX3;NUPR1;CASP8;BIRC2;PELI1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.4158511732733813,1.1864987062010286,0.22666666666666666,0.944265113456805,1.0,27/118,13.77%,WTIP;MEF2C;PDLIM5;SDC2;INF2;FERMT2;PLXND1;PHLDB2;CLASP2;CHN1;KIF1A;MAPT;GDNF;NEDD4;CDH2;BRSK1;PAK2;EPHA2;RAP2A;ARHGAP35;TSPAN12;TNIK;BCL6;SARM1;CLASP1;CAPZB;LRRK2
prerank,negative regulation of lipid storage (GO:0010888),-0.4243611975899271,-1.1860475712155376,0.225,0.8038450763231458,1.0,5/19,6.69%,OSBPL8;ABCA1;NFKBIA;ITGAV;ABHD5
prerank,purine nucleotide metabolic process (GO:0006163),-0.3977757351398493,-1.1860223313498932,0.22356495468277945,0.8019278754343856,1.0,10/24,23.26%,XDH;NT5E;GART;HPRT1;PRPSAP2;ITPA;GPX1;PNP;GUK1;PRPS2
prerank,positive regulation of cyclase activity (GO:0031281),0.56116982171307,1.1859652425478118,0.29654036243822074,0.9446753548725346,1.0,2/14,3.47%,CACNA1C;STIM1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.31518767157400257,-1.1854879034528771,0.17475728155339806,0.8017880242239189,1.0,13/58,9.21%,SGMS1;ST3GAL4;SGMS2;ELOVL7;CERS5;HACD4;SPTLC2;SPTSSA;ACER2;ALDH3A2;CERT1;CERS6;SGPP1
prerank,regulation of multicellular organismal development (GO:2000026),-0.39318388511276403,-1.1853442422863567,0.21921921921921922,0.8003211651926737,1.0,11/25,30.25%,PTN;TRIP12;INSR;SOX17;OAS2;SPAAR;DUSP6;KAT2A;TDG;CD24;RACGAP1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.4151273018508448,-1.1849628917039212,0.2549019607843137,0.799624503805312,1.0,8/20,12.27%,ITCH;DCUN1D3;UBQLN1;ZMIZ1;HSP90AB1;PRKN;DNAJB2;TGFBR1
prerank,cellular response to calcium ion (GO:0071277),0.44065833706131,1.184628169569449,0.23142509135200975,0.9478297529335965,1.0,7/67,5.55%,RYR1;MEF2C;RASGRP2;CAMK2D;SYT10;MEF2A;KCNH1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.5792709486979091,1.1845889326256618,0.2920962199312715,0.9465428068863158,1.0,2/11,6.81%,PRKCQ;IL12RB1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.3399262760934306,-1.183809983059352,0.1991701244813278,0.8014530040284537,1.0,12/49,12.40%,IGF1;IL31RA;IL15;KIT;GHR;IL18;ARL2BP;TNFRSF1A;IL6R;HES1;LYN;PARP14
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.517770836052866,1.1836737124903736,0.28526148969889065,0.9481299171070435,1.0,8/22,10.90%,PDGFB;PDGFC;PDGFD;RAP2C;VEGFA;CALM1;RAP2A;PDGFA
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5559986936529624,1.1833384121676904,0.3129139072847682,0.9479075636764049,1.0,3/15,6.97%,ENTPD1;AK7;ENTPD7
prerank,renal water homeostasis (GO:0003091),0.5073136980217039,1.183177048196912,0.2935323383084577,0.9470514589405139,1.0,9/23,15.39%,ADCY5;ADCY2;ADCY9;PRKACB;PRKAR1B;ADCY6;MYO5B;PRKACA;RAB11FIP2
prerank,plasma membrane repair (GO:0001778),0.5668505318727041,1.1830679878155623,0.31433823529411764,0.9460149525695861,1.0,4/13,7.14%,FER1L5;MYH9;DYSF;RAB3A
prerank,positive regulation of histone methylation (GO:0031062),-0.39455722278024336,-1.1826414580247326,0.25895316804407714,0.8034387402604123,1.0,7/24,17.44%,AUTS2;CTR9;CTNNB1;SNW1;OGT;CHTOP;SMAD4
prerank,positive regulation of cellular respiration (GO:1901857),-0.49473042382018073,-1.1824439959627837,0.28603603603603606,0.8021107821344441,1.0,4/11,22.30%,NUPR1;IFNAR1;PARK7;ISCU
prerank,cell chemotaxis (GO:0060326),0.4447364090133193,1.1819629930353275,0.2665832290362954,0.9482941328611171,1.0,13/60,11.28%,AGTR1;PDGFB;SEMA5A;NR4A1;ARHGEF16;PRKCQ;CXCR6;VEGFA;EPHA2;PARVA;PDGFRB;HBEGF;PRKCD
prerank,negative regulation of transposition (GO:0010529),-0.4474512246750447,-1.1817548690141644,0.23255813953488372,0.8025056989573043,1.0,7/16,30.92%,UBR2;SIRT7;TUT4;TEX15;TUT7;MOV10;SMYD5
prerank,extracellular structure organization (GO:0043062),0.39668868836405985,1.1817378416210742,0.21139896373056996,0.9475896263234188,1.0,39/204,12.48%,ITGA8;TTR;MMP17;COL18A1;COL4A1;COL4A2;ITGB6;ELN;ADAMTS14;ITGA7;LAMA5;PDGFB;ITGA1;ITGA3;ADAMTS5;ADAMTS19;COL4A6;BGN;ITGB1;JAM3;PXDN;ITGB5;LAMB2;LAMC1;COL27A1;ITGB3;COL4A5;ITGA4;ITGA9;AGRN;COL6A3;COL19A1;PDGFA;THSD4;COL3A1;ADAMTS20;ADAMTS16;COL8A1;COL14A1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.29785146344723257,-1.1817280919427235,0.1588235294117647,0.8006659516157605,1.0,18/73,7.58%,ELMO1;PIK3CA;GRB2;CYFIP2;PTK2;ABI1;WIPF2;BAIAP2;ARPC5;VAV2;WASF2;PLCG2;ARPC3;HSP90AB1;NCK1;PIK3CB;PRKCE;ARPC4
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.4538891171138757,1.1816712127153812,0.24828532235939643,0.9464087665031181,1.0,10/43,12.13%,ARHGEF7;ITGA1;SOCS5;SOCS4;DAB2IP;DUSP3;AREG;HBEGF;STAM2;TSG101
prerank,sprouting angiogenesis (GO:0002040),-0.3297375326560927,-1.1812364726200122,0.17647058823529413,0.8003275737510132,1.0,26/51,20.02%,ROBO1;EFNB2;ADGRA2;BMP4;SLIT2;TEK;CCBE1;PIK3R3;ENG;NRP1;ACVRL1;RECK;PTK2B;JMJD6;RNF213;BMPER;RAMP2;KDR;VEGFC;AKT1;FGF2;VEGFB;EPHB4;ITGB1BP1;MIA3;RSPO3
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.4913932360618067,1.1812233651789585,0.29154078549848944,0.9465220723506667,1.0,4/28,6.93%,NOTCH3;TCIM;FBXW7;YTHDF2
prerank,response to thyroid hormone (GO:0097066),-0.4741747773575233,-1.1809408105823522,0.27415730337078653,0.7993058438974117,1.0,7/13,21.30%,CTSL;CTSH;RDX;CTSB;THRB;LMO2;CTSS
prerank,histone H3 acetylation (GO:0043966),-0.3459969319333187,-1.179760815641924,0.205761316872428,0.8013132238156068,1.0,13/40,17.93%,LEF1;MBIP;TADA2A;YEATS2;TADA1;DR1;BRPF1;PER1;NAA60;TAF12;MEAF6;TRIM16;TAF6L
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.49309139870556823,-1.179641478057833,0.2597701149425287,0.7997700905610405,1.0,7/12,21.30%,CTSL;CTSH;RDX;CTSB;THRB;LMO2;CTSS
prerank,nucleic acid-templated transcription (GO:0097659),0.46914199959158065,1.1790691393260904,0.24828532235939643,0.9522983648240095,1.0,11/42,13.17%,POLR2L;POLR2I;MLF1;PWP1;MEF2A;POLR2G;TERT;NFKBIB;NR4A2;BAZ2A;POLR2J
prerank,angiogenesis involved in wound healing (GO:0060055),0.5738141046486531,1.1787171985075193,0.31153184165232356,0.9520454333935228,1.0,3/11,7.40%,MCAM;VEGFA;ITGB3
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.47318564740899094,1.1774477245116095,0.25383542538354253,0.9546848246689371,1.0,2/35,0.75%,NTF3;NTRK3
prerank,negative regulation of TORC1 signaling (GO:1904262),0.5523578306321599,1.1774138648127304,0.30715532286212915,0.9534091221844874,1.0,5/13,15.63%,RNF152;KPTN;CASTOR1;CASTOR2;ITFG2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.2990719274250234,-1.1772655777543388,0.14942528735632185,0.8055576352012115,1.0,18/71,7.58%,ELMO1;PIK3CA;GRB2;CYFIP2;PTK2;ABI1;WIPF2;BAIAP2;ARPC5;VAV2;WASF2;PLCG2;ARPC3;HSP90AB1;NCK1;PIK3CB;PRKCE;ARPC4
prerank,actin filament bundle organization (GO:0061572),0.473669564717162,1.1770515740442202,0.25245441795231416,0.9533308177883966,1.0,6/33,9.99%,PLS3;CALD1;LCP1;MYO1B;ADD2;PAWR
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5364014527620018,1.1759503863831924,0.32172470978441126,0.9556446487920721,1.0,4/18,4.35%,DLC1;ITGA3;KANK1;TNFAIP1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.41282695923830354,1.1758105022557668,0.23687150837988827,0.9547250807315868,1.0,15/100,7.85%,NTF3;NTRK3;PIP5K1B;PDGFB;PDGFC;ROR1;PIP4K2A;PLXNB1;CCL5;PDGFD;PIK3AP1;DAB2IP;NEDD4;TGFB2;SOX9
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.45797991888399187,1.1755562448001555,0.26294820717131473,0.954163653263157,1.0,7/39,6.91%,ACTN4;JAG1;KANK1;FZD4;GCNT2;AJAP1;CORO1C
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5029161852387944,-1.1748995749122795,0.2962138084632517,0.8111717095131781,1.0,4/10,16.91%,BMP6;RGCC;PPM1F;NOTCH4
prerank,cellular response to osmotic stress (GO:0071470),0.5191293637396096,1.1747247627745083,0.29923664122137406,0.9554508992125863,1.0,3/21,8.27%,MYLK;ARHGEF2;RCSD1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4555836268358032,1.1739777884657416,0.27417218543046357,0.9564628992301976,1.0,7/43,5.12%,RBPMS2;HTR1B;PDGFB;CDH13;IGFBP5;CCL5;BMPR1A
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.4552941055156721,-1.173728794296047,0.2775229357798165,0.8130225333067425,1.0,7/13,21.50%,NOS3;GCH1;PRKG2;AKT1;PTS;FPGS;SPR
prerank,regulation of coagulation (GO:0050818),0.5662955819986859,1.1733720624046797,0.3303886925795053,0.9570472673580117,1.0,2/11,6.29%,PROCR;CAV1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.42259285269860347,1.173361190781416,0.24723247232472326,0.9556962490234255,1.0,10/72,5.08%,ABRA;GPR20;DLC1;SYNPO2L;ITGA3;MYO9B;KANK1;NET1;TNFAIP1;ARHGEF2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.49472578313509563,-1.1731027196834087,0.26215644820295986,0.8131821209765113,1.0,8/10,46.97%,KIT;LYN;CD24;BTLA;FGR;BAG6;LILRB1;CD40
prerank,positive regulation of macrophage activation (GO:0043032),-0.42923709519005226,-1.1729220966667502,0.2579787234042553,0.811879633971974,1.0,5/17,21.69%,LBP;WNT5A;IL33;TTBK1;HSPD1
prerank,chloride transmembrane transport (GO:1902476),0.44828233893110014,1.1720749344148929,0.2532808398950131,0.9585837918422667,1.0,10/48,11.95%,ANO1;GABRE;ANO6;SLC4A8;GABRA4;GABRA5;GABRB2;GABRG1;ANO3;GABRB3
prerank,response to lipid (GO:0033993),-0.28477120713524173,-1.171850050966145,0.12781954887218044,0.8136156555932647,1.0,32/105,17.02%,FOXP1;SMAD6;LBP;RBP4;FOXO1;LGALS9;SOCS2;ACER2;IRAK1;CTSH;NOCT;RPS6KA3;CTNNB1;SPP1;PAQR7;PTPN22;PELI1;NOS3;IRAK3;TAB2;ESR1;TGFB1;PAQR8;PCK2;VPS4B;SNCA;GCH1;IFNAR1;RARA;SRR;PPARG;TRIM16
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4569426209429176,1.1716536061365994,0.26902173913043476,0.9585867899818244,1.0,11/40,7.78%,MEF2C;CCN1;ANO6;SLC8A1;TGFB3;ACVR2A;ALOX5;OSR2;BMPR1A;ATP2B1;FZD9
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.3256111149551657,-1.1710437475586168,0.19069767441860466,0.814418189039876,1.0,10/53,9.43%,EYA2;EYA1;EYA4;DDX5;SPRED2;ATR;EGFR;FBH1;SMCHD1;BRCC3
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.2999109000237412,-1.1709251175489794,0.16477272727272727,0.8129064287595996,1.0,18/70,7.58%,ELMO1;PIK3CA;GRB2;CYFIP2;PTK2;ABI1;WIPF2;BAIAP2;ARPC5;VAV2;WASF2;PLCG2;ARPC3;HSP90AB1;NCK1;PIK3CB;PRKCE;ARPC4
prerank,negative regulation of GTPase activity (GO:0034260),-0.40209214092143897,-1.170803756793834,0.2578125,0.8114403843245664,1.0,8/22,18.22%,CPEB2;WNK1;GMIP;GPSM1;RDX;RCC2;LRCH1;ARL2
prerank,actin filament bundle assembly (GO:0051017),0.4737148116406794,1.1702293521728444,0.2742857142857143,0.9618853990581259,1.0,6/33,9.99%,PLS3;CALD1;LCP1;MYO1B;ADD2;PAWR
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.4242128717812823,-1.1701784777120527,0.2513089005235602,0.8116977159077935,1.0,6/18,11.35%,DDX5;BMP4;EGFR;ESR1;TGFB1;MAP2K2
prerank,regulation of gene expression (GO:0010468),0.381286896699506,1.169875102155961,0.068,0.9616794434014215,1.0,96/903,8.93%,MYOM1;ACTA2;CCDC3;SOX6;MLF2;TMPRSS4;MYLK2;TTN;WTIP;ACTG2;MEF2C;NTRK3;CRIP1;ATP2B4;HEY2;ZFHX3;ACTA1;ANGPT1;PTP4A3;ROCK1;FGF1;CD36;LIMS1;LIMD1;MYD88;PDGFB;NAB1;CDK6;ALPK2;PLA2G3;RORA;SLC8A1;SLC8A2;MLF1;GABPA;HINFP;RBM38;ACTG1;SORT1;GCNT2;RBMS3;CD276;RBAK;PRDM1;MUSK;UBR5;ATXN1;OSR2;HAVCR2;BMPR1A;EMILIN1;SLC38A2;PRKCQ;TESC;MYBBP1A;ATP1B1;TERT;TAF1;MAPT;FBXW7;SLC2A10;VEGFA;TP53;ZBTB38;PIN1;SNAI2;YTHDF2;GDNF;SFPQ;YAP1;AR;MED1;CELF1;PPARGC1A;TRAF3;BTG1;C1QTNF1;PPARGC1B;ZNF431;DICER1;REXO4;NAT8;TGFB2;SOX9;RELA;KMT2D;ADNP2;DAPK3;CUX2;TRIM68;MBNL2;MAP2K1;RUNX1;NSD3;FUS;MSL3
prerank,negative regulation of protein modification process (GO:0031400),0.42610104021744344,1.169076461916816,0.26941176470588235,0.9629979894867642,1.0,13/79,9.26%,DMD;NTRK3;ATP2B4;SNTA1;CRTAP;MFHAS1;TPPP;MAPT;DAB2IP;CORO1C;ENSA;IMPACT;CDYL
prerank,response to UV-B (GO:0010224),0.5599511717678258,1.1688531215308353,0.292894280762565,0.9623163986843974,1.0,2/12,7.91%,CRIP1;RELA
prerank,positive regulation of cell killing (GO:0031343),-0.47290270849956917,-1.1683044601744703,0.29009433962264153,0.8161993488894469,1.0,6/13,37.11%,WNT5A;SYK;MAPK8;DVL2;NOXO1;NOX1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.4195278320434964,-1.1681594009870753,0.25405405405405407,0.81480433513301,1.0,6/19,19.83%,CAMK1D;MCU;MOSPD2;RIPOR2;NCKAP1L;TIRAP
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.3690081144278991,-1.1673183469884167,0.23659305993690852,0.815759498318327,1.0,6/29,11.50%,ZBTB20;APOE;LDLR;LPGAT1;CREBL2;CREB1
prerank,histone H3-K9 demethylation (GO:0033169),-0.4914389095379571,-1.1667765831936903,0.2792207792207792,0.8156800926771279,1.0,4/11,18.22%,KDM7A;KDM3B;KDM1A;KDM4D
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.4991027951919111,1.1660766169343817,0.2867981790591806,0.9698536132892813,1.0,4/24,6.68%,PPP1R3A;DYRK2;IRS1;SORBS1
prerank,nucleotide catabolic process (GO:0009166),-0.43548942863870715,-1.1641646607066798,0.2581453634085213,0.822422721996241,1.0,7/16,19.79%,XDH;NT5E;SAMHD1;NUDT3;ITPA;GPX1;PNP
prerank,regulation of axon guidance (GO:1902667),-0.49751926495554494,-1.163972374489165,0.2857142857142857,0.8211672734940357,1.0,5/10,12.51%,NRP1;MYCBP2;ZSWIM6;ZSWIM5;ZSWIM4
prerank,protein localization to membrane (GO:0072657),0.39154648549302784,1.1638562498114926,0.2232905982905983,0.9759151502129053,1.0,49/187,16.97%,CACNB2;FLNA;TSPAN32;FGF13;RAP1A;ROCK1;FERMT2;CLASP2;EHD2;KCNB1;FYB2;KCNIP3;TESC;ZDHHC2;ATP1B1;CAV1;TTC7A;RAB3A;RAMP1;SAV1;RAPGEF6;ITGA4;LIN7C;EPHA2;RAP2A;AGRN;ACTN2;ROCK2;DPP10;TMEM88;TNIK;PACSIN1;RAB40C;SLMAP;GAS6;RAB34;DVL1;RFTN1;RAB8B;TSPAN17;FLOT1;PRAM1;ANK1;SMURF1;RAB8A;TM9SF2;SH3PXD2B;LIN7A;RAB38
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.37291590875642944,-1.1637861083705439,0.23711340206185566,0.8198878543068612,1.0,9/31,26.65%,HMGB1;MAPK14;LGALS9;PLCG2;TLR3;TIRAP;HSPD1;SYK;LAPTM5
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.4858279582195292,-1.1635488196811754,0.2771618625277162,0.8188060370630136,1.0,6/11,22.62%,IP6K1;IP6K2;PPIP5K2;FGF2;ITPKB;IPPK
prerank,eye development (GO:0001654),-0.3213448288701064,-1.1633366907713367,0.18468468468468469,0.8175675610445781,1.0,8/54,4.04%,SHROOM2;FBN1;SMOC1;EFEMP1;LAMA1;PBX3;FBN2;RBP4
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5122890710068696,1.1632349975217493,0.3010590015128593,0.9765818065468009,1.0,5/22,12.35%,IL2;LAG3;CBFB;RUNX1;BCL6
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.29170509532099886,-1.1624909119882894,0.12857142857142856,0.8186461871039349,1.0,28/91,17.69%,BMP6;ABCG2;CP;FBXL5;APP;SLC39A10;SLC30A10;SCARA5;ABCB7;SLC39A8;ATOX1;FTL;ATP6AP1;ATP6V1G1;FTH1;SLC30A1;ACO1;SLC39A6;MT2A;SMAD4;MT1E;MT1F;MT1M;MT1B;MT1G;MT1A;MT1X;MT1H
prerank,regulation of necroptotic process (GO:0060544),-0.39052870049364874,-1.1624831049000326,0.2703488372093023,0.8168050334498909,1.0,8/23,15.61%,YBX3;CASP8;BIRC2;PELI1;SDCBP;OGT;STUB1;BIRC3
prerank,reverse cholesterol transport (GO:0043691),-0.46314465296184876,-1.162368745383584,0.28162291169451076,0.8153147414481292,1.0,2/13,2.70%,APOE;ABCA1
prerank,positive regulation of ossification (GO:0045778),0.4600008282890291,1.1622798014491378,0.2884882108183079,0.9782889804170638,1.0,12/39,7.78%,MEF2C;CCN1;ANO6;SLC8A1;TGFB3;ACVR2A;ALOX5;OSR2;BMPR1A;ATP2B1;FZD9;TGFB2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.40076260180966683,-1.1620194033138602,0.26063829787234044,0.8127752755107849,1.0,3/21,1.39%,EYA2;EYA1;EYA4
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.40076260180966683,-1.1620194033138602,0.26063829787234044,0.8127752755107849,1.0,3/21,1.39%,EYA2;EYA1;EYA4
prerank,positive regulation of telomerase activity (GO:0051973),0.4659791703940981,1.1620082691145344,0.2913816689466484,0.9777728970747172,1.0,5/33,8.31%,PARM1;PARN;PRKCQ;PKIB;NAF1
prerank,secondary palate development (GO:0062009),-0.4570272039743516,-1.1617576838053707,0.2870159453302961,0.8118171039517039,1.0,4/14,4.00%,TGFBR3;LEF1;CHD7;WNT5A
prerank,vesicle transport along microtubule (GO:0047496),0.5108787437795469,1.1616898374068267,0.30104321907600595,0.9774889821930302,1.0,9/23,12.16%,KIF3B;KIF1A;KIF5B;TRAK1;FYCO1;KIF1C;KIFAP3;FBXW11;KIF5A
prerank,histone H2A ubiquitination (GO:0033522),-0.429111733050599,-1.1614006841181017,0.2871536523929471,0.8112503452884142,1.0,6/17,22.38%,RYBP;UBR2;DDB1;DTX3L;BCOR;UBE2B
prerank,carnitine shuttle (GO:0006853),0.5661182203911208,1.1610006297450484,0.3145009416195857,0.9783878300792306,1.0,5/11,14.85%,PRKAB2;ACACB;CPT1B;CPT1A;PRKAA2
prerank,pyroptosis (GO:0070269),-0.43363261075826287,-1.1602461940402435,0.27228915662650605,0.8130509805724976,1.0,9/15,43.83%,GSDME;CASP8;GSDMD;CASP4;AIM2;CASP1;ZBP1;NLRC4;TREM2
prerank,Ras protein signal transduction (GO:0007265),0.39729632229026685,1.160128681897072,0.25272331154684097,0.9798187123909361,1.0,27/137,11.49%,AGTR1;RAP1A;ROCK1;CDC42EP3;PLCE1;CCNA2;RASGRP2;CDH13;MYO9B;RERG;NTN1;KSR1;ARHGAP6;ARHGDIG;RAP2C;RRAS;TP53;CYFIP1;RAPGEF6;RASGRP1;GNA12;ARHGAP1;RAP2A;ROCK2;ARHGAP5;RB1;RHOH
prerank,regulation of phospholipase activity (GO:0010517),-0.5024014087487013,-1.1601060690724192,0.28199566160520606,0.81168429651161,1.0,4/10,14.18%,LRP1;PDPK1;FGFR2;SNCA
prerank,long-term synaptic potentiation (GO:0060291),0.5110921037242542,1.1597846767734075,0.30434782608695654,0.9795592079332971,1.0,3/21,2.89%,CRHR2;SLC8A2;GRIN2C
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5308882422005614,1.1596638227695777,0.32358003442340794,0.9785510075758015,1.0,3/15,5.96%,KCNA5;KCNN2;ATP1B1
prerank,superoxide metabolic process (GO:0006801),0.47579541727981933,1.1589415459450256,0.30837004405286345,0.9795174542300404,1.0,1/29,0.36%,NCF2
prerank,limb morphogenesis (GO:0035108),-0.4003458667559111,-1.1583483286590472,0.2558746736292428,0.8155061696982313,1.0,4/20,5.69%,PCSK5;CYP26B1;PTCH1;MEGF8
prerank,manganese ion transport (GO:0006828),0.5458775802072194,1.1583029211346798,0.3167495854063018,0.9803018154482344,1.0,3/14,8.91%,TRPC6;SLC39A14;TRPC5
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.5515654365365316,1.1578249143303911,0.33221476510067116,0.9805219978831928,1.0,2/12,6.81%,PRKCQ;IL12RB1
prerank,leukocyte cell-cell adhesion (GO:0007159),0.5005265233175605,1.157500521254651,0.3076923076923077,0.9801661292187971,1.0,5/24,8.48%,ROCK1;CCL5;ITGB1;TNIP1;ITGA4
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4960738382570691,1.1572403877107136,0.3028485757121439,0.979653370086915,1.0,2/25,2.89%,MEF2C;GRIN2C
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4055958747157354,1.157214391264156,0.26102088167053367,0.9783769653052701,1.0,14/98,10.50%,NTF3;AGTR1;ANGPT1;PDGFB;DHRS4;CCL5;VEGFA;TP53;ACACB;CBR1;PPARA;PDGFRB;ATAD1;SCYL2
prerank,cellular response to interleukin-4 (GO:0071353),-0.5000665022523371,-1.1568990343834076,0.29555555555555557,0.8185542027206056,1.0,3/10,20.05%,LEF1;STAT6;SHPK
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.4314908850633695,-1.1559328852901225,0.2789473684210526,0.8197377776454872,1.0,6/17,19.83%,CAMK1D;MCU;MOSPD2;RIPOR2;NCKAP1L;TIRAP
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.32972929404248974,-1.1558498236216121,0.22868217054263565,0.8181774236309383,1.0,19/43,24.16%,CDC14B;MRE11;NAE1;RINT1;INTS3;BRCC3;BLM;NBN;FOXN3;TAOK1;NOP53;HUS1;ATM;CHFR;HMGA2;TAOK2;TRIM39;CLSPN;CDKN1A
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.5853876982011393,1.1552644173801756,0.3327239488117002,0.9819319811494659,1.0,2/10,8.84%,CDC42EP3;WASHC1
prerank,regulation of pseudopodium assembly (GO:0031272),0.5853876982011393,1.1552644173801756,0.3327239488117002,0.9819319811494659,1.0,2/10,8.84%,CDC42EP3;WASHC1
prerank,cellular response to fluid shear stress (GO:0071498),0.5466256317583252,1.1551691236493018,0.3158813263525305,0.9808842486698921,1.0,2/12,5.38%,MEF2C;HAS2
prerank,negative regulation of bone remodeling (GO:0046851),-0.48720982144066133,-1.1550793484016773,0.3076923076923077,0.8189207154865917,1.0,9/11,46.64%,GPR137B;TMEM119;GPR137;TNFAIP3;UBASH3B;GREM1;CALCA;CARTPT;SFRP1
prerank,cellular component assembly (GO:0022607),0.3825184675437825,1.1548604234737672,0.21721311475409835,0.9804948718682406,1.0,49/253,14.32%,FLNA;TCAP;PLS3;CALD1;LIMS1;FERMT2;LCP1;SH3BGR;ACTG1;MYO1B;SKAP2;FLNC;RSPH1;ACTB;CEP290;HAS2;CHAF1B;AFG3L2;TP53;LIMS2;ABCA3;RHOJ;YTHDF2;LAMC1;CYFIP1;YAP1;ADD2;PPARGC1A;MDN1;TOGARAM1;SOX9;MAGI1;PARVA;PAWR;SYCP2;TEAD1;DNM1L;TLCD2;PDGFA;KIFAP3;RHOH;SNX9;PDCD10;DMTN;KPNA3;FOXJ1;GAS6;EPRS1;DVL1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5145590619611007,1.1546604855980382,0.3232963549920761,0.9797870239079758,1.0,4/19,8.79%,MEF2C;TBX2;BMPR1A;RUNX1
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.3484984537837881,-1.1543978701400412,0.23076923076923078,0.8194028997509637,1.0,8/36,8.70%,RBBP4;CBX5;MGA;TFDP1;RYBP;PHC3;PHC1;MAX
prerank,apical junction assembly (GO:0043297),-0.31060505520435644,-1.153553902889484,0.23333333333333334,0.8202622986235241,1.0,8/53,6.81%,AFDN;DLG1;CDH5;PECAM1;PARD6G;OCLN;CLDN5;CLDN11
prerank,carboxylic acid catabolic process (GO:0046395),-0.4672603283408643,-1.153031441488598,0.28773584905660377,0.8202234619739869,1.0,10/12,48.56%,RENBP;ACOT8;AMDHD2;NPL;GNPDA1;PON3;NAGK;IL4I1;BCKDK;GNPDA2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4650626720188689,-1.152683836904002,0.2982885085574572,0.8195898245175416,1.0,6/14,32.77%,MOXD1;DAGLA;SLC5A7;DAGLB;ALDH9A1;SLC22A2
prerank,regulation of microglial cell activation (GO:1903978),-0.43978197252792817,-1.1522332035714486,0.2903225806451613,0.8192403224667876,1.0,6/15,22.76%,LDLR;CX3CL1;SYT11;GRN;TTBK1;SPHK1
prerank,telomere organization (GO:0032200),-0.33752919871920056,-1.1520217987592811,0.2423076923076923,0.8181068397863216,1.0,16/43,18.99%,ATR;PRKDC;XRCC5;STN1;MRE11;RAD50;PARP3;SP100;BLM;XRCC6;NBN;CTC1;HUS1;TERF2IP;LTO1;ATM
prerank,ERBB signaling pathway (GO:0038127),-0.30261339938243725,-1.1516957237657077,0.21465968586387435,0.8173843596551301,1.0,11/64,5.61%,PIK3CA;EFEMP1;TGFA;GRB2;PDPK1;PTPN11;EGFR;PTK2;SLC30A10;GAB1;PTK2B
prerank,ventricular septum morphogenesis (GO:0060412),0.48963264605207674,1.151422803057327,0.3063583815028902,0.989021044786753,1.0,5/27,7.78%,SLIT3;HEY2;HEYL;BMPR1A;TGFB2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.45262105983291245,1.1513273525905097,0.31911966987620355,0.9879283281554145,1.0,9/39,12.13%,ARHGEF7;ITGA1;PTPN18;DAB2IP;DUSP3;AREG;HBEGF;STAM2;TSG101
prerank,negative regulation of leukocyte activation (GO:0002695),0.5241858494840078,1.1510406476955062,0.3304647160068847,0.9875735056177939,1.0,5/15,11.01%,MILR1;HAVCR2;CD200;CD300A;GPER1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5865974221304276,1.1510211738916343,0.3351851851851852,0.9862790764669968,1.0,4/10,14.87%,PMAIP1;IRS1;PTH1R;IRS2
prerank,regulation of interleukin-12 production (GO:0032655),-0.3283501754829302,-1.1509543744297808,0.20851063829787234,0.8181189394009828,1.0,6/47,9.20%,FOXP1;HMGB1;MAPK14;LGALS9;PLCG2;IRAK3
prerank,digestive tract morphogenesis (GO:0048546),0.5439630445932809,1.1508132903277364,0.3111111111111111,0.9856140002387642,1.0,1/14,0.82%,RBPMS2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5373027863392552,1.1506419514483774,0.3338870431893688,0.984866764768062,1.0,4/15,12.23%,CD36;MYD88;EIF2AK2;USP50
prerank,positive regulation of chemotaxis (GO:0050921),0.45308981227434625,1.1501646280549545,0.28763440860215056,0.9850379516018027,1.0,9/43,9.69%,NTRK3;PDGFB;SEMA5A;CDH13;RARRES2;DSCAM;VEGFA;ADAM17;PDGFRB
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.39216012707265496,1.1499111383124951,0.2426550598476605,0.9844484145852935,1.0,23/151,11.69%,RAP1A;NTRK3;ANGPT1;CD36;PDGFB;PDGFC;ROR1;FERMT2;THPO;CCL5;GCNT2;PDGFD;MFHAS1;TNFRSF11A;FBXW7;GAREM1;RASGRP1;MAP2K1;PDGFRB;CCL14;PDGFA;GPER1;HTR2B
prerank,response to prostaglandin E (GO:0034695),-0.49483760902011875,-1.1496064522030285,0.27912087912087913,0.8209278908351373,1.0,1/10,0.16%,TGFBR3
prerank,regulation of actin filament depolymerization (GO:0030834),0.5508630780824443,1.148958071536047,0.3476764199655766,0.9863016163895898,1.0,4/12,8.09%,SEMA5A;WDR1;PLEK;CFL2
prerank,peptide hormone secretion (GO:0030072),0.49053128789553185,1.148949229905814,0.31921331316187596,0.9849727885287888,1.0,2/26,2.73%,CAMK2G;ANXA1
prerank,stabilization of membrane potential (GO:0030322),-0.43809607648495796,-1.1488562312411719,0.2827763496143959,0.8216081483273711,1.0,2/16,6.30%,KCNK2;KCNK5
prerank,telomere maintenance via telomerase (GO:0007004),-0.3620148679103858,-1.1485226456666053,0.26058631921824105,0.8208614118521984,1.0,17/28,37.84%,MRE11;HSP90AB1;RAD50;ANKRD28;PPP6R3;TERF2IP;WRAP53;TELO2;CDK2;GAR1;TINF2;PPP6C;NOP10;ACD;RPA1;RFC1;NHP2
prerank,positive regulation of apoptotic process (GO:0043065),0.37588325877592205,1.1482500263472324,0.23045685279187816,0.9859139115266256,1.0,46/293,12.71%,KCNMA1;OBSCN;ARHGEF7;MAP3K20;DLC1;MAP3K5;KALRN;PMAIP1;ABR;ARHGEF17;ANO6;ITSN1;TGFB3;ITGB1;NET1;PTGIS;ARHGEF16;ARHGEF2;ATG7;MYBBP1A;DAB2IP;RPS6KA2;ARL6IP5;TP53;PHLDA3;BTG1;FZD9;TGFB2;MAP3K10;DAPK3;TNFAIP8;ARHGEF4;HRK;SIRT2;PAWR;VAV1;DNM1L;GPER1;TRIM35;CLIP3;BOK;CSRNP3;BCL6;CLU;DIABLO;ITGB3BP
prerank,protein neddylation (GO:0045116),0.5535673849820302,1.148018397040367,0.31534569983136596,0.9853352433510078,1.0,5/13,12.18%,DCUN1D2;RNF7;UBE2F;DCUN1D1;UBA3
prerank,negative regulation of cyclase activity (GO:0031280),-0.4404066522935315,-1.1478822467575653,0.3,0.821101647767908,1.0,3/14,2.16%,ADGRV1;PALM;GRM3
prerank,regulation of cellular component movement (GO:0051270),0.4386999049882536,1.1472875064559713,0.29365079365079366,0.9864938803500763,1.0,10/49,10.78%,ACTN1;ACTN4;ROCK1;CDK6;VEGFA;DAPK3;ADAM17;PKN2;HBEGF;ROCK2
prerank,response to copper ion (GO:0046688),-0.4116455236000181,-1.1469886921830121,0.27595628415300544,0.822269181858754,1.0,11/20,18.55%,SNCA;MT2A;MT1E;MT1F;MT1M;MT1B;MT1G;MT1A;MT1X;MT1H;HSF1
prerank,neuron projection morphogenesis (GO:0048812),0.3925115002943694,1.1468703958033968,0.28169014084507044,0.9865655344642651,1.0,38/137,17.78%,NTF3;SDC2;ROCK1;PLXNB1;DOCK10;MAP1B;SLITRK5;ACTB;KLF7;MEF2A;SLITRK4;AFG3L2;DAB2IP;RAB3A;DICER1;IMPACT;BRSK1;FLRT1;S100A6;ZDHHC17;TNIK;PACSIN1;TAOK3;KIF20B;LRRK2;SGK1;EPHB1;DVL1;ANKRD27;ADGRB1;CNTNAP1;PTEN;DNM2;RAB8A;RYK;EIF2AK4;MAP1A;MAP1S
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.5259960274964939,1.1467157369186531,0.31629392971246006,0.9856866522805752,1.0,3/18,4.39%,RAP1A;SLC4A8;RIMS3
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.5767010663718242,1.14655282155081,0.3377862595419847,0.9848716802502935,1.0,2/10,5.22%,CHADL;EMILIN1
prerank,regulation of GTPase activity (GO:0043087),0.385820540581801,1.1462893995407553,0.2623126338329764,0.9844500642012215,1.0,33/177,10.93%,ARHGEF7;RAP1A;PRKG1;RGS6;LIMS1;RASGRP2;FERMT2;DOCK8;PLXND1;PLXNB1;CCL5;BCAR3;DOCK10;ITGB1;NET1;TBC1D20;RSU1;CHN1;LARS1;MAPRE2;RABGAP1;DAB2IP;PIN1;RAPGEF6;RASGRP1;EVI5;ARHGAP12;AGRN;SNX18;CCL14;ARHGAP15;VAV1;SH3BP4
prerank,autophagy of mitochondrion (GO:0000422),-0.3422012549347619,-1.1461428097294182,0.2251655629139073,0.8232013548113225,1.0,20/38,29.62%,RB1CC1;CISD2;ATG3;ATG5;FBXO7;PRKN;ATG2B;WIPI2;AMBRA1;ATG2A;FIS1;GABARAPL2;WDR45B;ULK2;MAP1LC3A;GABARAPL1;ATG12;MAP1LC3B;SQSTM1;WIPI1
prerank,regulation of lymphocyte activation (GO:0051249),0.5423468304569559,1.1461314348336618,0.3106457242582897,0.9836264728815894,1.0,2/12,9.78%,CCL5;PAG1
prerank,regulation of T cell migration (GO:2000404),0.5108697041455689,1.1460416774082585,0.3265940902021773,0.9826025819473896,1.0,4/18,7.13%,DOCK8;CCL5;CD200R1;CD200
prerank,endocardial cushion development (GO:0003197),0.492780982385847,1.145811237589369,0.305993690851735,0.9820434278448421,1.0,5/21,7.85%,TBX2;HEYL;BMPR1A;TGFB2;SOX9
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.3723806212325598,-1.1457827356746126,0.2744479495268139,0.8226369333026292,1.0,7/29,13.63%,LEF1;TLE1;TCF7L2;BCL9L;CTNNB1;EP300;LEO1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.47482776855401987,-1.1457784523808636,0.30045871559633025,0.8208804220126297,1.0,4/12,7.96%,TNKS2;PARP10;PARP11;PARP3
prerank,negative regulation of lyase activity (GO:0051350),-0.42430381176760124,-1.1454454516691692,0.2676767676767677,0.820190125892813,1.0,3/16,2.16%,ADGRV1;PALM;GRM3
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.31203859136347245,-1.1452601918745884,0.24752475247524752,0.8190862445515976,1.0,20/56,17.49%,KMT2E;DDX3X;CUL3;CCND3;EGFR;RAB11A;ADAMTS1;TFDP1;RDX;CDC23;UBE2E2;RGCC;VPS4B;RCC2;CDC25B;ANKRD17;AKT1;KLHL18;CDC25A;ANAPC4
prerank,protein tetramerization (GO:0051262),0.4224362787564846,1.145184545310594,0.29404466501240695,0.9827837538231591,1.0,11/67,12.68%,RYR1;KCNJ12;HSD17B10;CRYZ;ACACB;TRPM4;ALDOA;GLS;OSBPL2;TRPM2;HOMER1
prerank,neuron maturation (GO:0042551),-0.41775868676366074,-1.145158755159584,0.2786458333333333,0.8176866097057145,1.0,10/18,21.26%,APP;ADGRB3;ANKS1A;B4GALT6;SCARF1;EPHA8;CX3CL1;PICK1;LGI4;MTCH1
prerank,regulation of histone methylation (GO:0031060),-0.4553225517034456,-1.1449398618922055,0.3076923076923077,0.816622756763553,1.0,8/13,38.00%,NSD1;CTR9;CHTOP;PIH1D1;JARID2;PAF1;TTLL12;AASS
prerank,positive regulation of cell migration (GO:0030335),0.37846466803562673,1.1448362398424088,0.21465428276573786,0.9826678985496647,1.0,40/253,11.01%,NTF3;MYLK;ARHGEF7;NTRK3;ACTN4;FGF1;PDGFB;PPP3CA;CCN1;PDGFC;FERMT2;SEMA5A;CLASP2;CDH13;CCL5;ITGB1;ACTG1;GCNT2;PDGFD;SEMA6C;ARHGEF2;HAS2;SYNE2;CBLL1;CAV1;DAB2IP;VEGFA;SNAI2;TGFB2;SOX9;SUN2;ADAM17;WASHC1;HIF1A;PDGFRB;DOCK1;HBEGF;ROCK2;PDGFA;GPER1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.5385655922148775,1.144820952097974,0.3258620689655172,0.9813810036088959,1.0,3/14,11.01%,ANO6;ITGA4;GPER1
prerank,natural killer cell mediated immunity (GO:0002228),0.5220994150481628,1.1447065929760436,0.32081911262798635,0.9804192072835435,1.0,2/15,7.56%,LYST;KIF5B
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5560393478319808,1.144413898671246,0.340036563071298,0.9800341801724303,1.0,3/11,19.15%,PKD1L3;LPO;RTP4
prerank,adherens junction organization (GO:0034332),0.43923109053506315,1.143634657721707,0.29112271540469975,0.9812638944378721,1.0,13/48,12.93%,CDH6;VCL;FERMT2;CDH13;CDH4;ACTB;JAM3;CDHR3;CDH2;PAK2;TBCD;NECTIN2;CDH10
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4924780500319578,1.1433297315266662,0.3225806451612903,0.9809171074712298,1.0,1/19,0.51%,RYR2
prerank,Rap protein signal transduction (GO:0032486),0.5711175471697725,1.1433196581314147,0.334525939177102,0.9796337886913942,1.0,3/10,9.50%,RAP1A;RAP2C;RAP2A
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.5403594941320713,1.142982730994059,0.34582623509369675,0.979390027903251,1.0,1/13,1.51%,PMAIP1
prerank,protein localization to organelle (GO:0033365),-0.26597196273741025,-1.1425034378984416,0.13131313131313133,0.8228811769972948,1.0,39/133,17.80%,ANK2;BBS9;COL1A1;ZNF423;BMP7;BMP4;APP;DDX3X;RAB11A;CEP68;IFT122;GBF1;CEP250;ALDH3A2;CYB5A;TULP3;STX5;CNTLN;TMEM30A;OPTN;GCC2;MDM2;TOPORS;SSB;TOR1AIP1;SCG3;SGTA;SIX1;CALR;EMD;TOLLIP;EHD1;LMBRD1;STX1A;GABARAPL2;XPA;COG7;TRAM2;OBSL1
prerank,regulation of neutrophil migration (GO:1902622),0.5794227704734818,1.1424824905903121,0.34074074074074073,0.9796913850472166,1.0,4/10,15.59%,JAM3;RHOH;MPP1;RHOG
prerank,fluid transport (GO:0042044),-0.4667348079818888,-1.1420551623766717,0.32494279176201374,0.8225870611804988,1.0,1/12,1.67%,PDPN
prerank,alcohol catabolic process (GO:0046164),-0.4975136883345246,-1.1415127917405232,0.28728070175438597,0.8227559747197992,1.0,3/10,10.71%,CYP27A1;APOE;SCARF1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3628804885536624,-1.1414290319168923,0.24924012158054712,0.8213039178094081,1.0,12/29,27.96%,VTI1A;COPB2;COG6;COPE;GABARAPL2;COG2;TRAPPC3;NAPG;COPB1;GOLGA5;COPG2;GOSR1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.407425124571703,-1.1412746804142424,0.2826086956521739,0.8201027384226165,1.0,4/18,11.42%,PTN;NF1;PTPRZ1;HES1
prerank,negative regulation of coagulation (GO:0050819),-0.44767536137124264,-1.1411180888864716,0.2938271604938272,0.8188400069687268,1.0,5/14,8.19%,APOE;VTN;TFPI;CD34;THBD
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5493686480335729,1.1403260463531548,0.33512544802867383,0.9853272058694681,1.0,2/12,7.19%,CACNA1H;AKR1B1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.3184621851728182,-1.140246160252805,0.22413793103448276,0.819992724218545,1.0,29/52,29.82%,DCPS;RC3H2;SAMD4B;LSM1;DIS3;EXOSC1;DCP2;PAN2;EXOSC9;PAN3;CNOT11;TUT4;EDC4;TUT7;LSM7;EXOSC2;EDC3;LSM5;LSM2;EXOSC3;EXOSC7;CNOT10;LSM3;EXOSC5;ZFP36;PNLDC1;LSM6;PDE12;POLR2D
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5475914983603759,1.1401441703533122,0.35800344234079173,0.9846198059093149,1.0,3/12,8.12%,DMD;ATP1B1;WNK2
prerank,contractile actin filament bundle assembly (GO:0030038),0.5221608764985494,1.1396699967300283,0.3305227655986509,0.9835733348974086,1.0,7/15,12.47%,PDLIM1;ITGB1;TNFAIP1;ITGB5;SORBS1;FHDC1;PDCD10
prerank,stress fiber assembly (GO:0043149),0.5221608764985494,1.1396699967300283,0.3305227655986509,0.9835733348974086,1.0,7/15,12.47%,PDLIM1;ITGB1;TNFAIP1;ITGB5;SORBS1;FHDC1;PDCD10
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.44398047577914257,-1.139589044688034,0.3051643192488263,0.8202832267104917,1.0,3/13,2.16%,ADGRV1;PALM;GRM3
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.37049135532442773,1.1395709783119572,0.19114688128772636,0.9825688522756673,1.0,56/390,10.90%,NTF3;ARHGEF7;NCF2;COL4A2;NTRK3;SDC2;ANGPT2;ANGPT1;ROCK1;FGF1;KALRN;MERTK;POLR2L;MST1R;PDGFB;POLR2I;PDGFC;ROR1;PDK4;FRK;ITSN1;COL4A6;BCAR3;ACTG1;SORT1;PDGFD;MUSK;CHN1;ACTR3;ACTB;RARRES2;ATP6V1H;POLR2G;IRS1;ATP6V0A2;MAPKAPK2;VEGFA;SORBS1;LCP2;CYFIP1;ITGB3;PLCB1;SLC39A14;PAK2;SLA;EPHA2;ATP6V1C1;PDGFRB;SIRT2;AXL;DOCK1;FLRT1;GALNT3;VAV1;ROCK2;PDGFA
prerank,carboxylic acid transport (GO:0046942),-0.3060368602121347,-1.1388175565900673,0.21658986175115208,0.8209525025958543,1.0,21/55,22.23%,SLC6A13;SLC16A12;SLC13A3;SLC16A9;SLC6A12;SLC6A6;SLC16A1;SLC3A2;SLC7A5;SLC16A11;SLC6A9;SLC6A11;CLN3;SLC66A1;SLC38A5;SLC38A6;SLC15A4;SLC1A4;PSAP;SLC36A1;SLC1A1
prerank,regulation of inclusion body assembly (GO:0090083),-0.47960552367805914,-1.138750950605378,0.31516587677725116,0.8194343281337432,1.0,6/11,35.22%,SNCAIP;DNAJB2;BAG5;DNAJA4;DNAJB1;HSPA1A
prerank,response to interleukin-1 (GO:0070555),0.41812388572168685,1.1385521431278671,0.2834928229665072,0.984471747326775,1.0,21/73,18.76%,MYD88;ANXA1;CCL5;PTGIS;UPF1;HAS2;TNFRSF11A;DAB2IP;SOX9;RELA;NR1D1;HIF1A;CCL14;YTHDC2;GBP2;HYAL1;PRKCA;IL1R1;CCL25;CD47;CCL19
prerank,positive regulation of type 2 immune response (GO:0002830),-0.4463744852812647,-1.1384335107150854,0.31116389548693585,0.8187696196727743,1.0,4/14,24.38%,IL18;DENND1B;RARA;CD86
prerank,potassium ion export across plasma membrane (GO:0097623),0.5370791611898252,1.1382249781750682,0.32926829268292684,0.9841875448917256,1.0,3/13,7.01%,KCNA5;KCNE4;KCNT2
prerank,myeloid cell development (GO:0061515),-0.4112352438932729,-1.1379918990916988,0.30512820512820515,0.8185120927243931,1.0,5/18,7.94%,FOXP1;KIT;ANXA2;APP;ALAS1
prerank,insulin secretion (GO:0030073),0.5215992782067894,1.1377359421248392,0.3333333333333333,0.9844354788178568,1.0,2/19,2.73%,CAMK2G;ANXA1
prerank,extracellular matrix organization (GO:0030198),0.3779036368323017,1.137646013688846,0.24338085539714868,0.9834169131562318,1.0,48/276,11.54%,ITGA8;TTR;MMP17;COL18A1;COL4A1;COL4A2;ITGB6;ELN;ADAMTS14;ITGA7;LAMA5;P3H2;PDGFB;ITGA1;ITGA3;ADAMTS5;LOXL2;LCP1;KLK2;HTRA1;CRTAP;ADAMTS19;COL4A6;BGN;ITGB1;DST;JAM3;HAS2;PXDN;ITGB5;LAMB2;LAMC1;COL27A1;ITGB3;TGFB2;COL4A5;ITGA4;CAPN2;WASHC1;ITGA9;AGRN;P4HA2;COL6A3;COL19A1;PDGFA;THSD4;COL3A1;ADAMTS20
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5074284914827538,1.1373309157891194,0.3359746434231379,0.9831097039191606,1.0,3/20,5.96%,KCNMA1;SLC8A1;ATP1B1
prerank,diterpenoid metabolic process (GO:0016101),0.43008110765047153,1.1370847250059248,0.31925465838509315,0.9825762973799547,1.0,7/55,7.19%,TTR;SDC2;LPL;DHRS3;RARRES2;GPC4;AKR1B1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.486360897215701,1.1369366035305968,0.32315112540192925,0.9817981900553553,1.0,6/21,13.72%,LAX1;DUSP3;PIBF1;PAG1;SAMSN1;FOXJ1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.46268313547476353,-1.1368131025898927,0.3170731707317073,0.8206187573053062,1.0,4/13,8.39%,AKT3;HMGB1;PDPK1;IGF2
prerank,T cell homeostasis (GO:0043029),0.5600747051109345,1.136651180700805,0.34191176470588236,0.9814083600434735,1.0,1/10,1.51%,PMAIP1
prerank,regulation of NMDA receptor activity (GO:2000310),-0.3546495241205735,-1.13647843576481,0.2956810631229236,0.8199824130261333,1.0,8/32,8.45%,DAPK1;DLG1;APP;NLGN1;PTK2B;LRRC7;SLC6A9;NEFL
prerank,sodium ion transmembrane transport (GO:0035725),0.40900470011150214,1.13613631543147,0.2877871825876663,0.9817692339322404,1.0,10/84,5.96%,SCN4A;ASIC3;SLC6A17;ANO6;SLC8A1;SLC8A2;SLC4A8;SLC6A5;SLC6A2;ATP1B1
prerank,response to organic cyclic compound (GO:0014070),0.4338923749036637,1.1360156317552856,0.314070351758794,0.9808986432833919,1.0,7/52,6.53%,PMAIP1;ABCB4;ANXA1;IGFBP5;CCL5;STRN3;ARL6IP5
prerank,nitric oxide metabolic process (GO:0046209),-0.43583928859135285,-1.1358537938357558,0.3016627078384798,0.8202324180870683,1.0,6/14,21.50%,NOS3;CYP1B1;GCH1;AKT1;DDAH2;SPR
prerank,positive regulation of secretion (GO:0051047),-0.48465788060030024,-1.1357938832378212,0.3632183908045977,0.818705515977524,1.0,2/11,9.84%,NPR1;ACSL3
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.376322782950423,-1.1353599019609673,0.28901734104046245,0.8183446781732838,1.0,10/25,18.28%,SMAD3;PKD2;NOS1AP;HSP90AB1;DDAH1;PTGS2;KLF2;INSR;AKT1;DDAH2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.446151698887775,1.1353566619332283,0.2963917525773196,0.981759725463375,1.0,13/48,13.02%,POLR2L;PADI2;H1-0;ARID1A;ACTB;MYBBP1A;CHEK1;ERCC6;POLR1E;SERTAD2;POLR1H;SF3B1;SMARCA5
prerank,synaptic vesicle membrane organization (GO:0048499),-0.4262320547491494,-1.1352988261581045,0.32180851063829785,0.816851985326652,1.0,8/17,26.45%,STX3;STX4;SNAP29;STX1A;SYP;STX2;TOR1A;SYNGR2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.26878960754922715,-1.1350521347934424,0.1485148514851485,0.8160545845207654,1.0,16/113,6.06%,PTN;BMP6;IGF1;NRP2;AKT3;NOTCH2;TGFA;TCF7L2;BMP4;TEK;EGFR;NRP1;WNT5A;F3;BMPR2;SRSF6
prerank,maintenance of blood-brain barrier (GO:0035633),0.46946519569127354,1.13409363291607,0.32951289398280803,0.9846696676128539,1.0,8/30,7.81%,DMD;VCL;ITGB1;ACTG1;ACTB;JAM3;LAMC1;MBP
prerank,ethanol metabolic process (GO:0006067),0.5527898039079486,1.1338049296238768,0.3435374149659864,0.9842160843741451,1.0,1/12,0.92%,ACSS1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.5567536072253415,1.1335189943948283,0.3267148014440433,0.9838597868338393,1.0,4/11,10.22%,P3H2;CRTAP;P4HTM;P4HA2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.46388643618542397,-1.1333622921747248,0.3136792452830189,0.8197201343953322,1.0,5/12,27.82%,PPHLN1;SETDB1;MPHOSPH8;RESF1;SETDB2
prerank,regulation of cell growth (GO:0001558),0.3823942831899914,1.1333002021946352,0.2678386763185109,0.9832584795724463,1.0,42/204,14.96%,SLIT3;AGTR1;AKAP6;PAPPA2;MYL2;PLCE1;RASGRP2;CAMK2D;RERG;IL2;PABIR1;NET1;FHL1;FXN;BCL2;ATAD3A;JADE1;PRKCQ;NDRG3;TP53;BTG1;TGFB2;ADNP2;ADAM17;NDUFS3;SERTAD2;CRLF3;SH3BP4;RB1;TCHP;ACVR1B;DCBLD2;BCL6;HDGFL2;CEP43;N6AMT1;MUL1;SGK1;NUBP1;HYAL1;VGLL4;EIF4G2
prerank,cellular response to lipid (GO:0071396),0.37992276398539526,1.1330724197232231,0.27424400417101147,0.9826827010013495,1.0,31/191,11.18%,MEF2C;NR1H4;ADCY5;MYD88;ADCY2;RORA;ABCB4;PDK4;VIM;LPL;FZD4;CD14;UPF1;TESC;IRS1;DAB2IP;CHMP5;AR;MED1;SOX9;RELA;NFKBIB;ADNP2;GSTP1;NR1D1;ADCY6;AXL;BRINP1;ROCK2;GPER1;CD180
prerank,regulation of leukocyte migration (GO:0002685),0.5236621487062796,1.132731418613917,0.3492822966507177,0.9825164541100261,1.0,4/16,15.59%,ANXA1;VEGFA;RHOH;RHOG
prerank,response to interleukin-4 (GO:0070670),-0.48367608489403546,-1.1326934684908585,0.31096196868008946,0.820170891225579,1.0,1/10,0.83%,LEF1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.4655680042303415,1.1326381222027502,0.31683168316831684,0.9815487757451565,1.0,8/32,11.28%,DLC1;ITGA1;PPP2R5A;PIN1;CALM1;CD300A;PDGFRB;PRKCD
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.38359278355633836,-1.1323960632821692,0.2796352583586626,0.8194885480456722,1.0,3/22,1.84%,ALDH1A2;RBP1;VKORC1L1
prerank,regulation of protein import into nucleus (GO:0042306),0.45522297999342065,1.1323002599439387,0.30248618784530384,0.9813522069375495,1.0,3/36,4.45%,FLNA;CABP1;UBR5
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.2851408529285243,-1.1321672801320226,0.2191780821917808,0.8185184012277809,1.0,17/76,9.09%,NFAT5;UACA;SASH1;BMP7;DLG1;APP;DDX3X;EGFR;NOD1;PPM1B;NFKBIA;LGALS9;IRAK1;HDAC7;RASSF2;PTPN22;CCN3
prerank,nuclear membrane disassembly (GO:0051081),-0.4385026670455513,-1.1319882951346827,0.3139240506329114,0.817447604266383,1.0,4/14,18.17%,PRKCB;AKAP8L;NEK9;NEK6
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.4821253757089834,-1.1319482700159196,0.3142857142857143,0.8158829933149151,1.0,4/10,14.35%,USP7;SIRT7;OGT;DGKQ
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.477205588369136,-1.1311766444555615,0.30952380952380953,0.8166399692427796,1.0,4/11,16.62%,SCARA3;CASP8;UNC93B1;TLR3
prerank,synapse assembly (GO:0007416),0.4221497658305905,1.1306965892972984,0.3073170731707317,0.9851896429720894,1.0,16/67,14.32%,FGF13;IGFN1;FZD5;PLXND1;PLXNB1;KIRREL3;DSCAM;PCDHB14;PCDHB11;CDH2;GABRB2;CBLN4;GABRB3;SHANK2;PLXNB2;DVL1
prerank,positive regulation of protein processing (GO:0010954),0.5018666917527306,1.1306754279739653,0.3409785932721712,0.9839960879704756,1.0,3/19,8.15%,ANGPTL8;MYH9;LPCAT3
prerank,cochlea morphogenesis (GO:0090103),0.5601440856993802,1.1296431581796378,0.3508137432188065,0.9860511814039952,1.0,2/10,7.85%,TBX18;SOX9
prerank,regulation of endopeptidase activity (GO:0052548),0.42209061420148025,1.1295441527615868,0.309462915601023,0.9850958710434631,1.0,3/59,3.30%,SERPINB8;SERPINI1;SERPINE2
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.33855161466701855,-1.1292359564018226,0.23381294964028776,0.8212708767378845,1.0,12/39,16.91%,TSPAN5;ROBO1;AAK1;BMP2K;ZMIZ1;NOS3;CCN3;SNW1;EP300;JAG2;MAML1;NOTCH4
prerank,diol biosynthetic process (GO:0034312),-0.43365640027335295,-1.1290993992988998,0.2972292191435768,0.8200640482827087,1.0,7/15,22.76%,SPTLC2;ACER2;ASAH2;GCH1;SPR;ABCA2;SPHK1
prerank,membrane repolarization (GO:0086009),-0.4329643879251722,-1.1283845972064321,0.2935560859188544,0.8206315869926148,1.0,4/15,9.79%,ATP1A2;ATP1B3;KCND3;ATP1B2
prerank,regulation of gene silencing by miRNA (GO:0060964),0.4270983493527989,1.1275709842341353,0.30663329161451813,0.9899747249953901,1.0,15/62,15.63%,WTIP;POLR2L;LIMD1;POLR2I;NUP62;POLR2G;SEC13;NUP153;NUP107;AAAS;POLR2J;NUP37;NUP98;STAT3;NUP210
prerank,genitalia development (GO:0048806),0.5506215979445597,1.1274890210409882,0.3361921097770154,0.9889682692898112,1.0,1/12,0.60%,LHCGR
prerank,cellular potassium ion homeostasis (GO:0030007),0.5387247763129627,1.1270718876473458,0.35578583765112265,0.9889910183697453,1.0,2/13,5.96%,KCNMA1;ATP1B1
prerank,phosphatidylserine metabolic process (GO:0006658),-0.34901836363681993,-1.1262895257629384,0.2588996763754045,0.8257620825141972,1.0,8/32,14.10%,OSBPL8;OSBPL10;PLA1A;SERINC1;SERINC5;PTDSS2;PLAAT3;ABHD12
prerank,acute-phase response (GO:0006953),0.5455831675904332,1.1261245995461706,0.34766355140186916,0.9906579683581888,1.0,3/12,7.80%,ITIH4;IL22;MBL2
prerank,negative regulation of protein binding (GO:0032091),0.4127083320508948,1.1258255278936986,0.3067484662576687,0.9903741285786503,1.0,17/71,14.32%,XIRP1;ROCK1;ATP2A2;PDGFB;ACTB;PTPRF;CAV1;PIN1;ITGA4;PPP1CA;PSME3IP1;ATP2A3;PRKCD;BAG2;LRRK2;CSNK1E;DVL1
prerank,epithelial to mesenchymal transition (GO:0001837),0.4349510831429541,1.1250394020853844,0.304635761589404,0.991509563499463,1.0,12/47,10.78%,HEY2;ROCK1;LIMS1;LOXL2;FAM83D;HEYL;SNAI2;TGFB2;SOX9;HIF1A;AKNA;ROCK2
prerank,glycine transport (GO:0015816),0.5625802478267867,1.1250378373583305,0.3546099290780142,0.9902487085920307,1.0,3/10,10.31%,SLC6A17;SLC6A5;SLC7A8
prerank,protein polyubiquitination (GO:0000209),-0.24564008543809743,-1.1241692120281157,0.043478260869565216,0.830806433199022,1.0,74/297,15.14%,TTC3;SASH1;NEDD4L;FBXL7;TRIP12;FBXL5;RNF146;AREL1;ITCH;FBXO10;CUL3;ANAPC1;TNKS2;RNF20;PPIL2;UBE2D3;NPEPPS;RNF135;RNF144B;RC3H2;SHPRH;RNF217;UNKL;RNF6;UBR2;CTNNB1;BIRC2;FBXO9;PSMD7;PSMD9;PSMD13;RNF213;PELI1;MDM2;UBE2E3;FBXO4;TOPORS;WWP1;CDC23;UBE2E2;RBCK1;FBXO7;PRKN;RNF31;UBE3A;SMURF2;RNF144A;UBE4B;PSMB3;UBC;TRIM5;RNF34;STUB1;RMND5A;SKP2;HECTD2;DZIP3;LONRF1;TRIM14;RNF125;RNF166;DTX3L;PSMC5;FBXW8;SIAH1;PSMA5;PSMA1;PSMC2;HECW1;RNF115;UBE2H;CDC26;KLHL3;NHLRC3
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.3342318370583096,-1.1241121661956122,0.23693379790940766,0.8293492905287405,1.0,13/40,12.27%,DAB2;SMAD3;LEF1;COL1A1;PDPN;TCF7L2;BCL9L;CTNNB1;SDCBP;TGFB1;WWTR1;RGCC;TGFBR1
prerank,negative regulation of chemotaxis (GO:0050922),-0.36129979096152576,-1.1240518552141432,0.3055555555555556,0.8278886158635953,1.0,8/31,7.65%,ROBO1;SEMA3D;SEMA3C;SEMA6A;SLIT2;SEMA7A;SEMA3A;SEMA4D
prerank,positive regulation of JUN kinase activity (GO:0043507),0.49082151460451373,1.1238016814762941,0.3470319634703196,0.9929138465903457,1.0,5/23,12.59%,MAP3K5;TNFRSF11A;DAB2IP;MAP3K10;TAOK3
prerank,epithelial cell morphogenesis (GO:0003382),0.5184409239006524,1.123790909210453,0.34477124183006536,0.991682585471528,1.0,1/17,0.67%,COL18A1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.4558678224550138,1.1233854021444976,0.33477011494252873,0.9917239456201276,1.0,10/35,13.76%,DLC1;ITGA3;KANK1;TNFAIP1;DAB2IP;TGFB2;MFN2;ARHGAP35;SCAI;ARHGAP24
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5133340866628218,1.1231053711887173,0.3397548161120841,0.9913261876538889,1.0,5/15,14.87%,PMAIP1;IRS1;PPARA;LDLRAP1;IRS2
prerank,vitamin D metabolic process (GO:0042359),0.5415368642932046,1.1228584410592835,0.35858585858585856,0.9908359034328,1.0,2/13,5.68%,PIAS4;GC
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.4495479944998001,-1.1227701334114721,0.3473193473193473,0.8303476370025638,1.0,2/13,2.43%,DKK3;APOE
prerank,positive regulation of B cell activation (GO:0050871),0.4371953841553658,1.1223932685999365,0.3254281949934124,0.9909330638830637,1.0,11/50,17.43%,MEF2C;IL2;TNFSF13B;BCL2;PAXIP1;RIF1;IRS2;KMT5B;VAV3;MAD2L2;MIF
prerank,ventricular septum development (GO:0003281),0.4489396048343171,1.1222480573622589,0.3293172690763052,0.9901191370617807,1.0,5/37,7.78%,SLIT3;HEY2;HEYL;BMPR1A;TGFB2
prerank,catecholamine metabolic process (GO:0006584),-0.43656071812877795,-1.122218946017672,0.3302325581395349,0.8304044002112483,1.0,4/14,21.17%,SNCAIP;PRKN;DDC;DRD2
prerank,negative regulation of stem cell differentiation (GO:2000737),0.5346821047888795,1.1219356056167713,0.3591549295774648,0.9899094586594147,1.0,4/12,12.66%,JAG1;YTHDF2;HNRNPU;NELFB
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3975808063339596,-1.1217060008951856,0.31215469613259667,0.8304864637707822,1.0,4/20,7.12%,B2M;IL18;CD55;DENND1B
prerank,regulation of mitochondrial translation (GO:0070129),0.49370573975428195,1.1216916107459625,0.3328220858895706,0.9893897090874068,1.0,11/21,20.54%,RPUSD3;TRMT10C;RCC1L;TSFM;RPUSD4;FASTKD2;TRUB2;RMND1;MALSU1;UQCC2;C1QBP
prerank,regulation of cholesterol efflux (GO:0010874),-0.37037799920903247,-1.1216237641791205,0.3016393442622951,0.82913003975728,1.0,6/30,4.97%,LRP1;PLTP;APOE;PTCH1;LAMTOR1;NFKBIA
prerank,ureteric bud morphogenesis (GO:0060675),-0.4216801055772197,-1.1216211815463422,0.3148148148148148,0.8275062313622021,1.0,5/16,16.51%,BMP4;PKD2;SALL1;SIX1;FGF2
prerank,nitric oxide biosynthetic process (GO:0006809),-0.44338231348399,-1.1216012533810442,0.31862745098039214,0.8259672459282841,1.0,6/13,21.50%,NOS3;CYP1B1;GCH1;AKT1;DDAH2;SPR
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.31921309781258644,-1.12148468101238,0.26104417670682734,0.8247013666377305,1.0,12/45,11.61%,DDX5;BMP4;POLR2A;EGFR;NMD3;SIRT7;RBM20;SETX;TGFB1;DIMT1;MAP2K2;ERN1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.4539323014385188,-1.1211752632496519,0.3260340632603406,0.8240654311479872,1.0,5/13,7.77%,PLXNA2;NRP2;NRP1;SEMA3A;PLXNA4
prerank,potassium ion transmembrane transport (GO:0071805),0.3874938479231195,1.1209791316435098,0.3150384193194292,0.9903804918434003,1.0,17/135,11.36%,KCNAB1;KCNJ12;KCNA5;KCNQ5;KCNQ4;KCNN2;KCNE4;KCNB1;CCDC51;KCNH1;ATP1B1;KCNT2;SLC9A8;ABCC8;KCNH8;KCNK3;KCNA2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.410460968371409,-1.1208773440126012,0.3139240506329114,0.8233631879679556,1.0,7/18,17.54%,NLGN1;PTK2B;SHANK3;NRXN1;NLGN2;NLGN3;RIMS2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.45078510559998597,1.1206284219055884,0.32514450867052025,0.9902478613164282,1.0,6/35,9.69%,PPP1R12A;ITGA1;CALM1;NUAK1;CD300A;PDGFRB
prerank,positive regulation of protein import into nucleus (GO:0042307),0.4668036318197108,1.1204097416080179,0.3285917496443812,0.9896914054518233,1.0,5/28,13.74%,FLNA;UBR5;BAG3;PRKCD;TRIM28
prerank,anion transmembrane transport (GO:0098656),-0.30120073473111636,-1.1203289144333672,0.22169811320754718,0.8235906290575264,1.0,32/67,31.80%,SLC6A13;SLC13A4;SLC16A12;SLC13A3;SLC1A3;LRRC8B;SLC3A2;SLC7A5;SLC39A8;SLC6A9;SLC25A14;SFXN2;SLC35A2;SLC25A30;SLC38A5;SLC25A11;SLC25A38;LRRC8D;SLC1A1;SLC6A8;SLC25A22;ABCC5;SLC1A2;SLC5A6;LRRC8A;SLC25A21;SLC25A19;SLC35C2;SLC25A18;SFXN3;SLC1A6;SLC13A5
prerank,purine nucleotide catabolic process (GO:0006195),-0.4447531515863925,-1.120244179410591,0.32235294117647056,0.8222227545677812,1.0,6/13,19.79%,XDH;NT5E;HINT1;ITPA;GPX1;PNP
prerank,glucose catabolic process to pyruvate (GO:0061718),0.4799566908118725,1.119704258690172,0.3382352941176471,0.9893733878009514,1.0,5/24,11.40%,PFKP;ENO3;HK2;ALDOA;PFKM
prerank,canonical glycolysis (GO:0061621),0.4799566908118725,1.119704258690172,0.3382352941176471,0.9893733878009514,1.0,5/24,11.40%,PFKP;ENO3;HK2;ALDOA;PFKM
prerank,lipid transport (GO:0006869),-0.27470195361919336,-1.1194976375938903,0.20261437908496732,0.8229211760259825,1.0,20/97,8.91%,OSBPL8;PITPNA;ATP8A1;ABCA9;PLTP;APOE;ABCA1;SLCO2B1;LBP;CHKA;ABCA4;LDLR;SLCO1C1;NCOA1;SLC25A17;SLCO2A1;PITPNC1;SLCO3A1;ABCC4;CERT1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.27204479566107276,-1.1193695312129242,0.16101694915254236,0.821755598929245,1.0,40/110,24.97%,UPF2;PPP2CA;RPL27A;SMG1;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;PABPC1;RPLP0;RPS29;RPL28;RPS10;RPLP1;RPS20;RPL34;RPL23A;NCBP2;RPS8;RPL36A;RPS21;RPL9;SMG6;RPL27;RPS7;PNRC2;RPL18A;RPL11;RPL37A;RPL38;RPL29;RPL32;RPL10A;RPS4X;RPS27;RNPS1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.3931979213926665,-1.119004063750939,0.30140845070422534,0.8213348860094758,1.0,4/20,12.98%,IGF1;NIBAN2;TGFB1;EP300
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5116180189273412,1.1189644557886644,0.3550488599348534,0.9904387933627083,1.0,4/18,8.48%,ROCK1;ITGB1;ADD2;ITGA4
prerank,peptidyl-lysine methylation (GO:0018022),0.4754448508665282,1.1187016368172131,0.3382352941176471,0.9900001971341138,1.0,8/26,15.26%,SMYD1;SETD6;SUV39H2;SETD3;ATPSCKMT;VCPKMT;N6AMT1;EEF1AKMT2
prerank,regulation of feeding behavior (GO:0060259),-0.4542683456799332,-1.1181155487425931,0.2979683972911964,0.8224774939903539,1.0,1/11,0.87%,LEPR
prerank,regulation of osteoclast differentiation (GO:0045670),-0.3513361161701266,-1.118039434586396,0.2925170068027211,0.821143069695667,1.0,11/33,34.41%,FBN1;TCTA;CEBPB;PRXL2A;TLR3;GPR137B;GPR137;MAFB;CAMK4;FSTL3;UBASH3B
prerank,sphingosine biosynthetic process (GO:0046512),-0.46384284305529583,-1.118018979395554,0.32272727272727275,0.8180479260186369,1.0,5/11,22.76%,SPTLC2;ACER2;ASAH2;ABCA2;SPHK1
prerank,sphingoid biosynthetic process (GO:0046520),-0.46384284305529583,-1.118018979395554,0.32272727272727275,0.8180479260186369,1.0,5/11,22.76%,SPTLC2;ACER2;ASAH2;ABCA2;SPHK1
prerank,carboxylic acid metabolic process (GO:0019752),0.44655800019483693,1.1180086627516832,0.34433285509325684,0.9908894033621499,1.0,10/33,14.36%,CSGALNACT1;PTGIS;GNE;TBXAS1;SLC23A2;SLC23A1;ST6GAL1;SIRT4;PLA2G4A;CYB5R3
prerank,negative regulation of translation (GO:0017148),0.4027504839003387,1.1179979047127242,0.30221703617269546,0.98968989887465,1.0,20/87,14.16%,RBM24;ROCK1;IGFBP5;SAMD4A;MRPL13;BTG2;EIF4EBP1;CPEB1;YTHDF2;CELF1;FTO;DAPK3;EIF3E;EIF2AK2;ROCK2;CNOT7;CPEB3;SYNCRIP;GIGYF2;EPRS1
prerank,urogenital system development (GO:0001655),0.5390100389379899,1.1175808498121917,0.35431654676258995,0.9897133913797266,1.0,3/11,7.85%,ANXA1;OSR2;SOX9
prerank,negative regulation of phagocytosis (GO:0050765),0.5164997031032174,1.1173573770744443,0.3497536945812808,0.9891287322575361,1.0,4/17,8.34%,FER1L5;DYSF;PIP4P2;CD300A
prerank,positive regulation of locomotion (GO:0040017),0.4806406376519309,1.117197842184605,0.34107402031930334,0.9884011438384687,1.0,5/27,9.69%,CAVIN1;PDGFB;NTN1;RARRES2;PDGFRB
prerank,regulation of osteoblast proliferation (GO:0033688),0.513618106684962,1.1171446534475966,0.34735202492211836,0.9873274399947005,1.0,4/17,10.44%,CCN1;PLXNB1;MN1;EIF2AK2
prerank,defense response to symbiont (GO:0140546),0.39475385917589223,1.1168285495727859,0.31485849056603776,0.9871148489641002,1.0,9/92,7.91%,FLNA;PMAIP1;MYD88;CGAS;BCL2;ATG7;LYST;ABCE1;RELA
prerank,positive regulation of tissue remodeling (GO:0034105),0.5622966350194835,1.1168252138439227,0.3649906890130354,0.9859072654848874,1.0,2/10,3.27%,ROCK1;IL2
prerank,protein insertion into ER membrane (GO:0045048),-0.3392150956465341,-1.1164188407227835,0.2696245733788396,0.8213428105400573,1.0,12/37,19.35%,APP;EMC2;ALDH3A2;CYB5A;STX5;SGTA;EMC3;EMC8;EMD;STX1A;TRAM2;MMGT1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5290087541281293,1.1161415826121273,0.35547576301615796,0.9867300155516553,1.0,5/14,9.47%,RAD51AP1;PARP1;ERCC6;FUS;FANCB
prerank,primary miRNA processing (GO:0031053),-0.4756342610377331,-1.1158487279521274,0.35777777777777775,0.8215046629371109,1.0,3/10,8.76%,SMAD3;SRRT;METTL3
prerank,mitochondrion morphogenesis (GO:0070584),-0.4713872931988598,-1.1156537781608258,0.3430493273542601,0.8205075033383461,1.0,5/11,21.94%,PID1;FIS1;PNPT1;NUBPL;SLIRP
prerank,positive regulation of multicellular organismal process (GO:0051240),0.36574415197174637,1.1154427645287524,0.25842696629213485,0.9876076703819487,1.0,44/308,11.69%,SOX6;PRDM16;SOX5;ROCK1;PRKAB2;CD36;PDGFB;PDGFC;PLA2G3;FERMT2;FST;EBF2;ADRA1D;LOXL2;IL2;TGFB3;GCNT2;TSHR;TGFB1I1;BMPR1A;TAPT1;TERT;CAV1;VEGFA;TRPV2;FABP4;GDNF;MED1;PPARGC1A;DIO2;PPARGC1B;TGFB2;SOX9;PLCB1;TRPM4;PAXIP1;RBM19;RIF1;EIF2AK2;NR2C2;NKX6-1;MFN2;ACVR1B;HTR2B
prerank,autophagy of peroxisome (GO:0030242),-0.45276175519367445,-1.1153409308347764,0.3555045871559633,0.8199211616725567,1.0,6/12,28.83%,RB1CC1;PEX5;ACBD5;ATM;MAP1LC3B;SQSTM1
prerank,protein polyglutamylation (GO:0018095),0.5447036966529528,1.1152725762792035,0.3784786641929499,0.9869305802195899,1.0,2/11,3.86%,TTLL7;CEP41
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.33516588375253137,-1.1149372202110694,0.2899022801302932,0.8197053452206223,1.0,12/38,23.35%,BMP6;SASH1;PUM1;POLR3F;RIOK3;POLR3B;DDX60;ANKRD17;GRN;SLC15A4;GBP5;POLR3C
prerank,protein ubiquitination (GO:0016567),-0.23767648929869298,-1.1148414102302255,0.25,0.8184722326951488,1.0,113/471,15.22%,RNF220;SASH1;NEDD4L;ARRB1;SH3RF1;FBXL7;TRIP12;FBXL5;RNF146;AREL1;ITCH;RNF38;FBXO10;CUL3;RNF185;PRKDC;TNKS2;RNF20;PPIL2;MYCBP2;KLHL12;PEX14;UBE2D3;NPEPPS;RNF135;BIRC6;RNF144B;RC3H2;SHPRH;ATG3;RNF217;UNKL;TRIM24;RNF6;DERL1;UBR2;CTR9;CTNNB1;BIRC2;RNF13;PHC1;RNF25;FBXO9;PSMD7;FBH1;USP7;HERC2;PSMD9;PSMD13;COMMD1;RNF213;PELI1;MDM2;UBE2E3;FBXO4;TOPORS;WWP1;CDC23;UBE2E2;RBCK1;TRIM25;KLHL2;FBXO7;PRKN;PEX5;RNF31;UBE3A;CUL7;MGRN1;SMURF2;RNF144A;FBXO25;MKRN2;UBE4B;RNF181;PSMB3;UBC;SH3RF3;DDB1;TRIM5;RNF34;STUB1;KLHL22;RMND5A;SKP2;HECTD2;DZIP3;LONRF1;DTX1;TRIM14;TRIM33;RNF125;VPS18;RNF166;DTX3L;SH3RF2;RTF1;PSMC5;FBXW8;LEO1;SIAH1;PSMA5;OS9;PSMA1;PSMC2;HECW1;RNF115;UBE2H;RNF10;OBI1;KLHL3;NHLRC3;RNF43
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5018944078523664,1.1143828201901333,0.3416666666666667,0.9884067715619184,1.0,5/16,15.74%,CHMP4C;CHMP5;VPS36;STAM;LEPROT
prerank,protein localization to nucleus (GO:0034504),-0.27067036951929524,-1.113756262788722,0.152,0.8201522674491857,1.0,35/102,22.09%,APPL2;COL1A1;BMP7;BMP4;E2F3;FAM53A;NUP88;PML;ARL2BP;TOR1AIP2;MDM2;TOPORS;NUTF2;IPO8;TOR1AIP1;SIX1;PTTG1IP;APPL1;NUP50;CALR;EIF4ENIF1;NOP53;AKT1;TBRG1;XPA;ARL2;RPL11;NUP85;TAF3;RPF2;IPO11;BCL3;NXT2;NUP214;RAN
prerank,neurogenesis (GO:0022008),0.4376093037756562,1.1135235224320335,0.34106412005457026,0.9899768991825477,1.0,8/43,8.47%,CDK6;CLN5;ANXA1;BTBD2;MAPT;TGFB2;ERCC6;TRAK1
prerank,ephrin receptor signaling pathway (GO:0048013),0.40469360242593266,1.1133890627232594,0.3097238895558223,0.9891656733870607,1.0,9/82,4.76%,ARHGEF7;SDC2;ROCK1;KALRN;ITSN1;ACTG1;CHN1;ACTR3;ACTB
prerank,regulation of small molecule metabolic process (GO:0062012),0.46434280502213,1.1133397048494988,0.33775811209439527,0.9880791469288268,1.0,3/28,2.53%,NR1H4;RORA;PDK4
prerank,defense response to virus (GO:0051607),0.3897961627128755,1.1130278880439868,0.32036613272311215,0.9879324175177254,1.0,14/100,12.55%,FLNA;PMAIP1;MYD88;CGAS;BCL2;ATAD3A;ATG7;LYST;ABCE1;RELA;ZDHHC1;EIF2AK2;CNOT7;OASL
prerank,ganglioside metabolic process (GO:0001573),-0.40938644941838476,-1.1127971702337571,0.3283582089552239,0.8215507343639471,1.0,10/20,29.53%,ST8SIA4;ST3GAL5;ST6GALNAC3;ST8SIA2;HEXA;ST6GALNAC5;ABCA2;NEU1;ST6GALNAC4;ST8SIA3
prerank,protein localization to cell-cell junction (GO:0150105),-0.430760854279346,-1.112538909126599,0.345088161209068,0.820768595297691,1.0,5/15,6.44%,TJP1;CGNL1;TJP2;CDH5;LSR
prerank,regulation of viral entry into host cell (GO:0046596),0.46043696616128343,1.112492522346578,0.34744525547445254,0.9884092805489155,1.0,1/30,0.21%,TMPRSS4
prerank,embryonic axis specification (GO:0000578),-0.4302894879200406,-1.1120867887803236,0.32860520094562645,0.8205554269312757,1.0,3/15,3.65%,COBL;SMAD6;PTCH1
prerank,alpha-amino acid catabolic process (GO:1901606),0.46150752447138776,1.111716377746593,0.353204172876304,0.9896765924805584,1.0,6/29,10.74%,HSD17B10;HGD;BLMH;KMO;GOT2;SARDH
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.44783866424943497,1.111577594694421,0.3333333333333333,0.9889078661686214,1.0,5/35,4.78%,FLNA;PLXND1;SEMA5A;PLXNB1;SEMA6C
prerank,peptide catabolic process (GO:0043171),-0.38577178547709856,-1.1114650035192357,0.3188405797101449,0.8209278763797961,1.0,6/23,9.95%,ANPEP;XPNPEP1;NPEPPS;CTSH;ECE1;ACE
prerank,negative regulation of myotube differentiation (GO:0010832),-0.4536855862735142,-1.111216994759919,0.352112676056338,0.8201447105562304,1.0,4/12,21.97%,HDAC4;CCN3;BHLHE41;TMEM119
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5559337342405809,1.111181480610127,0.3834862385321101,0.988921702342755,1.0,2/10,6.54%,SMARCD3;VEGFA
prerank,male gonad development (GO:0008584),0.456403491120115,1.1110576859263834,0.34051724137931033,0.9880883631906314,1.0,5/34,7.85%,LHCGR;CSDE1;AR;TGFB2;SOX9
prerank,transport along microtubule (GO:0010970),0.5285007238243941,1.1107714107291253,0.3693379790940767,0.9877407074180438,1.0,5/13,11.62%,APBA1;ARHGAP21;BAG3;DYNC1I2;CLIP3
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.39240442200234693,1.110286091705338,0.2957422324510932,0.9879722276964501,1.0,14/95,9.27%,ASPN;PRDM16;VASN;ZEB2;ITGA3;TGFB1I1;EMILIN1;CAV1;SLC2A10;PPM1A;PIN1;PPARA;ADAM17;SKI
prerank,organophosphate ester transport (GO:0015748),-0.378210798036601,-1.1101611046137307,0.3323442136498516,0.8218400708962974,1.0,5/24,5.71%,OSBPL8;PITPNA;PLTP;LDLR;PITPNC1
prerank,cranial nerve development (GO:0021545),-0.4607220634158872,-1.110093838283625,0.33867276887871856,0.8205358507745624,1.0,3/11,21.58%,CHD7;SALL1;TMEM126A
prerank,regulation of fibroblast migration (GO:0010762),0.4891294159155463,1.1096712928189882,0.3625,0.988640881567446,1.0,4/20,8.73%,ARHGEF7;ITGB1;CORO1C;GNA12
prerank,bone development (GO:0060348),-0.3270061729148461,-1.1095555649677948,0.27898550724637683,0.8206755655050529,1.0,6/39,2.93%,RANBP3L;AKAP13;SULF1;GJA1;GNAS;CYP26B1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4199117611401043,1.109292880091742,0.3299492385786802,0.9886001726937663,1.0,8/55,9.73%,AGTR1;PDGFB;DHRS4;ALOX5;TP53;CBR1;PDGFRB;SIRT2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.5564395425687398,1.1091626854199497,0.37543859649122807,0.9865861342709521,1.0,5/11,15.32%,INPP5A;SYNJ2;INPP5B;INPP5J;PTEN
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.5564395425687398,1.1091626854199497,0.37543859649122807,0.9865861342709521,1.0,5/11,15.32%,INPP5A;SYNJ2;INPP5B;INPP5J;PTEN
prerank,hippo signaling (GO:0035329),-0.3754320457688967,-1.108854493441997,0.29080118694362017,0.8212301487835755,1.0,9/26,12.88%,TJP1;TJP2;AMOTL1;TEAD4;LATS2;WWC1;TEAD2;WWTR1;MOB1B
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.36699356486682455,-1.108667574637902,0.3263473053892216,0.8202442217578131,1.0,10/26,18.28%,SMAD3;PKD2;NOS1AP;HSP90AB1;DDAH1;PTGS2;KLF2;INSR;AKT1;DDAH2
prerank,regulation of protein kinase A signaling (GO:0010738),0.496951858387247,1.1083691000031606,0.3643410852713178,0.9878035483631041,1.0,2/20,2.05%,AKAP6;TCIM
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.41751758913531767,-1.1080476048040528,0.31343283582089554,0.8206211161985194,1.0,4/16,11.37%,POGZ;PDS5A;MAU2;NAA50
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.44746876020141657,1.10723352140568,0.33835616438356164,0.9901963267127541,1.0,7/32,12.02%,CAVIN1;POLR2L;GTF2H4;TAF1;POLR1E;CDK7;POLR1H
prerank,autophagy of nucleus (GO:0044804),-0.4060733479449032,-1.1071651468344945,0.33080808080808083,0.8217031927088922,1.0,7/16,16.85%,RB1CC1;ATG3;ATG5;ATG2B;WIPI2;ATG2A;WDR45B
prerank,magnesium ion transport (GO:0015693),-0.4621062430335062,-1.107103425279289,0.33016627078384797,0.8203811663807858,1.0,5/12,19.35%,TUSC3;SLC41A1;NIPAL2;NIPAL3;MMGT1
prerank,Golgi ribbon formation (GO:0090161),-0.441426214055662,-1.107101615503568,0.33410672853828305,0.8188712483469427,1.0,5/13,8.94%,VTI1A;TMED5;OPTN;GCC2;GOLPH3
prerank,regulation of organelle organization (GO:0033043),0.4009699513361091,1.1070864008368615,0.3444976076555024,0.9894327399796508,1.0,20/80,17.41%,NEXN;PDE4DIP;ZEB2;PLXNB1;MAPT;MIEF2;CAPN2;PAK2;STX18;DNM1L;PDCD10;MUL1;MAPK1;RHOT1;VPS35;CLIC4;PREB;MARK2;S100A8;S100A9
prerank,negative regulation of receptor binding (GO:1900121),0.567670599704678,1.1066086822578938,0.381651376146789,0.9897088239834921,1.0,3/10,10.53%,ATP2A2;PTPRF;ATP2A3
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3674091441601981,1.106491444768939,0.2869022869022869,0.988888906665075,1.0,38/214,12.41%,RAP1A;NTRK3;ANGPT1;CD36;PDGFB;CCN1;PDGFC;ROR1;FERMT2;FAM83D;THPO;CCL5;GCNT2;PDGFD;MFHAS1;EMILIN1;DAB2IP;FBXW7;DUSP3;RRAS;PTPN1;PIN1;GAREM1;RASGRP1;WNK2;TNIP1;MAP2K1;GSTP1;CNKSR3;EPHA2;PDGFRB;CCL14;PDGFA;GPER1;ZDHHC17;HTR2B;DUSP29;CHRNA7
prerank,positive regulation of programmed cell death (GO:0043068),0.3642421140604943,1.1064530973235407,0.294478527607362,0.9878218189060531,1.0,40/272,12.71%,KCNMA1;OBSCN;ARHGEF7;MAP3K20;MAP3K5;KALRN;PMAIP1;ABR;ARHGEF17;ANO6;ITSN1;TGFB3;ITGB1;NET1;ARHGEF16;ARHGEF2;ATG7;DAB2IP;RPS6KA2;ARL6IP5;TP53;PHLDA3;FZD9;MAP3K10;DAPK3;TNFAIP8;ARHGEF4;HRK;PAWR;VAV1;DNM1L;GPER1;TRIM35;CLIP3;BOK;CSRNP3;BCL6;CLU;DIABLO;ITGB3BP
prerank,regulation of hippo signaling (GO:0035330),0.5075606034056017,1.1064026891627825,0.35064935064935066,0.9868148069481641,1.0,2/17,1.90%,WTIP;LIMD1
prerank,positive regulation of neutrophil migration (GO:1902624),-0.40734108526459023,-1.1059737669256242,0.3277777777777778,0.8205775615336671,1.0,6/18,19.83%,CAMK1D;MCU;MOSPD2;RIPOR2;NCKAP1L;TIRAP
prerank,cellular response to leucine starvation (GO:1990253),0.5478674564522764,1.1057645285105886,0.3544061302681992,0.9875058459868201,1.0,3/10,9.74%,LARS1;IMPACT;RRAGB
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.3354265700637315,-1.1051831775921794,0.29491525423728815,0.821546001305156,1.0,13/33,16.51%,TJP1;GLUL;SEMA6A;PDPK1;EPN1;PIK3CB;BMPER;ITGA5;ADAMTS9;KLF2;CEMIP2;CREB3L1;FGF2
prerank,negative regulation of cytokine production (GO:0001818),-0.2544245013959835,-1.1051592104391106,0.2,0.8201047380198485,1.0,43/163,21.20%,LGR4;LEF1;APPL2;ARRB1;HMGB1;FN1;ITCH;OTUD7B;RNF135;MAPKBP1;LGALS9;APOD;HDAC7;ILRUN;ADCY7;UFD1;SRGN;CD34;PCBP2;PTPN22;NAV3;IRAK3;TRIM25;HOMER3;PDCD4;RGCC;SIRPA;RNF125;CX3CL1;ANXA4;SYT11;C1QTNF3;SSC5D;RARA;NLRC5;UBA7;NCKAP1L;ZC3H12A;TWSG1;CEACAM1;CD274;BCL3;PPP1R11
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.46291206365323045,-1.1049655991287566,0.3684210526315789,0.8192084536994968,1.0,5/11,15.33%,RIN3;SLIT2;NBL1;CCN3;DUSP1
prerank,peptidyl-asparagine modification (GO:0018196),-0.34906663714811215,-1.104176464093557,0.2978723404255319,0.8201826647810256,1.0,13/31,24.71%,TUSC3;MGAT1;FUT8;UGGT2;OSTC;MCFD2;MGAT5;LMAN1;HIF1AN;RPN2;MGAT2;DPM3;STT3B
prerank,regulation of protein neddylation (GO:2000434),0.5490515957143971,1.1041284506422921,0.3881932021466905,0.9912955641372413,1.0,4/10,9.82%,DCUN1D2;DCUN1D1;HIF1A;RPL5
prerank,P-body assembly (GO:0033962),0.5339126938059241,1.1041175136198158,0.3866231647634584,0.9901403418549883,1.0,2/12,5.59%,LIMD1;ATXN2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.37524241654092916,-1.103924818132989,0.3274336283185841,0.8193687800940016,1.0,18/24,45.63%,XRCC1;UBC;LIG3;UBB;LIG1;RPA3;RFC3;RPA2;POLD3;LIG4;RPA1;POLE;RFC1;RFC4;RFC5;POLB;POLD2;RFC2
prerank,endoderm development (GO:0007492),0.5229714868277588,1.1038240479395802,0.385146804835924,0.989837610532165,1.0,2/13,6.95%,DUSP5;LAMC1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.45535666559901,-1.103603343355656,0.36585365853658536,0.8189000078884802,1.0,4/11,13.73%,NECAB1;ITM2A;BACE2;SOAT1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.25619596757266716,-1.1030015310315968,0.2077922077922078,0.8192632612149048,1.0,29/129,14.08%,RNF220;LRRK1;LGR4;COL1A1;ADGRA2;WNK1;RNF146;DDX3X;PTK7;EGFR;LYPD6;TNKS2;PPM1B;PSMD7;PSMD9;PSMD13;WLS;ATP6AP2;SMURF2;TGFB1;FGFR2;PSMB3;SFRP4;SOX4;ZBED3;PSMC5;PSMA5;PSMA1;PSMC2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.49722741442138607,1.1023230893470588,0.351027397260274,0.9933526081334962,1.0,3/17,4.18%,CACNA2D1;SNTA1;KCNE4
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.37711894474340685,1.101875893326424,0.32849162011173183,0.9935848135376129,1.0,39/128,20.39%,PPP1R12A;PPP1R12B;DYNLL1;CCNA2;FBXL22;CEP41;HAUS8;CEP290;ENSA;PLCB1;PPP1CB;BRSK1;CDK7;CEP192;DYNC1I2;FBXW11;NEDD1;CEP72;ARPP19;CLASP1;DCTN3;CEP43;CSNK1E;HAUS7;HAUS2;PRKACA;DNM2;PLK4;CDK14;DCTN1;MASTL;BRSK2;MNAT1;HAUS4;CEP135;ACTR1A;CKAP5;SFI1;KDM8
prerank,telomere maintenance via recombination (GO:0000722),-0.4604703179144717,-1.1018049412287636,0.3536036036036036,0.8212828098842421,1.0,6/11,24.26%,RAD50;SMC5;TPRKB;NSMCE2;ERCC1;ERCC4
prerank,cellular response to glucose stimulus (GO:0071333),-0.3482228899828518,-1.1015341132227279,0.2911392405063291,0.8206663708097147,1.0,8/30,12.55%,ZBTB20;UNC13B;PTPRN2;TRA2B;RAB11FIP5;ERN1;SOX4;PCK2
prerank,positive regulation of binding (GO:0051099),-0.2779489180030093,-1.1014215179585045,0.27848101265822783,0.8195256878563657,1.0,29/84,22.16%,IGF1;LRP1;TCF7L2;HMGB1;BMP4;APP;APOE;VTN;B2M;NVL;CLDN5;DERL1;GPSM1;NMD3;MED25;FKBP1A;PRKN;HES1;DTX3L;SPPL3;RARA;PPARG;KDM4D;RALB;RPL11;NME1;DACT1;RAN;STMN1
prerank,positive regulation of chromosome organization (GO:2001252),-0.42655327821929434,-1.1013687302643467,0.3341288782816229,0.8181920583454846,1.0,5/15,12.85%,MRE11;PML;RAD50;GNL3;NBN
prerank,cellular response to gamma radiation (GO:0071480),0.5107940179782289,1.1013001423676747,0.36824877250409166,0.9941049099515725,1.0,3/17,7.10%,MAP3K20;TP53;YAP1
prerank,regulation of protein kinase activity (GO:0045859),0.3835715104940637,1.101281673141,0.3295711060948081,0.9929751283660122,1.0,23/106,14.77%,TTN;RAP1A;PLCE1;CCN1;SMG8;MMD;PPM1E;CAMKK2;RAP2C;LCP2;ANKRD54;GSTP1;PAK2;CENPE;RB1;CEP85;SNX9;CEP43;MAP2K3;GNAQ;GAS6;DVL1;MAPRE3
prerank,B cell receptor signaling pathway (GO:0050853),0.4540529795007727,1.1005734777692788,0.3633841886269071,0.9939717575268983,1.0,3/32,4.40%,MEF2C;CD79A;BCL2
prerank,apical protein localization (GO:0045176),0.5435923242530372,1.1004647992844485,0.3788706739526412,0.9931431628694554,1.0,5/10,11.32%,ATP8B1;ACTB;JAM3;INSC;GOPC
prerank,positive regulation of response to external stimulus (GO:0032103),-0.2658584086565198,-1.1003655092169486,0.23404255319148937,0.8197928351079714,1.0,34/128,17.04%,PTN;BMP6;SASH1;IL15;APP;IL18;WNT5A;STX3;NFKBIA;PUM1;POLR3F;GPR4;STX4;NAPEPLD;THBD;TNFRSF1A;OPTN;RIOK3;TGFB1;PDCD4;SCARF1;POLR3B;DDX60;IL33;NFKBIZ;PPM1F;CX3CL1;SNCA;ANKRD17;PLA2G7;GRN;TLR3;SERPINE1;PDE2A
prerank,organophosphate biosynthetic process (GO:0090407),-0.3316210560944018,-1.1001548884913293,0.3003533568904594,0.8189639360609329,1.0,19/37,33.35%,AGPAT4;IP6K1;GNPAT;IP6K2;TKT;PPIP5K2;GPAM;FGF2;AGPAT5;ITPKB;GK5;IPPK;FADS1;GK;NFS1;PPIP5K1;TPI1;FITM2;TPK1
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.3660583752801318,-1.1001157041861622,0.331306990881459,0.8175963603387512,1.0,9/24,16.99%,HMGB1;SLIT2;NBL1;MOSPD2;CCN3;LYN;DUSP1;PLA2G7;SERPINE1
prerank,zinc ion transmembrane transport (GO:0071577),-0.38597024270630276,-1.10004561154318,0.3081232492997199,0.8163346792531785,1.0,7/22,15.68%,SLC39A10;SLC30A10;SLC39A11;SLC39A8;SLC30A1;SLC39A1;SLC39A6
prerank,signal transduction in response to DNA damage (GO:0042770),0.42156148030310586,1.0998297034638969,0.3632760898282695,0.9938599762271851,1.0,12/49,10.71%,MAP3K20;HINFP;BRIP1;NDRG1;TP53;RAD9A;CHEK1;ERCC6;PAXIP1;STK33;FBXO6;RHNO1
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.34502522822535286,-1.0996955744640915,0.3102310231023102,0.8158209435988405,1.0,5/30,11.56%,HMGB1;LGALS9;PLCG2;CD34;CD46
prerank,sterol transport (GO:0015918),0.4947815021983257,1.0996474763602784,0.3742138364779874,0.9932351737523777,1.0,5/19,13.77%,CD36;CAV1;OSBPL2;LDLRAP1;OSBPL5
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.46516201078004143,1.0992152126473254,0.3741109530583215,0.993289183058969,1.0,6/27,9.09%,FBXL22;CRTC1;USP2;TP53;PPP1CB;PPP1CA
prerank,negative regulation of axonogenesis (GO:0050771),0.4619940658743783,1.0991353338634418,0.353204172876304,0.9923717730926735,1.0,2/27,4.95%,FGF13;PTPRS
prerank,negative regulation of DNA recombination (GO:0045910),0.43124005718290814,1.0987709726801649,0.3527080581241744,0.9923191217793164,1.0,11/43,13.78%,POLR2L;POLR2I;CGAS;H1-0;POLR2G;FANCB;RIF1;TERF2;RMI2;POLR2J;ZRANB3
prerank,sulfation (GO:0051923),-0.45032105186643406,-1.09873106099131,0.3615023474178404,0.8174766294281277,1.0,1/11,0.11%,UST
prerank,regulation of biosynthetic process (GO:0009889),0.5310640666600089,1.0978590633664511,0.36395759717314485,0.9939094470794341,1.0,6/11,23.06%,ALOX5;GSTP1;SLC25A33;THRSP;PIKFYVE;MID1IP1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3574664025053513,1.0976808909243259,0.3046153846153846,0.9932568349262588,1.0,33/259,10.64%,FLNA;MYLK;ARHGEF7;RAP1A;DYNLL1;VCL;KIF27;PLA2G3;ANO6;CDH13;EHD2;ITGB1;CEP41;NTN1;KIF3B;ACTR3;CEP290;IFT43;IFT81;RAP2C;CYFIP1;STK26;PIBF1;RAPGEF6;WHAMM;BBIP1;ARHGEF4;IQCB1;RAP2A;PARVA;ACTN2;EXOC6;RAB11FIP3
prerank,rRNA transcription (GO:0009303),0.500240626613832,1.0973702978477329,0.3695299837925446,0.9930019731300729,1.0,6/17,19.23%,CAVIN1;GTF3C4;POLR1E;SPIN1;GTF3A;NIFK
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3938618308058279,1.097225992045097,0.33597285067873306,0.9922622146864306,1.0,18/101,9.69%,ATP2B4;FGF1;MST1R;TCIM;PDGFB;PDGFC;FERMT2;CCND2;SLC8A2;PDGFD;DAB2IP;VEGFA;CALM1;RASGRP1;CCND1;MAP2K1;ADAM17;PDGFRB
prerank,regulation of cell differentiation (GO:0045595),0.37321884337454886,1.096475671810847,0.3232758620689655,0.9933008139670019,1.0,24/148,13.34%,NTF3;HEY2;ZFHX3;ROCK1;CDK6;PHLDB2;CLASP2;ALOX5;CBFB;TAF8;SNAI2;GDNF;PA2G4;AR;RUNX1;NR1D1;EIF2AK2;BMPR1B;ZFP36L1;BCL6;MOSMO;CLASP1;NSUN2;CASZ1
prerank,monocarboxylic acid transport (GO:0015718),0.41800446416113973,1.0962553615854658,0.35471204188481675,0.9928202601430164,1.0,6/51,2.87%,NR1H4;CD36;ATP8B1;ABCB4;SLC16A7;SLC10A1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.47971817963815133,-1.0962017274541807,0.36123348017621143,0.8236421584834281,1.0,5/10,14.09%,ATP1A2;NEDD4L;PRKCE;OSR1;HECW1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.5163090703575224,1.0961487471623446,0.36330935251798563,0.9919852621549069,1.0,2/13,6.54%,COL4A1;VEGFA
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.4487972340270315,-1.096073670998422,0.33573141486810554,0.8225834023922804,1.0,5/12,22.49%,STX3;STX4;SNAP29;STX1A;STX2
prerank,regulation of autophagosome maturation (GO:1901096),-0.4267976988174651,-1.0960255391103284,0.35294117647058826,0.8212761147577603,1.0,7/13,28.82%,IRGM;TBC1D25;CLN3;UVRAG;SMCR8;PHF23;ADRB2
prerank,dephosphorylation (GO:0016311),0.3730001879453601,1.0957873638841693,0.3336875664187035,0.9919109548542264,1.0,29/147,13.27%,PPP1R12A;PPM1L;PPM1J;PPP3CA;DUSP5;MTMR7;PPP2R1B;ACP3;PPM1E;PTPN18;PTPRS;LHPP;PTPRF;SDHAF2;PPP2R5A;DUSP3;PPM1A;PTPN1;PLPPR1;PPP1CB;PPP1CA;CTDSP2;FBXW11;DUSP29;SBF1;CTDSP1;DUSP16;TPTE;PPP3CB
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.3798980925966241,-1.0952671357151127,0.3278236914600551,0.8221527127187713,1.0,4/22,2.43%,AKAP13;AEBP1;PIK3CA;APOE
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.32643032040863984,-1.095172550848253,0.3106060606060606,0.8210004206634405,1.0,16/39,25.76%,ABCA1;SEL1L;RAB12;CANX;STEAP3;GOLPH3;PDIA4;RCN3;ARFGAP3;MON1A;RAB13;PPY;MIA3;SVBP;RAB3D;COPG2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.44471232661674875,1.0946643968974876,0.3558823529411765,0.9940716756897643,1.0,10/28,13.82%,SORT1;BCL2;GABARAP;DAB2IP;BAG3;DEDD2;CASP8AP2;DIABLO;DEDD;TNFRSF10B
prerank,positive regulation of rRNA processing (GO:2000234),-0.46972508044953754,-1.0938619848220488,0.363013698630137,0.8236062330223081,1.0,6/10,35.25%,SIRT7;DIMT1;BUD23;HEATR1;RIOK2;TRMT112
prerank,positive regulation of insulin secretion (GO:0032024),-0.3292314238699518,-1.0938561075268896,0.2901023890784983,0.822169731780599,1.0,13/36,17.62%,TCF7L2;MYRIP;RBP4;MCU;PSMD9;STX4;NNAT;SOX4;PLA2G6;NLGN2;CAPN10;AACS;ACSL4
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3945324524459579,1.0933880926994244,0.353437876960193,0.9966922711964887,1.0,14/79,10.70%,RBPMS2;ATP2B4;CRIM1;ACVR2A;BMPR1A;EMILIN1;MMRN2;EPN2;DAB2IP;PTPN1;NEDD4;SKI;VWC2L;UBE2D1
prerank,cellular response to interleukin-6 (GO:0071354),-0.362593043006271,-1.0933131476715463,0.3421828908554572,0.8224371507542743,1.0,6/26,8.54%,PID1;ST3GAL6;SBNO2;PTPN11;CTR9;IL6R
prerank,histone mRNA metabolic process (GO:0008334),-0.34989948225940937,-1.0931560611817421,0.3388888888888889,0.8214183213192072,1.0,9/27,19.09%,SSB;SLBP;LSM1;DCP2;NCBP2;TUT4;CPSF2;ATM;TUT7
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.5118187486142636,1.0930934709251197,0.38209982788296043,0.9964036079185568,1.0,5/13,15.58%,CRLF1;OASL;STAT1;JAK2;STAT3
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.42909326570998957,1.0929338595384939,0.35041551246537395,0.995679633508134,1.0,9/40,13.42%,NTF3;ANGPT1;HIP1;VEGFA;DGKD;ATAD1;SCYL2;CLU;LDLRAP1
prerank,positive regulation of protein import (GO:1904591),0.4501407131875766,1.0927029479702557,0.36056338028169016,0.9952237643571881,1.0,2/30,4.45%,FLNA;UBR5
prerank,regulation of cell population proliferation (GO:0042127),0.35738647924410816,1.092525856790736,0.2602602602602603,0.9945723090015424,1.0,78/691,8.79%,MYOCD;NTF3;AGTR1;IGFBP7;COL18A1;NTRK3;DLC1;LIFR;ELN;TBX2;TMIGD3;FGF1;S1PR3;LIMS1;MST1R;P3H2;SPEG;PDGFB;ITGA1;CDK6;PDGFC;TRNP1;CCND2;CDH13;FRK;CRLF1;ADRA1D;THPO;JAG1;RERG;IL2;TGFB3;GCNT2;NACC2;BTG2;PDGFD;NUP62;IL12RB2;TSHR;FXN;TGFB1I1;BCL2;KSR1;OSR2;ARHGEF2;BMPR1A;HAS2;KCNH1;TESC;IRS1;JUND;TNFRSF11A;DAB2IP;RPS6KA2;VEGFA;TP53;TIPIN;GDNF;YAP1;CD200;GAREM1;AREG;AR;BNIPL;CELF1;BTG1;NUAK1;TGFB2;SOX9;RELA;KMT2D;WNK2;DIS3L2;MAP2K1;TRPM4;MVD;ADAM17;RUNX1
prerank,negative regulation of type I interferon production (GO:0032480),-0.32372267671325283,-1.0923397447520062,0.2972972972972973,0.8225057887557232,1.0,17/40,28.21%,ITCH;PPM1B;RNF135;ILRUN;UFD1;PCBP2;TRIM25;SIRPA;RNF125;RELB;NLRC5;UBA7;NLRX1;CYLD;NLRC3;GPATCH3;IKBKE
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.44721904682673935,1.092298092426235,0.352773826458037,0.9941465367279985,1.0,6/29,11.01%,PMAIP1;PPP2R1B;CAV1;PAK2;DEDD2;GPER1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.44467231921445616,1.0922077968078796,0.3514644351464435,0.9932621988132404,1.0,8/34,11.01%,RORA;FERMT2;RUNX1T1;ASXL1;BBS12;YAP1;SIRT2;GPER1
prerank,neuromuscular synaptic transmission (GO:0007274),0.4865060066422515,1.0920660804869544,0.37720706260032105,0.9925375298580348,1.0,4/18,10.13%,DTNA;STAC3;RIMBP2;FCHSD2
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5336043274519562,1.0920497079101286,0.3828264758497317,0.9914368940121578,1.0,2/11,9.73%,MST1R;SIRT2
prerank,regulation of G0 to G1 transition (GO:0070316),-0.32622092534414754,-1.0920460248615969,0.30985915492957744,0.8219200871964378,1.0,8/38,8.70%,RBBP4;CBX5;MGA;TFDP1;RYBP;PHC3;PHC1;MAX
prerank,negative regulation of cellular process (GO:0048523),0.3596294994637753,1.0920250518797538,0.2925851703406814,0.9903759894088161,1.0,74/521,11.85%,MYOCD;SLIT3;ACTN1;IGFBP7;COL18A1;DLC1;ANGPT1;MYL2;TMIGD3;FER1L5;P3H2;SPEG;ITGA1;CCN1;CDK6;FERMT2;MYH9;DYSF;PLXND1;SEMA5A;PLXNB1;CDH13;FRK;NR4A1;RERG;TGFB3;GMNN;NACC2;BTG2;FHL1;NUP62;TGFB1I1;ALOX5;PIP4P2;BCL2;JADE1;ARHGDIG;EMILIN1;TESC;CBLL1;DSCAM;DAB2IP;NDRG3;RPS6KA2;TMEM98;TP53;CD200;AR;BNIPL;CELF1;BTG1;TGFB2;ADNP2;WNK2;LPCAT3;DIS3L2;MAP2K1;IMPACT;SKI;NDUFS3;SERTAD2;SIRT2;TNFRSF21;CRLF3;EIF2AK2;BRINP1;SH3BP4;GPER1;RB1;TCHP;COPS8;ACVR1B;HTR2B;CNOT7
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4078931242235308,-1.0919778990871956,0.35789473684210527,0.8207002385776873,1.0,6/16,15.93%,APOE;NPR3;NOS1AP;PIK3CB;GCH1;AKT1
prerank,leukotriene metabolic process (GO:0006691),0.4792561794552823,1.0919522204512186,0.3817891373801917,0.9894650566343085,1.0,4/19,14.03%,ALOX5;MAPKAPK2;PTGR1;PLA2G4A
prerank,proteoglycan biosynthetic process (GO:0030166),-0.33612592970214383,-1.0918975018953179,0.3184931506849315,0.819492849826069,1.0,15/31,21.40%,IGF1;CHST11;EXTL3;BMPR2;CHST9;HS3ST3B1;UGDH;GLCE;CANT1;XYLT1;FOXL1;PXYLP1;CHST12;B4GALT7;B3GAT1
prerank,artery morphogenesis (GO:0048844),0.4497374795652608,1.0918603612026034,0.3627167630057804,0.9885965067662943,1.0,7/30,9.69%,HEY2;TBX2;JAG1;BMPR1A;VEGFA;TGFB2;PDGFRB
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.38935804705658417,1.0918165833372198,0.3391812865497076,0.987592300824833,1.0,16/87,12.92%,NEB;DLC1;ROCK1;RHOBTB3;ARHGAP17;DAPK3;RHOF;PDGFRB;ROCK2;PDGFA;PRKCD;RHOH;ARHGAP35;RICTOR;TRPM2;DMTN
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.47250244710675754,-1.0916674747110418,0.38495575221238937,0.8188111733494867,1.0,2/10,2.70%,APOE;ABCA1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.41538450870414223,1.091614138545838,0.34061696658097684,0.9870663539103164,1.0,14/51,15.61%,NTF3;PLXNB1;DAB2IP;DICER1;TNIK;PACSIN1;TAOK3;KIF20B;LRRK2;SGK1;ANKRD27;SNX1;CNTNAP1;DNM2
prerank,purine-containing compound catabolic process (GO:0072523),-0.4365168730035395,-1.0916078418250073,0.3762135922330097,0.8175479952343218,1.0,6/13,19.79%,XDH;NT5E;ITPA;DPYD;GPX1;PNP
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4239871395207907,1.091528766568109,0.34432717678100266,0.9861961543930015,1.0,15/48,18.78%,CRIP1;DYRK2;BCL2;TP53;PHLDA3;RPS27L;BCL2L2;EPHA2;BOK;FNIP2;MCL1;HIPK2;MSH2;USP28;ABL1
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.3532812973590533,-1.0915090984825235,0.33436532507739936,0.8164176033239139,1.0,9/27,18.47%,ARRB1;PTPN22;IRAK3;SIRPA;CX3CL1;SYT11;C1QTNF3;NCKAP1L;ZC3H12A
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5065793741450832,1.0911377001213245,0.36177474402730375,0.9862565636629889,1.0,2/14,6.97%,ENTPD1;ENTPD7
prerank,response to alcohol (GO:0097305),0.4680012700992284,1.09106359682064,0.363103953147877,0.9853555562623778,1.0,1/27,0.17%,SLIT3
prerank,regulation of lipase activity (GO:0060191),0.5304378542454538,1.0906017495431153,0.39368770764119604,0.9856062979765462,1.0,2/13,3.09%,ANGPTL8;LPL
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.44195456590326554,-1.0894945418853133,0.3712871287128713,0.821125906573825,1.0,2/12,1.03%,DAB2;FOXP1
prerank,adipose tissue development (GO:0060612),0.528817918582162,1.0894137080382833,0.39042357274401474,0.9880028311070417,1.0,5/11,16.65%,ARID5B;DYRK1B;LRP5;NAMPT;SH3PXD2B
prerank,sphingolipid biosynthetic process (GO:0030148),-0.28459280828791106,-1.0892416867901458,0.2874251497005988,0.8204420636774465,1.0,16/71,9.83%,SGMS1;SGMS2;ELOVL7;CERS5;HACD4;ST3GAL5;SPTLC2;ST8SIA1;B4GALT6;SPTSSA;ACER2;ALDH3A2;CERT1;CERS6;SGPP1;ASAH2
prerank,regulation of signal transduction (GO:0009966),0.3654035468269397,1.0892222635533708,0.32346723044397463,0.9874380009869945,1.0,38/190,13.86%,IGFBP7;LIFR;RGS6;CD36;PLCE1;RORA;SEMA5A;RGS4;ZFAND2B;ITGA3;SLC8A2;SOCS5;IGFBP5;NUP62;DHRS3;CBFB;IFT81;CASTOR1;IGFBP4;RFNG;PTPN1;GDNF;YJEFN3;ANKRD54;PLCB1;RUNX1;MGLL;AMFR;CDC42SE2;ZDHHC17;SREBF2;TSPAN12;CHRNA7;CLU;HOMER1;NCK2;LRRK2;USP20
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.42094966921719124,1.0891598844400172,0.35113484646194926,0.9865030330481108,1.0,4/45,3.09%,CD36;MYD88;FZD5;LPL
prerank,regulation of glycolytic process (GO:0006110),-0.2806812529725202,-1.0887019511167337,0.23728813559322035,0.8205958754563327,1.0,22/68,21.97%,IGF1;ZBTB20;PRKAG2;NUPR1;APP;NUP88;HDAC4;ENTPD5;OGT;EP300;PFKFB2;NUP50;INSR;ARNT;PRXL2C;NDC1;GIT1;NUP85;PFKFB3;CBFA2T3;PRKAA1;NUP214
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.49073430567936105,1.0886445644462441,0.384375,0.9869116742115817,1.0,4/19,6.85%,DYRK2;TP53;PHLDA3;RPS27L
prerank,embryonic eye morphogenesis (GO:0048048),-0.44469400169644946,-1.0870632736001034,0.3724137931034483,0.8239914398340401,1.0,4/11,3.68%,FBN1;EFEMP1;FBN2;MFAP5
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5523369653425728,1.0869186343603046,0.395910780669145,0.9908315285260645,1.0,4/11,9.67%,PADI2;ARID1A;CHEK1;SERTAD2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.44292695967100104,-1.086363140041378,0.3559322033898305,0.8247184587344366,1.0,7/12,28.82%,SETX;IRGM;INSR;UVRAG;SMCR8;JMJD4;ADRB2
prerank,regulation of leukocyte activation (GO:0002694),0.5061869171643844,1.0860791232403753,0.38687392055267705,0.9921889996077954,1.0,4/14,11.01%,MFHAS1;MYO18A;CD200;GPER1
prerank,methylguanosine-cap decapping (GO:0110156),-0.4712093210371517,-1.0854502176787462,0.36807095343680707,0.8259794785330911,1.0,6/10,22.42%,DCPS;LSM1;DCP2;EDC4;PNRC2;EDC3
prerank,aspartate family amino acid metabolic process (GO:0009066),0.4912436645932851,1.0849674093957271,0.37987012987012986,0.9944238704568628,1.0,8/18,20.44%,NAT8L;GOT1;GOT2;ADI1;SMS;SLC25A12;ASNS;NIT2
prerank,ribosomal small subunit assembly (GO:0000028),-0.40419204713515444,-1.0849512070863008,0.3542713567839196,0.826068355170025,1.0,10/16,29.75%,PRKDC;XRCC5;RPS19;RPSA;ERAL1;RRP7A;RPS27;MRPS11;RPS5;RPS15
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4932304506994618,1.0849088964285818,0.38047138047138046,0.9934487243035799,1.0,5/17,11.37%,FGF1;LPCAT3;MBTPS1;ABCG1;SREBF2
prerank,defense response to protozoan (GO:0042832),0.525114989207135,1.0848854533960737,0.40418118466898956,0.9924090927024001,1.0,3/12,12.41%,MYD88;LYST;GBP2
prerank,photoperiodism (GO:0009648),0.4582153492840427,1.0845220214965505,0.3923512747875354,0.9923429891427373,1.0,8/28,14.30%,FBXL22;CRTC1;USP2;TP53;PPP1CB;PPP1CA;CLOCK;MTA1
prerank,response to interferon-alpha (GO:0035455),-0.39703478460654573,-1.0841105832419264,0.3553921568627451,0.8271559026164507,1.0,10/16,30.18%,IFNAR2;ADAR;BST2;IFNAR1;IFITM1;IFITM3;RO60;IFITM2;PDE12;KLHL20
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3676129105147292,-1.0830974109757134,0.3405994550408719,0.8288276505002755,1.0,9/22,22.78%,MAN1C1;RNF185;SEL1L;UGGT2;UBC;OS9;SYVN1;UBB;MAN1A2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.22778293948614892,-1.0830299702752064,0.16666666666666666,0.827603152503341,1.0,82/314,19.24%,ECPAS;NEDD4L;ARRB1;FBXL7;FBXL5;ATXN3;AREL1;ITCH;CUL3;RNF185;SEL1L;ANAPC1;UBXN4;UBE2D3;UBQLN1;DNAJB12;UFD1;DERL1;PML;UBR2;HSPA5;DNAJC10;CTNNB1;USP19;BIRC2;PCBP2;FBXO9;PSMD7;PSMD9;PSMD13;LTN1;PELI1;MDM2;FBXO4;TOPORS;WWP1;CDC23;RBCK1;TRIM25;ARMC8;PRKN;SMURF2;RMND5B;SGTA;KCTD2;UBE4B;PSMB3;UBC;DDB1;RNF34;STUB1;KLHL22;RMND5A;SKP2;DNAJB2;HSP90B1;PSMC5;SGTB;SIAH1;PSMA5;BUB3;OS9;NEMF;PSMA1;PSMC2;HECW1;CDC26;NHLRC3;UBXN1;UBQLN2;AMN1;ANAPC4;UBE2S;DNAJB9;SYVN1;UBXN8;HERPUD1;SPOPL;FBXW5;SIAH2;SPSB4;BTRC
prerank,long-chain fatty acid transport (GO:0015909),0.45017529381803656,1.0829626244576673,0.3776119402985075,0.9957986384876907,1.0,6/30,8.96%,PRKAB2;CD36;ACACB;FABP4;CPT1B;ABCD4
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.468338869717536,-1.0829074962052612,0.38663484486873506,0.8265628085988028,1.0,3/10,7.89%,ANXA2;EPHA4;FURIN
prerank,negative regulation of anoikis (GO:2000811),0.5040130054027899,1.0827980283086418,0.40134907251264756,0.9951337591820713,1.0,5/14,6.93%,PDK4;ITGB1;BCL2;CAV1;SNAI2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.4604598608262873,1.0820026090333452,0.3682678311499272,0.9964154980821336,1.0,4/27,4.92%,ATP2B4;SNTA1;CAMK2D;UTRN
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3587693875212827,1.0818216779769456,0.3425238600212089,0.9958249938200784,1.0,43/198,15.58%,ITPK1;PLCE1;LIMD1;PFKP;INPP4B;PPP3CA;PLA2G3;PLCB4;PIP4K2A;DUSP5;LPL;HK2;PFKFB1;ACP3;INPP5A;NUDT4;GFPT1;LHPP;COQ8A;DUSP3;PPM1A;CALM1;PLPPR1;PLCB1;PPP1CA;PAK2;INPPL1;PLCD1;INPP5B;ALDOA;PFKM;HTR2B;ITPKC;DUSP16;TPTE;PPP3CB;PLB1;LRRK2;PLA2G4A;PLA2G4C;INPP5J;PTEN;STAT3
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4647463352677641,-1.0814296783119441,0.3624161073825503,0.8294587491375525,1.0,4/10,14.93%,PRKCB;VTN;ITGA5;ARNT
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.35931622226491106,-1.0811665865176094,0.33881578947368424,0.8287974427540703,1.0,5/26,7.32%,POR;APOE;NPR3;NOS1AP;PIK3CB
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.39648143314021295,-1.0806991235857475,0.3676092544987147,0.8287989078375367,1.0,5/16,26.60%,LDLR;ABHD5;MFSD2A;DAGLB;PNPLA2
prerank,hexose biosynthetic process (GO:0019319),0.4179164261446504,1.080639116402119,0.3562005277044855,0.9981578007937597,1.0,12/42,15.62%,ENO3;PFKFB1;MDH1;AKR1B1;PPARGC1A;GOT1;GOT2;SLC39A14;ALDOA;CRTC2;SLC25A12;GAPDHS
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.33229421959159544,-1.0804130131797083,0.33797909407665505,0.8282700621980432,1.0,8/35,5.54%,FLT1;NF1;SULF1;SPARC;APOE;XDH;COL4A3;PTPRM
prerank,organelle assembly (GO:0070925),0.351561922945661,1.0801911790461243,0.30251256281407035,0.9983544976480175,1.0,83/384,17.75%,LMOD1;FLNA;DYNLL1;LMOD2;LMOD3;ATP2A2;CHMP4C;LIMD1;KIF27;PLA2G3;EHD2;CEP41;NUP62;HAUS8;KIF3B;ACTR3;CSDE1;CEP290;ATG16L2;ATG7;MAPRE2;GABARAP;ATXN2;IFT43;TUBGCP6;MAPT;IFT81;CHMP5;ABCA3;CIRBP;YTHDF2;PIBF1;AUP1;BBIP1;SYNPO;IQCB1;ANLN;PARVA;IST1;CENPE;EXOC6;NSFL1C;RAB11FIP3;RPS23;STX12;STAM2;FHDC1;STK36;WDR45;CHMP2B;TSG101;HPS4;VPS36;PIK3C3;CHMP2A;FOXJ1;TTC39C;G3BP1;HAUS7;HAUS2;RAB8B;MAPRE3;STAM;PLA2G4C;STX7;ATG13;CCDC66;RFX3;CFAP43;PRRC2C;RAB8A;PLK4;INO80;SH3PXD2B;CENPW;RAB38;VPS4A;DZIP1L;FARP2;GALNT11;STARD9;UBXN2B;DHX29
prerank,inorganic cation import across plasma membrane (GO:0098659),0.39076889824549105,1.079646353993001,0.34798534798534797,0.9988987862272698,1.0,9/75,8.82%,ATP2B4;CACNA2D1;KCNJ12;SLC8A1;SLC8A2;ATP1B1;TRPV2;TRPM4;SLC39A14
prerank,regulation of myeloid cell differentiation (GO:0045637),0.40148193305889585,1.079261271230201,0.35236938031591736,0.9989405056652194,1.0,8/62,8.79%,MYL9;MEF2C;CDK6;CBFB;CNOT4;PRKCQ;KMT2D;RUNX1
prerank,spliceosomal complex assembly (GO:0000245),-0.3056837621542881,-1.078900166155869,0.29959514170040485,0.8313616220603246,1.0,13/46,19.12%,CELF2;KHDC4;RBM5;SNRNP200;SRSF6;SRSF5;CELF4;SETX;CRNKL1;SNRPD1;SRPK1;SMN1;SCAF11
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.365367045379118,-1.0788677815694843,0.3560830860534125,0.8300404320585393,1.0,6/22,16.84%,ZBTB20;APOE;CREBL2;CREB1;AKT1;PPARG
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.38169150276109187,1.078809895181204,0.3583617747440273,0.9991655476068478,1.0,15/95,11.18%,MEF2C;MYD88;FZD5;VIM;CD14;UPF1;DAB2IP;CHMP5;RELA;NFKBIB;GSTP1;NR1D1;SIRT2;AXL;CD180
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.478709927078433,1.0787810772494695,0.38,0.9981271668662983,1.0,6/17,12.46%,ROCK1;RTN2;PIN1;RTN1;CHRNA7;CLU
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.3998364239334559,-1.0785639526464148,0.3743169398907104,0.8295773800505568,1.0,6/16,18.22%,PRKDC;PARP3;SMCHD1;DTX3L;WRAP53;KDM4D
prerank,ion homeostasis (GO:0050801),0.446781124780977,1.0779507745667176,0.3683453237410072,0.9994938323208811,1.0,7/30,8.12%,CAMK2D;SLC4A8;P2RY2;FHL1;SLC4A3;SLC4A7;WNK2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.43514806989386684,1.0777272550636792,0.389196675900277,0.9990304559154878,1.0,10/38,11.49%,NR1H4;RORA;CARD19;DAB2IP;PPM1A;TNIP1;OTUD7A;GSTP1;NR1D1;RHOH
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5296534479201321,1.0775680790350293,0.4118705035971223,0.9983578171931003,1.0,5/11,18.52%,TP53;RPS27L;MAD2L2;HIPK2;RPS6KA6
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.46840756432296715,1.0775585066197912,0.38058551617873654,0.9972614304976946,1.0,3/22,6.15%,RASL11A;PWP1;SMARCB1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3950273073434601,1.0773537859044056,0.3635250917992656,0.996752953229053,1.0,10/72,6.98%,FGF13;TRIM54;CHADL;CLASP2;KANK1;ARHGEF2;EMILIN1;DYRK1A;TPX2;HDGFL3
prerank,cell cycle G2/M phase transition (GO:0044839),0.3677450774193471,1.077325280779252,0.35294117647058826,0.9957313325726032,1.0,39/129,20.39%,PPP1R12A;PPP1R12B;DYNLL1;CCNA2;FBXL22;CEP41;HAUS8;CEP290;ENSA;PLCB1;PPP1CB;BRSK1;CDK7;CEP192;DYNC1I2;FBXW11;NEDD1;CEP72;ARPP19;CLASP1;DCTN3;CEP43;CSNK1E;HAUS7;HAUS2;PRKACA;DNM2;PLK4;CDK14;DCTN1;MASTL;BRSK2;MNAT1;HAUS4;CEP135;ACTR1A;CKAP5;SFI1;KDM8
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.42031613010100544,1.0770473067405029,0.3612565445026178,0.9954074696070954,1.0,11/48,15.63%,PRDM16;NUP62;SEC13;NUP153;HIF1A;NUP107;AAAS;ZBTB7A;NUP37;NUP98;NUP210
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.33808622787213816,-1.0764560943537356,0.35873015873015873,0.8342017372888313,1.0,6/30,6.45%,DAB2;FOXP1;DDX5;SAFB2;RNF6;PRMT2
prerank,fatty acid transport (GO:0015908),0.48487122783530956,1.076228456308014,0.3753993610223642,0.9967145167900968,1.0,4/17,7.92%,CD36;FABP4;CPT1B;GOT2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.46808317253802434,1.0757828740876283,0.391304347826087,0.9968743146859438,1.0,9/23,17.81%,MTMR7;PIP4P2;SYNJ2;SACM1L;INPP5B;TPTE;INPP5J;PTEN;MTMR3
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.31510747930550354,-1.0757089906629156,0.3161764705882353,0.8351355130496949,1.0,14/39,16.91%,BMP4;SLIT2;ENG;GLI2;NRP1;PKD2;TIE1;CTNNB1;RASIP1;SALL1;SIX1;KDR;FGF2;NOTCH4
prerank,cytoplasmic translational initiation (GO:0002183),0.495553399797092,1.0752422286659615,0.39408866995073893,0.9974022345944211,1.0,4/17,8.62%,DENR;EIF3M;EIF2D;EIF4A1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.531778724972983,1.0750486634509964,0.40671641791044777,0.9968461346853962,1.0,4/10,12.86%,DGKD;GAP43;HTR2B;PRKD3
prerank,regulation of glucose metabolic process (GO:0010906),0.434416283427712,1.0746303414633656,0.38011695906432746,0.9969666638076559,1.0,4/34,5.71%,PMAIP1;RORA;PDK4;IRS1
prerank,organophosphate catabolic process (GO:0046434),-0.44591387089736345,-1.0743154581413257,0.41216216216216217,0.8378848616079502,1.0,2/11,14.10%,ENPP2;ABHD12
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.47584440076813617,1.0742705298587427,0.3954248366013072,0.996914458503173,1.0,4/20,11.01%,ANO6;PIAS4;ITGA4;GPER1
prerank,negative regulation of dephosphorylation (GO:0035305),0.49135948891266235,1.073979351799023,0.40229885057471265,0.9966829956512551,1.0,5/18,15.59%,PPP1R26;MFHAS1;ENSA;ARPP19;URI1
prerank,response to molecule of bacterial origin (GO:0002237),-0.28220388656932505,-1.0739737866592078,0.313953488372093,0.8374667328927952,1.0,17/69,16.20%,FOXP1;SMAD6;LBP;LGALS9;IRAK1;NOCT;RPS6KA3;CYRIB;PTPN22;PELI1;NOS3;IRAK3;TAB2;SNCA;GCH1;IFNAR1;SRR
prerank,neuron projection regeneration (GO:0031102),-0.4669721231605927,-1.0735983104355717,0.3859275053304904,0.8371812953410147,1.0,2/10,10.68%,PTN;MAPK8IP3
prerank,regulation of Golgi organization (GO:1903358),0.4926987642185203,1.0725852618396485,0.4028662420382166,0.9996650483330723,1.0,5/17,13.94%,PDE4DIP;MAP2K1;STX18;PDCD10;MAPK1
prerank,regulation of nervous system development (GO:0051960),0.4279028298677919,1.0724391409406553,0.3804195804195804,0.999002332557888,1.0,7/37,9.73%,HEY2;HEYL;PRUNE1;GBX1;YTHDF2;YAP1;SIRT2
prerank,triglyceride metabolic process (GO:0006641),-0.3025898647991589,-1.071909046469865,0.3261802575107296,0.840872056504291,1.0,5/48,4.77%,AGMO;APOE;SEL1L;LPGAT1;LPIN2
prerank,metal ion export (GO:0070839),0.44090707204143426,1.0717349842881014,0.39500734214390604,0.9999480882017003,1.0,5/31,7.01%,ATP2B4;KCNA5;KCNE4;ATP1B1;KCNT2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3239691351872313,-1.071726949588983,0.33447098976109213,0.8399998826486861,1.0,3/33,1.00%,IGF1;NF1;PIK3CA
prerank,regulation of cellular component size (GO:0032535),0.4432914768168534,1.0716241298691287,0.3931133428981349,0.9991735119460144,1.0,4/30,10.66%,NEB;LARS1;PPP1CA;VAV1
prerank,protein transport (GO:0015031),-0.2208419194901436,-1.071420620792314,0.16666666666666666,0.8395517704783925,1.0,91/332,19.92%,SPTBN1;PRKCB;LRP1;VAMP5;CALCRL;APOE;TBC1D16;ABCA1;SNX27;SEL1L;RABGAP1L;RAB5A;STXBP1;STX3;TBC1D15;RAB12;SCAMP2;USO1;ERP29;TBC1D8B;ATP6V0A4;GOLGA4;TMED5;SEC23IP;SCG5;TBC1D2B;TBC1D13;SLC10A7;TBC1D5;CANX;STX5;HERC2;STEAP3;STX4;OPTN;ARL5B;GCC2;TMED7;TBC1D8;GOLPH3;TMED10;COPB2;WLS;PPT1;ATP6AP1;ATP6V1G1;RAB3GAP2;PDIA4;BLZF1;SNX6;ARF3;UNC93B1;ARFIP2;SNX15;RAMP2;RCN3;TBC1D25;HSP90B1;SGSM1;GRTP1;TOM1;TBC1D9B;MYO6;TBC1D30;ARFGAP3;RAB1A;TBC1D22A;RAB29;TBC1D9;MON1A;EHD1;STX1A;SGSM3;TCIRG1;NDC1;PPARG;COG7;TMED3;RAB13;PICK1;RAB1B;STX8;SCFD1;ARRDC1;TBC1D10A;NAPG;TMED4;SCAMP3;MCOLN1;PPY;MIA3
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5270575965461474,1.0714132186196326,0.400355871886121,0.9986949259192814,1.0,4/13,9.67%,PADI2;ARID1A;CHEK1;SERTAD2
prerank,phosphorylation (GO:0016310),0.34866286247869327,1.07134531786103,0.3441295546558704,0.9977895176879813,1.0,73/384,14.00%,DGKB;DGKG;MAP3K20;STK38L;TNNI3K;PRKG1;MAP3K5;ROCK1;DYRK2;MERTK;LIMD1;PDGFB;CDK6;PDK4;FRK;FAM20A;CAMK2D;ACVR2A;PEAK1;CAMKK2;MARK1;BMPR1A;DYRK1A;MAP4K3;MAP4K5;TAF1;MAPKAPK2;COQ8A;DYRK1B;STK26;NUAK1;FGGY;CHEK1;TGFB2;WNK2;DAPK3;PRKACB;PRKAR1B;MAP2K1;CCNT1;BRSK1;PKN2;PAK2;CDK7;DGKD;STK24;CDK18;EIF2AK2;ROCK2;PRKCD;COPS8;ACVR1B;HTR2B;STK36;CDK12;DMPK;BMPR1B;TNIK;BCR;CDC42BPB;TAOK3;CDK15;FNIP2;MAST1;PPP3CB;LRRK2;SGK1;PDK2;DGKZ;STK10;GAS6;MAPK1;CSNK1E
prerank,regulation of mitochondrial fusion (GO:0010635),-0.4441635152904201,-1.0711804068404323,0.37748344370860926,0.8388559857631636,1.0,2/11,9.61%,PID1;PRKN
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4452166795445641,1.0711622474384412,0.37423312883435583,0.9972099082243562,1.0,12/26,19.75%,SOCS5;SOCS4;FBXW7;AREG;ADAM17;HBEGF;TSG101;NCK2;CBLB;ADRA2A;SHC1;ERRFI1
prerank,positive regulation of DNA binding (GO:0043388),-0.33043217412109666,-1.0710966700679747,0.31446540880503143,0.8377330296728385,1.0,12/31,27.54%,IGF1;NIBAN2;HMGB1;PRKN;TGFB1;HES1;PPARG;PARK7;NME1;TWIST1;HMGB2;EGF
prerank,cation transmembrane transport (GO:0098655),-0.3107129586757345,-1.071031404992721,0.35036496350364965,0.8365264862664629,1.0,8/44,9.87%,TRPM3;ATP1A2;TRPM6;PKD2;SLC3A2;SLC7A5;SLC6A9;SFXN2
prerank,myeloid dendritic cell activation (GO:0001773),-0.4350019584081148,-1.0709807922421894,0.3922902494331066,0.8352735715094397,1.0,9/12,52.58%,HMGB1;DOCK2;CAMK4;BATF;PYCARD;BATF2;TGFBR2;IL4;BATF3
prerank,synaptic vesicle exocytosis (GO:0016079),-0.32693935684344955,-1.0709802378575721,0.384,0.8338952322825265,1.0,11/40,17.54%,UNC13C;UNC13B;STX3;SYT1;STX4;SNAP29;SNCA;PCLO;SNPH;STX1A;RIMS2
prerank,positive regulation of DNA recombination (GO:0045911),0.45185496080922966,1.0705561906440386,0.3948948948948949,0.997905338087305,1.0,8/27,9.87%,RAD51AP1;ZCWPW1;PARP1;ERCC6;FUS;PAXIP1;FANCB;RIF1
prerank,regulation of telomerase activity (GO:0051972),0.4194585065503131,1.070532202654225,0.3803763440860215,0.996878320739179,1.0,7/45,9.65%,PARM1;PARN;PRKCQ;PKIB;TP53;NAF1;CERS1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.421432921924521,1.070397906537694,0.3624161073825503,0.9961712905759655,1.0,7/46,6.10%,RBPMS2;ELN;PDGFB;CDH13;IGFBP5;CCL5;OGN
prerank,regulation of protein metabolic process (GO:0051246),-0.3067997542792638,-1.069938259032417,0.32075471698113206,0.8358825015510278,1.0,17/44,18.44%,NEDD4L;APP;APOE;LDLR;LTBP4;HSP90AB1;FURIN;FKBP1A;MDM2;ACE;KLF2;SSH1;HGS;GSAP;CHEK2;ODC1;SPOPL
prerank,aerobic electron transport chain (GO:0019646),0.3867604535421209,1.069516009575765,0.36385836385836384,0.9977016443751456,1.0,24/68,18.72%,COX7A2L;NDUFS1;NDUFA2;NDUFA11;SDHC;SDHAF2;COX8A;NDUFC1;NDUFB6;NDUFS3;COX7B;NDUFB8;NDUFV2;NDUFS2;SDHA;NDUFAB1;NDUFA1;UQCRFS1;NDUFAF1;UQCRH;COX6C;COX5B;NDUFV3;UQCRQ
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.22893873372810197,-1.069458167477758,0.13333333333333333,0.8359821274831438,1.0,118/341,25.67%,TTC3;NEDD4L;ARRB1;FBXL7;TRIP12;RNF146;ATXN3;AREL1;ITCH;FBXO10;CUL3;RNF185;ANAPC1;RNF20;UBE2D3;UBQLN1;OTUD7B;BIRC6;RNF144B;RC3H2;RNF217;UBL7;RNF6;UFD1;PML;CTNNB1;BIRC2;UBAP1;PCBP2;RNF13;PSMD7;WDR91;PSMD9;PSMD13;RNF213;PELI1;MDM2;TOPORS;WWP1;CDC23;RBCK1;TRIM25;ARMC8;FBXO7;PRKN;SMURF2;RNF144A;RMND5B;KCTD2;UBE4B;PSMB3;DDB1;RNF34;STUB1;KLHL22;RMND5A;SKP2;RNF125;VPS4B;RNF166;DTX3L;PSMC5;SIAH1;PSMA5;BUB3;OS9;PSMA1;PSMC2;HECW1;RNF115;UBE2H;CDC26;KLHL3;TOLLIP;NHLRC3;UBXN1;RNF43;UBQLN2;RNF130;ANAPC4;UBE2S;MVB12B;SYVN1;HERPUD1;SPOPL;FBXW5;SIAH2;ARRDC1;SPSB4;BTRC;CHFR;UBAP1L;ARIH1;NUB1;PPP1R11;ZFAND2A;SHARPIN;WDR81;PSME3;KCTD17;PSMC4;UBE2B;ZNRF3;KEAP1;IFI27;PSMB6;TBL1XR1;FBXL19;MVB12A;SIAH3;RAD23B;VPS37C;HECTD3;ANAPC15;UBR4;UCHL1;TRIM32;PSMB10
prerank,negative regulation of macrophage activation (GO:0043031),-0.4063588167812221,-1.0693398261925493,0.39753086419753086,0.8349634670949332,1.0,6/16,18.47%,IL31RA;LDLR;CX3CL1;SYT11;GRN;ZC3H12A
prerank,gluconeogenesis (GO:0006094),0.41994063807579285,1.0686391030443334,0.36314363143631434,0.9992566765220173,1.0,11/39,15.62%,ENO3;PFKFB1;MDH1;PPARGC1A;GOT1;GOT2;SLC39A14;ALDOA;CRTC2;SLC25A12;GAPDHS
prerank,translesion synthesis (GO:0019985),-0.3117537454083284,-1.0685112103579446,0.37404580152671757,0.8359152953819826,1.0,22/42,36.85%,UFD1;PARP10;TRIM25;POLDIP2;UBC;REV1;POLN;USP10;PRIMPOL;UBB;POLE2;ZBTB1;POLI;RPA3;RFC3;USP43;RPA2;POLD3;PCLAF;RPA1;RFC1;RFC4
prerank,histone lysine methylation (GO:0034968),0.4374401077889145,1.0684017443369562,0.3692528735632184,0.9988920582820102,1.0,8/33,14.13%,SMYD1;SETD6;SUV39H2;KMT2D;SETD3;PAXIP1;N6AMT1;WDR5B
prerank,microtubule nucleation (GO:0007020),0.4700413907954628,1.0680930606811228,0.4156050955414013,0.9987278342206671,1.0,4/19,6.89%,CLASP2;TUBGCP6;TPPP;TPX2
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.3970419440099557,1.0680460201064,0.3889570552147239,0.997785359792881,1.0,10/66,11.28%,FLNA;FERMT2;MCRS1;UBR5;TERT;YAP1;KAT7;BAG3;CCT3;PRKCD
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5141394586771936,1.067848779414004,0.4027072758037225,0.9972711517382841,1.0,2/12,3.45%,DOCK8;CCL5
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.43512912942183357,-1.0676701653681295,0.3844282238442822,0.8369848357065625,1.0,3/12,18.17%,PRKCB;NEK9;NEK6
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.40447039618258307,-1.0676700844449154,0.36683417085427134,0.8356172134259962,1.0,14/15,59.59%,CD55;PNP;SYK;CCR2;HSPH1;NKAP;SHH;IL12A;GLI3;IL23A;EBI3;IHH;IL12B;IL23R
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.429285164903275,-1.0668385939641265,0.38789237668161436,0.8366569874987636,1.0,4/13,9.76%,GLUL;ALDH4A1;NOS3;DDAH1
prerank,monocyte chemotaxis (GO:0002548),0.43853037390525196,1.066727420648217,0.37446808510638296,0.9994290382790856,1.0,5/32,10.49%,PDGFB;ANXA1;CCL5;TNFRSF11A;CCL14
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5310868129999713,1.0665948564902399,0.39664804469273746,0.9987263555184068,1.0,4/10,14.65%,SOX9;PDGFA;LRP5;STAT1
prerank,regulation of neuron death (GO:1901214),0.3828517709480458,1.0664734469504147,0.383054892601432,0.998001365596964,1.0,22/82,18.82%,MEF2C;MAP3K5;TRIM2;CCL5;INPP5A;CD200R1;MAPT;CD200;PPARGC1A;FAIM2;CHRNA7;CLU;SARM1;LRRK2;EPHB1;SNCG;DHCR24;VPS35;SNCB;LANCL1;EGR1;SIGMAR1
prerank,positive regulation of biosynthetic process (GO:0009891),0.4223927197075373,1.0664352747776316,0.38524590163934425,0.9970399629000305,1.0,9/40,8.79%,CD36;VIM;SLC5A3;CCL5;TGFB3;SORBS1;PPARA;SUCO;RUNX1
prerank,B cell activation (GO:0042113),0.3985597934609034,1.066232617694863,0.3790123456790123,0.9965085243250459,1.0,11/68,11.64%,MEF2C;CD79A;ITGB1;LAX1;HDAC9;BCL2;RASGRP1;ITGA4;ADAM17;TPD52;ZBTB7A
prerank,negative regulation of protein polymerization (GO:0032272),-0.3499949773196448,-1.0660643667859089,0.375,0.8375044303329141,1.0,10/27,14.18%,CDH5;SLIT2;KANK3;CYRIB;EML2;SSH2;PFN1;PFN2;SSH1;SNCA
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.29982753180747335,-1.0659326425304487,0.3247863247863248,0.8365408684434732,1.0,17/50,20.48%,ZIC1;PTCH1;GAS1;DCDC2;IFT122;MEGF8;TULP3;INTU;MGRN1;HERC4;FGFR2;EVC;GLIS2;TXNDC15;BTRC;GPC3;PDCL
prerank,stress granule assembly (GO:0034063),0.46559092071136293,1.065447859817527,0.40853658536585363,0.9977315006488896,1.0,10/20,20.48%,CSDE1;ATXN2;MAPT;CIRBP;YTHDF2;RPS23;G3BP1;PRRC2C;BICD1;EIF2S1
prerank,cellular component maintenance (GO:0043954),0.5163712877467526,1.0651770341982636,0.4083769633507853,0.9974524948769317,1.0,2/12,4.99%,ITGA3;LNPK
prerank,dermatan sulfate metabolic process (GO:0030205),-0.43400205577787165,-1.0650191638228694,0.37435897435897436,0.8379621550286405,1.0,3/13,1.17%,UST;DCN;DSE
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.37434049583550055,-1.0645504395937821,0.3780160857908847,0.8380702519007356,1.0,7/20,11.60%,IL18;LBP;IRAK1;PRKCE;PTPN22;TGFB1;LYN
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.44213405647465515,-1.0645186813582945,0.3925925925925926,0.8367975829079911,1.0,3/12,1.17%,UST;DCN;DSE
prerank,regulation of inflammatory response (GO:0050727),0.3598019127545631,1.0644557393128782,0.3617021276595745,0.9983855146473852,1.0,30/190,11.46%,AGTR1;NR1H4;MYD88;RORA;ANXA1;LPL;IL2;CCL5;FEM1A;PTGIS;ALOX5;MFHAS1;SETD6;PIK3AP1;CD200R1;TNFAIP6;CD200;CELF1;RELA;LPCAT3;TNIP1;PPARA;NR1D1;MGLL;AKNA;AOAH;GPSM3;GPER1;PRKCD;RB1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.40096269504316184,-1.0644254736179983,0.40441176470588236,0.8357334820906357,1.0,2/15,2.62%,CPEB2;DDX3X
prerank,visual perception (GO:0007601),-0.2711908802318269,-1.0642412329615745,0.33727810650887574,0.8349430923190617,1.0,12/84,9.66%,PITPNA;COL1A1;EYA4;ABLIM1;EFEMP1;ADGRV1;COL11A1;SLC4A10;ZIC2;CEP250;EML2;MYO9A
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.46463731041972134,1.0641486568739775,0.3842443729903537,0.9982119346980834,1.0,6/19,12.46%,ROCK1;RTN2;PIN1;RTN1;CHRNA7;CLU
prerank,rRNA pseudouridine synthesis (GO:0031118),0.5260935048758564,1.0640565543487213,0.4024604569420035,0.9973727354517572,1.0,3/10,13.79%,RPUSD3;NAF1;RPUSD4
prerank,muscle tissue development (GO:0060537),0.5130642439215011,1.0638036683784193,0.42407407407407405,0.9969919722843495,1.0,2/13,1.67%,CSRP1;CSRP3
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.402171711776671,-1.0632963222915075,0.3883495145631068,0.8363158809536603,1.0,10/14,28.87%,ADK;GMPS;ADSS2;PFAS;GART;ATIC;RFK;IMPDH1;IMPDH2;PAICS
prerank,amyloid fibril formation (GO:1990000),0.4030387070903977,1.063123084037919,0.36895674300254455,0.9978428497097298,1.0,6/51,7.75%,TTR;MFGE8;CD36;MAPT;CALB1;NAT8
prerank,cytoplasmic microtubule organization (GO:0031122),0.398229700318188,1.0628433596858409,0.37786259541984735,0.9975782782049296,1.0,6/54,6.20%,TRDN;HOOK2;DST;TUBGCP6;TPPP;MAPT
prerank,regulation of centrosome cycle (GO:0046605),0.48079691380595,1.0627085048523517,0.4037854889589905,0.9969110828938602,1.0,5/21,13.62%,CHMP4C;NAT10;CHMP5;CHMP2B;CHMP2A
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.44660984737676696,-1.0623461958957152,0.42042755344418054,0.8376672996405349,1.0,3/11,9.44%,SLC30A10;ABCB7;COA8
prerank,establishment of endothelial barrier (GO:0061028),-0.33318123331069543,-1.0622096486689419,0.3566666666666667,0.8367440638765616,1.0,7/29,8.39%,AFDN;TJP1;TJP2;PECAM1;RAPGEF1;RAP1B;RDX
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.32926734337279195,-1.0619247944823065,0.35668789808917195,0.8362087656015186,1.0,15/34,18.92%,FLT1;PIK3CA;SEMA6A;MAPK14;NRP1;GAS1;GAB1;ERN1;SPRY2;RAMP2;KDR;VEGFC;VEGFB;MT1G;ITGB1BP1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.47267422846177837,1.061855701048649,0.409967845659164,0.9983237779361837,1.0,4/18,7.13%,CRTC1;CRTC3;VEGFA;CD200
prerank,receptor signaling pathway via STAT (GO:0097696),-0.35834346577865317,-1.0617334384410368,0.3652173913043478,0.8354351881267295,1.0,10/25,18.98%,IL31RA;IFNAR2;GHR;PKD2;SOCS2;CTR9;STAT2;IFNAR1;STAT5A;STAT6
prerank,establishment of protein localization to membrane (GO:0090150),-0.2841845298736696,-1.0615230601376209,0.35,0.8347520634944414,1.0,13/66,13.56%,AFDN;EGFR;RAB11A;ZDHHC18;ATG3;SYNE3;ZDHHC15;SDCBP;SEC63;RAB3GAP2;FRMPD1;ZDHHC20;ZDHHC9
prerank,hemopoiesis (GO:0030097),-0.26743289313402435,-1.061436517747217,0.30201342281879195,0.8336898504481033,1.0,17/87,10.80%,TGFBR3;FLT1;MECOM;NOTCH2;KIT;BMP4;TEK;RUNX2;MFAP5;WNT5A;PGM3;CD34;TET2;FUT10;TGFB1;FGFR2;FLT3LG
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.36589142781214773,1.061325126735388,0.3762597984322508,0.9987516252292835,1.0,15/121,7.40%,NTF3;ANGPT1;ANGPT4;PDGFB;CRLF1;CSPG4;IL2;CCL5;ARHGEF2;DOK7;VEGFA;TP53;PTPN1;PIBF1;ITGB3
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.452761646008619,-1.0611897207784142,0.37888198757763975,0.8317618582939549,1.0,4/10,41.06%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.452761646008619,-1.0611897207784142,0.37888198757763975,0.8317618582939549,1.0,4/10,41.06%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,negative regulation of catabolic process (GO:0009895),0.40383811648054735,1.0608712239276525,0.3884514435695538,0.9989771229828276,1.0,6/47,9.73%,FLNA;PFKFB1;PIN1;SF3B3;PPARA;SIRT2
prerank,type I interferon signaling pathway (GO:0060337),-0.3161332638003074,-1.0600116575911855,0.3418181818181818,0.832644753400169,1.0,18/41,23.09%,IFNAR2;IRAK1;SAMHD1;IP6K2;STAT2;IRF9;SP100;IFIT1;IFIT3;ADAR;BST2;IFNAR1;OAS2;IFITM1;IFITM3;IFIT2;RNASEL;IFI27
prerank,cellular response to type I interferon (GO:0071357),-0.3161332638003074,-1.0600116575911855,0.3418181818181818,0.832644753400169,1.0,18/41,23.09%,IFNAR2;IRAK1;SAMHD1;IP6K2;STAT2;IRF9;SP100;IFIT1;IFIT3;ADAR;BST2;IFNAR1;OAS2;IFITM1;IFITM3;IFIT2;RNASEL;IFI27
prerank,potassium ion import across plasma membrane (GO:1990573),-0.3167801410953802,-1.059800158436772,0.3384615384615385,0.8319261750736663,1.0,6/41,10.00%,ATP1A2;ATP1B3;SLC12A2;SLC12A7;ATP1B2;KCNJ13
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.49985967624126604,1.0595841513939506,0.4072727272727273,1.0,1.0,4/13,14.28%,SOCS5;SOCS4;TSG101;CBLB
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4075156602753554,1.0594237101820143,0.39690721649484534,1.0,1.0,14/52,11.81%,ATP2B4;STAC;ITGA3;ITGB1;ARHGEF16;CNST;ZDHHC2;STAC3;SORBS1;KIF5B;EPHA2;GPER1;CLIP3;DPP10
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5031871022320143,1.0588720871081083,0.4083769633507853,1.0,1.0,5/12,16.92%,CGAS;CAV1;MUL1;FLOT1;DHX9
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3837090807416417,-1.0587737535978763,0.38337801608579086,0.8336090778018513,1.0,9/20,17.74%,MCU;LETM1;SPG7;MCUB;MAIP1;MICU2;STOML2;YME1L1;SLC8B1
prerank,iron ion transmembrane transport (GO:0034755),-0.4469565291372538,-1.0586268042136913,0.3700440528634361,0.8327045646591104,1.0,4/10,14.13%,SCARA5;ABCB7;SLC39A8;SLC25A28
prerank,photoreceptor cell development (GO:0042461),0.4976170741678636,1.0584047218742199,0.4176991150442478,1.0,1.0,3/14,6.54%,CDHR1;CEP290;VEGFA
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.4182253887903966,1.0583654446467199,0.3918918918918919,1.0,1.0,13/38,18.22%,NDUFS1;NDUFA2;NDUFA11;NDUFC1;NDUFB6;NDUFS3;NDUFB8;NDUFV2;NDUFS2;NDUFAB1;NDUFA1;NDUFAF1;NDUFV3
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.44017704170810823,-1.0583514727904435,0.3995584988962472,0.8321258474961067,1.0,4/11,9.45%,RNF185;UFD1;DERL1;UGGT2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.4926519665462952,1.0582050833104624,0.4023972602739726,1.0,1.0,2/14,3.05%,ANXA1;SOCS5
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.4515604726455667,1.0580962440069572,0.3975720789074355,0.9995036971056032,1.0,4/23,9.59%,CHMP4C;PABIR1;CHEK1;ZWINT
prerank,vesicle coating (GO:0006901),-0.2822400490387944,-1.0578853473197412,0.3617021276595745,0.8295207850841783,1.0,18/61,19.42%,TGFA;CUL3;KLHL12;USO1;SEC23IP;STX5;TMED10;SEC24B;MCFD2;ANKRD28;RAB1A;F8;PPP6R3;LMAN1;RAB1B;SCFD1;TRAPPC3;TFG
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.2822400490387944,-1.0578853473197412,0.3617021276595745,0.8295207850841783,1.0,18/61,19.42%,TGFA;CUL3;KLHL12;USO1;SEC23IP;STX5;TMED10;SEC24B;MCFD2;ANKRD28;RAB1A;F8;PPP6R3;LMAN1;RAB1B;SCFD1;TRAPPC3;TFG
prerank,COPII vesicle coating (GO:0048208),-0.2822400490387944,-1.0578853473197412,0.3617021276595745,0.8295207850841783,1.0,18/61,19.42%,TGFA;CUL3;KLHL12;USO1;SEC23IP;STX5;TMED10;SEC24B;MCFD2;ANKRD28;RAB1A;F8;PPP6R3;LMAN1;RAB1B;SCFD1;TRAPPC3;TFG
prerank,cell projection organization (GO:0030030),0.4432539307903184,1.0577456917827477,0.39739884393063585,0.9994133136359167,1.0,8/30,11.49%,PACSIN2;ITGB1;RHOJ;CYFIP1;PLEK;PARVA;PDGFA;RHOH
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.46347637430359984,-1.0574111778790964,0.4066666666666667,0.8295778532050527,1.0,4/10,19.35%,EMC2;EMC3;EMC8;MMGT1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.4412035212219314,-1.057304188289884,0.3952941176470588,0.8285544560389405,1.0,4/12,19.24%,CDC14B;RAB1A;UBE2S;BTRC
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.38486909161747207,-1.0569755029040258,0.4114713216957606,0.8281704441499683,1.0,4/17,11.42%,PTN;PTPRZ1;TGFB1;HES1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.35490677586833064,1.0567238631908111,0.3682572614107884,1.0,1.0,28/234,10.62%,MYOCD;ABRA;CD36;MYD88;ROR1;CRTC1;ARID5B;FZD4;CRTC3;ARHGEF2;MTDH;PRKCQ;TNFRSF11A;SMARCB1;TAF1;CAV1;VEGFA;CD200;AR;PPARGC1A;PPARGC1B;RELA;NFKBIB;TRIM68;RTKN2;TRAF5;EIF2AK2;NKX6-1
prerank,phospholipid translocation (GO:0045332),-0.336789151668916,-1.0565615796969081,0.3633633633633634,0.8280979279949103,1.0,8/28,8.20%,PLSCR4;ATP8A1;ABCA1;PLSCR2;ABCA4;ATP11C;ATP8A2;TMEM30A
prerank,regulation of cilium assembly (GO:1902017),-0.2896265173417306,-1.0564937435217807,0.3626373626373626,0.8270232887488769,1.0,31/62,25.76%,TBC1D16;LIMK2;TBC1D15;DCDC2;CEP97;ATG3;TBC1D2B;TBC1D13;TBC1D5;TBC1D8;IFT88;ATG5;RABEP2;TBC1D9B;TBC1D24;TBC1D30;TBC1D22A;DYNLT2B;SGSM3;ODF2L;TBC1D10A;SDCCAG8;TBC1D7;KCTD17;TBC1D14;CYLD;CROCC;TBC1D2;CCP110;BBS4;CDKL1
prerank,histone H4-K8 acetylation (GO:0043982),0.5022446839918012,1.0563400512153478,0.41694915254237286,1.0,1.0,6/15,12.36%,MCRS1;JADE1;KAT7;KANSL3;JADE3;KANSL1
prerank,histone H4-K5 acetylation (GO:0043981),0.5022446839918012,1.0563400512153478,0.41694915254237286,1.0,1.0,6/15,12.36%,MCRS1;JADE1;KAT7;KANSL3;JADE3;KANSL1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.3686647117706479,-1.0560823160954254,0.3888888888888889,0.8269163866526699,1.0,13/21,42.10%,EPHA7;BIRC2;DELE1;BIRC3;TTBK1;PSMB9;PYCARD;NGF;GRIN1;AIM2;FYN;GRIN2B;BEX3
prerank,release of cytochrome c from mitochondria (GO:0001836),0.473838301162757,1.0560607927553762,0.3973941368078176,1.0,1.0,8/17,18.18%,BCL2;FZD9;DNM1L;GGCT;BOK;CLU;BBC3;MFF
prerank,peptide cross-linking (GO:0018149),0.4561763982818275,1.0559958187503975,0.4046153846153846,0.9991725791344852,1.0,2/25,2.73%,FCGR3A;ANXA1
prerank,negative regulation of cell activation (GO:0050866),0.5009487381830835,1.0559559848251088,0.41318327974276525,0.998221714577426,1.0,7/14,11.01%,PDGFB;EMILIN1;CD200;C1QTNF1;NR1D1;PDGFA;GPER1
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.361426143065743,-1.0552549967093698,0.38439306358381503,0.8279943703338841,1.0,7/22,14.06%,SLIT2;KANK3;CYRIB;SSH2;PFN1;PFN2;SSH1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.3816398540485404,1.05513779537836,0.3799019607843137,0.9994231133061494,1.0,24/69,18.72%,COX7A2L;NDUFS1;NDUFA2;NDUFA11;SDHC;SDHAF2;COX8A;NDUFC1;NDUFB6;NDUFS3;COX7B;NDUFB8;NDUFV2;NDUFS2;SDHA;NDUFAB1;NDUFA1;UQCRFS1;NDUFAF1;UQCRH;COX6C;COX5B;NDUFV3;UQCRQ
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.34973408380015497,-1.055077435167003,0.4049586776859504,0.82724958595319,1.0,9/24,24.96%,NF1;EPHA7;NUPR1;CTNNB1;GRN;BAX;ATF4;FOXO3;CDK5R1
prerank,sensory perception of chemical stimulus (GO:0007606),0.4893790627071342,1.054672884049011,0.4169435215946844,0.9996941381640729,1.0,2/15,4.51%,CD36;SYT10
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.33432372461568927,-1.0544897425432833,0.3541666666666667,0.8276662622382129,1.0,12/30,24.71%,TUSC3;MGAT1;FUT8;UGGT2;OSTC;MCFD2;MGAT5;LMAN1;RPN2;MGAT2;DPM3;STT3B
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.39551020824212113,-1.0544396174414066,0.38308457711442784,0.8265662217033928,1.0,6/16,10.81%,ST8SIA4;ST3GAL5;ST6GALNAC3;ST8SIA1;B4GALT6;ST8SIA2
prerank,atrial septum morphogenesis (GO:0060413),0.5082156550990209,1.053927481964457,0.4272890484739677,1.0,1.0,2/10,7.78%,HEY2;TGFB2
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.48634159706636904,1.053841475337185,0.4230769230769231,0.9999619911042991,1.0,4/15,12.26%,ANXA1;HNRNPU;GPER1;ZFP36L1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.42572899341881654,-1.0534587991835127,0.4037122969837587,0.8280100552898144,1.0,3/12,5.69%,CYP26B1;PTCH1;MEGF8
prerank,positive regulation of cellular process (GO:0048522),0.3427658519927008,1.0530589369576742,0.36236236236236236,1.0,1.0,98/565,15.59%,NTF3;TPM1;RYR2;NTRK3;AKAP6;LIFR;ACTN4;ZFHX3;TBX2;FGF1;CD36;MERTK;S1PR3;MST1R;PDGFB;PPP3CA;PDGFC;CCND2;CRLF1;ADRA1D;THPO;IL2;CCL5;TGFB3;GCNT2;PABIR1;PDGFD;IL12RB2;TSHR;FXN;BCL2;OSR2;HAS2;IRS1;TNFRSF11A;TPPP;MAPT;CAV1;VEGFA;TIPIN;ACACB;GDNF;GAREM1;PA2G4;AREG;AR;CELF1;DICER1;CHEK1;TGFB2;SOX9;RELA;KMT2D;ADNP2;CCND1;TRPM4;MVD;ADAM17;PDGFRB;SIRT2;RTKN2;IL13RA1;CCL14;HBEGF;PDGFA;GPER1;LRP5;PRKCD;HTR2B;CNOT7;BMPR1B;ZFP36L1;CHRNA7;PDCD10;POU3F3;HDGFL2;KIF20B;CITED2;S1PR2;NSMCE4A;SHANK2;FGF10;CEP43;N6AMT1;GAS6;HYAL1;UFL1;PRKAA2;IRS2;EIF4G2;PRKCA;MLXIPL;SRPK2;PTEN;FBXO5;FLOT1;CIAO1;RHOG
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.41014297319774995,1.0530432846658837,0.4016393442622951,1.0,1.0,14/37,18.34%,PMAIP1;NACC2;BCL2;CAV1;TP53;SFPQ;DNM1L;EIF5A;BOK;S100A8;S100A9;BBC3;BCAP31;DDIT3
prerank,receptor clustering (GO:0043113),0.4415995989986849,1.0527286276135124,0.40428790199081166,0.9999408140397962,1.0,5/27,10.21%,FLNA;MUSK;SAV1;ITGA4;AGRN
prerank,anterior/posterior axis specification (GO:0009948),0.5008962347876937,1.052432703024647,0.41300813008130083,0.9997758041361775,1.0,2/15,9.27%,FZD5;SKI
prerank,organic anion transport (GO:0015711),-0.2733030711404929,-1.051998842239728,0.36585365853658536,0.8309349746698479,1.0,15/76,8.63%,ABCG2;SLC4A10;SLCO2B1;SLC26A7;SLCO1C1;SLC25A17;SLCO2A1;SLC52A1;CYB5R4;CA2;SLC39A8;SLC22A6;SLC4A2;SLCO3A1;ABCC4
prerank,response to progesterone (GO:0032570),0.47087258988803404,1.0519872630370468,0.42276422764227645,0.9999690869065971,1.0,4/18,7.78%,TGFB3;CAV1;YAP1;TGFB2
prerank,regulation of AMPA receptor activity (GO:2000311),0.45074313979724356,1.0517118863530233,0.4257871064467766,0.999755758896136,1.0,4/25,7.53%,MEF2C;SHISA9;CNIH2;GSG1L
prerank,post-translational protein modification (GO:0043687),0.34751737384838505,1.0515564304660412,0.37601626016260165,0.9991894735585323,1.0,53/332,12.65%,IGFBP7;MFGE8;LTBP1;SPARCL1;SDC2;ASB15;HRC;KCTD7;ASB10;CCN1;FBXO40;ASB18;FBXL22;SOCS5;IGFBP5;FEM1C;FEM1A;LMO7;ASB2;ASB1;CUL2;SOCS6;RNF7;NUCB1;ASB8;PSMC6;FBXW7;FBXO30;FBXL18;ELOC;IGFBP4;KTN1;LAMB2;LAMC1;UBE2F;RAB3A;CUL9;DCUN1D1;CDH2;HIF1A;PSME4;FBXO6;PSMB1;SUMF1;MBTPS1;PSMD5;FBXO32;COPS8;FBXW11;UBA3;DCAF11;WSB1;PSMB2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.35704828023385926,1.05137021258973,0.3919062832800852,0.9986529066284907,1.0,32/182,12.76%,CCDC3;MEF2C;ATP2B4;HEY2;PDGFB;PLA2G3;HINFP;RBMS3;HAVCR2;BMPR1A;EMILIN1;ATXN2;TERT;TAF1;MAPT;FBXW7;SLC2A10;VEGFA;YAP1;CELF1;DICER1;TGFB2;MAP2K1;RUNX1;HIF1A;ROCK2;GPER1;RB1;TERF2;CNOT7;PDCD10;CITED2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.5047029964102514,1.0512818663144796,0.4180887372013652,0.9978645914059384,1.0,8/12,20.51%,CDYL;LRIF1;HNRNPU;PCGF5;PCGF3;RBM15;RLIM;YTHDC1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.42001243840346064,1.0512595716266764,0.39645776566757496,0.996899376788104,1.0,6/40,7.34%,PMAIP1;BCL2;NDUFS1;MAPT;ARL6IP5;HEBP2
prerank,positive regulation of MAPK cascade (GO:0043410),0.34814435336895844,1.0509370028782863,0.39026915113871635,0.9968212239792742,1.0,38/245,12.59%,RAP1A;NTRK3;ANGPT1;ROCK1;FGF1;CD36;MST1R;PDGFB;PDGFC;ROR1;FERMT2;ADRA1D;THPO;CCL5;BCAR3;GCNT2;PDGFD;MFHAS1;KSR1;DAB2IP;FBXW7;ARL6IP5;VEGFA;GAREM1;RASGRP1;TGFB2;MAP2K1;PDGFRB;PELI2;EIF2AK2;CCL14;ROCK2;PDGFA;GPER1;HTR2B;CHRNA7;PDCD10;TAOK3
prerank,ESCRT complex disassembly (GO:1904896),0.52050292012881,1.0509093809195296,0.42028985507246375,0.9948600859085533,1.0,5/10,17.21%,CHMP5;IST1;CHMP2B;CHMP2A;VPS4A
prerank,ESCRT III complex disassembly (GO:1904903),0.52050292012881,1.0509093809195296,0.42028985507246375,0.9948600859085533,1.0,5/10,17.21%,CHMP5;IST1;CHMP2B;CHMP2A;VPS4A
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.28866302713401926,-1.0508677448477035,0.3706896551724138,0.8328626771806388,1.0,19/54,25.30%,CARM1;TFDP1;PML;ARID3A;MDM2;SOX4;RGCC;EP300;PLK2;CRADD;CNOT11;BAX;CHEK2;E2F4;ATM;PCBP4;PLAGL1;CDKN1A;CNOT10
prerank,regulation of steroid biosynthetic process (GO:0050810),0.5135193884513992,1.0507721618958352,0.41459074733096085,0.9942244125739382,1.0,1/11,1.24%,NR1H4
prerank,collagen fibril organization (GO:0030199),0.37837780677971733,1.0505620873543307,0.4140715109573241,0.9938262280401233,1.0,19/88,12.48%,COL18A1;COL4A1;COL4A2;ADAMTS14;P3H2;LOXL2;CRTAP;COL4A6;DST;PXDN;COL27A1;TGFB2;COL4A5;P4HA2;COL6A3;COL19A1;COL3A1;COL8A1;COL14A1
prerank,cardiac ventricle development (GO:0003231),0.47070448272652304,1.0504565053638582,0.40476190476190477,0.9930947674465219,1.0,2/20,3.07%,HEY2;HEYL
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.39634804851988087,-1.0503346070615383,0.4025,0.8330285087532432,1.0,7/17,20.92%,ARRB1;OTUD7B;MAPKBP1;PTPN22;ANXA4;SSC5D;BCL3
prerank,activation of phospholipase C activity (GO:0007202),0.43990799908937345,1.0502286122640105,0.4030261348005502,0.9927164694525009,1.0,2/29,4.80%,EDNRA;ARHGAP6
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.495176135571973,1.0501928444317485,0.400679117147708,0.991796449975156,1.0,4/13,11.86%,LARGE1;CHST5;CHST3;CHST1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.3168835491602662,-1.049963021476501,0.3498233215547703,0.8328187728963347,1.0,13/37,19.19%,GRM3;APP;GRM7;PTK2B;HOMER3;GRIN3A;DAGLA;GRIK3;GRM5;CLN3;GRID2;FMR1;GRIK1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.49325382889847524,1.0498806380472876,0.4194690265486726,0.991621599326171,1.0,4/15,11.53%,FST;ACVR2A;SKI;ACVR1B
prerank,positive regulation of hemostasis (GO:1900048),-0.44858469182187094,-1.049862390263969,0.4080717488789238,0.8305549087405095,1.0,3/10,19.21%,ST3GAL4;SERPINE1;ENPP4
prerank,positive regulation of coagulation (GO:0050820),-0.44858469182187094,-1.049862390263969,0.4080717488789238,0.8305549087405095,1.0,3/10,19.21%,ST3GAL4;SERPINE1;ENPP4
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.3635094641779285,-1.0492728792895234,0.38997214484679665,0.8310322832850902,1.0,12/22,29.59%,URB1;ERI3;EXOSC9;RPS21;FTSJ3;NOP9;EXOSC2;UTP20;EXOSC3;EXOSC7;PES1;RRS1
prerank,toxin transport (GO:1901998),-0.4545654744135204,-1.0489857323294438,0.4192139737991266,0.8305557528953518,1.0,7/10,45.77%,ADAM10;RAB29;RAB40B;SLC22A2;ANTXR2;SLC22A3;SLC29A4
prerank,regulation of biomineral tissue development (GO:0070167),0.4414244102913664,1.0488406454147048,0.42752562225475843,0.9934603911114228,1.0,7/26,16.18%,HEY2;ROCK1;SOX9;ROCK2;GAS6;FBXO5;ANKH
prerank,negative regulation of metabolic process (GO:0009892),0.39590678119007144,1.0484424397262757,0.40850515463917525,0.9935086084468036,1.0,7/54,9.11%,CCDC3;ADAMTS5;PLCL1;LNPEP;ADAM17;GSTP1;NR1D1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.3605415549908901,-1.0483679770516587,0.407514450867052,0.8309444107361614,1.0,10/27,17.51%,ANAPC1;UBE2D3;UBE2E3;CDC23;UBE2E2;PRKN;UBE2H;CDC26;ANAPC4;UBE2S
prerank,macrophage activation involved in immune response (GO:0002281),0.493533768263796,1.0483131856455317,0.4275618374558304,0.9928504188672548,1.0,2/13,2.48%,FER1L5;DYSF
prerank,peptide metabolic process (GO:0006518),0.37825666724745255,1.0480670076971172,0.42576687116564416,0.992480303319701,1.0,12/75,12.15%,DMD;CLN5;ETHE1;LNPEP;APEH;GSTT1;ENPEP;NAT8;GSTP1;MIPEP;OPLAH;GSTA4
prerank,negative regulation of binding (GO:0051100),0.3740407149649295,1.047964659432034,0.4075382803297998,0.9917599091486776,1.0,15/81,14.32%,PLN;XIRP1;ROCK1;PDGFB;ACTB;CAV1;PIN1;PPP1CA;PSME3IP1;PEX19;PRKCD;BAG2;LRRK2;CSNK1E;DVL1
prerank,histone H4-K16 acetylation (GO:0043984),0.4765649155287638,1.0479414965290377,0.4326923076923077,0.9908137418474714,1.0,8/19,15.21%,MCRS1;JADE1;MSL3;KAT7;KANSL3;JADE3;KANSL1;MSL1
prerank,transcription by RNA polymerase I (GO:0006360),0.42265710961016006,1.047766216597781,0.3948439620081411,0.9902992202173047,1.0,7/34,12.02%,CAVIN1;POLR2L;GTF2H4;TAF1;POLR1E;CDK7;POLR1H
prerank,mitotic sister chromatid segregation (GO:0000070),0.3720153654032409,1.0477501301102772,0.425629290617849,0.9893368555864107,1.0,24/98,17.49%,TTN;CHMP4C;NUP62;SET;NCAPD3;CHMP5;PIBF1;DIS3L2;TENT4A;ZWINT;CENPE;WRAP73;RB1;NCAPD2;CHMP2B;CHMP2A;KIF18A;KNSTRN;TEX14;INO80;RAD21;DSN1;VPS4A;CENPK
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.5011689045259765,1.047678846129473,0.423407917383821,0.9885274721391268,1.0,5/13,15.14%,SLC8A2;SHISA9;RAB3A;PPFIA3;SHISA6
prerank,positive regulation of protein phosphorylation (GO:0001934),0.342133875959746,1.0475209529502019,0.3911290322580645,0.9879618773780952,1.0,59/348,13.94%,NTF3;RBPMS;RAP1A;NTRK3;ATP2B4;ANGPT1;FGF1;ANGPT4;PDGFB;CCN1;PDGFC;CCND2;CSPG4;FAM20A;THPO;BCAR3;TGFB3;MMD;PDGFD;ACVR2A;MUSK;CAMKK2;ARHGEF2;BMPR1A;RARRES2;RAP2C;CAV1;VEGFA;TP53;PIN1;LCP2;CALM1;ITGB3;RASGRP1;TGFB2;SOX9;CCND1;ADAM17;PAK2;RAP2A;GDF1;CENPE;PELI2;ROCK2;PDGFA;GPER1;CLIP3;TNIK;AKTIP;CHRNA7;SNX9;PDCD10;S1PR2;FNIP2;FGF10;MAP2K3;LRRK2;GAS6;MAPK1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.42366603792339785,-1.047180772966985,0.41723356009070295,0.8331225408557434,1.0,6/11,16.25%,SEMA6A;EPN1;PIK3CB;ADAMTS9;KLF2;CREB3L1
prerank,positive regulation of axon extension (GO:0045773),0.46078436966169034,1.0469541018971809,0.4233128834355828,0.9885809021091381,1.0,5/22,6.54%,SEMA5A;NTN1;DSCAM;MAPT;VEGFA
prerank,tRNA export from nucleus (GO:0006409),0.43649105452223136,1.0463662213952332,0.43081312410841655,0.9882218501058383,1.0,13/32,20.82%,NOL6;NUP62;SEC13;NUP153;NUP107;AAAS;NUP37;NUP98;NUP210;NUP54;NUP160;NUP133;TPR
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.43649105452223136,1.0463662213952332,0.43081312410841655,0.9882218501058383,1.0,13/32,20.82%,NOL6;NUP62;SEC13;NUP153;NUP107;AAAS;NUP37;NUP98;NUP210;NUP54;NUP160;NUP133;TPR
prerank,regulation of epidermal cell differentiation (GO:0045604),0.46502293375052955,1.0463047138591934,0.4113263785394933,0.9874167426179653,1.0,6/21,12.26%,ROCK1;CBFB;KLF7;RUNX1;ROCK2;ZFP36L1
prerank,T cell activation involved in immune response (GO:0002286),0.5107451646465351,1.0462947163697658,0.4120603015075377,0.9864501649611872,1.0,1/12,3.09%,LCP1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.39078562449494997,-1.0462389454899796,0.38686131386861317,0.8347117032560188,1.0,5/16,12.74%,DDX5;SRSF6;CELF4;HNRNPM;DDX17
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4563008627026663,1.0455436075196545,0.4171974522292994,0.9875082419818002,1.0,2/21,6.30%,ATP2A1;AFG3L2
prerank,chemical synaptic transmission (GO:0007268),0.34424136269985445,1.0454450613488346,0.4099895941727367,0.9868033826181665,1.0,44/284,12.68%,CACNB2;STXBP2;HCRTR1;APBA1;HTR1B;DTNA;GABRE;KCNMB1;GRIN2C;SLC6A5;SLC6A2;CACNB4;SYT10;CAMKK2;GABARAP;PCDHB14;STAC3;RPS6KA2;GABRA4;RAB3A;CALM1;GABRA5;MBP;PCDHB11;PRKACB;PRKAR1B;GRIK5;RAPSN;LIN7C;BRSK1;RIMBP2;GABRB2;HRH3;GABRG1;FCHSD2;CBLN2;KCNK3;HTR2B;CACNA1B;GABRB3;KIF5A;CHRNA7;CHRFAM7A;HOMER1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.27401307753046583,-1.0453281193181432,0.35106382978723405,0.8360159510997,1.0,27/72,25.30%,CARM1;TFDP1;ACER2;PML;ARID3A;MDM2;SP100;SOX4;RGCC;NBN;EP300;MYO6;PLK2;CRADD;CNOT11;BAX;CHEK2;E2F4;ATM;USP10;BCL3;PCBP4;PLAGL1;CDKN1A;SESN2;TFAP4;CNOT10
prerank,negative regulation of cell growth (GO:0030308),0.3679960522831537,1.0452162749098204,0.4136413641364136,0.9864177486925593,1.0,20/121,12.35%,SLIT3;FGF13;MYL2;RERG;FHL1;JADE1;PTPRS;NDRG3;TP53;BTG1;TGFB2;NDUFS3;SERTAD2;CRLF3;SH3BP4;RB1;TCHP;ACVR1B;DCBLD2;BCL6
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4454463378538215,1.0451838829448024,0.41389728096676737,0.9855225026458131,1.0,6/24,12.26%,ROCK1;CBFB;MED1;RUNX1;ROCK2;ZFP36L1
prerank,inorganic anion transmembrane transport (GO:0098661),0.38858715489318557,1.0451463189839796,0.42038216560509556,0.9846272066492985,1.0,11/63,10.05%,ANO1;GABRE;ANO6;SLC4A8;SLC20A2;GABRA4;GABRA5;GABRB2;XPR1;GABRG1;ANO3
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.441545394713791,-1.0450393804481946,0.4214123006833713,0.8356381601543521,1.0,6/10,30.40%,PTPN22;PDCD4;AIDA;HIPK3;MAPK8IP1;DUSP19
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.24354375813286655,-1.0447926030841532,0.39473684210526316,0.8350175971405179,1.0,34/132,16.65%,IGF1;ZBTB20;DAPK1;DCN;HMGB1;APP;APOE;NRDC;ITCH;TPCN1;FOXO1;ABHD5;PRR5L;PIK3CB;TFEB;FURIN;OPTN;RDX;STK11;ENTPD5;TRIM5;IRGM;GTPBP1;TRIM14;PTTG1IP;DTX3L;PFKFB2;INSR;SNCA;TMEM59;ARNT;PLK2;PRXL2C;MID2
prerank,negative regulation of receptor internalization (GO:0002091),-0.42463624020840063,-1.0444937239632228,0.41089108910891087,0.8346442124791166,1.0,4/12,15.97%,RIN3;ANKRD13A;SDCBP;UBQLN2
prerank,positive regulation of dendritic spine development (GO:0060999),-0.36617720346488986,-1.04435371447921,0.4198250728862974,0.8337609242523929,1.0,7/20,19.17%,APOE;NLGN1;SHANK3;CAMK1;LRP8;DBN1;FMR1
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3738315431156298,-1.0436968333197787,0.39948453608247425,0.8342984572704798,1.0,9/18,27.61%,NGLY1;SAMHD1;ADAMTS9;FBXO17;BPGM;NAGA;STT3B;DERA;FBXO44
prerank,midbody abscission (GO:0061952),0.4705174509900442,1.0436726705436767,0.40901771336553944,0.9876336068755776,1.0,5/17,17.21%,CHMP4C;CHMP5;CHMP2B;CHMP2A;VPS4A
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.43844438868506136,1.0433535068831923,0.3976945244956772,0.987521055871863,1.0,4/27,8.69%,WTIP;LIMD1;TP53;MAP2K1
prerank,negative regulation of blood pressure (GO:0045776),-0.42550845604659193,-1.0433307556495561,0.4125,0.8340982472010402,1.0,4/13,21.17%,BMPR2;NOS3;SCPEP1;DRD2
prerank,lipid translocation (GO:0034204),-0.36465710379394367,-1.0432279468138346,0.39945652173913043,0.8331109798652501,1.0,7/21,8.20%,ATP8A1;ABCA1;ABCA4;ATP11C;ATP8A2;RFT1;TMEM30A
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3405286840152391,1.0430226624147418,0.3891675025075226,0.9874013757314427,1.0,50/476,10.54%,ACTA2;MYOCD;PRDM16;TNNI2;MEF2C;HEY2;ZFHX3;MAP3K5;NR1H4;SMARCD3;LBH;PDGFB;RORA;ETS2;FZD4;HINFP;TGFB3;NUP62;NR2F2;TGFB1I1;ARID1A;CAMKK2;OSR2;CEP290;DYRK1A;TESC;PPM1A;TP53;DYRK1B;YAP1;AR;MED1;PPARGC1A;MED12;SOX9;RELA;SETD3;PLCB1;ZXDC;PPARA;MAP2K1;RUNX1;NSD3;NR1D1;HIF1A;SFR1;CRLF3;MED14;TEAD1;NAT14
prerank,regulation of protein processing (GO:0070613),0.45163475569712724,1.043015168252317,0.4367469879518072,0.9864379852402434,1.0,5/21,13.77%,ANGPTL8;SERPINE2;RUNX1;BAG2;LRRK2
prerank,fatty acid beta-oxidation (GO:0006635),0.38770187131538003,1.0414278721616512,0.4269081500646831,0.9898104018241874,1.0,12/51,10.29%,HSD17B10;PEX2;HSD17B4;ACAD11;MECR;CRAT;ETFA;ABCD4;ACADS;ACAD10;HADHB;SCP2
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.3713286298778903,-1.0412685534964488,0.39617486338797814,0.837598738472625,1.0,8/19,24.71%,TPST1;BPNT2;SLC26A2;ENPP1;PAPSS1;SLC35B3;PAPSS2;BPNT1
prerank,regulation of neurotransmitter transport (GO:0051588),0.48217439051770755,1.0411512917660017,0.4226475279106858,0.9895439912847956,1.0,1/16,0.72%,MEF2C
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3959836358955671,1.041004363264253,0.42412451361867703,0.9889732184412499,1.0,1/54,0.09%,CCDC3
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.40972262664865156,-1.0408074750734042,0.42280285035629456,0.8377005758208778,1.0,4/13,9.51%,BMP7;BMP4;NR3C1;ESR1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.3366881683190542,-1.0407426804949929,0.37110481586402266,0.8366529761839081,1.0,3/26,1.39%,EYA2;EYA1;EYA4
prerank,mitotic cell cycle phase transition (GO:0044772),0.3449825311433731,1.0407135141197668,0.4065469904963041,0.9888234197786954,1.0,54/203,19.14%,PPP1R12A;PPP1R12B;DYNLL1;CCNA2;CDK6;FBXL22;CLASP2;CCND2;HINFP;CEP41;EIF4EBP1;HAUS8;CUL2;CEP290;ENSA;PLCB1;CCND1;PPP1CB;BRSK1;CDK7;CEP192;CRLF3;GSPT1;DYNC1I2;RB1;ACVR1B;FBXW11;NEDD1;CEP72;ARPP19;CLASP1;DCTN3;CHMP2A;CEP43;CSNK1E;HAUS7;HAUS2;CCNJL;EIF4E;PRKACA;DNM2;PLK4;CDK14;CCNF;DCTN1;MASTL;CUL5;BRSK2;MNAT1;CACUL1;HAUS4;PPP2R2D;CEP135;ACVR1
prerank,negative regulation of autophagy (GO:0010507),-0.28603222711650206,-1.0405792779350471,0.35294117647058826,0.8358317013916788,1.0,20/54,22.84%,LEPR;PIK3CA;NUPR1;FOXK2;SMG1;NRBP2;DAP;PTPN22;RASIP1;TAB2;KLHL22;EIF4G3;DAPL1;SNCA;AKT1;ZKSCAN3;QSOX1;TLK2;TBC1D14;LZTS1
prerank,negative regulation of cell adhesion (GO:0007162),0.38073535611760023,1.0403125969477784,0.4095354523227384,0.9889727229117625,1.0,13/72,6.93%,ANGPT1;PLXND1;SEMA5A;PLXNB1;CDH13;JAG1;FZD4;GCNT2;JAM3;ARHGDIG;CBLL1;DSCAM;SNAI2
prerank,regulation of intracellular signal transduction (GO:1902531),0.34166388501828077,1.039870895212445,0.3850806451612903,0.9892349254450359,1.0,82/420,14.33%,OBSCN;ARHGEF7;NTRK3;AKAP6;DLC1;FGF1;KALRN;PRKAB2;DYRK2;LBH;ABR;PIP5K1B;ARHGEF17;PIP4K2A;FAM83D;MYO9B;DEPDC1B;ITSN1;BRIP1;NET1;PRDM1;ARHGAP21;ARHGAP10;USP2;ARHGEF16;CHN1;ARHGAP6;ARHGDIG;ARHGEF2;TAF1;MAPT;DAB2IP;CASTOR1;VEGFA;RRAS;TP53;RHOJ;PIN1;TPX2;TRAF3;RAD9A;NUAK1;CHEK1;ANKRD54;RELA;ARHGAP17;PEX5L;RHOF;PRKAR1B;GNA12;ARHGAP39;ARHGAP30;ARHGEF4;PAK2;ARHGAP1;RRAGB;RPL5;ARHGAP12;TRAF5;ARHGAP15;VAV1;PRR5;RHNO1;INPP5B;ARHGAP5;RHOH;ARHGAP35;ZFAND6;RICTOR;ARHGAP32;TNIK;BCR;TAOK3;TPTE;RMI2;CHD4;ARHGAP24;LRRK2;SGK1;MAPK1;TMSB4X;CASTOR2
prerank,regulation of anoikis (GO:2000209),0.4649321824991066,1.0398538639127137,0.41930379746835444,0.9883074080926741,1.0,6/19,6.93%,PDK4;ITGB1;BCL2;MYBBP1A;CAV1;SNAI2
prerank,global genome nucleotide-excision repair (GO:0070911),-0.3483206960037927,-1.039583518517901,0.40294117647058825,0.8374801667779136,1.0,13/26,24.87%,USP45;UBC;DDB1;CHD1L;XPA;GTF2H2;GTF2H5;GTF2H3;UBB;ERCC2;ERCC1;ERCC4;RAD23B
prerank,protein localization to kinetochore (GO:0034501),-0.4049823284539702,-1.0393401468878447,0.4028103044496487,0.836926112123141,1.0,8/14,41.46%,IK;RCC2;BUB3;ZWILCH;KNL1;TTK;CENPT;SPDL1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.43534312085635396,1.0392003548047535,0.43026706231454004,0.9890699222877836,1.0,6/32,6.85%,PMAIP1;DYRK2;MYBBP1A;TP53;PHLDA3;RPS27L
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.30757572166724556,-1.039192555566373,0.37109375,0.8361028746321945,1.0,13/38,18.33%,DDX3X;TNFSF10;CASP8;BCL2L1;MADD;STX4;NOS3;RNF34;SP100;FAIM;GPX1;SERPINE1;TMBIM1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.34938881245970127,1.0391299475380948,0.40170031880977686,0.9882900284713869,1.0,35/172,15.75%,DGKB;DGKG;PIP5K1B;INPP4B;PIP4K2A;MTMR7;SLC44A5;PITPNM3;STARD7;SYNJ2;SACM1L;SLC44A1;LPCAT3;AGPAT3;INPPL1;DGKD;MTMR14;PCYT2;TAMM41;GPD1L;CDIPT;SBF1;PIK3C3;CPNE3;PNPLA3;DGKZ;PLA2G4A;CHKB;RAB14;PLEKHA1;PLA2G4C;INPP5J;PTEN;PITPNM2;VAC14
prerank,histone H3-K4 methylation (GO:0051568),-0.34424955239009153,-1.0390593987950731,0.39090909090909093,0.8352422025718677,1.0,13/26,30.64%,TET3;CTR9;TET2;OGT;KMT2C;DPY30;SETD1A;KDM6A;PRDM9;CXXC1;KMT2A;RBBP5;BEND3
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4545610142162931,1.0387198675647715,0.4171779141104294,0.9884145709909644,1.0,3/22,6.91%,ROCK1;PACSIN3;TIMP4
prerank,epithelial cell differentiation (GO:0030855),0.3698200847103892,1.0385985850685076,0.40993071593533487,0.9877658513288282,1.0,9/88,8.87%,TAGLN;ANXA1;JAG1;TAGLN2;DMBT1;VEGFA;CNN3;CBR1;VDAC1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.4402753902343206,-1.0385704733263457,0.4178082191780822,0.8353966646446244,1.0,3/10,19.83%,LBP;PTPN22;TIRAP
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.34501033126554614,-1.038375029693325,0.4084084084084084,0.8346761144908792,1.0,10/23,22.96%,NUPR1;CRY1;HDAC4;SIK1;EP300;C1QTNF3;GIT1;CBFA2T3;PGP;CLK2
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4813902692469469,1.0383585521190168,0.4276315789473684,0.9874414692491836,1.0,4/15,11.86%,LARGE1;CHST5;CHST3;CHST1
prerank,regulation of type I interferon production (GO:0032479),-0.2678162003936921,-1.0383092987204947,0.38405797101449274,0.8336435861672162,1.0,42/84,28.21%,ITCH;PRKDC;XRCC5;RNF135;MRE11;IRAK1;ILRUN;POLR3F;UFD1;CTNNB1;PCBP2;PTPN22;TRIM25;POLR3B;XRCC6;POLR3A;RNF125;EP300;NLRP4;POLR3H;TRIM56;NLRC5;UBA7;POLR3E;STAT6;POLR2K;TIRAP;POLR2F;POLR2H;POLR3GL;NLRX1;POLR3C;CYLD;TRIM21;DDX41;TRIM32;POLR3D;POLR2E;NFKB2;GPATCH3;PQBP1;IKBKE
prerank,T cell proliferation (GO:0042098),0.507144279693714,1.0380664922070229,0.4156521739130435,0.9872999473975084,1.0,4/13,13.27%,DOCK8;RASGRP1;LMBR1L;PPP3CB
prerank,regulation of mitotic spindle assembly (GO:1901673),0.47250063729985037,1.0375416450273323,0.4278996865203762,0.9878098881238018,1.0,5/19,13.62%,CHMP4C;CHMP5;HNRNPU;CHMP2B;CHMP2A
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.43028230846343746,-1.037308265833488,0.3874709976798144,0.8353334451293609,1.0,3/12,5.61%,NOTCH2;DOCK11;PTK2B
prerank,negative regulation of MAPK cascade (GO:0043409),-0.2613733461753976,-1.0367928189217874,0.37267080745341613,0.8355969945109976,1.0,25/87,22.92%,NF1;FBLN1;SEMA6A;BMP7;DLG1;BMP4;APOE;SPRED2;FOXO1;STK38;PIK3CB;IRAK3;LYN;SPRY2;SIRPA;IGBP1;DUSP1;LMO3;SMAD4;ITGB1BP1;QARS1;PTPN2;PEBP1;EPHB2;DUSP7
prerank,positive regulation of cell population proliferation (GO:0008284),0.3404353468047351,1.0364416144478015,0.43705941591137965,0.9898533491084369,1.0,67/423,12.80%,NTF3;MEF2C;NTRK3;RBPMS2;LIFR;TBX2;FGF1;S1PR3;MST1R;PDGFB;CCN1;CDK6;PDGFC;CCND2;CDH13;CRLF1;ADRA1D;THPO;IL2;CCL5;TGFB3;GCNT2;PDGFD;IL12RB2;TSHR;FXN;BCL2;OSR2;BMPR1A;HAS2;IRS1;TNFRSF11A;TERT;VEGFA;TIPIN;LAMC1;GDNF;YAP1;GAREM1;AREG;AR;FZD9;TGFB2;SOX9;RELA;KMT2D;SAAL1;TRPM4;MVD;ADAM17;PDGFRB;RTKN2;IL13RA1;HNRNPU;CCL14;S100A6;HBEGF;PDGFA;GPER1;LRP5;HTR2B;CNOT7;CHRNA7;PDCD10;POU3F3;KIF20B;S1PR2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.38042385243866667,-1.0361094246346945,0.42216358839050133,0.8362721475685445,1.0,10/17,27.44%,CD44;MDM2;PRKN;RNF34;PTTG1IP;KDM1A;ARMC10;YJU2;TWIST1;SNAI1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.48251015863985347,1.0360398207797568,0.44020797227036396,0.9899584477926529,1.0,6/13,18.75%,GLRX5;ISCA1;ISCA2;GLRX3;CIAO1;NFU1
prerank,protein heterooligomerization (GO:0051291),-0.39507612411780535,-1.0359918747288992,0.42408376963350786,0.8353394097791251,1.0,4/17,13.94%,PKD2;KCNC2;FARSB;TMEM120A
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.4109235005991076,-1.0358296531039846,0.4206730769230769,0.8345670147544866,1.0,9/13,30.79%,SART3;PRPF19;LSM2;AAR2;PRPF31;PRPF8;SRSF12;PRPF3;DDX20
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.42875172891868185,-1.0357557802914792,0.43358395989974935,0.8335300040602454,1.0,3/12,14.97%,PTK2;LYN;BST2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4881463508290965,1.0356836433734236,0.4392220421393841,0.9899342092367451,1.0,4/16,15.00%,ACP3;SLC39A14;GPER1;PRKCA
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.36816832739897376,1.035557816114908,0.4129651860744298,0.9893236347389792,1.0,17/86,13.29%,NTF3;ANGPT1;ANGPT4;PDGFB;CSPG4;ARHGEF2;RAP2C;VEGFA;TP53;ITGB3;PAK2;SAMSN1;PDGFA;PRKCD;CNOT7;DMTN;FGF10
prerank,response to retinoic acid (GO:0032526),-0.2791274273621031,-1.0353143683311667,0.3910891089108911,0.8336490630271056,1.0,18/59,18.99%,PTK7;WNT5A;RBP4;EPHA3;ACER2;PTK2B;CTSH;WNT9A;ABL2;SETX;SNW1;CREB1;LYN;RARA;WNT6;TRIM16;RORB;ATM
prerank,endochondral bone morphogenesis (GO:0060350),0.5090396342585717,1.0348368453529577,0.42680776014109345,0.9902752123357348,1.0,3/11,12.26%,MEF2C;INPPL1;BMPR1B
prerank,cellular amino acid catabolic process (GO:0009063),0.37315546852293696,1.034505224371766,0.4346820809248555,0.9901760048558362,1.0,15/87,11.14%,BCAT2;MCCC2;HSD17B10;CARNS1;HIBADH;HGD;BLMH;DLD;KMO;DLST;GOT1;GOT2;SARDH;GLS;GLS2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.49152627452908254,1.0340990843313382,0.43137254901960786,0.9903144548089855,1.0,3/12,13.27%,ANO1;TRPM4;PPP3CB
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.35628978088170415,-1.0336210021719527,0.41040462427745666,0.8373412802891437,1.0,8/23,19.83%,SLIT2;CAMK1D;MCU;MOSPD2;RIPOR2;DPP4;NCKAP1L;TIRAP
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.313800028786704,-1.032917348583268,0.4057971014492754,0.8380335588499391,1.0,19/36,31.36%,SGMS1;DEPTOR;MADD;ASAH2;TGFBR1;MAZ;CX3CL1;CRADD;BCL2L12;QARS1;TRIM39;TMBIM6;CYLD;CSNK2A1;CSNK2A2;STYXL1;PPIA;TRAF1;TPD52L1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.3687729987397538,-1.0327710739280966,0.41131105398457585,0.8372339455412846,1.0,15/18,50.72%,OFD1;CCDC39;SPEF2;NEK10;CFAP53;ROPN1L;ADCY10;SPAG17;AQP4;SPA17;DNAAF2;ODAD4;CCDC40;NPHP3;DNAAF4
prerank,regulation of protein modification process (GO:0031399),-0.28873148726193193,-1.03266423948036,0.3884297520661157,0.8363245612254422,1.0,12/50,15.83%,CDH5;FN1;SPRED2;PTK2;PPP2CA;ASPSCR1;PML;IGF2;STAT2;LYN;GRM5;NOP53
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5214118390508214,1.0325512857722654,0.4486486486486487,0.9935348476974406,1.0,3/10,15.26%,SETD6;SETD3;EEF1AKMT2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.4340422964883702,1.0324427354956738,0.4398826979472141,0.9928689773988671,1.0,4/26,8.66%,CD36;SLC5A3;ALOX5;PPARA
prerank,positive regulation of embryonic development (GO:0040019),-0.3737476848093889,-1.0319634756371112,0.4005102040816326,0.8370068263273788,1.0,4/19,12.95%,NIBAN2;WNT4;OSR1;ZBED3
prerank,regulation of dendrite development (GO:0050773),-0.31298648681411373,-1.031291851604983,0.3890784982935154,0.8377853370909463,1.0,9/37,9.72%,PTN;COBL;NEDD4L;BMP7;ADGRB3;CAMK1D;ZDHHC15;SEMA4D;ALK
prerank,negative regulation of defense response (GO:0031348),0.3713466540651128,1.0308748618782688,0.4292565947242206,0.9961514543020896,1.0,15/77,11.46%,NR1H4;RORA;FEM1A;PTGIS;ALOX5;MFHAS1;TNFAIP6;LPCAT3;PPARA;NR1D1;SIRT2;AOAH;GPER1;PRKCD;RB1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.44680702386751364,1.0306686732877839,0.4222560975609756,0.995738791104456,1.0,4/21,5.12%,HTR1B;PDGFB;IGFBP5;BMPR1A
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.356342493990242,1.0306426908828332,0.4295377677564825,0.99483283116047,1.0,12/110,9.75%,LHCGR;PTGER3;ADCY5;S1PR3;ADCY2;ADRA1D;ADCY9;TSHR;RAMP1;PTH1R;ADCY6;ADGRL2
prerank,positive regulation of neuron differentiation (GO:0045666),0.40961038003945405,1.0301167158081987,0.43411927877947293,0.9953299031382469,1.0,6/40,10.63%,MEF2C;HEYL;MMD;ARHGEF2;IMPACT;BRINP1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.3435464598146553,1.0297645802460074,0.43160127253446445,0.995305175284937,1.0,34/224,12.68%,CACNB2;HCRTR1;APBA1;HTR1B;DTNA;GABRE;KCNMB1;SLC6A5;SLC6A2;CACNB4;SYT10;CAMKK2;GABARAP;PCDHB14;RPS6KA2;GABRA4;CALM1;GABRA5;MBP;PCDHB11;PRKACB;PRKAR1B;RAPSN;GABRB2;HRH3;GABRG1;KCNK3;HTR2B;CACNA1B;GABRB3;KIF5A;CHRNA7;CHRFAM7A;HOMER1
prerank,negative regulation of chemokine production (GO:0032682),-0.39660976171534273,-1.029302348355465,0.4322429906542056,0.8421751869399352,1.0,4/14,14.96%,LGALS9;APOD;SIRPA;C1QTNF3
prerank,bile acid biosynthetic process (GO:0006699),0.4328214669261681,1.0292605095345582,0.4244712990936556,0.995674089389371,1.0,5/24,11.98%,HSD17B10;CYP7B1;HSD17B4;SCP2;OSBPL2
prerank,regulation of protein autophosphorylation (GO:0031952),0.42153988693997924,1.0291730917687532,0.443019943019943,0.9949518146001349,1.0,10/36,10.90%,PDGFB;PDGFC;PDGFD;RAP2C;PPP2R5A;VEGFA;CALM1;IMPACT;RAP2A;PDGFA
prerank,regulation of cell development (GO:0060284),0.4081270235402279,1.0286671620922996,0.44084507042253523,0.9953381720270288,1.0,6/36,7.10%,HEY2;HEYL;HDAC9;PRUNE1;YTHDF2;YAP1
prerank,T cell differentiation in thymus (GO:0033077),0.48676236095990993,1.0285414716146877,0.45439469320066334,0.9947217390866767,1.0,5/14,21.91%,ADAM17;ZFP36L1;MR1;PTPRC;ZFP36L2
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.38027890354990385,-1.0281175889924834,0.4373401534526854,0.8443657454143253,1.0,6/17,28.96%,PDE3B;ALK;AKT1;PRKAA1;MFSD2A;BSCL2
prerank,bicarbonate transport (GO:0015701),0.44605658513439217,1.028006186309576,0.43870014771048743,0.9951866980381987,1.0,4/25,8.02%,CA3;SLC4A8;SLC4A3;SLC4A7
prerank,plasma membrane organization (GO:0007009),0.38082406470908325,1.0274399549369304,0.4083969465648855,0.9956907282023199,1.0,16/61,12.51%,FER1L5;MYH9;DYSF;ANO6;PACSIN3;PACSIN2;EHD2;FA2H;RAB3A;WHAMM;TLCD2;OSBPL2;NSF;SNX9;A4GALT;PACSIN1
prerank,plasma membrane invagination (GO:0099024),0.4262819351664577,1.0268129396996737,0.4314574314574315,0.9963987616801718,1.0,7/29,12.43%,CD36;MYH9;SPIRE1;DOCK1;ARHGAP12;SNX18;SNX9
prerank,mitotic cytokinetic process (GO:1902410),0.45489191781741795,1.0267874946880617,0.4250386398763524,0.9954973479259153,1.0,6/20,17.44%,CHMP4C;CHMP5;CHMP2B;CHMP2A;VPS4A;CNTROB
prerank,regulation of bone mineralization (GO:0030500),0.3859100742655361,1.0265796205441975,0.4362244897959184,0.9951131067785802,1.0,12/55,8.71%,MEF2C;CCN1;ANO6;SLC8A1;TGFB3;ACVR2A;ALOX5;OSR2;BMPR1A;ATP2B1;FZD9;TRPM4
prerank,endothelial cell migration (GO:0043542),0.4087199532560442,1.0260724960909353,0.4369747899159664,0.9955312150459564,1.0,6/37,2.97%,PTP4A3;MYH9;PLXND1;CDH13;NR4A1;LOXL2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.3231019204478256,-1.0257630918320488,0.42524916943521596,0.8498732952558271,1.0,19/31,39.93%,PEX14;PEX5;TIMM44;DNAJC19;AIFM1;TIMM17B;HSPD1;TOMM70;TIMM21;TIMM23;GRPEL1;PEX16;PEX6;DNLZ;TOMM40L;TOMM40;TIMM50;GRPEL2;PEX12
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.4668791793612731,1.0257019223831254,0.4576271186440678,0.9955648944733768,1.0,4/15,17.25%,MYD88;HIF1A;STAT3;TICAM1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.45862128395638224,1.0255401000796225,0.43057722308892354,0.9950580633447756,1.0,3/19,5.55%,NR1H4;CD14;PIK3AP1
prerank,regulation of interferon-gamma production (GO:0032649),0.37656663061114726,1.0253134506350954,0.437726723095526,0.9947136530712314,1.0,10/71,11.32%,NR1H4;FZD5;CD276;IL12RB2;CD14;HAVCR2;IL12RB1;RASGRP1;AXL;PDE4D
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.33558150051571295,1.0250332087451897,0.426,0.9945232644176902,1.0,73/509,11.71%,NTF3;FLNA;NTRK3;ACTN4;ANGPT1;PTP4A3;ROCK1;FGF1;PMAIP1;LIMS1;MST1R;HIP1;MYD88;TCIM;PDGFB;PDGFC;ROR1;FERMT2;SEMA5A;PLXNB1;CDH13;ADRA1D;THPO;CGAS;CCL5;BCAR3;ITGB1;GCNT2;PDGFD;NUP62;BCL2;MFHAS1;KSR1;CD14;LARS1;PIK3AP1;MTDH;IRS1;CAV1;DAB2IP;HEXIM1;PPM1A;VEGFA;TP53;NEDD4;AREG;TIFA;TGFB2;GOLT1B;SOX9;RELA;TRIM68;SEC13;THEM4;EDAR;PDGFRB;RRAGB;AXL;RTKN2;TRAF5;PELI2;EIF2AK2;HBEGF;VAV1;DNM1L;ROCK2;PDGFA;DDX1;GPER1;ZDHHC17;HTR2B;BOK;RICTOR
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.3983898266542699,-1.0247521654585359,0.4418052256532066,0.8502473787462048,1.0,4/13,17.46%,GRB2;IL15;IL15RA;STAT5A
prerank,cellular response to interleukin-15 (GO:0071350),-0.3983898266542699,-1.0247521654585359,0.4418052256532066,0.8502473787462048,1.0,4/13,17.46%,GRB2;IL15;IL15RA;STAT5A
prerank,cellular response to hexose stimulus (GO:0071331),-0.34218268902938254,-1.0244214864608292,0.4273743016759777,0.8499727725017175,1.0,6/23,12.55%,ZBTB20;UNC13B;TRA2B;ERN1;SOX4;PCK2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.23646835029063815,-1.0243023357257803,0.38095238095238093,0.8490786664531991,1.0,32/152,14.08%,RNF220;LRRK1;LGR4;COL1A1;SULF1;ADGRA2;WNK1;RNF146;DDX3X;PTK7;EGFR;LYPD6;TNKS2;PPM1B;PSMD7;PSMD9;PSMD13;WLS;ATP6AP2;RSPO2;SALL1;SMURF2;TGFB1;FGFR2;PSMB3;SFRP4;SOX4;ZBED3;PSMC5;PSMA5;PSMA1;PSMC2
prerank,mitotic spindle organization (GO:0007052),0.34719252253357846,1.0242803793227542,0.45,0.9955704078272607,1.0,29/153,14.41%,FLNA;DYNLL1;CLASP2;KIF2A;CENPP;TOGARAM2;KIF3B;DCTN6;EFHC1;EML1;TPX2;PIBF1;TOGARAM1;SUN2;CENPO;SEC13;ZWINT;CEP192;CENPE;WRAP73;NUP107;AAAS;DYNC1I2;ITGB3BP;CLASP1;NUP37;MAP4;NUP98;KIF18A
prerank,cellular response to decreased oxygen levels (GO:0036294),0.379505426921102,1.02415595549134,0.4377358490566038,0.9949449900702946,1.0,12/65,9.73%,PMAIP1;ANGPT4;RORA;PTGIS;SUV39H2;CPEB1;TERT;NDRG1;VEGFA;TP53;HIF1A;SIRT2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.4183134241399433,-1.0241392331721006,0.44036697247706424,0.8483444759204086,1.0,6/11,21.50%,NOS3;GCH1;PRKG2;AKT1;PTS;SPR
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.4441409947390347,-1.0240742576162165,0.4688995215311005,0.8473398987977528,1.0,4/10,34.80%,LGALS9;CD274;SCRIB;PRKAR1A
prerank,development of primary male sexual characteristics (GO:0046546),0.4214743604751029,1.0240370672081662,0.4283646888567294,0.9943234035917026,1.0,5/34,7.85%,LHCGR;CSDE1;AR;TGFB2;SOX9
prerank,regulation of protein ubiquitination (GO:0031396),-0.24467059987719694,-1.0239786035282967,0.3515625,0.8463632229637063,1.0,29/108,15.93%,SASH1;ARRB1;NXN;CUL3;MYCBP2;UBQLN1;CRY1;DERL1;HSP90AB1;BIRC2;PRMT3;COMMD1;FKBP1A;SIRT7;FBXO4;PRKN;UBE3A;OGT;STUB1;SOX4;SPRY2;DNAJB2;TGFBR1;PTTG1IP;SH3RF2;FANCI;UBXN1;BIRC3;AKT1
prerank,protein complex oligomerization (GO:0051259),-0.26196826492023984,-1.0238219469252081,0.4217687074829932,0.8456226929167812,1.0,28/85,24.63%,SPAST;PKD2;RNF135;MCU;LETM1;WDCP;JMJD6;RNF213;UGDH;KCNC2;BLM;GSDMD;UPB1;TMEM120A;SNCA;STOML2;G3BP2;EHD1;YME1L1;LRRC8D;ZC3H12A;PNPT1;EHD3;CLDN1;RBMX;CPSF6;ZBTB1;ALS2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.4951995506082211,1.0236636189157131,0.45454545454545453,0.9944045459174707,1.0,2/12,4.52%,CCDC68;BICD2
prerank,regulation of fibrinolysis (GO:0051917),-0.40052734007156754,-1.0233559206687266,0.4218362282878412,0.8457265242697376,1.0,11/13,59.97%,THBD;SERPINE1;USF1;HRG;KLKB1;PLG;APOH;FAP;THBS1;F11;F2
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4179509238705323,1.0230662944216244,0.4477401129943503,0.9950714956129414,1.0,6/30,12.02%,CAVIN1;POLR2L;GTF2H4;POLR1E;CDK7;POLR1H
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.5069933302026695,1.0228285681733251,0.46059544658493873,0.994755659214715,1.0,4/11,15.58%,IL12RB2;STAT1;JAK2;STAT3
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3622348974518085,1.0221972147781955,0.4315304948216341,0.9954954248195267,1.0,19/98,11.81%,ATP2B4;STAC;PMAIP1;ITGA3;SLC5A3;ITGB1;BCL2;ARHGEF16;KCNB1;STAC3;TP53;SORBS1;KIF5B;MIEF2;MIEF1;EPHA2;GPER1;CLIP3;DPP10
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.3673437819061481,-1.0219572692743815,0.45144356955380577,0.8484496562774669,1.0,10/18,33.65%,PTBP3;RPS13;ESR1;TGFB1;NRDE2;ZC3H12A;TMBIM6;ZC3H10;NCOR1;NUDT16
prerank,potassium ion homeostasis (GO:0055075),0.44128760480608054,1.0219565021031463,0.4377880184331797,0.9952287683818892,1.0,2/23,5.96%,KCNMA1;ATP1B1
prerank,tRNA transport (GO:0051031),0.41854523136821353,1.0212699770444027,0.4465753424657534,0.9960916411186485,1.0,13/35,20.82%,NOL6;NUP62;SEC13;NUP153;NUP107;AAAS;NUP37;NUP98;NUP210;NUP54;NUP160;NUP133;TPR
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3715384449944373,1.0211100660185746,0.4485207100591716,0.9955743661088666,1.0,13/76,10.70%,KLHL40;ANGPT1;UBA2;DCUN1D2;PIAS4;SAE1;CAV1;FBXW7;DCUN1D1;TNIP1;AMER1;PAXIP1;UBE2D1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5055913940189564,1.0211038549975098,0.4538878842676311,0.9946455211236269,1.0,2/10,5.80%,SET;KLF15
prerank,protein destabilization (GO:0031648),-0.322629290444308,-1.0209927760190791,0.40878378378378377,0.8499500818807988,1.0,9/32,14.18%,CUL3;CTSH;DERL1;MDM2;PRKN;IRGM;EP300;SOX17;SNCA
prerank,positive regulation of defense response (GO:0031349),0.3667183563489359,1.0209784658224,0.4444444444444444,0.9940364868373683,1.0,6/89,3.66%,AGTR1;MEF2C;LPL;IL2;CCL5;FEM1A
prerank,cellular protein modification process (GO:0006464),0.3330453572277788,1.0206048710621742,0.419,0.9940823877218617,1.0,187/982,15.32%,ART1;PPP1R12A;MAP3K20;IGFBP7;MFGE8;LTBP1;SPARCL1;SDC2;STK38L;TNNI3K;PRKG1;MAP3K5;ASB15;PPM1L;ROCK1;HRC;DYRK2;MERTK;PPM1J;KCTD7;ASB10;FCGR3A;PDGFB;PPP3CA;CCN1;CDK6;FBXO40;ASB18;LARGE1;FBXL22;PDK4;ANXA1;DUSP5;FRK;MTMR7;LOXL2;FAM20A;SOCS5;CAMK2D;PPP2R1B;IGFBP5;FEM1C;FEM1A;GCNT2;PPM1E;ACVR2A;SIRT3;MCRS1;LMO7;PEAK1;ASB2;PTPN18;CAMKK2;ASB1;MARK1;PTPRS;SEPHS1;CUL2;SOCS6;BMPR1A;RNF7;LHPP;NUCB1;DYRK1A;ATG7;PHKA2;MAP4K3;MAP4K5;CHST5;PTPRF;ASB8;PSMC6;SDHAF2;TAF1;PPP2R5A;MAPKAPK2;FBXW7;FBXO30;FBXL18;ELOC;COQ8A;PARP1;PPM1A;IGFBP4;DYRK1B;PTPN1;ART4;KTN1;LAMB2;LAMC1;UBE2F;RAB3A;STK26;CUL9;NUAK1;CHEK1;TGFB2;DCUN1D1;SETD3;WNK2;DAPK3;PRKACB;DDOST;PRKAR1B;MAP2K1;UBE2E1;CDH2;CCNT1;PPP1CB;BRSK1;PPP1CA;PKN2;PAK2;CDK7;HIF1A;PSME4;SIRT2;STK24;FBXO6;PSMB1;CTDSP2;SUMF1;CDK18;EIF2AK2;MBTPS1;PSMD5;ROCK2;PHEX;FBXO32;ST8SIA5;PRKCD;COL3A1;COPS8;ACVR1B;STK36;FBXW11;WDR45;CDK12;DUSP29;MAN2A2;UBA3;DMPK;BMPR1B;DCAF11;TNIK;BCR;WSB1;CDC42BPB;SBF1;CTDSP1;TAOK3;MACROD1;PSMB2;DUSP16;TPTE;ST3GAL2;CDK15;FNIP2;PIK3C3;MAST1;PPP3CB;PRSS23;DNAJC3;LRRK2;SGK1;PDK2;STK10;SIRT4;GAS6;MAPK1;CSNK1E;TNC;PIGH;UFL1;PSMB7;PRKAA2;FEM1B;KCTD6;PSMD3;PRKCA;PRKACA;CSNK1A1;COPS4;UBE2L6;JAK2;SRPK2;PTEN
prerank,hexose metabolic process (GO:0019318),-0.30236562079414514,-1.0205538335879554,0.4397163120567376,0.8499197260934498,1.0,15/39,27.65%,APOD;BRAT1;SORD;PMM2;HECTD4;SLC35A2;FPGT;GALK2;FUCA2;ALDOC;GALM;PGM1;GALK1;PMM1;GDPGP1
prerank,COPII-coated vesicle budding (GO:0090114),-0.26919509784682627,-1.02017980590833,0.4127906976744186,0.8498580084621095,1.0,34/68,35.62%,TGFA;CUL3;KLHL12;USO1;SEC23IP;STX5;TMED10;SEC23B;SEC24B;MCFD2;ANKRD28;RAB1A;F8;PPP6R3;LMAN1;RAB1B;SCFD1;TRAPPC3;TFG;MIA3;F5;TRAPPC2;SAR1A;PEF1;PPP6C;CTSC;SEC16B;PPP6R1;TRAPPC6A;SAR1B;CSNK1D;TRAPPC5;SCAP;CNIH3
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.36731880899770264,-1.0201131399969514,0.44054054054054054,0.8488675901469449,1.0,4/18,9.94%,HDAC7;CD34;NAV3;HOMER3
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.500290675841621,1.020014236666662,0.4219858156028369,0.9947170068979732,1.0,4/10,10.56%,FBXW7;AREG;ADAM17;HBEGF
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.22990148217437056,-1.0199138400415677,0.43478260869565216,0.8482414155949672,1.0,39/186,14.09%,MCC;BICC1;DAB2;MLLT3;TLE1;IGFBP2;LRP1;TCF7L2;NXN;DKK3;FZD6;APOE;CUL3;WNT5A;WWOX;APCDD1;SOX13;KLHL12;CTNND1;TMEM64;PSMD7;LATS2;PSMD9;PSMD13;RNF213;STK11;PRKN;IGFBP6;KREMEN1;PSMB3;SFRP4;WWTR1;PSMC5;NOTUM;PSMA5;PSMA1;SOX17;PSMC2;HECW1
prerank,thymus development (GO:0048538),-0.406883906281161,-1.0189223664974598,0.43577981651376146,0.849649174922825,1.0,6/13,28.17%,SIX1;HES1;TGFBR1;ZBTB1;FOXE1;EPHB3
prerank,C21-steroid hormone metabolic process (GO:0008207),0.4513888426382401,1.0188272620522163,0.43042071197411,0.996818009028726,1.0,2/20,7.19%,HSD17B10;AKR1B1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.4851419301065916,1.0188116358325607,0.45500848896434637,0.9959210189721536,1.0,3/13,5.12%,RBPMS;TGFB3;BMPR1A
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.3731034593142069,-1.0187309432563778,0.45,0.8489956823098761,1.0,7/18,17.50%,APOE;ADAM10;APH1A;NCSTN;CLN3;APH1B;PSEN2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.4420753283284836,1.018311285324375,0.4580745341614907,0.9963266212360109,1.0,4/21,6.49%,RBPMS;TGFB3;BMPR1A;SLC2A10
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4557587609255392,1.0182344751046328,0.44049459041731065,0.9955808127017358,1.0,4/18,8.07%,SUV39H2;ASH1L;KMT2D;SETD3
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.37485204841041553,-1.0181152204625834,0.4306930693069307,0.8495355818229877,1.0,8/18,23.94%,RAB11A;VPS4B;RCC2;CDC25B;CDC25A;MECP2;CDC7;RAD51C
prerank,sphingolipid metabolic process (GO:0006665),-0.25065613313396207,-1.017953069898371,0.39622641509433965,0.8487281621690344,1.0,23/108,11.59%,SGMS1;SGMS2;ELOVL7;CERK;CERS5;HACD4;SPTLC2;ST6GALNAC3;PPP2CA;SPTSSA;ACER2;ALDH3A2;ENPP2;SERINC1;SUMF2;CERT1;CERS6;SGPP1;PPT1;ASAH2;HEXA;SPNS2;B3GALNT1
prerank,error-prone translesion synthesis (GO:0042276),-0.35865817967237024,-1.0179343247933406,0.44533333333333336,0.8476017702744633,1.0,12/21,36.85%,UBC;REV1;PRIMPOL;UBB;POLE2;POLI;RPA3;RFC3;RPA2;RPA1;RFC1;RFC4
prerank,cellular response to amino acid starvation (GO:0034198),0.37172782319417585,1.017875299221421,0.44272076372315033,0.9956154797085576,1.0,22/71,20.48%,MAP3K5;RNF152;LARS1;KPTN;ATP6V1H;CASTOR1;IMPACT;SEC13;ATP6V1C1;NPRL2;RRAGB;EIF2AK2;ATP6V0D2;MAPK1;CASTOR2;ITFG2;EIF2AK3;EIF2AK4;PRKD1;ATP6V0C;LAMTOR3;EIF2S1
prerank,intestinal absorption (GO:0050892),0.47930587181641154,1.0176680308769603,0.4405594405594406,0.9952427502246101,1.0,1/13,1.65%,CD36
prerank,glycolytic process (GO:0006096),0.4234826945988398,1.017667536881135,0.4490674318507891,0.9943091139999684,1.0,11/28,23.27%,ENO3;HK2;PFKFB1;ALDOA;PFKM;GAPDHS;LDHA;PKM;GAPDH;PGAM4;PGAM1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.38959902697154913,1.0172788042768117,0.4514501891551072,0.9944113427921907,1.0,9/48,9.58%,ANGPT1;ANGPT4;PDGFB;ANXA1;HDAC9;VEGFA;RHOJ;ADAM17;HIF1A
prerank,regulation of programmed cell death (GO:0043067),0.34681968818174364,1.0172424113601672,0.46178686759956944,0.9935699244325265,1.0,29/161,15.56%,NTF3;ACTN1;ACTN4;PMAIP1;HIP1;ALPK2;NUP62;NDRG1;TP53;STK26;SOX9;DAPK3;ACTN2;GLS2;ZBTB7A;TNFRSF25;BCL6;CLU;TMEM219;PERP;RBM25;LRRK2;TNFRSF10B;SGK1;USP42;STAT1;JAK2;MAGED1;RAF1
prerank,mitochondrial gene expression (GO:0140053),0.3988255939727077,1.0171842698169462,0.4507042253521127,0.9927869462615151,1.0,17/42,20.40%,FASTKD5;GATB;IARS2;MRPS28;MRPL51;GFM2;MRPL23;MRPL16;TFB2M;MRPL47;LARS2;FASTKD2;MRPS21;TEFM;GATC;MRPS14;SLC25A33
prerank,regulation of vacuole organization (GO:0044088),-0.357221421498437,-1.0171136356362984,0.4301675977653631,0.8486699902687853,1.0,10/20,24.38%,ANXA2;RAB5A;NPRL3;SCARB2;IFT88;UBQLN2;RAB1B;ENO2;TBC1D14;ENO1
prerank,base conversion or substitution editing (GO:0016553),-0.4171965891272753,-1.017053719521372,0.43201754385964913,0.8476726672457096,1.0,4/11,33.65%,METTL3;ADAR;ADARB2;NUDT16
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3472925254120372,1.0170219085012708,0.4566410537870472,0.9922851856071038,1.0,16/138,9.85%,NTF3;NTRK3;LIFR;MERTK;MST1R;ROR1;FRK;ACVR2A;MUSK;PTPRF;LCP2;SLA;EPHA2;NPR2;PDGFRB;AXL
prerank,regulation of interleukin-4 production (GO:0032673),-0.35409167464302166,-1.0167293961225592,0.41688654353562005,0.8474386736708885,1.0,8/21,25.72%,LEF1;LGALS9;SLC7A5;CEBPB;RARA;CD86;SYK;ZFPM1
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.34938086251948675,-1.0167105775272876,0.41847826086956524,0.8463121925866424,1.0,6/22,19.78%,APPL2;PTPRZ1;TAFA1;NES;KDM1A;NAP1L1
prerank,negative regulation of innate immune response (GO:0045824),-0.3155166353876892,-1.016324846288101,0.41007194244604317,0.8461767640486987,1.0,20/34,37.50%,RPS19;METTL3;SAMHD1;IRAK3;STAT2;GRN;NLRC5;SERPING1;YTHDF3;PTPN2;A2M;TRIM21;NLRC3;USP18;NMI;TNFAIP3;TYRO3;LYAR;DHX58;TTLL12
prerank,gene silencing by miRNA (GO:0035195),0.4223638854625221,1.0162148761457146,0.4498567335243553,0.9934965688264883,1.0,2/32,1.90%,WTIP;LIMD1
prerank,cardiac atrium morphogenesis (GO:0003209),0.4580655317928751,1.0161495727492305,0.4588815789473684,0.9927416274617853,1.0,2/16,7.78%,HEY2;TGFB2
prerank,negative regulation of wound healing (GO:0061045),0.42396970066003387,1.0158918808096313,0.438136826783115,0.9925211413788739,1.0,5/28,6.70%,PHLDB2;CLASP2;SERPINE2;ALOX5;AJAP1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.37318989809086145,1.0158330225502206,0.45323741007194246,0.9917625132604974,1.0,11/74,7.78%,VASN;FERMT2;PHLDB2;CLASP2;LOXL2;TGFB3;GCNT2;TGFB1I1;SDHAF2;DAB2IP;TGFB2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.43189484302078784,-1.015662295779795,0.46987951807228917,0.8468836132677386,1.0,5/11,11.73%,LGALS9;CD34;ATP6AP2;CD46;PTGS2
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.3228290037633392,-1.0155372311483395,0.4266666666666667,0.8460628444984636,1.0,11/31,18.55%,ATXN3;DNAJB12;HSPA5;OPTN;PRKN;STUB1;ERN1;HSPA13;HSPA9;BAX;HSF1
prerank,response to amino acid starvation (GO:1990928),0.369562792593754,1.015506243885114,0.4470868014268728,0.9916958544783571,1.0,23/72,20.98%,MAP3K5;RNF152;LARS1;KPTN;ATP6V1H;CASTOR1;IMPACT;SEC13;ATP6V1C1;NPRL2;RRAGB;EIF2AK2;ATP6V0D2;MAPK1;CASTOR2;ITFG2;EIF2AK3;EIF2AK4;PRKD1;ATP6V0C;LAMTOR3;EIF2S1;LARP1
prerank,secretory granule organization (GO:0033363),-0.432080802844423,-1.0154894592725916,0.4551422319474836,0.8450352632872199,1.0,3/10,9.25%,ABCA1;SRGN;DTNBP1
prerank,regulation of apoptotic process (GO:0042981),0.33025467281597043,1.015342227220471,0.44744744744744747,0.9911713741544493,1.0,101/676,13.93%,NTF3;FLNA;KCNMA1;OBSCN;ARHGEF7;MAP3K20;ACTN1;MEF2C;NAA38;ACTN4;MAP3K5;NR1H4;ANGPT1;KALRN;PMAIP1;ABR;HIP1;MYD88;ANGPT4;TCIM;TRIM2;ARHGEF17;ALPK2;ANO6;CCND2;ANXA1;IL2;ITSN1;TGFB3;ITGB1;NET1;NUP62;ARHGAP10;FXN;BCL2;ATAD3A;ARHGEF16;ARHGEF2;MYO18A;ATG7;MTDH;DAB2IP;NDRG1;RPS6KA2;ARL6IP5;VEGFA;TP53;PHLDA3;GDNF;STK26;PA2G4;MED1;BCL2L2;OPA1;NAT8;FZD9;SOX9;RELA;MAP3K10;DAPK3;API5;CBX4;VDAC1;TNFAIP8;ARHGEF4;GSTP1;PAK2;HRK;BAG3;AXL;PAWR;FAIM2;ACTN2;VAV1;DNM1L;GPER1;TRIM35;GLS2;ZFAND6;CLIP3;ZBTB7A;HTR2B;BOK;TNFRSF25;CSRNP3;BCL6;CLU;PDCD10;POU3F3;DIABLO;ITGB3BP;CITED2;TMEM219;PERP;DNAJC3;SON;RBM25;TNFRSF10B;SGK1;BNIP1;GAS6
prerank,secondary alcohol metabolic process (GO:1902652),-0.2964449292738169,-1.0153095179635958,0.4684014869888476,0.844352036639692,1.0,20/42,37.08%,CYP27A1;APOE;ABCA1;SOAT1;PIP4P1;SQLE;GBA2;IDH3G;CLN8;RXRA;EBP;TSKU;PPARD;ABCA5;ANGPTL3;CLN6;SCAP;LCAT;IDH1;CH25H
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.2762139192281476,-1.0153043594554592,0.4330357142857143,0.8432035764055762,1.0,12/51,17.34%,PTN;HMGB1;PTK2;LGALS9;MOSPD2;IL6R;AKIRIN1;VEGFC;CALR;PLA2G7;SERPINE1;VEGFB
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.3019099213740187,-1.0149934721625335,0.4175084175084175,0.8429637901437352,1.0,20/39,32.47%,RPS19;RPSA;RPS24;RIOK3;WDR3;RRP36;DDX52;RPS7;ERAL1;RRP7A;EMG1;SURF6;RPS27;NOL11;MRPS11;LSM6;RPS5;RPS15;RIOK2;TSR3
prerank,positive regulation of dephosphorylation (GO:0035306),0.42721536084548295,1.014455894158175,0.444121915820029,0.9925437972004867,1.0,5/27,11.28%,DLC1;PPP2R5A;PIN1;CALM1;PRKCD
prerank,actin cytoskeleton reorganization (GO:0031532),0.37187076354156845,1.014000877370735,0.4353826850690088,0.9928439835570098,1.0,15/63,13.34%,FLNA;MYH9;ANXA1;PTPN1;PLEK;WHAMM;RAP2A;PARVA;RICTOR;TNIK;CDC42BPB;S1PR2;DMTN;FGF10;MKLN1
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4673693349072317,1.0138163542534517,0.47096774193548385,0.9914616330934442,1.0,5/19,13.17%,POLR2L;POLR2I;POLR2G;TERF2;POLR2J
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4673693349072317,1.0138163542534517,0.47096774193548385,0.9914616330934442,1.0,5/19,13.17%,POLR2L;POLR2I;POLR2G;TERF2;POLR2J
prerank,establishment of protein localization to organelle (GO:0072594),0.36949498483221194,1.0135880940073712,0.456865127582017,0.9911493922921196,1.0,20/72,16.16%,RYR2;HK2;NUP62;IL10RA;RANBP17;SPRN;SEC13;NUP153;NEURL1B;PPP1R10;NUP107;PEX19;RANBP6;TNPO3;FAM53B;IPO4;TSPAN17;STAT3;IPO7;FAM53C
prerank,regulation of centrosome duplication (GO:0010824),0.42031253588994383,1.0129182159136998,0.4579172610556348,0.9919306982267037,1.0,9/29,19.33%,CHMP4C;NAT10;CHMP5;CHMP2B;CEP120;CHMP2A;CCNF;CEP295;CENATAC
prerank,response to unfolded protein (GO:0006986),-0.28544681774663894,-1.0125205524247334,0.4434782608695652,0.8486870073081677,1.0,18/48,19.58%,HSPA4L;HSPA4;SERPINH1;DERL1;HSPA5;HSP90AB1;OPTN;PRKN;ERN1;DNAJB2;HSPA13;HSPA9;BAX;HSPE1;HERPUD1;DNAJB4;HSF1;DNAJC4
prerank,cellular lipid catabolic process (GO:0044242),-0.32341489916714905,-1.0125029742153495,0.4556213017751479,0.8475743474228384,1.0,8/27,18.60%,LPIN2;ENPP2;CYP1B1;ACOT8;ACBD5;ABHD12;ACOX1;LPIN3
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.38794774282104494,-1.012431592287849,0.4430051813471503,0.8466287007915664,1.0,4/15,17.02%,BMP4;PRKCH;SFRP4;TRIM16
prerank,positive regulation of chemokine production (GO:0032722),-0.29450876087206385,-1.0116252448263647,0.44649446494464945,0.8477692669241408,1.0,7/44,8.54%,HMGB1;APP;DDX3X;IL18;WNT5A;LGALS9;IL6R
prerank,regulation of macroautophagy (GO:0016241),-0.24806487288337928,-1.0112491354438262,0.424,0.8476226616184074,1.0,37/105,26.49%,PRKAG2;PIK3CA;DCN;RB1CC1;PAFAH1B2;CAPNS1;LAMTOR1;UBQLN1;SMG1;NRBP2;GPSM1;IKBKG;ATP6V1G1;RHEB;SNX6;ERN1;TBC1D25;KDR;CLN3;AKT1;UBQLN2;EXOC1;EXOC7;BNIP3L;QSOX1;PRKAG3;PRKAA1;LZTS1;ATP6V0D1;SMCR8;SESN2;RRAGD;LAMTOR2;CDK5R1;UCHL1;MAPK8;PRKAG1
prerank,signal release from synapse (GO:0099643),0.39226350573505603,1.0101367621263466,0.45989304812834225,0.9982281841191692,1.0,6/43,9.21%,STXBP2;SYT10;RAB3A;LIN7C;BRSK1;HRH3
prerank,myelination (GO:0042552),-0.28708352527475367,-1.0091928655547535,0.45495495495495497,0.8520469401407575,1.0,16/46,23.41%,NF1;PLP1;ADGRG6;B4GALT6;SBF2;PLLP;MAL;ARHGEF10;CMTM8;LGI4;MYOC;EIF2B5;BCAS1;PMP22;GPC1;SLC8A3
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.38345563635651553,-1.0091515360897336,0.45121951219512196,0.8509884441581458,1.0,6/15,16.68%,IGF1;GHITM;BCL2L1;PRKN;AKT1;GPX1
prerank,mucosal immune response (GO:0002385),-0.38201459286578915,-1.0091239640821517,0.45792079207920794,0.8498849371281886,1.0,2/15,8.89%,OTUD7B;DEFA6
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.4392863622608836,1.0091159295812648,0.4608294930875576,0.9999641644009839,1.0,3/21,7.78%,SMARCD3;VEGFA;FZD9
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.41927855589931157,-1.0088859740506488,0.46136363636363636,0.8493392616388769,1.0,3/12,7.08%,MYCBP2;B4GALT6;HSP90AB1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.4853667976695458,1.0087721533704985,0.46924428822495606,0.9999109272426727,1.0,2/13,6.97%,ENTPD1;ENTPD7
prerank,polyamine metabolic process (GO:0006595),0.4864651218979456,1.0086860585063457,0.4388111888111888,0.9992327504172107,1.0,4/13,15.17%,OAZ2;SAT2;SMS;PAOX
prerank,endocrine system development (GO:0035270),0.44668579377437223,1.0084318959592597,0.45396825396825397,0.9989693063656869,1.0,1/21,0.40%,TG
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3544452585068374,1.0082975476904699,0.45970488081725314,0.9983965194521288,1.0,14/101,9.85%,MEF2C;MYD88;VIM;CCL5;CD14;UPF1;MTDH;DAB2IP;CHMP5;RELA;NFKBIB;GSTP1;NR1D1;AXL
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.33043747763846754,1.00827724971491,0.49645390070921985,0.9975296203155685,1.0,45/327,12.04%,SOX6;MLF2;WTIP;MEF2C;ACTN4;ZFHX3;PTP4A3;LIMD1;NAB1;RORA;MLF1;HINFP;RBAK;ATXN1;PRKCQ;MYBBP1A;TP53;ZBTB38;SNAI2;SFPQ;PPARGC1A;BTG1;PPARGC1B;ZNF431;REXO4;RELA;KMT2D;DAPK3;NSD3;FUS;MSL3;PPIE;KAT7;HIF1A;NR2C2;NUP107;SRSF10;RB1;RHOH;ACVR1B;BAZ2A;NFX1;ESRRA;PSPC1;USP13
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.43444097707554563,-1.0082246973901523,0.4831223628691983,0.8499907881952012,1.0,4/10,15.91%,NT5E;UPP2;UPB1;DPYD
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3337928955288006,-1.0082035969439966,0.44108761329305135,0.8488819966607921,1.0,10/24,26.25%,B2M;CANX;SEC24B;ACE;CALR;ABCB9;TAP1;TAPBP;HFE;TAPBPL
prerank,protein sumoylation (GO:0016925),0.387742770241254,1.0081803438436479,0.44903225806451613,0.9968637259079761,1.0,21/49,20.82%,UBA2;NUP62;PIAS4;SAE1;TRPM4;NUP153;NUP107;AAAS;PIAS2;NUP37;TRIM28;NUP98;NUP210;PIAS1;BCL11A;NUP54;SUMO1;UBE2I;NUP160;NUP133;TPR
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4579191771041118,1.0081281359725778,0.46864686468646866,0.9960741126779906,1.0,6/16,13.09%,AMPD1;LHPP;AMPD2;NUDT2;PPAT;ADSS1
prerank,negative regulation of nuclear division (GO:0051784),-0.4261803353990382,-1.0081159971560676,0.485838779956427,0.8479810432241485,1.0,2/11,2.07%,BMP7;BMP4
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.32894653512668004,-1.0079830340367784,0.45121951219512196,0.8472173130968021,1.0,5/25,9.55%,RIN3;APP;ANKRD13A;ITGAV;SDCBP
prerank,retinoid metabolic process (GO:0001523),0.37177689825901966,1.0078625419053648,0.4399524375743163,0.9958029632774837,1.0,7/71,7.19%,TTR;SDC2;LPL;DHRS3;RARRES2;GPC4;AKR1B1
prerank,regulation of macrophage cytokine production (GO:0010935),-0.41155476574905236,-1.007752362972169,0.4666666666666667,0.8466646774335214,1.0,5/13,10.39%,WNT5A;SEMA7A;PLCG2;IRAK3;TGFB1
prerank,cellular response to retinoic acid (GO:0071300),-0.29310577808277904,-1.007212716970062,0.4453125,0.8469564334401385,1.0,13/42,18.99%,PTK7;WNT5A;EPHA3;PTK2B;WNT9A;ABL2;SETX;SNW1;CREB1;LYN;WNT6;RORB;ATM
prerank,chemical homeostasis (GO:0048878),-0.2728735731063948,-1.0072044825566981,0.43157894736842106,0.8458355135527222,1.0,10/61,8.15%,ZBTB20;RBP1;NEDD4L;WNK1;DDX3X;SLC4A10;WNK4;ABHD5;WNK3;SLC4A2
prerank,cellular glucan metabolic process (GO:0006073),0.49107327488117514,1.007199992627002,0.4698581560283688,0.9965493859219952,1.0,1/11,1.09%,PYGM
prerank,neural crest cell development (GO:0014032),-0.30078480179474953,-1.0071751631453145,0.4375,0.8447791205437806,1.0,9/44,7.65%,SEMA3D;SEMA3C;SEMA6A;KLHL12;RADIL;ANXA6;SEMA7A;SEMA3A;SEMA4D
prerank,regulation of protein localization to nucleus (GO:1900180),-0.29557974986874314,-1.0069107037752913,0.43359375,0.8443351113860005,1.0,17/43,24.44%,GLUL;BMP4;LIMK2;OTUD7B;NVL;ILRUN;LATS2;CARD10;TGFB1;WWTR1;DTX3L;AKT1;SUMO3;PARK7;SESN2;TFRC;BYSL
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.3248090054200808,-1.0068364193389947,0.44761904761904764,0.8433559233112202,1.0,11/26,15.93%,KMT2E;DDX3X;CCND3;EGFR;ADAMTS1;TFDP1;RDX;UBE2E2;RGCC;ANKRD17;AKT1
prerank,regulation of fat cell differentiation (GO:0045598),0.36543549996216584,1.0064765079374336,0.44096385542168676,0.9975731038542486,1.0,17/74,12.26%,RORA;FERMT2;RUNX1T1;LPL;ALOX5;RARRES2;ASXL1;BBS12;TAF8;YAP1;FTO;TRPM4;NR1D1;SIRT2;GPER1;LRP5;ZFP36L1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.42455940223340893,-1.0064330968260695,0.4692874692874693,0.8432825857367361,1.0,2/11,0.29%,DAB2;MLLT3
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.43243728862021535,1.0059841831369085,0.4574468085106383,0.997932158012203,1.0,9/25,12.73%,DDX23;TXNL4A;SF3B3;SRSF4;SRSF10;PRPF4;SF3A3;SRRM1;SF3B1
prerank,epithelium development (GO:0060429),0.3543193976365906,1.0058735776815486,0.46734234234234234,0.9973098809889474,1.0,11/107,8.87%,TAGLN;TBX2;VCL;TAGLN2;DMBT1;VEGFA;SNAI2;CNN3;SOX9;CBR1;VDAC1
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3129216983701994,-1.0058234555828005,0.42745098039215684,0.8438181093551379,1.0,13/35,23.38%,SASH1;DLG1;XDH;LGALS9;RELL1;PTPN22;MAP3K4;PER1;DUSP1;ZC3H12A;GADD45B;SPHK1;CYLD
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4321889309041618,1.005615258031683,0.48121387283236994,0.9970783009450189,1.0,4/27,8.30%,CD36;MYD88;CD14;TNIP1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.3955745673905605,-1.005532930206071,0.4543147208121827,0.8435203223720378,1.0,4/14,16.62%,PUM1;DDX60;ANKRD17;TLR3
prerank,negative regulation of lymphocyte migration (GO:2000402),0.49641030019746357,1.005373437262292,0.453551912568306,0.9967833937958156,1.0,3/10,7.13%,PADI2;CD200R1;CD200
prerank,regulation of developmental growth (GO:0048638),-0.3168234599790476,-1.0053029114962766,0.46646341463414637,0.8430136828621437,1.0,10/29,22.17%,IGF1;APP;APOE;GHR;LATS2;SIX1;INSR;STAT5A;SPAAR;MFSD2A
prerank,inositol phosphate-mediated signaling (GO:0048016),0.45320064752338907,1.005126594259676,0.45648604269293924,0.996520869444049,1.0,3/19,4.10%,PLCE1;PPP3CA;INPP5A
prerank,positive regulation of viral transcription (GO:0050434),0.4256779506304817,1.0045669657412946,0.4534351145038168,0.9970199105796823,1.0,9/25,17.88%,POLR2L;POLR2I;POLR2G;CCNT1;NELFB;POLR2J;NELFCD;DHX9;RSF1
prerank,nervous system development (GO:0007399),0.3304461371067067,1.0045621125442403,0.49547738693467336,0.9961244035907519,1.0,51/429,11.90%,SOX6;NTF3;FGF13;MEF2C;SERPINI1;IGFN1;KALRN;MERTK;DPYSL4;CRIM1;APBA1;MST1R;ZEB2;NAB1;PDGFC;CLN5;EDNRB;FZD5;PLXND1;SEMA5A;JAG1;KIRREL3;ATXN1;DYRK1A;BTBD2;MBD5;DSCAM;PCDHB14;VEGFA;GDNF;YAP1;FZD9;MBP;ERCC6;PCDHB11;TRAK1;CDH2;TRPC5;GSTP1;AXL;COX7B;MBNL1;TEAD1;NR2C2;HAPLN2;GFRA1;NDUFV2;SREBF2;ACVR1B;NDUFS2;SDHA
prerank,protein export from nucleus (GO:0006611),-0.32682528905242964,-1.0045037514934307,0.43934426229508194,0.8441067796368648,1.0,8/27,22.09%,RANBP3L;NUTF2;RANBP3;TGFB1;CALR;CCHCR1;NUP214;RAN
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.27502839203890855,-1.0044539989079955,0.4380952380952381,0.8431076320411361,1.0,29/57,35.82%,GLUL;RPS19;SDAD1;NVL;RPS24;NOC2L;RRP36;PAK1IP1;LTO1;RPS7;RPL11;RPL38;RPF2;DDX31;EMG1;SURF6;EBNA1BP2;BYSL;RBIS;PES1;NIP7;RRS1;RPL35A;RPS15;RIOK2;URB2;WDR74;RPL14;MRTO4
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.44117958388521544,1.0044534238532743,0.45481927710843373,0.9955180245141967,1.0,2/20,2.64%,ENTPD1;ANO6
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.30945135160887394,-1.0042547202502812,0.4533762057877814,0.8425256478162587,1.0,7/35,9.70%,VTN;B2M;HNRNPK;AAK1;BMP2K;PIK3CB;PPT1
prerank,inositol phosphate catabolic process (GO:0071545),0.4923672357796835,1.0039320859053136,0.47058823529411764,0.9959548270553753,1.0,5/12,15.32%,INPP5A;SYNJ2;INPP5B;INPP5J;PTEN
prerank,positive regulation of interleukin-1 production (GO:0032732),0.3813065672968228,1.0038981961547804,0.46405228758169936,0.9951394717752077,1.0,4/51,3.09%,CD36;MYD88;FZD5;LPL
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.25473177909245054,-1.0037759879763504,0.4171779141104294,0.8427871265635488,1.0,22/77,19.56%,IGF1;SH3RF1;TCF7L2;BMP4;ITGA6;DDX3X;BIRC6;ITGAV;GHITM;BCL2L1;PRKN;ASAH2;TGFBR1;MAZ;CX3CL1;NOC2L;AKT1;GPX1;HERPUD1;SIAH2;QARS1;PARK7
prerank,peptidyl-serine modification (GO:0018209),0.3408661436119482,1.0037312666193148,0.47334754797441364,0.994662322823828,1.0,43/166,17.19%,STK38L;MAST4;ROCK1;DYRK2;PDGFB;CAMK2D;GALNT16;MARK1;DYRK1A;PRKCQ;TAF1;MAPKAPK2;RPS6KA2;PARP1;DYRK1B;MAP3K10;BRSK1;PKN2;PAK2;GALNT3;ROCK2;PRKCD;RICTOR;DMPK;GALNT2;HPF1;MAST1;LRRK2;SGK1;GAS6;MAPK1;CSNK1E;GALNT1;PRKCA;PRKACA;CSNK1A1;SRPK2;MAPK12;HIPK2;MAST3;EIF2AK3;MAP3K13;MARK2
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.31335512505243857,-1.0035037827170636,0.46204620462046203,0.8423718521040914,1.0,10/32,13.45%,JCAD;STARD13;AKT3;HDAC7;MEOX2;FOXC2;MAP3K3;CARD10;PTGS2;KDR
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.404595955709591,1.0034696215068972,0.4605809128630705,0.9944358576663627,1.0,8/35,7.65%,PADI2;ARID1A;UBR5;NEDD4;YAP1;AR;MED1;PPARGC1B
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.4078972612828019,1.0034111876036547,0.45694444444444443,0.9937072855085762,1.0,5/37,6.21%,DYNLL1;DYNLRB1;KIF3B;IFT43;IFT81
prerank,chloride transport (GO:0006821),0.36265969030535333,1.0019454602622448,0.46359223300970875,0.9965227294902371,1.0,12/74,10.05%,ANO1;GABRE;ANO6;SLC4A8;CLCN6;GABRA4;TTYH1;GABRA5;ANO10;GABRB2;GABRG1;ANO3
prerank,positive regulation of translation (GO:0045727),0.35793267281750285,1.001790901902931,0.46352941176470586,0.9960020392717859,1.0,35/94,20.98%,VIM;RPUSD3;CCL5;SAMD4A;NAT10;TRMT10C;POLR2G;RCC1L;RPS27L;CIRBP;YTHDF2;PYM1;RPL5;EIF3E;EIF5A;EIF5AL1;RBM3;ZCCHC4;CPEB3;PLXNB2;RPUSD4;FASTKD2;PIWIL2;DHX9;TRUB2;EEF2;RMND1;UPF3A;HABP4;PKM;NSUN5;UQCC2;C1QBP;ERBB2;LARP1
prerank,retrograde axonal transport (GO:0008090),0.45650874052133644,1.0017726709114676,0.46622734761120266,0.9951371202456163,1.0,6/16,12.16%,DST;KIF1A;KIF5B;KIF1C;FBXW11;KIF5A
prerank,negative regulation of growth (GO:0045926),0.3523336631472984,1.0015473561838188,0.47687224669603523,0.9948175723921917,1.0,19/121,12.35%,SLIT3;TMPRSS4;MYL2;RERG;FHL1;JADE1;NDRG3;TP53;BTG1;TGFB2;NDUFS3;SERTAD2;CRLF3;SH3BP4;RB1;TCHP;ACVR1B;DCBLD2;BCL6
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.48371149697174903,1.0013974793454603,0.4735915492957746,0.9942915406057306,1.0,1/12,1.76%,DPYSL4
prerank,negative regulation of cell population proliferation (GO:0008285),0.3337809385645346,1.0013247008483377,0.49291497975708504,0.9935844067038915,1.0,39/351,9.27%,MYOCD;IGFBP7;COL18A1;DLC1;TMIGD3;P3H2;SPEG;ITGA1;CDK6;PLXNB1;CDH13;FRK;RERG;IGFBP5;TGFB3;NACC2;BTG2;NUP62;TGFB1I1;PEX2;MN1;TESC;OGN;DAB2IP;RPS6KA2;TP53;CD200;AR;BNIPL;CELF1;BTG1;TGFB2;SOX9;WNK2;DIS3L2;CD300A;MAP2K1;GSTP1;SKI
prerank,regulation of extracellular matrix organization (GO:1903053),-0.38114531469113055,-1.0010165116271352,0.46078431372549017,0.8480046654530262,1.0,3/15,6.23%,AEBP1;LRP1;TIE1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.46743922219845124,1.0006698601001078,0.4686411149825784,0.9943997605588256,1.0,6/15,21.01%,SEMA5A;VEGFA;TMSB4X;P2RX4;PRKD1;HSPB1
prerank,cellular response to starvation (GO:0009267),0.33605232678703945,0.999918165165154,0.4715359828141783,0.9954556704189609,1.0,32/147,14.85%,MAP3K5;PMAIP1;RNF152;PDK4;LARS1;KPTN;ATG7;ATP6V1H;GABARAP;MYBBP1A;CASTOR1;TP53;STK26;NUAK1;PPARA;IMPACT;SEC13;BRSK1;XPR1;ATP6V1C1;NPRL2;RRAGB;STK24;EIF2AK2;SREBF2;WDR45;PIK3C3;ATP6V0D2;LRRK2;MAPK1;CASTOR2;PRKAA2
prerank,regulation of protein localization to centrosome (GO:1904779),0.49368676006903,0.9998947874981344,0.4918918918918919,0.994619003115199,1.0,5/10,18.39%,NUP62;NSFL1C;CEP72;UBXN2B;BICD1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.38381536186617965,0.9998790627233782,0.45013123359580054,0.9937689937477678,1.0,7/47,7.76%,ATP2B4;PTGIS;CAV1;FBXW7;SNAI2;PLEK;GLA
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5010267008430899,0.9998521072708153,0.4658040665434381,0.9929476913285157,1.0,4/10,18.52%,TP53;RPS27L;HIPK2;RPS6KA6
prerank,regulation of interleukin-2 production (GO:0032663),-0.28202431528709676,-0.9997650382462661,0.4789272030651341,0.8502589718638516,1.0,6/43,9.94%,SPTBN1;HDAC7;PLCG2;CD34;NAV3;HOMER3
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.22823090830729634,-0.9995779902355737,0.4805194805194805,0.8496574526998548,1.0,49/168,19.69%,DDX5;UPF2;PPP2CA;DCPS;RPL27A;SMG1;RC3H2;RPS19;SAMD4B;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;PABPC1;LSM1;RPLP0;RPS29;RPL28;RPS10;DCP2;RPLP1;RPS20;RPL34;RPL23A;NCBP2;PAN2;EXOSC9;RPS8;RPL36A;RPS21;PAN3;CNOT11;TUT4;RPL9;SMG6;RPL27;ZC3H12A;RPS7;PNRC2;ATM;RPL18A;TUT7;RPL11;NBDY;RPL37A;RPL38
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.3321158307866959,-0.9994839986504249,0.48773006134969327,0.8488318106882413,1.0,8/26,19.83%,HMGB1;DDX3X;LBP;PTPN22;RTN4;TLR3;SLC15A4;TIRAP
prerank,regulation of sodium ion transport (GO:0002028),0.40870104563063453,0.9987655626500218,0.4678111587982833,0.994853802947467,1.0,11/34,15.71%,ATP2B4;SNTA1;NEDD4;PRSS8;WNK2;CNKSR3;AHCYL1;GPD1L;SLMAP;YWHAH;NOS1
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.3433220987901237,-0.9986230395797815,0.45454545454545453,0.8499907399476433,1.0,7/21,18.60%,CYP26B1;LPIN2;ACOT8;ACBD5;HOGA1;ACOX1;LPIN3
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.3509967837221413,-0.9985717895282417,0.4713896457765668,0.8490126431040818,1.0,5/18,17.63%,DAB2;RDX;MAP2K2;DNAJC13;SNX3
prerank,regulation of collagen biosynthetic process (GO:0032965),0.4466751381157016,0.9983507006737687,0.45339652448657186,0.9950312899534751,1.0,5/19,8.79%,VIM;TGFB3;EMILIN1;SUCO;RUNX1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.46011261342495813,0.9983170677195937,0.45408163265306123,0.994218454632333,1.0,5/16,16.25%,CGAS;FANCB;RIF1;RMI2;MAD2L2
prerank,regulation of defense response to virus (GO:0050688),-0.39077546063101254,-0.9982063837475825,0.47715736040609136,0.8488932813375737,1.0,4/14,7.40%,ITCH;PPM1B;ILRUN;PCBP2
prerank,cellular response to organic substance (GO:0071310),0.35085977674571645,0.9979910607310901,0.4716981132075472,0.994146653856009,1.0,12/116,7.29%,SLIT3;AKAP6;NR1H4;CACNA1H;PDGFB;IGFBP5;CCL5;ACVR2A;PTPN18;BMPR1A;ARL6IP5;RAMP1
prerank,ERBB2 signaling pathway (GO:0038128),-0.31562326993995826,-0.9978688564475392,0.44694533762057875,0.8486804244075604,1.0,6/31,11.46%,PIK3CA;GRB2;EGFR;GAB1;NRG2;STUB1
prerank,keratinocyte differentiation (GO:0030216),0.4173269750397407,0.9978088141563464,0.4622356495468278,0.9937018279505295,1.0,5/29,12.38%,ANXA1;JAG1;MED1;EPHA2;BCR
prerank,regulation of water loss via skin (GO:0033561),0.4583604597324003,0.9977048215809615,0.46621621621621623,0.9922251172863135,1.0,2/15,4.19%,TMEM79;FA2H
prerank,establishment of skin barrier (GO:0061436),0.4583604597324003,0.9977048215809615,0.46621621621621623,0.9922251172863135,1.0,2/15,4.19%,TMEM79;FA2H
prerank,positive regulation of viral process (GO:0048524),0.3720579269205246,0.9974848027923409,0.4666666666666667,0.991877247538282,1.0,19/60,17.88%,POLR2L;POLR2I;CCL5;TBC1D20;POLR2G;PPARA;CCNT1;PKN2;PPIE;AXL;CNOT7;KPNA2;NELFB;POLR2J;SRPK2;NELFCD;DHX9;VPS4A;RSF1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.38761572923577764,0.9965009960737966,0.467680608365019,0.9935084450061319,1.0,8/50,10.44%,ACTN4;PTP4A3;LIMS1;TCIM;CD14;RELA;RTKN2;EIF2AK2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.2502892029813089,-0.9964302267328711,0.4519774011299435,0.8514722048046679,1.0,18/80,16.68%,UACA;DAPK1;EPHA7;SH3RF1;HMGB1;DDX3X;NOD1;TNFSF10;RPS6KA3;CD44;DELE1;PDCD5;PPM1F;IGBP1;SNCA;FIS1;AKT1;GPX1
prerank,nucleic acid metabolic process (GO:0090304),0.3678370578498342,0.9961845939413225,0.4703030303030303,0.9934213269224959,1.0,15/69,14.87%,LSM8;POLR2L;POLR2I;HNRNPR;ATXN2;POLR2G;HNRNPU;DDX1;POLG;HNRNPC;KPNA2;POLR2J;DXO;DNASE1L1;EXD2
prerank,positive regulation of growth (GO:0045927),0.36875528866910023,0.9960621229719968,0.4720496894409938,0.9928522524436943,1.0,19/64,17.41%,AKAP6;IL2;PABIR1;FXN;BCL2;TGFB2;ADNP2;PLCB1;ADAM17;HDGFL2;CEP43;N6AMT1;RFTN1;HYAL1;EIF4G2;INO80;DDX49;S100A8;S100A9
prerank,regulation of cytoplasmic translation (GO:2000765),0.4702121020449356,0.9956388915360191,0.4825174825174825,0.9930470558988166,1.0,2/14,6.03%,RBM24;CPEB1
prerank,mitochondrial membrane organization (GO:0007006),0.4026974402454326,0.9954599291776594,0.4502840909090909,0.9926771973212745,1.0,7/32,11.23%,PMAIP1;BCL2;RCC1L;MTX1;OPA1;DNAJC11;MFN2
prerank,cellular response to oxidative stress (GO:0034599),0.3444416234702958,0.9949591742805308,0.4850828729281768,0.9930654456408952,1.0,28/118,17.05%,TPM1;NCF2;ANKRD2;CAMKK2;MAPT;PARP1;TP53;PPARGC1A;ADNP2;SRXN1;NUDT2;GSTP1;PYROXD1;LONP1;HIF1A;SIRT2;PRKCD;TXNRD2;LRRK2;PDK2;MAPK1;PRKAA2;ZFAND1;RAD52;MT3;PRDX5;PRDX6;SOD3
prerank,protein homotrimerization (GO:0070207),-0.3820548913440128,-0.9948142128217649,0.47317073170731705,0.8536194588464145,1.0,2/14,3.86%,CLYBL;SCARA5
prerank,protein trimerization (GO:0070206),-0.3820548913440128,-0.9948142128217649,0.47317073170731705,0.8536194588464145,1.0,2/14,3.86%,CLYBL;SCARA5
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4427046450988214,0.9944165768025023,0.453416149068323,0.9936098922844916,1.0,5/20,7.78%,HEY2;HEYL;HAS2;SNAI2;TGFB2
prerank,positive regulation of protein modification process (GO:0031401),0.3326697113771217,0.9941104045012138,0.4984391259105099,0.9935101515402408,1.0,34/203,12.41%,NTRK3;DLC1;ANGPT1;FGF1;CCN1;CCND2;FAM20A;THPO;ACVR2A;MUSK;CAMKK2;DYRK1A;ATG7;RARRES2;PPP2R5A;VEGFA;PIN1;CALM1;TRABD2B;RAMP1;ITGB3;RASGRP1;SOX9;CCND1;ADAM17;RAP2A;PELI2;ROCK2;GPER1;PRKCD;CLIP3;TNIK;AKTIP;CHRNA7
prerank,miRNA metabolic process (GO:0010586),0.44584836865579447,0.9939233214532781,0.47987117552334946,0.9930835770888015,1.0,6/20,13.56%,PARN;DICER1;DIS3L2;XPO5;DROSHA;DGCR8
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.4390057244029365,0.9932540918903491,0.4753577106518283,0.9939305899408444,1.0,5/19,13.21%,AMPD1;TERT;AMPD2;POLD1;GMPR
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.25869391095808647,-0.9931523893504411,0.4382716049382716,0.8569247026325477,1.0,23/76,18.47%,ARRB1;BMP7;ITCH;NFKBIA;IRAK1;PRMT2;PARP10;DAP;USP7;COMMD1;PYDC1;IRAK3;CYP1B1;RBCK1;IRAK2;CHUK;ANXA4;G3BP2;MTURN;NLRC5;LRRC14;NWD1;ZC3H12A
prerank,endoderm formation (GO:0001706),0.402654966002611,0.992771256841378,0.4711673699015471,0.9942577053864624,1.0,5/35,8.48%,COL4A2;ITGA7;DUSP5;ITGB5;ITGA4
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3922840203071094,-0.9926668780654303,0.48687350835322196,0.8570495768526153,1.0,9/14,34.87%,NT5E;UPP2;UPB1;DPYD;DHODH;NT5C1A;UMPS;CAD;ERH
prerank,regulation of Notch signaling pathway (GO:0008593),0.35869790333004753,0.9925239483804394,0.47381242387332523,0.9940306861073129,1.0,16/76,12.47%,NOTCH3;TCIM;JAG1;EPN2;FBXW7;RFNG;MAML2;YTHDF2;YAP1;YJEFN3;TGFB2;MAML3;SREBF2;ZBTB7A;TM2D3;PDCD10
prerank,negative regulation of cell division (GO:0051782),0.48814189293744964,0.9925055119242611,0.4735915492957746,0.9932089464383252,1.0,1/11,1.79%,CHMP4C
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.3958460188957886,-0.9921762086930316,0.47276688453159044,0.857244314014513,1.0,2/13,3.50%,BMP4;GLI2
prerank,regulation of phagocytosis (GO:0050764),0.37949942578714274,0.9919809165728715,0.4726810673443456,0.993652975922087,1.0,4/53,4.36%,MERTK;FER1L5;DYSF;PIP4P2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.4563234890584772,0.9919380918445212,0.45699831365935917,0.9928806321104824,1.0,2/16,2.53%,RORA;PDK4
prerank,Fc receptor signaling pathway (GO:0038093),-0.23656769131663088,-0.9915819701430065,0.45045045045045046,0.8577356944538297,1.0,22/110,14.08%,NFATC3;PIK3CA;GAB2;GRB2;KIT;PDPK1;VAV2;PLCG2;PIK3CB;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;PSMA5;PSMA1;PSMC2
prerank,ncRNA 3'-end processing (GO:0043628),-0.38610271018993364,-0.9914457746007184,0.4755244755244755,0.8569869997931547,1.0,8/14,28.61%,INTS6;TRNT1;SSB;INTS2;PTCD1;ELAC2;INTS14;TOE1
prerank,axon development (GO:0061564),0.3603547901980452,0.9912890327151767,0.4697508896797153,0.9935854640949301,1.0,23/78,18.98%,SEMA5A;MAP1B;SLITRK5;ACTB;KLF7;SLITRK4;MAPT;AFG3L2;RAB3A;BRSK1;GAP43;S100A6;ZDHHC17;ARHGAP35;RTN4RL1;ADGRB1;RAB8A;RYK;MARK2;MAP1A;MAP1S;BRSK2;NREP
prerank,positive regulation of immune effector process (GO:0002699),-0.32406865166112186,-0.9911109231336878,0.44542772861356933,0.8568360449146073,1.0,7/27,15.28%,APPL2;LBP;LGALS9;RPS19;DDX60;CD46;ANKRD17
prerank,regulation of steroid metabolic process (GO:0019218),0.43079226951102967,0.9910185539349823,0.4737654320987654,0.9933729194859969,1.0,2/23,2.36%,NR1H4;RORA
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.47129716241301395,0.9904926559024131,0.514480408858603,0.9937927102309508,1.0,5/14,17.38%,IRS1;PPARA;LONP2;IRS2;MTLN
prerank,regulation of telomere capping (GO:1904353),-0.3308525272788081,-0.9901763571520978,0.45396825396825397,0.858203404285174,1.0,8/23,18.99%,TNKS2;RAD50;USP7;MAP3K4;NBN;HNRNPD;SMG6;ATM
prerank,positive regulation of signaling (GO:0023056),-0.3056350124023934,-0.990140083377173,0.4486301369863014,0.8572114247995057,1.0,13/37,28.15%,ANXA2;SYT1;ECE1;WLS;SNCA;RAB29;RIMS2;CD80;INPP5F;NMU;SCRIB;SOX11;EDN3
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.4196978263367738,0.9898742365116674,0.48807631160572335,0.9944136577370948,1.0,12/25,20.65%,ELL;HEXIM1;HNRNPU;CDK12;NELFB;NELFCD;ZMYND11;BRD4;EAPP;CDK13;NELFA;WDR43
prerank,negative regulation of cellular component movement (GO:0051271),0.45462789211124904,0.9898512772831594,0.4752475247524752,0.9936070546871547,1.0,2/15,6.84%,ACTN1;PIN1
prerank,sphingolipid catabolic process (GO:0030149),-0.3770554442669126,-0.9898357428154995,0.4854368932038835,0.8569668970072822,1.0,4/15,9.83%,ACER2;ENPP2;PPT1;ASAH2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.36740105893235414,-0.9897158655958248,0.44502617801047123,0.8561529584063411,1.0,5/17,13.37%,BMP6;SASH1;CD55;TRIM5;CX3CL1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5091841045047363,0.9895272434434728,0.49544626593806923,0.9935421714023148,1.0,3/10,9.08%,ACAD11;ETFA;ACADS
prerank,regulation of ERAD pathway (GO:1904292),-0.4113061811788173,-0.9894388860561708,0.4594594594594595,0.8558137785184755,1.0,7/11,23.50%,ATXN3;RNF185;USP19;UBXN1;HERPUD1;RNFT1;USP25
prerank,multivesicular body assembly (GO:0036258),0.4048905029685175,0.9889460186564522,0.47832369942196534,0.99406303753585,1.0,10/30,17.21%,CHMP4C;CHMP5;IST1;STAM2;CHMP2B;TSG101;VPS36;CHMP2A;STAM;VPS4A
prerank,response to peptide hormone (GO:0043434),0.3930365183389723,0.9888704339116285,0.48501362397820164,0.9933894992065487,1.0,11/43,15.58%,ROCK1;ANXA1;IGFBP5;SORT1;IRS1;CAV1;ROCK2;GPER1;ZFP36L1;STAT1;STAT3
prerank,regulation of protein sumoylation (GO:0033233),0.44887097211851534,0.9885491837704328,0.4798657718120805,0.993265712138178,1.0,3/17,5.99%,UBA2;PIAS4;SAE1
prerank,NAD biosynthetic process (GO:0009435),0.4403270107639399,0.9884998758247904,0.472,0.9925436291395187,1.0,6/20,16.13%,NMNAT2;PTGIS;NAXE;NMNAT1;NNMT;NAMPT
prerank,modulation of chemical synaptic transmission (GO:0050804),0.342798096683036,0.9884969359708589,0.49099099099099097,0.9916948882859493,1.0,7/107,4.39%,NTF3;MEF2C;ABR;SLC8A2;SLC4A8;ITGB1;RIMS3
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.24412312535563496,-0.9880236717236549,0.4444444444444444,0.858502339425626,1.0,36/108,21.18%,TLE1;LRP1;SULF1;NXN;APP;PTK7;WWOX;APCDD1;PPP2CA;DCDC2;CTNNB1;WLS;ESR1;ATP6AP2;PRKN;RSPO2;SALL1;FGFR2;KREMEN1;CCNY;SFRP4;NOTUM;TMEM237;EMD;RNF43;FOXL1;SNX3;DACT3;CTNND2;DISC1;BTRC;GPC3;RSPO3;MDFI;NFATC1;DACT1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3201481841707254,0.9878358815538969,0.535,0.9924994556536604,1.0,107/834,11.48%,MYOCD;NOTCH3;PPP1R12A;FHL5;HJV;ABRA;MEF2C;HEY2;ZFHX3;NR1H4;SMARCD3;FGF1;MICAL2;CSRP3;ZEB2;PDGFB;PPP3CA;CCN1;MLIP;RORA;FZD5;PLXND1;SS18L2;CDH13;NR4A1;CRTC1;GABPA;HEYL;JAG1;MRTFA;HINFP;TGFB3;CRTC3;FOSL2;ACVR2A;NR2F2;MCRS1;LMO7;VEZF1;ACTR3;ELL;SP7;OSR2;ARHGEF2;BMPR1A;KLF7;MEF2A;NCOA7;ASXL1;FOXJ3;RXRG;DBP;KLF15;JUND;SMARCB1;TERT;DAB2IP;PARP1;VEGFA;TP53;ZBTB38;GRHL1;MAML2;PIN1;GDNF;HOXC4;SFPQ;YAP1;AR;MED1;PPARGC1A;PPARGC1B;MED12;TGFB2;SOX9;RELA;KMT2D;SETD3;TNIP1;MAML3;PPARA;RUNX1;CCNT1;NR1D1;SKI;NR4A2;PAXIP1;KAT7;CDK7;HIF1A;AKNA;SIRT2;KANSL3;CRLF3;AGRN;MED14;HNRNPU;TEAD1;NR2C2;NKX6-1;EIF5A;GPER1;LRP5;SREBF2;PFKM;PCGF5;ATF3
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.3983152676558966,-0.9871265121277172,0.4818181818181818,0.859878098877084,1.0,3/12,8.39%,GKAP1;PTPN11;IGF2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.259857123427747,-0.986957060522247,0.4807692307692308,0.8591969795075974,1.0,22/63,25.30%,CARM1;PRKDC;TFDP1;PML;ARID3A;MDM2;SOX4;RGCC;EP300;PLK2;CRADD;CNOT11;BAX;CHEK2;E2F4;ATM;FBXO31;PCBP4;PLAGL1;CDK2;CDKN1A;CNOT10
prerank,regulation of interleukin-1 production (GO:0032652),-0.3819026205864786,-0.9869175514651366,0.4807692307692308,0.8582006097496891,1.0,4/15,12.39%,FOXP1;HMGB1;TMED10;SIRPA
prerank,positive regulation of autophagy (GO:0010508),-0.24932498786027749,-0.9864597019130875,0.48125,0.8583186109613324,1.0,24/81,19.56%,DAPK1;DCN;HMGB1;PAFAH1B2;TPCN1;FOXO1;GPSM1;PIK3CB;TFEB;OPTN;IKBKG;STK11;FBXO7;PRKN;TRIM5;IRGM;TRIM14;KDR;TMEM59;PLK2;MID2;ZC3H12A;BNIP3L;PARK7
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.38634041954533327,-0.9863782392131282,0.4754521963824289,0.8574383011265111,1.0,5/14,19.83%,IRAK1;CARD10;CARD14;TLR3;TIRAP
prerank,neutrophil activation (GO:0042119),-0.39734276993119877,-0.986109673439448,0.4780600461893764,0.8570271786060243,1.0,2/12,2.00%,KMT2E;IL15
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3418987723552707,-0.9860840695389791,0.48158640226628896,0.8560057767980407,1.0,6/22,16.16%,BMP7;B2M;HES1;DTX1;CALR;CNTN4
prerank,carbohydrate catabolic process (GO:0016052),0.39376175782078565,0.9860813023457418,0.48700410396716826,0.9959170941400298,1.0,7/38,11.40%,ENO3;HK2;PFKFB1;NEU3;MAN2C1;ALDOA;PFKM
prerank,T cell receptor signaling pathway (GO:0050852),-0.23272085263401904,-0.9859714667604438,0.48717948717948717,0.8551914889139074,1.0,29/138,15.91%,PIK3CA;WNK1;PDPK1;KHDRBS1;RC3H2;FYB1;PLCG2;DENND1B;NCK1;PIK3CB;PSMD7;PSMD9;PSMD13;PTPN22;IKBKG;RBCK1;TAB2;RNF31;PSMB3;CHUK;EIF2B3;NFKBIZ;PSMC5;PSMA5;PSMA1;PSMC2;STOML2;THEMIS;SPPL3
prerank,regulation of filopodium assembly (GO:0051489),-0.292507080384787,-0.9856812403125055,0.47126436781609193,0.854856356649045,1.0,17/38,28.30%,PALM;DOCK11;NRP1;RAB5A;NLGN1;FNBP1L;RIPOR2;DPYSL3;RHOQ;CDC42;FMR1;GPM6A;FSCN1;FXR1;ABITRAM;ARAP1;TENM1
prerank,regulation of mRNA stability (GO:0043488),0.3412611352617486,0.9856785061391263,0.47261009667024706,0.9960515974358646,1.0,29/145,15.00%,RBM24;TENT5B;ROCK1;VIM;SAMD4A;PARN;SET;PSMC6;MAPKAPK2;CIRBP;YTHDF2;GDNF;CELF1;FTO;FASTKD1;FUS;PSME4;PSMB1;HNRNPU;PSMD5;ROCK2;PRKCD;DCP1A;ZFP36L1;PSMB2;GIGYF2;PSMB7;PSMD3;PRKCA
prerank,phosphatidylinositol metabolic process (GO:0046488),0.3447181444679229,0.9856501217708541,0.49099099099099097,0.9952473730931761,1.0,28/109,15.75%,PIP5K1B;INPP4B;PLA2G3;PIP4K2A;MTMR7;PITPNM3;PIP4P2;SYNJ2;SACM1L;PLEK;PLCB1;INPPL1;PLCD1;PDGFRB;MTMR14;INPP5B;CDIPT;SBF1;TPTE;PIK3C3;PLA2G4A;RAB14;PLEKHA1;PLA2G4C;INPP5J;PTEN;PITPNM2;VAC14
prerank,neurotransmitter secretion (GO:0007269),0.38297686008948467,0.9855828094604752,0.4900662251655629,0.9945567755299344,1.0,6/44,9.21%,STXBP2;SYT10;RAB3A;LIN7C;BRSK1;HRH3
prerank,negative regulation of stress fiber assembly (GO:0051497),0.41937506852704287,0.9854080619318166,0.46766917293233085,0.9941409575800666,1.0,4/24,4.80%,DLC1;PHLDB2;CLASP2;ARHGAP6
prerank,positive regulation of cellular component organization (GO:0051130),-0.23721694125606002,-0.9849102745991544,0.46788990825688076,0.8558755697669627,1.0,29/107,20.07%,DAB2;FRMPD4;LRP1;NEDD4L;BMP7;CDH5;APOE;ABCB7;SHANK3;SLF2;CAMK1;TMEM30A;SURF4;ICE1;TGFB1;SLF1;NRXN1;TGFBR1;INSR;SNCA;MMP1;GPX1;LMAN1;BAX;PARK7;AJUBA;GPC3;TIRAP;BID
prerank,intracellular protein transport (GO:0006886),-0.20748390960514645,-0.9843615159397304,0.5555555555555556,0.8562601775299015,1.0,82/304,19.20%,RANBP3L;APPL2;TBC1D16;KIF13B;SNX27;E2F3;RABGAP1L;RAB5A;NLGN1;STXBP1;STX3;FAM53A;TBC1D15;USO1;ERP29;TBC1D8B;NUP88;TMED5;RASSF9;SEC23IP;SCG5;TBC1D2B;TBC1D13;TBC1D5;STX5;HERC2;STX4;ARL5B;TMED7;TBC1D8;SURF4;NUTF2;IPO8;TMED10;COPB2;WLS;FUT10;HOMER3;RANBP3;TGFB1;RAB3GAP2;SNX6;ARF3;UNC93B1;ARFIP2;SNX15;PTTG1IP;TBC1D25;SGSM1;GRTP1;TBC1D9B;APPL1;MYO6;NUP50;TBC1D30;ARFGAP3;RAB1A;MAIP1;CALR;TBC1D22A;RAB29;TBC1D9;CCHCR1;GIPC1;EIF4ENIF1;EHD1;STX1A;AKT1;SGSM3;COG7;LMAN1;TMED3;PICK1;RAB1B;STX8;SCFD1;TBC1D10A;NAPG;RPL11;TMED4;SRPRA;NUP85
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.37183457556107624,0.9841688162934766,0.47741147741147744,0.9964394881076086,1.0,15/61,16.77%,NR1H4;OAZ2;PDK4;PSMC6;CAV1;PPARA;PSME4;PSMB1;PSMD5;PSMB2;PDK2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,regulation of fatty acid oxidation (GO:0046320),0.4515269991843644,0.9839767554147233,0.4940374787052811,0.9960632539742772,1.0,6/16,13.93%,PDK4;PPARGC1A;SOX9;PPARA;LONP2;SIRT4
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.32489610138528463,-0.983898880151283,0.4602649006622517,0.8564076607689813,1.0,3/25,0.68%,IGF1;NSD1;NIBAN2
prerank,mesonephros development (GO:0001823),0.48754432310907314,0.9836227461809788,0.4982394366197183,0.9960811209400512,1.0,2/11,4.96%,FGF1;OSR2
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.3138275253608622,-0.9835457956095007,0.46357615894039733,0.8562328863772644,1.0,17/31,28.95%,DCPS;LSM1;DIS3;EXOSC1;DCP2;EXOSC9;EDC4;LSM7;EXOSC2;EDC3;LSM5;LSM2;EXOSC3;EXOSC7;LSM3;EXOSC5;LSM6
prerank,positive regulation of signal transduction (GO:0009967),0.3266376761439374,0.9834455075947596,0.5229645093945721,0.9956170760276801,1.0,45/238,14.21%,NTF3;FLNA;NTRK3;SLC2A4;FGF1;LIMS1;JAG1;DEPDC1B;KANK1;PTGIS;ASXL1;MN1;IRS1;MBD5;EPN2;SMARCB1;TERT;DAB2IP;LIMS2;SORBS1;MAML2;YAP1;ITGB3;TGFB2;TTC23;MAML3;CUX2;SLC39A14;SKI;HIF1A;AXL;GPER1;CD180;STK36;TM2D3;CHRNA7;PDCD10;HOMER1;CITED2;DMTN;SPIN1;LRRK2;GAS6;TUBD1;RAB34
prerank,ncRNA export from nucleus (GO:0097064),0.3991854240615232,0.9830323728552661,0.49511854951185497,0.9957683329838705,1.0,13/36,20.82%,NOL6;NUP62;SEC13;NUP153;NUP107;AAAS;NUP37;NUP98;NUP210;NUP54;NUP160;NUP133;TPR
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3507813982977277,0.9830165597738583,0.5068181818181818,0.9949461481336636,1.0,8/107,6.56%,ATP2A1;MAP3K5;ATP2A2;ITPR1;TMEM259;BCL2;DAB2IP;TP53
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.31128169459666705,-0.9827809408950252,0.4636363636363636,0.8570585409550929,1.0,9/28,19.99%,PRKDC;PARP3;SMCHD1;SIRT7;DTX3L;WRAP53;KDM4D;HSF1;HMGA2
prerank,negative regulation of ossification (GO:0030279),0.42785231913175326,0.9826675295086504,0.4795144157814871,0.994913529295483,1.0,3/23,8.71%,MEF2C;SOX9;TRPM4
prerank,embryonic digestive tract development (GO:0048566),0.45045021450042727,0.982645867760007,0.4766666666666667,0.9941132358168814,1.0,3/18,7.78%,RBPMS2;RARRES2;TGFB2
prerank,ribosomal large subunit assembly (GO:0000027),0.43437927238389085,0.9824893469467212,0.4884080370942813,0.9936489226839088,1.0,7/24,17.48%,RPL3L;NLE1;MDN1;RPL5;DHX30;FASTKD2;BOP1
prerank,long-term memory (GO:0007616),0.43646458161089563,0.9822768593662591,0.495114006514658,0.9933557197122167,1.0,4/19,13.83%,SLC2A4;CALB1;CPEB3;SGK1
prerank,protein heterotetramerization (GO:0051290),-0.39189240856545376,-0.9822006518557209,0.49537037037037035,0.8574870595410847,1.0,6/13,41.71%,PKD2;FARSB;CPSF6;HSD17B8;GRIN1;GRIN2B
prerank,histone deubiquitination (GO:0016578),-0.362538245782093,-0.9821179234783319,0.46965699208443273,0.8566111430725433,1.0,4/18,14.57%,USP7;BRCC3;USP3;ATXN7
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3213234364736465,0.9818764125324797,0.5262096774193549,0.9934703205104266,1.0,51/366,12.04%,SOX6;MLF2;WTIP;MEF2C;ZFHX3;PTP4A3;LIMD1;CCNA2;NAB1;RORA;MLF1;HINFP;GMNN;RBAK;ATXN1;PRKCQ;ATXN2;MYBBP1A;TP53;ZBTB38;SNAI2;SFPQ;CYFIP1;PPARGC1A;BTG1;PPARGC1B;ZNF431;REXO4;RELA;KMT2D;DAPK3;NSD3;FUS;MSL3;PPIE;KAT7;HIF1A;NR2C2;NUP107;PDGFA;SRSF10;RBM3;DDX25;RB1;RHOH;ACVR1B;BAZ2A;NFX1;ESRRA;PSPC1;USP13
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3674077536379141,0.9818763901643457,0.49302915082382764,0.9926204742140106,1.0,9/60,10.85%,PARM1;PDGFB;PARN;PRKCQ;PKIB;CHTF18;NAF1;PDGFRB;CCT3
prerank,muscle cell migration (GO:0014812),0.46740693949875767,0.9818542406899007,0.5018450184501845,0.9918200553726786,1.0,2/10,7.40%,ROCK1;ITGB3
prerank,tRNA 5'-end processing (GO:0099116),0.447178081556191,0.9815743332081426,0.4852459016393443,0.9916716454213134,1.0,2/15,5.62%,HSD17B10;TRMT10C
prerank,steroid metabolic process (GO:0008202),0.36261658265889807,0.9814359200006127,0.4907521578298397,0.9911387756056941,1.0,7/72,5.68%,HSD17B10;CYP7B1;DHRS4;HSD17B7;PIAS4;GC;HSD17B4
prerank,copper ion homeostasis (GO:0055070),-0.3509844586382743,-0.9813850671254822,0.5089514066496164,0.8574125395469758,1.0,4/17,15.71%,APP;ATOX1;COMMD1;MT2A
prerank,regulation of stem cell proliferation (GO:0072091),-0.3589555961565043,-0.9813121045743992,0.49193548387096775,0.8565374463693028,1.0,3/17,1.74%,AGO3;FBLN1;GJA1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.37571902665645873,0.9812737299869828,0.4896907216494845,0.9906813380005173,1.0,12/52,11.81%,ATP2B4;STAC;ITGA3;ITGB1;ARHGEF16;STAC3;SORBS1;KIF5B;EPHA2;GPER1;CLIP3;DPP10
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.41609161956641855,0.9811329339174126,0.4904831625183016,0.9902113552237302,1.0,5/25,11.01%,PMAIP1;TP53;HRK;DNM1L;GPER1
prerank,pore complex assembly (GO:0046931),-0.35291882416976417,-0.9804234350282628,0.48517520215633425,0.8578153727786424,1.0,8/19,22.41%,AFDN;ADAM10;AHCTF1;GSDMD;RTN4;NDC1;PLEKHA7;PDZD11
prerank,regulation of membrane depolarization (GO:0003254),0.44521303284034763,0.9802205457408734,0.49421487603305786,0.9916044418588125,1.0,5/18,16.30%,CAMK2D;FHL1;GPD1L;LRRK2;GJA5
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.3273571313802298,-0.980139746938158,0.4900662251655629,0.8574903955842849,1.0,9/26,17.95%,LGR4;APPL2;BIRC2;IRAK3;APPL1;BIRC3;GPR108;TLR3;LRRC14
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.32450186132041225,-0.980124206875771,0.4660493827160494,0.8564657740954311,1.0,11/26,33.55%,PDE8A;FBXO7;PRKN;AKT1;PARK7;ATF4;MAPK7;BAG5;HTRA2;PPIA;GPR37
prerank,multivesicular body organization (GO:0036257),0.40028699986690547,0.9792412230193218,0.4964131994261119,0.9932244195859302,1.0,10/31,17.21%,CHMP4C;CHMP5;IST1;STAM2;CHMP2B;TSG101;VPS36;CHMP2A;STAM;VPS4A
prerank,regulation of defense response (GO:0031347),0.35493083292385064,0.9792020037658814,0.5047846889952153,0.9924728102029231,1.0,12/76,9.64%,AGTR1;MYD88;ANXA1;ALOX5;ELMOD2;SETD6;PIK3AP1;CELF1;TRAF3;RELA;MGLL;AKNA
prerank,regulation of intracellular protein transport (GO:0033157),-0.3054393629612496,-0.9789024696334674,0.5231316725978647,0.8587289666614328,1.0,10/32,10.39%,PTPN14;BMP4;PCM1;RUFY3;PRR5L;UHMK1;GCC2;SIRT7;ICE1;TGFB1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.47180685655129156,0.9787325599023837,0.5140961857379768,0.9927684097865109,1.0,5/14,18.51%,NMNAT2;AK7;NMNAT1;CMPK1;CMPK2
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.4681877152142161,0.9778703283505199,0.5043630017452007,0.994020360874624,1.0,3/13,6.68%,DYRK2;IRS1;SORBS1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.40381028654470874,-0.9771630948411425,0.4911504424778761,0.862266732830455,1.0,2/11,7.18%,WNT5A;CTNNB1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.3703551267558565,-0.9764710083654805,0.47869674185463656,0.8629501945107444,1.0,3/15,1.17%,UST;DCN;DSE
prerank,regulation of neuron migration (GO:2001222),-0.3235949977275705,-0.9763544586662338,0.4839650145772595,0.8621693476491261,1.0,4/26,7.43%,PHACTR1;SEMA6A;SRGAP2;SEMA3A
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.40695253128071396,0.9761770449867655,0.4952120383036936,0.9973054834533006,1.0,3/29,6.31%,VASN;SDHAF2;DAB2IP
prerank,anterior/posterior pattern specification (GO:0009952),-0.2735564047890196,-0.9760951248970829,0.4470046082949309,0.8617859222530928,1.0,12/53,12.27%,HOXB6;HOXB3;PCSK5;HOXA3;HOXB4;HOXA5;BMPR2;WLS;ATP6AP2;HES1;BHLHE41;TGFBR1
prerank,response to gamma radiation (GO:0010332),0.42364821052126783,0.9760474452406801,0.5055292259083728,0.996772683206936,1.0,3/24,7.10%,MAP3K20;TP53;YAP1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.41229423619604544,-0.9755627339497486,0.49330357142857145,0.8621234597624426,1.0,4/10,13.33%,WNK1;PODXL;PIEZO1;DPP4
prerank,histone mRNA catabolic process (GO:0071044),-0.37450600317415317,-0.9755383524758189,0.4940898345153664,0.8611150939462086,1.0,6/15,19.09%,SSB;LSM1;DCP2;TUT4;ATM;TUT7
prerank,mitochondrial fusion (GO:0008053),0.4367260615218461,0.9753617043211754,0.4930232558139535,0.9975797811739627,1.0,9/18,21.84%,AFG3L2;OPA1;MIEF2;MIEF1;MFN2;USP30;MFF;MFN1;GDAP1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.4739795573412061,0.9753552635919807,0.49644128113879005,0.996757519834419,1.0,3/12,6.68%,DYRK2;IRS1;SORBS1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.4507233348518317,0.9751471003270736,0.4890756302521008,0.9964200480835672,1.0,2/16,5.14%,RYR2;TAPT1
prerank,regulation of mitotic spindle organization (GO:0060236),0.3999198983385386,0.9749766617293966,0.5013927576601671,0.9959666685658931,1.0,10/35,19.02%,CHMP4C;NUP62;CHMP5;TPX2;HNRNPU;CHMP2B;CHMP2A;MAP9;DCTN1;CLTC
prerank,selective autophagy (GO:0061912),-0.26394825878813605,-0.9748532661358262,0.4838709677419355,0.8618291841306737,1.0,23/56,21.96%,RB1CC1;DYNC1I1;DYNC1LI2;UBQLN1;RETREG1;TEX264;IFT88;ATG5;PRKN;PEX5;ATG2B;UBC;AMBRA1;ACBD5;ATG2A;LGALS8;KLHL3;ATM;PARK7;DYNLL2;PCNT;WDR81;UBB
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.4244571397214288,-0.9745928922212739,0.5033259423503326,0.8615032601712499,1.0,5/10,23.24%,NF2;PPP2CA;PARP14;PTPN2;INPP5F
prerank,regulation of mast cell activation (GO:0033003),0.4807592476302498,0.9745781580132864,0.5125448028673835,0.9960718975596423,1.0,2/10,12.09%,MILR1;NECTIN2
prerank,sulfur compound catabolic process (GO:0044273),0.39610830070587366,0.9745219784510554,0.5166204986149584,0.9953622064529091,1.0,5/38,6.10%,CSPG4;NUDT7;BGN;TXN2;OGN
prerank,regulation of integrin activation (GO:0033623),0.4569128005255345,0.9742992565210452,0.5177065767284992,0.9950223981486042,1.0,3/15,7.53%,FERMT2;JAM3;PLEK
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.3406265643988901,-0.9742344660015285,0.4831168831168831,0.8614275933389237,1.0,9/21,22.58%,CGNL1;SLIT2;CYRIB;CD2AP;SPRY2;ARHGAP25;SYNGAP1;MAPKAP1;EPHB2
prerank,regulation of JUN kinase activity (GO:0043506),0.3994078175073915,0.9740348338757115,0.5110803324099723,0.994803890340247,1.0,5/33,9.05%,MAP3K5;TNFRSF11A;DAB2IP;MAP3K10;GSTP1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.44013328127758733,0.9739574856629541,0.49682539682539684,0.9941759257214352,1.0,5/19,13.94%,CCL5;JAM3;RARRES2;MPP1;MAPK1
prerank,nucleosome organization (GO:0034728),0.3668714310171794,0.9736513671445739,0.5037974683544304,0.994095246419983,1.0,8/55,9.94%,SMARCD3;H1-0;SET;ARID1A;CHAF1B;SMARCB1;SOX9;MCM3AP
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.47518050139758145,0.9733405611540095,0.5172413793103449,0.9939799644880337,1.0,1/11,2.72%,CDH13
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.4270798634013174,0.9733286588221215,0.5109375,0.9931768686823172,1.0,6/20,13.09%,AMPD1;NT5C2;LHPP;AMPD2;PPAT;ADSS1
prerank,phospholipid catabolic process (GO:0009395),-0.330667642714575,-0.9729322066184617,0.4813753581661891,0.8637783514637677,1.0,10/24,32.67%,ENPP2;GDPD1;ABHD12;GPCPD1;GDE1;PNPLA6;ENPP6;SMPDL3A;SMPD4;ANGPTL3
prerank,carboxylic acid transmembrane transport (GO:1905039),0.39171737585646726,0.9728593061160085,0.496513249651325,0.993505679929443,1.0,6/40,10.31%,SLC38A11;SLC16A7;SLC38A2;SLC23A2;SLC23A1;SLC7A8
prerank,regulation of epithelial cell differentiation (GO:0030856),0.4504997926542089,0.9728007437503363,0.49122807017543857,0.9928136676011378,1.0,4/17,7.85%,KLF7;CAV1;AJAP1;SOX9
prerank,carbohydrate derivative transport (GO:1901264),-0.34825189094886494,-0.9724418461823428,0.4735376044568245,0.8639763846935017,1.0,6/18,22.17%,PLTP;LBP;SLC10A7;CLN3;SLC15A4;MFSD2A
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.4650835824403474,0.9724187751796243,0.4948805460750853,0.9928898780930285,1.0,2/13,2.99%,LTBP1;GREM2
prerank,negative regulation of synaptic transmission (GO:0050805),-0.3300385526109508,-0.9723695366124333,0.5027027027027027,0.8630830088383638,1.0,10/23,25.78%,STXBP1;GRIK3;PRRT1;SLC30A1;SYT11;PLK2;PICK1;DRD2;MTMR2;SLC24A2
prerank,regulation of axon regeneration (GO:0048679),-0.395960673263138,-0.9721606210495903,0.5,0.8625237576021157,1.0,2/12,2.83%,PTN;EPHA4
prerank,glucose metabolic process (GO:0006006),0.36273619501623305,0.9720264907790241,0.4898989898989899,0.9930743523170596,1.0,14/58,15.62%,ENO3;PFKFB1;MDH1;ADPGK;PPARGC1A;GOT1;GOT2;SLC39A14;ALDOA;LRP5;CRTC2;SLC25A12;IRS2;GAPDHS
prerank,response to chemokine (GO:1990868),-0.39093383602488724,-0.9716326770885001,0.47101449275362317,0.8628465613725148,1.0,6/13,18.47%,WNK1;SLC12A2;RIPOR2;DUSP1;LRCH1;ZC3H12A
prerank,inflammatory response (GO:0006954),0.3268045301982353,0.9716249830482547,0.5477439664218258,0.9932400844275697,1.0,13/195,7.91%,AGTR1;AOC3;TMIGD3;PTGER3;ANXA1;CCL5;HDAC9;MFHAS1;CD14;TNFAIP6;MAPKAPK2;IL22;RELA
prerank,defense response to fungus (GO:0050832),0.43684799160546506,0.9716226478390471,0.5071542130365659,0.9924178336214167,1.0,4/17,17.41%,RARRES2;FAM3A;S100A8;S100A9
prerank,regulation of transposition (GO:0010528),-0.3912824736497826,-0.9715972364801464,0.504950495049505,0.8618974027285352,1.0,3/13,17.92%,UBR2;SIRT7;TEX15
prerank,homeostasis of number of cells (GO:0048872),-0.39245556089681694,-0.9715213208812767,0.4930232558139535,0.8610612867133418,1.0,3/12,9.09%,NAPEPLD;NOS3;CCN3
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.37644152318826957,0.9713186295816347,0.5020408163265306,0.9923307895908139,1.0,11/42,16.62%,CGAS;RAD51AP1;PARP1;CHEK1;ERCC6;FUS;FANCB;RIF1;RMI2;MAD2L2;SIRT6
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.30117939891471,-0.9711798406338565,0.5121107266435986,0.8608777616942925,1.0,5/34,8.32%,WNT5A;RBP4;SLC7A5;STX4;PTPN22
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.3904769054442513,-0.971162457172092,0.5092592592592593,0.8598685195593025,1.0,3/11,18.55%,CASP8;TGFB1;HSF1
prerank,negative regulation of cellular protein localization (GO:1903828),-0.2995488180504936,-0.970714303876712,0.476038338658147,0.8598702694957345,1.0,7/34,8.84%,NEDD4L;ANKRD13A;OTUD7B;ILRUN;LATS2;COMMD1;RIPOR2
prerank,regulation of cellular protein metabolic process (GO:0032268),0.3720393390754822,0.9703723764639149,0.5025510204081632,0.9937547790848328,1.0,6/47,11.42%,AGTR1;EDNRB;ATXN2;CYFIP1;RBM3;DDX25
prerank,positive regulation of type I interferon production (GO:0032481),-0.25582004176937156,-0.9703396469343581,0.47619047619047616,0.8597761506188086,1.0,34/73,27.49%,DDX3X;PTPN11;PRKDC;XRCC5;RNF135;MRE11;IRAK1;POLR3F;CTNNB1;PTPN22;RIOK3;POLR3B;CHUK;XRCC6;POLR3A;EP300;POLR3H;TRIM56;TLR3;OAS2;POLR3E;STAT6;POLR2K;POLR2F;POLR2H;HSPD1;POLR3GL;POLR3C;TOMM70;DDX41;POLR3D;POLR2E;NFKB2;PQBP1
prerank,regulation of spindle assembly (GO:0090169),0.42270858943774353,0.9702807279339707,0.49244712990936557,0.9931515637332835,1.0,6/25,13.62%,CHMP4C;CHMP5;HNRNPU;CHMP2B;SENP6;CHMP2A
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.31158570092265825,-0.9697739376286381,0.4878048780487805,0.8601810064281737,1.0,7/26,15.58%,DAB2;FOXP1;CRY1;VPS18;PER1;CALR;CRY2
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.4286945361046141,0.969104549354842,0.516380655226209,0.9951599443831319,1.0,6/19,10.78%,ROCK1;CBFB;SNAI2;RUNX1;EPHA2;ROCK2
prerank,fibrinolysis (GO:0042730),-0.3844670203094172,-0.9688702868310657,0.4892086330935252,0.8614926569069381,1.0,9/13,56.84%,PLAT;SERPINE1;PLAUR;PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA
prerank,protein import (GO:0017038),-0.24892040331682525,-0.9688295085547562,0.5510204081632653,0.8605529573103147,1.0,28/84,22.09%,APPL2;APOE;HSPA4;E2F3;PEX14;FAM53A;SLC25A17;NUP88;ALDH3A2;NUTF2;IPO8;PEX5;ACBD5;PTTG1IP;ABCD3;APPL1;NUP50;FIS1;EIF4ENIF1;AKT1;SAMM50;NUP85;IPO11;PXMP2;NXT2;PEX13;NUP214;RAN
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.37860028362554166,-0.9688228229042752,0.5318627450980392,0.8595258381361555,1.0,3/14,3.91%,ATR;TNKS2;XRCC5
prerank,cholesterol metabolic process (GO:0008203),-0.2527109008207709,-0.9687783805649908,0.5055555555555555,0.8585865398840616,1.0,32/68,37.08%,CYP27A1;APOE;ABCA1;LBR;GGPS1;CYP51A1;SCARF1;HMGCR;ACLY;ARV1;SOAT1;INSIG1;PIP4P1;SQLE;GBA2;PMVK;LSS;MVK;CLN8;RXRA;INSIG2;EBP;TSKU;PPARD;ABCA5;ANGPTL3;TM7SF2;CLN6;SCAP;DHCR7;LCAT;CH25H
prerank,positive regulation of neurogenesis (GO:0050769),-0.2567341786121445,-0.9680877585214969,0.5697674418604651,0.8593611104909101,1.0,21/68,19.78%,PLXNA2;ROBO1;SLIT2;CUX1;SHANK3;TIAM2;CTNNB1;PLXNA4;CDKL3;SPEN;CUL7;PTPRD;SNW1;FBXW8;CX3CL1;FAIM;NUMB;OBSL1;KDM1A;DISC1;NAP1L1
prerank,Golgi to endosome transport (GO:0006895),-0.3584458793901708,-0.96798028581939,0.49640287769784175,0.8586002033692991,1.0,4/16,10.78%,VPS13A;MON2;GBF1;EPS15
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.4674598484129525,0.9670335856361832,0.5160256410256411,0.9992842863034819,1.0,2/13,5.55%,MYD88;PIK3AP1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.34453063992477784,0.9662163772929906,0.5036231884057971,1.0,1.0,9/75,7.78%,COL4A2;ATP2B4;ROCK1;ANGPT4;ALOX5;EMILIN1;DAB2IP;YJEFN3;TGFB2
prerank,lipid oxidation (GO:0034440),0.4638504686073859,0.9654372272534553,0.4893238434163701,1.0,1.0,2/12,7.37%,ALOX5;PPARGC1A
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.45033339730877364,0.9652172312485618,0.523728813559322,1.0,1.0,4/13,8.66%,PDGFB;SOX9;RELA;PPARA
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.3344735132736587,-0.9650854933262115,0.47904191616766467,0.865028023585968,1.0,6/21,13.45%,IGF1;LGALS9;CTSH;ITGAV;MAP2K2;KDR
prerank,positive regulation of developmental growth (GO:0048639),-0.27323312458449733,-0.9647471134929655,0.5146443514644351,0.8648650117920456,1.0,7/49,7.65%,NEDD4L;GHR;SEMA7A;RUFY3;GOLGA4;SYT1;SEMA4D
prerank,nucleus organization (GO:0006997),0.37669039776411023,0.96470742360959,0.5111989459815547,1.0,1.0,15/47,20.82%,CHMP4C;SYNE1;PITPNB;CHMP5;SUN2;CHMP2B;DMPK;CHMP2A;NUP98;SUN1;VPS4A;USP36;NUP54;NUP133;TPR
prerank,calcineurin-mediated signaling (GO:0097720),-0.4095291402659025,-0.9645649462801534,0.4988962472406181,0.863268088460309,1.0,2/10,0.85%,NFAT5;NFATC3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4095291402659025,-0.9645649462801534,0.4988962472406181,0.863268088460309,1.0,2/10,0.85%,NFAT5;NFATC3
prerank,regulation of MAPK cascade (GO:0043408),0.32795165813968163,0.9645617740240404,0.5313531353135313,1.0,1.0,31/157,14.68%,NTRK3;ROCK1;LBH;PDGFB;CCN1;ROR1;ADRA1D;FAM83D;THPO;BCAR3;KSR1;CAV1;DAB2IP;DUSP3;RRAS;RASGRP1;MAP2K1;GSTP1;PAK2;EPHA2;PELI2;ROCK2;PDGFA;GPER1;ZDHHC17;TNIK;TAOK3;FGF10;MAPK1;EPHB1;ROR2
prerank,regulation of protein catabolic process (GO:0042176),0.33816945407379234,0.9644683125200223,0.515358361774744,1.0,1.0,10/99,7.94%,FLNA;NKD1;OAZ2;FAM83D;ATG7;ZDHHC2;DAB2IP;PIN1;NEDD4;SF3B3
prerank,lytic vacuole organization (GO:0080171),0.3939828343270742,0.9638794778733878,0.5,1.0,1.0,9/32,13.77%,CLN5;HOOK2;ACP3;CLVS1;HOOK1;MBTPS1;AKTIP;HPS4;LRRK2
prerank,positive regulation of interferon-gamma production (GO:0032729),0.37236462583594937,0.9638250735038703,0.5045513654096229,1.0,1.0,6/48,7.48%,FZD5;CD276;IL12RB2;CD14;IL12RB1;RASGRP1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.36967179833659586,0.9632426898170222,0.5033200531208499,1.0,1.0,8/46,13.93%,FLNA;UBR5;TP53;NEDD4;BAG3;PRKCD;TRIM28;GAS6
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.4151827533164985,-0.9632082439936093,0.5525114155251142,0.8657659203874586,1.0,3/10,5.53%,WNK1;WNT5A;ADAM10
prerank,detection of visible light (GO:0009584),-0.35629239509449334,-0.962774027460045,0.5071090047393365,0.8658563277698279,1.0,7/16,41.06%,ABCA4;CEP250;RP1;CACNA2D4;TULP1;GNA11;CNGB1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3128384013804007,0.9615312719537571,0.657,1.0,1.0,124/1082,10.84%,ACTA2;MYOCD;PRDM16;PPP1R12A;FHL5;TNNI2;HJV;ABRA;MEF2C;HEY2;ZFHX3;MAP3K5;NR1H4;SMARCD3;FGF1;LBH;CSRP3;RASL11A;ZEB2;PDGFB;PPP3CA;CCN1;MLIP;RORA;FZD5;SS18L2;CDH13;NR4A1;CRTC1;GABPA;HEYL;JAG1;ETS2;PADI2;MRTFA;FZD4;HINFP;TGFB3;CRTC3;H1-0;FOSL2;ACVR2A;NUP62;NR2F2;MCRS1;LMO7;TGFB1I1;ARID1A;VEZF1;CAMKK2;ACTR3;ELL;SP7;OSR2;ARHGEF2;BMPR1A;CEP290;KLF7;MEF2A;DYRK1A;NCOA7;ASXL1;FOXJ3;RXRG;TESC;DBP;KLF15;JUND;SMARCB1;DAB2IP;PARP1;PPM1A;VEGFA;TP53;DYRK1B;ZBTB38;GRHL1;MAML2;PIN1;GDNF;HOXC4;SFPQ;YAP1;AR;MED1;PPARGC1A;PPARGC1B;CHEK1;MED12;SOX9;ERCC6;RELA;KMT2D;SETD3;PLCB1;TNIP1;ZXDC;MAML3;PPARA;MAP2K1;RUNX1;CCNT1;NSD3;NR1D1;SKI;NR4A2;KAT7;CDK7;HIF1A;AKNA;SERTAD2;SIRT2;KANSL3;SFR1;CRLF3;AGRN;MED14;HNRNPU;TEAD1;NR2C2;NAT14;NKX6-1;RAI1;EIF5A
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.4135735273422997,-0.9611585989569538,0.5296803652968036,0.8691004891083416,1.0,5/10,35.82%,IRAK3;MAPK7;SIGIRR;TLE5;KLF4
prerank,regulation of protein kinase B signaling (GO:0051896),0.32261727819810054,0.9611138824499281,0.5570680628272251,1.0,1.0,38/193,15.69%,NTRK3;ANGPT1;FGF1;MST1R;HIP1;PDGFB;FERMT2;SEMA5A;THPO;ITGB1;GCNT2;MFHAS1;PIK3AP1;MTDH;IRS1;RRAS;PHLDA3;AREG;PPARA;THEM4;EPHA2;PDGFRB;AXL;HBEGF;VAV1;PDGFA;GPER1;RICTOR;TPTE;FGF10;MUL1;GAS6;PLEKHA1;IRS2;PTEN;RHOG;PPP2R5C;MYDGF
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.3800313616738743,0.9610276718924625,0.5158620689655172,1.0,1.0,7/38,12.46%,ATP2B4;CD36;PTGIS;CAV1;GLA;ROCK2;CLU
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4305792854815069,0.9603473013952649,0.5134228187919463,1.0,1.0,2/18,2.48%,FER1L5;DYSF
prerank,amino acid transport (GO:0006865),0.3781542339454735,0.9603166266358515,0.5298804780876494,1.0,1.0,11/49,14.95%,SLC38A11;SLC6A17;SLC38A2;SLC25A29;SLC1A5;SLC7A8;SH3BP4;SLC6A15;SLC38A1;SLC7A2;SLC38A3
prerank,regulation of catabolic process (GO:0009894),0.4318392829693001,0.9602636984510211,0.49921996879875197,1.0,1.0,4/18,5.91%,FAM83D;ITGB1;RARRES2;ZDHHC2
prerank,regulation of ruffle assembly (GO:1900027),-0.32564232690597533,-0.9596859377993581,0.5302593659942363,0.871835257136056,1.0,8/23,16.18%,EPS8;NLGN1;RDX;PLEKHM1;PFN1;PFN2;EPS8L2;EVL
prerank,inner ear morphogenesis (GO:0042472),-0.32852739432541816,-0.9596693817906828,0.5014925373134328,0.8708402619588503,1.0,5/22,13.58%,ZIC1;CHD7;FGFR2;SIX1;MYO6
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.3873570368392074,0.9596608901873019,0.5173852573018081,1.0,1.0,3/39,2.64%,ANGPT1;SEMA5A;ANO6
prerank,histone acetylation (GO:0016573),-0.2562169215708162,-0.9596246028220362,0.5157894736842106,0.8699317502646451,1.0,18/69,17.93%,LEF1;PHF20;MBIP;TADA2A;YEATS2;TADA1;ATF2;NAA50;DR1;EP300;BRPF1;PER1;NAA60;TAF12;MORF4L2;MEAF6;TRIM16;TAF6L
prerank,regulation of chemokine production (GO:0032642),-0.2923206249509842,-0.9594407796571225,0.5136986301369864,0.8694020212384787,1.0,6/36,8.54%,FOXP1;APP;IL18;WNT5A;LGALS9;IL6R
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.4089905188711275,-0.9593168666754573,0.5077262693156733,0.8686805809888699,1.0,2/10,1.69%,SH3RF1;HMGB1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3954942465563371,0.9593072528172508,0.5094614264919942,1.0,1.0,7/31,11.17%,CRIM1;LIMD1;CDK6;SOX9;TRPM4;SKI;LRP5
prerank,response to reactive oxygen species (GO:0000302),0.36300800204355044,0.9585852643595725,0.5080946450809465,1.0,1.0,12/54,14.60%,TPM1;CAMKK2;MAPT;STK26;GSTP1;HIF1A;STK24;TXNRD2;PDCD10;PDK2;MAPK1;HYAL1
prerank,nucleoside catabolic process (GO:0009164),-0.39953040014563224,-0.9584184137841596,0.5319148936170213,0.8700894410931479,1.0,6/11,29.53%,NT5E;UPP2;UPB1;DPYD;DERA;NT5C1A
prerank,receptor catabolic process (GO:0032801),-0.3227723091988027,-0.9583459379979629,0.49702380952380953,0.8692307908772046,1.0,11/24,31.21%,GPRASP1;TGFB1;AP2S1;RNF43;AP2A2;CLTA;UVRAG;ZNRF3;MVB12A;AP2M1;SNX25
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.3513530125903806,0.9576457756246987,0.5071428571428571,1.0,1.0,14/70,16.77%,NCF2;CD36;LNPEP;ITGB5;PSMC6;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;MFSD6;PSMA2;PSMD14
prerank,regulation of cellular component biogenesis (GO:0044087),0.3821818504486194,0.9569315774292501,0.5333333333333333,1.0,1.0,3/39,1.65%,RAP1A;ROCK1;CD36
prerank,negative regulation by host of viral process (GO:0044793),-0.4120336085462409,-0.9569299275100032,0.5432372505543237,0.8717935491500407,1.0,3/10,21.07%,PRKN;ZC3H12A;CCNK
prerank,protein dephosphorylation (GO:0006470),0.3282880368214237,0.9567263285713413,0.5446623093681917,1.0,1.0,27/135,13.27%,PPP1R12A;PPM1L;PPM1J;PPP3CA;DUSP5;MTMR7;PPP2R1B;PPM1E;PTPN18;PTPRS;LHPP;PTPRF;SDHAF2;PPP2R5A;DUSP3;PPM1A;PTPN1;PPP1CB;PPP1CA;CTDSP2;FBXW11;DUSP29;SBF1;CTDSP1;DUSP16;TPTE;PPP3CB
prerank,positive regulation of myelination (GO:0031643),0.4741412137908302,0.9566068263389023,0.5140845070422535,1.0,1.0,2/11,7.67%,TPPP;DICER1
prerank,regulation of lipid storage (GO:0010883),0.41215212994793043,0.9562533979103875,0.5112179487179487,1.0,1.0,4/22,7.94%,LPL;FBXW7;ITGB3;FTO
prerank,protein processing (GO:0016485),0.33851967468270966,0.956211909404731,0.5247191011235955,1.0,1.0,5/102,4.30%,TMPRSS4;HJV;CLN5;KLK2;FXN
prerank,bile acid metabolic process (GO:0008206),0.3935883200857001,0.9560461949110051,0.5074626865671642,1.0,1.0,5/27,11.98%,HSD17B10;CYP7B1;HSD17B4;SCP2;OSBPL2
prerank,autonomic nervous system development (GO:0048483),-0.3556022270748195,-0.9560391724306823,0.5281173594132029,0.872959881804808,1.0,5/17,11.99%,NF1;FN1;NRP1;SEMA3A;SOX4
prerank,monocarboxylic acid metabolic process (GO:0032787),0.32820696056558935,0.9551627469279168,0.5316742081447964,1.0,1.0,18/117,11.07%,CKM;CD36;CKMT2;MCCC2;LPL;FA2H;ME3;DLD;CPT1B;MECR;GOT2;PPARA;VDAC1;THEM4;AASDHPPT;SCP2;AOAH;PTGR1
prerank,ATP transport (GO:0015867),-0.40876697837299747,-0.9543632284904358,0.5468085106382978,0.8762808501398099,1.0,4/10,34.63%,SLC25A17;SLC25A24;SLC17A9;SLC25A4
prerank,regulation of dendrite morphogenesis (GO:0048814),0.39153129440355916,0.9542969367271174,0.5259259259259259,1.0,1.0,8/32,13.10%,SDC2;SS18L2;NEDD4;CUX2;RAP2A;IL1RAPL1;TNIK;SARM1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.37873260432730527,-0.954258818203905,0.5243619489559165,0.875500851057232,1.0,5/12,26.50%,WNK1;AKT1;MIA3;ASS1;SKAP1
prerank,regulation of T cell chemotaxis (GO:0010819),-0.4000472024016267,-0.9541752597633977,0.5407925407925408,0.8747018962915848,1.0,3/11,5.53%,WNK1;WNT5A;ADAM10
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.422859356903866,0.9540273216122181,0.525,1.0,1.0,4/21,3.48%,CHSY3;CSPG4;CSGALNACT1;BGN
prerank,RNA modification (GO:0009451),0.3569877748407058,0.9533509869226299,0.5078947368421053,1.0,1.0,7/54,5.51%,WDR4;TRDMT1;NAT10;PARN;CDKAL1;FTSJ1;TYW5
prerank,regulation of chromatin organization (GO:1902275),-0.37957584174687925,-0.9533184562596582,0.5278450363196125,0.8759036014006516,1.0,5/14,22.37%,MLLT3;IGF2;SETD5;SETD1A;TLK2
prerank,regulation of mitochondrion organization (GO:0010821),0.3623489697949888,0.9532904760380537,0.5265888456549935,1.0,1.0,16/47,19.01%,INF2;FZD5;MAPT;FBXW7;PPARGC1A;MIEF2;VDAC1;DNM1L;SREBF2;MUL1;LRRK2;RHOT1;VPS35;USP36;MFF;HDAC6
prerank,negative regulation of response to external stimulus (GO:0032102),0.3332816820992329,0.9532488455616027,0.5405714285714286,1.0,1.0,18/105,11.46%,NR1H4;RORA;FEM1A;PTGIS;ALOX5;MFHAS1;PTPRS;TNFAIP6;DUSP3;AJAP1;LPCAT3;PPARA;NR1D1;SIRT2;AOAH;GPER1;PRKCD;RB1
prerank,protein O-linked mannosylation (GO:0035269),-0.34787108181478665,-0.9522656701815484,0.5260416666666666,0.8775410430158445,1.0,4/18,7.35%,TMTC1;TMTC2;RXYLT1;TMTC4
prerank,membrane repolarization during action potential (GO:0086011),0.43997332148943114,0.9519065805421377,0.49913344887348354,1.0,1.0,2/13,5.96%,KCNE4;ATP1B1
prerank,melanocyte differentiation (GO:0030318),0.4703897794153462,0.9517553191806224,0.5107142857142857,1.0,1.0,3/11,12.04%,MEF2C;MREG;USP13
prerank,positive regulation of cell division (GO:0051781),-0.28464206752316384,-0.9516463248238766,0.5268456375838926,0.8780594432483589,1.0,14/38,23.10%,PKP4;CDC14B;SPAST;CUL3;PRKCE;FGFR2;CDC25B;CIT;GIPC1;CDC42;DRD2;CSPP1;SVIL;TAL1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.45378716955648113,0.9515697993198766,0.5267558528428093,1.0,1.0,5/14,16.25%,PAXIP1;RIF1;NECTIN2;KMT5B;MAD2L2
prerank,positive regulation of intracellular protein transport (GO:0090316),0.32484655298774445,0.9512277083017583,0.5497835497835498,1.0,1.0,32/144,18.18%,FLNA;PMAIP1;OAZ2;FZD5;BCL2;UBR5;KCNB1;CEP290;ZDHHC2;SAE1;FBXW7;TP53;MIEF2;MIEF1;BAG3;PRKCD;SREBF2;PDCD10;KIF20B;HPS4;TRIM28;MTCL1;GAS6;ZFAND1;YWHAH;LEPROT;ATG13;SLC51B;USP36;BBC3;TOMM7;MFF
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.3754415518222834,-0.9506703419375844,0.568922305764411,0.8795372799192291,1.0,5/14,16.58%,IGF1;LDLR;CX3CL1;SYT11;GRN
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.4330439780794397,0.950254450777086,0.5105348460291734,1.0,1.0,4/16,7.65%,PADI2;ARID1A;AR;PPARGC1B
prerank,establishment of melanosome localization (GO:0032401),-0.34534965489390723,-0.9495225555509913,0.5292479108635098,0.8815313833653922,1.0,2/19,3.92%,SHROOM2;RAB11A
prerank,"phagocytosis, engulfment (GO:0006911)",0.38147564220115016,0.9494347343414977,0.5367847411444142,1.0,1.0,8/36,15.59%,CD36;MYH9;XKR4;DOCK1;ARHGAP12;RHOH;ADGRB1;RHOG
prerank,DNA packaging (GO:0006323),0.4311214668732805,0.9485810584749463,0.5086805555555556,1.0,1.0,4/16,10.61%,H1-0;CHAF1B;TP53;HAT1
prerank,positive regulation of sodium ion transport (GO:0010765),0.45298805893117816,0.9484876571996478,0.5218181818181818,1.0,1.0,5/12,15.71%,PRSS8;CNKSR3;AHCYL1;GPD1L;NOS1
prerank,protein O-linked glycosylation (GO:0006493),-0.2338330923543113,-0.9482194096998334,0.5658914728682171,0.8838526600612994,1.0,15/96,13.00%,TMTC1;GXYLT2;ST3GAL4;TMTC2;ST3GAL1;GALNT10;TET3;RXYLT1;PGM3;TMTC4;TET2;ST3GAL3;OGT;PLOD2;GALNT12
prerank,positive regulation of T cell proliferation (GO:0042102),-0.2652684403121759,-0.9481586811130206,0.5223880597014925,0.8829514384325483,1.0,8/55,8.39%,IGF1;IGFBP2;HMGB1;IL15;IL18;VCAM1;NCK1;IGF2
prerank,protein import into peroxisome membrane (GO:0045046),-0.32611057969099416,-0.9480979506317387,0.532394366197183,0.8820578249984276,1.0,9/22,21.45%,PEX14;SLC25A17;ALDH3A2;PEX5;ACBD5;ABCD3;FIS1;PXMP2;PEX13
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.45511340800547756,0.9477822113817346,0.5243445692883895,1.0,1.0,3/12,12.41%,ROCK1;ROCK2;CHRNA7
prerank,regulation of neuroblast proliferation (GO:1902692),-0.36243672699997187,-0.9476541776254358,0.5107913669064749,0.8821721079589764,1.0,8/15,21.17%,PTN;NF1;TAFA1;CTNNB1;CX3CL1;KDM1A;DISC1;DRD2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.3295698681560578,-0.9473474292038633,0.520618556701031,0.8818982524992337,1.0,8/21,23.94%,RAB11A;VPS4B;RCC2;CDC25B;CDC25A;MECP2;CDC7;RAD51C
prerank,negative regulation of viral transcription (GO:0032897),-0.3774789444576905,-0.9470936523097757,0.5244755244755245,0.8814251675466148,1.0,8/13,31.89%,TRIM14;LARP7;MID2;IFITM3;TRIM21;TRIM32;ZFP36;TRIM13
prerank,apoptotic process (GO:0006915),0.3162416251111382,0.9469130336600478,0.5768025078369906,1.0,1.0,38/203,15.56%,ATP2A1;DLC1;PMAIP1;RNF152;HIP1;MYD88;HK2;TNFAIP1;BCL2;JADE1;NDUFS1;CD14;PARP1;BNIPL;CHEK1;MAP3K10;DAPK3;VDAC1;NUDT2;TRPC5;ATCAY;AHCYL1;TNFRSF21;PAWR;PRKCD;RELT;TCHP;BOK;TNFRSF25;DMPK;DIABLO;TNFRSF10B;BNIP1;FEM1B;DHCR24;JAK2;FASTKD2;RAF1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.34537913290118194,0.9467657490099933,0.5444711538461539,1.0,1.0,10/75,9.58%,AGTR1;PDGFB;SEMA5A;CDH13;NR4A1;VEGFA;ITGB3;ITGA4;ADAM17;HIF1A
prerank,regulation of interleukin-8 production (GO:0032677),-0.25113399956201243,-0.9466295497513254,0.5824175824175825,0.881558931863334,1.0,17/69,20.92%,ARRB1;HMGB1;LBP;F3;NOD1;OTUD7B;MAPKBP1;LGALS9;PTPN22;ANXA4;RAB1A;SSC5D;TLR3;SERPINE1;PARK7;TIRAP;BCL3
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.3382295576202249,-0.9464868673764196,0.5367847411444142,0.8808975021444604,1.0,12/20,37.36%,FAR2;PPT1;ACSL3;ACLY;ACSL4;HSD17B8;DGAT2;FITM2;GCDH;SCD;SLC25A1;ACACA
prerank,cellular senescence (GO:0090398),0.3941484709905939,0.9461408634131069,0.5304964539007092,1.0,1.0,5/27,11.51%,TBX2;OPA1;MAP2K1;PRKCD;TERF2
prerank,regulation of plasminogen activation (GO:0010755),0.45933168011286274,0.9460665324269376,0.5285451197053407,1.0,1.0,2/12,8.79%,SERPINE2;RUNX1
prerank,regulation of JNK cascade (GO:0046328),-0.23185763545829224,-0.9460263684365517,0.6451612903225806,0.881002921369523,1.0,30/101,23.38%,TGFBR3;MECOM;SH3RF1;HMGB1;APP;ITCH;EGFR;PTK2B;MBIP;SEMA3A;RASSF2;SDCBP;PRKN;MAPK8IP3;SH3RF3;SIRPA;SH3RF2;PER1;TAOK1;AIDA;MTURN;TIRAP;GADD45B;DACT1;TAOK2;FLT4;MAP3K11;AXIN1;WNT16;CYLD
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3107875402269777,0.945906612706338,0.641566265060241,1.0,1.0,90/572,13.22%,PRDM16;MYOZ2;HJV;MEF2C;HEY2;ZFHX3;NR1H4;TBX2;ZEB2;PDGFB;EDNRB;MLIP;FRK;ID4;FST;LOXL2;ARID5B;ETS2;ZNF436;H1-0;NACC2;PRDM1;NR2F2;HDAC9;NR2C1;ANKRD2;USP2;ATXN1;CBFB;OSR2;KCNIP3;KLF7;MEF2A;PEX2;MTDH;SUV39H2;ARID5A;TAF1;CAV1;DAB2IP;PARP1;HEXIM1;PPM1A;VEGFA;TP53;SNAI2;NEDD4;SFPQ;YAP1;AR;MED1;ZNF431;DICER1;HSF4;SOX9;RELA;LIN37;CUX2;CCND1;PPARA;CBX4;RUNX1;IMPACT;MTA3;NR1D1;SKI;NR4A2;LRRFIP1;BAG3;SIRT2;RIF1;ZNF3;HNRNPU;NR2C2;NKX6-1;UBE2D1;SREBF2;RB1;ATF3;ZBTB7A;NFX1;BCL6;ORC2;NR6A1;CITED2;CPEB3;MXD4;FNIP2;ZFP69;ZBTB5
prerank,cellular respiration (GO:0045333),0.3767823254569924,0.9458379495292785,0.5430183356840621,1.0,1.0,17/41,22.34%,SIRT3;ME3;NDUFS1;SDHC;PPARGC1A;ETFA;SDHA;LYRM7;UQCRFS1;UQCRH;MTLN;MDH2;ATP5F1D;NDUFS4;OXA1L;COQ10A;ETFRF1
prerank,negative regulation of apoptotic process (GO:0043066),0.3086336379997478,0.9455135028768488,0.6377396569122099,1.0,1.0,52/444,10.00%,NTF3;FLNA;MEF2C;NAA38;NR1H4;ANGPT1;MERTK;MYD88;ANGPT4;TCIM;PLA2G3;PDK4;CCND2;ANXA1;CRLF1;IL2;TGFB3;ITGB1;NUP62;ARHGAP10;FXN;SET;BCL2;ATAD3A;MYO18A;MTDH;CAV1;VEGFA;TP53;SNAI2;GDNF;SFPQ;YAP1;PA2G4;MED1;BCL2L2;PPARGC1A;OPA1;NAT8;FZD9;SOX9;RELA;API5;CBX4;VDAC1;TNFAIP8;GSTP1;PAK2;NR4A2;BAG3;AXL;FAIM2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.3082243106737378,-0.9454769221900078,0.514018691588785,0.8813738025901774,1.0,12/25,26.17%,EPHA4;PML;HSP90AB1;SGTA;OPHN1;GABARAPL2;RPS7;RPL11;TRIM39;CSNK2A1;CSNK2A2;HFE
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.28416284285973886,-0.9453495163575916,0.5201465201465202,0.8806808670654569,1.0,22/39,36.85%,ERCC5;FAN1;UBC;DDB1;CHD1L;XPA;GTF2H2;GTF2H5;GTF2H3;UBB;ERCC2;ERCC1;ERCC4;OGG1;RPA3;RFC3;ERCC3;RPA2;POLD3;RPA1;RFC1;RFC4
prerank,defense response to Gram-positive bacterium (GO:0050830),0.3733698006489316,0.9452065364497161,0.5006821282401092,1.0,1.0,10/40,16.21%,MYD88;DMBT1;RARRES2;MBL2;ADAM17;GBP2;DROSHA;RNASE3;MR1;MPEG1
prerank,nucleotide metabolic process (GO:0009117),0.41512355173467785,0.9451715304937612,0.5430656934306569,1.0,1.0,12/23,22.91%,NMNAT2;DCTD;AK7;NMNAT1;CMPK1;REXO2;CMPK2;DCK;FHIT;CTPS2;NMNAT3;NUDT5
prerank,pulmonary valve morphogenesis (GO:0003184),0.42373776470952595,0.9449750460540876,0.5292207792207793,1.0,1.0,4/17,7.78%,HEY2;HEYL;JAG1;TGFB2
prerank,mitochondrial genome maintenance (GO:0000002),0.46804155672450276,0.9449418177616191,0.5301418439716312,1.0,1.0,4/11,9.13%,MEF2A;PARP1;OPA1;LONP1
prerank,stem cell differentiation (GO:0048863),0.37945553006458577,0.9449002216764799,0.5204918032786885,1.0,1.0,8/39,12.66%,MEF2C;SP7;SETD6;TP53;TGFB2;LMBR1L;HTR2B;NELFB
prerank,regulation of protein dephosphorylation (GO:0035304),0.37849183086077454,0.9447134993155304,0.5337837837837838,1.0,1.0,8/37,12.97%,DLC1;MFHAS1;PPP2R5A;PIN1;CALM1;ENSA;PRKCD;ARPP19
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.3606170875762639,-0.9446607198590752,0.5411140583554377,0.8814699686951075,1.0,4/15,12.27%,PDGFRA;FGFR2;SIX1;TGFBR1
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.3938318786818883,-0.9446573742593157,0.530952380952381,0.8804635031503811,1.0,5/11,27.82%,PPHLN1;SETDB1;MPHOSPH8;RESF1;SETDB2
prerank,regulation of neuron projection development (GO:0010975),0.3194674313528323,0.9446284264735207,0.5697674418604651,1.0,1.0,19/163,9.57%,RAP1A;NTRK3;PDLIM5;CAMK2G;SERPINI1;PLA2G3;ROR1;KANK1;CHN1;MARK1;PTPRS;ITM2C;KIF1A;DAB2IP;NCS1;CDH2;BRSK1;PAK2;ADCY6
prerank,negative regulation of transport (GO:0051051),0.3642574645984092,0.944341135855212,0.5448717948717948,1.0,1.0,6/51,7.40%,FER1L5;DYSF;PACSIN3;PIP4P2;ARL6IP5;ITGB3
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.44707171917666455,0.9442806447319689,0.5429042904290429,1.0,1.0,5/14,14.31%,TBC1D20;SEC31B;SEC13;SEC24A;SEC24C
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4293130489303302,0.9436619272127433,0.5155993431855501,1.0,1.0,2/16,7.56%,LYST;KIF5B
prerank,positive regulation of ERAD pathway (GO:1904294),-0.37227178560850993,-0.9435601798370097,0.5319148936170213,0.882340132584632,1.0,7/13,19.06%,ATXN3;RNF185;UBQLN1;SGTA;UBQLN2;HERPUD1;RNFT1
prerank,cellular response to ionizing radiation (GO:0071479),0.362464396613106,0.9435423955381376,0.5388739946380697,1.0,1.0,6/47,7.58%,MAP3K20;NET1;RAD51AP1;TP53;YAP1;RAD9A
prerank,regulation of fibroblast proliferation (GO:0048145),0.37110817278950664,0.9431260138358997,0.5514018691588785,1.0,1.0,11/45,10.90%,PDGFB;CDK6;PDGFC;PEX2;DAB2IP;TP53;CD300A;GSTP1;SKI;S100A6;PDGFA
prerank,female gamete generation (GO:0007292),-0.2960290288662843,-0.9429556544858207,0.5341614906832298,0.8827723508501747,1.0,2/29,1.35%,PTN;MARF1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3596361917008024,0.9429337255108151,0.5298701298701298,1.0,1.0,14/52,18.00%,PMAIP1;FZD5;BCL2;SAE1;FBXW7;TP53;SREBF2;HPS4;YWHAH;LEPROT;ATG13;USP36;BBC3;TOMM7
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.3288122316009337,-0.9426727840723746,0.5223097112860893,0.8824660986389441,1.0,8/20,28.97%,WNT4;PRMT3;SIK1;WDTC1;CEACAM1;ABCA2;ASXL3;ACADVL
prerank,ncRNA metabolic process (GO:0034660),0.3820002760206229,0.9426435911904812,0.5543328748280605,1.0,1.0,11/37,20.63%,PARN;DTD1;MAPT;DICER1;XPO5;DROSHA;DGCR8;PIWIL2;NIFK;PRKRA;KHSRP
prerank,positive regulation of histone modification (GO:0031058),-0.29387970156708876,-0.9425963046879458,0.5434083601286174,0.8816631643081021,1.0,16/33,35.47%,ARRB1;TADA2A;AKAP8;AKAP8L;SART3;CHTOP;KDM1A;FMR1;RPS6KA4;ZBTB7B;TADA2B;RUVBL2;SAP30BP;APLNR;BRCA1;PAF1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4586275611939373,0.9424261569174935,0.5342706502636204,1.0,1.0,2/11,5.56%,CCL5;PRKCQ
prerank,respiratory tube development (GO:0030323),0.3952719630604244,0.942047501805564,0.5245901639344263,1.0,1.0,5/28,7.51%,FGF1;ITGA3;VEGFA;ABCA3;HECA
prerank,establishment of spindle localization (GO:0051293),0.44984048248115305,0.9418765251405397,0.555,1.0,1.0,4/14,18.67%,CLASP2;CLASP1;MAP4;CFL1
prerank,zymogen activation (GO:0031638),-0.27619698088273714,-0.9418179138430618,0.53515625,0.8826198350922015,1.0,6/39,7.89%,CYFIP2;PLAT;CTSL;CTSH;CASP8;FURIN
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.39809234415938766,0.9416465429053694,0.5273556231003039,1.0,1.0,8/24,9.58%,EMILIN1;MMRN2;EPN2;DAB2IP;PTPN1;NEDD4;ITGB3;HIF1A
prerank,regulation of peptidase activity (GO:0052547),-0.3307322260454044,-0.9395397361724902,0.5522788203753352,0.8872341024661841,1.0,4/19,12.56%,NRDC;CTSH;FURIN;RCN3
prerank,central nervous system myelination (GO:0022010),-0.3964675760811575,-0.939515385919001,0.562358276643991,0.8862641298858215,1.0,2/11,4.87%,PLP1;B4GALT6
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3293218610473909,0.9394674428975369,0.5455580865603644,1.0,1.0,19/101,13.37%,AGTR1;VIM;ASPH;SAMD4A;NAT10;ATG7;RPS27L;CIRBP;PYM1;AMER1;IST1;RPL5;EIF3E;RBM3;ZCCHC4;FBXW11;CPEB3;PLXNB2;PERP
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.4704060952558623,0.9393273717201949,0.5393258426966292,1.0,1.0,5/10,25.95%,FTO;MPG;ASCC1;ALKBH1;ALKBH5
prerank,DNA dealkylation (GO:0035510),0.4704060952558623,0.9393273717201949,0.5393258426966292,1.0,1.0,5/10,25.95%,FTO;MPG;ASCC1;ALKBH1;ALKBH5
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.4226436914656826,0.9391468803568137,0.5372168284789643,1.0,1.0,2/17,3.45%,ANO6;CCL5
prerank,intracellular lipid transport (GO:0032365),0.41205906034528805,0.9390988086254193,0.5222405271828665,1.0,1.0,6/21,14.85%,PRKAB2;ACACB;CPT1B;ABCD4;CPT1A;PRKAA2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.36109185783671355,0.9384196453233025,0.54296875,1.0,1.0,9/51,12.26%,RBPMS2;CRIM1;GREM2;ACVR2A;BMPR1A;SKI;VWC2L;UBE2D1;BMPR1B
prerank,regulation of cell morphogenesis (GO:0022604),0.3919419517454611,0.9381708326393051,0.5406162464985994,1.0,1.0,2/30,2.37%,WTIP;FERMT2
prerank,regulation of cytokinesis (GO:0032465),-0.2373361265370817,-0.9379714076255249,0.621301775147929,0.889086354667646,1.0,26/78,26.64%,PKP4;CDC14B;SPAST;CUL3;RAB11A;BIRC6;AHCTF1;BCL2L1;PRKCE;CDC25B;CIT;GIPC1;PLK2;GIT1;CDC42;UVRAG;DRD2;CSPP1;SVIL;ZFYVE26;PLK5;CCP110;PRPF40A;BBS4;KIF23;CALM3
prerank,regulation of osteoblast differentiation (GO:0045667),0.3307430081960041,0.937726589249569,0.5394581861012956,1.0,1.0,14/82,9.27%,MEF2C;CRIM1;LIMD1;CCN1;CDK6;FERMT2;ACVR2A;BMPR1A;SNAI2;YAP1;SOX9;TRPM4;SUCO;SKI
prerank,DNA recombination (GO:0006310),-0.28769242889270386,-0.9376402627849129,0.5570469798657718,0.8888986030125866,1.0,17/37,37.68%,HMGB1;MRE11;RAD50;FBH1;BLM;RAD51C;ERCC1;IGHMBP2;TSN;XRCC2;RAD54L;RPAIN;RAD51;LIG4;RPA1;HDAC10;GEN1
prerank,cellular response to peptide (GO:1901653),0.35193272019009925,0.9369977162179485,0.5309734513274337,1.0,1.0,10/56,12.26%,CACNA2D1;CD36;VIM;ARHGEF2;CAV1;CHMP5;TP53;ITGA4;GPER1;ZFP36L1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.40407255323215274,-0.936361753980789,0.5452631578947369,0.8909381738924039,1.0,5/10,14.09%,NEDD4L;PRKCE;COMMD1;OSR1;HECW1
prerank,regulation of MAP kinase activity (GO:0043405),0.33278141889480456,0.9358500568254594,0.5804195804195804,1.0,1.0,19/92,12.47%,FGF1;MST1R;PDGFB;PDGFC;PDGFD;KSR1;DAB2IP;VEGFA;PTPN1;RASGRP1;CD300A;GSTP1;PDGFRB;PDGFA;PRKCD;HTR2B;CDK12;TSG101;PDCD10
prerank,proteolysis (GO:0006508),0.31106543172075724,0.9358099660386202,0.6053997923156802,1.0,1.0,34/252,15.05%,TMPRSS4;TINAGL1;MMP17;PAPPA2;PGPEP1L;HTRA1;LNPEP;RNPEP;APEH;AFG3L2;ENPEP;TRABD2B;CPA4;CPA3;ADAM17;CAPN2;LONP1;MIPEP;FBXO6;MBTPS1;PHEX;ATG4D;LONP2;RSPRY1;UBA3;ATG4A;DDI2;DPP8;SENP6;ADAM19;HM13;SPPL2B;CTSA;PCSK4
prerank,positive regulation of transmembrane transport (GO:0034764),0.44746550981601757,0.9345245211261158,0.5323741007194245,1.0,1.0,4/13,15.79%,ANO6;ACSL5;CLIP3;AZIN2
prerank,small GTPase mediated signal transduction (GO:0007264),0.3239977379528863,0.9344736398288848,0.5697808535178778,1.0,1.0,20/103,12.38%,ABR;PLCE1;CCNA2;RASGRP2;RRAD;RERG;NTN1;KSR1;NUCB1;RRAS;TP53;RAPGEF6;RASGRP1;RIN2;ARHGAP30;ARHGAP1;RB1;USP50;ARHGAP32;BCR
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4127506724700025,0.9341161876953904,0.5429017160686428,1.0,1.0,5/20,13.42%,NR1H4;LPCAT3;MBTPS1;SREBF2;LDLRAP1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.39154926246136307,-0.9340790169446647,0.5573033707865168,0.8956908269575793,1.0,2/11,2.57%,IGF1;GHR
prerank,phospholipid dephosphorylation (GO:0046839),0.3789788410027584,0.9336084554310193,0.5480378890392422,1.0,1.0,9/37,15.32%,MTMR7;PIP4P2;SYNJ2;SACM1L;PLPPR1;INPP5B;TPTE;INPP5J;PTEN
prerank,regulation of amyloid-beta formation (GO:1902003),0.37473828623733774,0.9333598363389632,0.5495750708215298,1.0,1.0,9/34,12.46%,ROCK1;RTN2;PIN1;RELA;RTN1;ROCK2;ABCG1;CHRNA7;CLU
prerank,proteasomal protein catabolic process (GO:0010498),-0.2060555451794545,-0.9328802890324693,0.7777777777777778,0.8976496720809131,1.0,69/201,25.67%,NEDD4L;ARRB1;ATXN3;AREL1;ITCH;CUL3;RNF185;SEL1L;UBE2D3;DNAJB12;DERL1;PML;CTNNB1;BIRC2;PCBP2;PSMD7;PSMD9;PSMD13;PELI1;MDM2;TOPORS;WWP1;RBCK1;ARMC8;PRKN;SMURF2;RMND5B;KCTD2;UBE4B;PSMB3;DDB1;RNF34;STUB1;KLHL22;RMND5A;SKP2;RCN3;PSMC5;SIAH1;PSMA5;PSMA1;PSMC2;HECW1;NHLRC3;UBXN1;SYVN1;SPOPL;FBXW5;SIAH2;SPSB4;RNF41;BTRC;ZFAND2A;SHARPIN;PSME3;KCTD17;PSMC4;PRPF19;UBE2B;CCDC47;IFI27;PSMB6;TBL1XR1;FBXL19;SIAH3;RAD23B;HECTD3;UCHL1;PSMB10
prerank,regulation of sensory perception of pain (GO:0051930),0.4592500468992342,0.9327991463461336,0.5350089766606823,1.0,1.0,3/11,12.03%,ACP3;MGLL;ATPSCKMT
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.2981442280075477,-0.9327409960257431,0.5683229813664596,0.8969807895325199,1.0,12/27,26.07%,NIBAN2;DACH1;ACVRL1;BMPR2;RGCC;FGF2;SMG6;ATM;FGFR4;CDKN1A;PRKD2;PARP4
prerank,positive regulation of TOR signaling (GO:0032008),-0.28020661569501343,-0.9326352799847967,0.572,0.8961918392831646,1.0,19/40,30.86%,PIK3CA;LAMTOR1;GOLPH3;RHEB;KLHL22;PIP4P1;NCKAP1L;GPR137B;TELO2;MIOS;SMCR8;RRAGD;LAMTOR2;GPR137;SIK3;PIH1D1;RRAGA;SLC38A9;RPTOR
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.3928220967404755,-0.9318154149970005,0.5671981776765376,0.8972131585283489,1.0,5/11,28.05%,FBXO7;PRKN;PARK7;ATF4;RACK1
prerank,vitamin transport (GO:0051180),-0.29262087357939787,-0.9317799563733965,0.5779036827195467,0.8962950905723132,1.0,5/29,9.65%,ABCG2;PDPN;SLC25A32;SLC52A1;SLC35F3
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3137053313606628,0.9317312528417813,0.5927116827438371,1.0,1.0,38/175,17.33%,ACTN4;LIMS1;TNFSF13B;CCL5;ARHGEF2;HAS2;TNFRSF11A;PSMC6;DAB2IP;TP53;TRAF3;RELA;ADAM17;NR1D1;EDAR;PSME4;TNFRSF21;TRAF5;PSMB1;CCL14;PSMD5;EIF5A;GPER1;ZFAND6;TNFRSF25;ZFP36L1;GBP2;PSMB2;TMSB4X;HYAL1;STAT1;PSMB7;PSMD3;JAK2;PSMA2;PSMD14;DHX9;TNFSF12
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3175210969979879,0.9315204712888634,0.582441113490364,1.0,1.0,37/153,17.19%,STK38L;MAST4;ROCK1;DYRK2;PDGFB;CAMK2D;MARK1;DYRK1A;PRKCQ;TAF1;MAPKAPK2;RPS6KA2;DYRK1B;MAP3K10;BRSK1;PKN2;PAK2;ROCK2;PRKCD;RICTOR;DMPK;MAST1;LRRK2;SGK1;GAS6;MAPK1;CSNK1E;PRKCA;PRKACA;CSNK1A1;SRPK2;MAPK12;HIPK2;MAST3;EIF2AK3;MAP3K13;MARK2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3440509809643262,0.9314260824561744,0.5433962264150943,1.0,1.0,10/61,11.84%,ABRA;GPR20;SYNPO2L;NET1;MAPRE2;RASGRP1;GPR17;VAV1;COL3A1;LPAR4
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.37079794061060783,-0.9313732166966441,0.5307125307125307,0.8962859509369397,1.0,3/13,8.03%,STX3;HSP90AB1;STX4
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.2678319403019097,-0.9310297406031028,0.5672727272727273,0.8961278584865016,1.0,11/41,16.10%,IGF1;LBP;LGALS9;ILRUN;CD34;PTPN22;IRAK3;SIRPA;CX3CL1;SYT11;RARA
prerank,long-chain fatty acid import into cell (GO:0044539),0.46444639315495156,0.9307784447705765,0.5421903052064632,1.0,1.0,1/10,1.65%,CD36
prerank,positive regulation of protein maturation (GO:1903319),0.46637670575876966,0.9307509144139863,0.5521367521367522,1.0,1.0,1/11,1.96%,ANGPTL8
prerank,regulation of protein localization (GO:0032880),-0.25699151043370116,-0.9302051237949849,0.6084905660377359,0.8971260178565704,1.0,12/58,12.66%,AFDN;DLG1;AAK1;RABGAP1L;HSP90AB1;CAMK1;FKBP1A;TRIM25;RSL1D1;TRIM5;TRIM14;PPM1F
prerank,eosinophil chemotaxis (GO:0048245),0.44394316840815246,0.9299958667463686,0.5414551607445008,1.0,1.0,1/14,3.45%,CCL5
prerank,eosinophil migration (GO:0072677),0.44394316840815246,0.9299958667463686,0.5414551607445008,1.0,1.0,1/14,3.45%,CCL5
prerank,negative regulation of bone mineralization (GO:0030502),-0.36446597676088344,-0.9296250017917377,0.559322033898305,0.897518082081742,1.0,6/13,29.45%,PTK2B;SRGN;ENPP1;BCOR;RFLNA;RFLNB
prerank,positive regulation of cell projection organization (GO:0031346),0.32624888554708675,0.929621188191038,0.5819397993311036,1.0,1.0,9/115,3.42%,RAP1A;NTRK3;SERPINI1;PLA2G3;ROR1;PLXND1;SS18L2;PLXNB1;FZD4
prerank,RNA metabolic process (GO:0016070),0.31715172362445937,0.9295402850085137,0.574468085106383,1.0,1.0,24/127,13.25%,RBPMS;LSM8;POLR2L;POLR2I;HNRNPR;PARN;ATXN1;ATXN2;POLR2G;DICER1;FTO;FASTKD1;PAPOLA;DHX8;DEDD2;HNRNPU;PRPF4;RBM3;RBM6;HNRNPC;DROSHA;POLR2J;SYNCRIP;PCBP3
prerank,negative regulation of angiogenesis (GO:0016525),0.3289739434219831,0.9295007768697899,0.5529131985731273,1.0,1.0,10/84,7.78%,COL4A2;ATP2B4;ROCK1;ANGPT4;ALOX5;EMILIN1;EPN2;DAB2IP;YJEFN3;TGFB2
prerank,purine-containing compound salvage (GO:0043101),0.44587758509311964,0.9295003260391523,0.5301418439716312,1.0,1.0,2/12,6.80%,AMPD1;AMPD2
prerank,regulation of response to external stimulus (GO:0032101),0.32145863847640754,0.9294172945911575,0.5964718853362734,1.0,1.0,17/121,9.90%,AGTR1;CD36;MYD88;ANXA1;ALOX5;ELMOD2;SAG;SETD6;PIK3AP1;CAV1;CALM1;CELF1;TRAF3;RELA;MGLL;AKNA;STK24
prerank,melanosome localization (GO:0032400),-0.32817829726528913,-0.9290160212494334,0.5480225988700564,0.8980524248523092,1.0,2/21,3.92%,SHROOM2;RAB11A
prerank,positive regulation of transferase activity (GO:0051347),0.32112678558991736,0.9280727361909545,0.5945054945054945,1.0,1.0,19/142,9.85%,PARM1;NTRK3;MERTK;MST1R;ROR1;DCUN1D2;MUSK;PARN;PRKCQ;FBXW7;PKIB;PIN1;CD200;CHTF18;DCUN1D1;NAF1;EPHA2;PDGFRB;AXL
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.404757823636521,0.9272894928328994,0.5449010654490106,1.0,1.0,4/21,9.53%,NDST3;EXT2;HS2ST1;HS6ST1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.38823642000340597,-0.927248069107379,0.578494623655914,0.901499924538559,1.0,6/11,37.15%,STX4;CAMK4;TYROBP;ITGB2;SPI1;ITGAM
prerank,chromatin organization (GO:0006325),0.3188374016275321,0.9271689378879477,0.5938529088913282,1.0,1.0,17/132,11.88%,PRDM16;PADI3;SMARCD3;LOXL2;PADI2;CHRAC1;ARID1A;SUV39H2;SMARCB1;HMGN3;INO80C;SOX9;MCM3AP;RB1;BAZ2A;ZBTB7A;RUVBL1
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.3355820034681391,-0.927056269912259,0.5435356200527705,0.9009466680530596,1.0,4/16,9.95%,BMPR2;PLCB3;DDAH1;ACE
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.39556028404325205,-0.9267350567600439,0.5705128205128205,0.9007302244563686,1.0,4/10,26.43%,ENPP2;PLA2G6;PLA2G7;PNPLA8
prerank,placenta development (GO:0001890),-0.37404096309297524,-0.926329536899204,0.535632183908046,0.9006963781012209,1.0,3/12,16.84%,PTK2;CUL7;PPARG
prerank,protein palmitoylation (GO:0018345),0.39155411866184975,0.9261762850876628,0.5541310541310541,1.0,1.0,12/30,18.42%,GOLGA7B;ZDHHC2;HHAT;ZDHHC1;ZDHHC14;ZDHHC17;CLIP3;ZDHHC13;ZDHHC4;ZDHHC8;ZDHHC5;ZDHHC3
prerank,transcription by RNA polymerase II (GO:0006366),0.3022145943090618,0.9259225783109567,0.6534954407294833,1.0,1.0,36/305,9.42%,NOTCH3;SOX5;NR1H4;POLR2L;POLR2I;RORA;NR4A1;PRRX1;TEAD3;ADRM1;HDAC9;GTF2H4;NR2C1;WDR33;ELL;CBFB;PCF11;RXRG;POLR2G;TAF1;ELOC;PARP1;TAF8;MAML2;YAP1;AR;MED1;PPARGC1A;ERCC6;PAPOLA;MAML3;PPARA;CCNT1;NR1D1;NR4A2;CDK7
prerank,eye photoreceptor cell development (GO:0042462),0.4244508782762536,0.9258150262835404,0.5295109612141653,1.0,1.0,3/15,6.54%,CEP290;RPGRIP1L;VEGFA
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4113013780173893,0.925727686502508,0.5627980922098569,1.0,1.0,5/20,9.58%,CHD6;VEGFA;RELA;CARF;HIF1A
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.40000034773560506,0.925321287166943,0.5483359746434231,1.0,1.0,4/23,15.20%,PLA2G3;LPCAT3;PLA2G4A;PLA2G4C
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.34687407363880485,-0.9251241518804214,0.5862944162436549,0.9027690140005425,1.0,7/16,18.39%,OGFOD1;IRAK3;GLE1;TBC1D25;INSR;CLN3;SHFL
prerank,icosanoid metabolic process (GO:0006690),0.36423692202361074,0.9246108233679232,0.5333333333333333,1.0,1.0,12/40,19.78%,PTGIS;ALOX5;TBXAS1;MAPKAPK2;MGLL;PTGR1;PLA2G4A;PLA2G4C;EPHX1;PON2;FAAH;ABCC10
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.3939040553302513,0.9245467207783226,0.5604229607250756,1.0,1.0,11/27,20.26%,PDGFB;CDK6;PDGFC;S100A6;PDGFA;GAS6;DHX9;MIF;DDR2;AGT;NDUFS4
prerank,Wnt signaling pathway (GO:0016055),-0.23609403995927353,-0.9245371999000919,0.6194029850746269,0.9032359210374843,1.0,16/92,10.98%,LEF1;WNT4;TCF7L2;NXN;FZD6;DDX3X;WNT5A;KLHL12;BCL9L;DIXDC1;PLCG2;WNT9A;CTNNB1;WLS;UBC;SFRP4
prerank,response to glucose (GO:0009749),-0.26521642931319783,-0.9244710726267832,0.5909090909090909,0.9023721202088494,1.0,9/46,12.95%,ZBTB20;UNC13B;TCF7L2;TRA2B;ERN1;SOX4;EIF2B3;PCK2;ZBED3
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.4284067155196475,0.9244259024288847,0.54421768707483,1.0,1.0,5/15,12.85%,BTG2;POLR2G;TENT4A;CNOT7;CPEB3
prerank,endothelial cell proliferation (GO:0001935),0.42327676126606617,0.9244083088087036,0.5621970920840065,1.0,1.0,3/17,2.97%,ANGPT4;SEMA5A;LOXL2
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.24736619548391203,-0.9242840195259004,0.6318407960199005,0.9017992741712235,1.0,19/59,16.85%,NFKBIA;BIRC2;TNFRSF1A;NKIRAS1;IKBKG;RBCK1;TAB2;RNF31;IRAK1BP1;UBC;IRAK2;CHUK;TAB1;FAIM;BIRC3;AKT1;RELB;TLR3;PRDX4
prerank,tRNA 5'-leader removal (GO:0001682),-0.36590135197627316,-0.9242485999224732,0.5642857142857143,0.9008799656129676,1.0,7/13,43.31%,SSB;POP1;POP4;RPP38;RPP21;RPP25L;POP7
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.46345519748030817,0.9241755334360613,0.5657894736842105,1.0,1.0,1/10,5.18%,SAG
prerank,regulation of angiogenesis (GO:0045765),0.30579833114604077,0.9238707877546907,0.6048472075869337,1.0,1.0,25/192,9.58%,COL4A2;ATP2B4;ROCK1;FGF1;ANGPT4;HSPB6;PLXND1;SEMA5A;HK2;STIM1;ITGB1;PTGIS;ALOX5;EMILIN1;MTDH;DAB2IP;VEGFA;RRAS;RHOJ;BTG1;YJEFN3;TGFB2;RUNX1;EPHA2;HIF1A
prerank,cellular response to interferon-beta (GO:0035458),-0.36195257931671887,-0.9237886615081555,0.5558252427184466,0.9010794976335398,1.0,9/14,39.83%,IRGM;PNPT1;IFITM2;HTRA2;CDC34;NDUFA13;TRIM6;IRF1;AIM2
prerank,regulation of response to cytokine stimulus (GO:0060759),0.42375216889077316,0.9232550387443342,0.5756630265210608,1.0,1.0,3/19,8.79%,LIFR;CBFB;RUNX1
prerank,visual system development (GO:0150063),-0.2689248052496145,-0.922951477716416,0.6135593220338983,0.9021545153322605,1.0,17/37,37.15%,SMOC1;PBX3;RBP4;MEIS2;MEIS3;PBX4;C1QA;PBX1;SIPA1L3;SMG9;ZDHHC16;ATF6;MEIS1;SALL2;ADAMTS18;C3;ITGAM
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.36826297169572986,-0.9228205992751046,0.5697399527186762,0.9014667626951669,1.0,3/13,8.39%,GKAP1;PTPN11;IGF2
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.39130683525057486,0.9227008649391696,0.5455882352941176,1.0,1.0,2/26,2.53%,PRKAB2;PDK4
prerank,regulation of trophoblast cell migration (GO:1901163),-0.3553336298310319,-0.9226071363319096,0.5693430656934306,0.9009438429361046,1.0,5/14,20.24%,GJA1;SMURF2;ARHGDIB;CALR;YTHDF3
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.32688729129207433,-0.9224735146320838,0.5582655826558266,0.9002694097546844,1.0,14/18,46.83%,LIG3;GINS3;LIG1;RFC3;GINS4;POLD3;GINS1;POLE;RFC4;MCM3;POLA1;POLE3;POLD2;GINS2
prerank,response to organonitrogen compound (GO:0010243),-0.27455163181108644,-0.9224378682230345,0.5783582089552238,0.8993501175430608,1.0,13/38,22.39%,RNF185;SEL1L;DNAJB12;DERL1;GLRB;IRAK3;PRKN;GLRA2;RCN3;SYVN1;GLRA1;DRD2;CCDC47
prerank,positive regulation of kinase activity (GO:0033674),0.32011572468794247,0.9223944250808209,0.5784851811196488,1.0,1.0,14/107,10.11%,RAP1A;NTRK3;MERTK;MST1R;CCN1;ROR1;MMD;MUSK;MAPT;LCP2;EPHA2;PDGFRB;AXL;CENPE
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.40233083371382705,0.9223182467695437,0.5453172205438066,1.0,1.0,2/24,2.53%,ANGPT1;SEMA5A
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3106881809804339,-0.9221972141618077,0.6055045871559633,0.898904206960777,1.0,5/27,4.97%,LRP1;PLTP;APOE;PTCH1;NFKBIA
prerank,regulation of actomyosin structure organization (GO:0110020),0.4440670828157357,0.9221399955261018,0.5489130434782609,1.0,1.0,2/13,3.64%,ROCK1;ACTG1
prerank,mitochondrion organization (GO:0007005),0.30979148106349774,0.9218554452307539,0.6128680479825518,1.0,1.0,54/165,21.35%,ATP2A1;HSD17B10;GABPA;HK2;SIRT3;ATAD3A;COX7A2L;NDUFS1;MEF2A;TERT;AFG3L2;PARP1;PPARGC1A;MTX1;OPA1;MIEF2;MIEF1;TRAK1;ATCAY;LONP1;DNM1L;TFB2M;MFN2;ESRRA;ADCK1;MUL1;LRRK2;SIRT4;USP30;DNM2;CAV2;RHOT1;TOMM5;MGME1;RAB38;ATP23;BCAP31;TOMM7;MFF;ATP5F1D;AGTPBP1;GABPB1;VPS13C;PPRC1;MTX3;HIGD2A;PHB2;MFN1;SLC25A33;CLUH;BIK;OXA1L;TIMM9;TIMM22
prerank,regulation of T cell differentiation (GO:0045580),0.37406626195137366,0.9215979879305843,0.5692090395480226,1.0,1.0,5/33,11.49%,IL2;PRDM1;CBFB;RUNX1;RHOH
prerank,cell cycle G1/S phase transition (GO:0044843),0.34199904648607815,0.9215382180410127,0.5771144278606966,1.0,1.0,11/61,11.53%,CCNA2;CDK6;HINFP;EIF4EBP1;CUL2;CCND1;CDK7;CRLF3;GSPT1;RB1;ACVR1B
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.22123338522746838,-0.9214467458755035,0.6491228070175439,0.899746875895494,1.0,21/109,14.08%,NFATC3;PIK3CA;GAB2;GRB2;PDPK1;VAV2;PLCG2;PIK3CB;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;PSMA5;PSMA1;PSMC2
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4103704836593333,0.9211786840784445,0.5605590062111802,1.0,1.0,8/22,18.42%,GOLGA7B;ZDHHC2;ZDHHC1;ZDHHC14;CLIP3;ZDHHC4;ZDHHC8;ZDHHC3
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4103704836593333,0.9211786840784445,0.5605590062111802,1.0,1.0,8/22,18.42%,GOLGA7B;ZDHHC2;ZDHHC1;ZDHHC14;CLIP3;ZDHHC4;ZDHHC8;ZDHHC3
prerank,negative regulation of telomere maintenance (GO:0032205),-0.34840866060468834,-0.921106607938488,0.5233415233415234,0.8995860288365409,1.0,8/15,24.26%,TNKS2;RAD50;NBN;TERF2IP;SMG6;ATM;ERCC1;ERCC4
prerank,mRNA catabolic process (GO:0006402),-0.26777589884353276,-0.9209362637821318,0.5893536121673004,0.8990115669269011,1.0,20/44,30.55%,AGO3;DDX5;METTL3;ERN1;DCP2;EXOSC9;TUT4;PNPT1;TUT7;NBDY;METTL16;LSM5;LSM2;CNOT10;NUDT12;AGO4;ZFP36;LSM6;PDE12;THRAP3
prerank,establishment of mitotic spindle localization (GO:0040001),0.38625553619939423,0.9208550811029969,0.5691176470588235,1.0,1.0,8/28,17.68%,CLASP2;ITGB1;INSC;NSFL1C;FBXW11;CLASP1;DCTN1;UBXN2B
prerank,lysosome organization (GO:0007040),0.36891855825916436,0.9203151479352887,0.5491573033707865,1.0,1.0,9/36,13.77%,CLN5;HOOK2;ACP3;CLVS1;HOOK1;MBTPS1;AKTIP;HPS4;LRRK2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.30072272388032417,-0.9201178491257275,0.5783475783475783,0.8990395832325979,1.0,9/29,30.29%,ACSF2;ACOT8;DBI;ACLY;ACOT9;CROT;ACOT7;ACOT11;OXSM
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.30072272388032417,-0.9201178491257275,0.5783475783475783,0.8990395832325979,1.0,9/29,30.29%,ACSF2;ACOT8;DBI;ACLY;ACOT9;CROT;ACOT7;ACOT11;OXSM
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.2883761297563059,-0.9200459380829258,0.6095890410958904,0.8982335180010392,1.0,12/33,18.92%,PTPN11;PTK2;ACER2;FOXC2;PDE3B;CYP1B1;LYN;EPHA8;DPP4;SERPINE1;NCKAP1L;ITGB1BP1
prerank,synaptic vesicle transport (GO:0048489),0.45627257265414134,0.9195916561260895,0.5633802816901409,1.0,1.0,6/11,22.13%,KIF5B;KIF5C;KIF5A;DNM2;SNAPIN;SYNJ1
prerank,protein localization to condensed chromosome (GO:1903083),-0.37590340246533116,-0.9191234881975312,0.5642701525054467,0.8995532649522171,1.0,10/12,54.96%,IK;BUB3;ZWILCH;KNL1;TTK;SPDL1;CDK1;MTBP;AURKB;CHAMP1
prerank,transition metal ion homeostasis (GO:0055076),0.38309275012459626,0.9190262160426347,0.5598227474150664,1.0,1.0,4/28,9.58%,HJV;HMOX2;SLC39A14;NEO1
prerank,cellular response to ATP (GO:0071318),0.4275033157292945,0.9189908703056259,0.5440677966101695,1.0,1.0,2/14,6.20%,P2RY2;TAF1
prerank,UV-damage excision repair (GO:0070914),-0.3766590350621167,-0.9187535965960004,0.5652173913043478,0.8995033923558131,1.0,7/12,41.59%,DDB1;XPA;ACTR5;ERCC1;POLD3;XPC;POLA1
prerank,regulation of dendritic spine development (GO:0060998),0.41545299521982104,0.9182054789120055,0.5540334855403348,1.0,1.0,3/19,6.19%,MEF2C;PTPRS;KIF1A
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.2586840295249911,-0.917773832016268,0.616822429906542,0.9009077898717776,1.0,12/50,19.56%,SH3RF1;DDX3X;RPS6KA3;CD44;RNF34;IGBP1;SNCA;AKT1;GPX1;BCL2L12;SIAH2;PARK7
prerank,monocyte differentiation (GO:0030224),-0.3945708346961815,-0.9175330235877218,0.5727482678983834,0.9005268788440443,1.0,6/10,17.66%,IL31RA;PIR;BMP4;THOC5;PPARG;MT1G
prerank,positive regulation of macroautophagy (GO:0016239),-0.26415556458113465,-0.9175138409132676,0.5954545454545455,0.8995846826223275,1.0,16/48,24.48%,DCN;PAFAH1B2;SPTLC2;PIP4K2B;GPSM1;OPTN;IKBKG;RAB3GAP2;IRGM;KDR;RALB;BNIP3L;UVRAG;SMCR8;SESN2;LRSAM1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3270384835216456,0.917488301069031,0.5928074245939675,1.0,1.0,14/85,9.11%,ANGPT1;FGF1;LIMS1;CDK6;NR4A1;OSR2;PEX2;DAB2IP;VEGFA;LAMC1;YAP1;TGFB2;SOX9;NR1D1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.20882205949955066,-0.917466029300739,0.7058823529411765,0.8986933791491686,1.0,28/149,13.37%,PRKCB;EDA;APP;PRKCH;IL18;WNT5A;NOD1;NFKBIA;LGALS9;IRAK1;RNF25;SLCO3A1;IKBKG;IRAK3;RBCK1;TRIM25;TAB2;ALK;RNF31;UBC;TRIM5;IRAK2;CHUK;CARD14;TRIM14;EP300;TAB1;CX3CL1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.3863046762444037,0.9173437459734815,0.5682492581602374,1.0,1.0,4/27,4.80%,DLC1;PHLDB2;CLASP2;ARHGAP6
prerank,cyclooxygenase pathway (GO:0019371),0.46022120745081474,0.9172967657172519,0.5535390199637024,1.0,1.0,3/10,8.66%,PTGIS;TBXAS1;CBR1
prerank,positive regulation of establishment of protein localization (GO:1904951),0.41048269692640893,0.9170890499012414,0.5529801324503312,1.0,1.0,3/18,12.04%,PTP4A3;CCT3;CEP120
prerank,negative regulation of RNA splicing (GO:0033119),-0.3348795582410662,-0.9169340317142549,0.5922077922077922,0.8990592924233404,1.0,10/19,26.90%,PTBP3;SRSF7;SRSF6;RPS13;SFSWAP;RBMX;PCBP4;TMBIM6;RNPS1;SRSF12
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.32496785184072124,0.9168999425760246,0.5675675675675675,1.0,1.0,17/84,14.16%,ROCK1;IGFBP5;RTN2;SAMD4A;MRPL13;BTG2;PIN1;RTN1;DAPK3;EIF2AK2;CNOT7;CHRNA7;CLU;CPEB3;SYNCRIP;GIGYF2;EPRS1
prerank,positive regulation of lipid transport (GO:0032370),-0.37953258086281594,-0.9166708169271344,0.5899772209567198,0.8987372010009167,1.0,4/12,10.39%,LRP1;APOE;SPP1;DBI
prerank,synaptic membrane adhesion (GO:0099560),0.43084430819383845,0.9166520443017501,0.5618729096989966,1.0,1.0,3/14,6.08%,PTPRS;GPC4;PTPRF
prerank,negative regulation of interferon-gamma production (GO:0032689),0.3981258932230305,0.9166091348188324,0.5596330275229358,1.0,1.0,4/23,13.93%,NR1H4;HAVCR2;AXL;GAS6
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.4344181547454371,0.9165361672353661,0.5737122557726465,1.0,1.0,6/12,20.46%,HEXIM1;HNRNPU;NELFB;NELFCD;EAPP;NELFA
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.31344828609248004,0.9164361507721287,0.6440860215053763,1.0,1.0,21/150,10.90%,ANGPT1;FGF1;MST1R;HIP1;PDGFB;FERMT2;SEMA5A;THPO;ITGB1;GCNT2;MFHAS1;PIK3AP1;MTDH;IRS1;AREG;THEM4;PDGFRB;AXL;HBEGF;VAV1;PDGFA
prerank,neutrophil degranulation (GO:0043312),0.3008934992877449,0.9161907436523197,0.6981891348088531,1.0,1.0,67/425,14.93%,TTR;STXBP2;RAP1A;DYNLL1;VCL;ROCK1;CD36;FCGR3B;CNN2;ANO6;FRK;AGL;PADI2;UNC13D;ACP3;HMOX2;ALOX5;PLEKHO2;CRISPLD2;PYGB;CD14;CEP290;BRI3;ATG7;APEH;TNFAIP6;RAP2C;CYFIP1;RAB3A;PA2G4;IGF2R;HEBP2;CAP1;GLA;PRG2;STOM;CD300A;DDOST;STBD1;RHOF;GSTP1;PPIE;GCA;IST1;PSMB1;ALDOA;PRKCD;DGAT1;YPEL5;VPS35L;TRPM2;GM2A;CPNE3;DNAJC3;CD53;DNASE1L1;STK10;MAPK1;CFP;CYB5R3;GDI2;RAB14;GLB1;CPPED1;CTSA;PSMB7;PSMD3
prerank,negative regulation of cellular component organization (GO:0051129),-0.23865256642121296,-0.9160625728300009,0.5911949685534591,0.8992149678055466,1.0,19/74,18.55%,BMP6;DDX3X;XRCC5;EPHA3;MCTP1;HSPA5;IAPP;RDX;IRAK3;PEX5;RIOK3;SPRY2;DNAJB2;EP300;SYT11;AIDA;NOP53;CDC42;HSF1
prerank,positive regulation of vasculature development (GO:1904018),0.3226978782304462,0.9160357085893136,0.5950704225352113,1.0,1.0,14/94,9.58%,FGF1;ANGPT4;HSPB6;SEMA5A;HK2;STIM1;ITGB1;PTGIS;MTDH;VEGFA;RRAS;BTG1;RUNX1;HIF1A
prerank,serine family amino acid biosynthetic process (GO:0009070),0.44360746824302,0.9158533062663446,0.532312925170068,1.0,1.0,2/12,5.00%,SEPHS2;SEPHS1
prerank,protein hydroxylation (GO:0018126),0.42882072099812363,0.9158284805067417,0.5611015490533563,1.0,1.0,2/15,2.86%,P3H2;ASPH
prerank,neurotransmitter transport (GO:0006836),0.33292922382382156,0.915743783086413,0.571604938271605,1.0,1.0,15/73,14.36%,STXBP2;APBA1;SLC6A2;SLC38A2;RAB3A;LIN7C;BRSK1;HRH3;SLC6A15;GLS;GLS2;SLC29A1;PPFIA3;DVL1;SLC38A1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.29735362004005494,-0.9155566822215536,0.5874587458745875,0.8995279413459832,1.0,11/29,22.91%,IFNAR2;PTPN11;WNT5A;HSP90AB1;METTL3;SAMHD1;STAT2;NLRC5;YTHDF3;PTPN2;RNASEL
prerank,negative regulation of immune effector process (GO:0002698),-0.3660485575290022,-0.9154983811422287,0.5754716981132075,0.8986722293005402,1.0,5/13,16.58%,CD55;RPS19;ENPP3;APPL1;GRN
prerank,regulation of DNA replication (GO:0006275),-0.2648893310641688,-0.9154117874517358,0.5650406504065041,0.8979039077587556,1.0,14/49,16.30%,ATR;GLI2;EGFR;ACVRL1;STN1;PPP2CA;PDS5A;ORC5;BLM;CTC1;TSPYL2;OBI1;ANKRD17;USP37
prerank,engulfment of apoptotic cell (GO:0043652),0.42849261830300367,0.915208458336573,0.5784313725490197,1.0,1.0,4/15,15.59%,XKR4;RHOH;ADGRB1;RHOG
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.2982929586140657,-0.91515731281329,0.6092307692307692,0.8975580484051842,1.0,5/30,5.68%,NIBAN2;DACH1;ACVRL1;STN1;BMPR2
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.3333634839730545,-0.9146742446496368,0.5775401069518716,0.8977326250173248,1.0,4/18,12.24%,ATP1A2;NEDD4L;COMMD1;SLC43A2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.25218786725939035,-0.9141116489784789,0.6289592760180995,0.8981778336184609,1.0,14/52,15.25%,CELF2;DDX5;KHDRBS1;RBM5;RBFOX3;SRSF6;TRA2B;NOVA1;CELF4;DDX17;SMU1;NOVA2;KHDRBS2;RBFOX1
prerank,negative regulation of gene expression (GO:0010629),0.3013410198632382,0.9140548294935423,0.6504559270516718,1.0,1.0,46/302,13.44%,CCDC3;MEF2C;ATP2B4;HEY2;PDGFB;PLA2G3;IGFBP5;HINFP;SAMD4A;RBMS3;MRPL13;BTG2;HDAC9;ASB1;HAVCR2;BMPR1A;EMILIN1;TERT;TAF1;MAPT;FBXW7;SLC2A10;VEGFA;YTHDF2;YAP1;CELF1;DICER1;ATP2B1;TGFB2;DAPK3;DIS3L2;MAP2K1;RUNX1;HIF1A;PTBP2;EIF2AK2;ROCK2;GPER1;RB1;TERF2;CNOT7;PDCD10;CITED2;CPEB3;SYNCRIP;DXO
prerank,mRNA 3'-end processing (GO:0031124),-0.23717715993989702,-0.9139372029644548,0.6368421052631579,0.8975951306543326,1.0,35/78,31.91%,APP;THOC2;PABPN1;SRSF7;SRSF6;SRSF11;SRSF5;POLDIP3;PABPC1;SLBP;THOC5;SRSF2;LEO1;NCBP2;CHTOP;SRSF3;CPSF2;PAPOLG;SARNP;SCAF8;SSU72;CPSF6;CSTF2T;CPSF4;RNPS1;DHX38;CSTF2;ALYREF;CPSF1;LSM11;CLP1;POLR2D;PAPOLB;SLU7;DDX39A
prerank,neutrophil activation involved in immune response (GO:0002283),0.2999451298345856,0.9138633485871281,0.7022132796780685,1.0,1.0,67/428,14.93%,TTR;STXBP2;RAP1A;DYNLL1;VCL;ROCK1;CD36;FCGR3B;CNN2;ANO6;FRK;AGL;PADI2;UNC13D;ACP3;HMOX2;ALOX5;PLEKHO2;CRISPLD2;PYGB;CD14;CEP290;BRI3;ATG7;APEH;TNFAIP6;RAP2C;CYFIP1;RAB3A;PA2G4;IGF2R;HEBP2;CAP1;GLA;PRG2;STOM;CD300A;DDOST;STBD1;RHOF;GSTP1;PPIE;GCA;IST1;PSMB1;ALDOA;PRKCD;DGAT1;YPEL5;VPS35L;TRPM2;GM2A;CPNE3;DNAJC3;CD53;DNASE1L1;STK10;MAPK1;CFP;CYB5R3;GDI2;RAB14;GLB1;CPPED1;CTSA;PSMB7;PSMD3
prerank,negative regulation of T cell proliferation (GO:0042130),-0.2927576989888191,-0.9137682252369987,0.5805369127516778,0.8970924052424716,1.0,7/28,24.60%,LGALS9;CEBPB;SDC4;CD80;CD274;CD86;SCRIB
prerank,establishment of vesicle localization (GO:0051650),-0.33443807521073393,-0.9132484201640924,0.5721925133689839,0.8973542373398533,1.0,6/18,14.20%,LIMK2;RAB11A;TMEM230;IKBKG;CCDC186;SYT11
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.3852541194839702,-0.9129314162192793,0.5764462809917356,0.8971112968242219,1.0,8/10,44.91%,DLGAP1;DLGAP2;NPTXR;DLGAP3;AKAP9;BEGAIN;NPTX2;CACNG5
prerank,brain development (GO:0007420),0.313816495176798,0.9129230400745556,0.6043956043956044,1.0,1.0,9/136,6.62%,SOX6;COL4A1;ZFHX3;CLN5;SLC6A17;GRIN2C;ATXN1;SYNJ2;EML1
prerank,regulation of RNA metabolic process (GO:0051252),-0.25038453842626984,-0.9129178686071912,0.6272727272727273,0.8961652728108374,1.0,11/59,10.13%,PTBP3;RASA1;RC3H2;AHNAK2;TRA2B;NOVA1;PCBP2;BRDT;AHNAK;RBM20;CLK3
prerank,positive regulation of synapse assembly (GO:0051965),-0.2955755021668268,-0.912453005726435,0.5735735735735735,0.8962869406832864,1.0,13/27,28.17%,NLGN1;SEMA4D;PTPRD;NRXN1;NLGN2;NLGN3;LRRC4B;GRID2;IL1RAP;EPHB2;SRPX2;SYNDIG1;EPHB3
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.31393701010379704,-0.9115542052064464,0.5847457627118644,0.8975574534400712,1.0,10/23,21.49%,IGF1;ZBTB20;APP;ENTPD5;PFKFB2;INSR;ARNT;PRXL2C;PFKFB3;PRKAA1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.3380889000214383,-0.9114845368604627,0.6368563685636857,0.8967615874549103,1.0,7/18,15.52%,DCN;MCU;PRKN;DDHD1;RALBP1;KDR;FIS1
prerank,mitochondrial protein processing (GO:0034982),0.44866400749057983,0.9114722726004282,0.5531135531135531,1.0,1.0,6/11,18.47%,AFG3L2;MIPEP;PMPCB;PMPCA;ATP23;IMMP1L
prerank,cholesterol efflux (GO:0033344),-0.3202981763316432,-0.9111679462904437,0.5802816901408451,0.8965067298950498,1.0,2/20,2.70%,APOE;ABCA1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.41964735193867664,0.9109867053367918,0.5540765391014975,1.0,1.0,6/16,16.95%,PIGN;PIGA;PIGH;PIGB;PIGP;DPM2
prerank,brain morphogenesis (GO:0048854),-0.3710201788882734,-0.9105931343358035,0.5691244239631337,0.8968477783177392,1.0,6/12,29.34%,PAFAH1B1;SHANK3;SPEF2;MKKS;BBS4;CTNNA2
prerank,linoleic acid metabolic process (GO:0043651),0.4184712249576766,0.9104770283097918,0.5842696629213483,1.0,1.0,3/17,9.05%,ALOX5;FADS2;GSTP1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.32453754816613384,0.910027076635044,0.5779376498800959,1.0,1.0,32/82,23.45%,DYNLL1;CEP41;HAUS8;CEP290;TP53;TPX2;CEP192;DYNC1I2;NEDD1;CEP72;CLASP1;DCTN3;CEP43;CSNK1E;HAUS7;HAUS2;PRKACA;PLK4;DCTN1;HAUS4;CEP135;ACTR1A;CKAP5;SFI1;MAPRE1;ODF2;PPP2R1A;NINL;YWHAG;TUBA4A;CEP63;NDE1
prerank,7-methylguanosine RNA capping (GO:0009452),0.37909206998714656,0.9099340267215438,0.5573294629898403,1.0,1.0,5/31,9.42%,POLR2L;POLR2I;GTF2H4;POLR2G;CDK7
prerank,7-methylguanosine mRNA capping (GO:0006370),0.37909206998714656,0.9099340267215438,0.5573294629898403,1.0,1.0,5/31,9.42%,POLR2L;POLR2I;GTF2H4;POLR2G;CDK7
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.3798372512876589,-0.9098191953833014,0.5947867298578199,0.8976960584208369,1.0,3/11,7.30%,MECOM;WNT5A;CD34
prerank,response to zinc ion (GO:0010043),0.3873825817769537,0.9097363437306147,0.5857805255023184,1.0,1.0,2/25,3.55%,CRIP1;D2HGDH
prerank,proteasome assembly (GO:0043248),0.46001360436398675,0.9096641957380938,0.5654450261780105,1.0,1.0,3/11,10.55%,ADRM1;OTUD6B;PSMD5
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.28942847263185595,-0.9095665607735874,0.6048951048951049,0.8973530996105739,1.0,7/30,10.39%,MLLT3;FLT1;KIT;BMP4;HOXB4;ACE;TGFB1
prerank,actin filament polymerization (GO:0030041),-0.2924625746706909,-0.909543404427388,0.6261682242990654,0.8964299754147561,1.0,2/29,0.70%,GAS7;COBL
prerank,regulation of tissue remodeling (GO:0034103),-0.3226468022116951,-0.9094741493188038,0.6230366492146597,0.8956266361358411,1.0,3/18,3.17%,LEPR;IL15;IL18
prerank,cellular protein localization (GO:0034613),0.29694102459417165,0.9090954905979356,0.6653061224489796,1.0,1.0,52/285,17.07%,FLNA;DMD;STXBP2;HEY2;TBC1D1;ANGPT1;VCL;CSRP3;FERMT2;ITSN1;BICD2;JAM3;ARHGEF2;RABGAP1;SEC31B;VPS26A;EVI5;EIF2D;SEC13;VPS26B;RAP2A;RRAGB;STX12;MFN2;WDR45;SNX13;NSF;SNX9;PACSIN1;FGF10;FOXJ1;LRRK2;RAB14;SNX17;CTSA;SNX1;USP4;CNTNAP1;STX7;YWHAH;GGA2;RUNDC1;ATG13;TBC1D22B;SMURF1;VPS35;TM9SF2;SH3PXD2B;TBC1D12;ARL4D;RAB38;COPA
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.2764693213181212,-0.9090303167744566,0.6103448275862069,0.8956963791381088,1.0,7/37,9.61%,RIN3;APOE;ANKRD13A;ITGAV;OPTN;SDCBP;PRKN
prerank,negative regulation of cell cycle process (GO:0010948),-0.24876171673121908,-0.90895461322188,0.6243654822335025,0.8949155475026128,1.0,10/61,8.70%,BMP7;RBBP4;BMP4;CBX5;MGA;TFDP1;RYBP;PHC3;PHC1;MAX
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.3692426245509199,0.9087860659112731,0.5531295487627366,1.0,1.0,7/33,10.48%,PDGFB;TERT;TP53;TGFB2;RELA;HIF1A;TEAD1
prerank,regulation of ion transport (GO:0043269),-0.23028665040437207,-0.9083580953824899,0.688622754491018,0.8953719313790927,1.0,16/76,14.21%,NEDD4L;WNK1;B2M;NKAIN3;SYT1;CA2;NKAIN4;SIK1;DTNBP1;PRKN;KCNJ13;SNX6;PER1;SNCA;SYT11;SYT12
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.43731021512083323,0.9077815584634064,0.5736301369863014,1.0,1.0,3/12,11.70%,DAB2IP;PTPN1;BOK
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.3739859463939047,-0.9076662075180676,0.5606407322654462,0.8941724150853789,1.0,5/11,26.80%,PPCDC;PANK1;DCAKD;ACOT7;PPCS
prerank,coenzyme A biosynthetic process (GO:0015937),-0.3739859463939047,-0.9076662075180676,0.5606407322654462,0.8941724150853789,1.0,5/11,26.80%,PPCDC;PANK1;DCAKD;ACOT7;PPCS
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.3739859463939047,-0.9076662075180676,0.5606407322654462,0.8941724150853789,1.0,5/11,26.80%,PPCDC;PANK1;DCAKD;ACOT7;PPCS
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.305969994560378,-0.9075067123624713,0.6092896174863388,0.8935988718427712,1.0,3/24,3.56%,PID1;LEPR;COQ10B
prerank,tRNA methylation (GO:0030488),0.36055018784953363,0.9074878124376488,0.5609065155807366,1.0,1.0,8/34,16.79%,HSD17B10;TRDMT1;FTSJ1;TRMT10C;METTL6;NSUN2;TRMT44;WDR6
prerank,fatty acid oxidation (GO:0019395),0.337965745348811,0.9074169609542213,0.5913272010512484,1.0,1.0,11/57,10.29%,HSD17B10;PEX2;HSD17B4;PPARGC1A;ACAD11;MECR;ABCD4;ACADS;ACAD10;HADHB;SCP2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.3530915720992497,-0.9072528304197109,0.5761124121779859,0.8932402840585527,1.0,8/13,32.24%,PGM3;RENBP;UAP1;AMDHD2;GFPT2;GNPDA1;UAP1L1;GNPNAT1
prerank,neutrophil mediated immunity (GO:0002446),0.29772801836175006,0.9072133081870581,0.7185929648241206,1.0,1.0,68/432,14.93%,TTR;STXBP2;RAP1A;DYNLL1;VCL;ROCK1;CD36;FCGR3B;CNN2;ANO6;FRK;AGL;PADI2;UNC13D;ACP3;HMOX2;ALOX5;PLEKHO2;CRISPLD2;PYGB;CD14;CEP290;BRI3;ATG7;APEH;TNFAIP6;RAP2C;CYFIP1;RAB3A;PA2G4;IGF2R;HEBP2;CAP1;GLA;PRG2;STOM;CD300A;DDOST;STBD1;RHOF;ADAM17;GSTP1;PPIE;GCA;IST1;PSMB1;ALDOA;PRKCD;DGAT1;YPEL5;VPS35L;TRPM2;GM2A;CPNE3;DNAJC3;CD53;DNASE1L1;STK10;MAPK1;CFP;CYB5R3;GDI2;RAB14;GLB1;CPPED1;CTSA;PSMB7;PSMD3
prerank,positive regulation of immune system process (GO:0002684),0.42289105697471796,0.9069120324096764,0.5627062706270627,1.0,1.0,3/16,7.78%,ANXA1;VEGFA;TGFB2
prerank,ncRNA processing (GO:0034470),-0.20210060351766695,-0.9068816816594174,0.7346938775510204,0.8931356918892098,1.0,76/200,29.89%,SMAD3;AGO3;INTS6;SRRT;RPL27A;RPS19;SENP3;NVL;RPL21;RPS24;RPL36;RPL18;METTL3;INTS3;SSB;POP1;RPLP0;C1D;DIS3;EXOSC1;RPL28;WDR3;RPLP1;INTS2;RPL34;RPL23A;ADAR;RRP36;MPHOSPH10;FCF1;NOP53;EXOSC9;RPL36A;AARS1;TUT4;SMAD2;RPL9;RPL27;DDX52;RPS7;RPL18A;TUT7;RPL11;RPL37A;RPL38;RRP7A;EMG1;DCAF13;RPL29;EXOSC2;EBNA1BP2;UTP20;RPL32;RPL10A;INTS11;BYSL;RPS27;EXOSC3;UTP18;EXOSC7;NOL11;NOP56;HEATR1;NOLC1;IMP3;WDR18;EXOSC5;AGO4;PIH1D1;RPL4;PES1;UTP6;NOL8;RPL35A;RPS15;FBL
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3200640037295013,0.9068506560632188,0.6113636363636363,1.0,1.0,13/95,6.10%,SDC2;ANGPT1;CHSY3;CSPG4;CSGALNACT1;BGN;EXT2;GCNT2;HS2ST1;HAS2;GPC4;CHST5;OGN
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3568815952095289,-0.9065632409491061,0.5946601941747572,0.8929730392541342,1.0,7/14,23.20%,BCL2L1;PRKN;CREB3L1;SYVN1;HERPUD1;PARK7;TMBIM6
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.2951049251019272,-0.9065091024112718,0.5966101694915255,0.8921665919321448,1.0,13/29,31.04%,RPS19;RRP36;RPS8;RPS21;TSR2;NOP9;DCAF13;UTP20;HEATR1;MRPS11;UTP6;RRS1;TBL3
prerank,tRNA aminoacylation (GO:0043039),0.35673331546217163,0.906453157955045,0.5840336134453782,1.0,1.0,12/37,16.00%,HARS2;LARS1;GATB;IARS2;AIMP1;IARS1;SARS2;EPRS1;KARS1;LARS2;SARS1;FARS2
prerank,clathrin-dependent endocytosis (GO:0072583),-0.30410245061876584,-0.9063282126255001,0.5897435897435898,0.891658828559868,1.0,9/26,18.75%,FCHO2;DNAJC6;FNBP1L;CANX;AP2S1;LMBRD1;CLTB;AP2A2;CLTA
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.29566969703628304,0.906104519590393,0.768,1.0,1.0,102/807,10.70%,FLNA;PRDM16;MYOZ2;HJV;MEF2C;HEY2;ZFHX3;NR1H4;TBX2;LBH;LIMS1;LIMD1;ZEB2;PDGFB;NAB1;ATP8B1;EDNRB;MLIP;FRK;ID4;FST;LOXL2;ARID5B;RUNX1T1;HEYL;ETS2;PBXIP1;HINFP;GMNN;ZNF436;H1-0;RBAK;NACC2;PRDM1;NR2F2;HDAC9;SET;NR2C1;MTERF3;ANKRD2;USP2;ATXN1;CBFB;OSR2;PIAS4;KCNIP3;KLF7;MEF2A;PEX2;MTDH;SUV39H2;MYBBP1A;ARID5A;TAF1;CAV1;DAB2IP;PARP1;HEXIM1;PPM1A;VEGFA;TP53;ZBTB38;SNAI2;BCL7A;SFPQ;YAP1;PA2G4;AR;MED1;L3MBTL2;ZNF431;DICER1;HSF4;SOX9;RELA;MAP3K10;PLCB1;LIN37;CUX2;CCND1;PPARA;CBX4;RUNX1;IMPACT;MTA3;NR1D1;SKI;NR4A2;LRRFIP1;KAT7;ZBTB33;SIRT2;RIF1;MIDEAS;DEDD2;SPINDOC;PCGF6;ZNF3;HNRNPU;NR2C2;NKX6-1;UBE2D1
prerank,cellular response to alcohol (GO:0097306),-0.26845075755847453,-0.9058711657173868,0.6164383561643836,0.8917417631075714,1.0,13/42,15.89%,PTCH1;GRAMD1C;CDH1;ADCY7;CTNNB1;ADAM15;ADCY1;GOLPH3;AHR;GLRA2;BLM;GRAMD1A;ADCY3
prerank,regulation of presynapse organization (GO:0099174),-0.33211652172055095,-0.9056871523495101,0.5733695652173914,0.8902850397236403,1.0,5/18,16.98%,GPC6;APP;PTPRD;SNCA;LRRC4B
prerank,regulation of presynapse assembly (GO:1905606),-0.33211652172055095,-0.9056871523495101,0.5733695652173914,0.8902850397236403,1.0,5/18,16.98%,GPC6;APP;PTPRD;SNCA;LRRC4B
prerank,AMP metabolic process (GO:0046033),0.43307433468200174,0.905586535052504,0.5831903945111492,1.0,1.0,4/13,13.09%,AMPD1;AMPD2;NUDT2;ADSS1
prerank,negative regulation of viral release from host cell (GO:1902187),-0.3621086516039023,-0.9055163074265435,0.5895522388059702,0.8897530496024834,1.0,6/13,31.89%,PML;TRIM5;MID2;TRIM21;TRIM32;TRIM13
prerank,cellular response to hypoxia (GO:0071456),0.31299083108244485,0.9054218956426621,0.6046255506607929,1.0,1.0,19/126,10.55%,PMAIP1;LIMD1;ANGPT4;RORA;PTGIS;CUL2;SUV39H2;CPEB1;PSMC6;TERT;NDRG1;ELOC;VEGFA;TP53;HIF1A;PSME4;SIRT2;PSMB1;PSMD5
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.34134527648560253,0.9053964953013475,0.5954198473282443,1.0,1.0,19/56,21.86%,NDUFS1;NDUFA2;NDUFA11;NDUFC1;NDUFB6;NDUFS3;NDUFB8;NDUFV2;NDUFS2;NDUFAB1;NDUFAF5;NDUFA1;NDUFAF2;NDUFAF1;NDUFV3;NDUFS4;OXA1L;NDUFA3;NDUFAF6
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.34134527648560253,0.9053964953013475,0.5954198473282443,1.0,1.0,19/56,21.86%,NDUFS1;NDUFA2;NDUFA11;NDUFC1;NDUFB6;NDUFS3;NDUFB8;NDUFV2;NDUFS2;NDUFAB1;NDUFAF5;NDUFA1;NDUFAF2;NDUFAF1;NDUFV3;NDUFS4;OXA1L;NDUFA3;NDUFAF6
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.25856258823939116,-0.9053225560831273,0.6431372549019608,0.8892701830224755,1.0,13/43,20.29%,IGF1;LBP;LGALS9;ILRUN;CD34;PTPN22;IRAK3;SIRPA;CX3CL1;SYT11;RARA;ZC3H12A;CD274
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.37447722606004175,0.9051859379924464,0.5454545454545454,1.0,1.0,5/29,7.85%,DCUN1D2;FEM1A;FBXW7;PIN1;DCUN1D1
prerank,retina homeostasis (GO:0001895),0.39562221296394673,0.9051000643499424,0.5786259541984733,1.0,1.0,3/23,4.76%,ACTG1;POTEF;ACTB
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.38592189902380514,0.904894691781695,0.5626911314984709,1.0,1.0,3/23,6.56%,PMAIP1;BCL2;TP53
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.38592189902380514,0.904894691781695,0.5626911314984709,1.0,1.0,3/23,6.56%,PMAIP1;BCL2;TP53
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.2292028018657528,-0.9048842390612308,0.6967741935483871,0.889328137051403,1.0,29/80,23.96%,GBF1;RINT1;KDELR1;ERGIC3;TMED7;GOLPH3;SURF4;TMED10;COPB2;ARFGAP2;ARF3;COPE;ARFGAP1;ARFGAP3;RAB1A;RER1;KLC2;COG7;TMED3;PICK1;RAB1B;SCFD1;UVRAG;KIF26A;ARF5;ATP9A;USE1;COPB1;TAPBP
prerank,negative regulation of transferase activity (GO:0051348),0.37409506710383067,0.9046469458247992,0.5665680473372781,1.0,1.0,9/28,18.96%,MAPT;TP53;CERS1;NPRL2;HNRNPU;IRS2;FBXO5;ABL1;MEN1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.43854381228838035,0.9044507324158594,0.5804195804195804,1.0,1.0,5/13,18.59%,EDEM2;UBE2J1;SVIP;BCAP31;BRSK2
prerank,regulation of organelle assembly (GO:1902115),-0.23642272882288717,-0.9043289845255312,0.6484848484848484,0.8896856846279599,1.0,30/72,25.76%,TBC1D16;RAB5A;TBC1D15;DCDC2;NPRL3;ATG3;TBC1D2B;TBC1D13;TBC1D5;RDX;TBC1D8;IFT88;ATG5;RABEP2;TBC1D9B;TBC1D24;TBC1D22A;PLK2;UBQLN2;DYNLT2B;SGSM3;RAB1B;TBC1D10A;SDCCAG8;KIF9;TBC1D14;CYLD;TBC1D2;CEP76;CDKL1
prerank,regulation of platelet activation (GO:0010543),0.40015701599799147,0.9041744182022798,0.572901325478645,1.0,1.0,7/21,15.00%,PDGFB;PRKCQ;PLEK;C1QTNF1;PDGFA;PLA2G4A;PRKCA
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.44739949258122735,0.9040895709711111,0.583804143126177,1.0,1.0,4/10,12.76%,IMPACT;BAG3;SIRT2;CITED2
prerank,regulation of dephosphorylation (GO:0035303),-0.3447084018470652,-0.9032852458960045,0.5718015665796344,0.8911051122871042,1.0,6/15,35.27%,MTMR4;IGBP1;SMG6;MTMR2;SRC;MTMR1
prerank,regulation of nuclear division (GO:0051783),0.40826654759649134,0.9028444656682468,0.5636070853462157,1.0,1.0,7/20,19.50%,PIN1;CUL9;DAPK3;KIF20B;FBXO5;CAV2;CDK13
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.4356725264545206,0.9026620985282623,0.5616197183098591,1.0,1.0,3/12,7.85%,VEGFA;GDNF;SOX9
prerank,protein maturation (GO:0051604),0.31826344295563913,0.901986470422305,0.5961098398169337,1.0,1.0,17/95,15.56%,TMPRSS4;TSPAN32;TESC;AFG3L2;ISCA1;ADAM17;PHEX;LONP2;NDUFAB1;GALNT2;DDI2;ADAM19;TSPAN17;NAA35;PCSK4;GLRX3;CIAO1
prerank,tyrosine metabolic process (GO:0006570),0.4375137191134699,0.9017026850030843,0.5806451612903226,1.0,1.0,2/11,10.96%,HGD;THAP4
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.38957419619303013,-0.901651684413716,0.6098654708520179,0.8939017881243353,1.0,4/10,9.35%,WNK1;ACER2;PDE3B;CYP1B1
prerank,protein K63-linked ubiquitination (GO:0070534),-0.26796994047891365,-0.9015718998192588,0.6044776119402985,0.8931685377890453,1.0,17/41,25.69%,ITCH;RNF135;PELI1;UBE2E3;UBE2E2;PRKN;TRIM5;STUB1;RNF115;TRIM56;UBE2S;PRPF19;UBE2B;HECTD1;TRIM21;UBE2O;PELI3
prerank,sterol biosynthetic process (GO:0016126),-0.2749088699501784,-0.9014660864731108,0.6338983050847458,0.8924747378066546,1.0,11/33,22.63%,PRKAG2;LBR;GGPS1;CYP51A1;HMGCR;ACLY;ARV1;INSIG1;SQLE;PMVK;LSS
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3782110994308017,0.9012217796941204,0.5924308588064047,1.0,1.0,7/29,14.91%,STRN3;CBFB;YAP1;KMT2D;RUNX1;UFL1;KCTD6
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.3132251141489651,0.9010621643008759,0.6152125279642058,1.0,1.0,25/114,17.33%,ACTN4;LIMS1;TNFSF13B;TNFRSF11A;PSMC6;TP53;TRAF3;RELA;ADAM17;EDAR;PSME4;TRAF5;PSMB1;PSMD5;EIF5A;TNFRSF25;PSMB2;TMSB4X;STAT1;PSMB7;PSMD3;JAK2;PSMA2;PSMD14;TNFSF12
prerank,intracellular sterol transport (GO:0032366),-0.35375234731643346,-0.9003884308972805,0.5829268292682926,0.8941113948963914,1.0,6/13,23.50%,ABCA1;ARV1;STARD4;OSBP;RELCH;NPC1
prerank,neuron fate commitment (GO:0048663),-0.352150308164808,-0.900325080352381,0.6056338028169014,0.8933106398245095,1.0,10/14,53.70%,TGFBR1;POU3F2;DLL4;DLL1;SHH;POU4F1;PAX6;ASCL1;ISL1;MYT1L
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.2146598596877875,-0.8995184380693215,0.7699115044247787,0.8941601706171223,1.0,29/110,20.07%,CDH5;APOE;DDX3X;HJURP;ABCA1;PTPN11;STXBP1;HSPA5;IAPP;SLF2;PEX5;HCFC1;RIOK3;ICE1;TGFB1;SLF1;IRGM;EP300;AIDA;NOP53;MMP1;BAX;CDC42;RALB;HSF1;PARK7;AJUBA;TIRAP;BID
prerank,positive regulation of innate immune response (GO:0045089),-0.289531051654868,-0.8991067873366172,0.6144578313253012,0.894222244313066,1.0,11/30,25.69%,LBP;WNT5A;RPS19;POLR3F;RIOK3;POLR3B;NLRC5;SLC15A4;GBP5;POLR3C;POLR3D
prerank,regulation of ERBB signaling pathway (GO:1901184),0.41195515003978156,0.8988507119328435,0.555735056542811,1.0,1.0,2/15,4.56%,CDH13;PTPN18
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.28896019952582236,-0.8987884683121055,0.6601307189542484,0.8940469012882919,1.0,5/27,12.39%,NFAT5;IRAK1;CYRIB;CD44;SIRPA
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.350929210280081,-0.8985564439677556,0.5870967741935483,0.8936312335968366,1.0,4/14,18.60%,CHKA;LPIN2;SELENOI;LPIN3
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.2982370829268188,-0.8983641085964099,0.6283185840707964,0.893159353481471,1.0,9/26,17.54%,APP;NLGN1;PTK2B;SHANK3;TMEM108;NRXN1;NLGN2;NLGN3;RIMS2
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.3653013513163882,-0.8979115738992021,0.6157303370786517,0.8932683032815484,1.0,4/12,17.56%,GNL3;CCT8;CCT4;WRAP53
prerank,neuropeptide signaling pathway (GO:0007218),0.3409514645119215,0.8977364228189556,0.5912031047865459,1.0,1.0,3/58,5.46%,HCRTR1;SORT1;CYSLTR2
prerank,response to interferon-gamma (GO:0034341),-0.23607712513676057,-0.897149410217212,0.6839080459770115,0.8940423207584786,1.0,15/67,18.39%,DAPK1;WNT5A;LGALS9;CXCL16;GBP7;SP100;SIRPA;CX3CL1;GBP4;SNCA;GCH1;BST2;IFITM1;IFITM3;SHFL
prerank,cellular response to increased oxygen levels (GO:0036295),0.43562997027118455,0.8969866990720171,0.5749128919860628,1.0,1.0,3/11,6.29%,ATG7;ATP6V0A2;CAV1
prerank,in utero embryonic development (GO:0001701),-0.30092192373493376,-0.89663656287338,0.621875,0.8942566639076176,1.0,7/25,12.27%,CHD7;ARNT2;ADAM10;FUT8;IGF2;FGFR2;TGFBR1
prerank,negative regulation of protein secretion (GO:0050709),-0.2662544697814004,-0.8964499630185526,0.6210526315789474,0.8937316665983155,1.0,9/38,13.11%,APOE;ERP29;PSMD9;CCN3;RAB11FIP5;PRKN;CYP51A1;HMGCR;RAB11FIP1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3230576290381766,0.8955939300318493,0.6120283018867925,1.0,1.0,25/80,18.57%,VIM;SAMD4A;NAT10;SIRT3;RPS27L;CIRBP;RELA;PYM1;RPL5;EIF3E;ROCK2;ABCG1;RBM3;PRKCD;ZCCHC4;CHRNA7;CLU;CPEB3;PLXNB2;SP1;PIWIL2;SMPD2;LRRTM3;EEF2;UPF3A
prerank,cellular protein metabolic process (GO:0044267),0.2912368800850317,0.8955347479151614,0.7334004024144869,1.0,1.0,32/396,7.05%,IGFBP7;MFGE8;LTBP1;PAPPA2;SPARCL1;SDC2;MSRB3;LMCD1;RPL3L;HRC;CCN1;CLN5;LOXL2;IGFBP5;D2HGDH;MRPL36;MRPL13;MCRS1;HARS2;SEPHS1;DMBT1;NUCB1;PHKA2;ZDHHC2;AFG3L2;DAB2IP;IGFBP4;ABCA3;KTN1;LAMB2;LAMC1;RPL8
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.43487219379672676,0.8954878604222681,0.5864527629233511,1.0,1.0,2/12,6.31%,ATP2B4;DAB2IP
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3333805495616729,0.8953716002442887,0.6097867001254705,1.0,1.0,13/57,13.69%,PMAIP1;CAMKK2;TP53;PPARGC1A;MIEF2;MIEF1;SPIRE1;HRK;DNM1L;GPER1;BOK;ADCK1;MUL1
prerank,regulation of gene silencing by RNA (GO:0060966),0.3490109611374782,0.8950698153906823,0.5948051948051948,1.0,1.0,18/50,21.41%,POLR2L;POLR2I;NUP62;POLR2G;SEC13;NUP153;NUP107;AAAS;POLR2J;NUP37;NUP98;NUP210;NUP54;AGO1;NUP160;NUP133;TPR;H3-3A
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3490109611374782,0.8950698153906823,0.5948051948051948,1.0,1.0,18/50,21.41%,POLR2L;POLR2I;NUP62;POLR2G;SEC13;NUP153;NUP107;AAAS;POLR2J;NUP37;NUP98;NUP210;NUP54;AGO1;NUP160;NUP133;TPR;H3-3A
prerank,axonal transport of mitochondrion (GO:0019896),0.4312501520706348,0.8946337442028199,0.5678571428571428,1.0,1.0,4/11,9.58%,MAPT;OPA1;TRAK1;HIF1A
prerank,regulation of nervous system process (GO:0031644),-0.3296877021456076,-0.8943698351003615,0.6176470588235294,0.8975737494893209,1.0,6/18,11.94%,APP;DLGAP1;TMEM108;NOS3;DLGAP2;HTR2C
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.36849138746975935,-0.894198159220985,0.6165919282511211,0.8970222806817961,1.0,8/11,32.24%,PGM3;RENBP;UAP1;AMDHD2;GFPT2;GNPDA1;UAP1L1;GNPNAT1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.34251430847017716,0.893247713573413,0.5922974767596282,1.0,1.0,9/43,12.26%,MEF2C;CCN1;FERMT2;ACVR2A;BMPR1A;YAP1;SUCO;LRP5;BMPR1B
prerank,natural killer cell activation (GO:0030101),0.39298523411824865,0.8932086040406976,0.6042296072507553,1.0,1.0,4/23,9.85%,IL2;RASGRP1;KAT7;AXL
prerank,cellular response to glucose starvation (GO:0042149),0.3484745592129921,0.8924298803183331,0.6,1.0,1.0,13/41,18.59%,PMAIP1;KPTN;MYBBP1A;TP53;NUAK1;IMPACT;BRSK1;PIK3C3;PRKAA2;ITFG2;EIF2AK3;MTMR3;BRSK2
prerank,aminoglycan biosynthetic process (GO:0006023),0.3450985343240371,0.8923045278260453,0.607095926412615,1.0,1.0,7/49,10.21%,SDC2;EXT2;GCNT2;HS2ST1;GPC4;HS6ST1;AGRN
prerank,histone methylation (GO:0016571),0.3778110601036313,0.8918573454057518,0.5967741935483871,1.0,1.0,5/26,8.94%,SMYD1;SETD6;SUV39H2;NSD3;PRMT7
prerank,regulation of cholesterol storage (GO:0010885),0.4109023778476728,0.8915376103905869,0.5789473684210527,1.0,1.0,4/15,11.37%,LPL;PPARA;ABCG1;SREBF2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.33850658802524763,0.8913715602294187,0.610236220472441,1.0,1.0,19/49,18.34%,PMAIP1;BCL2;CAV1;TP53;BCL2L2;NDUFS3;RTKN2;DNM1L;BOK;MCL1;URI1;EIF2AK3;PTPMT1;S100A8;S100A9;BBC3;BCAP31;DAPK2;DDIT3
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3135824916476637,-0.8912073243471799,0.6106442577030813,0.9020264110632491,1.0,14/21,36.04%,ERCC5;DDB1;CHD1L;XPA;GTF2H2;GTF2H5;GTF2H3;ERCC2;ERCC1;ERCC4;RPA3;ERCC3;RPA2;RPA1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3135824916476637,-0.8912073243471799,0.6106442577030813,0.9020264110632491,1.0,14/21,36.04%,ERCC5;DDB1;CHD1L;XPA;GTF2H2;GTF2H5;GTF2H3;ERCC2;ERCC1;ERCC4;RPA3;ERCC3;RPA2;RPA1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.3300567608244713,0.8908565566439712,0.614921780986763,1.0,1.0,12/67,16.77%,NCF2;CD36;ITGB5;PSMC6;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,autophagosome maturation (GO:0097352),0.3602873361233686,0.8908122036650411,0.5829662261380323,1.0,1.0,5/32,7.56%,ATP2A2;LIX1L;GABARAP;CALM1;LIX1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.3635888715432019,0.8903356570705915,0.6027210884353742,1.0,1.0,8/34,13.10%,MFHAS1;CD14;PTPRS;DAB2IP;CD300A;NR1D1;OTUD4;SARM1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.44971035502155793,0.8902810127983464,0.5879120879120879,1.0,1.0,2/10,8.34%,ANO6;CD300A
prerank,Rac protein signal transduction (GO:0016601),-0.32048250433188485,-0.8901214701906914,0.5971014492753624,0.9035871503120395,1.0,2/18,1.20%,ELMO1;EPS8
prerank,icosanoid biosynthetic process (GO:0046456),0.4423768045585945,0.8901064599626743,0.5919540229885057,1.0,1.0,2/10,14.03%,ALOX5;PLA2G4A
prerank,regulation of dendrite extension (GO:1903859),-0.3230931290073576,-0.8900416073401791,0.6155844155844156,0.9028550994336381,1.0,8/18,36.53%,NEDD4L;SYT1;RIMS2;SYT2;SYT3;PLAA;CPNE5;CPNE9
prerank,protein-containing complex subunit organization (GO:0043933),0.312183633747332,0.8900157833652379,0.6326987681970885,1.0,1.0,20/109,14.16%,TCAP;SH3BGR;SKAP2;AFG3L2;TP53;LAMC1;YAP1;ADD2;PPARGC1A;MDN1;SOX9;MAGI1;TEAD1;DNM1L;KIFAP3;SNX9;DMTN;KPNA3;NUP98;EPRS1
prerank,histone H4 deacetylation (GO:0070933),0.4359146844900053,0.8898875795349898,0.5732142857142857,1.0,1.0,4/10,19.91%,HDAC9;SIRT2;HDAC1;SMARCAD1
prerank,negative regulation of cell migration (GO:0030336),0.30759105552903093,0.8891116902365913,0.6520307354555434,1.0,1.0,15/137,7.18%,TPM1;DLC1;VCL;TMIGD3;PHLDB2;CLASP2;JAG1;KANK1;IGFBP5;BMPR1A;RAP2C;DAB2IP;DUSP3;CORO1C;STK26
prerank,alanine transport (GO:0032328),0.4497619994939642,0.889101392874673,0.6184448462929476,1.0,1.0,1/10,2.31%,SLC6A17
prerank,regulation of axon extension (GO:0030516),-0.27014158872235916,-0.8889900505978914,0.6332046332046332,0.9043589626770469,1.0,8/37,12.29%,APOE;SEMA7A;RUFY3;GOLGA4;RNF6;SEMA3A;CDKL3;RTN4
prerank,protein targeting to membrane (GO:0006612),-0.22521021070007402,-0.8885846554026363,0.7456647398843931,0.904347274443197,1.0,29/83,25.34%,SEC62;ZDHHC18;PEX14;SLC25A17;ATG3;ALDH3A2;ZDHHC15;SDCBP;PEX5;SEC63;SGTA;ACBD5;ABCD3;ZDHHC20;SGTB;ZDHHC9;FIS1;SSR1;SEC61A1;SRPRA;CHM;SSR2;PXMP2;TAOK2;PEX13;VPS37C;CHMP4B;CHMP4A;ZDHHC24
prerank,protein phosphorylation (GO:0006468),0.2897984980326646,0.887908637538351,0.748496993987976,1.0,1.0,79/478,14.00%,MYLK2;MAP3K20;STK38L;TNNI3K;PRKG1;MAP3K5;MAST4;ROCK1;DYRK2;MERTK;PDGFB;CCNA2;CDK6;PDK4;FRK;FAM20A;CAMK2D;ACVR2A;MUSK;GTF2H4;PEAK1;CAMKK2;MARK1;BMPR1A;DYRK1A;PRKCQ;MAP4K3;MAP4K5;TAF1;DAB2IP;MAPKAPK2;RPS6KA2;COQ8A;DYRK1B;STK26;NUAK1;CHEK1;TGFB2;WNK2;MAP3K10;DAPK3;PRKACB;PRKAR1B;MAP2K1;CCNT1;BRSK1;PKN2;PAK2;CDK7;PDGFRB;STK33;STK24;CDK18;EIF2AK2;ROCK2;PRKCD;COPS8;ACVR1B;RICTOR;STK36;CDK12;DMPK;BMPR1B;TNIK;BCR;CDC42BPB;TAOK3;CDK15;FNIP2;MAST1;EEF2K;PPP3CB;LRRK2;SGK1;PDK2;STK10;GAS6;MAPK1;CSNK1E
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.4002798489325514,0.8876928925570877,0.5865834633385335,1.0,1.0,6/18,9.27%,PEX2;DAB2IP;TP53;CD300A;GSTP1;SKI
prerank,cellular response to unfolded protein (GO:0034620),-0.2946316984389973,-0.8874721837458328,0.6158536585365854,0.9060670048129518,1.0,12/26,29.17%,HSPA5;OPTN;PRKN;ERN1;HSPA13;HSPA9;BAX;HSF1;HSPD1;TMBIM6;PACRG;HSPA8
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.3435060067864979,-0.887197289875412,0.6199460916442049,0.904818155842579,1.0,7/15,30.84%,DTNBP1;AP3M2;AP3S1;AP3M1;BLOC1S6;BLOC1S2;AP3S2
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.3435060067864979,-0.887197289875412,0.6199460916442049,0.904818155842579,1.0,7/15,30.84%,DTNBP1;AP3M2;AP3S1;AP3M1;BLOC1S6;BLOC1S2;AP3S2
prerank,dendritic cell migration (GO:0036336),0.4016995488247871,0.8871132577816576,0.5918032786885246,1.0,1.0,4/16,12.46%,CCL5;ALOX5;TRPM4;TRPM2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4078459999546936,0.8865131571713492,0.5959119496855346,1.0,1.0,4/17,8.74%,PDGFB;CCND2;CCND1;ADAM17
prerank,double-strand break repair (GO:0006302),-0.20709587950614453,-0.8863160940036826,0.7702702702702703,0.9058644032535864,1.0,55/158,28.26%,EYA1;HMGB1;PRKDC;KDM2A;XRCC5;MRE11;TDP2;RAD50;ACTR8;FBH1;HERC2;PARP3;ERCC5;SAMHD1;XRCC1;FAN1;BRCC3;SETX;MDC1;LIG3;POLM;BLM;XRCC6;NBN;DTX3L;UBXN1;SMC5;RMI1;MMS22L;HUS1;ZSWIM7;POLN;CHEK2;KDM4D;DCLRE1A;ATM;IFFO1;SMARCAL1;PRPF19;ACTR5;NSMCE2;ZFYVE26;NSMCE1;RAD51C;ERCC1;NUCKS1;ERCC4;DCLRE1B;AP5Z1;MAPK8;HMGB2;RPA3;CYREN;DNA2;XRCC2
prerank,positive regulation of lipid catabolic process (GO:0050996),0.39830786948036156,0.8862811064089308,0.5984126984126984,1.0,1.0,5/19,17.38%,IRS1;PPARA;PRKCD;IRS2;MTLN
prerank,cellular protein-containing complex assembly (GO:0034622),0.3041151309900299,0.885914553726957,0.665948275862069,1.0,1.0,24/159,14.38%,DMD;ANGPT1;PDE4DIP;CASQ1;HIP1;ADRM1;COX7A2L;MAPT;BBS12;OTUD6B;NUP153;LONP1;ANLN;CENPE;NUP107;TBCD;SNX9;CLU;NCK2;CHMP2A;SRP19;NUP98;HOPX;PTGES3L
prerank,transcription by RNA polymerase III (GO:0006383),0.3760974501170864,0.8858618452874785,0.5891016200294551,1.0,1.0,3/27,4.87%,POLR2L;GTF3C4;ELL
prerank,zinc ion transport (GO:0006829),-0.31026605668702134,-0.8855308213387603,0.6397849462365591,0.9066961094978513,1.0,6/21,15.68%,SLC30A10;SLC39A11;SLC39A8;SLC30A1;SLC39A1;SLC39A6
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3022269306950654,0.8855307545171244,0.6579804560260586,1.0,1.0,30/150,15.32%,NTF3;DMD;NTRK3;PPM1E;EMILIN1;CAV1;DAB2IP;CORO1C;CALM1;IMPACT;GSTP1;PAK2;CNKSR3;SIRT2;SAMSN1;GPD1L;PRKCD;PDE4D;RB1;CEP85;DMTN;NCK2;DNAJC3;CEP43;LRRK2;GNAQ;DVL1;MLXIPL;INPP5J;PTEN
prerank,regulation of melanin biosynthetic process (GO:0048021),0.4342619125400081,0.8854484117858097,0.5949367088607594,1.0,1.0,1/10,2.08%,ZEB2
prerank,regulation of spindle organization (GO:0090224),0.3918767288341204,0.8853618322808117,0.5901639344262295,1.0,1.0,6/18,19.02%,NUP62;TPX2;SENP6;MAP9;DCTN1;CLTC
prerank,DNA biosynthetic process (GO:0071897),0.4075017046817131,0.8850449240232566,0.6198347107438017,1.0,1.0,3/16,11.30%,TERT;WRNIP1;POLD1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.3708323281818635,-0.884878286454157,0.6041189931350115,0.9071851822670512,1.0,2/12,1.69%,FOXP1;HMGB1
prerank,chromatin assembly or disassembly (GO:0006333),0.43017743457386454,0.884502081051051,0.5793499043977055,1.0,1.0,3/11,6.56%,CHAF1B;SUV39H2;TP53
prerank,negative regulation of cell motility (GO:2000146),0.3129146447648544,0.8836681000132148,0.63954802259887,1.0,1.0,11/108,7.18%,TPM1;DLC1;VCL;TMIGD3;JAG1;KANK1;IGFBP5;RAP2C;DUSP3;PIN1;STK26
prerank,snRNA 3'-end processing (GO:0034472),-0.31239465949750045,-0.8836347470687316,0.6123456790123457,0.9091380568491062,1.0,9/19,28.61%,INTS6;INTS2;EXOSC9;EXOSC2;EXOSC3;EXOSC7;EXOSC5;INTS14;TOE1
prerank,negative regulation of neuron projection development (GO:0010977),-0.25072100437399547,-0.8835932607537431,0.7201834862385321,0.9083031105123065,1.0,15/56,21.38%,EFNB2;LPAR1;APOE;EPHA4;NLGN1;RUFY3;SEMA3A;RTN4;DPYSL3;RAB29;CBFA2T2;HDAC2;PRAG1;PTPRO;EFNB3
prerank,MAPK cascade (GO:0000165),0.2930876019671918,0.8833868915153092,0.7213779128672746,1.0,1.0,54/295,15.56%,MAP3K20;FGF13;MEF2C;MAP3K5;ANGPT1;FGF1;PDGFB;RASAL2;DUSP5;IL2;CCL5;KSR1;CAMKK2;MEF2A;PRKCQ;IRS1;PSMC6;DAB2IP;MAPKAPK2;GDNF;CALM1;AREG;RASGRP1;MBP;SOX9;MAP2K1;PPP1CB;PDGFRB;PSME4;PSMB1;ACTN2;PSMD5;HBEGF;PDGFA;GFRA1;ABHD17B;HTR2B;FBXW11;ZFP36L1;TNIK;TAOK3;PSMB2;SPTB;FGF10;LRRK2;MAPK1;CSF2RA;PSMB7;IRS2;PSMD3;KARS1;JAK2;MAPK12;RAF1
prerank,RNA splicing (GO:0008380),0.3138038004789759,0.8832695907568472,0.6440092165898618,1.0,1.0,26/95,15.30%,DDX23;TXNL4A;SFPQ;PPARGC1A;SF3B3;SRSF4;PRPF18;SNRPN;FUS;ZMAT5;DHX8;U2AF1;RBM8A;MBNL1;SRSF10;PRPF4;SF3A3;HNRNPC;CDK12;SRRM1;SF3B2;SF3B1;ZCRB1;SYNCRIP;PDCD7;SRPK2
prerank,regulation of T cell cytokine production (GO:0002724),0.41098298700255775,0.8831868567435441,0.579734219269103,1.0,1.0,2/15,8.71%,FZD5;TRPM4
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3164943588698828,0.8830975471330557,0.6434378629500581,1.0,1.0,21/86,16.77%,LIMD1;ANKRD2;CUL2;PSMC6;ELOC;VEGFA;TP53;CHEK1;IMPACT;BAG3;HIF1A;PSME4;PSMB1;PSMD5;ATF3;PSMB2;PSMB7;PSMD3;PSMA2;INO80;PSMD14
prerank,gas transport (GO:0015669),0.4240523755871565,0.8827336588232106,0.5767857142857142,1.0,1.0,1/10,3.02%,MB
prerank,regulation of endocytosis (GO:0030100),0.32837247899399413,0.882731437851389,0.6287128712871287,1.0,1.0,7/61,6.67%,ROCK1;HIP1;CDH13;PACSIN3;PACSIN2;CBLL1;PTPN1
prerank,error-free translesion synthesis (GO:0070987),-0.30319389012604464,-0.8817239985584229,0.6376404494382022,0.9115665322941984,1.0,11/22,36.85%,UFD1;POLDIP2;UBC;REV1;UBB;RPA3;RFC3;RPA2;RPA1;RFC1;RFC4
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4216622951469321,0.881659504485722,0.5862068965517241,1.0,1.0,5/13,19.18%,KPNA4;KPNA2;KPNA3;CBLB;NUP54
prerank,aspartate family amino acid catabolic process (GO:0009068),0.3959851372526946,0.881624357243569,0.5861538461538461,1.0,1.0,4/19,7.92%,DLD;DLST;GOT1;GOT2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3750157990378634,0.881592355476293,0.6148148148148148,1.0,1.0,4/27,3.48%,CHSY3;CSPG4;CSGALNACT1;BGN
prerank,positive regulation of dendrite extension (GO:1903861),-0.3298364308911916,-0.8813926947052325,0.6259946949602122,0.9114324946720375,1.0,8/17,36.53%,NEDD4L;SYT1;RIMS2;SYT2;SYT3;PLAA;CPNE5;CPNE9
prerank,pulmonary valve development (GO:0003177),0.39492842322239047,0.881310374760486,0.6009463722397477,1.0,1.0,4/18,7.78%,HEY2;HEYL;JAG1;TGFB2
prerank,regulation of cell cycle phase transition (GO:1901987),0.316233612337373,0.8808869322521182,0.623391812865497,1.0,1.0,22/91,18.22%,ATP2B4;TCIM;ANAPC10;MN1;PSMC6;TAF1;FBXW7;TP53;UBE2E1;PSME4;PSMB1;PSMD5;UBE2D1;PSMB2;PSMB7;PSMD3;FBXO5;PSMA2;PSMD14;ANAPC16;ANAPC5;ANAPC11
prerank,glycosphingolipid metabolic process (GO:0006687),0.3452449519779659,0.8807406944796391,0.6122177954847278,1.0,1.0,11/42,14.81%,ESYT2;LARGE1;NEU3;GLA;SUMF1;ST8SIA5;A4GALT;GM2A;GLTP;GLB1;CTSA
prerank,regulation of cell-substrate adhesion (GO:0010810),0.34463757435735276,0.8806019562087803,0.6108108108108108,1.0,1.0,6/42,6.91%,LIMS1;PDGFB;FZD4;GCNT2;RSU1;CORO1C
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.3698966589125422,0.8801765151801269,0.6033182503770739,1.0,1.0,14/26,23.49%,DAB2IP;DUSP3;SNAI2;GAREM1;MED1;SOX9;ZFP36L1;KNSTRN;PTPN12;ERBB2;ZFP36L2;DUSP22;ZPR1;PLCG1
prerank,carbohydrate transport (GO:0008643),0.4310362192137095,0.8797379336053902,0.6022944550669216,1.0,1.0,2/11,8.14%,SLC23A2;SLC23A1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.31972138931268823,0.8795295360047688,0.6184834123222749,1.0,1.0,16/78,11.81%,ATP2B4;STAC;ITGA3;ITGB1;ARHGEF16;ACTB;ZDHHC2;STAC3;PPP2R5A;SORBS1;AR;KIF5B;EPHA2;GPER1;CLIP3;DPP10
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.357037144630642,0.8791237793901329,0.6156111929307806,1.0,1.0,4/33,4.64%,CDK6;NACC2;FHL1;JADE1
prerank,glutathione biosynthetic process (GO:0006750),0.43392025858343947,0.8789667422872319,0.6082289803220036,1.0,1.0,5/11,20.88%,GGCT;OPLAH;CHAC2;CNDP2;HAGH
prerank,regulation of stem cell differentiation (GO:2000736),0.3161490320713823,0.8785216613458936,0.661697247706422,1.0,1.0,20/89,14.93%,RBM24;JAG1;CBFB;SP7;BMPR1A;PSMC6;YTHDF2;GDNF;YAP1;RUNX1;PSME4;PSMB1;HNRNPU;EIF2AK2;PSMD5;PSMB2;NELFB;NSUN2;PSMB7;PSMD3
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.23229485000214836,-0.8783706756434001,0.7374301675977654,0.9171614700424646,1.0,24/73,22.54%,ROBO1;SMAD3;XDH;F3;COL4A3;NOD1;SENP1;ACER2;TNFSF10;CASP8;DAP;EGLN3;SNCA;CASP9;APAF1;CRADD;PPARG;BAX;HSPE1;AIFM1;BID;MTCH1;HSPD1;CASP4
prerank,fatty acid metabolic process (GO:0006631),0.29779893513851585,0.8781519673153524,0.655210643015521,1.0,1.0,18/115,14.13%,CD36;LPL;FA2H;ALOX5;PEX2;ACSL5;PPARGC1A;CPT1B;MECR;CRAT;PPARA;THEM4;NUDT19;AOAH;NDUFAB1;CPT1A;PNPLA3;ACOT6
prerank,microtubule anchoring (GO:0034453),0.4184446468189247,0.877781174697919,0.5812720848056537,1.0,1.0,2/12,4.52%,CLASP2;BICD2
prerank,regulation of microtubule-based movement (GO:0060632),-0.3675961343643659,-0.8776624697250315,0.6180555555555556,0.917786287630523,1.0,7/11,45.89%,IGBP1;DYNLT2B;LAMP1;DRC1;HAP1;CCDC65;CFAP298
prerank,camera-type eye morphogenesis (GO:0048593),0.42954194970369675,0.8775047765008449,0.6163410301953819,1.0,1.0,3/10,9.27%,TBX2;VEGFA;SKI
prerank,regulation of defense response to virus by host (GO:0050691),0.3613546183460447,0.8774991505142256,0.6014388489208633,1.0,1.0,8/30,17.75%,CGAS;IL12RB1;ZDHHC1;MUL1;STAT1;SIN3A;DHX9;EIF2AK4
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.30656653943107953,-0.8773479986126436,0.6308539944903582,0.9175587817683913,1.0,14/20,35.47%,HOXA5;PTK2B;CTR9;MEIS2;LEO1;HSPA9;HOXB8;HOXA9;ZFP36;MAFB;CIB1;LDB1;MEIS1;PAF1
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.29864507494616294,-0.8773289556049031,0.6350148367952523,0.9166671818513963,1.0,7/22,22.76%,SASH1;XDH;RELL1;MAP3K4;ZC3H12A;GADD45B;SPHK1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3592967768223305,0.8771571464390896,0.6225626740947076,1.0,1.0,8/36,11.69%,ATP2B4;TERT;CAV1;CALM1;GLA;HIF1A;TERF2;HTR2B
prerank,regulation of BMP signaling pathway (GO:0030510),0.32184165561734657,0.8769997516478986,0.6262135922330098,1.0,1.0,7/73,5.12%,RBPMS2;CRIM1;CCN1;ITGA3;FST;ACVR2A;BMPR1A
prerank,RNA processing (GO:0006396),0.2934805629636434,0.8767176119787978,0.6995708154506438,1.0,1.0,43/176,16.68%,RBPMS;HNRNPR;FASTKD5;DDX23;ATXN1;U2AF2;SFPQ;CELF1;PPARGC1A;DICER1;SF3B3;SRSF4;TENT4A;PRPF18;SNRPN;FUS;ZMAT5;DHX8;U2AF1;DEDD2;RBM8A;MBNL1;HNRNPU;PRPF4;RBM3;SF3A3;RBM6;HNRNPC;CDK12;SRRM1;DROSHA;SF3B2;SF3B1;ZCRB1;SYNCRIP;SON;PDCD7;PRKACA;SRPK2;FASTKD2;SF3A1;WBP4;PIWIL2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.391099137551205,0.8765859997021541,0.6016260162601627,1.0,1.0,2/17,3.84%,ADRA1D;ADCY9
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2484050317315954,-0.876570802846891,0.6867469879518072,0.9174453567397468,1.0,9/44,18.59%,SH3RF1;DDX3X;RPS6KA3;CD44;IGBP1;SNCA;AKT1;GPX1;SIAH2
prerank,regulation of keratinocyte migration (GO:0051547),0.420554485509116,0.8762636156686318,0.6007259528130672,1.0,1.0,3/12,15.32%,MAPRE2;FGF10;PTEN
prerank,cellular response to UV (GO:0034644),0.3170405111096889,0.8761928577506897,0.6456599286563615,1.0,1.0,11/76,11.30%,CRIP1;TAF1;PARP1;TP53;NEDD4;CHEK1;IMPACT;CERS1;RHNO1;PRKCD;POLD1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3427624661183592,0.8761490253064761,0.6183510638297872,1.0,1.0,6/45,9.65%,RBPMS;TGFB3;ACVR2A;BMPR1A;TGFB2;GDF1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.45261608503675105,0.8761003049485477,0.6146616541353384,1.0,1.0,3/10,12.60%,TERT;DICER1;DROSHA
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.38302964163083025,0.8760703242743987,0.6075949367088608,1.0,1.0,3/21,5.16%,SAMD4A;PARN;CNOT4
prerank,regulation of stem cell population maintenance (GO:2000036),-0.318300266466818,-0.8760163694168609,0.6440677966101694,0.917721603021276,1.0,1/18,0.13%,PTN
prerank,cortical actin cytoskeleton organization (GO:0030866),0.39181853654279497,0.8759120143739666,0.6282467532467533,1.0,1.0,4/20,10.78%,ROCK1;LCP1;PLEK;ROCK2
prerank,intracellular cholesterol transport (GO:0032367),-0.3277545325020677,-0.875688253491118,0.6381909547738693,0.9175752436410518,1.0,6/15,23.50%,ABCA1;LDLR;STARD4;OSBP;RELCH;NPC1
prerank,negative regulation of cartilage development (GO:0061037),0.42022550417724636,0.8750039570368779,0.6149732620320856,1.0,1.0,3/13,7.85%,CHADL;SNAI2;SOX9
prerank,megakaryocyte differentiation (GO:0030219),0.4339313483959176,0.8748093890988876,0.608540925266904,1.0,1.0,2/11,7.26%,THPO;MED1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.31810210619896395,-0.8747512820824208,0.6057441253263708,0.9186846336386126,1.0,7/18,21.96%,RNF185;SEL1L;UGGT2;UBC;OS9;SYVN1;UBB
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.408408140611514,0.8743241884515902,0.6102564102564103,1.0,1.0,2/15,7.78%,TGFB3;TGFB2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.3765108867629582,-0.873892837404996,0.6136865342163356,0.9197282626308669,1.0,5/10,18.98%,GHR;LYN;PRLR;STAT5A;STAT6
prerank,positive regulation of phospholipid transport (GO:2001140),0.448610455831284,0.8737125976369582,0.6094890510948905,1.0,1.0,2/10,6.73%,ABCB4;ABCA3
prerank,cardiac conduction system development (GO:0003161),0.3794347896061467,0.8735675238085138,0.6155038759689923,1.0,1.0,3/24,5.12%,HEY2;TBX18;BMPR1A
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.23588935511123196,-0.8735020263704745,0.7035398230088495,0.9197096208579568,1.0,22/57,24.16%,CDC14B;PRKDC;MRE11;RINT1;BRCC3;ATF2;MDC1;BLM;NBN;FOXN3;TAOK1;NOP53;HUS1;CHEK2;ATM;FBXO31;HMGA2;TAOK2;TRIM39;CLSPN;CDK2;CDKN1A
prerank,dendritic cell chemotaxis (GO:0002407),0.4034777884407152,0.8734870278116925,0.5989847715736041,1.0,1.0,3/14,12.46%,CCL5;TRPM4;TRPM2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.22655492872094665,-0.8734803600917237,0.6976744186046512,0.9188326871639522,1.0,29/72,29.83%,MRE11;RAD50;FBH1;ERCC5;FAN1;UBC;DDB1;RNASE4;CHD1L;ENPP1;XPA;GTF2H2;GTF2H5;EDC4;ZC3H12A;PNRC2;GTF2H3;UBB;EDC3;ERCC2;ERCC1;ERCC4;MUS81;SPO11;OGG1;RPA3;DNA2;PDE12;RFC3
prerank,gland development (GO:0048732),0.32819119176569106,0.8734399798190032,0.6432225063938619,1.0,1.0,10/59,13.29%,TG;ANXA1;ARID5B;TGFB3;CAV1;SOX9;ARHGAP35;GFER;CITED2;FGF10
prerank,myelin assembly (GO:0032288),0.4359808695568055,0.8733836866667566,0.5973282442748091,1.0,1.0,3/10,15.11%,TPPP;DICER1;CNTNAP1
prerank,positive regulation of actin nucleation (GO:0051127),0.42569216924473624,0.8731040714362265,0.5863970588235294,1.0,1.0,3/11,10.13%,CYFIP1;WHAMM;FCHSD2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.39658744334507473,0.8726278861058544,0.5996758508914101,1.0,1.0,4/18,12.04%,PMAIP1;TMEM259;BOK;USP13
prerank,embryonic organ morphogenesis (GO:0048562),0.34464929175095244,0.8723882366334521,0.6206434316353887,1.0,1.0,4/42,7.03%,RYR2;RBPMS2;OSR2;HOXC4
prerank,arachidonic acid secretion (GO:0050482),0.42827110246664885,0.872356025663571,0.5974499089253188,1.0,1.0,1/10,2.73%,ANXA1
prerank,arachidonate transport (GO:1903963),0.42827110246664885,0.872356025663571,0.5974499089253188,1.0,1.0,1/10,2.73%,ANXA1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.3099232890714143,0.8723174893249768,0.6531322505800464,1.0,1.0,14/86,12.76%,RBPMS;ZEB2;CCN1;TGFB3;ACVR2A;TGFB1I1;BMPR1A;SLC2A10;TGFB2;ADAM17;GDF1;ACVR1B;BMPR1B;CITED2
prerank,regulation of primary metabolic process (GO:0080090),0.30427377606280465,0.8723053600861909,0.6794310722100656,1.0,1.0,27/126,16.77%,SMARCD3;PRKAB2;ANGPTL8;OAZ2;PSMC6;ACACB;MED1;IDI1;PPARA;MVD;NR1D1;PSME4;PSMB1;PSMD5;ROCK2;SREBF2;TGS1;PSMB2;ZFP69;EDF1;PSMB7;IRS2;PSMD3;SIN3A;SP1;PSMA2;PSMD14
prerank,mitochondrial fission (GO:0000266),-0.3251247587703111,-0.8722395796083522,0.6269035532994924,0.9206683345102572,1.0,4/16,9.61%,DNM3;DNM1;MTFR1;PRKN
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.35737387830982115,-0.8721912208144583,0.6608695652173913,0.9180276227625871,1.0,6/12,30.17%,CUL3;CDC23;ANAPC4;NSMCE2;CDC16;CDC27
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.35737387830982115,-0.8721912208144583,0.6608695652173913,0.9180276227625871,1.0,6/12,30.17%,CUL3;CDC23;ANAPC4;NSMCE2;CDC16;CDC27
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.35737387830982115,-0.8721912208144583,0.6608695652173913,0.9180276227625871,1.0,6/12,30.17%,CUL3;CDC23;ANAPC4;NSMCE2;CDC16;CDC27
prerank,response to iron ion (GO:0010039),-0.3572877430977493,-0.8715145016671398,0.6355140186915887,0.9185926172433203,1.0,4/12,14.26%,BMP6;B2M;SNCA;ACO1
prerank,cellular response to dsRNA (GO:0071359),0.39879050191812604,0.8714803113070673,0.6104347826086957,1.0,1.0,5/15,16.92%,CGAS;CAV1;MUL1;FLOT1;DHX9
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.4106754454611887,0.8713707576206454,0.6101694915254238,1.0,1.0,4/16,8.79%,VIM;TGFB3;SUCO;RUNX1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.33965091589835206,0.8709965527542817,0.611185086551265,1.0,1.0,11/41,16.62%,ALOX5;FADS3;HSD17B4;FADS2;GSTP1;MGLL;SCP2;PTGR1;PLA2G4A;PLA2G4C;EPHX1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.21421306832557258,-0.8709174284568447,0.7787610619469026,0.9189428944896576,1.0,21/94,15.07%,NOD1;NFKBIA;IRAK1;PSMD7;PSMD9;PSMD13;PELI1;IKBKG;IRAK3;MAP3K3;TAB2;PSMB3;UBC;IRAK2;CHUK;PSMC5;TAB1;PSMA5;PSMA1;PSMC2;TOLLIP
prerank,carbohydrate homeostasis (GO:0033500),0.31903852796766924,0.8706466026100982,0.6621454993834772,1.0,1.0,7/67,5.94%,SLC2A4;PDK4;ALOX5;KCNB1;KLF7;IRS1;MBD5
prerank,chondroitin sulfate catabolic process (GO:0030207),0.422107457632537,0.8704368334374509,0.5947826086956521,1.0,1.0,2/13,3.48%,CSPG4;BGN
prerank,regulation of protein phosphorylation (GO:0001932),0.2878019707105753,0.8702758078695798,0.7237512742099899,1.0,1.0,42/256,13.93%,TTN;NTRK3;ANGPT1;FGF1;HRC;PLCE1;CCN1;CCND2;FAM20A;THPO;SMG8;ACVR2A;MUSK;CAMKK2;RARRES2;DAB2IP;PPP2R5A;VEGFA;PIN1;CORO1C;ITGB3;RASGRP1;ANKRD54;SOX9;CCND1;ADAM17;IMPACT;RAP2A;PELI2;ROCK2;PDGFA;GPER1;ATF3;CLIP3;TNIK;AKTIP;CHRNA7;FNIP2;FGF10;PLXNB2;LRRK2;GAS6
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.2773142813678585,-0.8701569606162626,0.6880733944954128,0.9196679288104894,1.0,15/29,37.36%,ELOVL7;PPT1;ACSL3;ACLY;ACSL4;ELOVL6;HACD2;ELOVL1;ACSL1;HSD17B8;ELOVL5;GCDH;SCD;SLC25A1;ACACA
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.22307594688965587,-0.8701094271216548,0.7674418604651163,0.9188550877202988,1.0,26/72,27.66%,IRAK1;BIRC2;PSMD7;PSMD9;PSMD13;CARD10;PSMB3;CHUK;CARD14;PSMC5;PSMA5;PSMA1;PSMC2;BIRC3;AKT1;RELB;TLR3;BTRC;TIRAP;PSME3;PSMC4;PSMB6;PSMB10;NFKB2;PSMA4;PSME1
prerank,positive regulation of phosphorylation (GO:0042327),0.28810028957776757,0.8699660271274525,0.7303370786516854,1.0,1.0,48/240,15.75%,NTRK3;ANGPT1;FGF1;MERTK;MST1R;CCN1;ROR1;CCND2;FAM20A;THPO;CCL5;PFKFB1;ACVR2A;MUSK;CAMKK2;RARRES2;DSCAM;VEGFA;PIN1;AR;ITGB3;RASGRP1;SOX9;CCND1;ADAM17;EPHA2;RAP2A;HIF1A;PDGFRB;AXL;PELI2;ROCK2;GPER1;CLIP3;TNIK;AKTIP;CHRNA7;FGF10;LRRK2;GAS6;EPHB1;ROR2;PRKAA2;MLXIPL;FLOT1;GAPDHS;MYDGF;VAC14
prerank,regulation of vasculature development (GO:1901342),-0.2868368897039624,-0.8697491297939208,0.6574585635359116,0.9188246975750387,1.0,5/26,11.64%,NF1;ADGRA2;CTNNB1;BMPER;SP100
prerank,negative regulation of insulin secretion (GO:0046676),0.39264413694332656,0.8697300027451256,0.6102819237147595,1.0,1.0,3/17,5.71%,KCNB1;KLF7;IRS1
prerank,regulation of myelination (GO:0031641),-0.2875824340012898,-0.869383436897114,0.6411042944785276,0.9187176403253281,1.0,3/25,5.91%,PTN;JAM2;PTPRZ1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.3942713368178399,0.869246969326869,0.5962837837837838,1.0,1.0,1/17,2.35%,PLA2G3
prerank,positive regulation of neuron projection development (GO:0010976),0.3115292451878222,0.8688734321239185,0.6561771561771562,1.0,1.0,5/85,2.36%,RAP1A;NTRK3;SERPINI1;PLA2G3;ROR1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.31792752578405287,0.8688543097949558,0.6608260325406758,1.0,1.0,13/64,13.17%,POLR2L;POLR2I;ADRM1;GTF2H4;ELL;POLR2G;ELOC;CCNT1;POLR1E;CDK7;CDK12;NELFB;POLR2J
prerank,cellular copper ion homeostasis (GO:0006878),-0.32788403208012906,-0.8687006664342135,0.6421568627450981,0.9192658159873862,1.0,4/14,23.33%,APP;ATOX1;MT2A;SLC31A1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.30503575239785663,-0.8685263718026158,0.6430446194225722,0.9187373689133332,1.0,3/18,7.99%,THOC2;PABPN1;POLDIP3
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.2999999709233517,0.8682623009764779,0.681868743047831,1.0,1.0,35/119,19.26%,PIP5K1B;INPP4B;PIP4K2A;MTMR7;SOCS5;PITPNM3;PIGN;SOCS6;SOCS4;SYNJ2;PIGA;SACM1L;TTC7A;INPPL1;MTMR14;ITPKC;CDIPT;SBF1;PIK3C3;RAB14;PLEKHA1;PIGH;INPP5J;PIGB;PTEN;PITPNM2;VAC14;PIGP;DPM2;PLEKHA2;MTMR3;INPP4A;PGAP4;MBOAT7;PIK3R2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.28145897106365436,0.8682352637589623,0.939,1.0,1.0,273/1646,16.25%,ACTA2;MYOCD;SOX6;MLF2;PRDM16;SOX5;TNNI2;WTIP;MEF2C;ATP2B4;HEY2;ZFHX3;MAP3K5;NR1H4;TBX2;SMARCD3;PTP4A3;LBH;POLR2L;LIMS1;EBF1;LIMD1;TCIM;ZEB2;PDGFB;NAB1;ATP8B1;ALX4;RORA;MLF1;ID4;NR4A1;EBF2;SIM2;PRRX1;TEAD3;LOXL2;GABPA;ARID5B;RUNX1T1;HEYL;ETS2;IFRD1;CAMK2D;PBXIP1;IRX5;FZD4;HINFP;TGFB3;BRIP1;GMNN;ZNF436;RBAK;FOSL2;NACC2;PRDM1;NUP62;NR2F2;HDAC9;SET;TGFB1I1;ARID1A;NR2C1;MTERF3;VEZF1;ANKRD2;CAMKK2;ATXN1;CBFB;SP7;OSR2;PIAS4;TBX18;CEP290;KLF7;CCNQ;MEF2A;DYRK1A;NCOA7;GBX1;KLF16;MTDH;PRKCQ;FOXJ3;RXRG;TESC;DBP;KLF15;SUV39H2;JUND;MYBBP1A;CHD2;SMARCB1;ARID5A;DAB2IP;ZNF418;ELOC;HEXIM1;PPM1A;VEGFA;TP53;DYRK1B;ZBTB38;GRHL1;SNAI2;HDGFL3;BCL7A;HOXC4;SFPQ;YAP1;PA2G4;AR;MED1;ZFP28;PPARGC1A;L3MBTL2;BTG1;PPARGC1B;ZNF431;MED29;MED12;REXO4;HSF4;SOX9;ERCC6;ZFP62;RELA;KMT2D;SETD3;EPC2;MAP3K10;PLCB1;DAPK3;ZXDC;CUX2;MED13L;TRAK1;ZKSCAN4;PPARA;MAP2K1;BBX;CBX4;CARF;RUNX1;CCNT1;NSD3;FUS;MSL3;MTA3;NR1D1;PPIE;NR4A2;LRRFIP1;KAT7;ZBTB33;HIF1A;SIRT2;SFR1;ZBTB41;CRLF3;MIDEAS;DEDD2;SPINDOC;PCGF6;ZNF3;CDK18;MED14;TEAD1;NR2C2;NAT14;NUP107;NKX6-1;RAI1;SRSF10;PIAS2;LRP5;ZKSCAN1;SREBF2;PCGF5;RB1;ATF3;RHOH;ACVR1B;HOXC8;BAZ2A;ZBTB7A;NFX1;FBXW11;LCORL;ESRRA;CNOT7;RUVBL1;PSPC1;USP13;LIN9;CSRNP3;BCL6;ZBTB10;TSFM;POU3F3;HDGFL2;TOX4;CTDSP1;NR6A1;CITED2;ZXDB;MED8;SMARCA5;CDK15;MXD4;ZNF83;ZFP69;ZBTB5;PPP3CB;CASZ1;CHD4;IKZF1;MEF2B;RFX7;CLOCK;SPIN1;HMG20A;FOXJ1;MAP2K3;TRIM28;ZNF276;GAS6;ETV3;ZKSCAN7;HOPX;SP4;DVL1;ZBTB4;STAT1;RFX1;EDF1;VGLL4;EBF3;MAPRE3;PCGF3;ZNF711;KLF6;IRF2BPL;UXT;ZSCAN22;KARS1;HOXB2;MLXIPL;KDM2B;MAGED1;POFUT1;FBXO5;YWHAH;RBM15;CIAO1;STAT3;URI1;RHOG;DNM2;NR5A1;HOXC5;NOS1;CALCOCO1;RFX3;ELP3;ZBTB9;SIN3A;SP1;MLXIP;ZMYND11;IKZF4;ZSCAN18;MAD2L2
prerank,positive regulation of collagen metabolic process (GO:0010714),0.403740099627406,0.8681655509039004,0.6235489220563848,1.0,1.0,4/17,8.79%,VIM;TGFB3;SUCO;RUNX1
prerank,hyaluronan metabolic process (GO:0030212),-0.2897999655228883,-0.8681584705542134,0.6939890710382514,0.9186040567244811,1.0,6/23,16.51%,CEMIP;CD44;TGFB1;HEXA;CEMIP2;FGF2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.3907143469483663,0.8681326512793881,0.618421052631579,1.0,1.0,6/17,15.88%,VEZF1;BTG1;SOX9;NKX6-1;FOXJ1;RFX3
prerank,peptidyl-lysine modification (GO:0018205),0.308989401136692,0.8681003198479561,0.660958904109589,1.0,1.0,33/99,19.95%,UBA2;LOXL2;NUP62;SIRT3;HDAC9;PIAS4;SAE1;TRPM4;NUP153;SIRT2;NUP107;AAAS;PIAS2;ATPSCKMT;NDUFAB1;SENP6;VCPKMT;NUP37;TRIM28;SIRT4;NUP98;EEF1AKMT2;NUP210;PIAS1;BCL11A;ESCO1;HDAC6;NUP54;SUMO1;SENP2;UBE2I;NUP160;NUP133
prerank,stress-activated MAPK cascade (GO:0051403),0.3297349987814399,0.8680625306460429,0.6588669950738916,1.0,1.0,9/61,15.10%,MAP3K20;MAP3K5;MAP4K3;MAP3K10;FBXW11;ZFP36L1;MAP2K3;MAPK1;MAP2K4
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.3472869161942258,-0.8670807393065514,0.6376470588235295,0.920063177414973,1.0,7/12,33.97%,ESR1;TGFB1;PPARG;ZC3H12A;ZC3H10;NCOR1;ELAVL1
prerank,regulation of cellular response to heat (GO:1900034),0.3151118440911019,0.8663945155014361,0.6511085180863477,1.0,1.0,24/77,21.18%,CAMK2G;CAMK2D;NUP62;MAPT;MAPKAPK2;SEC13;NUP153;BAG3;NUP107;AAAS;BAG2;NUP37;MAPK1;NUP98;NUP210;FKBP4;DNAJB6;HSPB8;NUP54;NUP160;NUP133;TPR;HIKESHI;PTGES3
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.3409346872937369,-0.8662783755537469,0.651685393258427,0.9208230247302454,1.0,8/12,28.87%,GMPS;ADSS2;PFAS;GART;ATIC;IMPDH1;IMPDH2;PAICS
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3448767313340262,0.8662757566374443,0.6442307692307693,1.0,1.0,7/39,12.68%,TRPC6;FHL1;UTRN;NEDD4;AHCYL1;GPD1L;HOMER1
prerank,postreplication repair (GO:0006301),-0.24416209791489787,-0.8661953351030725,0.7198443579766537,0.9200928864912077,1.0,23/45,36.85%,PARP10;TRIM25;UBC;REV1;POLN;USP10;PRIMPOL;UBB;UBE2B;NSMCE1;ZBTB1;POLI;RPA3;RFC3;USP43;RAD18;RPA2;POLD3;BRCA1;PCLAF;RPA1;RFC1;RFC4
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.35968504460113726,0.8658763942929875,0.6260744985673352,1.0,1.0,9/30,18.00%,FZD5;SAE1;FBXW7;SREBF2;HPS4;LEPROT;ATG13;USP36;TOMM7
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.3446482286465473,-0.8658579145741773,0.6361323155216285,0.9198964201643136,1.0,7/13,41.05%,DUSP1;ANAPC15;DYNC1LI1;MAD2L1;GEN1;NDC80;XRCC3
prerank,endomembrane system organization (GO:0010256),0.29164755719981417,0.8658110075868455,0.7046908315565032,1.0,1.0,36/178,17.68%,ARHGEF7;FER1L5;SYNE1;ATP8B1;DYSF;CLASP2;HOOK2;TBC1D20;ARHGAP21;LNPK;MYO18A;SEC31B;SUN2;HOOK1;NSFL1C;DNM1L;TLCD2;CHMP2B;OSBPL2;DMPK;USP50;AKTIP;A4GALT;PLEKHJ1;CLASP1;LRRK2;BNIP1;CSNK1A1;CAV2;SUN1;EIF2AK3;VPS4A;ARFGEF2;TRAPPC12;VPS51;UBXN2B
prerank,endocytic recycling (GO:0032456),0.3275436783109178,0.8653697534427108,0.6334661354581673,1.0,1.0,15/50,17.55%,EHD2;ANKRD50;VPS26A;WASHC1;RAB11FIP4;RAB11FIP3;DENND1A;VPS35L;VPS50;ANKRD27;RAB14;SNX17;VPS35;SNX4;VPS51
prerank,glucose homeostasis (GO:0042593),0.3124288815382351,0.8653554331380561,0.6836363636363636,1.0,1.0,19/83,17.64%,SLC2A4;PDK4;HK2;ALOX5;KCNB1;KLF7;IRS1;MBD5;PPARGC1A;NR1D1;HIF1A;CRTC2;PDK2;PRKAA2;MLXIPL;STAT3;SELENOT;RPS6;ADRA2A
prerank,snRNA metabolic process (GO:0016073),-0.3220198330179361,-0.8650009093242603,0.6700251889168766,0.9208652569772997,1.0,5/17,23.35%,INTS6;INTS3;INTS2;RBM7;INTS11
prerank,cellular component disassembly (GO:0022411),0.3241394080329746,0.8647488347502533,0.6340852130325815,1.0,1.0,7/53,8.84%,ADAMTS5;LCP1;KLK2;HTRA1;LAMC1;CAPN2;WASHC1
prerank,lipid homeostasis (GO:0055088),-0.2375578744123618,-0.8647458193624205,0.7339449541284404,0.9204679263219987,1.0,5/57,2.70%,ZBTB20;RBP1;APOE;DDX3X;ABCA1
prerank,regulation of TORC1 signaling (GO:1903432),0.35232290316179715,0.864687074279992,0.6089466089466089,1.0,1.0,5/33,9.74%,RNF152;LARS1;KPTN;CASTOR1;RRAGB
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.38444841504555727,0.8642107908387221,0.6211878009630819,1.0,1.0,4/18,9.78%,LAX1;DUSP3;PPARA;PAG1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2316773896834708,-0.8636829402581085,0.7719298245614035,0.9217727265998578,1.0,15/72,11.28%,ELF1;IFNAR2;PTPN11;IRAK1;HSP90AB1;CASP8;BIRC2;MADD;TNFRSF1A;IKBKG;IRAK3;RBCK1;RNF31;IRAK2;CHUK
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.3647998797692677,0.8635900630020686,0.6439169139465876,1.0,1.0,5/27,6.67%,PIP4K2A;KANK1;PRKCQ;IRS1;PTPN1
prerank,protein oxidation (GO:0018158),0.430248216419037,0.8633183824935553,0.6083916083916084,1.0,1.0,2/11,10.31%,LOXL2;SUMF1
prerank,cellular response to nutrient levels (GO:0031669),0.3165024383896914,0.8627484706971482,0.6666666666666666,1.0,1.0,13/62,14.85%,PDK4;LPL;KCNB1;ATG7;STK26;PPARA;RRAGB;STK24;SREBF2;WDR45;LRRK2;PDK2;PRKAA2
prerank,skeletal system development (GO:0001501),0.2977533831479521,0.8627266974188839,0.6933760683760684,1.0,1.0,6/148,3.08%,SOX6;SOX5;PLS3;SNORC;ALX4;ETS2
prerank,aromatic amino acid family catabolic process (GO:0009074),0.399236765348016,0.8625842295701603,0.6023489932885906,1.0,1.0,3/15,13.88%,HGD;KMO;QDPR
prerank,cell-cell junction organization (GO:0045216),0.3105802725190048,0.8623142773417035,0.6326767091541136,1.0,1.0,11/79,8.81%,CDH6;LIMS1;GJC1;CDH13;TGFB3;CDH4;CDHR3;LIMS2;TLN1;TGFB2;CDH2
prerank,microtubule anchoring at centrosome (GO:0034454),0.43639084466484473,0.8621505273699843,0.6395348837209303,1.0,1.0,1/10,2.08%,CCDC68
prerank,regulation of mitochondrial fission (GO:0090140),0.3750377774328323,0.861741292097662,0.6544585987261147,1.0,1.0,10/24,18.18%,INF2;MAPT;MIEF2;MIEF1;SPIRE1;DNM1L;MUL1;LRRK2;VPS35;MFF
prerank,positive regulation of inflammatory response (GO:0050729),0.3091397253652409,0.8616671339483969,0.669364161849711,1.0,1.0,5/86,3.66%,AGTR1;PLA2G3;LPL;IL2;FEM1A
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3077816019484971,0.8616524331957194,0.6933638443935927,1.0,1.0,17/104,12.47%,CCNA2;CCND2;SLC8A1;SLC8A2;KSR1;ACTB;DAB2IP;CALM1;CCND1;MAP2K1;CCNT1;CDK7;LRP5;RB1;CDK12;TSG101;PDCD10
prerank,extracellular matrix disassembly (GO:0022617),0.32378225545009154,0.8611077611749978,0.6468354430379747,1.0,1.0,7/53,8.84%,ADAMTS5;LCP1;KLK2;HTRA1;LAMC1;CAPN2;WASHC1
prerank,translational termination (GO:0006415),0.3071055745588631,0.8611026327131815,0.6851851851851852,1.0,1.0,33/95,22.19%,MRPL36;MRPS31;MRPL13;APEH;MRPL30;ABCE1;MRPL43;MRPS35;MRPS28;MRPL51;MRPL45;GFM2;MRPL21;MRPL23;MRPL16;GSPT1;MRPL47;MRPL9;MRPL42;N6AMT1;ETF1;MRPL14;MRPL4;MRPS21;MRPL40;MRPL22;MRPL50;MRPS14;MRRF;OXA1L;MRPL24;MRPS12;MRPS10
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.36631412736812513,-0.8610283515349899,0.6584269662921348,0.9265640263071571,1.0,3/10,9.95%,MLLT3;HOXB4;ACE
prerank,cellular response to acid chemical (GO:0071229),0.3603062911982692,0.860791367087177,0.6201201201201201,1.0,1.0,7/27,12.85%,LARS1;CPEB1;VEGFA;CAPN2;RRAGB;SH3BP4;CPEB3
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.24993716422259832,-0.8604183402360032,0.7058823529411765,0.9269653300335591,1.0,24/42,42.75%,PARP10;TRIM25;UBC;REV1;POLN;USP10;PRIMPOL;UBB;ZBTB1;POLI;RPA3;RFC3;USP43;RPA2;POLD3;PCLAF;RPA1;POLE;RFC1;RFC4;CDKN2D;DTL;POLA1;RFC5
prerank,positive regulation of integrin activation (GO:0033625),0.43168677546707557,0.860388905121856,0.6223021582733813,1.0,1.0,2/11,7.53%,FERMT2;PLEK
prerank,positive regulation of T cell differentiation (GO:0045582),-0.25988361182496555,-0.8603715387064889,0.6666666666666666,0.9261572834733682,1.0,7/36,19.79%,LEF1;GLI2;ZMIZ1;CD46;SOX4;NCKAP1L;PNP
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.3473154432811375,-0.8600127122011114,0.660377358490566,0.9259654018439598,1.0,6/14,15.33%,PPP2R2B;PPP2CA;PPP2CB;NCK1;PPM1F;DUSP1
prerank,cortical cytoskeleton organization (GO:0030865),0.3424454276733807,0.8594645581240862,0.6517615176151762,1.0,1.0,7/41,11.49%,ROCK1;LCP1;RHOBTB3;PLEK;RHOF;ROCK2;RHOH
prerank,positive regulation of superoxide anion generation (GO:0032930),0.4067505347849011,0.8593932019402151,0.6324626865671642,1.0,1.0,3/13,11.28%,MAPT;GSTP1;PRKCD
prerank,positive regulation of protein kinase activity (GO:0045860),0.29327907008877163,0.8590686503698753,0.6885775862068966,1.0,1.0,26/148,13.93%,RAP1A;PDGFB;CCN1;SLC8A2;CCL5;MMD;DOK7;DAB2IP;VEGFA;PTPN1;LCP2;TPX2;CALM1;ITGB3;TGFB2;MAP2K1;PAK2;CENPE;PRKCD;TNIK;SNX9;CLU;PDCD10;TAOK3;MAP2K3;GAS6
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.40804672707175405,0.8582058381144995,0.6056338028169014,1.0,1.0,4/13,15.76%,IL12RB1;NECTIN2;STX7;MR1
prerank,regulation of pH (GO:0006885),0.4237447619312828,0.8578506828313684,0.6283185840707964,1.0,1.0,1/11,2.53%,PDK4
prerank,cognition (GO:0050890),0.33511924517840286,0.85777896344389,0.625,1.0,1.0,7/42,12.41%,LHCGR;SLC8A2;CYFIP1;CUX2;HRH3;CHMP2B;CHRNA7
prerank,amino sugar biosynthetic process (GO:0046349),-0.34580269173229283,-0.8576012779924923,0.6612529002320185,0.930169142057106,1.0,8/12,32.24%,PGM3;RENBP;UAP1;AMDHD2;GFPT2;GNPDA1;UAP1L1;GNPNAT1
prerank,membrane fusion (GO:0061025),0.3433248471099683,0.857368883112578,0.6219879518072289,1.0,1.0,10/33,17.90%,FER1L5;DYSF;OPA1;GCA;NSFL1C;DNM1L;NSF;DNM2;UBXN2B;SNAP23
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.25523028136375925,-0.8572390977912647,0.7198581560283688,0.9300400909284081,1.0,19/37,26.17%,RYBP;PML;HSP90AB1;USP7;SDCBP;SGTA;OGT;GIPC1;UBXN1;NOP53;RPS7;RPL11;PARK7;TRIM39;TLK2;BAG5;CSNK2A1;CSNK2A2;HFE
prerank,cellular response to metal ion (GO:0071248),0.29854681924572296,0.8563745645763492,0.6762430939226519,1.0,1.0,8/123,5.55%,RYR1;MEF2C;CACNA1H;RASGRP2;CAMK2D;SYT10;MEF2A;KCNH1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.3150123992497563,-0.8563609952430423,0.6604774535809018,0.9310179627448014,1.0,3/18,12.45%,LBP;WNT5A;IL33
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.31810432348689116,0.8563166366189032,0.6413881748071979,1.0,1.0,16/55,18.34%,PMAIP1;BCL2;CAV1;DAB2IP;TP53;PAK2;DEDD2;DNM1L;GPER1;BOK;TNFSF12;S100A8;S100A9;BBC3;BCAP31;DDIT3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2643401071600303,-0.8563017011161045,0.7163636363636363,0.9302167569450717,1.0,11/33,19.56%,DDX5;CARM1;SAFB2;RNF6;PRMT2;ESR1;EP300;GPAM;CALR;KDM1A;PARK7
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.25709252400272486,-0.8559473298535818,0.7027972027972028,0.9300481004164989,1.0,20/37,36.85%,ERCC5;UBC;DDB1;CHD1L;XPA;GTF2H2;GTF2H5;GTF2H3;UBB;ERCC2;ERCC1;ERCC4;RPA3;RFC3;ERCC3;RPA2;POLD3;RPA1;RFC1;RFC4
prerank,response to exogenous dsRNA (GO:0043330),0.3808127781114457,0.855826724914748,0.617693522906793,1.0,1.0,7/18,17.25%,CGAS;CAV1;MUL1;RFTN1;FLOT1;DHX9;TICAM1
prerank,regulation of monocyte differentiation (GO:0045655),0.4000233713382625,0.8557771840965513,0.6282894736842105,1.0,1.0,4/14,20.44%,CDK6;ZFP36L1;ACIN1;CTNNBIP1
prerank,response to histamine (GO:0034776),0.4238134662166169,0.8556007545583088,0.6496350364963503,1.0,1.0,2/10,11.95%,GABRB2;GABRB3
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.28223273906288254,-0.8554317758809606,0.6603260869565217,0.9302149081876164,1.0,8/27,18.60%,CHKA;LPIN2;NAAA;NAPEPLD;PLA2G6;PLAAT3;SELENOI;LPIN3
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.36518894856873174,-0.8554219162140158,0.6757369614512472,0.9293336854719931,1.0,5/10,21.40%,DSE;DSEL;XYLT1;PXYLP1;B3GAT1
prerank,cellular amide metabolic process (GO:0043603),-0.2122757055166167,-0.8550207905088396,0.7835820895522388,0.9292676333186812,1.0,21/102,18.60%,AEBP1;CERK;ST3GAL1;PPP2CA;SLC25A32;PCCA;NAAA;NAPEPLD;ACSF2;ASAH2;ACOT8;DBI;ACOT9;PLAAT3;CPD;MTHFS;ALDH1L1;FPGS;CPXM1;ABCB9;MCCC1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.41664354195711145,0.8548481187435933,0.6216216216216216,1.0,1.0,2/14,5.43%,CCL5;RARRES2
prerank,aorta development (GO:0035904),0.39910182021471585,0.854591653982964,0.6287625418060201,1.0,1.0,2/14,3.07%,TBX2;JAG1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.2871562205645516,-0.8544382123047942,0.6873065015479877,0.9295699683545523,1.0,13/26,32.72%,FBN1;TCTA;RARA;TLR3;GPR137B;CEACAM1;PTPN2;C1QC;ZFPM1;GPR137;MAFB;FSTL3;INHA
prerank,apoptotic DNA fragmentation (GO:0006309),-0.3223236422759642,-0.8544160969673876,0.6470588235294118,0.9287146422879514,1.0,3/16,5.24%,HMGB1;CECR2;KPNA1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.34908717033163816,-0.8540323651816267,0.6876456876456877,0.9286652628483972,1.0,3/12,6.49%,ABCA1;NFKBIA;ITGAV
prerank,aminoglycan catabolic process (GO:0006026),0.3590237580274063,0.8537731895161954,0.6401137980085349,1.0,1.0,5/28,15.19%,SDC2;GPC4;AGRN;GLB1;HSPG2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.34881592150496593,0.8537462139981631,0.6487603305785123,1.0,1.0,3/31,4.77%,CACNA1H;SYT10;KCNB1
prerank,fat cell differentiation (GO:0045444),0.32087910656006546,0.8531356184891459,0.657516339869281,1.0,1.0,8/57,12.87%,PRDM16;NR4A1;MED1;PPARGC1A;NR4A2;CLIP3;ZBTB7A;OSBPL11
prerank,spermatid development (GO:0007286),0.3425373814552874,0.8531333960416255,0.620253164556962,1.0,1.0,6/32,12.09%,RSPH1;ACRBP;CDYL;DDX25;NECTIN2;YTHDC2
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.306522554448049,0.8529477150358765,0.6844602609727165,1.0,1.0,18/79,15.96%,DYNLL1;KIF2A;LAG3;KIF3B;DCTN6;SEC13;CENPE;DYNC1I2;KIFAP3;KIF5A;SEC24A;CAPZB;DCTN3;SEC24C;KIF18A;MFSD6;DNM2;AP1S3
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.3314244731428214,-0.8528647959812314,0.6527777777777778,0.9302003383917062,1.0,7/13,29.75%,SDAD1;NUP88;NMD3;NOP9;RAN;RRS1;RPS15
prerank,protein deubiquitination (GO:0016579),-0.18636949445542783,-0.8527819798743465,0.9428571428571428,0.9294850120201883,1.0,59/242,19.37%,SMAD3;ATXN3;USP46;FOXK2;USP11;ASXL2;NFKBIA;OTUD7B;WDR48;USP45;UFD1;USP19;BIRC2;ACTR8;PSMD7;USP7;PSMD9;PSMD13;USP12;MDM2;IKBKG;BRCC3;ESR1;PRKN;HCFC1;SENP8;SMURF2;PSMB3;UBC;OGT;SKP2;TGFBR1;USP3;IL33;SUDS3;EP300;PSMC5;TAB1;USP29;PSMA5;PSMA1;PSMC2;ATXN7;MINDY1;BIRC3;HGS;USP37;VCPIP1;OTUD3;EIF3F;CDC25A;SMAD2;SMAD4;SNX3;USP24;ZC3H12A;SIAH2;USP10;USP32
prerank,cell projection assembly (GO:0030031),0.3749429077155338,0.8526805400598692,0.6217054263565891,1.0,1.0,6/22,15.59%,RHOJ;CYFIP1;PARVA;PDGFA;RHOH;RHOG
prerank,negative regulation of TOR signaling (GO:0032007),0.33905920652480476,0.8524928669723648,0.6335664335664336,1.0,1.0,9/36,15.63%,RNF152;KPTN;CASTOR1;NPRL2;EPM2A;SH3BP4;CASTOR2;PRKAA2;ITFG2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.35984824010918387,-0.8524536727600014,0.6487695749440716,0.9292676267296532,1.0,5/10,21.96%,UBC;TUT4;TUT7;CHFR;UBB
prerank,regulation of T cell activation (GO:0050863),0.332039649226897,0.8518710450849674,0.6535326086956522,1.0,1.0,5/42,9.78%,CCL5;LAX1;PRKCQ;DUSP3;PAG1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.3084965695484084,-0.8513265131441565,0.6866840731070496,0.9307649097420677,1.0,8/19,18.32%,CUX1;CDKL3;CUL7;PTPRD;FBXW8;LRP8;OBSL1;DBN1
prerank,protein modification process (GO:0036211),-0.21933384649211107,-0.8512419549438798,0.7894736842105263,0.9300341728285514,1.0,25/76,27.12%,ST3GAL6;ST8SIA4;PLAT;ST3GAL1;PRKDC;UBE2D3;STK38;ATG3;CDKL3;ABL2;ST8SIA2;PPP4R2;PLOD2;NTAQ1;UBA7;UBE2S;CHRM3;B4GALT7;RPN2;FBXW2;USP25;SERP1;PARP4;LOX;QPCT
prerank,positive regulation of telomere maintenance (GO:0032206),-0.2638881555813422,-0.8507665761201115,0.6840277777777778,0.9300683973330672,1.0,8/31,13.62%,TNKS2;MRE11;PML;RAD50;GNL3;MAP3K4;NBN;HNRNPD
prerank,positive regulation of neuron death (GO:1901216),-0.24420518514401723,-0.8504322596424962,0.7663934426229508,0.9298614280868248,1.0,6/46,7.18%,NF1;EPHA7;EFNB2;NUPR1;WNT5A;CTNNB1
prerank,transition metal ion transport (GO:0000041),0.3467422881952486,0.850360998987417,0.6583333333333333,1.0,1.0,8/35,16.74%,TRPC6;TTYH1;TRPC5;SLC30A5;ATP7B;SLC31A2;IREB2;MT3
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.4044052820068783,0.8500589470280936,0.6267361111111112,1.0,1.0,3/14,7.85%,CHADL;SNAI2;SOX9
prerank,protein homooligomerization (GO:0051260),0.293452688872433,0.8497641550925755,0.6941045606229144,1.0,1.0,16/114,13.96%,RYR1;KCNJ12;HSD17B10;CRYZ;NACC2;ACACB;TIFA;TRPM4;FUS;SLC1A5;ALDOA;GLS;OSBPL2;TRPM2;CHMP2A;VSTM5
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.32182325457866856,-0.8497435127517659,0.675609756097561,0.9304293268344315,1.0,5/16,15.18%,DCPS;SNRNP200;CWC15;SFSWAP;NCBP2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.2854840654633084,0.849733906495942,0.732620320855615,1.0,1.0,42/166,18.76%,DYRK2;CD36;ZEB2;PDGFB;VIM;CCL5;BCAR3;SAMD4A;NAT10;IRS1;SORBS1;RPS27L;CIRBP;PPARGC1A;PYM1;NR1D1;PTH1R;KAT7;HIF1A;PDGFRB;RPL5;EIF3E;RBM3;ZCCHC4;CLU;CPEB3;ARPP19;PLXNB2;NNMT;IRS2;MLXIPL;PAOX;SP1;PIWIL2;DHX9;FAF1;NR1H3;P2RX4;EEF2;EGR1;UPF3A;CCL19
prerank,erythrocyte differentiation (GO:0030218),-0.2525702873911509,-0.8493806678219583,0.7250996015936255,0.9303393672089272,1.0,13/44,26.18%,TGFBR3;KMT2E;KIT;RPS19;ALAS1;LYN;HSPA9;SLC25A38;NCKAP1L;PTPN2;TAL1;ZFPM1;UBA5
prerank,regulation of interleukin-6 production (GO:0032675),-0.20787549692943366,-0.8492304026957334,0.8181818181818182,0.9297844406892327,1.0,22/96,21.89%,ARRB1;HMGB1;APP;PTPN11;LBP;WNT5A;LGALS9;PLCG2;PTPN22;IL6R;IRAK3;SIRPA;IL33;CX3CL1;SYT11;C1QTNF3;TLR3;NCKAP1L;ZC3H12A;TIRAP;HSPD1;POU2F2
prerank,acylglycerol catabolic process (GO:0046464),0.3582701519292027,0.8489550144293354,0.6213450292397661,1.0,1.0,4/30,13.49%,LPL;FABP4;MGLL;PNPLA3
prerank,positive regulation of cell junction assembly (GO:1901890),0.31662012852153326,0.8485585346213538,0.6527958387516255,1.0,1.0,8/56,11.41%,ROCK1;LIMS1;FERMT2;CAV1;VEGFA;CUX2;EPHA2;IL1RAPL1
prerank,positive regulation of blood coagulation (GO:0030194),-0.3060738975363258,-0.8481578985112579,0.6888297872340425,0.93106802615755,1.0,6/17,22.34%,ST3GAL4;F3;THBD;SERPINE1;ENPP4;USF1
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.3129703417360308,-0.8481145717004961,0.6624040920716112,0.9302701260801901,1.0,7/17,23.64%,RNF20;CTR9;VIRMA;NCBP2;ZC3H3;HSF1;CPSF6
prerank,endodermal cell differentiation (GO:0035987),0.35194513431950797,0.8479004031031042,0.6429587482219061,1.0,1.0,4/31,8.48%,COL4A2;ITGA7;ITGB5;ITGA4
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.3462083699692324,0.8475248668548513,0.6499261447562777,1.0,1.0,9/33,15.58%,THPO;ACVR2A;TESC;MED1;ANKRD54;HIF1A;ACVR1B;STAT1;STAT3
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.3285051962674772,-0.8472711809817661,0.675609756097561,0.9310164085296506,1.0,5/15,23.93%,ZC3H12B;POP1;ZC3H12C;ZC3H12A;KHNYN
prerank,myoblast differentiation (GO:0045445),0.39335929561087596,0.8471813279218373,0.6237113402061856,1.0,1.0,5/14,11.46%,JAG1;HINFP;PLEKHM3;MBNL1;RB1
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.2799212401891822,-0.8471531541831986,0.6875,0.9303722975713915,1.0,4/25,3.57%,APP;ITGA6;EGFR;NRP1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.27735570676304394,0.8469933310882358,0.8199195171026157,1.0,1.0,50/417,10.19%,PRDM16;HEY2;TBX2;LBH;LIMS1;LIMD1;PDGFB;NAB1;ATP8B1;ID4;LOXL2;ARID5B;RUNX1T1;HEYL;PBXIP1;HINFP;GMNN;RBAK;NACC2;NR2F2;HDAC9;SET;MTERF3;ATXN1;PIAS4;SUV39H2;MYBBP1A;ARID5A;DAB2IP;HEXIM1;TP53;ZBTB38;BCL7A;SFPQ;PA2G4;L3MBTL2;SOX9;RELA;MAP3K10;PLCB1;CBX4;MTA3;NR1D1;KAT7;ZBTB33;SIRT2;MIDEAS;DEDD2;SPINDOC;PCGF6
prerank,ribosome assembly (GO:0042255),0.3325391896597707,0.8464227238461932,0.6649006622516557,1.0,1.0,7/47,9.82%,RPL3L;MTERF3;RPS27L;NLE1;MDN1;PWP2;RPL5
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.2934295851067265,0.8460899926442601,0.7104072398190046,1.0,1.0,16/124,11.46%,TPM1;ROCK1;FRY;ARMC2;BTG2;MAPT;GDNF;HDGFL3;NEDD4;CYFIP1;PLEK;ERCC6;ATCAY;SAMD14;KIFAP3;RB1
prerank,macrophage activation (GO:0042116),0.33956224670535107,0.8454274599301433,0.6471408647140865,1.0,1.0,4/34,6.20%,FER1L5;DYSF;CRTC3;MAPT
prerank,isotype switching (GO:0045190),-0.36523700267388776,-0.8453852151374719,0.6629213483146067,0.9330626650448809,1.0,5/10,35.23%,MSH6;HSPD1;EXOSC3;BATF;LIG4
prerank,regulation of establishment of cell polarity (GO:2000114),0.39065225987530694,0.8451792222757727,0.6233333333333333,1.0,1.0,4/16,12.64%,ROCK1;KANK1;ROCK2;KIF20B
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.29316907650518453,-0.8449887867148351,0.703601108033241,0.9330400555185023,1.0,10/22,24.87%,UBC;DDB1;CHD1L;XPA;GTF2H2;GTF2H5;GTF2H3;UBB;ERCC2;RAD23B
prerank,Golgi organization (GO:0007030),0.2951190126585576,0.8447514174829841,0.7105561861520999,1.0,1.0,7/112,5.36%,ARHGEF7;SYNE1;ATP8B1;CLASP2;TBC1D20;ARHGAP21;MYO18A
prerank,positive regulation of defense response to virus by host (GO:0002230),0.3602937036178865,0.844204318123762,0.638680659670165,1.0,1.0,6/24,17.75%,CGAS;IL12RB1;ZDHHC1;STAT1;SIN3A;EIF2AK4
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.29546784948127036,-0.8438148372478196,0.6785714285714286,0.9345799379786331,1.0,4/21,9.61%,SLC30A10;ABCB7;COA8;PRKN
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.3437618372498907,-0.8437351500542603,0.6818181818181818,0.9338635295571849,1.0,5/13,20.81%,GLUL;ASPA;ACOT8;MTHFS;GAD1
prerank,positive regulation of T cell migration (GO:2000406),0.36815689291354314,0.8436905706478912,0.6442748091603053,1.0,1.0,3/20,8.74%,DOCK8;CCL5;ADAM17
prerank,regulation of embryonic development (GO:0045995),0.336256928560875,0.8423976940577896,0.6600846262341326,1.0,1.0,7/34,14.46%,PHLDB2;CLASP2;PLCB1;RBM19;NR2C2;CLASP1;RAB14
prerank,lung epithelium development (GO:0060428),-0.36727745389209376,-0.8422954837414124,0.6681318681318681,0.9358686591729873,1.0,2/10,12.56%,BMP4;RCN3
prerank,intraciliary retrograde transport (GO:0035721),-0.3489532588865206,-0.8422534367960349,0.6674311926605505,0.9350655848766911,1.0,5/12,27.87%,IFT122;DYNC2H1;DYNLT2B;DYNC2I2;DYNC2I1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.31967942904618496,0.8421578587465159,0.6763224181360201,1.0,1.0,8/56,9.65%,RBPMS;TGFB3;ACVR2A;BMPR1A;EMILIN1;PIN1;TGFB2;GDF1
prerank,negative regulation of cilium assembly (GO:1902018),-0.3486993743143984,-0.8420318908087172,0.6935483870967742,0.9346131394887707,1.0,7/12,28.92%,LIMK2;CEP97;TBC1D30;ODF2L;TBC1D7;CCP110;TESK1
prerank,iron-sulfur cluster assembly (GO:0016226),0.3627215340478698,0.841687391474611,0.6594761171032357,1.0,1.0,8/24,15.56%,FXN;GLRX5;ISCA1;ISCA2;NUBP1;NUBP2;GLRX3;CIAO1
prerank,cardiolipin metabolic process (GO:0032048),0.386399984829968,0.8416797069596561,0.6473684210526316,1.0,1.0,6/13,21.29%,HADHB;TAMM41;PLA2G4A;HADHA;PTPMT1;CRLS1
prerank,sulfur amino acid metabolic process (GO:0000096),0.36376437323601735,0.841640179915917,0.6411411411411412,1.0,1.0,4/24,10.83%,TXN2;ADI1;AHCY;SMS
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3408543245203538,0.8413331803202019,0.6581196581196581,1.0,1.0,9/32,15.64%,PRKAB2;PDK4;SORBS1;PPARA;GPER1;SIRT4;PRKAA2;MLXIPL;NR5A1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.2320156789539301,-0.8408591588790914,0.7433628318584071,0.9361942164084317,1.0,21/52,30.03%,EXTL3;HSPA5;SRPRB;CUL7;ERN1;ARFGAP1;TSPYL2;ZBTB17;DNAJB9;SYVN1;SSR1;SRPRA;TPP1;ATP6V0D1;CXXC1;SERP1;PPP2R5B;ACADVL;WIPI1;PARP16;KLHDC3
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.37170403138544245,0.8405936221975348,0.6630602782071098,1.0,1.0,9/22,19.50%,ELL;ERCC6;CCNT1;KAT7;CDK12;BRD4;HMGN1;EAPP;CDK13
prerank,body fluid secretion (GO:0007589),-0.318205549440024,-0.8405015762091476,0.7021276595744681,0.9360422861742853,1.0,3/15,12.60%,NPR1;SLC22A4;PRLR
prerank,positive regulation of organelle assembly (GO:1902117),0.3288582814896708,0.8404714697140615,0.6762295081967213,1.0,1.0,8/44,14.21%,PIP4K2A;LCP1;NUP62;TAPT1;STX18;ARHGAP35;CEP120;G3BP1
prerank,O-glycan processing (GO:0016266),-0.2296383784204934,-0.8404614735305926,0.7791666666666667,0.9352686941398219,1.0,4/54,3.34%,GXYLT2;ST3GAL4;ST3GAL1;GALNT10
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3208046893080915,0.8403421169078574,0.6834437086092715,1.0,1.0,11/46,12.01%,EMILIN1;DAB2IP;DUSP3;PTPN1;PIN1;WNK2;TNIP1;GSTP1;CNKSR3;GPER1;DUSP29
prerank,leukotriene biosynthetic process (GO:0019370),0.38599831482965763,0.8399799573662794,0.6109215017064846,1.0,1.0,2/14,14.03%,ALOX5;PLA2G4A
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.2216244200554245,-0.8398735256812536,0.79,0.9355377048210431,1.0,8/68,8.54%,HMGB1;APP;PTPN11;LBP;WNT5A;LGALS9;PLCG2;IL6R
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3186771377043898,0.839557819312114,0.6826196473551638,1.0,1.0,7/54,10.21%,SDC2;EXT2;GCNT2;HS2ST1;GPC4;HS6ST1;AGRN
prerank,myelination in peripheral nervous system (GO:0022011),-0.33000146117509477,-0.8395440856095072,0.6763990267639902,0.9353226450063845,1.0,5/13,19.07%,NF1;ADGRG6;ARHGEF10;LGI4;MYOC
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.32016861993796114,-0.8395197310276235,0.6925,0.9344922239492618,1.0,7/16,23.24%,NF2;PPP2CA;PARP14;HGS;PTPN2;BCL3;INPP5F
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.33330184539753777,-0.8392391293682786,0.6864197530864198,0.9341791531057159,1.0,8/13,39.22%,TMEM30A;GCC2;INSIG1;SAR1A;SEC16B;SAR1B;CD81;TM9SF4
prerank,glutathione derivative biosynthetic process (GO:1901687),0.36755098396159885,0.8391856031409355,0.6453576864535768,1.0,1.0,4/20,12.15%,GSTT1;GSTP1;ESD;GSTA4
prerank,glutathione derivative metabolic process (GO:1901685),0.36755098396159885,0.8391856031409355,0.6453576864535768,1.0,1.0,4/20,12.15%,GSTT1;GSTP1;ESD;GSTA4
prerank,cellular response to mechanical stimulus (GO:0071260),0.32389758931872614,0.8391745126508283,0.6582781456953642,1.0,1.0,11/46,20.71%,MYD88;CNN2;CHEK1;SOX9;CASP8AP2;TNFRSF10B;MAP2K4;MAP3K2;HABP4;SLC9A1;TLR7
prerank,endoplasmic reticulum organization (GO:0007029),0.3044309448371477,0.8391573427370221,0.6730083234244947,1.0,1.0,13/72,16.66%,TRDN;LNPK;SEC31B;LPCAT3;STX18;DNM1L;GET4;TRAM1;LRRK2;BNIP1;CAV2;SEC61B;EIF2AK3
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.308516165365664,0.8389762525664721,0.6926952141057935,1.0,1.0,12/62,13.17%,POLR2L;POLR2I;ADRM1;GTF2H4;ELL;POLR2G;ELOC;CCNT1;CDK7;CDK12;NELFB;POLR2J
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.33531937092352554,0.8377640958652505,0.6649006622516557,1.0,1.0,7/41,10.56%,PDGFB;DOK7;FBXW7;PTPN1;AREG;ADAM17;HBEGF
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.36009145105732093,-0.837758683691142,0.6800847457627118,0.9362986191808884,1.0,5/10,44.62%,LGALS9;CEACAM1;ARRB2;FCGR2B;LILRB1
prerank,negative regulation of viral genome replication (GO:0045071),-0.24576213537410252,-0.8362920973706285,0.7827715355805244,0.9384747287987049,1.0,15/40,25.13%,PARP10;SETDB1;IFIT1;BST2;MPHOSPH8;OAS2;IFITM1;IFITM3;SRPK1;SHFL;HMGA2;RNASEL;RESF1;ZC3HAV1;IFITM2
prerank,lung development (GO:0030324),0.33895986391707444,0.8361508097536045,0.6439499304589708,1.0,1.0,4/33,6.73%,FGF1;ITGA3;VEGFA;ABCA3
prerank,phagosome maturation (GO:0090382),0.3387965329512601,0.835718024075165,0.6727785613540197,1.0,1.0,16/35,25.85%,ATP6V1H;ATP6V0A2;MREG;ATP6V1C1;ATP6V0D2;RAB34;RAB14;RAB38;ATP6V0C;PIKFYVE;ATP6V1F;ATP6V0E1;ATP6V1B2;RAB7A;ATP6V1G2;ATP6V0A1
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.26529463161619454,-0.8357007381998399,0.7357859531772575,0.9387094728545583,1.0,14/30,32.06%,ELOVL7;HACD4;ABCD3;ELOVL4;ACOX1;ELOVL6;HACD2;SLC27A4;ELOVL1;HACD3;ACSL1;ELOVL5;TECRL;SLC27A2
prerank,response to peptide (GO:1901652),0.3378825291109147,0.8354643320837483,0.6718528995756718,1.0,1.0,7/33,15.58%,ANXA1;IRS1;KAT7;CACNA1B;CHRNA7;STAT1;STAT3
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.3665330681193805,0.8350483478769873,0.6324921135646687,1.0,1.0,6/22,10.42%,PSMC6;TP53;MED1;MED12;PAXIP1;MED14
prerank,protein deacylation (GO:0035601),-0.2826220753928068,-0.834910127766747,0.6810344827586207,0.939420212965717,1.0,7/23,15.56%,LYPLA1;HDAC7;HDAC4;SIRT7;PPT1;NOTUM;ABHD17C
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.37698847103613614,0.8346703705621843,0.6568144499178982,1.0,1.0,2/18,4.49%,CABP1;MFHAS1
prerank,negative regulation of proteolysis (GO:0045861),0.33949362592040233,0.8343843770644486,0.6490727532097005,1.0,1.0,5/34,13.77%,ROCK1;SERPINE2;TIMP4;DNAJC1;LRRK2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.21772345272276716,-0.8343818917243592,0.8037974683544303,0.9396338425443574,1.0,32/80,28.49%,DENND2A;GBF1;VTI1A;TBC1D5;STX5;TMEM87B;GCC2;SURF4;HEATR5A;SNX6;RBSN;RAB29;YKT6;LMAN1;SNX3;VPS53;TBC1D10A;EHD3;RAB9A;VPS52;STX6;TBC1D14;BET1L;UBE2O;ARL1;ERC1;BAIAP3;PHETA1;GOSR1;RIC1;DENND5A;SNX12
prerank,cholesterol homeostasis (GO:0042632),0.3060851384600096,0.8338955405813159,0.6863468634686347,1.0,1.0,10/64,14.23%,RORA;CYP7B1;LPL;HDAC9;CAV1;NR1D1;LRP5;ABCG1;LDLRAP1;MTTP
prerank,steroid hormone biosynthetic process (GO:0120178),0.35737179367254895,0.8335825250300782,0.6711309523809523,1.0,1.0,4/29,10.88%,HSD17B7;AKR1B1;MED1;SRD5A3
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.3447444137556215,-0.8335796196974762,0.6912751677852349,0.9403753317190632,1.0,4/11,19.56%,UBQLN1;PRKN;P4HB;PARK7
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3004165091583285,0.8335726763504975,0.7090261282660333,1.0,1.0,17/78,15.96%,DYNLL1;KIF2A;LAG3;KIF3B;DCTN6;SEC13;CENPE;DYNC1I2;KIFAP3;KIF5A;SEC24A;CAPZB;DCTN3;SEC24C;KIF18A;DNM2;AP1S3
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3004165091583285,0.8335726763504975,0.7090261282660333,1.0,1.0,17/78,15.96%,DYNLL1;KIF2A;LAG3;KIF3B;DCTN6;SEC13;CENPE;DYNC1I2;KIFAP3;KIF5A;SEC24A;CAPZB;DCTN3;SEC24C;KIF18A;DNM2;AP1S3
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.3197485822118045,-0.8332440000687386,0.6945169712793734,0.9401323184096023,1.0,6/17,13.72%,FSTL1;SULF1;SLIT2;TMEM204;SFRP4;CASK
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3513683632824446,0.8332292053104852,0.6476761619190404,1.0,1.0,6/24,11.87%,NAT10;PARP1;SLX4;HNRNPU;TERF2;HNRNPC
prerank,protein K48-linked deubiquitination (GO:0071108),-0.28991612627356594,-0.8330230029670643,0.7063953488372093,0.9396562693765959,1.0,12/23,33.84%,ATXN3;OTUD7B;MINDY1;USP37;VCPIP1;OTUD3;USP25;YOD1;USP34;TNFAIP3;MINDY2;BAP1
prerank,protein-DNA complex assembly (GO:0065004),-0.19844024675107055,-0.8329184823094192,0.9363636363636364,0.9389872642724091,1.0,52/116,35.33%,TCF4;CCNH;PSMD7;PSMD9;PSMD13;ERCC5;PSMB3;UBC;ORC5;DDB1;ORC6;PSMC5;PSMA5;NAA60;CHD1L;PSMA1;PSMC2;SART3;ASF1A;XPA;GTF2H2;GTF2H5;NAP1L1;GTF2H3;PSME3;UBB;PSMC4;ERCC2;PSMB6;ORC4;RAD23B;PSMB10;HMGB2;PSMA4;RPA3;PSME1;ORC1;ATRX;PSMF1;SPTY2D1;PSMB9;NAP1L3;PSME2;KAT6B;PSMA8;CETN2;ERCC3;MCM8;RPA2;RAD51;CHAF1A;PSMD8
prerank,cellular response to ketone (GO:1901655),0.33399934214357324,0.8326965530004536,0.6562942008486563,1.0,1.0,5/35,10.78%,ADCY5;ADCY2;AR;ADCY6;ROCK2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.39139956748888405,0.8324698229108698,0.6758957654723127,1.0,1.0,3/16,6.57%,ZFAND2B;IGFBP5;IGFBP4
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.3311558764367438,-0.8323319814947631,0.6866028708133971,0.939235313622196,1.0,3/14,10.02%,STARD13;MEOX2;CARD10
prerank,response to ethanol (GO:0045471),-0.32529465068271224,-0.8322287521004508,0.6786632390745502,0.9385482729821257,1.0,9/14,41.71%,ADCY7;GRIN3A;GLRA2;GLRA1;SDF4;GRIN2A;GRIN1;SOD1;GRIN2B
prerank,phosphate ion homeostasis (GO:0055062),-0.360004003542607,-0.8322111270408457,0.6926503340757239,0.9376986960677741,1.0,3/10,20.94%,SFRP4;ENPP1;FGFR4
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.20792141762568966,-0.8308965114568208,0.8394160583941606,0.9393973183988537,1.0,33/85,30.65%,FZD6;VANGL1;PRICKLE2;WNT5A;MAGI2;PSMD7;PSMD9;PSMD13;SMURF2;PSMB3;AP2S1;PSMC5;PFN1;PSMA5;PSMA1;PSMC2;CDC42;AP2A2;PSME3;PSMC4;CELSR1;VANGL2;PSMB6;PSMB10;TIAM1;DVL2;PSMA4;PSME1;WNT11;AP2M1;PSMF1;ARHGEF19;PSMB9
prerank,lipoprotein transport (GO:0042953),-0.3582063485998962,-0.8306863085486298,0.6859688195991092,0.9388820969595931,1.0,2/10,1.18%,PRKCB;LRP1
prerank,aerobic respiration (GO:0009060),0.36876741054706214,0.8306256884581984,0.6527131782945736,1.0,1.0,3/20,5.64%,SIRT3;ME3;SDHC
prerank,mononuclear cell differentiation (GO:1903131),-0.2786203128160693,-0.8304318001662291,0.7327327327327328,0.9384506023152778,1.0,8/24,17.66%,IL31RA;PIR;BMP4;LYN;THOC5;RELB;PPARG;MT1G
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3023702648442509,0.8304076741399019,0.682219419924338,1.0,1.0,11/68,14.13%,AMPD1;NT5C2;SULT4A1;AMPD2;ENTPD7;OPA1;THEM4;EPHA2;ADSS1;LRRK2;ACOT6
prerank,fatty acid catabolic process (GO:0009062),0.30553820748302324,0.8303333436575981,0.6821705426356589,1.0,1.0,12/67,10.29%,HSD17B10;NUDT7;PEX2;HSD17B4;ACAD11;MECR;ABCD4;ACADS;ACAD10;HADHB;NUDT19;SCP2
prerank,kinetochore organization (GO:0051383),-0.3407606663314529,-0.8302300943961741,0.6926713947990544,0.9379568016925374,1.0,2/13,5.46%,POGZ;CENPC
prerank,protein secretion (GO:0009306),-0.22704335247983867,-0.8300339940589494,0.8118811881188119,0.9374780488232506,1.0,23/56,26.39%,PCSK5;ABCA1;SEL1L;RAB12;CYB5R4;CANX;STEAP3;GOLPH3;WLS;PDIA4;RCN3;ARFGAP3;MON1A;RAB13;RIMS2;PARK7;PPY;MIA3;PTPRN;SVBP;RAB3D;COPG2;ADCYAP1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2854349108345775,0.8299916013910112,0.724669603524229,1.0,1.0,30/122,18.76%,DYRK2;PDGFB;VIM;BCAR3;SAMD4A;NAT10;IRS1;SORBS1;RPS27L;CIRBP;AR;TGFB2;PYM1;KAT7;PDGFRB;RPL5;EIF3E;RBM3;ZCCHC4;CPEB3;PLXNB2;IRS2;JAK2;NAMPT;PIWIL2;DHX9;FAF1;EEF2;UPF3A;CCL19
prerank,regulation of catecholamine secretion (GO:0050433),-0.261263936241693,-0.8297121902368743,0.7348993288590604,0.9372369399801734,1.0,16/29,31.50%,SYT1;DTNBP1;PRKN;GRK2;SNCA;SYT11;SYT12;STX1A;SYT6;DRD2;SYT2;SYT7;SYT9;CHGA;SYT13;SYT3
prerank,cellular response to estradiol stimulus (GO:0071392),-0.3021922792949393,-0.8288416419555523,0.6967213114754098,0.9379966789578198,1.0,12/18,52.46%,EGFR;ESR1;CCDC62;RUVBL2;FAM210B;NCOA3;SSTR2;SFRP1;POU4F1;RAMP3;CRHBP;SSTR1
prerank,aggrephagy (GO:0035973),0.34689098592019474,0.8284378685615327,0.6923076923076923,1.0,1.0,2/27,2.63%,DYNLL1;VIM
prerank,sterol homeostasis (GO:0055092),0.30425637051748106,0.8284197710617319,0.6908866995073891,1.0,1.0,10/65,14.23%,RORA;CYP7B1;LPL;HDAC9;CAV1;NR1D1;LRP5;ABCG1;LDLRAP1;MTTP
prerank,DNA double-strand break processing (GO:0000729),-0.3007040312042228,-0.8283013432334354,0.7116883116883117,0.9381956527085616,1.0,5/18,18.99%,MRE11;RAD50;BLM;NBN;ATM
prerank,ncRNA transcription (GO:0098781),0.39991363200476604,0.8278976386887529,0.6437389770723104,1.0,1.0,1/13,1.69%,CAVIN1
prerank,retinal metabolic process (GO:0042574),-0.33331115866733363,-0.8278628509730925,0.7089552238805971,0.9381787360259185,1.0,2/12,9.35%,ABCA4;CYP1B1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.33840385403518364,-0.827663339746501,0.704225352112676,0.9376727737746999,1.0,4/11,20.29%,HMGB1;LGALS9;TWSG1;CD274
prerank,positive regulation of cilium assembly (GO:0045724),0.37240929684431096,0.8273646157173941,0.662847790507365,1.0,1.0,4/18,12.04%,TAPT1;WRAP73;ARHGAP35;CEP120
prerank,nuclear membrane organization (GO:0071763),-0.2935116741552132,-0.8272565277514683,0.7193460490463215,0.9375385383771383,1.0,9/19,27.07%,SPAST;TOR1AIP1;AKAP8L;TARDBP;EMD;TMEM43;CHMP4B;TOR1A;CHMP7
prerank,regulation of viral transcription (GO:0046782),0.3306706573345743,0.827068334262132,0.6917613636363636,1.0,1.0,10/39,17.88%,POLR2L;POLR2I;POLR2G;HEXIM1;CCNT1;NELFB;POLR2J;NELFCD;DHX9;RSF1
prerank,integrin-mediated signaling pathway (GO:0007229),0.3031257804158147,0.8269179417017767,0.7202881152460985,1.0,1.0,10/73,7.53%,ITGB6;LAMA5;FERMT2;MYH9;ITGB1;DST;FYB2;ITGB5;ITGB3;PLEK
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.37235397349188637,0.8267801356874185,0.6513157894736842,1.0,1.0,4/18,11.88%,PARN;NAF1;CCT3;RUVBL1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3040402971838408,-0.8267630663756201,0.6839506172839506,0.9376183971137015,1.0,4/17,12.11%,IL18;CD55;CD46;GNL1
prerank,L-glutamate transmembrane transport (GO:0015813),-0.3569991749495468,-0.8266543533142106,0.6810344827586207,0.9369783895610605,1.0,7/10,32.82%,SLC1A3;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6;PRAF2
prerank,positive regulation of nuclear division (GO:0051785),0.35022290118655874,0.8264537599461156,0.6666666666666666,1.0,1.0,5/25,11.17%,PDGFB;NUP62;PDGFRB;SIRT2;LRP5
prerank,regulation of interleukin-1 beta production (GO:0032651),0.30511616257305957,0.8263610836490544,0.7144670050761421,1.0,1.0,4/66,3.09%,CD36;MYD88;FZD5;LPL
prerank,cellular response to estrogen stimulus (GO:0071391),0.3893665921462693,0.8263497370143502,0.6451612903225806,1.0,1.0,5/14,18.24%,ARID5A;AR;SFR1;PELP1;SERPINB9
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3850830804423068,0.82625540759291,0.660472972972973,1.0,1.0,3/14,10.92%,FASTKD5;FASTKD1;TFB2M
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.26983679679428124,-0.8259970962379902,0.7515923566878981,0.9373658599702571,1.0,16/29,33.77%,CCNH;ERCC5;UBC;DDB1;CHD1L;XPA;GTF2H2;GTF2H5;GTF2H3;UBB;ERCC2;RAD23B;RPA3;CETN2;ERCC3;RPA2
prerank,vasculogenesis (GO:0001570),0.3300714859406935,0.8259951760807477,0.674863387978142,1.0,1.0,5/32,9.69%,HEY2;HAS2;CAV1;VEGFA;PDGFRB
prerank,regulation of endothelial cell proliferation (GO:0001936),0.29461869844823696,0.8254248944040613,0.7149587750294464,1.0,1.0,10/88,7.40%,ANGPT1;PDGFB;SEMA5A;CDH13;NR4A1;NR2F2;ALOX5;CAV1;VEGFA;ITGB3
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.2801254859476573,-0.8253376416292953,0.7436619718309859,0.9377827756795616,1.0,6/23,20.71%,HSP90AB1;IRGM;PARP14;PPARG;NLRC5;PTPN2
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.19651302000859291,-0.8252752119492223,0.9175257731958762,0.9370529146148863,1.0,23/124,14.08%,LEF1;AGO3;WNT4;TCF7L2;FZD6;VANGL1;PRICKLE2;WNT5A;PLCB3;CTNNB1;PSMD7;PSMD9;PSMD13;SMURF2;PSMB3;SFRP4;TNRC6A;AP2S1;PSMC5;PFN1;PSMA5;PSMA1;PSMC2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.26622912091487505,-0.8252380755196531,0.761437908496732,0.9362609630524004,1.0,8/29,16.62%,UBE2D3;CASP8;BIRC2;IKBKG;UBC;CHUK;BIRC3;TLR3
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.291288355845747,0.8250519496244612,0.7394285714285714,1.0,1.0,14/113,7.53%,CD36;MYD88;FERMT2;LCP1;GTF2H4;MPP7;PSMC6;TPPP;DAB2IP;PARP1;VEGFA;TP53;TRABD2B;PLEK
prerank,embryonic organ development (GO:0048568),0.3120968000207367,0.8244221853187764,0.6818181818181818,1.0,1.0,9/61,10.90%,HEY2;TBX2;TEAD3;BMPR1A;RARRES2;GDNF;TGFB2;TEAD1;PDGFA
prerank,lipoprotein localization (GO:0044872),-0.34496389509152725,-0.8242819937587651,0.7074829931972789,0.9372824600692888,1.0,2/11,1.18%,PRKCB;LRP1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.2286270807401466,-0.8240853918991459,0.7887931034482759,0.936824413023052,1.0,17/54,20.30%,ARRB1;NXN;DCUN1D3;CRY1;CTNNB1;PRMT3;SIRT7;OGT;SOX4;SPRY2;SH3RF2;UBXN1;AKT1;SPOPL;RPL11;PARK7;PIAS3
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.26236991719693814,-0.8240655739885631,0.7741935483870968,0.9360026803586103,1.0,8/30,16.62%,UBE2D3;CASP8;BIRC2;IKBKG;UBC;CHUK;BIRC3;TLR3
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.29610632931765224,-0.824037519793798,0.712082262210797,0.935200659475767,1.0,6/18,27.56%,FBN1;TCTA;TLR3;GPR137B;GPR137;MAFB
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.33684888770547755,0.8236646262186957,0.6652482269503546,1.0,1.0,6/36,8.15%,PPP3CA;FZD5;FZD4;GNAO1;CALM1;PLCB1
prerank,response to X-ray (GO:0010165),-0.3226116091673713,-0.8235711151735731,0.6886363636363636,0.935244467990747,1.0,7/14,24.24%,XRCC5;BRCC3;BLM;XRCC6;ATM;IKBIP;NUCKS1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.3741083350739265,0.8234262805746742,0.6502546689303905,1.0,1.0,6/17,16.94%,ARL6IP5;TGFB2;EIF2AK2;PDCD10;TAOK3;SEMA4C
prerank,regulation of translation (GO:0006417),0.27874021699191126,0.8231651251136921,0.7805907172995781,1.0,1.0,45/173,18.89%,VIM;IGFBP5;SAMD4A;MRPL13;NAT10;BTG2;UPF1;CSDE1;ATXN2;EIF1;RPS27L;CIRBP;CYFIP1;DAPK3;PYM1;IMPACT;RPL5;EIF3E;EIF2AK2;DDX1;GSPT1;RBM3;DDX25;ZCCHC4;EIF3H;CNOT7;TSFM;CPEB3;SYNCRIP;PLXNB2;GIGYF2;EPRS1;CTIF;EIF4E;EIF4G2;NANOS1;ETF1;EIF2AK3;PIWIL2;DHX9;EIF2AK4;METAP1;EEF2;UPF3A;ILF3
prerank,calcium import into the mitochondrion (GO:0036444),-0.3564367495939468,-0.8229282735711351,0.6752688172043011,0.935613231557643,1.0,4/10,14.91%,MCU;MCUB;MAIP1;MICU2
prerank,negative regulation of signal transduction (GO:0009968),0.27485837159773,0.8227502260453077,0.7987679671457906,1.0,1.0,27/249,7.53%,NOTCH3;NKD1;TCIM;PIP4K2A;SOCS5;KANK1;IGFBP5;CCL5;NTN1;BCL2;PTPN18;EMILIN1;ASXL1;MMRN2;PRKCQ;IRS1;RPGRIP1L;EPN2;DAB2IP;FBXW7;SLC2A10;PTPN1;SNAI2;YTHDF2;NEDD4;TRABD2B;PLEK
prerank,heterochromatin assembly (GO:0031507),-0.28338010963086996,-0.8226835510635236,0.746031746031746,0.9352004544245095,1.0,6/20,20.69%,EZH1;SMCHD1;NRDE2;RRP8;HMGA2;SUV39H1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.409697657859721,0.8224425245672241,0.6599264705882353,1.0,1.0,2/11,6.15%,PWP1;SMARCB1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.26716841483266424,0.8221812153237148,0.984,1.0,1.0,219/1668,13.35%,MYOCD;SOX6;PRDM16;PPP1R12A;FHL5;MYOZ2;SOX5;HJV;ABRA;MEF2C;ATP2B4;HEY2;ZFHX3;NR1H4;TBX2;SMARCD3;FGF1;CSRP3;EBF1;ZEB2;PPP3CA;CCN1;EDNRB;MLIP;ALX4;RORA;FZD5;SS18L2;CDH13;FRK;ID4;NR4A1;FST;EBF2;SIM2;CRTC1;PRRX1;TEAD3;LOXL2;GABPA;ARID5B;HEYL;JAG1;ETS2;IFRD1;CAMK2D;IRX5;MRTFA;HINFP;TGFB3;BRIP1;CRTC3;ZNF436;H1-0;RBAK;FOSL2;NACC2;PRDM1;ACVR2A;NR2F2;HDAC9;GTF2H4;MCRS1;LMO7;ARID1A;NR2C1;VEZF1;ANKRD2;USP2;ACTR3;ATXN1;CBFB;SP7;OSR2;PIAS4;TBX18;ARHGEF2;BMPR1A;KCNIP3;KLF7;CCNQ;MEF2A;PEX2;NCOA7;ASXL1;GBX1;KLF16;MTDH;FOXJ3;RXRG;DBP;KLF15;SUV39H2;JUND;CHD2;SMARCB1;ARID5A;TAF1;CAV1;DAB2IP;ZNF418;ELOC;PARP1;HEXIM1;PPM1A;VEGFA;TP53;ZBTB38;GRHL1;MAML2;PIN1;SNAI2;GDNF;HDGFL3;HOXC4;SFPQ;YAP1;AR;MED1;ZFP28;PPARGC1A;PPARGC1B;ZNF431;DICER1;MED29;MED12;HSF4;SOX9;ZFP62;RELA;KMT2D;SETD3;EPC2;TNIP1;ZXDC;MAML3;LIN37;CUX2;MED13L;TRAK1;ZKSCAN4;CCND1;PPARA;BBX;CBX4;CARF;RUNX1;CCNT1;IMPACT;FUS;MTA3;NR1D1;SKI;NR4A2;LRRFIP1;KAT7;CDK7;ZBTB33;HIF1A;AKNA;SIRT2;KANSL3;RIF1;ZBTB41;CRLF3;MIDEAS;PCGF6;AGRN;ZNF3;MED14;HNRNPU;TEAD1;NR2C2;NKX6-1;UBE2D1;RAI1;EIF5A;GPER1;PIAS2;LRP5;ZKSCAN1;SREBF2;PFKM;PCGF5;RB1;ATF3;HOXC8;ZBTB7A;NFX1;LCORL;ESRRA;RUVBL1;CDK12;LIN9;BMPR1B;CSRNP3;BCL6;ZBTB10;POU3F3;HDGFL2;TOX4;ORC2;CTDSP1;NR6A1;CITED2;CPEB3;ZXDB;MED8;SMARCA5;CRTC2;MXD4;ZNF83;FNIP2;NCK2;ZFP69;ZBTB5;PPP3CB;CASZ1;CHD4
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.31573256639566377,-0.822060677353992,0.7167487684729064,0.9354586599834865,1.0,10/14,59.59%,ATP6AP1;TYROBP;POU4F1;CCR1;OCSTAMP;IL23A;TNF;TNFSF11;IL12B;IL23R
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.2396497725009695,-0.821873632710393,0.7857142857142857,0.9349380145913935,1.0,7/42,11.90%,LBP;RPS19;OPTN;IL6R;DEFA6;IRGM;GSDMD
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.281432870089295,-0.821681870969908,0.7586206896551724,0.9344619933766614,1.0,5/22,13.47%,APPL2;LBP;PTPN22;LYN;APPL1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.33349232031756726,0.8216343002621378,0.6802244039270687,1.0,1.0,6/34,6.67%,DUSP5;PTPN18;PTPRS;PTPRF;DUSP3;PTPN1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.24609293185495296,-0.8214665797638555,0.78125,0.9340059949619833,1.0,16/40,26.65%,PTK2;PTK2B;PML;COMMD1;UBE3A;SGTA;RPS7;RPL11;NUB1;TRIM39;AXIN1;RAD23B;CSNK2A1;CSNK2A2;HFE;LAPTM5
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3635474910346842,0.8212337422824602,0.6942277691107644,1.0,1.0,5/22,12.88%,DUSP5;PPM1E;PPM1A;PPP1CA;DUSP16
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3026240215864282,0.8212165774575367,0.6970074812967582,1.0,1.0,8/59,12.11%,HSD17B10;CYP7B1;LPL;ALOX5;HSD17B4;SCP2;OSBPL2;NDUFAB1
prerank,membrane protein proteolysis (GO:0033619),0.32619453074443316,0.8211041441271133,0.6857923497267759,1.0,1.0,9/37,14.50%,MYH9;PRKCQ;AFG3L2;RELA;ADAM17;MBTPS1;ADAM19;HM13;SPPL2B
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.3385646415328567,0.8208127529728947,0.6744525547445256,1.0,1.0,8/29,20.69%,PLA2G3;LPCAT3;PLB1;PLA2G4A;PLA2G4C;NR1H3;MBOAT7;LPCAT1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2945282676083756,0.820788820460499,0.7105575326215896,1.0,1.0,10/80,10.70%,KLHL40;ANGPT1;DCUN1D2;CAV1;FBXW7;PIN1;DCUN1D1;AMER1;PAXIP1;UBE2D1
prerank,positive regulation of double-strand break repair (GO:2000781),0.325128674520581,0.8203807911016848,0.6703910614525139,1.0,1.0,8/39,9.87%,RAD51AP1;ZCWPW1;PARP1;ERCC6;SPIRE1;FUS;FANCB;RIF1
prerank,negative regulation of translational initiation (GO:0045947),0.4010055649047213,0.8203609229874632,0.6547231270358306,1.0,1.0,5/13,20.98%,EIF4EBP1;EIF3E;EIF2AK4;TPR;LARP1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3669309201166303,0.8201877184370857,0.6661073825503355,1.0,1.0,4/17,12.31%,DHDDS;MVD;SRD5A3;ALG13
prerank,positive regulation of keratinocyte migration (GO:0051549),0.3990681252828271,0.820075244624435,0.6635514018691588,1.0,1.0,2/10,13.29%,MAPRE2;FGF10
prerank,protein-containing complex disassembly (GO:0032984),0.3100021766002353,0.8195708523093117,0.6783854166666666,1.0,1.0,11/54,15.05%,FZD5;LIX1L;GABARAP;CAV1;LIX1;PYM1;AMER1;PPP1CA;TSG101;DVL1;CSNK1A1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.3659644956712357,0.8189443637795027,0.6524590163934426,1.0,1.0,3/18,12.26%,ANXA1;HNRNPU;ZFP36L1
prerank,regulation of dopamine secretion (GO:0014059),-0.27105344205989046,-0.8187286909041004,0.7156862745098039,0.938197762731127,1.0,11/25,25.53%,SYT1;DTNBP1;PRKN;SNCA;SYT11;SYT12;SYT6;DRD2;SYT2;SYT7;SYT9
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.3481380214263593,-0.8186793782551275,0.7049180327868853,0.9374374801889389,1.0,3/11,26.17%,AHR;CEACAM1;HFE
prerank,covalent chromatin modification (GO:0016569),-0.3166424500450741,-0.818643502361888,0.7139240506329114,0.9366414243504778,1.0,4/14,19.56%,SIRT7;CHD1;SETD5;PARK7
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3646667260933781,0.8176868737855915,0.6692913385826772,1.0,1.0,7/21,18.34%,PMAIP1;OPA1;BOK;LRRK2;EIF2AK3;CREB3;DDIT3
prerank,regulation of neurogenesis (GO:0050767),0.3028350974972786,0.8174865794093747,0.710828025477707,1.0,1.0,5/55,7.10%,HEY2;HEYL;PRUNE1;YTHDF2;YAP1
prerank,regulation of transport (GO:0051049),-0.2506753827782271,-0.8167230657915296,0.7624113475177305,0.9393655008658187,1.0,8/36,14.18%,LEPR;NRP1;RAB11A;PRKN;WWC1;MYO6;ICA1;SNCA
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.23755440811794487,-0.8166657103216038,0.7941176470588235,0.9386231771812622,1.0,18/40,37.68%,ATR;FBH1;BLM;MMS22L;PRIMPOL;SMARCAL1;NUCKS1;DONSON;ALYREF;ATRX;BOD1L1;RFWD3;TIMELESS;TRAIP;RAD51;POLE;CENPX;GEN1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.2055894974809614,-0.8160363568920858,0.8875,0.9389513500683712,1.0,32/84,30.65%,CUL3;ANAPC1;PSMD7;PSMD9;PSMD13;CDC23;PSMB3;UBC;SKP2;PSMC5;PSMA5;BUB3;PSMA1;PSMC2;CDC26;ANAPC4;UBE2S;FBXO31;PSME3;UBB;PSMC4;CDK2;PSMB6;ANAPC15;PSMB10;PSMA4;PSME1;PSMF1;CDC16;CDC27;FZR1;PSMB9
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2909577450443146,0.8156490179283575,0.7327080890973037,1.0,1.0,15/88,14.16%,EDNRB;SERPINE2;IGFBP5;SAMD4A;MRPL13;BTG2;DAB2IP;DAPK3;EIF2AK2;DNAJC1;CNOT7;CPEB3;SYNCRIP;GIGYF2;EPRS1
prerank,organelle transport along microtubule (GO:0072384),0.33465027422086246,0.815300173609149,0.6992805755395683,1.0,1.0,10/31,18.39%,ARHGAP21;BICD2;MAPT;KIF5B;TRAK1;FBXW11;UXT;RHOT1;MAP1S;BICD1
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.30914642652942265,-0.8150573070095062,0.7114914425427873,0.9398648489309273,1.0,4/15,13.33%,LRP1;PDPN;TGFB1;DPP4
prerank,mitochondrion transport along microtubule (GO:0047497),0.3863473856151252,0.8148761740682104,0.6415094339622641,1.0,1.0,6/13,17.78%,MAPT;OPA1;HIF1A;UXT;RHOT1;MAP1S
prerank,protein localization to chromatin (GO:0071168),-0.3030486547052,-0.8148630737189522,0.6984536082474226,0.9393734549866418,1.0,7/18,33.76%,PPHLN1;ESR1;LEMD2;CHMP7;PIH1D1;RUVBL2;MCM8
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.3549637133314114,-0.814814935828824,0.692,0.9386242977979435,1.0,4/10,14.08%,HMGB1;ESR1;PSMC5;PSMC2
prerank,protein localization to mitochondrion (GO:0070585),0.4027488991130153,0.8144726498292348,0.6648550724637681,1.0,1.0,3/11,17.89%,HK2;LRRK2;ISG15
prerank,regulation of myoblast fusion (GO:1901739),0.3993515421187985,0.8143840056594683,0.6642468239564429,1.0,1.0,4/11,15.49%,EHD2;CD53;ADGRB1;FLOT1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.311977574261753,-0.8143277984874805,0.7036082474226805,0.9385968892807383,1.0,2/15,6.96%,GRB2;FRS2
prerank,ion transport (GO:0006811),0.286211574421128,0.8132325566485583,0.7539863325740319,1.0,1.0,13/111,10.76%,TRPC6;ANO1;ANO6;SLC8A1;SLC8A2;SLC20A2;KCNN2;PKD1L3;SLC9A8;ANO10;VDAC1;SLC25A26;PANX1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.28014193103182516,0.8130723466223873,0.7913513513513514,1.0,1.0,25/151,15.20%,DMD;PPM1L;LARGE1;SLC44A5;FA2H;STARD7;TYW5;HACD1;GSTT1;SLC44A1;LPCAT3;TNIP1;GSTP1;MOCS1;CERS1;SAMD8;ESD;GSTA4;SLC25A2;PRKD3;ST3GAL2;PLA2G4A;CHKB;SPTLC1;PLA2G4C
prerank,regulation of Ras protein signal transduction (GO:0046578),0.2883122056642604,0.8127990893743822,0.7323113207547169,1.0,1.0,21/85,16.01%,DLC1;PLCE1;MYO9B;KANK1;NUP62;ARHGEF2;GABARAP;DAB2IP;RASGRP1;TGFB2;ARHGAP17;VAV1;DENND1A;MFN2;BCR;PDCD10;FGF10;IRS2;JAK2;RAF1;RALGPS1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.36679238118151214,0.8127698148710735,0.6672185430463576,1.0,1.0,4/16,11.51%,PARP1;NAF1;SLX4;TERF2
prerank,N-terminal protein amino acid modification (GO:0031365),-0.32172294635163695,-0.812530929930352,0.7209302325581395,0.9410154230079769,1.0,3/14,13.76%,METAP1D;NAA50;NAA60
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.3829967274257421,0.8124094073376945,0.6566164154103853,1.0,1.0,3/15,8.84%,ACTR3;WHAMM;WASHC1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.35092142280292726,-0.8122453075063015,0.7272727272727273,0.9406563692146529,1.0,1/10,1.69%,HMGB1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.3531502639822004,0.8121909272968321,0.6920731707317073,1.0,1.0,5/24,11.48%,CHD6;VEGFA;TP53;HIF1A;ATF3
prerank,synaptic vesicle cycle (GO:0099504),-0.2535598518981536,-0.8117508600445332,0.7967213114754098,0.9407124157477801,1.0,7/30,15.92%,RAB5A;NLGN1;SNCA;PCLO;SLC17A6;PLD2;STX1A
prerank,positive regulation of angiogenesis (GO:0045766),0.2829118954798621,0.8116518430394815,0.7534562211981567,1.0,1.0,14/108,9.58%,FGF1;ANGPT4;HSPB6;SEMA5A;HK2;STIM1;ITGB1;PTGIS;MTDH;VEGFA;RRAS;BTG1;RUNX1;HIF1A
prerank,regulation of interleukin-10 production (GO:0032653),-0.23233770889637784,-0.8109207996724235,0.8449612403100775,0.9413705702007493,1.0,17/44,39.41%,HMGB1;LGALS9;PLCG2;CD34;CD46;CD274;HSPD1;SYK;TYROBP;NOD2;TRIB2;JAK3;PYCARD;DLL1;FCGR2B;AGER;TLR4
prerank,apoptotic cell clearance (GO:0043277),0.33341861772740106,0.810910197255064,0.6866096866096866,1.0,1.0,8/30,17.53%,XKR4;ANXA1;ITGB3;RHOH;GAS6;ADGRB1;RHOG;NR1H3
prerank,rRNA processing (GO:0006364),-0.18217978952644492,-0.8107009866348174,0.9466666666666667,0.9409313108420256,1.0,71/172,31.41%,NSA2;PRKDC;RPL27A;RPS19;SENP3;NVL;RPL21;RPS24;RPL36;RPL18;RSL1D1;RIOK3;RPLP0;C1D;DIS3;EXOSC1;RPL28;WDR3;RPLP1;RPL34;RPL23A;MRPL1;RRP36;MPHOSPH10;FCF1;NOP53;EXOSC9;RPL36A;RPL9;RPL27;DDX52;RPS7;RPL18A;RPL11;RPL37A;RPL38;RRP7A;EMG1;DCAF13;RPL29;EXOSC2;EBNA1BP2;UTP20;RPL32;RPL10A;THUMPD1;BYSL;RPS27;EXOSC3;UTP18;EXOSC7;NOL11;NOP56;HEATR1;NOLC1;IMP3;WDR18;EXOSC5;PIH1D1;RPL4;PES1;LSM6;UTP6;NOL8;RPL35A;RPS15;FBL;SART1;POP4;TBL3;RPL35
prerank,steroid biosynthetic process (GO:0006694),-0.22460993685520325,-0.8105576857871124,0.8544600938967136,0.9403522595425523,1.0,26/56,35.57%,PRKAG2;CYP27A1;LBR;CYP51A1;ACOT8;HMGCR;PRLR;INSIG1;SQLE;OSBP;AMACR;DHRS11;PMVK;LSS;FDXR;OSBPL7;OSBPL9;INSIG2;EBP;SLC27A2;SC5D;STAR;TM7SF2;SRD5A1;HSD11B1;DHCR7
prerank,positive regulation of organelle organization (GO:0010638),0.3270899208863873,0.8101937915918286,0.6742857142857143,1.0,1.0,5/32,10.39%,ANXA1;LNPK;PPARGC1A;FYCO1;STX18
prerank,regulation of establishment of planar polarity (GO:0090175),-0.19999120202999446,-0.810189625381648,0.8928571428571429,0.9401400500209001,1.0,33/88,30.65%,FZD6;VANGL1;PRICKLE2;WNT5A;PSMD7;PSMD9;PSMD13;SMURF2;PSMB3;AP2S1;PSMC5;PFN1;PSMA5;PSMA1;PSMC2;CDC42;AP2A2;DACT1;PSME3;PSMC4;CELSR1;VANGL2;PSMB6;PSMB10;TIAM1;DVL2;PSMA4;PSME1;WNT11;AP2M1;PSMF1;ARHGEF19;PSMB9
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.39420798000014573,0.8101665618433246,0.6590106007067138,1.0,1.0,4/11,14.65%,SOX9;PDGFA;LRP5;STAT1
prerank,response to estrogen (GO:0043627),0.33607020495183815,0.8100286370457921,0.6789772727272727,1.0,1.0,9/31,18.24%,ARID5A;CAV1;AR;KMT2D;SFR1;CITED2;PELP1;ASH2L;SERPINB9
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.3301163204416982,-0.8094298329737594,0.7476190476190476,0.9407241052926955,1.0,5/13,31.04%,RPS21;NOP9;UTP20;RRS1;TBL3
prerank,metallo-sulfur cluster assembly (GO:0031163),0.35719561373333336,0.8094139840641594,0.6876971608832808,1.0,1.0,7/22,15.56%,FXN;GLRX5;ISCA1;ISCA2;NUBP1;NUBP2;CIAO1
prerank,positive regulation of T cell activation (GO:0050870),0.3013506474079936,0.8093700551689391,0.7332521315468941,1.0,1.0,5/62,5.56%,DOCK8;ANXA1;CCL5;CD276;PRKCQ
prerank,regulation of translational initiation (GO:0006446),0.3027354474892479,0.8091274191479866,0.7194513715710723,1.0,1.0,15/63,14.96%,CCL5;EIF4EBP1;CSDE1;POLR2G;EIF1;YTHDF2;IMPACT;EIF3E;DDX1;ATF3;EIF3H;NCK2;DNAJC3;CTIF;EIF4G2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.27764159851840176,-0.8090853322591741,0.775,0.9404868319252573,1.0,9/24,24.19%,SULF1;CCBE1;CYP1B1;TGFB1;PTGS2;ARNT;ATF4;FLT4;SULF2
prerank,positive regulation of cellular senescence (GO:2000774),0.3941676703456279,0.8087650346898363,0.6619217081850534,1.0,1.0,1/10,3.10%,CGAS
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.2778073120532612,-0.8083594212960006,0.7091988130563798,0.9409054159634526,1.0,4/23,15.46%,CADM1;LGALS9;PIK3R6;PVR
prerank,regulation of autophagy (GO:0010506),0.26699266253647447,0.8078110991568953,0.8118503118503119,1.0,1.0,63/216,19.78%,ROCK1;PRKAB2;RNF152;ITPR1;FZD5;PIP4K2A;BCL2;ATP6V1H;MTDH;IL10RA;MAPT;ATP6V0A2;FBXW7;VPS26A;NEDD4;DAPK3;TRIM68;WASHC1;VDAC1;VPS26B;ATP6V1C1;NPRL2;SIRT2;RRAGB;DNM1L;SH3BP4;SREBF2;HTR2B;BOK;USP13;ATP6V0D2;LRRK2;MCL1;UFL1;EIF4E;CTSA;TRIM65;PRKAA2;EIF4G2;PRKACA;STAT3;ATG13;RAB8A;VPS35;MT3;WDR6;SVIP;TICAM1;USP36;WDR41;DAPK2;MTMR3;DDIT3;ULK1;ABL1;PRKD1;HDAC6;KAT8;PIK3R2;ATP6V0C;DCAF12;PRKAB1;KDM4A
prerank,gene expression (GO:0010467),0.26466467858387166,0.8075270771140949,0.8804457953394124,1.0,1.0,67/348,16.51%,TSPAN32;RBPMS;ANGPT2;RPL3L;POLR2L;POLR2I;MLF1;MRPL36;MRPL13;NUP62;PWP1;HARS2;ATXN1;WDR33;UPF1;MEF2A;POLR2G;TESC;U2AF2;RPL8;NFKBIB;SRSF4;MRPL43;TNIP1;SEC13;NUP153;NR4A2;MRPL51;ZC3H11A;RPL5;MCM3AP;MRPL23;DHX8;U2AF1;DEDD2;RBM8A;HNRNPU;NUP107;RPS23;AAAS;GSPT1;PRPF4;THOC7;RBM3;DDX25;BAZ2A;RBM6;MRPL9;SRRM1;GALNT2;DROSHA;POLR2J;SYNCRIP;MRPL42;NUP37;NUP98;RPL15;TSPAN17;EIF4E;FASTKD2;NUP210;RPL22;SARS1;FIP1L1;XAB2;DNAJB11;RPL31
prerank,negative regulation of response to wounding (GO:1903035),0.35702222906630066,0.8074233426252022,0.6807511737089202,1.0,1.0,3/19,6.70%,ALOX5;PTPRS;AJAP1
prerank,ameboidal-type cell migration (GO:0001667),0.30612610317497,0.8072993321914711,0.7317073170731707,1.0,1.0,7/51,9.17%,PDLIM1;SEMA5A;SEMA6C;CORO1C;GDNF;ITGA4;PKN2
prerank,response to ATP (GO:0033198),0.3622955892557993,0.8072497210164826,0.6844660194174758,1.0,1.0,2/18,6.20%,P2RY2;TAF1
prerank,regulation of superoxide anion generation (GO:0032928),0.37553437759314223,0.8068989047845834,0.6850828729281768,1.0,1.0,3/14,11.28%,MAPT;GSTP1;PRKCD
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.36227201341919374,0.8067407542895109,0.6756756756756757,1.0,1.0,3/16,10.34%,SLX4;HFM1;TOP2B
prerank,organic cation transport (GO:0015695),-0.28101160308533424,-0.8066040742163736,0.7401574803149606,0.9432324494689075,1.0,5/20,13.57%,SLC47A1;SEC14L1;SLC22A4;RALBP1;SLC22A18
prerank,heterocycle biosynthetic process (GO:0018130),0.3841385593613997,0.8064065263471886,0.6564102564102564,1.0,1.0,2/14,9.37%,ALOX5;MOCS1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.35744642882982164,0.8063654135245917,0.6872037914691943,1.0,1.0,4/18,6.74%,ANXA1;HDAC9;VEGFA;RHOJ
prerank,cellular response to chemical stress (GO:0062197),0.2823526747205069,0.806281173262724,0.7607709750566893,1.0,1.0,21/96,17.05%,NCF2;ATG7;CAV1;PARP1;PPARGC1A;ADNP2;SRXN1;NUDT2;GSTP1;PYROXD1;LONP1;SIRT2;TXNRD2;LRRK2;PRKAA2;ZFAND1;RAD52;MT3;PRDX5;PRDX6;SOD3
prerank,negative regulation of phosphorylation (GO:0042326),0.28867473549323236,0.8062582191358356,0.7502958579881657,1.0,1.0,11/85,10.43%,NTRK3;DYNLL1;ROCK1;PFKFB1;MAPT;DAB2IP;CORO1C;PPARA;IMPACT;NPRL2;HNRNPU
prerank,respiratory system development (GO:0060541),0.33099097989099524,0.8062522465980544,0.7069701280227596,1.0,1.0,4/32,6.73%,FGF1;ITGA3;VEGFA;ABCA3
prerank,signal transduction by p53 class mediator (GO:0072331),0.33126133668427077,0.8062392341939121,0.6797583081570997,1.0,1.0,7/30,13.84%,PMAIP1;MYBBP1A;NDRG1;TP53;PAXIP1;BOK;PDK2
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3553428870015898,0.805903228751321,0.6747181964573269,1.0,1.0,6/21,14.50%,MYH9;PRKCQ;ADAM17;ADAM19;HM13;SPPL2B
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.27775115182765014,-0.8057532065370283,0.7407407407407407,0.9439285413291334,1.0,12/22,44.62%,WNT5A;SLC7A5;TRIL;LAPTM5;NOD2;BTK;TRIM6;SPHK2;CCR2;LACC1;TNFRSF14;LILRB1
prerank,amide biosynthetic process (GO:0043604),0.3122715327283149,0.8055264704706036,0.7225891677675033,1.0,1.0,2/47,4.19%,DMD;FA2H
prerank,organelle fusion (GO:0048284),0.351634717159494,0.8052510111182192,0.7048192771084337,1.0,1.0,9/22,21.84%,AFG3L2;OPA1;MIEF2;MIEF1;MFN2;USP30;MFF;MFN1;GDAP1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.37924430381425805,0.8047316724060987,0.6855123674911661,1.0,1.0,6/13,20.46%,HEXIM1;HNRNPU;NELFB;NELFCD;EAPP;NELFA
prerank,negative regulation of double-strand break repair (GO:2000780),0.3343297569716298,0.804690343877624,0.6848920863309352,1.0,1.0,6/30,13.00%,CGAS;UBR5;ERCC6;FANCB;RIF1;RMI2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.38641431435946844,0.8046882329412683,0.6441605839416058,1.0,1.0,4/11,15.38%,GMNN;TIPIN;ZRANB3;FBXO5
prerank,regulation of acute inflammatory response (GO:0002673),0.3632881185631751,0.804402239901037,0.6974110032362459,1.0,1.0,18/18,63.71%,GSTP1;OSMR;F12;C2CD4A;DNASE1L3;C2CD4B;PLA2G2D;DNASE1;FFAR2;OSM;CREB3L3;IL6;IL4;IL6ST;NLRP3;KLKB1;PTGES;ADAM8
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.2779596900036451,0.8043563555899668,0.766704416761042,1.0,1.0,21/125,14.41%,DYNLL1;CLASP2;KIF2A;CENPP;KIF3B;DCTN6;EFHC1;EML1;SUN2;CENPO;SEC13;ZWINT;CENPE;NUP107;DYNC1I2;ITGB3BP;CLASP1;NUP37;MAP4;NUP98;KIF18A
prerank,regulation of RNA export from nucleus (GO:0046831),-0.3427819670475287,-0.8042033388391169,0.7278761061946902,0.9458181675876334,1.0,5/11,23.64%,KHDRBS1;AKAP8L;NCBP2;NRDE2;CPSF6
prerank,protein targeting to lysosome (GO:0006622),-0.27894540451208016,-0.8038405655670484,0.7567567567567568,0.945586795406646,1.0,10/20,31.15%,SCARB2;GCC2;GNPTAB;AP3M1;HGS;M6PR;NCOA4;LAPTM5;HSPA8;GGA3
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.40085169506483975,0.8034359312525232,0.6937716262975778,1.0,1.0,2/13,8.79%,CBFB;RUNX1
prerank,heme biosynthetic process (GO:0006783),-0.27938360400340445,-0.8033372117359608,0.7545691906005222,0.9456389066396853,1.0,6/22,20.50%,ABCG2;ALAS1;COX10;PPOX;SLC25A38;UROS
prerank,nuclear export (GO:0051168),-0.20321326796045344,-0.8018803790005858,0.8838709677419355,0.9473909724127403,1.0,17/80,16.45%,RANBP3L;THOC2;SRSF7;SRSF6;SRSF11;SRSF5;POLDIP3;NUTF2;RANBP3;TGFB1;THOC5;SRSF2;NEMF;CALR;CCHCR1;NCBP2;CHTOP
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.3871082978957762,0.8017387508688568,0.686411149825784,1.0,1.0,4/13,12.85%,BTG2;POLR2G;CNOT7;CPEB3
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3059772701914468,-0.801238611169255,0.7201017811704835,0.9475629386930521,1.0,4/16,11.44%,AUTS2;RASGRF1;PIK3CB;OGT
prerank,protein methylation (GO:0006479),-0.2436538126787196,-0.8011154360643957,0.8112449799196787,0.9469634093191158,1.0,6/40,9.20%,NSD1;CARM1;CAMKMT;PRMT2;PRMT3;EEF1AKMT1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.2697740446189717,-0.8010823400882282,0.7544910179640718,0.9461782768075223,1.0,3/22,8.17%,BMP7;WNK1;CD44
prerank,positive regulation of endothelial cell migration (GO:0010595),0.28707964037362393,0.8008441441680036,0.7464454976303317,1.0,1.0,12/84,10.78%,ANGPT1;FGF1;ANGPT4;PDGFB;SEMA5A;VEGFA;RRAS;ITGB3;RIN2;ADAM17;HIF1A;ROCK2
prerank,axonal fasciculation (GO:0007413),-0.32712196598223486,-0.8005548576650109,0.7304964539007093,0.946244140185656,1.0,8/12,28.17%,EPHA4;EPHA3;MEGF8;RTN4;CNTN4;EPHB2;CDK5R1;EPHB3
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.2683629661910579,-0.8004027468482865,0.7881619937694704,0.9456659981324436,1.0,7/25,25.57%,SPTBN1;PLCG2;STOML2;PNP;CD80;CD86;PRKD2
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.39007459909701847,0.7997323689347501,0.6794171220400729,1.0,1.0,3/11,12.26%,PAPOLA;AHCYL1;ZFP36L1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.3079062292769997,-0.7997256435614626,0.7039800995024875,0.945991801105678,1.0,3/15,7.89%,APOE;NRDC;FURIN
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.29021231141250076,0.7992305137412822,0.7529002320185615,1.0,1.0,19/85,15.67%,KLHL40;SOCS5;PABIR1;TMEM259;GABARAP;PSMC6;TAF1;DAB2IP;FBXW7;RNF180;SIRT2;USP13;CLU;BAG2;LRRK2;CSNK1E;DVL1;CSNK1A1;HSPBP1
prerank,protein lipidation (GO:0006497),0.3037496137973452,0.7991455550327707,0.7329974811083123,1.0,1.0,20/59,19.72%,PIGN;ATG7;ZDHHC2;PIGA;HHAT;ZDHHC1;ZDHHC14;ZDHHC17;WDR45;PIK3C3;PIGH;PIGB;PIGP;ZDHHC13;DPM2;ZDHHC8;ZDHHC5;ZDHHC3;PGAP4;ATG10
prerank,cholesterol transport (GO:0030301),0.31335812479202696,0.7991021367631108,0.7142857142857143,1.0,1.0,10/45,17.28%,CD36;CAV1;STX12;ABCG1;OSBPL2;CLU;LDLRAP1;OSBPL5;VPS4A;LIMA1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.34581417337054465,0.7990333460579637,0.7046153846153846,1.0,1.0,7/24,22.53%,PLA2G3;ABCA3;PLA2G4A;LPCAT1;PLA2G15;CRLS1;SERAC1
prerank,negative regulation of endocytosis (GO:0045806),0.3389917782128901,0.7989959685251311,0.6875,1.0,1.0,3/24,8.34%,PACSIN3;CAV1;CD300A
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.31420684321080755,0.7983117541998493,0.7166437414030261,1.0,1.0,15/42,20.15%,NARS2;HARS2;LARS1;IARS2;AIMP1;IARS1;SARS2;EPRS1;KARS1;LARS2;SARS1;FARS2;GARS1;AARS2;CARS2
prerank,macroautophagy (GO:0016236),0.27132006899458694,0.7979495691269124,0.7555803571428571,1.0,1.0,32/118,20.30%,DYNLL1;PRKAB2;CHMP4C;PIP4K2A;MTERF3;LIX1L;ATG7;GABARAP;LIX1;VDAC1;MTMR14;STAM2;MFN2;CHMP2B;TSG101;VPS36;PIK3C3;CHMP2A;PRKAA2;STAM;ATG13;TOMM5;VPS4A;MTMR3;FUNDC1;TOMM7;ULK1;VPS37A;PRKAB1;ATG10;LAMP2;MFN1
prerank,regulation of humoral immune response (GO:0002920),-0.2331270926346971,-0.7978558662478646,0.8304347826086956,0.9483010915920752,1.0,12/44,27.73%,VTN;PROS1;CD55;CD46;SERPING1;C1QB;GATA6;CR1L;C1QC;C1QA;CFHR2;C2
prerank,iron ion transport (GO:0006826),-0.2238065486060574,-0.7977054595913944,0.8879668049792531,0.9477164706442457,1.0,8/47,10.69%,CP;SCARA5;ABCB7;ATP6V0A4;STEAP3;ATP6AP1;ATP6V1G1;FTH1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.3596641901872223,0.7976980186859267,0.6730769230769231,1.0,1.0,2/18,3.34%,ROCK1;KANK1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3563010652761351,0.7973074214147774,0.6985074626865672,1.0,1.0,4/20,8.74%,PDGFB;CCND2;CCND1;ADAM17
prerank,fatty acid biosynthetic process (GO:0006633),-0.21272998893087236,-0.7968608459548641,0.864321608040201,0.9483263781232406,1.0,24/63,32.07%,ELOVL7;HACD4;ASAH2;ACLY;PTGS2;ABCD3;ABHD3;EPHX2;ELOVL4;ELOVL6;DECR2;HACD2;ELOVL1;HACD3;FADS1;ACOT7;HPGD;ALOX12;HSD17B8;ELOVL5;DEGS1;OXSM;TECRL;GPX4
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.2713301881731586,-0.7966196534151075,0.7948717948717948,0.9479190025838985,1.0,5/22,13.71%,KIT;GHR;CYP1B1;HES1;MGAT5
prerank,import into nucleus (GO:0051170),-0.20558280817985589,-0.7960480274663438,0.8957055214723927,0.9480776666703874,1.0,22/73,23.62%,APPL2;E2F3;FAM53A;NUP88;NUTF2;IPO8;PTTG1IP;GEMIN8;APPL1;NUP50;SNRPD1;EIF4ENIF1;AKT1;GEMIN7;SMN1;NUP85;IPO11;NXT2;NUP214;RAN;HTATIP2;IPO13
prerank,organelle fission (GO:0048285),-0.2744887267432258,-0.7960382533521793,0.7744807121661721,0.9472566065623327,1.0,7/24,15.52%,DNM3;DNM1;MTFR1;PRKN;ACOT8;TMCC1;FIS1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.3046265608186059,-0.795940013111402,0.7248803827751196,0.9465808966796239,1.0,5/15,17.98%,CD44;MDM2;PRKN;PTTG1IP;KDM1A
prerank,oligodendrocyte development (GO:0014003),-0.3018181451726922,-0.7959385105297554,0.7209876543209877,0.9457523173106589,1.0,3/15,12.07%,PLP1;B4GALT6;EIF2B3
prerank,vacuolar acidification (GO:0007035),0.34879173959122706,0.7957982683576855,0.711864406779661,1.0,1.0,3/21,6.29%,CLN5;ATP6V1H;ATP6V0A2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.2953128985476953,0.7956307816048573,0.7285886610373945,1.0,1.0,14/65,17.21%,CHMP4C;PABIR1;FHL1;PSMC6;CHEK1;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14;VPS4A
prerank,B cell mediated immunity (GO:0019724),0.39323374340949024,0.7955301830761231,0.6745454545454546,1.0,1.0,10/10,60.70%,MSH2;CD27;CD70;CD74;CD19;SLA2;FCER1G;CARD9;TLR8;FCGR2B
prerank,cellular response to lectin (GO:1990858),-0.1937670142603055,-0.7955188238788994,0.9147286821705426,0.9447997394440024,1.0,35/104,33.10%,PDPK1;PLCG2;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;EP300;PSMC5;TAB1;PSMA5;PSMA1;PSMC2;KRAS;RELB;BTRC;PSME3;PSMC4;PSMB6;SYK;PSMB10;PSMA4;PSME1;ICAM2;PSMF1;SRC;PSMB9;NFKB1;PSME2;TYROBP;PSMA8;HRAS
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.1937670142603055,-0.7955188238788994,0.9147286821705426,0.9447997394440024,1.0,35/104,33.10%,PDPK1;PLCG2;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;EP300;PSMC5;TAB1;PSMA5;PSMA1;PSMC2;KRAS;RELB;BTRC;PSME3;PSMC4;PSMB6;SYK;PSMB10;PSMA4;PSME1;ICAM2;PSMF1;SRC;PSMB9;NFKB1;PSME2;TYROBP;PSMA8;HRAS
prerank,pyruvate metabolic process (GO:0006090),0.3024882555683589,0.7950800031730818,0.7197452229299363,1.0,1.0,8/52,11.40%,ENO3;HK2;PFKFB1;ME3;DLD;VDAC1;ALDOA;PFKM
prerank,modulation by symbiont of entry into host (GO:0052372),-0.29629210505892056,-0.7949226886367069,0.7328605200945626,0.9449623466703532,1.0,7/16,24.10%,TRIM25;TRIM5;EXOC2;TRIM14;EXOC7;FUCA2;TRIM21
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.29231601416069974,-0.7949021902518223,0.7525773195876289,0.9441728723799594,1.0,9/16,27.88%,KLHL22;PIP4P1;GPR137B;TELO2;RRAGD;GPR137;SIK3;PIH1D1;RRAGA
prerank,positive regulation of vacuole organization (GO:0044090),-0.33750899787724437,-0.7944333734695574,0.720620842572062,0.9441496396193377,1.0,5/10,18.43%,ANXA2;PIP4K2B;RAB3GAP2;GRN;RALB
prerank,limb development (GO:0060173),0.335205931593581,0.7941175934151784,0.7190684133915575,1.0,1.0,2/28,4.99%,MAP3K20;LNPK
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.26402161966213544,-0.7941143734417605,0.8005865102639296,0.9438638823914516,1.0,15/27,32.82%,SLC1A3;SLC47A1;SLC3A2;SLC7A5;SLC6A9;SLC38A5;SLC25A38;SLC1A4;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6;SLC22A2;PRAF2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.3224798575751064,-0.794012192309242,0.7146464646464646,0.9432121688417408,1.0,7/13,28.83%,APP;SHANK3;ADCY1;EPHB2;SHISA7;RELN;SQSTM1
prerank,cell-cell junction maintenance (GO:0045217),0.3838414575459505,0.7936149899436663,0.6827586206896552,1.0,1.0,1/11,2.37%,FERMT2
prerank,negative regulation of cell communication (GO:0010648),0.35110383724809036,0.7934821551517928,0.7099358974358975,1.0,1.0,2/21,6.67%,SOCS5;PTPN1
prerank,response to UV-A (GO:0070141),-0.30746141234849467,-0.7928942972432386,0.748730964467005,0.944276000030001,1.0,4/14,16.24%,EGFR;MMP2;AKT1;MMP1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.30241248841379054,0.7927498504061569,0.7259552042160737,1.0,1.0,8/52,8.68%,D2HGDH;MDH1;ME3;MTHFD2L;DLST;GOT1;GOT2;ALDH1L2
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.19262338125457504,-0.7927329353605291,0.9302325581395349,0.9437483591316105,1.0,35/105,33.10%,PDPK1;PLCG2;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;EP300;PSMC5;TAB1;PSMA5;PSMA1;PSMC2;KRAS;RELB;BTRC;PSME3;PSMC4;PSMB6;SYK;PSMB10;PSMA4;PSME1;ICAM2;PSMF1;SRC;PSMB9;NFKB1;PSME2;TYROBP;PSMA8;HRAS
prerank,regulation of transmembrane transport (GO:0034762),0.324815870624296,0.7927044325371354,0.7289855072463768,1.0,1.0,4/31,7.01%,KCNJ12;BCL2;ACTB;NEDD4
prerank,establishment of spindle orientation (GO:0051294),0.33802890071697383,0.7926542390698869,0.722473604826546,1.0,1.0,8/28,17.68%,ITGB1;INSC;NSFL1C;FBXW11;CLASP1;MAP4;DCTN1;UBXN2B
prerank,neural tube closure (GO:0001843),0.3220095122793502,0.792440508079908,0.7028885832187071,1.0,1.0,7/34,16.94%,DLC1;TGFB2;SKI;PLXNB2;DVL1;KDM2B;SEMA4C
prerank,DNA replication checkpoint signaling (GO:0000076),0.35793369508778766,0.7923078682000748,0.7016949152542373,1.0,1.0,3/16,7.92%,TIPIN;RAD9A;HUS1B
prerank,positive regulation of cell growth (GO:0030307),0.2803572043616809,0.7921083142949283,0.7632468996617813,1.0,1.0,23/96,17.41%,AKAP6;IL2;PABIR1;NTN1;FXN;BCL2;MAPT;TGFB2;ADNP2;ADAM17;ITSN2;HDGFL2;CEP43;N6AMT1;HYAL1;EIF4G2;SMURF1;INO80;MAP3K13;DDX49;RASAL1;S100A8;S100A9
prerank,cell part morphogenesis (GO:0032990),-0.31647045563665266,-0.7917794081291684,0.7394366197183099,0.9444983363841822,1.0,6/13,21.94%,PID1;FIS1;PNPT1;CSPG5;NUBPL;SLIRP
prerank,atrial septum development (GO:0003283),0.366677003728265,0.7916743007535402,0.6816546762589928,1.0,1.0,2/13,7.78%,HEY2;TGFB2
prerank,negative regulation of T cell activation (GO:0050868),0.3226346626132843,0.7916122505550579,0.7205479452054795,1.0,1.0,5/35,9.92%,LAX1;HAVCR2;DUSP3;PAG1;TNFRSF21
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2593736700792736,0.7913719021228497,0.914572864321608,1.0,1.0,56/497,10.44%,PRDM16;HEY2;TBX2;LBH;LIMS1;LIMD1;PDGFB;NAB1;ATP8B1;ID4;LOXL2;ARID5B;RUNX1T1;HEYL;PBXIP1;IGFBP5;HINFP;SAMD4A;GMNN;MRPL13;RBAK;NACC2;BTG2;NR2F2;HDAC9;SET;MTERF3;ATXN1;PIAS4;SUV39H2;MYBBP1A;ARID5A;DAB2IP;HEXIM1;TP53;ZBTB38;BCL7A;SFPQ;PA2G4;L3MBTL2;SOX9;RELA;MAP3K10;PLCB1;DAPK3;CBX4;MTA3;NR1D1;KAT7;ZBTB33;SIRT2;MIDEAS;DEDD2;SPINDOC;PCGF6;EIF2AK2
prerank,DNA conformation change (GO:0071103),-0.2952709582606365,-0.7913265567399604,0.7584541062801933,0.9444637526938414,1.0,9/17,33.58%,HMGB1;TOP1;HHEX;HMGB2;TOP3B;TOP1MT;NAA10;TOP2A;ERCC3
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.24245341145324464,-0.7912861788486883,0.8007246376811594,0.9437177930138989,1.0,7/34,13.87%,IGF1;TGFA;CUL3;IGF2;CDC23;RGCC;INSR
prerank,dendritic spine organization (GO:0097061),0.33899735440856055,0.7912306868239263,0.698170731707317,1.0,1.0,5/26,15.32%,ITGA3;DOCK10;CHRNA7;EPHB1;PTEN
prerank,meiosis I (GO:0007127),0.3509341778593445,0.7911128862135812,0.7391304347826086,1.0,1.0,2/23,5.58%,ZCWPW1;FOXJ3
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.26909489335656717,0.7907600279879742,0.8319502074688797,1.0,1.0,27/208,11.69%,FLNA;NR1H4;MYD88;RORA;ROR1;NUP62;CARD19;MTDH;DAB2IP;PPM1A;TRAF3;TIFA;GOLT1B;RELA;TNIP1;OTUD7A;TRIM68;GSTP1;NR1D1;EDAR;TRAF5;PELI2;DDX1;ZDHHC17;RHOH;ZFAND6;HTR2B
prerank,respiratory electron transport chain (GO:0022904),0.37954174956379627,0.7906852304187246,0.6877256317689531,1.0,1.0,5/14,16.32%,PPARGC1A;ETFA;SDHA;SLC25A12;UQCRFS1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.34708585263827374,0.7904723101848706,0.7006472491909385,1.0,1.0,3/16,12.46%,NACC2;SNAI2;CLU
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.30823834692876995,0.7903324695798768,0.7125,1.0,1.0,9/43,10.48%,PDGFB;TERT;TP53;TGFB2;SOX9;RELA;PPARA;HIF1A;TEAD1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.38411347891848646,0.7901841986107908,0.6959459459459459,1.0,1.0,3/12,10.29%,HSD17B4;FADS2;SCP2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.27430517669844856,0.7901238180403367,0.7708333333333334,1.0,1.0,14/92,10.78%,ANGPT1;FGF1;ANGPT4;CLASP2;MAPRE2;VEGFA;RRAS;ITGB3;TGFB2;SOX9;RIN2;HIF1A;DOCK1;ROCK2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.3773089981224941,0.7894241272106061,0.6794871794871795,1.0,1.0,3/12,8.61%,TP53;RPS27L;CCND1
prerank,cellular response to amino acid stimulus (GO:0071230),0.31691114642070495,0.7887646012796746,0.6864406779661016,1.0,1.0,8/33,14.33%,LARS1;CPEB1;CASTOR1;CAPN2;RRAGB;SH3BP4;CPEB3;CASTOR2
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.2758523517251514,-0.788278006720037,0.7513513513513513,0.9477508485405763,1.0,8/22,19.56%,APOD;BAG4;RANGAP1;SP100;INSIG1;LMAN1;ITGB1BP1;PARK7
prerank,immunoglobulin mediated immune response (GO:0016064),0.39053477278433346,0.7879146388710484,0.6988847583643123,1.0,1.0,10/10,60.97%,CD27;ZP3;CD74;GAPT;CD19;FCER1G;CARD9;TLR8;FCGR2B;CD81
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.27666210991533435,-0.78780316952507,0.7817745803357314,0.9477287573084803,1.0,8/19,28.77%,PRKDC;ZMIZ1;XRCC6;NCKAP1L;PPP2R3C;ZBTB1;SYK;MMP14
prerank,positive regulation of leukocyte migration (GO:0002687),-0.25292185275659634,-0.787417862513494,0.7889908256880734,0.9476012795423412,1.0,1/27,0.13%,PTN
prerank,lymphocyte differentiation (GO:0030098),0.29304888615790253,0.7874009212547242,0.7503090234857849,1.0,1.0,12/68,11.64%,CD79A;IL2;ITGB1;HDAC9;ITGA4;ADAM17;KAT7;AXL;TPD52;LMBR1L;RHOH;ZBTB7A
prerank,regulation of ATP biosynthetic process (GO:2001169),0.35925800133828945,0.7869409148839391,0.7064676616915423,1.0,1.0,5/16,14.25%,PARP1;PPARGC1A;PPARA;ATPSCKMT;TMSB4X
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.33978729147631764,0.7869182622650279,0.7149606299212599,1.0,1.0,5/23,14.28%,SOCS5;SOCS4;CAV1;TSG101;CBLB
prerank,dendrite morphogenesis (GO:0048813),0.31622222369568853,0.7866320256875725,0.7317415730337079,1.0,1.0,4/35,5.34%,SDC2;DOCK10;KLF7;MEF2A
prerank,regulation of smooth muscle cell migration (GO:0014910),0.3479040705652348,0.7854815070345968,0.7151607963246555,1.0,1.0,6/20,10.90%,PDGFB;IGFBP5;CCL5;BMPR1A;PDGFRB;PDGFA
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.3306411141292244,0.7854666613528984,0.7323529411764705,1.0,1.0,5/28,6.67%,PIP4K2A;KANK1;PRKCQ;IRS1;PTPN1
prerank,negative regulation of locomotion (GO:0040013),-0.3191710586456322,-0.7848525785922303,0.7625570776255708,0.9509459808002021,1.0,3/12,13.24%,FBLN1;FRMD5;CCDC125
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.26522302173054013,-0.7846677264356433,0.7944444444444444,0.9504405119458447,1.0,4/23,7.70%,HMGB1;CECR2;KPNA1;FBH1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.27084680227678054,0.7845470277297433,0.8008800880088008,1.0,1.0,14/136,9.33%,FLNA;TMIGD3;HEYL;PTGIS;HAVCR2;SETD6;TAF1;DAB2IP;CD200;TRAF3;ZNF431;MAP3K10;NFKBIE;PAXIP1
prerank,regulation of complement activation (GO:0030449),-0.22938439958349632,-0.7843004813693972,0.8273092369477911,0.9502372158882909,1.0,11/40,27.73%,VTN;PROS1;CD55;CD46;SERPING1;C1QB;CR1L;C1QC;C1QA;CFHR2;C2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.26920137074533523,-0.784231558808546,0.7793296089385475,0.9495412907679114,1.0,11/23,31.63%,ELOVL7;FAR2;ACSL3;ACSL4;ELOVL6;HACD2;ELOVL1;ACOT7;ACSL1;ELOVL5;DGAT2
prerank,central nervous system development (GO:0007417),0.2603119687506193,0.7840799032610514,0.8443298969072165,1.0,1.0,22/250,10.54%,SOX6;COL4A1;SERPINI1;ZFHX3;PDGFC;CLN5;SLC6A17;GRIN2C;ATXN1;SYNJ2;TPPP;EML1;MBP;SOX9;SLC23A1;CDH2;GSTP1;NR4A2;ADGRL2;COX7B;SCYL2;HAPLN2
prerank,organonitrogen compound catabolic process (GO:1901565),-0.21731390424044733,-0.7840325747544391,0.8237885462555066,0.9490302632598684,1.0,21/57,29.05%,GGACT;ANPEP;NPEPPS;TRIM24;RENBP;ENPP2;PPT1;ACE;PLA2G6;SIAH1;PLA2G7;CLPX;AMDHD2;USE1;TPP1;NPL;LRSAM1;PNPLA8;GNPDA1;CLN8;CPQ
prerank,glycogen biosynthetic process (GO:0005978),0.37690546162317723,0.7839415842917135,0.6888888888888889,1.0,1.0,3/12,10.15%,NR1D1;NHLRC1;GYS1
prerank,glucan biosynthetic process (GO:0009250),0.37690546162317723,0.7839415842917135,0.6888888888888889,1.0,1.0,3/12,10.15%,NR1D1;NHLRC1;GYS1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3135152399020559,-0.7836826259684171,0.7588652482269503,0.9488075279306767,1.0,3/12,17.24%,CENPC;RMDN1;MAD1L1
prerank,early endosome to late endosome transport (GO:0045022),0.35411062039999086,0.7835750529906028,0.7045813586097947,1.0,1.0,5/20,14.38%,HOOK2;HOOK1;AKTIP;PIK3C3;ANKRD27
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.2911951853388959,-0.7823566737236824,0.7810026385224275,0.9500935501220569,1.0,3/15,13.45%,EGFR;PTK2B;KDR
prerank,regulation of cellular catabolic process (GO:0031329),0.2906613894412703,0.7823304672210601,0.7521685254027262,1.0,1.0,20/62,19.60%,ROCK1;ITPR1;PIP4K2A;MAPT;DAPK3;RRAGB;LONP2;BOK;USP13;LRRK2;RAB8A;WDR41;DAPK2;MTMR3;DDIT3;ABL1;HDAC6;KAT8;PIK3R2;DCAF12
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3443186847277978,0.7821897304368489,0.7103658536585366,1.0,1.0,7/18,18.17%,RELA;ROCK2;ABCG1;CHRNA7;CLU;SP1;LRRTM3
prerank,DNA methylation or demethylation (GO:0044728),-0.27550014475135426,-0.7819965613530817,0.7643979057591623,0.9490137041187796,1.0,11/19,45.54%,KMT2E;PPM1D;TEX15;ATRX;BEND3;DNMT3B;EHMT2;DMAP1;ATF7IP;EHMT1;FOS
prerank,DNA alkylation (GO:0006305),-0.27550014475135426,-0.7819965613530817,0.7643979057591623,0.9490137041187796,1.0,11/19,45.54%,KMT2E;PPM1D;TEX15;ATRX;BEND3;DNMT3B;EHMT2;DMAP1;ATF7IP;EHMT1;FOS
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.3222598818418261,0.7819212985773413,0.7256011315417256,1.0,1.0,4/33,8.66%,ANGPT1;SEMA5A;YAP1;PPARA
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3089267789674839,0.7812809451863271,0.7440559440559441,1.0,1.0,9/35,15.58%,CDK6;ACVR2A;MED1;ANKRD54;HIF1A;ACVR1B;ZFP36L1;STAT1;STAT3
prerank,tRNA processing (GO:0008033),0.2910490765462509,0.7810525169973583,0.7568922305764411,1.0,1.0,13/61,16.35%,WDR4;TRDMT1;CDKAL1;FTSJ1;TYW5;TRMT10C;RTCB;DDX1;NSUN2;KARS1;SARS1;FARS2;TRUB1
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.32523341121584537,-0.7810515445441439,0.7547619047619047,0.9498047928758154,1.0,2/11,8.27%,NEDD4L;COMMD1
prerank,glutathione metabolic process (GO:0006749),0.31303694341099875,0.7809537897636056,0.7318435754189944,1.0,1.0,7/38,12.15%,ETHE1;GSTT1;NAT8;GSTP1;GGCT;OPLAH;GSTA4
prerank,chondroitin sulfate metabolic process (GO:0030204),0.324990325111346,0.7808571363733746,0.7066473988439307,1.0,1.0,4/30,3.48%,CHSY3;CSPG4;CSGALNACT1;BGN
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.278364435416338,-0.7807340253471868,0.7859078590785907,0.9495110538979523,1.0,6/21,19.24%,CDC14B;RAB1A;UBE2S;RPS7;RPL11;BTRC
prerank,pre-miRNA processing (GO:0031054),-0.3086609185795097,-0.7799788393312609,0.7458823529411764,0.9498880121694462,1.0,4/14,19.09%,AGO3;ADAR;TUT4;TUT7
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.27860236138675615,-0.7797503351561232,0.7631578947368421,0.9494373235750255,1.0,4/20,8.40%,FKBP5;CWC27;PPIL2;FKBP1A
prerank,negative regulation of cell projection organization (GO:0031345),-0.2204887266073589,-0.7797012235004399,0.816,0.9487079674084021,1.0,11/48,17.73%,EFNB2;LPAR1;APOE;EPHA4;SEMA3A;SPRY2;DPYSL3;RAB29;CBFA2T2;HDAC2;PRAG1
prerank,acylglycerol biosynthetic process (GO:0046463),-0.2692581907098991,-0.7793926823557059,0.8208955223880597,0.9483891491741204,1.0,3/23,4.77%,AGMO;LPGAT1;LPIN2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3660137712180329,0.7792642789948208,0.6937394247038917,1.0,1.0,1/13,1.51%,PMAIP1
prerank,regulation of hormone secretion (GO:0046883),0.36751773206474325,0.7783092924349274,0.7190226876090751,1.0,1.0,1/15,2.73%,ANXA1
prerank,regulation of macrophage activation (GO:0043030),-0.25013025773423125,-0.7782293181098499,0.8006430868167203,0.949422686607163,1.0,9/30,22.76%,IL31RA;LBP;WNT5A;IL33;ZC3H12A;GPR137B;SHPK;HSPD1;SPHK1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.3002579180312822,-0.7782274742682522,0.7736842105263158,0.9486182846436895,1.0,4/15,16.25%,GGACT;ALDH4A1;ABHD12;HOGA1
prerank,organelle disassembly (GO:1903008),-0.24064014205065443,-0.7776904040167231,0.8102766798418972,0.948638732828119,1.0,12/33,26.18%,RB1CC1;GBF1;STX5;RETREG1;TEX264;ATG2B;ATG2A;KIF9;MTIF3;ULK2;PLK5;UBA5
prerank,mitochondrial translation (GO:0032543),0.27496543704152293,0.7772275500867784,0.7947548460661346,1.0,1.0,34/104,22.19%,MRPL36;MRPS31;MRPL13;MRPL30;GATB;MRPL43;IARS2;MRPS35;MRPS28;MRPL51;MRPL45;GFM2;MRPL21;MRPL23;MRPL16;MRPL47;MRPL9;TSFM;MRPL42;LARS2;FASTKD2;MRPL14;MRPL4;MRPS21;MRPL40;MRPL22;MRPL50;GATC;MRPS14;MRRF;OXA1L;MRPL24;MRPS12;MRPS10
prerank,protein prenylation (GO:0018342),-0.33576315409621676,-0.7771192881389916,0.7551487414187643,0.9486621381305931,1.0,6/10,39.77%,CHM;RCE1;CHML;RABGGTA;FNTA;FNTB
prerank,regulation of neurotransmitter secretion (GO:0046928),0.31621275354227774,0.7763611984212924,0.7322175732217573,1.0,1.0,2/32,4.39%,MEF2C;RIMS3
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.2944562129114805,-0.7762459200011919,0.7615571776155717,0.9492913511688285,1.0,5/15,18.74%,OSBPL8;ABHD5;PLIN2;PPARG;PLIN3
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3113473095652435,0.7759822895423831,0.7590027700831025,1.0,1.0,8/40,12.46%,PMAIP1;FXN;TP53;OPA1;HRK;DNM1L;GPER1;CLU
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.2774841779263427,-0.77593537487525,0.7590027700831025,0.9489806318151578,1.0,7/18,30.00%,PRKN;AKT1;PARK7;MAPK7;BAG5;HTRA2;PPIA
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.24961972837106539,-0.7759319688091277,0.8,0.9481810141482038,1.0,14/26,31.29%,TET3;CTR9;TET2;OGT;SETD5;ETFBKMT;SETD1A;SUV39H1;PRDM9;EEF2KMT;KMT2A;BEND3;SMYD5;ANTKMT
prerank,epidermal cell differentiation (GO:0009913),0.30882413306040835,0.7758414536275227,0.7427785419532325,1.0,1.0,7/41,17.11%,ANXA1;JAG1;MED1;EPHA2;BCR;CLIC4;HDAC1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.3468909390207816,0.7754196269287428,0.7054009819967266,1.0,1.0,5/18,15.84%,PLCB1;HRH3;AGRN;GNAQ;RGS10
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.3305125416082647,-0.7750452352181196,0.7619047619047619,0.947985097121922,1.0,1/10,2.39%,WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.3305125416082647,-0.7750452352181196,0.7619047619047619,0.947985097121922,1.0,1/10,2.39%,WNK1
prerank,positive regulation of DNA replication (GO:0045740),-0.2975802846249641,-0.7748912022528508,0.7676767676767676,0.9474175613035821,1.0,3/16,4.67%,GLI2;EGFR;STN1
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.24890683398243538,-0.7748300129002317,0.8184615384615385,0.9467131809604106,1.0,16/26,41.71%,EPHA4;APH1A;LYN;NCSTN;APH1B;TTBK1;PSME3;PSENEN;PSME1;PSME2;PYCARD;GRIN1;AGER;AIM2;FYN;GRIN2B
prerank,regulation of exosomal secretion (GO:1903541),-0.2815815586916242,-0.7741372305401248,0.7676240208877284,0.9470045172681328,1.0,7/19,27.07%,SDCBP;PRKN;VPS4B;SDC4;HGS;ATP9A;SDC1
prerank,protein localization to microtubule organizing center (GO:1905508),0.3568067707045256,0.7740411464044703,0.6986301369863014,1.0,1.0,4/15,11.99%,PIBF1;CEP192;C2CD3;NEDD1
prerank,mitochondrial translational elongation (GO:0070125),0.2793079503812172,0.7738237182298615,0.7745327102803738,1.0,1.0,17/88,13.32%,MRPL36;MRPS31;MRPL13;MRPL30;MRPL43;MRPS35;MRPS28;MRPL51;MRPL45;GFM2;MRPL21;MRPL23;MRPL16;MRPL47;MRPL9;TSFM;MRPL42
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.29570652192887903,-0.7728026958138239,0.7842639593908629,0.9482850883883072,1.0,7/15,35.64%,ANAPC1;CDC23;NEK6;CDC16;CDC27;RIOK2;TACC3
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.22216523558246076,-0.7725934385081724,0.8708333333333333,0.947782504215708,1.0,13/42,22.57%,SMARCA2;RBBP4;CECR2;SMARCA1;ACTR8;CHD3;ACTR6;MTA2;HDAC2;ZNHIT1;ACTR5;SRCAP;SMARCD2
prerank,negative regulation of kinase activity (GO:0033673),-0.2059796733785905,-0.7718241151763848,0.883248730964467,0.9482036136664875,1.0,16/62,20.25%,PRKAG2;NF1;DEPTOR;PDPK1;PYDC1;DTNBP1;WWTR1;PPM1F;TAB1;SNCA;AKT1;ITGB1BP1;TRIB1;QARS1;PARK7;CEACAM1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.3346937982941394,-0.7717001816189918,0.7656903765690377,0.9476160563270714,1.0,4/10,29.22%,STOML2;CDC7;DBF4;ATRX
prerank,nucleotide-sugar metabolic process (GO:0009225),0.37183805155661664,0.7716156466805844,0.716636197440585,1.0,1.0,3/12,11.29%,CSGALNACT1;GFPT1;PARG
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.3329357075779105,0.7714636790345123,0.725609756097561,1.0,1.0,2/22,6.81%,FZD5;IL12RB1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.35922700359866,0.771240840002612,0.7227722772277227,1.0,1.0,2/15,6.54%,FGF1;VEGFA
prerank,neuron differentiation (GO:0030182),0.2632731487552609,0.7710467675437511,0.8224598930481284,1.0,1.0,16/165,9.53%,MEF2C;FZD5;IRX5;FZD4;FZD8;ITM2C;VEGFA;PIN1;TGFB2;ERCC6;ADNP2;MAP2K1;RUNX1;BRSK1;NR4A2;HS6ST1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.2859473844592512,0.7709269881965204,0.7861409796893668,1.0,1.0,17/69,15.42%,PLCE1;PLCB4;PLCL1;KCNH1;IRS1;PLCB1;PLCD1;PDGFRB;SIRT2;HTR2B;ZFP36L1;TPTE;PIK3C3;PLEKHA1;IRS2;PTEN;PITPNM2
prerank,response to insulin (GO:0032868),0.2772507063947055,0.7708492717680858,0.7920673076923077,1.0,1.0,9/80,8.82%,SLC2A4;SORT1;HDAC9;IRS1;CPEB1;PARP1;SORBS1;GOT1;SLC39A14
prerank,positive regulation of mRNA processing (GO:0050685),-0.2694571064992178,-0.7707928135250832,0.7950138504155124,0.9481756785744467,1.0,6/21,15.18%,TRA2B;CELF4;DAZAP1;SNW1;LEO1;NCBP2
prerank,positive regulation of signaling receptor activity (GO:2000273),0.30974795775765207,0.7707194832521128,0.7648686030428768,1.0,1.0,11/36,19.01%,ITGB1;TAF1;FBXW7;AREG;ADAM17;HIF1A;HBEGF;JAK2;HDAC1;ADRA2A;HDAC6
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.2988478349780864,-0.7705927574892486,0.7819548872180451,0.9476886751084682,1.0,6/15,20.71%,METTL3;SAMHD1;STAT2;NLRC5;YTHDF3;PTPN2
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2620804119458979,0.7702748179499799,0.8384697130712009,1.0,1.0,19/170,11.33%,TMPRSS4;CRIP1;CDK6;ALPK2;SLC8A1;SLC8A2;HINFP;SORT1;PRDM1;ATP1B1;PIN1;GDNF;ADNP2;TRIM68;HIF1A;TOB2;ROCK2;AFF1;ANKRA2
prerank,positive regulation of cell aging (GO:0090343),0.3662553617033995,0.770163582758008,0.696551724137931,1.0,1.0,1/11,3.10%,CGAS
prerank,pancreas development (GO:0031016),-0.3125631905623145,-0.7697820757977675,0.7775229357798165,0.9481045089664257,1.0,3/12,21.56%,TCF7L2;CCDC39;ZIC3
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.3244834395421426,-0.7697757010495254,0.7566265060240964,0.9473192744531006,1.0,3/10,20.79%,HSPA5;HERPUD1;ATF4
prerank,membrane organization (GO:0061024),0.2543852622161645,0.7695982154702682,0.8476683937823835,1.0,1.0,38/227,13.62%,TRDN;CHMP4C;FER1L5;HIP1;DYSF;PACSIN2;ITSN1;FZD4;ACTG1;ACTR3;ACTB;SYNJ2;TTPA;EPN2;CHMP5;CORO1C;AREG;IGF2R;OPA1;SUN2;LPCAT3;GCA;STX18;NSFL1C;HBEGF;DNM1L;TLCD2;STAM2;MFN2;CHMP2B;OSBPL2;DMPK;SNX9;A4GALT;FNBP1;GLTP;LDLRAP1;CHMP2A
prerank,B cell differentiation (GO:0030183),0.30201622742995804,0.769571575700545,0.7650130548302873,1.0,1.0,7/46,11.64%,CD79A;ITGB1;HDAC9;ITGA4;ADAM17;TPD52;ZBTB7A
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.3329739135118259,0.7692526014635677,0.7464788732394366,1.0,1.0,11/25,22.60%,ELL;ERCC6;CCNT1;KAT7;TSFM;ZMYND11;HMGN1;WDR43;HTATSF1;CCAR2;THOC1
prerank,response to lipopolysaccharide (GO:0032496),0.2638348148961076,0.7690461825943552,0.8116883116883117,1.0,1.0,15/138,9.85%,MEF2C;MYD88;VIM;CD14;UPF1;TNFRSF11A;DAB2IP;MAPKAPK2;CHMP5;RELA;NFKBIB;ADAM17;GSTP1;NR1D1;AXL
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.2632284892497798,-0.7685810109491519,0.7988338192419825,0.9482921293987144,1.0,3/23,5.95%,SLC12A2;SLC12A7;ATP6V0A4
prerank,glycerolipid catabolic process (GO:0046503),-0.2782358430571398,-0.7684270812972004,0.8272251308900523,0.9477388852214125,1.0,8/19,26.08%,GDPD1;ABHD12;GPCPD1;GDE1;PNPLA6;ABHD6;ENPP6;LYPLA2
prerank,mammary gland development (GO:0030879),0.34262487521769747,0.7683643847759178,0.7163009404388715,1.0,1.0,5/21,15.25%,TGFB3;CAV1;VEGFA;ARHGAP35;JAK2
prerank,regulation of DNA recombination (GO:0000018),0.3159745484271095,0.7682039047031033,0.7346938775510204,1.0,1.0,8/32,17.01%,H1-0;RAD51AP1;ZCWPW1;CHEK1;KPNA2;ZRANB3;SIRT6;MSH2
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.25329767390031444,0.7681222838621964,0.8742331288343558,1.0,1.0,53/241,16.45%,LSM8;POLR2L;POLR2I;HNRNPR;CWC25;RAVER2;DDX23;WDR33;PCF11;SF3B5;POLR2G;U2AF2;TXNL4A;SFPQ;SF3B3;SRSF4;PAPOLA;SNRPN;GPKOW;FUS;PPIL1;PPIE;ZMAT5;RBM19;DHX8;U2AF1;RBM8A;HNRNPU;SRSF10;PRPF4;SF3A3;RBM6;HNRNPC;PSPC1;SRRM1;SF3B2;SF3B1;ZCRB1;POLR2J;SYNCRIP;PPWD1;PDCD7;CWC22;SNRPB2;PPIL3;RBM15;RBM41;SF1;PUF60;SF3A1;FIP1L1;XAB2;WBP4
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.2963522201551244,0.7678615584173548,0.7737041719342604,1.0,1.0,6/50,9.42%,CCNA2;CCND2;ACTB;CCND1;CCNT1;CDK7
prerank,glycosaminoglycan catabolic process (GO:0006027),0.2924646362666886,0.7677658779197072,0.7899484536082474,1.0,1.0,5/55,6.10%,SDC2;CSPG4;BGN;GPC4;OGN
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.31708028783395126,-0.7677360991531351,0.7572383073496659,0.9480188269753906,1.0,5/11,28.82%,ARRB1;GRK2;GTF2H2;ADM;ADRB2
prerank,regulation of cell size (GO:0008361),-0.2635625184846951,-0.7671656667256541,0.7802547770700637,0.9480855064319971,1.0,4/23,8.39%,DEPTOR;PRR16;VAV2;RDX
prerank,snRNA processing (GO:0016180),-0.2879618355336703,-0.7670625672395848,0.7801932367149759,0.9474368228927664,1.0,6/16,28.61%,INTS6;INTS3;INTS2;INTS11;INTS14;TOE1
prerank,primary neural tube formation (GO:0014020),0.3146853130221021,0.7669946463220436,0.7492997198879552,1.0,1.0,3/30,9.27%,DLC1;TGFB2;SKI
prerank,GPI anchor biosynthetic process (GO:0006506),0.3193709255182177,0.7668224451232246,0.7715959004392386,1.0,1.0,12/30,23.15%,PIGN;PIGA;PIGH;PIGB;PIGP;DPM2;PGAP4;PIGK;PIGZ;GPAA1;PIGM;PIGS
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.3610528088907492,0.7664493116530618,0.7028862478777589,1.0,1.0,2/15,11.25%,PLA2G3;ABCG1
prerank,acyl-CoA metabolic process (GO:0006637),-0.23920250192590717,-0.7663877780836776,0.8552188552188552,0.9476389761241988,1.0,6/35,11.67%,SUCLG2;ACSF2;HMGCS2;ACOT8;DBI;ACOT9
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.34393520557096335,0.7663528754736395,0.7265372168284789,1.0,1.0,3/18,8.74%,MEF2C;ITGA4;ADAM17
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.37332955606018486,0.7659867264924538,0.7092198581560284,1.0,1.0,2/13,8.97%,CABP1;NUP153
prerank,stem cell development (GO:0048864),0.36338960476579757,0.7658551726051263,0.7422512234910277,1.0,1.0,3/16,8.81%,TAPT1;SNAI2;CDH2
prerank,nucleotide biosynthetic process (GO:0009165),0.3549445184280643,0.7654659804623084,0.7520259319286872,1.0,1.0,3/18,12.18%,NMNAT2;PPAT;NMNAT1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.28239564388197896,0.7650753875299362,0.7764565992865636,1.0,1.0,17/76,16.34%,KLHL40;SOCS5;PABIR1;GABARAP;TAF1;FBXW7;RNF180;SIRT2;CLU;BAG2;LRRK2;CSNK1E;DVL1;CSNK1A1;PTEN;HSPBP1;SMURF1
prerank,regulation of macrophage differentiation (GO:0045649),-0.28804397021325384,-0.7649718328260838,0.7894736842105263,0.9489050308688741,1.0,4/15,25.00%,CASP8;HSF1;PTPN2;C1QC
prerank,cellular response to amyloid-beta (GO:1904646),0.3072771170314855,0.7647989636053696,0.7635605006954103,1.0,1.0,2/35,1.65%,CACNA2D1;CD36
prerank,regulation of postsynapse organization (GO:0099175),0.32447123367815583,0.7642084679722893,0.76,1.0,1.0,8/28,16.38%,PDLIM5;KIF1A;ABHD17B;IL1RAPL1;HOMER1;LRRK2;LZTS3;VPS35
prerank,DNA geometric change (GO:0032392),-0.2597658853509079,-0.7636039649589534,0.8296703296703297,0.9500995822653265,1.0,5/24,12.85%,HMGB1;MRE11;RAD50;BLM;NBN
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.27611380805120633,0.7633403372213512,0.7992916174734357,1.0,1.0,14/87,14.60%,FGF1;POLR2L;POLR2I;NR4A1;CCL5;POLR2G;FLRT1;GALNT3;ZFP36L1;POLR2J;FGF10;MAPK1;RAB14;HYAL1
prerank,positive regulation of cell death (GO:0010942),0.2828770842242054,0.7628770234812838,0.7888198757763976,1.0,1.0,5/59,7.34%,MAP3K5;CD36;MAPT;CELF1;HEBP2
prerank,cellular biogenic amine catabolic process (GO:0042402),0.3763651854579706,0.7627803493122777,0.6907775768535263,1.0,1.0,3/10,13.69%,SLC44A1;SARDH;COMT
prerank,lymphocyte chemotaxis (GO:0048247),0.3127703539615341,0.7627131574403527,0.7561327561327561,1.0,1.0,6/34,18.76%,CYP7B1;CCL5;CCL14;GAS6;CCL25;CCL19
prerank,phospholipid metabolic process (GO:0006644),0.27697839255583834,0.7626703797880279,0.7963190184049079,1.0,1.0,11/71,15.20%,PLA2G3;PIP4K2A;LPL;PLPPR1;AGPAT3;PLCD1;PCYT2;PLB1;PNPLA3;PLA2G4A;PLA2G4C
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3030477037285636,0.7624953060689651,0.7455295735900963,1.0,1.0,10/38,18.00%,FZD5;SAE1;FBXW7;SREBF2;HPS4;LRRK2;LEPROT;ATG13;USP36;TOMM7
prerank,monoacylglycerol metabolic process (GO:0046462),0.36808990339553405,0.7622583284625092,0.7323232323232324,1.0,1.0,4/13,18.81%,MGLL;DGAT1;PLA2G4A;FAAH
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.3163463952482297,0.7610469570250951,0.7411242603550295,1.0,1.0,3/31,6.56%,PMAIP1;BCL2;TP53
prerank,maturation of 5.8S rRNA (GO:0000460),-0.2810345297812309,-0.7609850462037959,0.7907542579075426,0.9531543865501982,1.0,4/17,13.07%,NSA2;PRKDC;C1D;URB1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.28124473175959197,0.7606229861268621,0.7889570552147239,1.0,1.0,8/68,9.42%,CAVIN1;POLR2L;GTF2H4;WDR33;PCF11;PAPOLA;POLR1E;CDK7
prerank,positive regulation of cell cycle (GO:0045787),0.2879294134228552,0.7601450881517163,0.7832512315270936,1.0,1.0,15/62,15.30%,PDGFB;CCND2;EIF4EBP1;USP2;DUSP3;CHEK1;TGFB2;CCND1;ADAM17;PKN2;CITED2;EIF4E;MAPRE3;PRKCA;SRPK2
prerank,energy reserve metabolic process (GO:0006112),0.33972951647483246,0.7597264611023257,0.739344262295082,1.0,1.0,2/19,4.83%,PYGM;GFPT1
prerank,tube closure (GO:0060606),0.3121511132815116,0.758730384703005,0.7457865168539326,1.0,1.0,3/31,9.27%,DLC1;TGFB2;SKI
prerank,peroxisomal membrane transport (GO:0015919),-0.24773906439106042,-0.7586255954633248,0.8485804416403786,0.9557816180660592,1.0,9/27,21.45%,PEX14;SLC25A17;ALDH3A2;PEX5;ACBD5;ABCD3;FIS1;PXMP2;PEX13
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.29620707771993515,0.7585525785404521,0.7645569620253164,1.0,1.0,8/45,15.25%,CAMK2G;CAMK2D;TRIM68;PRKCD;GBP2;OASL;STAT1;JAK2
prerank,protein-containing complex assembly (GO:0065003),0.2524560483494814,0.7582549570104617,0.8817533129459735,1.0,1.0,34/259,13.04%,DMD;TCAP;PDE4DIP;FERMT2;ANO6;SH3BGR;TBC1D20;SKAP2;CNIH2;TERT;AFG3L2;TP53;LAMC1;YAP1;AREG;ADD2;PPARGC1A;MDN1;OPA1;SOX9;KMT2D;SEC13;AMER1;MAGI1;TEAD1;DNM1L;KIFAP3;BOK;RUVBL1;NSF;SNX9;SEC24A;DMTN;KPNA3
prerank,response to growth factor (GO:0070848),0.29739229758909225,0.7577644972832978,0.7716955941255007,1.0,1.0,12/41,19.65%,PDGFB;ACVR2A;BMPR1A;EPHA2;ACVR1B;BMPR1B;CPNE3;URI1;NOS1;HDAC6;ACVR1;SHC1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.32097403731102236,0.7576617937290515,0.7288888888888889,1.0,1.0,6/27,12.50%,CPA4;NAT8;MSL3;KAT7;RUVBL1;MORF4L1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.29680660684022797,-0.7572616791672607,0.7975903614457831,0.9570025637050025,1.0,2/13,8.92%,PID1;NOS3
prerank,regulation of chromatin binding (GO:0035561),-0.32176133260121836,-0.7568870597264089,0.7644444444444445,0.9567710515521584,1.0,4/10,18.22%,BTAF1;MED25;DTX3L;KDM4D
prerank,erythrocyte development (GO:0048821),0.3837068939086255,0.7567981895733522,0.7148217636022514,1.0,1.0,3/10,12.92%,MED1;ZBTB7A;DMTN
prerank,prostaglandin biosynthetic process (GO:0001516),0.34060251944914893,0.7566371455222687,0.7244224422442245,1.0,1.0,5/18,17.43%,PTGIS;TBXAS1;CBR1;PLA2G4A;MIF
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.3304339005013983,-0.7564131841816815,0.8018867924528302,0.9566752107650063,1.0,2/10,5.50%,LGALS9;CD55
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.3151231142221434,-0.7562575611448403,0.7855579868708972,0.9553277160754107,1.0,3/11,16.28%,CCT8;CCT4;LARP7
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.3151231142221434,-0.7562575611448403,0.7855579868708972,0.9553277160754107,1.0,3/11,16.28%,CCT8;CCT4;LARP7
prerank,histone deacetylation (GO:0016575),0.2938419780796251,0.7562442409044194,0.7486486486486487,1.0,1.0,15/43,19.91%,HDAC9;SFPQ;MSL3;MTA3;SIRT2;MIDEAS;BAZ2A;MORF4L1;MTA1;SIN3A;SIRT6;HDAC1;RBM14;HDAC6;SMARCAD1
prerank,L-amino acid transport (GO:0015807),-0.24984353345824345,-0.7561077372450742,0.865625,0.9547566135175659,1.0,13/28,32.82%,SLC1A3;SLC3A2;SLC7A5;CTNS;SLC38A5;SLC1A4;SLC36A1;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6;PRAF2
prerank,positive regulation of neuron migration (GO:2001224),0.3690718584615065,0.7560741874337154,0.730072463768116,1.0,1.0,3/11,12.64%,ARHGEF2;DAB2IP;KIF20B
prerank,response to sterol (GO:0036314),0.37071586559494824,0.7558303191565618,0.7232142857142857,1.0,1.0,1/11,2.36%,RORA
prerank,cilium organization (GO:0044782),0.25048246839629107,0.7555194914811578,0.8644421272158499,1.0,1.0,21/209,11.73%,FLNA;DYNLL1;KIF27;PLA2G3;EHD2;ARMC2;CEP41;KIF3B;ACTR3;CEP290;IFT43;IFT81;PIBF1;BBIP1;IQCB1;PARVA;EXOC6;RAB11FIP3;FHDC1;KIFAP3;STK36
prerank,translational elongation (GO:0006414),0.26903110427478105,0.7554628778572531,0.8033898305084746,1.0,1.0,27/101,19.16%,EEFSEC;MRPL36;MRPS31;MRPL13;MRPL30;MRPL43;MRPS35;MRPS28;MRPL51;MRPL45;GFM2;MRPL21;MRPL23;MRPL16;MRPL47;MRPL9;TSFM;EEF2K;MRPL42;GTPBP2;MRPL14;MRPL4;MRPS21;EEF2;MRPL40;MRPL22;MRPL50
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.3431021521158056,0.755446535508987,0.7266775777414075,1.0,1.0,2/16,6.96%,FGF1;GDNF
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.30333201507208457,0.7552601072175014,0.7594086021505376,1.0,1.0,5/38,6.67%,PDGFB;DOK7;RAP2C;CAV1;PTPN1
prerank,DNA methylation (GO:0006306),-0.2556337797671593,-0.7552080189554251,0.8160919540229885,0.9552292747407365,1.0,13/23,45.54%,KMT2E;PPM1D;PICK1;TEX15;ZFP57;ATRX;BEND3;DNMT3B;EHMT2;DMAP1;ATF7IP;EHMT1;FOS
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.24880693751663113,0.7549681002305175,0.8981670061099797,1.0,1.0,58/264,16.45%,LSM8;POLR2L;POLR2I;HNRNPR;CWC25;RAVER2;DDX23;WDR33;PCF11;SF3B5;POLR2G;U2AF2;TXNL4A;SFPQ;CLNS1A;SF3B3;SRSF4;PAPOLA;SNRPN;GPKOW;FUS;PRMT7;PPIL1;PPIE;ZMAT5;RBM19;DHX8;U2AF1;RBM8A;HNRNPU;DDX1;SRSF10;PRPF4;SF3A3;RBM6;HNRNPC;PSPC1;TGS1;SRRM1;SF3B2;SF3B1;ZCRB1;POLR2J;SYNCRIP;PPWD1;PDCD7;CWC22;SNRPB2;SRPK2;PPIL3;RBM15;RBM41;SF1;PUF60;SF3A1;FIP1L1;XAB2;WBP4
prerank,neuron projection development (GO:0031175),0.25556677435855535,0.7548059477266192,0.8439181916038752,1.0,1.0,30/168,15.61%,NTF3;ROCK1;FRY;PLXNB1;DOCK10;BTG2;MAPT;DAB2IP;GDNF;HDGFL3;NEDD4;DICER1;ERCC6;ATCAY;SAMD14;RB1;TNIK;PACSIN1;TAOK3;KIF20B;LRRK2;MAP4;SGK1;EPHB1;ANKRD27;STMN2;PPP1R9A;CNTNAP1;PTEN;DNM2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.2757676094122465,0.75474883770004,0.815035799522673,1.0,1.0,16/74,16.77%,LIMD1;CUL2;PSMC6;ELOC;VEGFA;HIF1A;PSME4;SIRT2;PSMB1;PSMD5;PSMB2;CITED2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,protein targeting (GO:0006605),0.26257575903357055,0.7545715355570923,0.8156108597285068,1.0,1.0,37/118,22.19%,AKAP6;ZFAND2B;GOLGA7B;NACA;GABARAP;ZDHHC2;TRAK1;ZDHHC1;ZDHHC14;PEX19;LONP2;MFN2;ZFAND6;HPS4;AP1S3;TOMM5;AP4E1;ZDHHC4;BCAP31;TOMM7;MFF;ZDHHC3;RTP4;VPS37A;SRP14;SPCS3;PEX1;PARD3;LAMP2;MYO1C;CACNG3;TIMM9;TIMM22;SEC61G;GDAP1;PIKFYVE;TOMM22
prerank,icosanoid secretion (GO:0032309),0.3585352570504599,0.754446878595996,0.7110332749562172,1.0,1.0,1/12,2.73%,ANXA1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3273425905036832,0.754378034556067,0.7472527472527473,1.0,1.0,1/22,1.44%,ROCK1
prerank,axonal transport (GO:0098930),0.3010099100779632,0.7535961588059064,0.7697547683923706,1.0,1.0,10/36,17.60%,KIF3B;DST;KIF1A;MAPT;OPA1;HIF1A;FBXW11;AP3B2;BLOC1S5;DCTN1
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.2766236045083255,-0.7533592077897575,0.7705382436260623,0.9570910745013883,1.0,3/17,6.84%,PID1;NUPR1;HDAC4
prerank,electron transport chain (GO:0022900),0.3441458831111387,0.7531286368332317,0.7385159010600707,1.0,1.0,5/15,16.32%,PPARGC1A;ETFA;SDHA;ENOX2;UQCRFS1
prerank,membrane raft organization (GO:0031579),0.3458193349625682,0.7524263823698123,0.724561403508772,1.0,1.0,5/15,15.49%,FA2H;YJEFN3;NAXE;RFTN1;FLOT1
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.2355247946411102,-0.7523154741216815,0.8590163934426229,0.9577334110530625,1.0,14/33,28.33%,PABPN1;SLBP;SETX;MAZ;NCBP2;CPSF2;SCAF8;SSU72;CSTF2T;CPSF4;CSTF2;CPSF1;LSM11;CLP1
prerank,response to steroid hormone (GO:0048545),0.3085441272257971,0.7522883464664337,0.7626112759643917,1.0,1.0,6/31,7.78%,TGFB3;CAV1;YAP1;AR;MED1;TGFB2
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.29296324951990454,0.752083107833861,0.8033854166666666,1.0,1.0,6/56,7.55%,CD36;MYD88;CD14;MAPKAPK2;TRAF3;TIFA
prerank,regulation of protein targeting to membrane (GO:0090313),0.310613811089273,0.7519387214725411,0.7441176470588236,1.0,1.0,10/28,22.61%,KCNB1;MIEF2;MIEF1;DMTN;MTCL1;SLC51B;MFF;MYO1C;ERBB2;PDZK1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.31078122518624474,0.7514964802248892,0.7669172932330827,1.0,1.0,3/31,4.64%,CDK6;FHL1;JADE1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.3462858619659971,0.7513694929628689,0.7248764415156508,1.0,1.0,3/15,7.85%,VEGFA;GDNF;SOX9
prerank,regulation of microtubule polymerization (GO:0031113),0.2999351613277646,0.7512582918490134,0.79750346740638,1.0,1.0,12/40,19.35%,PRUNE1;DYRK1A;MAPT;TOGARAM1;TBCD;CLIP3;CLASP1;STMN2;MAPRE3;DCTN1;ABL1;CAMSAP1
prerank,regulation of cellular response to stress (GO:0080135),0.2613012831190103,0.7504952377100684,0.834983498349835,1.0,1.0,21/115,14.44%,CAMK2G;CAMK2D;NUP62;ALOX5;SLC38A2;MAPT;MAPKAPK2;NUAK1;SEC13;NUP153;BAG3;AMFR;NUP107;AAAS;ROCK2;ATF3;BAG2;NUP37;MAPK1;NUP98;MCL1
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.2338412000682298,-0.750402436686736,0.8491803278688524,0.9595503941001335,1.0,10/30,22.63%,LBR;GGPS1;CYP51A1;HMGCR;ACLY;ARV1;INSIG1;SQLE;PMVK;LSS
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.29158541197567917,0.7498584113206193,0.7808398950131233,1.0,1.0,6/46,9.18%,CNN2;LCP1;IL12RB2;IL12RB1;PLCB1;PAK2
prerank,sensory perception (GO:0007600),0.29141786365519057,0.749781988701179,0.7802197802197802,1.0,1.0,5/45,12.41%,ASIC3;TRPV2;NTSR2;KCNA2;CHRNA7
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.3179339547480402,-0.7495314971658446,0.8101545253863135,0.9599604952653684,1.0,6/11,36.07%,UQCRC1;UQCRC2;UQCR11;CYC1;UQCC3;CYCS
prerank,inositol lipid-mediated signaling (GO:0048017),0.29215356440115126,0.7495114560780896,0.7806122448979592,1.0,1.0,8/50,9.69%,PLCE1;PLCB4;PLCL1;KCNH1;IRS1;PLCB1;PLCD1;PDGFRB
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.30341696127520545,0.7493336702179024,0.7729196050775741,1.0,1.0,6/33,8.74%,CCND2;ANXA1;FAM83D;PLCB1;CCND1;ADAM17
prerank,adrenergic receptor signaling pathway (GO:0071875),0.32314321880459285,0.7489540006301141,0.7421875,1.0,1.0,2/20,3.84%,ADRA1D;ADCY9
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.21491289479688191,-0.7482568196851412,0.9111111111111111,0.9609128487123537,1.0,5/49,5.41%,HMGB1;LBP;F3;NOD1;LGALS9
prerank,mRNA processing (GO:0006397),0.24500130162403647,0.7479197447749147,0.9014227642276422,1.0,1.0,62/287,16.45%,LSM8;POLR2L;POLR2I;HNRNPR;CWC25;RAVER2;GTF2H4;DDX23;WDR33;PCF11;SF3B5;POLR2G;U2AF2;TXNL4A;SFPQ;CELF1;PPARGC1A;SF3B3;SRSF4;PAPOLA;PRPF18;SNRPN;GPKOW;FUS;PPIL1;PPIE;ZMAT5;ZC3H11A;CDK7;RBM19;DHX8;U2AF1;RBM8A;HNRNPU;SRSF10;PRPF4;THOC7;SF3A3;RBM6;HNRNPC;PSPC1;SRRM1;SF3B2;SF3B1;ZCRB1;POLR2J;SYNCRIP;SON;PPWD1;PDCD7;CWC22;SNRPB2;PRKACA;PPIL3;RBM15;RBM41;SF1;PUF60;SF3A1;FIP1L1;XAB2;WBP4
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.35122394457253975,0.7475979578349534,0.7288135593220338,1.0,1.0,6/13,19.87%,ALOX5;LPCAT3;CLU;EIF2AK3;NR1H3;WFS1
prerank,canonical Wnt signaling pathway (GO:0060070),0.2776555428396645,0.7474281442067396,0.8070388349514563,1.0,1.0,18/68,17.70%,FZD5;FZD4;FZD8;CAV1;FZD9;AMER1;PPP1CA;NR4A2;SCYL2;LRP5;LRRK2;CSNK1E;DVL1;CSNK1A1;PTEN;RYK;WNT5B;TCF7
prerank,sister chromatid segregation (GO:0000819),0.3078021048052386,0.7473917285225689,0.7669491525423728,1.0,1.0,9/31,17.49%,ZWINT;WRAP73;TOP2B;RB1;KIF18A;KNSTRN;INO80;DSN1;CENPK
prerank,regulation of mRNA catabolic process (GO:0061013),0.26161405085489986,0.7469318499335966,0.8110497237569061,1.0,1.0,23/121,16.79%,RBM24;VIM;SAMD4A;PARN;SET;UPF1;PSMC6;MAPKAPK2;YTHDF2;PSME4;PSMB1;PSMD5;PRKCD;DCP1A;CNOT7;ZFP36L1;PSMB2;PSMB7;PSMD3;PRKCA;PSMA2;PSMD14;XPO1
prerank,replicative senescence (GO:0090399),0.36046340882870453,0.746838035730142,0.7200704225352113,1.0,1.0,3/12,7.68%,TERT;TP53;CHEK1
prerank,positive regulation of translational initiation (GO:0045948),0.33379667628067927,0.7460669469170367,0.7491803278688525,1.0,1.0,3/18,6.93%,CCL5;POLR2G;YTHDF2
prerank,cholesterol biosynthetic process (GO:0006695),-0.23077489982118637,-0.7460459145592434,0.85,0.9632140446825664,1.0,16/31,35.57%,LBR;GGPS1;CYP51A1;HMGCR;ACLY;ARV1;INSIG1;SQLE;PMVK;LSS;MVK;INSIG2;EBP;SC5D;TM7SF2;DHCR7
prerank,mitochondrial translational termination (GO:0070126),0.26771144612310566,0.7456343287255237,0.8142523364485982,1.0,1.0,28/88,22.19%,MRPL36;MRPS31;MRPL13;MRPL30;MRPL43;MRPS35;MRPS28;MRPL51;MRPL45;GFM2;MRPL21;MRPL23;MRPL16;MRPL47;MRPL9;MRPL42;MRPL14;MRPL4;MRPS21;MRPL40;MRPL22;MRPL50;MRPS14;MRRF;OXA1L;MRPL24;MRPS12;MRPS10
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.278838281354855,0.7451140950475014,0.7943805874840357,1.0,1.0,3/57,2.86%,MAP3K5;PMAIP1;ASPH
prerank,sensory perception of light stimulus (GO:0050953),0.2633229438572144,0.7449824545160816,0.8186101295641932,1.0,1.0,4/87,4.90%,COL18A1;CABP1;CRYZ;DHRS3
prerank,negative regulation of potassium ion transport (GO:0043267),-0.29935426452986313,-0.7445788731210564,0.7952380952380952,0.9643328646628174,1.0,2/13,5.61%,NEDD4L;PTK2B
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.2501716743295808,-0.7444282560326285,0.8488372093023255,0.9637393098357474,1.0,9/26,24.19%,SULF1;CCBE1;CYP1B1;TGFB1;PTGS2;ARNT;ATF4;FLT4;SULF2
prerank,histone H3 deacetylation (GO:0070932),0.3451927007151137,0.7443820250828184,0.7442244224422442,1.0,1.0,6/15,19.91%,HDAC9;SFPQ;SIRT2;SIRT6;HDAC1;SMARCAD1
prerank,ceramide transport (GO:0035627),-0.3089572802170597,-0.7442329143018955,0.8089887640449438,0.9631968007092224,1.0,6/12,22.41%,PLTP;CERT1;SGPP1;PLEKHA3;PSAP;ABCA2
prerank,positive regulation of phagocytosis (GO:0050766),0.2905592452556016,0.744205834370076,0.81877444589309,1.0,1.0,3/47,5.36%,MERTK;ANO6;MYO18A
prerank,protein import into nucleus (GO:0006606),0.2695767417476007,0.7437234125959286,0.7937649880095923,1.0,1.0,24/66,21.00%,NUP62;KPNA4;RANBP17;SPRN;SEC13;NUP153;PPP1R10;NUP107;RANBP6;KPNA2;KPNA3;TNPO3;FAM53B;CBLB;IPO4;STAT3;IPO7;FAM53C;NUP54;NUP133;PHB2;IPO9;TPR;HIKESHI
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.31985388124268777,-0.7433085942802932,0.8078703703703703,0.9636740453376684,1.0,1/10,4.03%,LPGAT1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.31991467284587655,0.7430571982860119,0.7492401215805471,1.0,1.0,3/24,6.47%,TTLL7;CEP41;PARP1
prerank,inorganic anion transport (GO:0015698),0.27851679540319585,0.742780834579946,0.7849872773536896,1.0,1.0,6/53,9.16%,ANO1;ANO6;CLCN6;TTYH1;ANO10;XPR1
prerank,protein stabilization (GO:0050821),0.2528777678927696,0.7425862088243191,0.8795309168443497,1.0,1.0,28/168,14.32%,FLNA;HIP1;CRTAP;TSPAN1;USP2;TESC;ATP1B1;TAF1;FBXW7;PIN1;PPARGC1A;CDK7;BAG3;PARVA;RPL5;STX12;PEX19;CCT3;PRKCD;USP13;TMEM88;CLU;PDCD10;HPS4;BAG2;MUL1;GNAQ;DVL1
prerank,clathrin coat assembly (GO:0048268),0.3396255024158606,0.7424189154656082,0.7466216216216216,1.0,1.0,1/15,1.88%,HIP1
prerank,anterograde axonal transport (GO:0008089),0.30181248078311823,0.742418715329366,0.7921348314606742,1.0,1.0,10/37,17.77%,KIF3B;KIF1A;KIF5B;TRAK1;KIF1C;KIF5C;KIF5A;AP3B2;BLOC1S5;MAP1A
prerank,negative regulation of programmed cell death (GO:0043069),0.24469401983951095,0.7415594800055887,0.9223697650663942,1.0,1.0,36/355,10.00%,FLNA;NAA38;NR1H4;ANGPT1;MYD88;ANGPT4;TCIM;CCND2;ANXA1;IL2;NUP62;ARHGAP10;FXN;BCL2;ATAD3A;MYO18A;MTDH;VEGFA;TP53;GDNF;PA2G4;MED1;BCL2L2;OPA1;NAT8;SOX9;RELA;API5;CBX4;VDAC1;TNFAIP8;GSTP1;PAK2;BAG3;AXL;FAIM2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.26812272133817977,0.7411412706136812,0.8277982779827798,1.0,1.0,18/70,17.33%,SORT1;BCL2;GABARAP;DAB2IP;BCL2L2;TGFB2;BAG3;DEDD2;CASP8AP2;ACVR1B;BOK;DIABLO;DEDD;TNFRSF10B;MCL1;JAK2;FGFR3;TNFSF12
prerank,peptidyl-methionine modification (GO:0018206),0.3613962922254855,0.7409847379360298,0.7395104895104895,1.0,1.0,2/12,8.23%,NAA25;NAA20
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.28151651676653183,-0.7408543453078786,0.8311688311688312,0.9662413558502068,1.0,7/15,26.73%,RNF213;SFRP4;GPC3;RSPO3;DACT1;ZNRF3;TIAM1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.3219250218360786,0.7407929044514572,0.7686567164179104,1.0,1.0,1/23,1.51%,PMAIP1
prerank,glycolipid biosynthetic process (GO:0009247),0.29508170973550796,0.7404772395607039,0.7947295423023578,1.0,1.0,10/38,16.95%,LARGE1;PIGN;PIGA;ST8SIA5;A4GALT;ST3GAL2;PIGH;PIGB;PIGP;DPM2
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2640652384372729,0.7402010594028313,0.8352668213457076,1.0,1.0,18/91,16.37%,HIP1;PLA2G3;CDH13;PACSIN3;PACSIN2;PTPN1;RAB3A;DENND10;MAP2K1;MBTPS1;NSF;PACSIN1;LRRK2;MAPK1;RAB8B;SNX17;STON1;RAB8A
prerank,positive regulation of protein metabolic process (GO:0051247),0.2558892606246853,0.7401537539275586,0.8372615039281706,1.0,1.0,7/110,7.48%,AGTR1;NKD1;OAZ2;ATG7;DAB2IP;NEDD4;RASGRP1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.2605476984538337,0.7398825577027386,0.8248259860788864,1.0,1.0,35/94,23.65%,DYNLL1;CEP41;HAUS8;CEP290;RPGRIP1L;IQCB1;CEP192;DYNC1I2;C2CD3;NEDD1;CEP72;CLASP1;DCTN3;CEP43;CSNK1E;HAUS7;HAUS2;PRKACA;PLK4;DCTN1;HAUS4;CEP135;ACTR1A;CKAP5;SFI1;MAPRE1;ODF2;NPHP4;PPP2R1A;NINL;YWHAG;TUBA4A;CEP63;NDE1;AHI1
prerank,cellular response to insulin stimulus (GO:0032869),0.2542765226301895,0.7397130672306229,0.8391061452513966,1.0,1.0,23/124,16.37%,SLC2A4;PDK4;BCAR3;HDAC9;RARRES2;ATP6V1H;IRS1;CPEB1;ATP6V0A2;PARP1;SORBS1;GOT1;SLC39A14;ATP6V1C1;ZFP36L1;ATP6V0D2;PDK2;EPRS1;RAB8B;IRS2;CAV2;NAMPT;RAB8A
prerank,regulation of immune effector process (GO:0002697),-0.2189232577858354,-0.7393974939344008,0.9024390243902439,0.9673915299751739,1.0,11/41,27.73%,VTN;PROS1;CD55;CD46;SERPING1;C1QB;CR1L;C1QC;C1QA;CFHR2;C2
prerank,cilium assembly (GO:0060271),0.24078884404140413,0.7389850506139276,0.9110212335692619,1.0,1.0,47/296,16.42%,FLNA;DYNLL1;KIF27;PLA2G3;EHD2;CEP41;HAUS8;DYNLRB1;RSPH1;KIF3B;ACTR3;TBC1D32;CEP290;IFT43;RPGRIP1L;IFT81;PIBF1;TOGARAM1;BBIP1;IQCB1;PARVA;CEP192;EXOC6;RAB11FIP3;DYNC1I2;FHDC1;KIFAP3;STK36;C2CD3;NEDD1;CEP72;CLASP1;SPATA6;DCTN3;CEP43;FOXJ1;CSNK1E;TTC39C;HAUS7;HAUS2;RAB8B;PRKACA;CCDC66;RFX3;CFAP43;RAB8A;PLK4
prerank,indolalkylamine catabolic process (GO:0046218),0.3668172412741235,0.7389358361514605,0.7472727272727273,1.0,1.0,1/10,6.81%,KMO
prerank,negative regulation of DNA replication (GO:0008156),-0.29187918977983834,-0.7387437389508836,0.8104265402843602,0.9674457219744349,1.0,3/13,14.85%,ATR;PDS5A;TSPYL2
prerank,arachidonic acid metabolic process (GO:0019369),0.29679960698403884,0.7384997593847316,0.788135593220339,1.0,1.0,8/35,16.62%,PTGIS;ALOX5;TBXAS1;CBR1;MGLL;PLA2G4A;PLA2G4C;EPHX1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2661050380633109,-0.7380679108584214,0.8146067415730337,0.9675285937746111,1.0,11/20,38.27%,GATM;PTDSS2;PLOD2;MTHFS;FPGS;GCLC;GCLM;PTDSS1;GAMT;PLSCR1;GGT1
prerank,mammary gland epithelium development (GO:0061180),-0.2897170352690412,-0.7374314578972574,0.8245192307692307,0.9675404257884407,1.0,1/14,1.09%,WNT4
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.2741091539697152,-0.7370805373354411,0.8405405405405405,0.9672142822991698,1.0,7/17,30.00%,UBQLN1;AKT1;P4HB;MAPK7;BAG5;HTRA2;PPIA
prerank,negative regulation of cellular catabolic process (GO:0031330),0.27501924142856427,0.7370482938690265,0.8067754077791719,1.0,1.0,14/63,16.79%,ROCK1;BCL2;IL10RA;DAB2IP;TIMP4;WASHC1;SIRT2;HTR2B;MCL1;EIF4E;EIF4G2;STAT3;MT3;WDR6
prerank,glycoprotein catabolic process (GO:0006516),-0.27465825400470434,-0.7368626801871783,0.8138957816377171,0.9667212660475569,1.0,6/17,27.61%,NGLY1;CTSL;ADAMTS9;FBXO17;STT3B;FBXO44
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.30453238370918134,-0.736741587825425,0.7873831775700935,0.9660809017906149,1.0,1/11,3.90%,LDLR
prerank,phagosome acidification (GO:0090383),0.3135066485941933,0.7367373285587908,0.7858197932053176,1.0,1.0,12/26,25.85%,ATP6V1H;ATP6V0A2;ATP6V1C1;ATP6V0D2;RAB38;ATP6V0C;ATP6V1F;ATP6V0E1;ATP6V1B2;RAB7A;ATP6V1G2;ATP6V0A1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.240031462976121,0.7365961260815292,0.977977977977978,1.0,1.0,54/532,10.84%,CAMK2G;LIFR;ACTN4;CD36;LIMS1;LAMA5;MYD88;PDGFB;RORA;CNN2;VIM;ANXA1;CRLF1;GREM2;SOCS5;LCP1;CAMK2D;IL2;TNFSF13B;CCL5;ITGB1;IL12RB2;ALOX5;BCL2;SOCS6;IL10RA;IRS1;TNFRSF11A;PSMC6;VEGFA;TP53;IL12RB1;YAP1;TRAF3;IL22;RELA;PLCB1;TRIM68;CCND1;ADAM17;PAK2;SLA;INPPL1;EDAR;HIF1A;PSME4;TRAF5;PSMB1;IL13RA1;PELI2;CCL14;PSMD5;VAV1;EIF5A
prerank,regulation of mitotic nuclear division (GO:0007088),0.28087735280348575,0.7363393584510161,0.8262548262548263,1.0,1.0,12/55,15.86%,PDGFB;NUP62;PIN1;CUL9;CHEK1;DAPK3;TOM1L2;PDGFRB;LRP5;KIF20B;FBXO5;CAV2
prerank,negative regulation of response to stimulus (GO:0048585),0.2742733107365963,0.7360708332432596,0.8014796547472256,1.0,1.0,18/60,20.51%,CDK6;SOCS5;ALOX5;KLF7;TERT;PTPN1;LPCAT3;COL3A1;TERF2;CLU;FBXO5;NR1H3;ADRA2A;ACVR1;VPS13C;HHIP;WFS1;BRAP
prerank,regulation of viral genome replication (GO:0045069),-0.2047062939095838,-0.7359030342902176,0.9400921658986175,0.9664319600085085,1.0,18/56,25.13%,DDX3X;STAU1;PARP10;PABPC1;DDB1;IFIT1;ADAR;BST2;PPIH;OAS2;IFITM1;IFITM3;SRPK1;SHFL;HACD3;RNASEL;ZC3HAV1;IFITM2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.31779876406980145,0.7349502439984791,0.7762762762762763,1.0,1.0,3/24,7.08%,PLCE1;ACTR3;CYFIP1
prerank,regulation of viral life cycle (GO:1903900),0.32595954710753394,0.7348430906344989,0.7464788732394366,1.0,1.0,5/21,12.13%,TRIM68;AXL;KPNA2;NECTIN2;TSG101
prerank,GPI anchor metabolic process (GO:0006505),0.31261590337562556,0.7346810400522725,0.7890044576523031,1.0,1.0,8/26,21.10%,PIGN;PIGA;PIGH;PIGB;PIGP;DPM2;PGAP4;PIGZ
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3546433880830183,0.734585276328023,0.7530017152658662,1.0,1.0,3/12,8.79%,CBFB;CD300A;RUNX1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.25067396524406654,0.7345193162408674,0.8877118644067796,1.0,1.0,21/161,10.89%,TMEM131L;NKD1;LIMD1;FZD4;RBMS3;JADE1;TBX18;PSMC6;SDHAF2;CAV1;DAB2IP;IGFBP4;SNAI2;SOX9;AMER1;PSME4;AMFR;PSMB1;SCYL2;PSMD5;LMBR1L
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.24416185543052865,-0.7342365341027882,0.8662790697674418,0.9678120977644131,1.0,10/26,32.27%,CUL3;CDC23;DUSP1;ANAPC4;NEK6;NSMCE2;ANAPC15;CDC16;CDC27;RIOK2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.3684100017861963,0.7339865962727183,0.7526881720430108,1.0,1.0,3/10,18.48%,RB1;CLU;EGR1
prerank,positive regulation of catalytic activity (GO:0043085),-0.22102587885490094,-0.7339677002505358,0.9037800687285223,0.9673631066556936,1.0,11/37,20.94%,MAPK14;XRCC5;STX4;IGF2;ABL2;APH1A;NCSTN;CHTOP;PSEN2;MSH6;FGFR4
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2598930419500892,0.7338995854555437,0.8297872340425532,1.0,1.0,20/83,19.14%,CDK6;HINFP;EIF4EBP1;CUL2;CCND1;CDK7;CRLF3;CDK18;GSPT1;RB1;ACVR1B;CDK15;EIF4E;FBXO5;CDK14;BRD4;CUL5;MNAT1;CACUL1;ACVR1
prerank,alpha-amino acid metabolic process (GO:1901605),0.28413579742102907,0.7332144361715436,0.7927321668909825,1.0,1.0,8/45,11.14%,RIMKLA;KMO;NAT8L;GOT1;GOT2;THAP4;GLS;GLS2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3270776440701376,0.733159480381035,0.740916271721959,1.0,1.0,3/20,7.53%,CCL5;RPGRIP1L;PLEK
prerank,lysosome localization (GO:0032418),0.29532204375557536,0.7330931262261627,0.800561797752809,1.0,1.0,4/37,7.56%,MYH9;MILR1;RAB3A;KIF5B
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.26854413747662814,0.7317204744220778,0.830423940149626,1.0,1.0,14/69,16.28%,POLR2L;POLR2I;ELL;POLR2G;TAF8;CCNT1;CDK7;INTS5;POLR2J;INTS12;INTS7;TAF11;SP1;INTS1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.29117694609824313,-0.7315438860504497,0.8210023866348448,0.9697453552135334,1.0,7/13,27.44%,CD44;MDM2;PTTG1IP;KDM1A;YJU2;TWIST1;SNAI1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.28544195849117704,-0.7312947552981739,0.8126520681265207,0.9692698207531677,1.0,5/13,33.55%,PDE8A;PARK7;RACK1;HGF;GPR37
prerank,regulation of cellular protein localization (GO:1903827),0.2834479580407735,0.7312588053330453,0.7799479166666666,1.0,1.0,11/45,15.84%,LCP1;GPC4;MAPT;PARP1;PTPN1;PIN1;CEP72;CSNK1E;DVL1;PRKAA2;CCDC66
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.2620645941042251,0.7311290848590117,0.8394332939787486,1.0,1.0,22/84,15.90%,RBM24;KHDRBS3;U2AF2;CIRBP;CELF1;RBMXL1;SRSF4;MBNL2;RBM8A;MBNL1;HNRNPU;SRSF10;RBM3;ZBTB7A;SON;RBM25;NUP98;CWC22;SRPK2;RBM15;SF1;PUF60
prerank,purine-containing compound biosynthetic process (GO:0072522),0.31753262046515585,0.7308425785840834,0.7693452380952381,1.0,1.0,4/25,13.21%,AMPD1;AMPD2;PPAT;GMPR
prerank,ubiquinone biosynthetic process (GO:0006744),-0.276800556964042,-0.7307711817066093,0.8333333333333334,0.9691460385718094,1.0,3/15,6.39%,COQ10B;COQ5;COQ8B
prerank,rRNA 3'-end processing (GO:0031125),-0.31707231645923595,-0.7302342293750548,0.832967032967033,0.9690490682247561,1.0,6/10,25.16%,ERI3;EXOSC9;RPS21;EXOSC2;EXOSC3;EXOSC7
prerank,toll-like receptor signaling pathway (GO:0002224),0.2669731979850362,0.7300742710068303,0.8384433962264151,1.0,1.0,8/84,8.30%,NR1H4;CD36;MYD88;CD14;PIK3AP1;MAPKAPK2;TRAF3;TNIP1
prerank,regulation of protein localization to membrane (GO:1905475),0.30147531427425955,0.7289635558627143,0.7891737891737892,1.0,1.0,5/28,7.20%,SLC5A3;ACTB;GPC4;ZDHHC2;AR
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.28831643964913906,0.7287056248166616,0.7970627503337784,1.0,1.0,6/43,6.68%,PIP4K2A;KANK1;PRKCQ;IRS1;PTPN1;SORBS1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.3332133000283152,0.7282913241688671,0.7632027257240205,1.0,1.0,4/15,17.53%,PPARGC1A;PPARA;MLXIPL;NR1H3
prerank,regulation of secretion (GO:0051046),-0.2895542622191803,-0.7278917587327576,0.8209302325581396,0.9711458877447084,1.0,4/13,18.25%,ACSL3;MYO6;OAS2;KCNQ1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.3086716726810266,0.7277582901556263,0.7846153846153846,1.0,1.0,7/25,15.58%,ACVR2A;MED1;ANKRD54;HIF1A;ACVR1B;STAT1;STAT3
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.3430113808023265,0.7276157490489462,0.7525083612040134,1.0,1.0,3/14,11.87%,MYD88;MAPKAPK2;HNRNPC
prerank,t-circle formation (GO:0090656),-0.3180053275865933,-0.7273162795214049,0.8272727272727273,0.9695333431223673,1.0,5/10,28.01%,BLM;NBN;SMARCAL1;ERCC1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.3180053275865933,-0.7273162795214049,0.8272727272727273,0.9695333431223673,1.0,5/10,28.01%,BLM;NBN;SMARCAL1;ERCC1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.3180053275865933,-0.7273162795214049,0.8272727272727273,0.9695333431223673,1.0,5/10,28.01%,BLM;NBN;SMARCAL1;ERCC1;DNA2
prerank,negative regulation of secretion by cell (GO:1903531),0.2909860935489449,0.7272971154465253,0.7892561983471075,1.0,1.0,5/38,11.41%,HTR1B;ANXA1;DPH3;HRH3;IL1RAPL1
prerank,ATP synthesis coupled proton transport (GO:0015986),0.33791911505494765,0.7268846556396625,0.7923930269413629,1.0,1.0,3/17,11.80%,ATP5MF;ATP5MC1;ATP5MG
prerank,signal peptide processing (GO:0006465),0.3569119007937032,0.7267195183803606,0.7684210526315789,1.0,1.0,1/11,2.24%,CLN5
prerank,negative regulation of myoblast differentiation (GO:0045662),0.3456090341116198,0.7265325773734979,0.7521222410865874,1.0,1.0,2/13,7.85%,ANKRD2;SOX9
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.3421143915187914,0.7264232096698338,0.7869918699186992,1.0,1.0,3/16,11.80%,ATP5MF;ATP5MC1;ATP5MG
prerank,regulation of exocytosis (GO:0017157),0.2799236173007792,0.7262579695726259,0.788787483702738,1.0,1.0,9/46,16.37%,CLASP2;ANXA1;UNC13D;RAB3A;IL1RAPL1;NSF;CLASP1;RAB8B;RAB8A
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.31283721512498586,0.7260858853680707,0.7883435582822086,1.0,1.0,4/23,8.74%,ZEB2;TGFB1I1;SLC2A10;ADAM17
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.31283721512498586,0.7260858853680707,0.7883435582822086,1.0,1.0,4/23,8.74%,ZEB2;TGFB1I1;SLC2A10;ADAM17
prerank,quinone biosynthetic process (GO:1901663),-0.2847294514096531,-0.7260125760801069,0.8677884615384616,0.9703432524980443,1.0,3/14,6.39%,COQ10B;COQ5;COQ8B
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.32508324591963433,0.7257787838810482,0.7917355371900826,1.0,1.0,5/18,13.20%,CLASP2;EMILIN1;RUNX1;RB1;CLASP1
prerank,cytosolic transport (GO:0016482),0.25591827164213,0.7257086638636974,0.8621089223638471,1.0,1.0,27/108,19.25%,MYO1D;CLN5;HOOK2;SORT1;RHOBTB3;VPS26A;EVI5;WASHC1;VPS26B;ANKFY1;HOOK1;AKTIP;PLEKHJ1;PIK3C3;TMEM87A;VPS50;ANKRD27;RAB14;SNX1;SPAG9;VPS35;CORO7;VPS51;DCTN1;CLTC;GAK;VPS13C
prerank,negative regulation of histone modification (GO:0031057),-0.2804760068486417,-0.7250275512170051,0.8292682926829268,0.9707754291686416,1.0,10/14,39.49%,NOC2L;SNCA;TAF7;TWIST1;JARID2;PRMT6;BRCA1;AASS;THAP7;SPHK2
prerank,regulation of cellular senescence (GO:2000772),0.30919000890654996,0.7248412585332521,0.7795620437956204,1.0,1.0,4/28,7.62%,CDK6;CGAS;TERT;NUAK1
prerank,neutral amino acid transport (GO:0015804),0.3103843735849915,0.7247958006619735,0.7829341317365269,1.0,1.0,7/28,14.95%,SLC6A17;SLC38A2;SLC1A5;SLC7A8;SLC6A15;SLC38A1;SLC38A3
prerank,maintenance of protein localization in organelle (GO:0072595),0.3336527047216008,0.7246858308563235,0.7732463295269169,1.0,1.0,4/19,10.43%,HK2;TAPT1;TAF8;HNRNPU
prerank,polarized epithelial cell differentiation (GO:0030859),-0.2829655764773836,-0.7241977070743641,0.8215158924205379,0.9709942771225316,1.0,11/13,51.74%,MYO9A;OPHN1;CDC42;SCRIB;SH3BP1;CAMSAP3;MSN;EZR;SYNE4;RHOA;ZDHHC7
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.26713057955047953,-0.7237991716594357,0.827027027027027,0.9706764281093427,1.0,5/18,22.41%,APOE;RDX;PTTG1IP;DACT1;ABCA2
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.2939559454041097,-0.7236882705901345,0.8356164383561644,0.9700288631994796,1.0,1/12,3.17%,IL18
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.2581766444284992,0.723569841234569,0.8541423570595099,1.0,1.0,27/87,21.86%,NDUFS1;NDUFA2;NDUFA11;SDHAF2;NDUFC1;NDUFB6;NDUFS3;NDUFB8;NDUFV2;NDUFS2;NDUFAB1;SDHAF3;NDUFAF5;NDUFA1;LYRM7;NDUFAF2;UQCRFS1;NDUFAF1;SCO1;NDUFV3;NDUFS4;UQCC2;SLC25A33;COA5;OXA1L;NDUFA3;NDUFAF6
prerank,cellular response to interleukin-1 (GO:0071347),0.24839634311713407,0.7235160451787722,0.8807733619763695,1.0,1.0,31/143,19.05%,MYD88;CCL5;PTGIS;UPF1;HAS2;PSMC6;DAB2IP;SOX9;RELA;PLCB1;NR1D1;HIF1A;PSME4;PSMB1;PELI2;CCL14;PSMD5;FBXW11;GBP2;PSMB2;HYAL1;PSMB7;PSMD3;PSMA2;PSMD14;IL1R1;CCL25;EGR1;CD47;CCL19;RPS27A
prerank,ubiquinone metabolic process (GO:0006743),-0.27793132594446435,-0.7233714375015584,0.8519417475728155,0.9696359396408473,1.0,9/15,33.44%,COQ10B;COQ5;COQ8B;AIFM2;COQ3;FDXR;UBIAD1;COQ6;COQ7
prerank,prostaglandin metabolic process (GO:0006693),0.30279298612864086,0.7228471663301219,0.7654867256637168,1.0,1.0,5/26,14.03%,PTGIS;TBXAS1;GSTP1;PTGR1;PLA2G4A
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.2953197812039428,0.7226842375260818,0.7960057061340942,1.0,1.0,8/31,17.19%,WDR1;LIN7C;RAP2A;MTCL1;PARD3B;ANK1;LIN7A;MARK2
prerank,snRNA transcription (GO:0009301),0.26420616128051916,0.7215066996784115,0.8380716934487021,1.0,1.0,14/70,16.28%,POLR2L;POLR2I;ELL;POLR2G;TAF8;CCNT1;CDK7;INTS5;POLR2J;INTS12;INTS7;TAF11;SP1;INTS1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.2710714293286517,-0.7211915543653393,0.8542713567839196,0.9714281247096455,1.0,5/17,19.35%,EMC2;SGTA;EMC3;EMC8;MMGT1
prerank,protein localization to centrosome (GO:0071539),0.32329903850020014,0.7210467222748329,0.7727272727272727,1.0,1.0,4/17,11.99%,PIBF1;CEP192;C2CD3;NEDD1
prerank,response to tumor necrosis factor (GO:0034612),0.2560698947397409,0.7205060384636564,0.8534278959810875,1.0,1.0,15/91,12.41%,CCL5;ARHGEF2;HAS2;MAP4K3;TNFRSF11A;DAB2IP;RELA;NR1D1;TNFRSF21;CCL14;GPER1;ZFAND6;YTHDC2;ZFP36L1;GBP2
prerank,positive regulation of macrophage migration (GO:1905523),0.33047278931661106,0.720394728690168,0.7788461538461539,1.0,1.0,2/19,5.43%,CCL5;RARRES2
prerank,positive regulation by host of viral transcription (GO:0043923),-0.27089747838350137,-0.7201452804377081,0.83,0.9719025264637059,1.0,6/15,24.74%,LEF1;SNW1;EP300;CHD1;NUCKS1;TFAP4
prerank,positive regulation of interleukin-4 production (GO:0032753),0.3269399821627235,0.719746592072926,0.7922297297297297,1.0,1.0,2/17,5.56%,HAVCR2;PRKCQ
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.26405371994857557,0.7193181190188006,0.8374851720047449,1.0,1.0,19/78,18.32%,KLHL40;SOCS5;PABIR1;GABARAP;TAF1;CAV1;RNF180;SIRT2;CLU;BAG2;LRRK2;CSNK1E;DVL1;CSNK1A1;HSPBP1;SIRT6;BCAP31;PIAS1;RCHY1
prerank,DNA replication initiation (GO:0006270),-0.21493943677607075,-0.7182067435582337,0.9209621993127147,0.9733796577083909,1.0,23/37,42.76%,ORC5;ORC6;POLE4;POLE2;CDK2;CDC7;ORC4;DBF4;POLA2;RPA3;ORC1;CDC34;PRIM1;MCM8;RPA2;CDC45;RPA1;POLE;MCM3;MCM5;POLA1;MCM10;POLE3
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.2866783778728905,-0.7181668651258204,0.8389423076923077,0.9726394887589007,1.0,10/13,49.88%,HES1;MGAT5;EGF;CRLF2;JAK3;PTPRT;PIGU;IL7R;TSLP;DOT1L
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.34899265476566943,0.7179785869756454,0.7768014059753954,1.0,1.0,5/12,20.88%,GGCT;OPLAH;CHAC2;CNDP2;HAGH
prerank,negative regulation of cell aging (GO:0090344),0.33258486316846225,0.7177992725385857,0.7684729064039408,1.0,1.0,5/16,17.43%,CDK6;TERT;TERF2;FBXO5;MIF
prerank,positive regulation of cell cycle process (GO:0090068),0.25014861698937707,0.7173652833172734,0.859608745684695,1.0,1.0,11/91,12.64%,MAP3K20;PDGFB;NUP62;PKN2;PDGFRB;SIRT2;NSFL1C;RHNO1;LRP5;CEP120;KIF20B
prerank,response to amyloid-beta (GO:1904645),0.2737656518432454,0.7173345146088318,0.7992073976221928,1.0,1.0,2/44,1.65%,CACNA2D1;CD36
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.30436430856909136,-0.717172456377906,0.835990888382688,0.9730188212808483,1.0,3/10,17.61%,MYO9A;OPHN1;CDC42
prerank,bone morphogenesis (GO:0060349),0.3383587545579718,0.716974891569116,0.8098360655737705,1.0,1.0,5/14,17.18%,OSR2;SKI;LRP5;BMPR1B;FGFR3
prerank,maintenance of protein location in nucleus (GO:0051457),0.3254591545291911,0.7166179427274266,0.7777777777777778,1.0,1.0,4/20,10.43%,SYNE1;TAF8;SUN2;HNRNPU
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.25887437800739593,-0.7165438114528004,0.8397932816537468,0.9729350039601303,1.0,3/18,8.54%,PTPN11;CTR9;IL6R
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.30773987314400086,-0.7164340530941143,0.8237885462555066,0.9715022626320272,1.0,4/10,29.00%,AP2S1;AP2A2;CLTA;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.30773987314400086,-0.7164340530941143,0.8237885462555066,0.9715022626320272,1.0,4/10,29.00%,AP2S1;AP2A2;CLTA;AP2M1
prerank,amino acid transmembrane transport (GO:0003333),0.27928033126329704,0.7163543756438007,0.816622691292876,1.0,1.0,1/45,0.33%,SLC38A11
prerank,lymphocyte mediated immunity (GO:0002449),0.3522482638689186,0.7161067203325636,0.764065335753176,1.0,1.0,1/12,3.07%,JAG1
prerank,glycerophospholipid metabolic process (GO:0006650),0.25950391694490216,0.715971788924113,0.8670658682634731,1.0,1.0,17/75,17.02%,PLA2G3;PIGN;PIGA;ABCA3;PLEK;PLCB1;PLCD1;PDGFRB;CPNE3;PNPLA3;PLA2G4A;PIGH;PLA2G4C;PIGB;PIGP;DPM2;PRDX6
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2617372001672622,0.7156792046525182,0.8514851485148515,1.0,1.0,12/67,13.33%,TBC1D1;ATP8B1;TBC1D20;RABGAP1;CAV1;EVI5;EPHA2;GAP43;MYO10;TRPM2;DMTN;CAPZB
prerank,negative regulation of B cell proliferation (GO:0030889),0.3549446644931374,0.7154524601124493,0.7989228007181328,1.0,1.0,2/11,9.92%,CD300A;TNFRSF21
prerank,melanosome organization (GO:0032438),-0.24019130861248225,-0.7151487663869801,0.9158878504672897,0.9721976500241409,1.0,9/26,31.83%,SHROOM2;DTNBP1;AP1M1;RAB29;AP1G1;BLOC1S6;RAB32;BLOC1S2;TRAPPC6A
prerank,regulation of protein polymerization (GO:0032271),-0.2253110634499517,-0.7151153389523596,0.9017543859649123,0.9714694505199065,1.0,9/35,20.39%,ARHGAP28;RASA1;PFN1;PFN2;TTBK1;TPPP3;ARL2;DBN1;GBA2
prerank,positive regulation of JNK cascade (GO:0046330),0.2599251955507505,0.7151008936445049,0.8307322929171669,1.0,1.0,9/70,10.19%,MAP3K5;MFHAS1;DAB2IP;TRAF3;RASGRP1;MAP3K10;PLCB1;EDAR;TRAF5
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3072156876059867,-0.7148953760524239,0.8278867102396514,0.9709377185334834,1.0,3/10,17.56%,CCT8;CCT4;WRAP53
prerank,response to acidic pH (GO:0010447),0.3313953852588094,0.7144370928772322,0.7826825127334465,1.0,1.0,2/13,8.90%,PKD1L3;IMPACT
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.2746860584929296,-0.7143243060615252,0.868421052631579,0.9708018035861673,1.0,1/15,1.04%,MOXD1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.26248898476431926,-0.7139557874402263,0.8810126582278481,0.9704393882519792,1.0,3/17,19.40%,LPGAT1;PLAAT3;PLA2G12A
prerank,negative regulation by host of viral transcription (GO:0043922),0.34765140811089057,0.7139379502933577,0.7688266199649737,1.0,1.0,1/12,3.45%,CCL5
prerank,rRNA catabolic process (GO:0016075),-0.26679876102933997,-0.7139041795354067,0.8721804511278195,0.9697232950245979,1.0,7/16,27.26%,TRIR;DIS3;EXOSC9;EXOSC2;EXOSC3;EXOSC7;EXOSC5
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.34454625595409105,0.713719468090426,0.7658450704225352,1.0,1.0,1/11,3.27%,IL2
prerank,cellular response to interleukin-2 (GO:0071352),0.34454625595409105,0.713719468090426,0.7658450704225352,1.0,1.0,1/11,3.27%,IL2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.3565396026141916,0.713547306920211,0.781021897810219,1.0,1.0,4/10,19.33%,PRMT7;PCGF5;PCGF3;DNMT3A
prerank,negative regulation of biosynthetic process (GO:0009890),0.32481235897534216,0.7134728166448326,0.7763157894736842,1.0,1.0,4/16,11.01%,EMILIN1;PPARA;GSTP1;GPER1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.2814076059928946,-0.713229592179422,0.8455882352941176,0.9697544779304376,1.0,6/13,27.12%,PRR5L;GTPBP1;ZC3H12A;PNPT1;ZC3HAV1;MOV10
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.28774017778387867,0.7129800935915208,0.8123167155425219,1.0,1.0,7/32,17.20%,HINFP;CDK18;RB1;CDK15;FBXO5;CDK14;BRD4
prerank,protein kinase B signaling (GO:0043491),0.3056271796096307,0.7129226885001672,0.7912087912087912,1.0,1.0,8/23,16.74%,CCL5;THEM4;EPHA2;SIRT2;ZFP36L1;GAS6;PTEN;MT3
prerank,regulation of exit from mitosis (GO:0007096),-0.21398712180529716,-0.7126911708335628,0.9185185185185185,0.9696255192345398,1.0,9/38,17.51%,CDC14B;ANAPC1;CDC23;UBC;RGCC;BUB3;CDC26;ANAPC4;UBE2S
prerank,"base-excision repair, gap-filling (GO:0006287)",0.28864033181585885,0.7126806260971823,0.8154929577464789,1.0,1.0,6/35,11.72%,MUTYH;PARP1;MBD4;PARG;POLD1;POLG
prerank,regulation of double-strand break repair (GO:2000779),0.2808162086790853,0.7126142508991838,0.7997293640054127,1.0,1.0,5/39,8.36%,UBR5;RAD51AP1;ZCWPW1;CHEK1;SPIRE1
prerank,cellular response to cytokine stimulus (GO:0071345),0.2313138177086476,0.7119868228016836,0.9509018036072144,1.0,1.0,62/416,15.25%,AKAP6;LIFR;CD36;LAMA5;RORA;DOCK8;VIM;ANXA1;CRLF1;GREM2;SOCS5;IL2;CCL5;ITGB1;PTGIS;IL12RB2;ALOX5;BCL2;PTPN18;UPF1;SOCS6;ARHGEF2;HAS2;IL10RA;DAB2IP;VEGFA;TP53;IL12RB1;IL22;SOX9;RELA;DAPK3;CCND1;NR1D1;SLA;INPPL1;HIF1A;NPR2;AXL;TNFRSF21;IL13RA1;HNRNPU;CCL14;VAV1;GPER1;IL1RAPL1;ZFAND6;ZFP36L1;BCL6;GBP2;NUMBL;SYNCRIP;LDLRAP1;GAS6;EPRS1;MCL1;HYAL1;CSF2RA;STAT1;PRKACA;UBE2K;JAK2
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.3288912833438688,0.7112850456600783,0.7698961937716263,1.0,1.0,4/15,11.71%,OSR2;CELF1;TGFB2;RICTOR
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2520903934220966,0.7107497206673239,0.8644264194669756,1.0,1.0,15/93,12.59%,MAP3K5;MFHAS1;DAB2IP;ARL6IP5;VEGFA;TRAF3;RASGRP1;TGFB2;MAP3K10;PLCB1;EDAR;TRAF5;EIF2AK2;PDCD10;TAOK3
prerank,cellular response to interleukin-12 (GO:0071349),0.2768666284726328,0.7100430413335095,0.8276315789473684,1.0,1.0,6/48,9.18%,CNN2;LCP1;IL12RB2;IL12RB1;PLCB1;PAK2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.2748756081009841,-0.7094535469418481,0.8704663212435233,0.9725230799898088,1.0,11/15,38.90%,ERN1;ZBTB8OS;TSEN34;CPSF4;CSTF2;CPSF1;CLP1;TSEN54;TRPT1;TSEN15;RTRAF
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.23301191727719878,0.7094108828938647,0.9432624113475178,1.0,1.0,44/306,13.61%,RPL3L;POLR2L;POLR2I;LARGE1;MLF1;EEFSEC;MRPL36;BRIP1;EXT2;MRPL13;PWP1;SET;HARS2;UPF1;MEF2A;POLR2G;TERT;TIPIN;RPL8;RAD9A;CHEK1;NFKBIB;MRPL43;TNIP1;NR4A2;MRPL51;KAT7;RPL5;MRPL23;RHNO1;RPS23;GSPT1;POLD1;BAZ2A;PTMS;MRPL9;TSFM;ORC2;ST3GAL2;RMI2;POLR2J;EEF2K;MRPL42;NT5M
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3379157930030954,0.7090648735968818,0.7890365448504983,1.0,1.0,3/14,14.70%,DAB2IP;PTPN1;UFL1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.29405327618144217,0.7079375451150648,0.8020086083213773,1.0,1.0,4/29,7.14%,SLC8A2;SHISA9;ZDHHC2;RAB3A
prerank,hemidesmosome assembly (GO:0031581),0.34960226432062447,0.7078791919719284,0.7641681901279708,1.0,1.0,2/11,6.95%,DST;LAMC1
prerank,regulation of ATP metabolic process (GO:1903578),0.2720132659916487,0.7077551419666066,0.8515723270440252,1.0,1.0,17/54,20.82%,NUP62;COX7A2L;SEC13;NUP153;HIF1A;NUP107;AAAS;ZBTB7A;NUP37;NUP98;NUP210;NUP54;NUP160;NUP133;UQCC2;SLC25A33;TPR
prerank,DNA strand elongation (GO:0022616),-0.25368383489890833,-0.7071928529160003,0.8810810810810811,0.9742655821055676,1.0,11/18,37.85%,MRE11;RAD50;NBN;GINS3;DCLRE1B;RFC3;GINS4;POLD3;GINS1;RFC4;MCM3
prerank,positive regulation of bone resorption (GO:0045780),-0.2941120113276733,-0.7071902938603919,0.8568232662192393,0.9734963665175851,1.0,3/11,11.36%,SPP1;ATP6AP1;PLEKHM1
prerank,negative regulation of cellular senescence (GO:2000773),0.34214867184650494,0.7070951411292351,0.7760683760683761,1.0,1.0,4/13,15.38%,CDK6;TERT;TERF2;FBXO5
prerank,glycerol metabolic process (GO:0006071),-0.3114375983215085,-0.7067826625468899,0.8481308411214953,0.9731867120984957,1.0,6/10,32.67%,GK5;COQ3;PGP;GK;TPI1;ANGPTL3
prerank,regulation of response to oxidative stress (GO:1902882),0.34874283500318676,0.706542514439351,0.7490706319702602,1.0,1.0,2/11,7.34%,ALOX5;HEBP2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.2400710243012576,0.7061235634211662,0.8969631236442517,1.0,1.0,31/145,17.60%,DYNLL1;CEP41;FHL1;HAUS8;CEP290;PSMC6;TPX2;CCND1;PSME4;CEP192;PSMB1;PSMD5;DYNC1I2;NEDD1;PSMB2;CEP72;CLASP1;DCTN3;CEP43;CSNK1E;HAUS7;HAUS2;PSMB7;PSMD3;PRKACA;FBXO5;PLK4;PSMA2;PSMD14;BRD4;DCTN1
prerank,positive regulation of RNA splicing (GO:0033120),0.29573999909487986,0.7060312811984137,0.8059259259259259,1.0,1.0,7/29,14.16%,SLC38A2;DYRK1A;U2AF2;CIRBP;RBMXL1;RBM3;NUP98
prerank,regulation of regulated secretory pathway (GO:1903305),0.2900804309172945,0.7059771237470248,0.8328611898016998,1.0,1.0,4/34,7.14%,UNC13D;RIMS3;SYT10;RAB3A
prerank,peptide biosynthetic process (GO:0043043),0.23912823521369123,0.7053713623384062,0.9005347593582887,1.0,1.0,14/153,11.07%,DMD;RPL3L;CARNS1;MRPL36;MRPL13;HARS2;RPL8;MRPL43;TNIP1;MRPL51;RPL5;MRPL23;RPS23;GSPT1
prerank,carnitine metabolic process (GO:0009437),0.3424984430451936,0.7052369390092772,0.7598627787307033,1.0,1.0,5/12,20.93%,CPT1B;CRAT;CPT1A;TMLHE;ACADM
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.2187625431045684,-0.7050685198295482,0.9096989966555183,0.9742626141070433,1.0,10/30,27.44%,BCL2L1;CD44;MDM2;THOC5;PTTG1IP;KDM1A;TRIM32;YJU2;TWIST1;SNAI1
prerank,nucleoside salvage (GO:0043174),-0.30054587822260215,-0.7050420603309144,0.8422222222222222,0.9735091203887216,1.0,2/10,11.77%,UPP2;HPRT1
prerank,non-motile cilium assembly (GO:1905515),0.293145765494221,0.7044793685679784,0.8112927191679049,1.0,1.0,5/30,7.54%,TBC1D32;CEP290;RPGRIP1L;PIBF1;TOGARAM1
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.25346519428407155,-0.704343386478602,0.8797814207650273,0.9735028678710531,1.0,4/19,21.69%,DDX3X;CHUK;TLR3;HSPD1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2910237114856848,0.7043417685371512,0.8191027496382055,1.0,1.0,4/32,8.15%,SLC44A5;STARD7;SLC44A1;LPCAT3
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.27501973850560735,-0.7042814067752878,0.8507462686567164,0.9728020322045494,1.0,1/14,3.17%,IL18
prerank,positive regulation of telomere capping (GO:1904355),0.3153058155121739,0.703974659031883,0.7981790591805766,1.0,1.0,3/17,13.94%,PRKCQ;PKIB;MAPK1
prerank,negative regulation of signaling (GO:0023057),0.3024777449683951,0.7039436963391289,0.8287037037037037,1.0,1.0,2/25,6.67%,SOCS5;PTPN1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.313798047317586,0.7036996564356273,0.7708333333333334,1.0,1.0,6/17,21.08%,COX7A2L;COX8A;COX7B;COX6C;COX5B;COX6A1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.24805665189066495,-0.7031584417772201,0.8844086021505376,0.973312953427608,1.0,5/19,19.56%,CAT;GPX1;PRDX4;ACOX1;PARK7
prerank,RNA biosynthetic process (GO:0032774),-0.22529258140872738,-0.7031178870152541,0.9006849315068494,0.9725856689707651,1.0,11/31,30.45%,POLR2A;SETX;TTF1;TAF12;TAF13;SMN1;TAF7;TAF5;POLA2;NCOA6;PRIM1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.3104711342060348,0.7026855340269836,0.8177641653905053,1.0,1.0,2/21,5.43%,CCL5;RARRES2
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.26163114977283175,-0.7026387675987462,0.8674351585014409,0.9723374915805547,1.0,5/18,17.90%,SPTBN1;APPL1;CLN3;VAMP8;STX8
prerank,proton transmembrane transport (GO:1902600),0.28293506936539725,0.7024432979717518,0.8274398868458275,1.0,1.0,3/36,5.54%,ATP5MF;UCP3;ATP6V1H
prerank,amyloid-beta metabolic process (GO:0050435),0.3224683562341629,0.7016637502703312,0.7925445705024311,1.0,1.0,3/16,7.75%,DYRK1A;APEH;NAT8
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.32247499020195586,0.7015621377070203,0.7887788778877888,1.0,1.0,3/15,11.28%,SIRT3;SAMD8;PRKCD
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.27906441312556507,-0.7013513027079564,0.8638392857142857,0.9729563659951482,1.0,4/13,20.44%,MPDU1;ALG14;ALG1;ALG12
prerank,cellular response to hydroxyurea (GO:0072711),-0.29877906674660926,-0.7011217389773658,0.8411016949152542,0.9724319108145199,1.0,8/10,50.29%,BLM;FMR1;ATRX;TIMELESS;NSMCE3;DDX11;RTF2;DDI1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.2763819791132896,0.7007544075093242,0.8125874125874126,1.0,1.0,2/37,6.97%,ENTPD1;ENTPD7
prerank,"transcription, DNA-templated (GO:0006351)",0.23327707723535981,0.7006798351287513,0.9320083682008368,1.0,1.0,27/207,13.17%,SOX5;POLR2L;POLR2I;MLF1;PWP1;GTF2H4;GTF3C4;ELL;CBFB;MEF2A;POLR2G;TAF1;ELOC;PARP1;TP53;ERCC6;NFKBIB;CCNT1;NR4A2;CDK7;NAT14;TFB2M;BAZ2A;NFX1;NELFB;SMARCA5;POLR2J
prerank,regulation of protein binding (GO:0043393),0.24468654992455918,0.7000243655072333,0.8852643419572553,1.0,1.0,22/114,15.49%,XIRP1;ROCK1;PDGFB;ACTB;TERT;TAF1;CAV1;PIN1;ADD2;PRMT7;PPP1CA;PSME3IP1;AMFR;PRKCD;AKTIP;BAG2;LDLRAP1;LRRK2;CSNK1E;DVL1;PRKACA;FLOT1
prerank,regulation of secretion by cell (GO:1903530),0.26893474457230865,0.6995875827975425,0.8265822784810126,1.0,1.0,2/54,2.73%,MEF2C;ANXA1
prerank,cellular response to radiation (GO:0071478),0.27379637646846716,0.6993394980114337,0.8294360385144429,1.0,1.0,10/40,19.88%,NET1;RAD51AP1;TP53;RAD9A;RHNO1;CLOCK;INTS7;INO80;SWI5;RAD9B
prerank,cellular response to pH (GO:0071467),0.318426493431671,0.6993119498727158,0.8145580589254766,1.0,1.0,3/17,14.60%,PKD1L3;IMPACT;HYAL1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.33908299757194194,0.6991211927317913,0.7750439367311072,1.0,1.0,1/11,4.49%,MFHAS1
prerank,response to cytokine (GO:0034097),0.24229504001280747,0.6987889367474024,0.8790496760259179,1.0,1.0,13/141,8.39%,AKAP6;LIFR;ITIH4;MYD88;ANXA1;BCL2;PTPN18;MAP4K3;TNFRSF11A;MAPKAPK2;TIMP4;RELA;DDOST
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.2974418450572702,0.6980789806497647,0.8149847094801224,1.0,1.0,9/24,22.61%,KCNB1;MIEF2;MIEF1;MTCL1;SLC51B;MFF;MYO1C;ERBB2;PDZK1
prerank,mitotic recombination (GO:0006312),-0.26752727822872147,-0.6980749769350014,0.8568019093078759,0.9749193383716598,1.0,5/15,24.18%,RAD50;SMC5;TPRKB;NSMCE2;ERCC1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.312438440447856,0.6975453057687498,0.7996820349761526,1.0,1.0,4/19,11.87%,NAT10;HNRNPU;TERF2;HNRNPC
prerank,translation (GO:0006412),0.23330939878259474,0.6968956159248696,0.9337539432176656,1.0,1.0,53/208,19.82%,RPL3L;EEFSEC;MRPL36;MRPL13;HARS2;LARS1;FTSJ1;APEH;GATB;ABCE1;RPL8;MRPL43;TNIP1;IARS2;MRPS28;MRPL51;RPL5;GFM2;MRPL23;MRPL16;RPS23;GSPT1;MRPL47;MRPL9;AIMP1;DRG2;TSFM;EEF2K;MRPL42;N6AMT1;IARS1;SARS2;EPRS1;RPL15;KARS1;LARS2;FASTKD2;RPL22;SARS1;FARS2;ETF1;RPL31;GTPBP2;RPS6;RPS17;MRPS21;EEF2;RPS27A;GARS1;ASMT;RPS14;GATC;MRPS14
prerank,regulation of astrocyte differentiation (GO:0048710),0.33644918660229106,0.696272120876315,0.787719298245614,1.0,1.0,1/12,3.30%,SERPINE2
prerank,cellular iron ion homeostasis (GO:0006879),0.25955583234532187,0.695717572934594,0.865979381443299,1.0,1.0,5/55,8.82%,HJV;HMOX2;FXN;ATP6V0A2;SLC39A14
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.27378901388446314,-0.6956033518663379,0.8833333333333333,0.9767102448274616,1.0,5/14,22.61%,PKD2;NFKBIA;G3BP2;MDFI;KEAP1
prerank,nucleotide-excision repair (GO:0006289),0.2423171352276115,0.6954014178536582,0.8927765237020316,1.0,1.0,14/101,11.52%,POLR2L;POLR2I;BRIP1;GTF2H4;POLR2G;PARP1;TP53;ERCC6;HUS1B;SLX4;PPIE;CDK7;POLD1;COPS8
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.2826592562413669,-0.6953490715566885,0.8743718592964824,0.976228195645152,1.0,2/12,8.17%,BMP7;CD44
prerank,prostanoid biosynthetic process (GO:0046457),0.32341430740724647,0.6952799157974776,0.7760683760683761,1.0,1.0,2/15,4.79%,PTGIS;TBXAS1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.29540891521820095,0.6941257625855536,0.8298507462686567,1.0,1.0,3/27,6.93%,PMAIP1;DYRK1A;SNAI2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.2557341564065514,0.6939059831815434,0.8587223587223587,1.0,1.0,8/71,9.13%,PMAIP1;CHMP4C;SOCS6;UBE2W;OTUD7A;CAPN2;NR1D1;LONP1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.2760244240487322,-0.6936608355294194,0.8700980392156863,0.9771850652369644,1.0,3/13,15.30%,TPST1;BPNT2;ENPP1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.27795939865648184,0.6924577026283038,0.848404255319149,1.0,1.0,14/41,20.82%,NUP62;SEC13;NUP153;HIF1A;NUP107;AAAS;ZBTB7A;NUP37;NUP98;NUP210;NUP54;NUP160;NUP133;TPR
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.29627182681338227,0.6924331313005243,0.8242811501597445,1.0,1.0,3/22,10.84%,PMAIP1;HEXIM1;EIF5A
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.2954564273797433,0.6920764509425635,0.8089368258859785,1.0,1.0,4/23,9.94%,CCL5;IL10RA;PIBF1;CRLF3
prerank,microtubule-based transport (GO:0099111),-0.278805188290262,-0.6919821644225513,0.8731343283582089,0.9781909068560259,1.0,9/12,50.72%,DYNC1I1;SPEF2;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,mRNA metabolic process (GO:0016071),0.24307110402660856,0.6918567577611948,0.8822843822843823,1.0,1.0,20/90,16.17%,HNRNPR;PCF11;U2AF2;TP53;YTHDF2;SFPQ;CELF1;PPARGC1A;SRSF4;DIS3L2;PRPF18;U2AF1;SF3A3;SF3B2;PCBP3;DXO;SON;PRKACA;SF3A1;LSM10
prerank,receptor internalization (GO:0031623),0.26880627982868194,0.691485279971721,0.8641975308641975,1.0,1.0,6/44,7.29%,CD36;ITGB1;SAG;CAV1;NEDD4;RAMP1
prerank,regulation of cytoplasmic transport (GO:1903649),0.3415859508337329,0.6913988980218794,0.7787307032590052,1.0,1.0,4/11,13.94%,DENND10;MAP2K1;LRRK2;MAPK1
prerank,regulation of histone deacetylation (GO:0031063),0.3404973630111027,0.6912885033850449,0.7951388888888888,1.0,1.0,1/13,3.13%,CAMK2D
prerank,regulation of lysosomal lumen pH (GO:0035751),0.33234706281032367,0.6910900144620424,0.779245283018868,1.0,1.0,1/12,2.24%,CLN5
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.24858725986434937,-0.6909669315435777,0.8805194805194805,0.978347014029074,1.0,8/18,30.02%,ELOVL7;ACSL3;ACSL4;ELOVL6;HACD2;ELOVL1;ACSL1;ELOVL5
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3258168297305154,0.6907676088014022,0.7775831873905429,1.0,1.0,4/13,16.13%,PTGIS;NAXE;NNMT;NAMPT
prerank,positive regulation of catabolic process (GO:0009896),0.2559273108022149,0.690512282017876,0.8606658446362515,1.0,1.0,5/65,7.01%,NKD1;OAZ2;ATG7;DAB2IP;NEDD4
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.31530147797174474,0.6904757739143872,0.8226351351351351,1.0,1.0,3/15,7.92%,TIPIN;RAD9A;HUS1B
prerank,DNA modification (GO:0006304),0.30603154491959617,0.6904207579250575,0.8215339233038348,1.0,1.0,4/22,11.51%,MUTYH;PARP1;MBD4;TERF2
prerank,cristae formation (GO:0042407),0.2941064919128179,0.6902420035777855,0.8168604651162791,1.0,1.0,8/27,18.97%,ATP5MF;AFG3L2;DNAJC11;ATP5MC1;ATP5MG;IMMT;APOOL;ATP5F1D
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.3398186814029053,0.6901467270137005,0.7891891891891892,1.0,1.0,2/12,5.45%,DHRS3;ASXL1
prerank,cellular response to interferon-gamma (GO:0071346),0.24714927201125153,0.689998946377643,0.8901601830663616,1.0,1.0,14/88,15.25%,CAMK2G;CAMK2D;CCL5;IL12RB1;DAPK3;TRIM68;CCL14;PRKCD;GBP2;OASL;SYNCRIP;EPRS1;STAT1;JAK2
prerank,RNA interference (GO:0016246),0.3192558124405633,0.6897946911605358,0.8141891891891891,1.0,1.0,7/17,19.68%,TERT;CELF1;DICER1;DROSHA;DHX9;AGO1;PRKRA
prerank,phosphatidylcholine metabolic process (GO:0046470),0.25466071732722917,0.6891235967811056,0.8830188679245283,1.0,1.0,16/70,20.89%,PLA2G3;SLC44A5;STARD7;ABCA3;SLC44A1;LPCAT3;PLB1;PLA2G4A;CHKB;PLA2G4C;NR1H3;SLC44A2;MBOAT7;CHPT1;LPCAT1;PLA2G15
prerank,protein import into peroxisome matrix (GO:0016558),0.3280488848117311,0.688903687479608,0.8023064250411862,1.0,1.0,5/12,20.12%,PEX2;PEX5L;PEX10;PEX26;PEX1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.2721430197611363,0.6888095733627468,0.8306010928961749,1.0,1.0,2/42,3.45%,THPO;CCL5
prerank,chromosome organization (GO:0051276),0.2394256811109889,0.6884490688774144,0.9010477299185099,1.0,1.0,23/99,21.65%,PADI3;PADI2;GEM;PARP1;HMGN3;TOP2B;COPS8;ZBTB7A;HMG20A;COPS4;CDAN1;CENPW;MSH2;HDAC1;COPS6;HMGN1;ABL1;RPS27A;NUP133;TCF7L1;EZH2;H3-3A;CENPV
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.3418028321393251,0.6880727817230208,0.7922535211267606,1.0,1.0,3/10,17.86%,SIRT3;PRKCD;SMPD2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.3418028321393251,0.6880727817230208,0.7922535211267606,1.0,1.0,3/10,17.86%,SIRT3;PRKCD;SMPD2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3053396313725602,0.6880107571833888,0.8256,1.0,1.0,4/20,14.44%,BCL2;BCL2L2;BOK;MCL1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.33421980126304907,0.6879454666200828,0.8096947935368043,1.0,1.0,4/11,20.90%,DCTD;NT5C3A;DCK;CTPS2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.31673095176883515,0.6878868029017837,0.8045774647887324,1.0,1.0,3/14,10.29%,HSD17B4;CRAT;SCP2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.2836039855880812,-0.6878128394278523,0.8606194690265486,0.9807585940072902,1.0,3/11,17.56%,CCT8;CCT4;WRAP53
prerank,neuron development (GO:0048666),0.2353780572971464,0.6874435658147421,0.9337078651685393,1.0,1.0,17/141,11.46%,MEF2C;ROCK1;FRY;CLN5;BTG2;MAPT;GDNF;HDGFL3;NEDD4;TGFB2;ERCC6;RUNX1;ATCAY;HS6ST1;SAMD14;TBCD;RB1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.23182603150054262,-0.6874034274394337,0.8938053097345132,0.9804226601405366,1.0,10/23,32.07%,ASAH2;PTGS2;EPHX2;ELOVL6;GSTM2;FADS1;ACOT7;HPGD;ALOX12;GPX4
prerank,copper ion transport (GO:0006825),-0.28486820016228503,-0.6870861339040424,0.8512195121951219,0.9799610107425077,1.0,4/11,23.33%,STEAP3;ATOX1;STEAP2;SLC31A1
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.2974820112223902,-0.6870641670263965,0.8552036199095022,0.9792130638233874,1.0,2/10,12.06%,CRY1;THOC5
prerank,regulation of cell projection organization (GO:0031344),-0.2758575486186987,-0.686727608433252,0.8408551068883611,0.978747596712942,1.0,6/13,27.18%,SEMA4D;MYO9A;SPRY2;MFSD2A;MOV10;NTNG1
prerank,positive regulation of exosomal secretion (GO:1903543),-0.2668352361329492,-0.6864571692748438,0.8803827751196173,0.9782764661113651,1.0,4/15,15.74%,SDCBP;VPS4B;SDC4;HGS
prerank,myelin maintenance (GO:0043217),0.3471699707955581,0.6858509187666937,0.7891891891891892,1.0,1.0,2/10,15.32%,CLU;PTEN
prerank,lipid droplet formation (GO:0140042),-0.2955995137339502,-0.685744192759806,0.8771551724137931,0.9782319425103285,1.0,6/10,32.81%,ZFYVE1;CDS1;SQLE;BSCL2;CDS2;FITM2
prerank,cellular glucose homeostasis (GO:0001678),0.2678950330957264,0.6855456967864298,0.8794520547945206,1.0,1.0,10/41,15.00%,HK2;KCNB1;PPARGC1A;SLC39A14;NR1D1;HIF1A;GPER1;GAS6;PRKAA2;PRKACA
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.28655578052400543,0.6850073044369063,0.8512064343163539,1.0,1.0,6/31,15.32%,PDLIM5;KIF1A;CUX2;LRRK2;LZTS3;PTEN
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.2649071793579147,0.6841729346580195,0.8646907216494846,1.0,1.0,12/47,14.24%,DAB2IP;ARL6IP5;RASGRP1;TGFB2;MAP2K1;GSTP1;RAP2A;EIF2AK2;PDCD10;TAOK3;MAPK1;EPHB1
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.2586121315401082,-0.6840537565798921,0.885,0.9790731998660767,1.0,2/16,9.57%,PTPN22;AHR
prerank,mitotic metaphase plate congression (GO:0007080),0.2584795629422671,0.6839288214498298,0.855146124523507,1.0,1.0,8/51,14.41%,CHMP4C;NUP62;CHMP5;PIBF1;CENPE;CHMP2B;CHMP2A;KIF18A
prerank,regulation of phosphorylation (GO:0042325),0.2397777391608057,0.6837059708887983,0.8980963045912654,1.0,1.0,19/120,14.16%,DYNLL1;ROCK1;CCL5;NUP62;DSCAM;PIN1;CORO1C;AR;SEC13;NUP153;HIF1A;SIRT2;NUP107;AAAS;ZBTB7A;FNIP2;PLXNB2;NUP37;NUP98
prerank,regulation of T cell proliferation (GO:0042129),0.25587659031977567,0.6836840723948625,0.8970588235294118,1.0,1.0,3/61,3.88%,ANXA1;CCL5;CD276
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.2232861121682223,-0.6835579223398861,0.9096774193548387,0.978820528283688,1.0,11/28,36.37%,PRKDC;CYRIB;XRCC6;SIRPA;NCKAP1L;HSPD1;THY1;TYROBP;NOD2;SH3KBP1;PYCARD
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.28108925478789926,0.6834420166384311,0.8504936530324401,1.0,1.0,2/29,3.45%,ANO6;CCL5
prerank,cellular biogenic amine metabolic process (GO:0006576),0.3392759748037323,0.6833625025010108,0.8236331569664903,1.0,1.0,2/12,10.83%,OAZ2;SMS
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.2626291033651726,0.6826893591364329,0.868766404199475,1.0,1.0,10/51,13.94%,NAT10;PARN;PRKCQ;PKIB;NAF1;HNRNPU;CCT3;TERF2;HNRNPC;MAPK1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.24317151172920987,-0.6826790949823208,0.9021739130434783,0.9788866829317808,1.0,3/20,7.97%,AGO3;PUM1;TSNAX
prerank,mRNA transport (GO:0051028),0.23931464495471394,0.6818292650919842,0.8956228956228957,1.0,1.0,23/101,16.11%,NUP62;WDR33;UPF1;U2AF2;SRSF4;SEC13;NUP153;ZC3H11A;MCM3AP;U2AF1;RBM8A;NUP107;AAAS;KIF5C;THOC7;DDX25;SRRM1;ZFP36L1;NUP37;NUP98;EIF4E;NUP210;FIP1L1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.22239360713951267,0.6818038449097318,0.9646107178968655,1.0,1.0,55/336,15.72%,CRIP1;RBM24;DYRK2;CGAS;HINFP;BTG2;MUTYH;GTF2H4;BCL2;UBR5;RAD51AP1;UPF1;TAF1;MAPKAPK2;PARP1;TP53;ZBTB38;YAP1;TDP1;MBD4;BCL2L2;RAD9A;CHEK1;REXO4;SLX4;CCND1;BRSK1;EPHA2;PSME4;STK33;RIF1;FBXO6;POLD1;BOK;BCL6;AKTIP;TAOK3;MACROD1;NSMCE4A;RMI2;HPF1;FNIP2;TRIM28;ZRANB3;SIRT4;CSNK1E;MCL1;ZBTB4;UFL1;UBA1;KMT5B;MAPK12;RAD52;CHRNA4;VAV3
prerank,keratan sulfate catabolic process (GO:0042340),-0.2883356286529419,-0.681632356023649,0.8653846153846154,0.979113646567409,1.0,4/11,19.11%,HEXA;FMOD;GALNS;OMD
prerank,regulation of cell aging (GO:0090342),-0.2924501539587848,-0.6815188555314301,0.8869565217391304,0.9784527509984267,1.0,4/11,19.97%,RSL1D1;NEK6;PNPT1;NEK4
prerank,regulation of immune response (GO:0050776),0.23547309128151583,0.6813861535713253,0.9197396963123644,1.0,1.0,12/135,8.48%,FCGR3B;FCGR3A;ITGB1;CD276;LAG3;ELMOD2;CD200R1;CD200;TRAF3;TGFB2;CD300A;ITGA4
prerank,regulation of cholesterol transport (GO:0032374),0.3049430168561128,0.6810699607975242,0.8234375,1.0,1.0,3/20,10.95%,ABCB4;YJEFN3;NAXE
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.23296888972533272,0.681054344744093,0.9097586568730325,1.0,1.0,16/158,11.69%,FLNA;MYD88;ROR1;NUP62;MTDH;PPM1A;TIFA;GOLT1B;RELA;TRIM68;EDAR;TRAF5;PELI2;DDX1;ZDHHC17;HTR2B
prerank,regulation of tumor necrosis factor production (GO:0032680),0.23575014377084305,0.6808291164013824,0.9037372593431483,1.0,1.0,10/112,9.05%,NR1H4;FZD5;LPL;CD14;HAVCR2;ARHGEF2;MAPKAPK2;RASGRP1;DICER1;GSTP1
prerank,negative regulation of DNA binding (GO:0043392),0.2872307011433344,0.6803820049417784,0.8234421364985163,1.0,1.0,1/28,1.08%,HEY2
prerank,epidermis development (GO:0008544),-0.18797952142530883,-0.6802738363927193,0.9593908629441624,0.9788494384650359,1.0,14/56,27.01%,SVEP1;EMP1;ALDH3A2;LAMA3;FGFR2;CRABP2;SCEL;HDAC2;PTHLH;GATA6;FGF7;YBX1;LAMC2;EDA2R
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.29792349592960343,0.6799311145423426,0.8049180327868852,1.0,1.0,5/20,15.84%,PLCB1;AGRN;CHRNA7;GNAQ;RGS10
prerank,regulation of cellular metabolic process (GO:0031323),0.2677311571509611,0.6799004073753809,0.8720316622691293,1.0,1.0,9/45,16.38%,ANGPTL8;PDK4;ACACB;PPARA;ABCG1;MKLN1;PDK2;FLOT1;VPS35
prerank,regulation of chromosome organization (GO:0033044),0.3002748673525558,0.679680433749119,0.8269230769230769,1.0,1.0,5/22,13.00%,UPF1;MAPT;RB1;TERF2;RMI2
prerank,positive regulation of hormone secretion (GO:0046887),0.31045487600440763,0.6795667301657122,0.8223270440251572,1.0,1.0,1/17,2.35%,PLA2G3
prerank,response to amino acid (GO:0043200),0.276264409650134,0.6789807044146093,0.8259629101283881,1.0,1.0,6/31,12.85%,LARS1;CPEB1;CAPN2;RRAGB;SH3BP4;CPEB3
prerank,histone H4 acetylation (GO:0043967),0.2669652125102893,0.6788869334989975,0.8668442077230359,1.0,1.0,15/47,19.24%,MCRS1;JADE1;MSL3;KAT7;KANSL3;HAT1;RUVBL1;JADE3;KANSL1;MORF4L1;MSL1;ZZZ3;TADA3;KAT8;ACTL6A
prerank,positive regulation of proteolysis (GO:0045862),0.2586114913472871,0.6786632164665003,0.8745148771021992,1.0,1.0,9/55,13.37%,ANGPTL8;PACSIN3;ASPH;TNIP1;IST1;FBXW11;SNX9;BAG2;PERP
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.32145151983886,0.6782976149934082,0.8111510791366906,1.0,1.0,3/13,13.77%,ENTPD7;OPA1;LRRK2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2843844284775623,0.6779569931184948,0.8442503639010189,1.0,1.0,6/27,16.31%,DCTD;AK7;NUDT13;AK2;CMPK1;GLRX
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.25394486364038027,-0.6779520677311667,0.8785529715762274,0.9802169028052173,1.0,1/16,0.85%,APPL2
prerank,neuron projection fasciculation (GO:0106030),0.3411065176426641,0.6778507078438911,0.8,1.0,1.0,2/10,11.50%,SEMA5A;ARHGAP35
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.25205826941994725,0.677597916164785,0.8811630847029077,1.0,1.0,10/60,10.42%,HEY2;CBFB;TP53;MED1;MED12;SOX9;RELA;CCND1;PAXIP1;MED14
prerank,regulation of viral release from host cell (GO:1902186),-0.2342724686412448,-0.676916634240168,0.9103641456582633,0.9803560377014647,1.0,7/21,25.47%,PML;TRIM25;DDB1;TRIM5;MID2;TRIM21;TRIM32
prerank,myeloid cell differentiation (GO:0030099),-0.18845013224721055,-0.6768921635592346,0.9661016949152542,0.9796156272373373,1.0,12/47,26.18%,KMT2E;KIT;RPS19;TET2;LYN;HSPA9;SLC25A38;TIRAP;PTPN2;TAL1;ZFPM1;UBA5
prerank,T cell activation (GO:0042110),0.2503254807181812,0.6767888348865413,0.8904933814681107,1.0,1.0,10/69,13.27%,PPP3CA;LCP1;IL2;CD276;RASGRP1;DDOST;LMBR1L;RHOH;NCK2;PPP3CB
prerank,negative regulation of protein processing (GO:0010955),0.32736854325272435,0.6766652740114187,0.8137432188065099,1.0,1.0,1/12,3.30%,SERPINE2
prerank,lipid catabolic process (GO:0016042),0.30535298180017156,0.6764041168184257,0.826645264847512,1.0,1.0,2/18,9.73%,LPL;SIRT2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.268132772859127,0.6763997074783792,0.8534246575342466,1.0,1.0,11/38,17.88%,CENPP;CENPO;HAT1;RUVBL1;ITGB3BP;CABIN1;SMARCA5;IPO4;CENPW;CENPK;RSF1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.29999989496031076,0.6763894768326874,0.8401253918495298,1.0,1.0,3/21,4.87%,NUDT7;NUDT4;NT5C2
prerank,protein modification by small protein conjugation (GO:0032446),0.22242194530583748,0.6760124806451737,0.96875,1.0,1.0,90/361,20.84%,TRIM54;UBA2;RNF152;TRIM55;TRIM63;DCUN1D2;PDZRN3;NUP62;LMO7;TNFAIP1;ASB2;ASB1;PIAS4;CUL2;CNOT4;RNF7;PEX2;ATG7;PCNP;CBLL1;SAE1;FBXW7;ELOC;UBE2W;NEDD4;UBE2F;CUL9;DCUN1D1;TRIM68;TRPM4;UBE2E1;NUP153;HIF1A;UHRF2;TRIM7;AMFR;NUP107;UBE2D1;AAAS;FBXO32;TRIM35;PIAS2;NFX1;FBXW11;UBA3;NUP37;MUL1;TRIM28;NUP98;UFL1;TSPAN17;UBA1;UBE2K;NUP210;PEX10;GAN;SMURF1;UBR3;CCNF;ANAPC16;RLIM;CUL5;PIAS1;UBE2A;ISG15;MIB2;ANAPC11;RCHY1;BCL11A;UBR1;RNF103;RPS27A;NUP54;MIB1;TRIM23;SUMO1;UBE2I;ATG10;NUP160;KCTD10;NUP133;UCHL3;BRAP;HIF3A;FBXO11;RNF111;KLHL7;TRIM47;TPR;TRIM44
prerank,lysine catabolic process (GO:0006554),0.33193270761658106,0.6751805339543764,0.804159445407279,1.0,1.0,2/12,6.99%,DLD;DLST
prerank,lysine metabolic process (GO:0006553),0.33193270761658106,0.6751805339543764,0.804159445407279,1.0,1.0,2/12,6.99%,DLD;DLST
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.24606168326171068,0.6749734736450682,0.8865598027127004,1.0,1.0,6/69,7.48%,FZD5;LPL;CD14;HAVCR2;ARHGEF2;RASGRP1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.29615178470504944,0.6749476834901745,0.8470031545741324,1.0,1.0,6/23,17.68%,ITGB1;INSC;NSFL1C;FBXW11;DCTN1;UBXN2B
prerank,regulation of mRNA processing (GO:0050684),0.27220863143500773,0.6749420678102424,0.8398268398268398,1.0,1.0,10/32,16.92%,KHDRBS3;PAPOLA;AHCYL1;SRSF10;ZFP36L1;SON;CWC22;SRPK2;SF1;DHX9
prerank,rRNA methylation (GO:0031167),-0.23712670644014916,-0.6744387611882027,0.917989417989418,0.9810978730637506,1.0,11/22,35.37%,DIMT1;BUD23;NSUN3;FTSJ3;METTL16;EMG1;METTL15;FBL;MRM2;TRMT112;MRM3
prerank,negative regulation of T cell differentiation (GO:0045581),0.3313980844534089,0.6741470566211997,0.8029197080291971,1.0,1.0,2/10,13.72%,LAG3;FOXJ1
prerank,exit from mitosis (GO:0010458),-0.27909761319233367,-0.6738016438761235,0.8878718535469108,0.980953897294565,1.0,3/12,8.67%,EPS8;SPAST;SIRT7
prerank,regulation of RNA splicing (GO:0043484),0.24711451162770393,0.6735069849180046,0.891358024691358,1.0,1.0,15/69,15.65%,KHDRBS3;RBM38;SLC38A2;DYRK1A;U2AF2;CELF1;MBNL2;FUS;PTBP2;MBNL1;SRSF10;SON;CWC22;SRPK2;SF1
prerank,regulation of lamellipodium assembly (GO:0010591),0.2735425719179929,0.6729638705542388,0.847124824684432,1.0,1.0,6/34,13.33%,PLCE1;ACTR3;CYFIP1;EPHA2;DMTN;CAPZB
prerank,tRNA modification (GO:0006400),0.24723454431517572,0.6729223821819611,0.8904109589041096,1.0,1.0,5/62,5.51%,WDR4;TRDMT1;CDKAL1;FTSJ1;TYW5
prerank,tryptophan metabolic process (GO:0006568),0.3279508096798519,0.6727016993906579,0.8318098720292505,1.0,1.0,1/11,6.81%,KMO
prerank,cellular response to light stimulus (GO:0071482),0.24656235643294866,0.6724405186550936,0.9013563501849569,1.0,1.0,15/66,20.94%,SAG;TAF1;PARP1;TP53;NEDD4;RHNO1;PRKCD;POLD1;INO80;EIF2AK4;USP28;N4BP1;YY1;EIF2S1;GNB1
prerank,insulin receptor signaling pathway (GO:0008286),0.24305753110926856,0.6723894240325743,0.8818615751789977,1.0,1.0,14/69,16.13%,PDK4;BCAR3;RARRES2;ATP6V1H;IRS1;ATP6V0A2;SORBS1;SLC39A14;ATP6V1C1;ATP6V0D2;PDK2;IRS2;CAV2;NAMPT
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.271562044330137,-0.6723636829561477,0.8853932584269663,0.9815202928363409,1.0,1/12,3.17%,IL18
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.2639875734458701,-0.6719795158850362,0.8885941644562334,0.9811360682012669,1.0,6/14,31.41%,RPL7L1;URB1;RPF2;FTSJ3;PES1;RPL35
prerank,positive regulation of cytokine production (GO:0001819),0.22241652830521105,0.6713127848916544,0.9560776302349336,1.0,1.0,26/292,9.58%,NR1H4;POLR2L;MYD88;RORA;FZD5;ANXA1;LPL;CGAS;IL2;CD276;IL12RB2;CD14;HAVCR2;ARHGEF2;PRKCQ;IL12RB1;CD200;PIBF1;RASGRP1;MBP;RELA;PLCB1;ADAM17;RUNX1;LRRFIP1;HIF1A
prerank,negative regulation of glycolytic process (GO:0045820),0.32750009797638424,0.6713010546116691,0.8166089965397924,1.0,1.0,2/10,8.66%,PFKFB1;PPARA
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.32750009797638424,0.6713010546116691,0.8166089965397924,1.0,1.0,2/10,8.66%,PFKFB1;PPARA
prerank,regulation of cell death (GO:0010941),0.23718109509667332,0.671020930663209,0.9158016147635525,1.0,1.0,20/94,17.80%,CD36;CCN1;FERMT2;CCL5;CELF1;ADNP2;IMPACT;HTR2B;CHRNA7;CLU;SARM1;CHMP2A;LRRK2;EPHB1;SNCG;DHCR24;VPS35;MT3;FAF1;SNCB
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.30819539000532653,0.6704446598757452,0.8451400329489291,1.0,1.0,1/16,1.76%,DPYSL4
prerank,regulation of lamellipodium organization (GO:1902743),-0.26769225053401946,-0.6702748546708632,0.8776978417266187,0.9818764601679684,1.0,2/14,8.17%,PDPN;CD44
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.24685865534854848,0.6699834888526144,0.8972188633615478,1.0,1.0,10/72,14.46%,FGF1;POLR2L;POLR2I;POLR2G;FLRT1;GALNT3;POLR2J;FGF10;MAPK1;RAB14
prerank,protein autophosphorylation (GO:0046777),0.22811274849149857,0.6693671421981872,0.941304347826087,1.0,1.0,25/157,14.24%,MYLK2;CAMK2D;MUSK;PEAK1;CAMKK2;DYRK1A;TAF1;MAPKAPK2;STK26;WNK2;MAP3K10;DAPK3;PAK2;PDGFRB;STK33;STK24;EIF2AK2;ACVR1B;CDK12;TNIK;TAOK3;EEF2K;LRRK2;STK10;EPHB1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.27585062766859314,-0.6691723103906504,0.8949880668257757,0.9821055134032932,1.0,6/12,32.17%,AKAP8;AKAP8L;PRKD2;ZBTB7B;SAP30BP;APLNR
prerank,transcription preinitiation complex assembly (GO:0070897),0.3272578429187201,0.6674656894123633,0.7979274611398963,1.0,1.0,3/12,16.00%,TAF1;POLR1E;TAF11
prerank,cellular response to sterol (GO:0036315),0.31772531324311226,0.6667646815058444,0.8071833648393195,1.0,1.0,1/13,2.36%,RORA
prerank,regulation of urine volume (GO:0035809),0.3325836632860696,0.666021988188314,0.8028419182948491,1.0,1.0,2/10,9.57%,HAS2;ADCY6
prerank,smoothened signaling pathway (GO:0007224),0.26865545251285117,0.6659529042740835,0.8585858585858586,1.0,1.0,4/32,11.79%,DYRK2;MAP3K10;STK36;DISP2
prerank,positive regulation of lipid localization (GO:1905954),0.33087894958776015,0.6646007778706268,0.8271844660194175,1.0,1.0,1/11,3.09%,LPL
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2249093912153237,0.6643259702270674,0.9383938393839384,1.0,1.0,28/148,17.58%,PRKAB2;DYRK2;PIP4K2A;BRIP1;PRDM1;USP2;TAF1;HEXIM1;TP53;PIN1;TPX2;RAD9A;NUAK1;CHEK1;RPL5;PRR5;RHNO1;RICTOR;RMI2;CHD4;SGK1;PRKAA2;PPP2R5C;TAF11;HIPK2;HDAC1;BOP1;BRD7
prerank,phospholipid homeostasis (GO:0055091),-0.2771916406581345,-0.6642973145700175,0.8915094339622641,0.985591217958057,1.0,2/11,12.56%,ABCA1;RCN3
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.2571540430825793,0.6632388639827107,0.8582887700534759,1.0,1.0,10/45,12.35%,BTG2;HECA;BTG1;CHEK1;TOM1L2;ZWINT;BRINP1;TRIM35;ZFP36L1;BCL6
prerank,granulocyte chemotaxis (GO:0071621),0.24989520808071566,0.6632218098105149,0.90875,1.0,1.0,9/55,18.95%,ANXA1;CCL5;TGFB2;CCL14;S100A8;S100A9;CCL25;CCL19;SCG2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.22736382939196556,0.6628411723229959,0.9269662921348315,1.0,1.0,7/108,6.85%,DLC1;MAP3K5;PMAIP1;HIP1;MAPT;ARL6IP5;RPS27L
prerank,inner dynein arm assembly (GO:0036159),-0.2817773007083433,-0.662623482360502,0.867579908675799,0.9861941780359958,1.0,2/10,13.14%,DNAAF5;CCDC39
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.2731740943561936,-0.6623704436344889,0.900709219858156,0.9856468593643644,1.0,3/12,12.73%,GART;HPRT1;PRPSAP2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.26864216350455267,0.6620011665313786,0.87,1.0,1.0,4/31,7.85%,DCUN1D2;FBXW7;PIN1;DCUN1D1
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.23338111986111615,-0.6612192220057496,0.9214659685863874,0.9858750145152828,1.0,4/18,18.19%,PRKDC;METTL3;XRCC6;NCKAP1L
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.29044636940076596,-0.6610881687821195,0.9004629629629629,0.9852192281996787,1.0,3/10,17.63%,CORO2B;PPM1F;SNX3
prerank,nuclear pore organization (GO:0006999),0.3154476268031825,0.6608732147024828,0.8506944444444444,1.0,1.0,6/14,20.82%,NUP153;NUP107;NUP98;NUP54;NUP133;TPR
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.24028690510791897,0.6604514949404293,0.8874251497005988,1.0,1.0,11/80,12.04%,CDC42EP3;PLCE1;TGFB3;ACTR3;TAPT1;CYFIP1;WASHC1;ANLN;AGRN;ARHGAP35;CEP120
prerank,autophagosome assembly (GO:0000045),0.24558108533190312,0.6603663462706778,0.8746770025839793,1.0,1.0,9/52,13.16%,ATP2A2;ATG16L2;ATG7;GABARAP;NSFL1C;STX12;MFN2;WDR45;PIK3C3
prerank,peroxisome organization (GO:0007031),0.2782313424217177,0.6598296836012169,0.8532526475037822,1.0,1.0,9/25,20.59%,PEX2;ABCD4;DNM1L;PEX19;LONP2;PEX10;MFF;PEX1;PEX3
prerank,negative regulation of interferon-beta production (GO:0032688),-0.27838580191254464,-0.6597513888866704,0.8984547461368654,0.9855855412152287,1.0,3/10,16.05%,PPM1B;SIRPA;RELB
prerank,protein localization to lysosome (GO:0061462),-0.20769012787908847,-0.6592362998211861,0.9382352941176471,0.9852241631962918,1.0,10/28,26.65%,SCARB2;GCC2;RTN4;AP3M1;HGS;LMBRD1;M6PR;GLMP;NCOA4;LAPTM5
prerank,regulation of mononuclear cell migration (GO:0071675),0.2912408289255007,0.6590029000224945,0.8520710059171598,1.0,1.0,4/23,13.94%,CCL5;RARRES2;STK10;MAPK1
prerank,sulfur compound biosynthetic process (GO:0044272),0.2316658659668942,0.6588018249935741,0.9280898876404494,1.0,1.0,17/104,13.46%,ANGPT1;CHSY3;CSPG4;CSGALNACT1;BGN;CHST5;OGN;GSTT1;GSTP1;CHST3;GGCT;OPLAH;ESD;CHST1;GSTA4;ST3GAL2;MAT2A
prerank,positive regulation of exocytosis (GO:0045921),0.263198706618265,0.658685721981425,0.8486562942008486,1.0,1.0,8/35,17.21%,CLASP2;UNC13D;RAB3A;TSG101;CLASP1;CHMP2A;STAM;VPS4A
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.24025801901077387,0.6586816870099179,0.8933333333333333,1.0,1.0,15/66,16.52%,CDK6;CCND2;ANXA1;FHL1;JADE1;PLCB1;CCND1;ADAM17;RB1;FGF10;HYAL1;PTEN;LSM10;INO80;CDK2AP2
prerank,histone modification (GO:0016570),0.23048065723611677,0.6585929005367037,0.941108545034642,1.0,1.0,35/109,22.41%,PADI3;CCNA2;PADI2;HDAC9;CPA4;NSD3;MSL3;PRMT7;MTA3;SIRT2;MIDEAS;PRKCD;BAZ2A;RUVBL1;MORF4L1;MTA1;UFL1;SIN3A;MT3;HDAC1;USP36;UBE2A;ATXN7L3;RBM14;HDAC6;KAT8;KDM4A;PRMT1;KAT6A;EZH2;RPS6KA5;BRD8;USP16;USP21;PRDM5
prerank,positive regulation of lipid storage (GO:0010884),0.29038168955643057,0.6584017240297785,0.843167701863354,1.0,1.0,3/21,12.87%,LPL;SREBF2;OSBPL11
prerank,Golgi localization (GO:0051645),0.32592882598752587,0.6583858646793176,0.8309608540925267,1.0,1.0,2/11,12.47%,ARHGAP21;PDCD10
prerank,RNA export from nucleus (GO:0006405),0.23215203131171158,0.6580736218960769,0.9293044469783353,1.0,1.0,22/100,16.11%,NUP62;WDR33;UPF1;U2AF2;SRSF4;SEC13;NUP153;ZC3H11A;MCM3AP;U2AF1;RBM8A;NUP107;AAAS;THOC7;DDX25;SRRM1;XPO5;NUP37;NUP98;EIF4E;NUP210;FIP1L1
prerank,cellular response to superoxide (GO:0071451),-0.28479343087965786,-0.6580507044609253,0.8984881209503239,0.985370416922687,1.0,6/10,41.63%,NOS3;ADPRS;PRDX1;PRDX2;ATP7A;SOD1
prerank,pre-replicative complex assembly (GO:0036388),-0.16855018040360037,-0.6579904288847058,0.989247311827957,0.9846704688308766,1.0,25/64,33.76%,PSMD7;PSMD9;PSMD13;PSMB3;UBC;ORC5;ORC6;PSMC5;PSMA5;PSMA1;PSMC2;PSME3;UBB;PSMC4;PSMB6;ORC4;PSMB10;PSMA4;PSME1;ORC1;PSMF1;PSMB9;PSME2;PSMA8;MCM8
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.21040968543519825,-0.6577552776811532,0.9544072948328267,0.9841120308586093,1.0,6/28,19.19%,OCLN;SLAIN2;NAV3;GIT1;ARL2;MECP2
prerank,iron ion homeostasis (GO:0055072),0.24357830986554968,0.6575716233221808,0.9065656565656566,1.0,1.0,4/58,6.29%,HJV;HMOX2;FXN;ATP6V0A2
prerank,positive regulation of viral genome replication (GO:0045070),0.27149598570977473,0.657496695883823,0.8536585365853658,1.0,1.0,6/29,11.85%,CCL5;PPARA;PKN2;PPIE;TOP2B;CNOT7
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.28244896333677116,0.6573538126430992,0.8482549317147192,1.0,1.0,7/22,18.17%,RELA;ROCK2;ABCG1;CHRNA7;CLU;SP1;LRRTM3
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.30530254619189723,0.6566547812821304,0.8302521008403362,1.0,1.0,3/15,11.88%,NAF1;CCT3;RUVBL1
prerank,response to estradiol (GO:0032355),0.2765223404283109,0.6565463056791504,0.8780487804878049,1.0,1.0,2/31,3.73%,ANXA1;STRN3
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.24596653046378347,0.656428939821767,0.8997395833333334,1.0,1.0,4/57,7.53%,MEF2C;SHISA9;CNIH2;GSG1L
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.2648421250614893,-0.6562793973945139,0.896551724137931,0.9845430423567484,1.0,5/12,27.94%,NAE1;HUS1;CHEK2;CLSPN;ORC1
prerank,regulation of cell killing (GO:0031341),0.3036208768174443,0.6561012358415155,0.839527027027027,1.0,1.0,2/16,7.78%,CFH;TGFB2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.3276350421921085,0.6560590166946395,0.8266423357664233,1.0,1.0,3/10,13.94%,MAP2K1;GSTP1;MAPK1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.32873741096107667,0.6559544541917188,0.8268551236749117,1.0,1.0,2/10,7.68%,SMARCB1;CHEK1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.20760920232521296,-0.6558605281241917,0.9550173010380623,0.9841275665309882,1.0,8/31,26.58%,LYN;CEBPB;SDC4;ATM;CD80;CD274;CD86;SOX11
prerank,vesicle organization (GO:0016050),0.2498292585040549,0.6554905652814854,0.8984375,1.0,1.0,11/46,17.67%,HOOK2;SORT1;CAV1;HOOK1;CHMP2B;USP50;AKTIP;PLEKHJ1;CAV2;ARFGEF2;ZFYVE16
prerank,mRNA polyadenylation (GO:0006378),0.27909215218255057,0.655123477136547,0.8883792048929664,1.0,1.0,4/26,9.43%,WDR33;PCF11;PAPOLA;AHCYL1
prerank,RNA polyadenylation (GO:0043631),0.27909215218255057,0.655123477136547,0.8883792048929664,1.0,1.0,4/26,9.43%,WDR33;PCF11;PAPOLA;AHCYL1
prerank,regulation of cell cycle (GO:0051726),0.2172842045550025,0.654725343219614,0.9754098360655737,1.0,1.0,43/271,15.58%,MAP3K20;CDK6;FBXL22;TRNP1;MLF1;NR4A1;GMNN;JUND;MYBBP1A;DAB2IP;RPS6KA2;TP53;CHEK1;FZD9;TGFB2;SOX9;WHAMM;DAPK3;LIN37;CCND1;MAP2K1;CDK7;UHRF2;SIRT2;CRLF3;HNRNPU;BRINP1;GPER1;MFN2;RB1;LIN9;KIF20B;CITED2;FGF10;SON;EIF4G2;PRKACA;MLXIPL;DHCR24;SRPK2;FBXO5;MAPK12;STAT3
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.23011418367661446,-0.6545875870788984,0.9259259259259259,0.982892059512593,1.0,12/20,41.45%,IK;KLHL22;BUB3;MAD1L1;ATM;BUB1B;MAD2L1;TTK;APC;CENPF;KNTC1;TRIP13
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.23011418367661446,-0.6545875870788984,0.9259259259259259,0.982892059512593,1.0,12/20,41.45%,IK;KLHL22;BUB3;MAD1L1;ATM;BUB1B;MAD2L1;TTK;APC;CENPF;KNTC1;TRIP13
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.23011418367661446,-0.6545875870788984,0.9259259259259259,0.982892059512593,1.0,12/20,41.45%,IK;KLHL22;BUB3;MAD1L1;ATM;BUB1B;MAD2L1;TTK;APC;CENPF;KNTC1;TRIP13
prerank,protein targeting to mitochondrion (GO:0006626),-0.17947106728366902,-0.6544221451065796,0.9871794871794872,0.9822849822336455,1.0,24/52,40.31%,HSPA4;FBXO7;TIMM44;DNAJC19;FIS1;SAMM50;TOMM34;AIFM1;TIMM17B;HSPD1;IMMP2L;TOMM70;TIMM21;TIMM23;TIMM8B;TIMM10B;GRPEL1;NDUFA13;DNLZ;TOMM40L;TOMM40;TIMM50;GRPEL2;TIMM10
prerank,dendritic spine morphogenesis (GO:0060997),0.29825712341421556,0.654188769295523,0.8366013071895425,1.0,1.0,3/15,15.32%,DOCK10;EPHB1;PTEN
prerank,RNA methylation (GO:0001510),0.24066916783976103,0.654049371119142,0.8893178893178894,1.0,1.0,12/60,16.79%,TRDMT1;FTSJ1;TRMT10C;CBLL1;TFB2M;ZCCHC4;TGS1;METTL6;NSUN2;TRMT44;RBM15;WDR6
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.22978943793476192,0.6536029357127227,0.9198645598194131,1.0,1.0,21/96,16.11%,NUP62;WDR33;UPF1;U2AF2;SRSF4;SEC13;NUP153;ZC3H11A;MCM3AP;U2AF1;RBM8A;NUP107;AAAS;THOC7;DDX25;SRRM1;NUP37;NUP98;EIF4E;NUP210;FIP1L1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.2607854658228964,-0.6524186944856954,0.9267734553775744,0.9830544225539097,1.0,7/14,26.90%,SRSF7;SRSF6;SFSWAP;RBMX;PCBP4;RNPS1;SRSF12
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.31492462743347827,0.6523730502316286,0.8222591362126246,1.0,1.0,3/12,11.37%,LPCAT3;MBTPS1;SREBF2
prerank,RNA transport (GO:0050658),0.23530759804863013,0.6523377231512746,0.8968446601941747,1.0,1.0,16/71,15.49%,NUP62;ATXN2;U2AF2;SRSF4;NUP153;ZC3H11A;U2AF1;RBM8A;KIF5C;THOC7;SRRM1;ZFP36L1;XPO5;RFTN1;EIF4E;FLOT1
prerank,androgen receptor signaling pathway (GO:0030521),0.316990784508324,0.6516302434926232,0.8300536672629696,1.0,1.0,2/11,7.20%,ARID1A;AR
prerank,neuron cell-cell adhesion (GO:0007158),0.3071019158507357,0.6509598786243432,0.8422876949740035,1.0,1.0,2/14,8.25%,ASTN2;ASTN1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2613668404420587,0.650763022223651,0.893048128342246,1.0,1.0,14/41,20.82%,NUP62;SEC13;NUP153;HIF1A;NUP107;AAAS;ZBTB7A;NUP37;NUP98;NUP210;NUP54;NUP160;NUP133;TPR
prerank,synaptic vesicle localization (GO:0097479),0.30788473152998413,0.6505482190866614,0.8277027027027027,1.0,1.0,6/13,22.13%,KIF5B;KIF5C;KIF5A;DNM2;SNAPIN;SYNJ1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.23753444385241662,0.6503582229672736,0.9224137931034483,1.0,1.0,6/73,7.48%,FZD5;LPL;CD14;HAVCR2;ARHGEF2;RASGRP1
prerank,ether lipid biosynthetic process (GO:0008611),0.325912368252697,0.6501721205888573,0.8216911764705882,1.0,1.0,4/10,20.41%,PEDS1;PLA2G4A;PLA2G4C;CHPT1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.27329151145801484,0.6501198067910438,0.8615819209039548,1.0,1.0,7/26,15.00%,EIF4EBP1;USP2;DUSP3;PKN2;PPP1R10;EIF4E;PRKCA
prerank,regulation of cellular pH (GO:0030641),0.27358015632742566,0.6500201860977929,0.8630338733431517,1.0,1.0,4/29,8.05%,SLC4A8;SLC4A3;SLC4A7;SLC9A8
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3073764283183136,0.6496661139392484,0.8324225865209471,1.0,1.0,5/12,20.18%,ACO2;IDH3A;SIRT4;IREB2;IDH3B
prerank,protein localization to vacuole (GO:0072665),0.31110405059903423,0.6485902093254047,0.8384879725085911,1.0,1.0,2/13,10.93%,KPTN;SH3BP4
prerank,long-chain fatty acid metabolic process (GO:0001676),0.2346642114096165,0.6480130720111419,0.9085290482076638,1.0,1.0,15/64,19.89%,ALOX5;HSD17B4;ACSL5;FADS2;GSTP1;MGLL;SCP2;CPT1A;PNPLA3;PLA2G4A;PLA2G4C;EPHX1;ACSBG1;FAAH;AIG1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3076735342045352,0.6473040175952149,0.8639455782312925,1.0,1.0,1/13,2.86%,ASPH
prerank,lipoprotein biosynthetic process (GO:0042158),0.31521057003030617,0.647106542404794,0.8383128295254832,1.0,1.0,3/11,13.16%,ATG7;WDR45;PIK3C3
prerank,glycolipid metabolic process (GO:0006664),0.25215002775020395,0.6470525555427936,0.9037433155080213,1.0,1.0,11/47,17.86%,ESYT2;NEU3;GLA;SUMF1;ST3GAL2;GM2A;GLTP;GLB1;CTSA;ESYT1;SMPD2
prerank,regulation of lipid kinase activity (GO:0043550),-0.27018918024704086,-0.6463036027215495,0.9211136890951276,0.9869309965536529,1.0,2/11,7.81%,PIK3R3;WDR91
prerank,ribonucleoprotein complex assembly (GO:0022618),0.22032179675978214,0.6460309534928887,0.9411764705882353,1.0,1.0,28/132,17.75%,RPL3L;DENR;DDX23;TXNL4A;RPS27L;NLE1;CELF1;MDN1;CLNS1A;DICER1;NAF1;PRPF18;EIF2D;PWP2;PRMT7;RPL5;DDX1;SRSF10;TGS1;SF3B1;SRPK2;SF1;PUF60;XAB2;DHX9;BOP1;LUC7L;DHX29
prerank,tryptophan catabolic process (GO:0006569),0.31415900823244153,0.6457003536523407,0.8576388888888888,1.0,1.0,1/11,6.81%,KMO
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.23323982949407918,-0.6456617380922413,0.9095607235142119,0.9866527331819713,1.0,6/17,28.25%,PTPN22;CEACAM1;PTPN2;THY1;LAPTM5;PTPRJ
prerank,lymphocyte migration (GO:0072676),0.26334402518591543,0.6454437648699521,0.875177304964539,1.0,1.0,5/32,19.84%,CCL5;CCL14;CCL25;CCL19;RET
prerank,piRNA metabolic process (GO:0034587),-0.23298984082634064,-0.6454333107372876,0.9407008086253369,0.9860739424532018,1.0,17/19,64.07%,TEX15;TDRKH;EXD1;TDRD9;DDX4;TDRD12;PIWIL4;FKBP6;MAEL;MOV10L1;HENMT1;ASZ1;GPAT2;BTBD18;TDRD1;PIWIL1;PLD6
prerank,cell cycle checkpoint signaling (GO:0000075),-0.2617447132582637,-0.6444219605301065,0.9016018306636155,0.9860309390869338,1.0,6/12,34.82%,PLK2;CHFR;ZWILCH;WEE1;NABP1;BUB1B
prerank,regulation of keratinocyte proliferation (GO:0010837),0.27884377548819145,0.6437613546716705,0.86084142394822,1.0,1.0,5/22,13.29%,SNAI2;AREG;MED1;ZFP36L1;FGF10
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.24740725288640486,-0.6436272367343997,0.915,0.985855925387715,1.0,3/15,14.73%,TCF7L2;CAMK1;EMD
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.3203172005665807,0.6433926216099523,0.833916083916084,1.0,1.0,2/10,12.85%,CPEB1;CPEB3
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.21972460594452947,0.6432909296952278,0.9662090813093981,1.0,1.0,27/163,16.77%,MEF2C;CD79A;CD276;LAX1;BCL2;FYB2;PRKCQ;PSMC6;LCP2;RELA;PAK2;PSME4;PAG1;TNFRSF21;PSMB1;PSMD5;PDE4D;FBXW11;PSMB2;PLEKHA1;RFTN1;PSMB7;PSMD3;PRAM1;VAV3;PSMA2;PSMD14
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.29044395646023113,0.6430937790547919,0.8685897435897436,1.0,1.0,1/18,3.91%,LAX1
prerank,regulation of B cell apoptotic process (GO:0002902),0.3174484946748113,0.6418687741383878,0.8538324420677362,1.0,1.0,3/12,14.87%,IL2;BCL6;IRS2
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.24812486690565752,-0.6418499922613863,0.9156327543424317,0.9863906556163393,1.0,5/14,24.60%,MYO9A;OPHN1;CDC42;FSCN1;SCRIB
prerank,neuron apoptotic process (GO:0051402),0.2831587157589928,0.6416331532910309,0.8724727838258165,1.0,1.0,4/19,12.68%,BCL2;TRPC5;TNFRSF21;DIABLO
prerank,regulation of mRNA metabolic process (GO:1903311),-0.2620549726192264,-0.6411011060350713,0.9116279069767442,0.9861811167509101,1.0,2/11,18.30%,SAFB2;SRPK1
prerank,regulation of response to stress (GO:0080134),0.32475537512858793,0.6410154332482125,0.8617021276595744,1.0,1.0,1/10,5.28%,SLC38A2
prerank,maturation of LSU-rRNA (GO:0000470),-0.21321746778866432,-0.6392408393487871,0.941358024691358,0.986763436689844,1.0,8/26,23.31%,NSA2;RSL1D1;RPL7L1;URB1;MRPL1;RPF2;FTSJ3;RPL10A
prerank,coenzyme A metabolic process (GO:0015936),-0.25243723401941004,-0.6385124743015423,0.9185185185185185,0.9865362579773909,1.0,7/14,26.80%,PPCDC;PANK1;ACLY;CROT;DCAKD;ACOT7;PPCS
prerank,negative regulation of histone acetylation (GO:0035067),0.3105289812989839,0.6383873456239462,0.8471223021582733,1.0,1.0,1/11,4.31%,SET
prerank,negative regulation of protein ubiquitination (GO:0031397),0.24691767109586682,0.6376817253250159,0.920911528150134,1.0,1.0,13/50,19.47%,KLHL40;U2AF2;TAF1;CAV1;BAG2;ADGRB1;UFL1;USP4;FBXO5;ISG15;ABL1;N4BP1;SENP2
prerank,nuclear membrane reassembly (GO:0031468),0.24439804480629948,0.6368681106966492,0.8982412060301508,1.0,1.0,17/54,19.95%,CHMP4C;SEC13;SIRT2;IST1;NSFL1C;NUP107;CHMP2B;NUP37;CHMP2A;NUP98;VPS4A;UBXN2B;LMNA;SUMO1;UBE2I;NUP160;NUP133
prerank,protein acylation (GO:0043543),0.2569748089404866,0.6365801655768834,0.898236092265943,1.0,1.0,11/38,18.42%,NAT10;ZDHHC2;HHAT;ZDHHC1;ZDHHC14;ZDHHC17;CLOCK;ZDHHC13;ZDHHC8;ZDHHC5;ZDHHC3
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.26644430334270336,0.6364551766231497,0.8841010401188707,1.0,1.0,7/28,16.34%,PSMC6;DAB2IP;FBXW7;CLU;BAG2;PTEN;SMURF1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.31076379611312555,0.6358249511818153,0.853448275862069,1.0,1.0,3/12,14.23%,LPCAT3;DGAT1;MTTP
prerank,DNA repair (GO:0006281),0.20951894678435556,0.6355447553987176,0.9794661190965093,1.0,1.0,53/284,17.01%,HINFP;BRIP1;BTG2;MUTYH;RAD51AP2;GTF2H4;RAD51AP1;WDR33;UPF1;PIAS4;FAAP24;MLH3;PARP1;TP53;WRNIP1;TDP1;MBD4;RAD9A;CHEK1;REXO4;ERCC6;HUS1B;FTO;TENT4A;SLX4;USP1;FANCB;PSME4;FAAP100;FBXO6;RHNO1;DDX1;POLD1;FANCE;KPNA2;NSMCE4A;RMI2;SMARCA5;HPF1;TRIM28;ZRANB3;CSNK1E;MTA1;EXD2;KMT5B;RAD52;CHRNA4;BABAM1;MAD2L2;INO80;MGME1;RAD21;MSH2
prerank,oxoacid metabolic process (GO:0043436),-0.20637088646460164,-0.6347572801654799,0.9684542586750788,0.9883625643161615,1.0,5/27,15.30%,TPST1;BPNT2;PPA1;PPA2;ENPP1
prerank,positive regulation of synaptic transmission (GO:0050806),0.23347596100324142,0.6345447506483133,0.9175757575757576,1.0,1.0,5/72,5.91%,CRHR2;SLC8A2;GRIN2C;RIMS3;ZDHHC2
prerank,sensory perception of smell (GO:0007608),0.31110656421797744,0.6344934469190315,0.8263157894736842,1.0,1.0,1/11,4.51%,SYT10
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.2856856624706551,0.6344413695360854,0.8758278145695364,1.0,1.0,2/18,5.71%,KCNB1;IRS1
prerank,regulation of oxidoreductase activity (GO:0051341),0.2946755636243845,0.6341834073514959,0.8347386172006745,1.0,1.0,5/13,21.28%,SIRT4;MT3;ABL1;HDAC6;OXA1L
prerank,integrated stress response signaling (GO:0140467),0.3035470674151554,0.6336242809399008,0.8743882544861338,1.0,1.0,6/14,22.56%,IMPACT;EIF2AK3;EIF2AK4;DDIT3;EIF2S1;QRICH1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.2576160727807358,-0.6336047545933196,0.9219143576826196,0.9884107170148103,1.0,1/12,4.04%,RBP4
prerank,cell proliferation in forebrain (GO:0021846),0.3215113510616775,0.6334014994583997,0.8604206500956023,1.0,1.0,3/10,12.94%,AKNA;CEP120;NUMBL
prerank,sodium ion import across plasma membrane (GO:0098719),0.285417536769906,0.6328561703180865,0.8593220338983051,1.0,1.0,3/17,12.75%,SLC8A1;TRPM4;HCN2
prerank,regulation of adaptive immune response (GO:0002819),-0.23027205931839817,-0.6315793969746379,0.9441624365482234,0.9890478016953222,1.0,11/18,49.62%,ADCY7;AHR;SKAP1;PYCARD;IRF1;FCGR2B;IRF7;FADD;IL4I1;IL6ST;SASH3
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.28458269635297473,0.6314341567910291,0.8641571194762684,1.0,1.0,5/16,17.02%,CIRBP;RBMXL1;RBM3;NUP98;PRDX6
prerank,JNK cascade (GO:0007254),0.2555490954239128,0.6307206205758932,0.8905013192612137,1.0,1.0,3/40,8.12%,MAP3K5;MAP4K3;MAP3K10
prerank,inner mitochondrial membrane organization (GO:0007007),0.2476649452032369,0.6305585043271997,0.9067017082785808,1.0,1.0,8/47,11.80%,ATP5MF;AFG3L2;MTX1;OPA1;DNAJC11;TIMM29;ATP5MC1;ATP5MG
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.3116891463309769,0.6303912841603518,0.8676470588235294,1.0,1.0,1/11,4.22%,PARN
prerank,protein catabolic process (GO:0030163),0.23452105377050964,0.6296750253428248,0.9372647427854455,1.0,1.0,6/59,10.25%,PMAIP1;CLN5;SOCS6;DAB2IP;NR1D1;FBXO6
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.31099581153622324,0.6293425730791832,0.8441558441558441,1.0,1.0,1/11,4.40%,BCL2
prerank,glycine metabolic process (GO:0006544),0.3046263318066632,0.6291212952061921,0.8464163822525598,1.0,1.0,1/12,6.02%,DLD
prerank,regulation of actin nucleation (GO:0051125),-0.2601489277067958,-0.6288313248848101,0.9495192307692307,0.990149138709108,1.0,10/12,49.12%,ARFIP2;PICK1;ARPIN;GSN;ARFIP1;CORO1B;WASHC5;CORO1A;SCIN;ARF1
prerank,nucleosome assembly (GO:0006334),0.2542517011080931,0.6283309481936843,0.9041487839771102,1.0,1.0,10/31,19.59%,CHAF1B;SOX9;HAT1;CABIN1;SMARCA5;IPO4;RSF1;NAP1L4;NAP1L2;BRD2
prerank,mismatch repair (GO:0006298),0.26288695988794375,0.6278217230546388,0.8816738816738817,1.0,1.0,6/27,18.78%,MUTYH;MLH3;POLD1;MSH5;MSH2;ABL1
prerank,peptidyl-proline modification (GO:0018208),0.26452583326946055,0.6270006634713182,0.9146706586826348,1.0,1.0,7/25,17.54%,P3H2;PIN1;PPIL1;PPIE;PPWD1;PPIL3;FKBP4
prerank,T cell differentiation (GO:0030217),0.24580333270322985,0.6267412705995633,0.9030054644808743,1.0,1.0,6/40,12.26%,ANXA1;IL2;ADAM17;LMBR1L;RHOH;ZFP36L1
prerank,lipid biosynthetic process (GO:0008610),0.22903631390211335,0.6265697987079861,0.9330085261875761,1.0,1.0,10/77,12.37%,LPL;ALOX5;ACSL5;PDSS2;AGPAT3;MVD;PCYT2;SCP2;NDUFAB1;PDSS1
prerank,Golgi to lysosome transport (GO:0090160),0.31080987238895946,0.6262310372454174,0.875438596491228,1.0,1.0,2/11,9.45%,SORT1;ANKFY1
prerank,I-kappaB phosphorylation (GO:0007252),-0.26586234641420314,-0.6253509310688058,0.9256756756756757,0.9916168356497351,1.0,4/10,25.45%,CHUK;TLR3;PRDX4;ERC1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.2719863165007411,0.625290483553485,0.8892307692307693,1.0,1.0,8/24,19.87%,ALOX5;OPA1;LPCAT3;CLU;LRRK2;CREB3;NR1H3;WFS1
prerank,regulation of proteolysis (GO:0030162),0.24014566750804486,0.6252880067621129,0.9163398692810457,1.0,1.0,8/48,13.37%,ASPH;SERPINE2;CAV1;TRAF3;IST1;DNAJC1;FBXW11;PERP
prerank,extracellular transport (GO:0006858),-0.25533525206782925,-0.624957155409899,0.9267139479905437,0.9911213498747938,1.0,9/12,50.72%,SPEF2;ARRDC1;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,nuclear migration (GO:0007097),0.29864604883079876,0.6248206574104598,0.8585858585858586,1.0,1.0,4/13,12.04%,SYNE2;SUN2;FBXW11;CEP120
prerank,positive regulation of chromatin organization (GO:1905269),-0.24968362197848587,-0.6242036239128986,0.9115479115479116,0.99087011746432,1.0,6/12,33.55%,TERF2IP;MIER1;TAL1;TINF2;ATRX;ACD
prerank,tetrahydrofolate metabolic process (GO:0046653),0.3098203292035425,0.6237220653265781,0.8527827648114902,1.0,1.0,1/10,5.70%,MTHFD2L
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.30537417719564175,0.6227354296292383,0.8406593406593407,1.0,1.0,4/11,20.77%,CAV1;ACTN2;KCNH2;CAB39
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2409603343314081,0.6225189521039771,0.9214929214929215,1.0,1.0,7/54,11.57%,RPL3L;RRP15;RPF1;NLE1;MDN1;RPL5;MAK16
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.2997273758038784,0.6222478726190965,0.8638059701492538,1.0,1.0,3/13,8.15%,SLC2A10;RAMP1;PLCB1
prerank,regulation of chromosome segregation (GO:0051983),-0.23204742637814565,-0.6222389194692696,0.9328537170263789,0.9913088357786657,1.0,10/16,51.10%,PUM1;SMC5;CSNK2A1;CSNK2A2;RAD18;MKI67;CDC6;BUB1;IHO1;KIF2C
prerank,autophagosome organization (GO:1905037),0.23343691157046914,0.6209534600510108,0.912532637075718,1.0,1.0,8/50,13.16%,ATP2A2;ATG16L2;ATG7;GABARAP;NSFL1C;STX12;WDR45;PIK3C3
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.3133819767732057,0.6205374154524408,0.8639705882352942,1.0,1.0,2/10,8.90%,CAV1;IMPACT
prerank,regulation of DNA metabolic process (GO:0051052),0.24157978477948586,0.6202148839087027,0.9154557463672391,1.0,1.0,8/44,12.02%,UPF1;WRNIP1;USP1;KAT7;PDGFA;PARG;TERF2;KPNA2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.2838979648296639,0.6196718954253868,0.8650927487352446,1.0,1.0,1/15,2.99%,FAM83D
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.18780040385234859,-0.6194690328401021,0.9868852459016394,0.9922665427703016,1.0,21/36,44.74%,WNT5A;PRKN;IRGM;PARP14;NLRC5;AGPAT1;CASP4;LAPTM5;AGPAT2;EDN1;HSPA1A;TRIM6;TXK;CASP1;IL7;ZBP1;CXCR4;CD300LF;PARP9;FADD;C1QTNF4
prerank,protein acetylation (GO:0006473),0.261188437633058,0.6193227812537764,0.9,1.0,1.0,5/30,15.03%,NAT10;MAPT;HAT1;CLOCK;NAA35
prerank,positive regulation of protein catabolic process (GO:0045732),0.22228823152241506,0.6185148363415403,0.9471210340775558,1.0,1.0,15/84,17.64%,NKD1;OAZ2;PACSIN3;ATG7;DAB2IP;NEDD4;AMER1;NSF;SNX9;VGLL4;SMURF1;VPS35;TNFSF12;FAF1;ADRA2A
prerank,response to ionizing radiation (GO:0010212),0.22264499593589618,0.6183108351380828,0.9457459926017263,1.0,1.0,18/70,19.88%,ANXA1;NET1;RAD51AP1;TP53;RAD9A;BRSK1;PAXIP1;RHNO1;CLOCK;MTA1;INTS7;BABAM1;INO80;MSH2;USP28;MEN1;SWI5;RAD9B
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.2587241528615863,0.6182489011416882,0.8913690476190477,1.0,1.0,8/29,17.88%,CENPP;CENPO;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1
prerank,CENP-A containing chromatin organization (GO:0061641),0.2587241528615863,0.6182489011416882,0.8913690476190477,1.0,1.0,8/29,17.88%,CENPP;CENPO;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.2250130265842752,0.6180996586682859,0.9263657957244655,1.0,1.0,18/73,21.70%,POLR2L;ACTB;MYBBP1A;ERCC6;PRMT7;POLR1E;POLR1H;SF3B1;SMARCA5;MTA1;TFAP2C;TAF1A;HDAC6;DNMT3A;MYO1C;EZH2;H3-3A;CTCF
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.26659390891559354,-0.6180392765011589,0.9386363636363636,0.9923684980025156,1.0,4/10,35.22%,DNAJB2;DNAJA4;DNAJB1;HSPA1A
prerank,cellular response to leucine (GO:0071233),-0.2627380241105046,-0.6179639070354092,0.9141630901287554,0.9909245485668429,1.0,5/10,30.86%,UBR2;KLHL22;SESN2;RRAGD;RPTOR
prerank,response to leucine (GO:0043201),-0.2627380241105046,-0.6179639070354092,0.9141630901287554,0.9909245485668429,1.0,5/10,30.86%,UBR2;KLHL22;SESN2;RRAGD;RPTOR
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.3113264516953236,0.6178737579318632,0.852994555353902,1.0,1.0,2/10,10.02%,LIN7C;ARHGAP12
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.21225070545166486,-0.6178048809999432,0.94579945799458,0.9902623894308406,1.0,7/23,24.87%,COPS2;UBC;DDB1;XPA;UBB;COPS7B;RAD23B
prerank,regulation of cellular amine metabolic process (GO:0033238),0.23986735180228672,0.6174338464719071,0.9112801013941698,1.0,1.0,10/50,16.77%,OAZ2;PSMC6;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.2678197883065879,-0.6174190706723583,0.9239373601789709,0.9897420138959219,1.0,2/10,13.45%,IL33;KDR
prerank,mRNA export from nucleus (GO:0006406),0.2159222350095111,0.616306300127241,0.9660249150622876,1.0,1.0,21/102,16.11%,NUP62;WDR33;UPF1;U2AF2;SRSF4;SEC13;NUP153;ZC3H11A;MCM3AP;U2AF1;RBM8A;NUP107;AAAS;THOC7;DDX25;SRRM1;NUP37;NUP98;EIF4E;NUP210;FIP1L1
prerank,base-excision repair (GO:0006284),0.2416100319825847,0.6162879405340241,0.919631093544137,1.0,1.0,7/48,11.72%,MUTYH;PARP1;MBD4;ERCC6;PARG;POLD1;POLG
prerank,regulation of protein transport (GO:0051223),0.2667095787639181,0.6161839295371692,0.8905775075987842,1.0,1.0,3/27,11.74%,LCP1;PTPN1;DNAJC1
prerank,receptor metabolic process (GO:0043112),0.23263708681110457,0.6152617739687922,0.934260429835651,1.0,1.0,11/53,17.26%,CD36;ITGB1;CAV1;NEDD4;RAMP1;PLEKHJ1;LDLRAP1;SNX1;DNM2;SMURF1;ARFGEF2
prerank,determination of bilateral symmetry (GO:0009855),0.2594372124976861,0.6150943518705269,0.8929663608562691,1.0,1.0,5/24,17.49%,KIF3B;DNAH11;CITED2;FOXJ1;GALNT11
prerank,negative regulation of B cell activation (GO:0050869),0.2694732510181086,0.6148265551676734,0.8909952606635071,1.0,1.0,4/21,13.72%,CD300A;SAMSN1;TNFRSF21;FOXJ1
prerank,mRNA methylation (GO:0080009),0.28602685236393716,0.6148155247090916,0.8659966499162479,1.0,1.0,3/15,13.27%,TRMT10C;CBLL1;NSUN2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.2565537947999674,0.6144626900171342,0.9078751857355126,1.0,1.0,3/27,7.67%,PARN;PCF11;DICER1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.28461366724236187,0.6139490431689204,0.8778979907264297,1.0,1.0,3/17,11.51%,MUTYH;MBD4;TERF2
prerank,calcium-ion regulated exocytosis (GO:0017156),0.2631570531364464,0.6124249205162379,0.891970802919708,1.0,1.0,3/27,8.01%,RIMS3;SYT10;ARHGAP17
prerank,TOR signaling (GO:0031929),-0.19609710974897737,-0.6122825235198002,0.9588235294117647,0.9919890326289965,1.0,7/26,21.71%,SMG1;NPRL3;PRR5L;AKT1;RPS6KB2;SYAP1;MAPKAP1
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.1735696514996761,-0.6114605616594722,0.9838056680161943,0.9916925588357657,1.0,22/46,40.31%,FBXO7;TIMM44;DNAJC19;FIS1;AKT1;TOMM34;AIFM1;TIMM17B;HSPD1;TOMM70;TIMM21;TIMM23;TIMM8B;TIMM10B;GRPEL1;DNLZ;TOMM40L;TOMM40;TIMM50;GRPEL2;RALA;TIMM10
prerank,regulation of cell division (GO:0051302),0.21938572031235554,0.6113597159918118,0.9588377723970944,1.0,1.0,10/72,13.16%,FGF1;EFHC1;PIN1;CALM1;INSC;SIRT2;RAB11FIP4;RAB11FIP3;HTR2B;PIK3C3
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.25121094851277126,0.6107817011157938,0.9250720461095101,1.0,1.0,6/32,13.94%,PARN;PRKCQ;PKIB;NAF1;CCT3;MAPK1
prerank,phospholipid biosynthetic process (GO:0008654),0.24664622063003944,0.610639004449353,0.9269662921348315,1.0,1.0,8/36,13.26%,IDI1;DHDDS;AGPAT3;MVD;PCYT2;SAMD8;SRD5A3;CPNE3
prerank,serine family amino acid metabolic process (GO:0009069),0.2824671808366911,0.6103583585503476,0.8793969849246231,1.0,1.0,2/16,9.31%,SEPHS2;SEPSECS
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.23049108417831118,-0.6101872972754179,0.9478908188585607,0.9916181546382077,1.0,8/17,41.78%,IK;BUB3;ZWILCH;BOD1;KNL1;TTK;SPDL1;CENPA
prerank,negative regulation of mitochondrion organization (GO:0010823),0.25367025790074876,0.6095495358807926,0.9204052098408104,1.0,1.0,7/33,13.69%,FXN;MAPT;OPA1;FZD9;CLU;ADCK1;MUL1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.20537977439197536,0.60897134903642,0.9767441860465116,1.0,1.0,42/184,19.14%,DYNLL1;CEP41;HAUS8;CEP290;ANAPC10;PSMC6;TPX2;UBE2E1;ANLN;PSME4;CEP192;SIRT2;CENPE;PSMB1;PSMD5;UBE2D1;DYNC1I2;NEDD1;ZFP36L1;PSMB2;CEP72;CLASP1;DCTN3;CEP43;CSNK1E;HAUS7;HAUS2;PSMB7;PSMD3;PRKACA;FBXO5;PLK4;PSMA2;INO80;PSMD14;ANAPC16;DCTN1;ANAPC5;ANAPC11;HAUS4;RPS27A;CEP135
prerank,amyloid precursor protein catabolic process (GO:0042987),0.28334411214454575,0.6087865222818378,0.872168284789644,1.0,1.0,4/14,13.50%,DYRK1A;ADAM17;ABCG1;ADAM19
prerank,negative regulation of cell death (GO:0060548),0.2168580742258767,0.6085355845644235,0.9655581947743468,1.0,1.0,13/88,13.77%,CCN1;FERMT2;NUP62;INPP5A;CD200R1;CD200;PPARGC1A;ADNP2;IMPACT;HTR2B;CLU;CHMP2A;LRRK2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.2979893421099739,0.608286467830248,0.8706099815157117,1.0,1.0,1/12,4.40%,BCL2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.2588697183271335,-0.6081813533618772,0.9388235294117647,0.9920207917190207,1.0,7/10,44.01%,GNB5;FMR1;DRD2;CALM3;CBARP;GPR35;CRHR1
prerank,establishment of epithelial cell polarity (GO:0090162),-0.21902744917041816,-0.607894336679784,0.9640883977900553,0.9914400555201967,1.0,5/19,17.61%,GOLPH3;MYO9A;OPHN1;CYTH1;CDC42
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.27255409477797166,0.6075793284567436,0.8906009244992296,1.0,1.0,1/21,3.17%,HK2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.2334108693804045,-0.6073674118881965,0.9312977099236641,0.9909942556681361,1.0,2/15,8.85%,LDLR;SIK1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.24121588017628492,0.6070470176071433,0.9189944134078212,1.0,1.0,9/38,15.68%,PHLDA3;PPARA;THEM4;EPHA2;GPER1;MUL1;PLEKHA1;PTEN;PPP2R5C
prerank,endosome organization (GO:0007032),0.23823467951617117,0.6070421449729676,0.9176954732510288,1.0,1.0,7/41,12.61%,HOOK2;CORO1C;HOOK1;CHMP2B;USP50;AKTIP;PLEKHJ1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.2478961890187862,0.6064447527277997,0.9147398843930635,1.0,1.0,1/30,1.17%,KLHL40
prerank,RNA 3'-end processing (GO:0031123),0.22108969058243955,0.6064047926717007,0.9547169811320755,1.0,1.0,11/69,12.20%,WDR33;PCF11;U2AF2;SRSF4;TENT4A;PAPOLA;ZC3H11A;U2AF1;RBM8A;THOC7;SRRM1
prerank,cellular response to chemokine (GO:1990869),0.2400740504159972,0.605997767319123,0.926829268292683,1.0,1.0,2/46,3.45%,DOCK8;CCL5
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.2707821414161051,0.6059910446909152,0.9011164274322169,1.0,1.0,1/19,2.11%,PDGFB
prerank,microglial cell activation (GO:0001774),-0.2124312314189611,-0.6041949586954232,0.9540229885057471,0.9919628034195366,1.0,4/21,16.58%,APP;CX3CL1;SNCA;GRN
prerank,glutamine family amino acid metabolic process (GO:0009064),0.24365901521094913,0.6035752937354638,0.916083916083916,1.0,1.0,7/33,13.93%,RIMKLA;ART4;GOT1;GOT2;GLS;GLS2;SIRT4
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.22242248460672398,0.6034597660884355,0.9637243047158404,1.0,1.0,16/72,19.05%,POLR2L;POLR2I;GTF2H4;POLR2G;ERCC6;PPIE;CDK7;POLD1;COPS8;POLR2J;COPS4;XAB2;COPS6;HMGN1;MNAT1;RPS27A
prerank,regulation of interferon-alpha production (GO:0032647),0.26518912227423347,0.6032506922089094,0.9092284417549168,1.0,1.0,8/23,24.03%,PTPRS;HAVCR2;STAT1;DHX9;IRF3;TLR7;TBK1;SETD2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.23931012518071693,0.6029111725132513,0.9396433470507545,1.0,1.0,4/37,9.58%,MYD88;ALOX5;PPARA;HIF1A
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.21467827727237823,0.6027906769176741,0.9766355140186916,1.0,1.0,18/87,17.58%,CDK6;FHL1;JADE1;PSMC6;PSME4;PSMB1;PSMD5;RB1;ZFP36L1;PSMB2;PSMB7;PSMD3;PTEN;FBXO5;PSMA2;CDK2AP2;PSMD14;BRD7
prerank,phosphate ion transport (GO:0006817),0.2815689182172927,0.6022930868836953,0.8733108108108109,1.0,1.0,2/16,9.16%,SLC20A2;XPR1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.21847695079767124,-0.6016391226846214,0.9604221635883905,0.9925500234785952,1.0,1/17,1.55%,CADM1
prerank,interstrand cross-link repair (GO:0036297),0.23169324092766033,0.6016359398713143,0.9439252336448598,1.0,1.0,8/53,11.96%,RAD51AP2;RAD51AP1;FAAP24;SLX4;USP1;FANCB;FAAP100;FANCE
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.23863834185804084,-0.6009674604454336,0.9667519181585678,0.9921799665647678,1.0,10/14,38.90%,ZBTB8OS;TSEN34;CPSF4;CSTF2;CPSF1;CLP1;TSEN54;TRPT1;TSEN15;RTRAF
prerank,regulation of neuron projection arborization (GO:0150011),-0.23031100878937083,-0.6008515537671681,0.9397905759162304,0.9914997041536125,1.0,7/15,27.18%,WNT5A;MYO9A;MFSD2A;GRIP1;MOV10;DVL2;NTNG1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.22861021863304148,0.600763433320387,0.9581151832460733,1.0,1.0,10/56,13.53%,ROCK1;EFHC1;SPIRE1;ANLN;IST1;SNX18;ROCK2;SNX9;SON;DCTN3
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.2581323189985673,0.600111632225664,0.9142419601837672,1.0,1.0,6/25,13.76%,KANK1;YAP1;PRKCD;TCHP;CAPZB;ARHGAP24
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2141755519215055,0.5998894914120388,0.9716874292185731,1.0,1.0,27/100,20.43%,KLHL40;SOCS5;PABIR1;GABARAP;TAF1;RNF180;GNA12;SIRT2;EIF3H;CLU;BAG2;LRRK2;CSNK1E;DVL1;UFL1;CSNK1A1;HSPBP1;XPO1;MAP1A;PIAS1;RCHY1;N4BP1;DESI1;SUMO1;UCHL5;FHIT;FOXF2
prerank,positive regulation of histone acetylation (GO:0035066),0.25892887642088247,0.5990870268754459,0.9112781954887218,1.0,1.0,4/23,9.42%,SMARCB1;PPARGC1A;PAXIP1;KAT7
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.22205135317647265,-0.5990653991713705,0.9620253164556962,0.99172426361987,1.0,1/16,1.55%,CADM1
prerank,regulation of isotype switching (GO:0045191),0.28040222178278895,0.5990273149836659,0.8968903436988543,1.0,1.0,4/14,16.25%,PAXIP1;RIF1;KMT5B;MAD2L2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.2419737945415609,0.598907463168395,0.9315642458100558,1.0,1.0,5/33,13.91%,DUSP3;RELA;CD300A;NECTIN2;DGKZ
prerank,chromatin assembly (GO:0031497),0.23753883102011936,0.5986031509981048,0.9415855354659249,1.0,1.0,12/38,21.70%,H1-0;CHAF1B;TP53;SOX9;SMARCA5;CDAN1;RSF1;NAP1L4;NAP1L2;BRD2;H3-3A;CTCF
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2401774621755094,0.5984820701524141,0.9329608938547486,1.0,1.0,6/35,13.94%,PARN;PRKCQ;PKIB;NAF1;CCT3;MAPK1
prerank,phosphate ion transmembrane transport (GO:0035435),0.2953501319446741,0.5976081202289489,0.8987566607460036,1.0,1.0,2/12,9.16%,SLC20A2;XPR1
prerank,dopaminergic neuron differentiation (GO:0071542),0.27101775076877094,0.5971520156697454,0.8887043189368771,1.0,1.0,3/19,16.80%,VEGFA;NR4A2;RYK
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.261853160642109,0.5960834119739079,0.9139784946236559,1.0,1.0,4/21,10.42%,MED1;MED12;PAXIP1;MED14
prerank,maturation of SSU-rRNA (GO:0030490),0.24645765286605711,0.5956052984414273,0.9333333333333333,1.0,1.0,4/34,8.88%,NAT10;NOB1;WDR46;PWP2
prerank,regulation of intracellular pH (GO:0051453),0.24119693682309065,0.5955272160241468,0.9209039548022598,1.0,1.0,4/34,8.05%,SLC4A8;SLC4A3;SLC4A7;SLC9A8
prerank,defense response to bacterium (GO:0042742),0.20960173532586643,0.5954527127597993,0.969732246798603,1.0,1.0,18/105,17.89%,MYD88;DMBT1;RARRES2;LYST;MBL2;ADAM17;LPO;PRKCD;GBP2;DROSHA;CFP;ADGRB1;RNASE3;MR1;MPEG1;S100A8;S100A9;ISG15
prerank,chromatin remodeling at centromere (GO:0031055),0.2467266353421799,0.5951659946651664,0.930780559646539,1.0,1.0,8/31,17.88%,CENPP;CENPO;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1
prerank,innate immune response in mucosa (GO:0002227),-0.257398353312241,-0.5949852170876032,0.9568034557235421,0.9930171851575229,1.0,1/10,8.89%,DEFA6
prerank,protein alkylation (GO:0008213),0.2563401898368992,0.5949121541026028,0.9119010819165378,1.0,1.0,9/22,19.81%,METTL22;GSPT1;VCPKMT;EEF1AKMT2;ETF1;PCMT1;FAM98B;SNRPD3;PRMT1
prerank,positive regulation of transport (GO:0051050),0.2128685917719454,0.5945140359748543,0.9664739884393063,1.0,1.0,5/85,5.88%,MERTK;KCTD7;ANXA1;ACTB;CBLL1
prerank,transferrin transport (GO:0033572),0.24560820355237672,0.5942753270957957,0.9206798866855525,1.0,1.0,8/33,19.34%,ATP6V1H;ATP6V0A2;ARHGAP1;ATP6V1C1;ATP6V0D2;DNM2;CLTC;ATP6V0C
prerank,retinol metabolic process (GO:0042572),-0.22962645661691194,-0.5941461364650538,0.9404466501240695,0.9926877177143103,1.0,2/14,9.35%,RBP4;CYP1B1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.1779450185059014,-0.5940844788771406,0.9855072463768116,0.9919727405007117,1.0,14/38,30.79%,GEMIN8;SART3;SNRPD1;GEMIN7;SMN1;PRPF19;LSM2;AAR2;PRPF31;PRPF8;SRSF12;PRPF3;SART1;DDX20
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.25695262939143465,-0.592266218257724,0.9346846846846847,0.9920959683578793,1.0,1/10,2.73%,PRKCH
prerank,positive regulation of protein deacetylation (GO:0090312),-0.23108547489882938,-0.5914047906976277,0.9587378640776699,0.9917774152382105,1.0,8/14,38.52%,AKAP8;AKAP8L;ZBTB7B;SAP30BP;APLNR;BRMS1;FNTA;ING2
prerank,regulation of mitochondrial depolarization (GO:0051900),0.2985957761965734,0.5904251075601336,0.857397504456328,1.0,1.0,3/10,13.77%,BCL2;FZD9;LRRK2
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.25629291244304747,-0.5901889306051816,0.9443207126948775,0.9916104527796229,1.0,5/10,37.02%,KDM1A;ATRX;JARID2;BRCA1;DNMT3B
prerank,chromatin remodeling (GO:0006338),0.21042801066643435,0.5900476744641653,0.9726027397260274,1.0,1.0,16/100,13.35%,SMARCD3;CHRAC1;ARID1A;ACTB;SUV39H2;SMARCB1;INO80C;SOX9;ERCC6;RB1;BAZ2A;ZBTB7A;HNRNPC;RUVBL1;SMARCA5;CHD4
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.2744505978696206,0.5897951720742121,0.9146757679180887,1.0,1.0,4/15,15.49%,EHD2;CD53;ADGRB1;FLOT1
prerank,nuclear pore complex assembly (GO:0051292),0.29747184267667415,0.5884317639720227,0.8864864864864865,1.0,1.0,3/10,14.16%,NUP153;NUP107;NUP98
prerank,centromere complex assembly (GO:0034508),0.23613905543797034,0.5879620793277434,0.9375886524822695,1.0,1.0,9/36,17.88%,CENPP;CENPO;CENPE;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1
prerank,DNA catabolic process (GO:0006308),0.2898509398180705,0.5875354570998281,0.9177101967799642,1.0,1.0,2/11,13.83%,REXO4;DNASE1L1
prerank,rRNA modification (GO:0000154),0.2568407483448195,0.5874860387190948,0.918918918918919,1.0,1.0,3/21,11.61%,NAT10;TFB2M;ZCCHC4
prerank,intracellular protein transmembrane transport (GO:0065002),0.2291400628601032,0.5865205021570732,0.9436241610738255,1.0,1.0,3/42,5.39%,ZFAND2B;RTN2;PEX2
prerank,positive regulation of immunoglobulin production (GO:0002639),0.24458886732179697,0.5864213181066474,0.9551820728291317,1.0,1.0,5/31,16.25%,IL2;PAXIP1;RIF1;KMT5B;MAD2L2
prerank,negative regulation of viral process (GO:0048525),0.21788675023668674,0.5849986746573956,0.9540942928039702,1.0,1.0,13/57,19.11%,CCL5;HEXIM1;MBL2;TNIP1;EIF2AK2;TRIM35;OASL;TRIM28;STAT1;SRPK2;ISG15;ILF3;N4BP1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.2257720151532917,0.5846894830471274,0.9382871536523929,1.0,1.0,10/53,16.77%,OAZ2;PSMC6;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.2791757129142495,0.5842199319945963,0.8974820143884892,1.0,1.0,2/12,9.05%,AR;GSTP1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.19525055577858752,-0.584127218844209,0.9710610932475884,0.9936605612952348,1.0,2/28,3.24%,ARHGAP28;RASA1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.2408113247029841,-0.5840881784363967,0.9311926605504587,0.9929406005267889,1.0,5/12,32.44%,UPP2;DHODH;UMPS;CDA;CAD
prerank,regulation of synapse maturation (GO:0090128),-0.2529274139302229,-0.5836817638683738,0.9498861047835991,0.9923923041600105,1.0,4/10,27.28%,NRXN1;ARHGEF15;YWHAZ;RELN
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.22967914775767106,-0.5833940539113736,0.9448441247002398,0.9918069290117102,1.0,6/13,31.83%,HSPA5;NCK1;DNAJB9;RACK1;PPP1R15B;ATF6B
prerank,lipoxygenase pathway (GO:0019372),0.26936029101928777,0.5826528419311346,0.9094076655052264,1.0,1.0,1/14,4.34%,ALOX5
prerank,positive regulation of isotype switching (GO:0045830),0.26947358072684835,0.5814294368124332,0.909688013136289,1.0,1.0,4/15,16.25%,PAXIP1;RIF1;KMT5B;MAD2L2
prerank,macromolecule catabolic process (GO:0009057),0.24158207528917355,0.5806655604409721,0.9335260115606936,1.0,1.0,2/26,7.01%,CLN5;NEDD4
prerank,intracellular pH reduction (GO:0051452),0.23597497365847678,0.5801963153116221,0.9468531468531468,1.0,1.0,13/33,25.85%,ATP6V1H;ATP6V0A2;ATP6V1C1;ATP6V0D2;RAB38;ATP6V0C;DMXL1;ATP6V1F;ATP6V0E1;ATP6V1B2;RAB7A;ATP6V1G2;ATP6V0A1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.25384514729413066,-0.5798093613155821,0.9455337690631809,0.9926669903933253,1.0,2/10,11.60%,LGALS9;LYN
prerank,response to light stimulus (GO:0009416),0.2186008409152242,0.579777705307044,0.9623115577889447,1.0,1.0,9/55,13.78%,MAP4K3;CIRBP;CPT1B;ERCC6;BRSK1;USP1;POLD1;CLOCK;ZRANB3
prerank,apoptotic nuclear changes (GO:0030262),0.24507227606547854,0.5795539687880376,0.94375,1.0,1.0,4/24,11.01%,H1-0;DICER1;DEDD2;GPER1
prerank,response to UV (GO:0009411),0.20400347938095703,0.5795067319621452,0.9725400457665904,1.0,1.0,23/95,19.11%,MAP4K3;TAF1;PARP1;TP53;CIRBP;NEDD4;ERCC6;RELA;CCND1;BRSK1;USP1;RHNO1;PRKCD;POLD1;ZRANB3;INO80;MSH2;SPRTN;EIF2AK4;UBE2A;USP28;MEN1;N4BP1
prerank,synaptonemal complex organization (GO:0070193),0.2709598677760653,0.5787406804912014,0.9069373942470389,1.0,1.0,14/15,61.22%,SYCP2;RAD21;SYCE3;SYCE1;SYCP1;HORMAD1;RAD21L1;STAG3;TEX12;SYCE2;TRIP13;BAG6;REC8;TEX11
prerank,synaptonemal complex assembly (GO:0007130),0.2709598677760653,0.5787406804912014,0.9069373942470389,1.0,1.0,14/15,61.22%,SYCP2;RAD21;SYCE3;SYCE1;SYCP1;HORMAD1;RAD21L1;STAG3;TEX12;SYCE2;TRIP13;BAG6;REC8;TEX11
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.23202932171383348,0.5779310432279282,0.9422535211267605,1.0,1.0,4/36,11.65%,KLHL40;F8A1;PSME3IP1;EIF3H
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.22686429728208085,-0.577852451559248,0.9497354497354498,0.9927984428512603,1.0,9/14,37.07%,ENPP3;ITPA;ENPP1;AK4;SMPDL3A;AK1;NME2;AK5;AK3
prerank,regulation of aerobic respiration (GO:1903715),0.26666493300270605,0.5776953186993958,0.9042386185243328,1.0,1.0,1/15,4.72%,COX7A2L
prerank,cellular response to oxygen levels (GO:0071453),-0.2492920253560874,-0.5773596167940895,0.9478458049886621,0.9922776321471353,1.0,5/10,26.87%,ATP6AP1;ATP6V1G1;PICK1;ATP6V0D1;TMEM199
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2272290598805069,0.5763987661363907,0.9318801089918256,1.0,1.0,9/40,15.38%,MAPT;WRNIP1;USP1;PRKCD;PARG;NSMCE4A;MCL1;FEM1B;FBXO5
prerank,GTP metabolic process (GO:0046039),0.2654784422222885,0.5759561204866844,0.9073426573426573,1.0,1.0,3/15,13.77%,ENTPD7;OPA1;LRRK2
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.24849385517391848,-0.5750811767599361,0.9525959367945824,0.9924709884109683,1.0,4/10,24.95%,MTMR4;DNAJC19;MFSD2A;MTMR2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.2550504050150204,0.5749696324023833,0.9114139693356048,1.0,1.0,2/17,7.78%,CCL5;TGFB2
prerank,motile cilium assembly (GO:0044458),-0.22951207757508055,-0.5747615024131291,0.9641943734015346,0.9918568153641545,1.0,2/12,18.55%,CCDC39;E2F4
prerank,regulation of sister chromatid cohesion (GO:0007063),0.2743687870310877,0.5746390599719029,0.9036608863198459,1.0,1.0,4/12,21.73%,RB1;RAD21;CTCF;WAPL
prerank,glutamate metabolic process (GO:0006536),0.2517300495410111,0.5735986316749597,0.8930722891566265,1.0,1.0,4/19,11.14%,GOT1;GOT2;GLS;GLS2
prerank,mitotic nuclear membrane organization (GO:0101024),0.22260487193568768,0.5733799678754075,0.9655172413793104,1.0,1.0,15/51,19.95%,CHMP4C;SEC13;SIRT2;IST1;NUP107;CHMP2B;NUP37;CHMP2A;NUP98;VPS4A;LMNA;SUMO1;UBE2I;NUP160;NUP133
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.22260487193568768,0.5733799678754075,0.9655172413793104,1.0,1.0,15/51,19.95%,CHMP4C;SEC13;SIRT2;IST1;NUP107;CHMP2B;NUP37;CHMP2A;NUP98;VPS4A;LMNA;SUMO1;UBE2I;NUP160;NUP133
prerank,nuclear body organization (GO:0030575),0.2828832371022666,0.5729954722351543,0.8904593639575972,1.0,1.0,7/12,23.29%,USP50;SRPK2;HIPK2;HABP4;SERBP1;ETS1;ZPR1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.26049310960076055,0.5726204677518324,0.9228130360205832,1.0,1.0,5/15,18.78%,RPL5;BAG2;FBXO5;MAD2L2;ABL1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.2634749303368376,0.5725604095229057,0.9174454828660437,1.0,1.0,6/20,16.57%,BBS12;LONP1;CLU;HOPX;PTGES3L;NDUFAF1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.2853346761945426,0.572281790661983,0.9277777777777778,1.0,1.0,2/10,9.84%,GNE;ST6GAL1
prerank,innate immune response (GO:0045087),0.1916638129750106,0.5713251154374099,0.9968976215098242,1.0,1.0,14/217,10.14%,NCF2;MYD88;FRK;ATAD3A;MFHAS1;DMBT1;RARRES2;TIFA;MBL2;RELA;TRIM68;SLA;MASP2;ZDHHC1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.20363023458269047,0.5711915910196196,0.9756662804171495,1.0,1.0,17/88,17.74%,FBXL22;CUL2;PSMC6;FBXW7;FBXL18;PSME4;FBXO6;PSMB1;PSMD5;FBXW11;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14;CCNF;CUL5
prerank,positive regulation of nervous system process (GO:0031646),0.25706410791699963,0.5709988152554516,0.9285714285714286,1.0,1.0,3/18,12.03%,TPPP;DICER1;ATPSCKMT
prerank,ncRNA catabolic process (GO:0034661),0.23416904334113853,0.5709813233794458,0.943683409436834,1.0,1.0,4/28,10.78%,PARN;DIS3L2;DEDD2;DIS3L
prerank,regulation of cellular protein catabolic process (GO:1903362),0.25622611808126255,0.5707760674103184,0.9375,1.0,1.0,5/18,17.38%,DAB2IP;AMER1;VGLL4;VPS35;FAF1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.19911060719138152,-0.5689648646418924,0.978494623655914,0.9933300445491721,1.0,5/21,18.99%,IK;KLHL22;BUB3;MAD1L1;ATM
prerank,regulation of mitotic cell cycle (GO:0007346),0.19458320999789644,0.5689229317282065,0.9894957983193278,1.0,1.0,36/171,18.22%,BTG2;EIF4EBP1;USP2;ANAPC10;PSMC6;DUSP3;PIN1;CUL9;HECA;BTG1;DAPK3;UBE2E1;PKN2;PSME4;PSMB1;HNRNPU;PSMD5;BRINP1;UBE2D1;TRIM35;RB1;KIF20B;PSMB2;EIF4E;PSMB7;PSMD3;PRKCA;FBXO5;CAV2;TTC28;PSMA2;PSMD14;ANAPC16;ANAPC5;BRINP2;ANAPC11
prerank,regulation of cell cycle process (GO:0010564),0.1981299859135863,0.5688778579775166,0.9884925201380897,1.0,1.0,20/104,16.69%,TIPIN;PIN1;YTHDF2;CALM1;CUL9;CHEK1;SOX9;DAPK3;RAB11FIP4;RAB11FIP3;GPER1;CEP85;KIF20B;RMI2;PIK3C3;KNSTRN;FBXO5;CAV2;PLK4;MAP9
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.2026491002434626,-0.5684986542515039,0.9781420765027322,0.9927606849510896,1.0,3/20,11.99%,ARRB1;TADA2A;SOX4
prerank,microtubule depolymerization (GO:0007019),0.2642435152224491,0.5683687381151002,0.929553264604811,1.0,1.0,5/17,20.81%,KIF2A;KIF18A;STMN2;CKAP5;STMN3
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.24826302932886032,0.5672000657732601,0.9267100977198697,1.0,1.0,7/21,19.61%,TTC23;STK36;TUBD1;RAB34;KIF7;DLG5;UCHL5
prerank,DNA duplex unwinding (GO:0032508),0.21719754025513188,0.566753836228797,0.950863213811421,1.0,1.0,5/50,11.00%,ANXA1;GTF2H4;PARP1;MCMDC2;DDX1
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.2205209314904149,-0.5667414725640193,0.9625550660792952,0.9927006092926624,1.0,5/13,32.29%,IL18;LAMP1;ZBTB1;AP1G1;TYROBP
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.2535177021632083,0.5639823398630323,0.9273021001615509,1.0,1.0,4/19,15.53%,RAPSN;CHRNA7;CHRFAM7A;CHRNA4
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.2863439290946384,0.5634898019403102,0.923217550274223,1.0,1.0,3/10,18.97%,ATP5MC1;ATP5MG;ATP5F1D
prerank,central nervous system neuron differentiation (GO:0021953),0.22295722772421334,0.563259374318146,0.9494949494949495,1.0,1.0,8/33,19.08%,MAPT;NR4A2;FAIM2;SIN3A;RYK;MDGA1;NPY;AGTPBP1
prerank,serine family amino acid catabolic process (GO:0009071),0.2817847191362192,0.5628089098284187,0.904424778761062,1.0,1.0,1/10,6.02%,DLD
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.22536035560247095,0.5624092783569197,0.9545454545454546,1.0,1.0,6/35,15.74%,CCL5;IL10RA;CAV1;CRLF3;JAK2;LEPROT
prerank,DNA replication (GO:0006260),0.1931920007710579,0.5622739549298588,0.9943374858437146,1.0,1.0,15/105,13.61%,BRIP1;SET;UPF1;TIPIN;WRNIP1;RAD9A;CHEK1;KAT7;RHNO1;POLD1;PTMS;POLG;ORC2;RMI2;NT5M
prerank,histone H2A monoubiquitination (GO:0035518),0.25617390474831764,0.5617963687036376,0.9369951534733441,1.0,1.0,5/17,19.71%,PCGF6;PCGF5;PCGF3;KDM2B;PCGF2
prerank,protein modification by small protein removal (GO:0070646),0.18634548321742167,0.5617768772539775,0.9979423868312757,1.0,1.0,61/252,19.61%,CCNA2;ADRM1;MCRS1;USP2;ACTB;ASXL1;MBD5;PSMC6;TP53;AR;INO80C;TRAF3;OTUD6B;TNIP1;OTUD7A;USP1;HIF1A;PSME4;PSMB1;PSMD5;UBE2D1;STAM2;NFRKB;OTUD4;COPS8;RUVBL1;USP13;USP50;WDR20;PSMB2;SENP6;USP35;JOSD1;USP20;USP30;USP42;PSMB7;PSMD3;STAM;USP4;COPS4;PTEN;ABRAXAS2;BABAM1;RHOT1;PSMA2;INO80;PSMD14;TADA3;USP36;MBD6;USP28;COPS6;INO80D;RPS27A;SMAD1;ACTL6A;DESI2;DESI1;SENP2;UCHL5
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.23614116725063433,0.5616716472933295,0.9523099850968704,1.0,1.0,3/26,12.97%,LARGE1;TNIP1;ST3GAL2
prerank,regulation of phosphatase activity (GO:0010921),0.24358069385419792,0.5614949837093781,0.9271623672230652,1.0,1.0,1/24,2.51%,PPP1R26
prerank,regulation of rRNA processing (GO:2000232),-0.2075474321563049,-0.5612645954007283,0.968503937007874,0.993991227273439,1.0,7/16,35.25%,SIRT7;DIMT1;BUD23;HEATR1;RIOK2;NUDT16;TRMT112
prerank,response to nitric oxide (GO:0071731),0.26987465663883137,0.5608765821399921,0.9192982456140351,1.0,1.0,1/13,3.91%,GUCY1B1
prerank,DNA metabolic process (GO:0006259),0.18456407155875643,0.5607109352284237,0.9989743589743589,1.0,1.0,42/270,15.53%,HINFP;GMNN;BTG2;MUTYH;GTF2H4;DDX23;RAD51AP1;UPF1;SMARCB1;TERT;PARP1;TDP1;PRIM2;MBD4;RAD9A;CHEK1;REXO4;HUS1B;SLX4;LONP1;UHRF2;PSME4;RIF1;FBXO6;TOP2B;PARG;POLD1;TERF2;POLG;KPNA2;ORC2;NSMCE4A;RMI2;TRIM28;ZRANB3;DNASE1L1;CSNK1E;EXD2;KMT5B;SRPK2;RAD52;CHRNA4
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.24083434423038005,0.5605649775711306,0.9401459854014599,1.0,1.0,2/23,7.15%,SAG;CALM1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.24369254450905506,0.5586947203338737,0.9432515337423313,1.0,1.0,2/19,8.68%,MTHFD2L;ALDH1L2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.2850683498486021,0.5585757178998962,0.9190647482014388,1.0,1.0,2/10,13.77%,STK26;LRRK2
prerank,rRNA metabolic process (GO:0016072),0.1915700125165886,0.5580241499938687,0.9902386117136659,1.0,1.0,37/160,20.87%,NOL6;UTP14A;MAPT;NOB1;WDR46;RPF1;RPL8;WDR36;MDN1;HELQ;PWP2;RPL5;DEDD2;DIS3L;NOP58;TEX10;RPL15;IMP4;PELP1;RPL22;LAS1L;RPL31;DDX49;RPS6;RCL1;BOP1;PDCD11;RPS17;MPHOSPH6;EXOSC10;NIFK;RPS14;DDX10;EXOSC8;DHX37;WDR43;UTP3
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.23036080535273307,-0.5569700182531003,0.9496402877697842,0.9948158433877421,1.0,6/12,35.77%,ESR1;TGFB1;ZC3H12A;ZC3H10;NCOR1;BCDIN3D
prerank,steroid catabolic process (GO:0006706),-0.2335113800379095,-0.5569577143626123,0.9440559440559441,0.9940941753872863,1.0,2/10,23.32%,SPP1;HSD17B11
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.23588938668660953,-0.5566728500845591,0.9510022271714922,0.9934734165119551,1.0,3/11,19.41%,RBBP4;ASF1A;HIRA
prerank,cilium-dependent cell motility (GO:0060285),0.24343497228934247,0.5566596372305259,0.9347471451876019,1.0,1.0,2/22,6.48%,DNAH17;EFHC1
prerank,negative regulation of protein kinase activity (GO:0006469),0.1985304603782064,0.5564763022406731,0.9869976359338062,1.0,1.0,15/88,14.32%,SLC8A1;PPM1E;CAV1;DAB2IP;DUSP3;PTPN1;CORO1C;GSTP1;PAK2;LRP5;RB1;CEP85;CEP43;GNAQ;DVL1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.23344199649296182,-0.5562587544619243,0.9519650655021834,0.9929072917190518,1.0,3/11,20.92%,NF2;HGS;BCL3
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.23495376087590236,0.5559212301655326,0.9553158705701078,1.0,1.0,6/24,21.94%,BCL2;SNAI2;CLU;MIF;TAF9B;CCAR2
prerank,microtubule bundle formation (GO:0001578),0.21647866852257897,0.5540508803957189,0.9698216735253772,1.0,1.0,9/42,17.78%,RSPH1;TPPP;TOGARAM1;AAAS;CLASP1;FOXJ1;MTCL1;CCDC66;MAP1S
prerank,negative regulation of mRNA processing (GO:0050686),0.25567665891274555,0.5531948998240974,0.9301533219761499,1.0,1.0,3/15,11.11%,U2AF2;SRSF4;SRSF10
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.25473295169378074,0.5526999840194877,0.9328968903436988,1.0,1.0,3/16,15.03%,NAA25;NAA20;NAA35
prerank,ceramide catabolic process (GO:0046514),0.26101091534600884,0.552666514041027,0.9367720465890182,1.0,1.0,3/14,13.12%,NEU3;GLA;GM2A
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.27908147691052215,0.5508001501364036,0.9129662522202486,1.0,1.0,3/10,19.51%,NAF1;RUVBL1;ZNHIT6
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.20298121274152803,-0.5506378229060194,0.9703703703703703,0.994014094807212,1.0,7/17,32.39%,WASF2;ARFIP2;PICK1;ABI2;CTNNA2;ARFIP1;GMFB
prerank,mitochondrial transport (GO:0006839),0.20650420934459093,0.5497231865144946,0.9717223650385605,1.0,1.0,15/53,23.31%,PMAIP1;BCL2;MFN2;TOMM5;BCAP31;TOMM7;MFF;SLC25A16;OXA1L;TIMM9;TIMM22;GDAP1;TOMM22;STARD3;PITRM1
prerank,regulation of immunoglobulin production (GO:0002637),0.24010183699663296,0.5495514047193455,0.9585889570552147,1.0,1.0,1/23,3.27%,IL2
prerank,aromatic amino acid family metabolic process (GO:0009072),0.26202330944952756,0.5469432925621394,0.9194139194139194,1.0,1.0,2/10,13.88%,THAP4;QDPR
prerank,positive regulation of cellular protein localization (GO:1903829),0.20247405239116745,0.5451483879382475,0.9900744416873449,1.0,1.0,7/69,11.06%,FERMT2;SLC5A3;NUP62;MAPT;YAP1;KAT7;GPD1L
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.22571467215764726,0.5445908264499536,0.9516358463726885,1.0,1.0,3/31,10.29%,ALOX5;MOCS1;SCP2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.25025550857231316,0.5418772767444807,0.9398998330550918,1.0,1.0,4/15,15.71%,CNOT7;ZFP36L1;CPEB3;NANOS1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.25025550857231316,0.5418772767444807,0.9398998330550918,1.0,1.0,4/15,15.71%,CNOT7;ZFP36L1;CPEB3;NANOS1
prerank,mitotic cytokinesis (GO:0000281),0.21004405313983976,0.5417739494996436,0.9800266311584553,1.0,1.0,7/47,13.49%,ROCK1;EFHC1;ANLN;SNX18;ROCK2;SNX9;SON
prerank,protein targeting to peroxisome (GO:0006625),0.22402920691400602,0.5403282697982709,0.9579100145137881,1.0,1.0,11/29,21.84%,PEX2;ATAD1;PEX19;LONP2;ZFAND6;RAB8B;PEX10;PEX26;PEX1;PEX3;GDAP1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.2295645007124868,-0.5401049419496332,0.964622641509434,0.9964239794388021,1.0,4/11,20.79%,HSPA5;CEBPB;CREB3L1;ATF4
prerank,response to organophosphorus (GO:0046683),-0.2042957443840701,-0.5399263436765716,0.979746835443038,0.9957675895470922,1.0,5/16,32.29%,DGKQ;TRIM16;RFC3;TYMS;VGF
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.24551669545693905,0.5398849909936221,0.9504132231404959,1.0,1.0,1/15,4.99%,LNPK
prerank,glial cell development (GO:0021782),0.23355336703986684,0.5382357277576073,0.9653614457831325,1.0,1.0,6/25,17.41%,CDK6;TPPP;NRROS;SOX10;MT3;S100A9
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.20021201194223598,0.5376234368736998,0.9791154791154791,1.0,1.0,11/62,15.59%,BCL2;ARHGEF2;SNAI2;BCL2L2;OPA1;NDUFS3;RTKN2;CLU;LRRK2;MCL1;URI1
prerank,prostanoid metabolic process (GO:0006692),0.2525044067050029,0.5370518449258682,0.9461663947797716,1.0,1.0,2/13,11.07%,GSTP1;PTGR1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.20741440468284372,0.5365660174144234,0.976158940397351,1.0,1.0,5/44,11.98%,HSD17B10;CYP7B1;HSD17B4;SCP2;OSBPL2
prerank,negative regulation of interleukin-12 production (GO:0032695),0.25060169091788514,0.5351878701770016,0.9479166666666666,1.0,1.0,1/14,7.25%,PIBF1
prerank,cellular response to UV-A (GO:0071492),-0.22319189992140664,-0.5336309472403071,0.9652777777777778,0.9968307894459503,1.0,4/11,33.31%,MMP2;MMP1;MME;OPN3
prerank,response to axon injury (GO:0048678),-0.19045497433361497,-0.5330407852645097,0.9775561097256857,0.9962719306292948,1.0,11/18,43.83%,APOD;MAPK8IP3;DPYSL3;FLRT3;MORN4;MTR;TYROBP;P2RY12;SOD1;DHFR;TREM2
prerank,folic acid metabolic process (GO:0046655),0.23620191637241522,0.5315912193831651,0.9469578783151326,1.0,1.0,2/18,8.68%,MTHFD2L;ALDH1L2
prerank,regulation of centriole replication (GO:0046599),0.23881908812089842,0.5302747679476212,0.9518459069020867,1.0,1.0,4/17,18.54%,NUP62;PLK4;RBM14;CEP295
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.2356627053117351,0.5297492148271505,0.9539170506912442,1.0,1.0,5/20,14.50%,RELA;ADAM17;MBTPS1;HM13;SPPL2B
prerank,recombinational repair (GO:0000725),0.1903454505517494,0.5296893186946768,0.9867310012062727,1.0,1.0,15/77,17.61%,RAD51AP2;RAD51AP1;PARP1;SFPQ;HUS1B;HELQ;SLX4;SFR1;RHNO1;MORF4L1;EXD2;RAD52;INO80;PSMD14;REV3L
prerank,neutrophil migration (GO:1990266),-0.14508355664282432,-0.5293577369855361,1.0,0.9964602907754179,1.0,4/58,7.80%,PECAM1;CXADR;GBF1;BSG
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.1964431990180188,0.5292313788634148,0.9878345498783455,1.0,1.0,14/70,16.77%,CBFB;PSMC6;YTHDF2;YAP1;RUNX1;PSME4;PSMB1;EIF2AK2;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.23539632240955669,0.5289449307984516,0.9573770491803278,1.0,1.0,8/19,22.24%,FOXJ1;MTCL1;PARD3B;CLIC4;MARK2;PARD3;ERBIN;PATJ
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.2222021928800338,0.5285265519498549,0.9574468085106383,1.0,1.0,5/26,17.60%,MAPT;TOGARAM1;CLASP1;STMN2;DCTN1
prerank,mRNA modification (GO:0016556),0.23159007463808903,0.5284587421655139,0.9536321483771252,1.0,1.0,6/22,19.09%,TRMT10C;CBLL1;NSUN2;TRUB1;TRUB2;TRMT6
prerank,male meiosis I (GO:0007141),0.25114421478097637,0.527652063760779,0.9514563106796117,1.0,1.0,1/16,5.58%,FOXJ3
prerank,regulation of B cell differentiation (GO:0045577),-0.19797423645155443,-0.5273209530830902,0.9716494845360825,0.9962555031242771,1.0,10/17,47.70%,NCKAP1L;PPP2R3C;SYK;MMP14;INHA;BTK;XBP1;IL4I1;SFRP1;IKZF3
prerank,"phototransduction, visible light (GO:0007603)",0.24584903173310496,0.5259540621536161,0.954225352112676,1.0,1.0,2/14,13.85%,SAG;GNAQ
prerank,response to nutrient levels (GO:0031667),0.23523361375657328,0.5254003096905562,0.9536878216123499,1.0,1.0,3/17,18.76%,KCNB1;PRKAA2;ULK1
prerank,protein deneddylation (GO:0000338),-0.22735186872762125,-0.5247781469387749,0.9654427645788337,0.9961375005076802,1.0,4/10,29.95%,COPS2;COPS7B;TOR1A;GPS1
prerank,ribosome biogenesis (GO:0042254),0.17759690232220476,0.5243005001105832,0.9989373007438895,1.0,1.0,43/187,20.87%,NOL6;MRPL36;UTP14A;NOB1;WDR46;ABCE1;RPF1;RPL8;WDR36;MDN1;NAF1;HELQ;PWP2;RPL5;NOP58;LSG1;TEX10;RPL15;IMP4;PELP1;RPL22;LAS1L;GTF3A;RPL31;XPO1;DDX49;RPS6;RCL1;BOP1;DHX29;PDCD11;RPS17;MPHOSPH6;MRPL22;EXOSC10;MALSU1;RPS14;DDX10;EXOSC8;DHX37;EIF2A;WDR43;UTP3
prerank,regulation of phosphate metabolic process (GO:0019220),-0.19580274741554415,-0.5229089441564153,0.9729064039408867,0.9958476635867086,1.0,7/16,40.01%,IGBP1;SMG6;SRPX2;CD24;PSEN1;TIGAR;IKBKB
prerank,nuclear envelope organization (GO:0006998),-0.1838711848666416,-0.522478418265048,0.9912023460410557,0.9952144841639127,1.0,8/20,31.40%,TOR1AIP1;EMD;LEMD2;TMEM43;TOR1A;REEP3;NUP155;NEMP1
prerank,pseudouridine synthesis (GO:0001522),-0.2062892725501057,-0.5183961094306243,0.9785714285714285,0.9954257722785409,1.0,6/13,37.84%,PUS7;PUS3;GAR1;NOP10;PUS1;NHP2
prerank,water-soluble vitamin metabolic process (GO:0006767),0.1870921891624916,0.5175317905807351,0.9889570552147239,1.0,1.0,10/68,14.57%,MCCC2;MTHFD2L;SLC23A2;SLC23A1;ALDH1L2;ABCD4;AASDHPPT;MMAB;CYB5R3;NNMT
prerank,regulation of TOR signaling (GO:0032006),0.190728527412887,0.5173240046584906,0.992638036809816,1.0,1.0,12/67,15.63%,FAM83D;LARS1;GNA12;SEC13;NPRL2;RRAGB;EPM2A;SH3BP4;RICTOR;GAS6;PRKAA2;ITFG2
prerank,peptidyl-lysine acetylation (GO:0018394),0.259269903587039,0.5171149467741418,0.945518453427065,1.0,1.0,3/10,23.08%,KAT7;ESCO1;KAT2B
prerank,protein localization to phagophore assembly site (GO:0034497),0.2578474134492322,0.5152904639708691,0.9584086799276673,1.0,1.0,3/11,15.82%,MFN2;WDR45;ATG13
prerank,homologous chromosome segregation (GO:0045143),-0.17696885698153925,-0.5145950352411071,0.9835164835164835,0.9955090878704393,1.0,6/20,32.37%,CENPC;SIRT7;PRDM9;FMN2;MEI4;FANCD2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.19634830494281247,0.5143374183566504,0.9881578947368421,1.0,1.0,14/53,20.43%,PSMC6;DAB2IP;FBXW7;F8A1;GNA12;PSME3IP1;BAG2;UFL1;PRKACA;PSMD14;XPO1;DESI1;UCHL5;FOXF2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.18948622301091417,0.5138856349011849,0.9903614457831326,1.0,1.0,14/73,16.77%,CBFB;PSMC6;YTHDF2;YAP1;RUNX1;PSME4;PSMB1;EIF2AK2;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.22302499246636026,0.5136123185300177,0.9615384615384616,1.0,1.0,5/22,16.44%,PSME4;PSMB1;PSMB2;PSMB7;PSMA2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.24815906587116493,0.513255445140921,0.9547826086956521,1.0,1.0,3/13,16.13%,GSTP1;JAK2;NAMPT
prerank,protein K63-linked deubiquitination (GO:0070536),0.21105416410052072,0.5125504290802677,0.9774011299435028,1.0,1.0,8/31,16.77%,OTUD7A;OTUD4;USP13;USP50;USP20;ABRAXAS2;BABAM1;PSMD14
prerank,homocysteine metabolic process (GO:0050667),0.251133399882411,0.5110665302561941,0.959409594095941,1.0,1.0,1/11,5.95%,BLMH
prerank,regulation of cytokine production (GO:0001817),0.17857909818963627,0.5103685579429692,0.994413407821229,1.0,1.0,9/126,7.69%,ANXA1;CD276;HDAC9;ALOX5;ASB1;MAPKAPK2;SNAI2;TRAF3;ATP2B1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.21699585937340188,0.5083504675812328,0.9733542319749217,1.0,1.0,2/24,4.89%,FXN;SUCLA2
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.25267729764595215,0.5082721331952086,0.9473684210526315,1.0,1.0,2/10,11.51%,RIF1;TERF2
prerank,neuron projection organization (GO:0106027),0.23677411454273173,0.5080339206868436,0.952054794520548,1.0,1.0,5/15,17.77%,CHRNA7;ATP1A3;PLS1;DCTN1;MAP1A
prerank,cellular response to inorganic substance (GO:0071241),-0.17694777330221073,-0.5059510212146855,0.9973190348525469,0.9964717944959989,1.0,8/21,31.87%,FOXO1;KCNC2;BLM;FMR1;CDK2;ATRX;TIMELESS;MTR
prerank,negative regulation of hydrolase activity (GO:0051346),0.1963612035474152,0.5059040369084175,0.9895424836601308,1.0,1.0,8/49,15.71%,PPP1R26;DAB2IP;SLC39A14;SH3BP4;TERF2;LRRK2;URI1;NOS1
prerank,positive regulation of immune response (GO:0050778),0.186856773201822,0.5058413966094355,0.9911616161616161,1.0,1.0,4/64,7.78%,IL2;CCL5;IL12RB1;TGFB2
prerank,antibacterial humoral response (GO:0019731),0.23058528330022765,0.5050376966580397,0.9688524590163935,1.0,1.0,1/16,5.18%,DMBT1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.17750828647540595,0.5040617190626491,0.9941724941724942,1.0,1.0,22/95,21.16%,RAD51AP2;RAD51AP1;PARP1;SFPQ;HUS1B;HELQ;SLX4;FANCB;SFR1;MCMDC2;MORF4L1;EXD2;RAD52;INO80;PSMD14;RAD21;REV3L;RAD54B;SWI5;YY1;MCM4;RAD51D
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.226641312970264,0.5019735286938825,0.9620853080568721,1.0,1.0,3/18,13.69%,FZD9;BOK;MUL1
prerank,tRNA metabolic process (GO:0006399),0.22873413718073202,0.5015120400588096,0.9618573797678275,1.0,1.0,4/17,16.00%,DTD1;KARS1;SARS1;FARS2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.22661565452118557,0.5014544478722021,0.9693053311793215,1.0,1.0,2/19,7.20%,ELL;AR
prerank,positive regulation of cell communication (GO:0010647),-0.15958773101818244,-0.49890982254052585,0.9941520467836257,0.9970337776576641,1.0,7/28,28.15%,SYT1;WLS;RIMS2;CD80;NMU;SOX11;EDN3
prerank,mitotic DNA replication (GO:1902969),-0.20987351251483952,-0.49829269595456627,0.9760348583877996,0.9964163656983543,1.0,6/10,41.59%,GINS3;LIG1;CDC45;GINS1;MCM3;POLA1
prerank,central nervous system neuron development (GO:0021954),0.233430926754584,0.4979150416642875,0.9674267100977199,1.0,1.0,4/15,18.36%,MAPT;ARHGAP35;PTEN;NPY
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.21551037919824928,-0.4977691208321874,0.9816933638443935,0.995791411621788,1.0,2/10,15.31%,OS9;INSIG1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.21009017556044213,0.4952685702105859,0.9848714069591528,1.0,1.0,3/23,7.85%,VEGFA;GDNF;SOX9
prerank,axoneme assembly (GO:0035082),0.20441780872497328,0.49517411035651254,0.9840116279069767,1.0,1.0,4/30,16.18%,RSPH1;TOGARAM1;FOXJ1;DNAI4
prerank,sensory perception of pain (GO:0019233),-0.17054418798333928,-0.4951078311815565,0.9973190348525469,0.9955355032259742,1.0,12/21,48.33%,RETREG1;SCN9A;MME;TRPA1;PTGES;CCR2;CCL2;KCNK4;OPRL1;CHRNB2;ALOXE3;PROK2
prerank,regulation of lipid catabolic process (GO:0050994),0.21987501204051962,0.4945952185194076,0.9815950920245399,1.0,1.0,2/19,11.01%,RARRES2;LONP2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.19540156232200928,0.4939574364338282,0.993421052631579,1.0,1.0,12/45,21.68%,GCNT2;ATXN2;CYFIP1;RBM3;DDX25;EIF4E;NANOS1;METAP1;EIF2A;YTHDC1;LARP1;RPL10
prerank,positive regulation of response to stimulus (GO:0048584),0.19406628588886685,0.49304862270958816,0.9838926174496644,1.0,1.0,5/40,12.95%,CGAS;TGFB2;PRKCD;HOMER1;NSMCE4A
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.2038611080800993,0.4928495450863891,0.9898843930635838,1.0,1.0,5/33,16.94%,TESC;RUNX1;ZFP36L1;PRKCA;ACIN1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.23615819209039554,0.49156104246062277,0.9658886894075404,1.0,1.0,12/12,76.40%,MCMDC2;MCM4;MCM7;MCM2;MCM6;GINS2;MCM5;MCM3;CDC45;GINS4;MUS81;CDC7
prerank,regulation of transferase activity (GO:0051338),0.22509522123129938,0.49119991922532086,0.9555921052631579,1.0,1.0,5/17,21.30%,FEM1A;FEM1B;PPP1R3F;HMBOX1;EMP2
prerank,modulation by host of viral genome replication (GO:0044827),0.23976327385454027,0.4908276519583273,0.9711864406779661,1.0,1.0,3/13,17.75%,TBC1D20;YTHDC2;EIF2AK4
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.20902267259072493,0.4903939090055936,0.9740458015267176,1.0,1.0,3/22,13.91%,DUSP3;CD300A;DGKZ
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.22003997725150337,0.48991579664232354,0.9793650793650793,1.0,1.0,3/17,12.92%,CALM1;SIRT2;DMTN
prerank,negative regulation of phosphatase activity (GO:0010923),0.20932167166294735,0.488720048684031,0.9825673534072901,1.0,1.0,2/25,7.78%,PPP1R26;TGFB2
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.20568205111742263,0.48669848552071937,0.9788838612368024,1.0,1.0,7/22,19.58%,NEDD4;TSG101;VPS36;STAM;VPS4A;TOM1L1;VPS37A
prerank,renal absorption (GO:0070293),0.24462042363804457,0.4857342390966277,0.9532374100719424,1.0,1.0,3/10,18.08%,HAS2;SGK1;SLC15A2
prerank,histone exchange (GO:0043486),0.19737461888335672,0.48477956018907475,0.9900990099009901,1.0,1.0,9/37,18.67%,CENPP;CENPO;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1;VPS72
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.22579822246694634,0.48371796755891316,0.9616055846422339,1.0,1.0,2/14,12.09%,RELA;NECTIN2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.2303035985746787,0.4834890542606267,0.9702797202797203,1.0,1.0,4/13,20.84%,AXL;GAS6;DHX9;TRIM44
prerank,hydrogen peroxide catabolic process (GO:0042744),0.234457197380011,0.4833157082397534,0.9535283993115319,1.0,1.0,1/11,5.81%,PXDN
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.21141613464870454,0.4833142578993237,0.9782608695652174,1.0,1.0,3/21,12.97%,MFHAS1;ENSA;ARPP19
prerank,histone H2A acetylation (GO:0043968),0.22676615379085074,0.48109201449988126,0.9794520547945206,1.0,1.0,3/16,12.50%,MSL3;RUVBL1;MORF4L1
prerank,cilium movement (GO:0003341),-0.13482653121269292,-0.4808213883913878,1.0,0.9970469777542086,1.0,32/47,51.67%,ODAD1;DNAAF5;CCDC39;DNHD1;SPEF2;GAS8;CFAP61;DNAH5;CFAP70;CFAP53;CFAP251;ROPN1L;ODAD2;CAMSAP3;ADCY10;SPAG17;ODAD3;SPA17;DNAAF2;ODAD4;TEKT2;DNAH9;CFAP100;CFAP206;RSPH9;CCDC40;CCDC63;CFAP91;TEKT5;DNAAF4;TTC29;DNAH1
prerank,glial cell differentiation (GO:0010001),0.20139708667751033,0.4803112130352259,0.9798561151079137,1.0,1.0,7/28,18.93%,TPPP;SOX9;CDH2;FGF10;STAT3;SOX10;METRN
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.23242835999783656,0.4770827656573914,0.9719626168224299,1.0,1.0,1/11,5.96%,ATP1B1
prerank,response to hexose (GO:0009746),0.20389382196714592,0.47648523380548047,0.9823269513991163,1.0,1.0,1/25,3.09%,LPL
prerank,regulation of B cell activation (GO:0050864),0.2007628708035859,0.4754702188027028,0.9747235387045814,1.0,1.0,3/25,13.72%,SAMSN1;ZFP36L1;FOXJ1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.23739878224844657,0.47517252459122733,0.9717314487632509,1.0,1.0,11/11,76.28%,TIMM29;TIMM9;TIMM22;ROMO1;TIMM13;AGK;TIMM10;NDUFA13;TIMM10B;TIMM8B;TOMM70
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.18008918306315272,0.4744178002873599,0.9924528301886792,1.0,1.0,10/55,16.77%,FHL1;PSMC6;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,modulation by host of symbiont process (GO:0051851),0.1960037459050987,0.47400212947750553,0.981638418079096,1.0,1.0,6/31,17.11%,CCL5;SMARCB1;CCNT1;TAF11;SP1;HDAC1
prerank,pinocytosis (GO:0006907),0.23296119677350996,0.4705397888503,0.9744058500914077,1.0,1.0,2/10,14.21%,MAPKAPK2;RAB34
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.20311130362801588,-0.46959983924478815,0.9929411764705882,0.9977402867843104,1.0,7/10,59.04%,NCKAP1L;TLR4;VSIR;IL12A;FOXP3;PRNP;IL12B
prerank,regulation of oxidative phosphorylation (GO:0002082),0.21484862392090986,0.4646664716524465,0.9686468646864687,1.0,1.0,4/16,20.40%,COX7A2L;MLXIPL;UQCC2;SLC25A33
prerank,melanosome transport (GO:0032402),0.20814401593283277,0.46348161895587886,0.985781990521327,1.0,1.0,5/18,21.43%,MREG;MLPH;BLOC1S5;BBS5;MYO5A
prerank,pigment granule transport (GO:0051904),0.20814401593283277,0.46348161895587886,0.985781990521327,1.0,1.0,5/18,21.43%,MREG;MLPH;BLOC1S5;BBS5;MYO5A
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.19779138470319896,-0.46264312513575007,0.9932432432432432,0.9978088544640142,1.0,6/10,39.25%,RCC2;CDC42;RACGAP1;ECT2;SPAG5;APC
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.191326962716804,0.4596010380017875,0.9882869692532943,1.0,1.0,4/29,19.07%,ZCWPW1;SYCP2;RAD21;TERB1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.18292351543988244,-0.45730266687825677,0.9930232558139535,0.9976379163428802,1.0,6/13,33.25%,UPP2;SMUG1;DUT;OGG1;TDG;NEIL1
prerank,response to hydroxyurea (GO:0072710),0.22046816054396523,0.45662762161854986,0.9732620320855615,1.0,1.0,2/11,12.82%,KAT7;DDI2
prerank,mesoderm development (GO:0007498),0.20257264413088316,0.45182022396637217,0.9822580645161291,1.0,1.0,4/18,17.54%,VEGFA;IKZF1;JAK2;GDF11
prerank,mitochondrial transcription (GO:0006390),0.22056699786884193,0.45140197673178856,0.9818840579710145,1.0,1.0,4/10,23.10%,TFB2M;TEFM;SLC25A33;TFAM
prerank,negative regulation of cholesterol transport (GO:0032375),0.22414009540547308,0.4486947771649568,0.969639468690702,1.0,1.0,10/10,77.60%,SREBF2;APOC3;ABCG8;PLA2G10;APOA2;ABCG5;SHH;APOC1;NFKB1;ABCA2
prerank,regulation of response to interferon-gamma (GO:0060330),0.21385366143548018,0.4453072962521186,0.9797297297297297,1.0,1.0,4/14,19.46%,STAT1;JAK2;PIAS1;SUMO1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.20830386952308624,0.44143618530502565,0.9862542955326461,1.0,1.0,4/13,21.48%,EDEM2;SLC51B;BCAP31;SEC16A
prerank,cell differentiation in hindbrain (GO:0021533),-0.18393762972549335,-0.44060765519252776,0.9978947368421053,0.9983066476822055,1.0,7/11,46.66%,OPHN1;GRID2;ATP7A;LHX1;CBLN1;CEND1;NOG
prerank,negative regulation of centrosome duplication (GO:0010826),0.21241719383004637,0.4405469703892544,0.9797047970479705,1.0,1.0,5/11,25.27%,CCNF;RBM14;CENATAC;KAT2B;TRIM37
prerank,DNA-dependent DNA replication (GO:0006261),0.15030183163659352,0.4402563870156657,1.0,1.0,1.0,20/128,17.61%,GMNN;DDX23;PSMC6;WRNIP1;PRIM2;PSME4;PSMB1;PSMD5;MCMDC2;POLD1;POLG;ORC2;PSMB2;PSMB7;PSMD3;SRPK2;PSMA2;PSMD14;MGME1;REV3L
prerank,phagolysosome assembly (GO:0001845),0.2104621733242786,0.4394735917567353,0.9777397260273972,1.0,1.0,6/12,25.12%,RAB34;RAB14;PIKFYVE;ARL8B;RAB7A;RAB7B
prerank,cellular response to interleukin-7 (GO:0098761),0.19805577693198675,0.43704045808391473,0.9886547811993517,1.0,1.0,3/17,15.58%,IRS1;IRS2;STAT3
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.19805577693198675,0.43704045808391473,0.9886547811993517,1.0,1.0,3/17,15.58%,IRS1;IRS2;STAT3
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.20802727637386315,0.4360927596431834,0.9838709677419355,1.0,1.0,1/12,7.25%,PIBF1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.2030013813889239,0.4359905680949095,0.9868852459016394,1.0,1.0,16/16,79.72%,TNFRSF21;MMP8;IL23R;IL12B;FOXP3;IL23A;PDCD1LG2;VSIR;LILRB1;AGER;FCGR2B;DLL1;JAK3;TRIB2;TYROBP;CD274
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.17926232033733133,0.4341966144940147,0.9941434846266471,1.0,1.0,4/29,15.26%,IL12RB1;RASGRP1;NECTIN2;STX7
prerank,outer dynein arm assembly (GO:0036158),0.20444351215370443,0.43347739123219686,0.9861351819757366,0.9997934351082363,1.0,1/14,5.23%,DNAH17
prerank,determination of left/right symmetry (GO:0007368),0.1720440147346786,0.4305691813817361,0.9971387696709585,0.9997998951070434,1.0,7/36,17.49%,KIF3B;DNAH11;CITED2;FOXJ1;RFX3;DAND5;GALNT11
prerank,regulation of cilium movement (GO:0003352),0.21314794970965575,0.4290112921795488,0.9809358752166378,0.9995926754702414,1.0,2/10,15.97%,DNAH11;CFAP43
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.19836995007245933,0.4246211229343051,0.9931623931623932,0.9997881091711776,1.0,2/16,15.26%,IL12RB1;STX7
prerank,B cell activation involved in immune response (GO:0002312),0.2008914558352689,0.4226968361059412,0.9892280071813285,0.9996171100347945,1.0,13/13,79.93%,CD180;MSH2;RNF168;CD40LG;GPR183;GAPT;CD19;RNF8;FCGR2B;LIG4;BATF;EXOSC3;MSH6
prerank,cell junction maintenance (GO:0034331),-0.16581714439238643,-0.41864940135109435,0.9976359338061466,0.9989593228131495,1.0,7/14,43.71%,NLGN2;CLDN1;CHCHD10;CSF1R;F2R;CBLN1;PRTN3
prerank,neutrophil chemotaxis (GO:0030593),0.15573106708192502,0.41329767688061875,1.0,1.0,1.0,10/53,22.63%,CCL5;TGFB2;CCL14;S100A8;S100A9;CCL25;CCL19;PIKFYVE;PPIB;CCL13
prerank,axonemal dynein complex assembly (GO:0070286),0.17075170646500282,0.40722832581601404,0.9985380116959064,1.0,1.0,2/27,8.63%,DNAH17;CFAP73
prerank,phagosome-lysosome fusion (GO:0090385),-0.17526511922444982,-0.4011813389307801,0.997716894977169,0.9989245590314828,1.0,3/10,29.71%,CLN3;SYT7;RAB39A
prerank,lipid droplet organization (GO:0034389),0.17447628554034866,0.3991494023527944,0.995398773006135,1.0,1.0,3/22,15.20%,AUP1;PNPLA3;PLA2G4C
prerank,nucleocytoplasmic transport (GO:0006913),0.15547418321082188,0.39835386393769456,1.0,1.0,1.0,9/40,21.15%,ATXN1;AAAS;LSG1;NUP98;XPO1;SNRPD3;GEMIN6;SNUPN;ANP32A
prerank,nuclear transport (GO:0051169),0.17418308874710245,0.3799347116946087,0.9933665008291874,1.0,1.0,5/16,23.23%,AAAS;NUP98;XPO1;ANP32A;RBM15B
prerank,receptor recycling (GO:0001881),0.18949284458950547,0.37843299542181463,0.9963963963963964,1.0,1.0,10/10,81.06%,PLEKHJ1;ARFGEF2;NSG1;RAB11B;LMTK2;SORL1;PHETA2;REP15;PHETA1;EHD3
prerank,tetrapyrrole metabolic process (GO:0033013),0.15837729213765372,0.35538309928928186,0.9983660130718954,1.0,1.0,18/18,84.18%,ABCD4;MMAB;ABCC1;MMAA;MMACHC;CBLIF;CTRC;TCN1;AMN;MTRR;TCN2;ABCB6;MMADHC;CD320;MTR;MMUT;CUBN;LMBRD1
prerank,dendritic cell differentiation (GO:0097028),0.15572435565727363,0.35527125630549855,0.9969558599695586,1.0,1.0,4/22,18.76%,AXL;TRPM2;GAS6;CCL19
prerank,tRNA wobble uridine modification (GO:0002098),0.16796654425466,0.3526464563105389,0.9982817869415808,1.0,1.0,2/14,15.91%,DPH3;ELP3
prerank,cobalamin metabolic process (GO:0009235),0.15836734693877536,0.35054052884351317,0.9983579638752053,1.0,1.0,17/17,84.18%,ABCD4;MMAB;ABCC1;MMAA;MMACHC;CBLIF;CTRC;TCN1;AMN;MTRR;TCN2;MMADHC;CD320;MTR;MMUT;CUBN;LMBRD1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.1600504362786465,0.34790872158575215,0.9983193277310924,1.0,1.0,15/16,65.16%,MCMDC2;MCM4;MCM7;MCM2;PURA;SSBP1;RECQL;MCM6;RECQL5;RECQL4;HMGA1;WRN;TWNK;RPA1;RAD51
prerank,tRNA wobble base modification (GO:0002097),0.1624313924655919,0.34452024648630775,1.0,1.0,1.0,2/14,15.91%,DPH3;ELP3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.15962588663611815,0.32226323920802324,0.9982300884955753,1.0,1.0,11/11,84.05%,JAK2;TMEM106A;IFNG;SIRT1;IL10;IL4;PF4;XBP1;CIITA;TAF7;HDAC2
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.12922556889583267,0.3142344083373312,1.0,0.9998041278021309,1.0,7/32,22.90%,FAM3A;RNASE3;S100A9;RPL30;ROMO1;CCL13;GAPDH
